data_6pqe_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6pqe _Structure_validation_residue.Date_analyzed 2019-09-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.442 HG21 HG22 ' A' ' 219' ' ' VAL . 11.6 m . . . . . 0 CA--C 1.557 1.226 0 CA-C-O 121.484 0.659 . . . . 74.31 110.976 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -111.95 151.6 29.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.621 0.768 . . . . 75.32 110.657 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.34 -113.37 0.07 OUTLIER Glycine 0 C--N 1.349 1.251 0 O-C-N 123.659 0.599 . . . . 72.33 111.71 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -112.5 177.69 4.55 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.406 0.683 . . . . 74.31 110.047 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.432 ' CZ3' HG23 ' A' ' 253' ' ' VAL . 13.6 m95 . . . . . 0 CA--C 1.54 0.57 0 CA-C-N 115.176 -0.92 . . . . 75.3 109.732 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 C--O 1.238 0.485 0 CA-C-O 121.616 0.722 . . . . 55.43 112.882 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.1 mt -130.88 147.3 52.51 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.653 -1.158 . . . . 73.51 110.157 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -114.71 122.81 47.58 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.587 -0.894 . . . . 71.44 108.587 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.506 ' HB1' ' HB3' ' A' ' 251' ' ' LEU . . . -133.14 -173.24 3.15 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.558 0.536 . . . . 73.22 110.532 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.5 m -123.81 135.88 54.06 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.797 0.839 . . . . 73.3 110.146 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.3 tp -96.01 109.18 21.61 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.746 -1.205 . . . . 74.55 107.746 170.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -85.43 99.69 11.37 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.664 -0.865 . . . . 71.34 108.664 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.625 ' HA ' HG12 ' A' ' 210' ' ' VAL . 18.9 t -111.61 112.31 54.0 Favored Pre-proline 0 C--N 1.344 0.342 0 N-CA-C 107.988 -1.115 . . . . 74.52 107.988 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.3 151.59 80.53 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.538 1.492 . . . . 74.33 110.693 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.82 -42.2 88.47 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 123.755 0.822 . . . . 74.33 113.203 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 11.1 Cg_endo -55.24 -56.67 2.14 Favored 'Trans proline' 0 C--N 1.392 2.828 0 C-N-CA 122.004 1.803 . . . . 71.25 113.824 172.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.412 HG21 HG13 ' A' ' 210' ' ' VAL . 59.4 mt -62.57 -31.28 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 122.942 0.497 . . . . 75.11 111.001 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.33 80.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.076 -0.511 . . . . 63.3 111.045 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.9 t -67.27 -50.41 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.987 0.915 . . . . 71.02 111.801 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.6 p -79.28 -25.89 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 120.813 0.34 . . . . 75.1 110.723 -172.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.95 73.0 1.07 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.92 -0.582 . . . . 75.24 111.778 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.13 -130.22 6.8 Favored Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.59 -0.604 . . . . 65.25 111.59 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -131.9 156.09 46.74 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.519 0.728 . . . . 74.15 110.104 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.625 HG12 ' HA ' ' A' ' 199' ' ' VAL . 26.8 m -144.79 158.05 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.064 0.853 . . . . 75.24 110.145 173.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -81.41 146.65 30.18 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.523 -0.762 . . . . 71.52 111.017 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 219' ' ' VAL . . . -121.84 125.68 47.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.727 1.211 . . . . 75.12 108.347 170.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.5 tpt -64.32 131.44 47.3 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.946 0.498 . . . . 75.01 110.851 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.32 -170.78 2.67 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.789 1.236 . . . . 73.52 108.888 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 216' ' ' GLU . 7.1 mt -63.54 -68.65 0.33 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 122.39 1.091 . . . . 73.22 111.869 -172.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 33.9 mt-10 -97.42 -39.83 8.99 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 112.707 -2.042 . . . . 75.13 109.266 -163.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -147.0 -165.39 11.69 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 113.981 -1.463 . . . . 72.14 111.565 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -96.89 151.46 1.07 Allowed 'Trans proline' 0 CA--C 1.551 1.35 0 C-N-CA 122.728 2.285 . . . . 72.13 114.907 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.555 ' HB ' ' HB1' ' A' ' 212' ' ' ALA . 54.0 t -97.86 162.88 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 114.195 -1.366 . . . . 75.43 107.535 165.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -144.65 119.23 9.74 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.18 -1.044 . . . . 65.31 108.18 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.408 HG11 HD11 ' A' ' 233' ' ' LEU . 12.7 p -112.07 142.66 23.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.56 0.744 . . . . 75.14 110.207 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.28 112.53 10.54 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.824 -0.806 . . . . 70.44 108.824 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.3 133.02 81.26 Favored Pre-proline 0 CA--C 1.553 1.075 0 N-CA-C 109.211 -0.663 . . . . 74.44 109.211 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.57 157.58 61.23 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.252 2.635 . . . . 65.34 111.237 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.57 135.11 40.86 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 121.98 1.786 . . . . 74.42 112.08 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.7 mtp-105 53.19 65.46 1.51 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.913 1.685 . . . . 71.14 113.34 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.504 HG22 ' HD2' ' A' ' 231' ' ' ARG . 77.7 m -87.95 139.01 30.95 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.87 -1.059 . . . . 73.42 111.711 176.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.621 ' HB2' HH12 ' A' ' 231' ' ' ARG . 25.9 mp0 -104.33 159.02 16.06 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.003 0.921 . . . . 74.21 110.086 172.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -86.19 152.32 22.92 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.111 -0.95 . . . . 74.3 111.46 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.11 -15.21 30.86 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 115.934 -0.575 . . . . 71.43 111.744 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.621 HH12 ' HB2' ' A' ' 228' ' ' GLN . 69.5 mtt85 -69.72 179.26 2.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.959 0.904 . . . . 72.21 109.769 166.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HA ' HG21 ' A' ' 253' ' ' VAL . 11.1 ptmt -166.0 155.66 12.1 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.917 -0.401 . . . . 74.45 109.917 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.555 HD13 HD13 ' A' ' 251' ' ' LEU . 79.8 mt -84.37 147.08 27.35 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.617 -0.512 . . . . 74.44 109.617 170.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -114.21 107.36 15.51 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.66 1.225 . . . . 72.23 107.958 167.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 63.3 mt -116.53 118.32 32.31 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.931 0.492 . . . . 74.01 110.863 -173.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -92.86 126.0 37.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.127 -0.488 . . . . 75.54 110.184 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.23 12.91 72.37 Favored Glycine 0 N--CA 1.471 1.022 0 O-C-N 124.264 0.978 . . . . 54.33 113.021 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -114.11 -3.32 13.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.689 0.796 . . . . 75.5 111.446 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.88 -177.34 51.47 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 110.556 -1.018 . . . . 53.04 110.556 166.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -57.5 141.52 78.43 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.753 0.649 . . . . 74.43 112.753 -171.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.45 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 7.8 Cg_exo -69.47 133.72 26.81 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.622 2.214 . . . . 70.04 110.512 171.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -135.31 174.63 21.13 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.888 -1.051 . . . . 63.14 112.621 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.62 -9.98 23.16 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.903 2.402 . . . . 74.21 112.71 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -105.29 11.07 33.32 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.094 0.958 . . . . 72.51 111.407 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 121.83 -113.02 2.16 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.187 -0.765 . . . . 72.32 111.187 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 65.0 mtt180 -143.87 164.06 31.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.276 1.03 . . . . 74.32 110.567 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -98.29 -163.87 30.79 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 114.748 -1.115 . . . . 63.43 113.29 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -115.6 160.21 20.3 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.183 0.993 . . . . 74.31 110.679 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.59 ' HG ' HD23 ' A' ' 251' ' ' LEU . 27.7 tp -131.47 109.66 10.45 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.469 0.708 . . . . 74.32 109.641 -171.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.442 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 20.2 m-85 -102.8 116.3 32.3 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.482 -0.932 . . . . 75.45 108.482 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.59 HD23 ' HG ' ' A' ' 249' ' ' LEU . 3.0 pp -127.76 114.47 17.33 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.384 0.611 . . . . 73.11 112.42 -173.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -68.74 119.73 13.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.923 1.289 . . . . 72.44 112.984 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.583 HG21 ' HA ' ' A' ' 232' ' ' LYS . 64.1 t -70.82 126.12 30.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-N 114.342 -1.299 . . . . 72.13 110.897 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -116.24 133.14 56.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.988 1.315 . . . . 72.31 108.34 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 43.0 mm -104.94 100.53 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 107.874 -1.158 . . . . 73.32 107.874 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.557 1.227 0 CA-C-O 117.773 -1.108 . . . . 74.54 109.506 -171.857 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 10.3 m . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.079 0.466 . . . . 74.44 111.114 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.52 151.13 38.0 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.911 -0.586 . . . . 75.34 111.703 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -77.05 -66.3 1.83 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.425 -0.807 . . . . 61.51 111.944 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -162.7 167.91 22.36 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 123.924 0.889 . . . . 64.44 111.096 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.551 ' CZ3' HG23 ' A' ' 253' ' ' VAL . 26.8 m95 . . . . . 0 CA--C 1.543 0.688 0 CA-C-N 114.516 -1.22 . . . . 75.33 108.613 167.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 C--O 1.239 0.542 0 N-CA-C 109.499 -0.556 . . . . 72.02 109.499 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.19 159.59 29.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.38 0.61 . . . . 75.43 111.046 -172.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 11.9 t80 -125.59 110.47 13.88 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.654 -1.157 . . . . 74.32 107.884 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.602 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . . . -118.96 -171.87 2.18 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.034 0.934 . . . . 54.32 110.056 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 69.2 m -127.26 118.52 24.39 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.438 0.695 . . . . 64.43 110.95 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.505 HD22 HG22 ' A' ' 253' ' ' VAL . 13.8 tp -78.71 111.37 14.74 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.732 -0.84 . . . . 75.14 108.732 169.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.75 109.6 18.75 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.949 -1.13 . . . . 74.05 107.949 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.6 ' HA ' HG12 ' A' ' 210' ' ' VAL . 21.5 t -118.36 114.19 36.57 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.602 -1.259 . . . . 74.32 107.602 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.96 146.05 76.18 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 121.214 1.276 . . . . 74.12 109.971 171.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.46 -44.54 82.99 Favored Pre-proline 0 CA--C 1.563 1.451 0 CA-C-O 117.869 -1.063 . . . . 71.21 112.817 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 16.5 Cg_endo -54.89 -48.93 18.55 Favored 'Trans proline' 0 C--N 1.399 3.2 0 C-N-CA 122.19 1.927 . . . . 75.22 112.754 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.471 HG21 HG13 ' A' ' 210' ' ' VAL . 50.8 mt -65.99 -35.3 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.006 0.523 . . . . 73.04 110.649 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.73 99.5 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.06 0.544 . . . . 74.22 111.14 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 201' ' ' ALA . 90.0 t -72.93 -50.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.156 0.982 . . . . 71.43 112.078 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 12.4 p -77.72 -27.93 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.703 0.401 . . . . 72.43 110.52 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.83 70.18 1.36 Allowed Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.336 -0.706 . . . . 51.31 111.336 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.69 -130.02 6.86 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.902 -0.479 . . . . 64.51 111.902 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -143.49 137.19 28.34 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.231 0.613 . . . . 73.51 109.921 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 199' ' ' VAL . 35.4 m -132.55 151.02 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.409 0.684 . . . . 64.51 110.235 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -75.23 140.04 42.97 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.941 0.497 . . . . 74.42 110.856 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -112.12 113.71 26.13 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.982 -1.488 . . . . 74.43 106.982 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 11.0 tpt -65.54 131.0 45.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.037 0.535 . . . . 72.34 111.489 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.479 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -133.71 -171.69 2.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.545 1.138 . . . . 74.34 110.644 -172.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mt -83.5 -64.22 1.21 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.777 1.275 . . . . 75.34 109.679 -168.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.8 -32.07 12.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 112.067 -2.333 . . . . 72.21 110.93 -166.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -164.44 144.29 9.27 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-O 118.672 -1.071 . . . . 51.42 111.442 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.33 143.88 71.99 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.686 2.257 . . . . 72.13 113.278 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 66.0 t -96.54 163.23 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.177 -1.374 . . . . 74.24 108.159 174.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.412 ' H ' ' HB ' ' A' ' 172' ' ' THR . 9.5 tt0 -147.08 134.06 20.28 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.767 -1.197 . . . . 74.24 107.767 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.451 HG22 HD21 ' A' ' 233' ' ' LEU . 12.0 p -126.49 135.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 C-N-CA 123.48 0.712 . . . . 73.43 110.951 -173.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.75 104.4 2.42 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.85 -1.068 . . . . 63.44 108.95 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.4 t -71.75 132.79 84.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 108.551 -0.907 . . . . 73.3 108.551 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.5 157.39 60.82 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.541 2.161 . . . . 74.44 111.839 171.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -64.71 137.48 54.29 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.103 1.868 . . . . 74.54 111.96 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 50.5 65.19 1.53 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.327 1.451 . . . . 72.34 113.192 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.417 HG21 ' HD2' ' A' ' 231' ' ' ARG . 68.1 m -82.87 144.55 30.0 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.947 -1.024 . . . . 74.24 111.071 174.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -105.79 155.92 18.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.749 0.82 . . . . 74.11 110.398 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -76.61 153.59 35.14 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.618 -1.174 . . . . 75.01 110.369 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.3 -10.93 59.97 Favored Glycine 0 N--CA 1.472 1.099 0 N-CA-C 112.351 -0.3 . . . . 64.55 112.351 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.417 ' HD2' HG21 ' A' ' 227' ' ' THR . 65.8 mtt85 -72.1 -177.23 2.0 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.126 0.97 . . . . 74.33 109.586 165.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.531 ' HA ' HG21 ' A' ' 253' ' ' VAL . 7.5 ptmt -167.25 161.83 14.63 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 111.275 0.102 . . . . 75.01 111.275 172.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.591 HD12 HD11 ' A' ' 251' ' ' LEU . 73.1 mt -88.49 151.28 22.64 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.468 -0.567 . . . . 74.33 109.468 166.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -111.85 109.33 19.09 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.49 -1.3 . . . . 73.42 107.49 162.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 64.0 mt -110.11 102.43 11.14 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.854 0.835 . . . . 70.3 109.784 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -76.68 119.1 20.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.095 -1.411 . . . . 74.43 110.853 -169.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.62 -3.95 86.6 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 124.072 0.858 . . . . 62.23 113.981 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.479 ' HD2' HG21 ' A' ' 214' ' ' THR . 32.6 mmtp -87.09 5.79 35.89 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.645 0.723 . . . . 64.03 112.565 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.98 174.02 49.24 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.123 -0.791 . . . . 74.42 111.123 166.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.04 148.16 88.98 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.85 0.46 . . . . 75.24 111.753 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 11.7 Cg_exo -68.69 133.32 27.29 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.659 2.239 . . . . 65.15 112.429 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -128.89 173.78 19.26 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.793 -1.094 . . . . 75.42 112.552 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.02 -24.82 20.17 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.92 2.413 . . . . 73.43 112.195 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.22 22.46 14.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.058 0.943 . . . . 72.11 110.833 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 101.16 -177.74 27.67 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.957 -0.857 . . . . 71.42 110.957 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.565 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 32.9 mtp180 -81.81 155.49 25.39 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.113 0.457 . . . . 73.52 111.161 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.2 -179.12 52.72 Favored Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.436 -0.802 . . . . 65.44 112.222 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -117.37 138.26 51.92 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.208 0.528 . . . . 75.21 109.789 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 38.8 tp -101.91 105.57 16.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.973 -1.012 . . . . 73.34 109.116 -170.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 60.5 m-85 -102.15 114.13 27.99 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.146 -1.057 . . . . 73.13 108.146 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 195' ' ' ALA . 2.5 pp -125.88 114.74 18.94 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.593 0.96 . . . . 73.35 113.593 -171.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -67.74 125.8 27.37 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.799 1.24 . . . . 74.2 112.766 -173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.551 HG23 ' CZ3' ' A' ' 176' ' ' TRP . 89.1 t -74.25 131.3 35.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-N 113.55 -1.659 . . . . 75.44 110.936 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -123.81 125.33 44.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.456 1.503 . . . . 75.12 107.851 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.01 105.91 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.566 -1.272 . . . . 75.02 107.566 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.564 1.495 0 CA-C-O 118.022 -0.99 . . . . 73.43 109.507 -169.724 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.407 HG21 HG22 ' A' ' 219' ' ' VAL . 13.4 m . . . . . 0 CA--C 1.555 1.156 0 CA-C-O 121.207 0.527 . . . . 74.31 110.959 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.74 166.17 12.58 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.744 0.817 . . . . 75.32 111.874 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.68 -96.56 0.92 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.525 -1.03 . . . . 72.33 110.525 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.14 174.86 9.61 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.982 0.513 . . . . 74.31 109.716 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.458 ' CZ3' HG23 ' A' ' 253' ' ' VAL . 9.9 m95 . . . . . 0 CA--C 1.539 0.53 0 CA-C-N 115.266 -0.879 . . . . 75.3 110.097 170.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 7.9 p-10 . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 112.366 0.506 . . . . 55.43 112.366 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.414 ' HB2' HD12 ' A' ' 249' ' ' LEU . 87.4 mt -116.75 147.22 42.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.391 1.076 . . . . 73.51 109.594 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -115.55 117.6 30.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.18 -1.045 . . . . 71.44 108.18 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -130.17 -173.61 3.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.456 0.702 . . . . 73.22 109.878 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.0 m -124.33 120.63 32.71 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.43 0.692 . . . . 73.3 110.311 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.508 HD21 HG22 ' A' ' 253' ' ' VAL . 18.3 tp -78.6 105.55 9.96 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.003 -1.11 . . . . 74.55 108.003 172.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -86.29 101.0 12.67 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.788 -0.819 . . . . 71.34 108.788 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.611 ' HA ' HG12 ' A' ' 210' ' ' VAL . 18.1 t -112.67 113.86 50.12 Favored Pre-proline 0 N--CA 1.47 0.556 0 N-CA-C 108.884 -0.784 . . . . 74.52 108.884 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.38 151.17 83.85 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 121.611 1.541 . . . . 74.33 110.642 171.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.19 -43.77 95.7 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-O 118.01 -0.995 . . . . 74.33 113.096 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.3 Cg_endo -55.37 -51.76 9.28 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 122.152 1.901 . . . . 71.25 112.98 174.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.471 HG21 HG13 ' A' ' 210' ' ' VAL . 38.6 mt -63.76 -34.85 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.07 0.548 . . . . 75.11 111.016 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.44 87.24 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.19 -0.459 . . . . 63.3 111.017 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.9 t -72.84 -49.03 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.826 0.85 . . . . 71.02 111.833 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.81 -24.72 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 122.329 0.252 . . . . 75.1 110.714 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.06 75.9 1.03 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.95 -0.568 . . . . 75.24 111.776 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.99 -144.78 10.9 Favored Glycine 0 N--CA 1.474 1.209 0 N-CA-C 110.815 -0.914 . . . . 65.25 110.815 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -122.29 150.73 41.94 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.107 0.953 . . . . 74.15 110.762 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 199' ' ' VAL . 24.8 m -141.06 149.21 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 115.354 -0.839 . . . . 75.24 109.978 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -73.83 145.13 45.18 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.292 0.568 . . . . 71.52 111.124 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -119.8 115.95 24.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.256 1.422 . . . . 75.12 107.281 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 15.9 tpt -64.26 130.88 45.6 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.27 0.628 . . . . 75.01 111.529 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.404 ' HG1' HG21 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -131.88 -172.41 2.87 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.166 1.386 . . . . 73.52 109.691 -179.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.04 -70.18 0.26 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.074 0.94 . . . . 73.22 110.668 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -114.88 -41.52 3.35 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 113.63 -1.623 . . . . 75.13 111.387 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -116.3 102.97 1.11 Allowed Glycine 0 C--N 1.349 1.294 0 CA-C-O 118.468 -1.184 . . . . 72.14 111.652 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.33 137.99 78.14 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.251 2.634 . . . . 72.13 112.625 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 91.0 t -90.37 163.46 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.451 1.1 . . . . 75.43 108.955 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -146.19 127.9 15.25 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.704 -1.221 . . . . 65.31 107.704 170.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.454 HG12 HD11 ' A' ' 233' ' ' LEU . 14.0 p -116.94 140.99 37.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 C-N-CA 123.722 0.809 . . . . 75.14 110.276 -174.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.93 106.82 5.81 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.59 -0.732 . . . . 70.44 109.052 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.91 128.61 92.75 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.755 0.822 . . . . 74.44 109.253 173.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -59.39 149.58 80.5 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.956 2.438 . . . . 65.34 111.961 170.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.39 132.18 39.78 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 121.751 1.634 . . . . 74.42 110.77 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 52.92 69.88 0.64 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.287 1.435 . . . . 71.14 112.672 -173.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.481 HG23 ' HD2' ' A' ' 231' ' ' ARG . 32.5 m -92.06 138.42 31.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.222 -1.354 . . . . 73.42 110.135 170.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -103.55 162.31 13.15 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.555 0.742 . . . . 74.21 111.044 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -82.76 155.88 24.02 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.187 -1.37 . . . . 74.3 111.741 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.07 -10.03 59.98 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 111.847 -0.501 . . . . 71.43 111.847 -173.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.481 ' HD2' HG23 ' A' ' 227' ' ' THR . 71.4 mtt85 -72.38 -179.52 2.98 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.067 0.947 . . . . 72.21 110.307 168.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.535 ' HA ' HG21 ' A' ' 253' ' ' VAL . 8.4 ptmt -167.8 153.23 7.1 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.88 -0.6 . . . . 74.45 109.909 171.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.548 HD13 HD13 ' A' ' 251' ' ' LEU . 85.4 mt -83.58 152.48 24.82 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.358 -0.608 . . . . 74.44 109.358 169.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -118.65 110.08 16.89 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 124.833 1.333 . . . . 72.23 107.593 168.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 58.6 mt -116.98 117.8 30.66 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.728 -0.669 . . . . 74.01 110.07 -171.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.484 ' HD3' ' HB3' ' A' ' 248' ' ' ASP . 27.2 mmtp -93.03 132.39 37.17 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.702 -0.481 . . . . 75.54 109.702 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.81 20.72 73.11 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 124.261 0.976 . . . . 54.33 112.912 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 26.6 mmtp -116.86 -5.47 11.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.178 0.807 . . . . 75.5 113.178 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.61 -172.32 46.78 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-O 119.794 -0.448 . . . . 53.04 112.124 166.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -58.77 139.14 86.56 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.077 0.551 . . . . 74.43 111.765 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 6.3 Cg_exo -76.61 136.8 17.61 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.728 2.285 . . . . 70.04 111.508 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -130.93 170.16 21.35 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.952 -0.567 . . . . 63.14 112.764 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.52 -28.9 21.03 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.892 2.395 . . . . 74.21 112.26 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.59 22.17 12.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.855 0.862 . . . . 72.51 110.849 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.91 169.44 24.26 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 111.115 -0.794 . . . . 72.32 111.115 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 96.6 mtt180 -73.78 175.1 7.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.711 0.767 . . . . 74.32 111.994 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.46 -167.43 33.93 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.193 -1.367 . . . . 63.43 112.147 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.484 ' HB3' ' HD3' ' A' ' 236' ' ' LYS . 2.2 p-10 -118.69 176.94 5.03 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.682 0.793 . . . . 74.31 110.41 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 27.2 tp -145.82 109.55 4.8 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.236 0.541 . . . . 74.32 110.973 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 16.9 m-85 -102.16 116.14 32.03 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.449 -0.945 . . . . 75.45 108.449 174.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.0 pp -127.91 115.24 18.27 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.138 0.792 . . . . 73.11 113.138 -175.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.42 119.6 13.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.392 1.477 . . . . 72.44 112.856 -170.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 232' ' ' LYS . 57.4 t -70.82 120.75 19.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-N 114.57 -1.196 . . . . 72.13 111.105 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -113.59 129.01 56.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.564 1.146 . . . . 72.31 108.908 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 31.9 mm -94.88 99.59 9.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.643 -1.243 . . . . 73.32 107.643 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 124.877 1.271 . . . . 74.54 108.436 -171.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.453 HG23 HG21 ' A' ' 219' ' ' VAL . 1.1 m . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 107.592 -1.262 . . . . 74.54 107.592 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.96 159.73 14.97 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.719 0.808 . . . . 70.23 111.681 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -92.08 -88.95 1.48 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 114.885 -1.052 . . . . 60.14 111.994 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.85 165.61 33.07 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.588 0.709 . . . . 73.21 112.801 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.494 ' CZ3' HG23 ' A' ' 227' ' ' THR . 34.5 m95 . . . . . 0 CA--C 1.541 0.601 0 CA-C-N 113.654 -1.612 . . . . 75.21 110.577 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 120.752 0.311 . . . . 72.34 110.292 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.0 mt -111.59 143.39 42.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.196 0.599 . . . . 65.35 110.653 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -113.41 114.82 27.13 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.594 -0.891 . . . . 75.12 108.594 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.577 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -128.13 -172.56 2.72 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.238 1.015 . . . . 62.23 109.603 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 254' ' ' ARG . 88.0 m -111.69 150.19 30.54 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.997 0.919 . . . . 72.53 110.442 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.56 HD22 ' HG ' ' A' ' 233' ' ' LEU . 16.7 tp -110.29 103.29 11.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.61 -1.626 . . . . 73.14 106.61 162.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.85 99.44 12.12 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.676 -0.861 . . . . 72.43 108.676 -173.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.61 ' HA ' HG11 ' A' ' 210' ' ' VAL . 15.6 t -106.73 113.02 63.29 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.118 -0.946 . . . . 74.04 108.518 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.31 148.37 88.39 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.531 1.487 . . . . 72.5 110.325 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -51.69 -44.28 89.9 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 117.725 -1.131 . . . . 72.54 112.579 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.1 Cg_endo -56.49 -49.94 13.41 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 122.052 1.835 . . . . 75.11 112.665 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.468 HG21 HG12 ' A' ' 210' ' ' VAL . 38.2 mt -65.36 -32.94 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.225 0.61 . . . . 75.02 110.818 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.84 -47.35 78.29 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.031 0.532 . . . . 54.41 110.344 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -70.25 -49.21 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.25 1.02 . . . . 64.21 111.945 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.0 p -79.68 -27.4 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.375 0.27 . . . . 72.01 110.715 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.3 70.6 1.34 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 112.217 -0.353 . . . . 71.41 112.217 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.33 -123.48 5.2 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 120.031 -0.316 . . . . 71.45 112.797 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -150.22 137.12 19.29 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.97 0.908 . . . . 74.21 110.052 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 199' ' ' VAL . 29.6 m -139.17 156.68 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 123.427 0.691 . . . . 75.33 111.317 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -77.6 141.47 39.47 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.007 0.923 . . . . 70.31 111.535 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.424 ' HB3' HD21 ' A' ' 251' ' ' LEU . . . -116.4 116.59 27.98 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.421 1.488 . . . . 74.34 108.477 172.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -66.21 130.64 43.93 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.864 0.865 . . . . 74.4 111.189 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.2 -171.2 2.69 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.323 1.049 . . . . 71.32 110.132 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.1 mt -68.28 -66.83 0.52 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.881 1.273 . . . . 71.41 111.205 -175.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -105.5 -42.32 5.25 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 113.229 -1.805 . . . . 74.11 111.385 -165.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -137.49 145.16 16.79 Favored Glycine 0 N--CA 1.467 0.765 0 CA-C-O 118.695 -1.059 . . . . 72.24 111.716 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.65 137.92 23.24 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.165 1.91 . . . . 74.41 112.38 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.453 HG21 HG23 ' A' ' 172' ' ' THR . 50.5 t -95.39 164.67 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 114.475 -1.239 . . . . 64.12 108.104 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -144.41 144.32 31.35 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.416 -1.327 . . . . 74.32 107.416 175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.431 HG12 HD23 ' A' ' 197' ' ' LEU . 15.0 p -135.65 140.39 44.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 123.223 0.609 . . . . 74.53 110.824 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.56 112.6 9.79 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.803 0.841 . . . . 71.33 109.392 172.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 83.8 t -76.74 132.61 71.43 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.533 0.733 . . . . 72.35 109.406 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.3 155.58 68.76 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.803 2.336 . . . . 74.02 111.353 169.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -65.63 136.22 45.2 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.001 1.801 . . . . 74.5 111.865 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 49.4 69.53 0.58 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.571 1.549 . . . . 64.13 112.773 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.494 HG23 ' CZ3' ' A' ' 176' ' ' TRP . 86.2 m -90.4 144.39 25.86 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.527 -1.215 . . . . 73.23 110.703 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -107.56 156.95 18.45 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.427 1.091 . . . . 74.31 110.556 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.05 155.45 30.63 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.481 -1.236 . . . . 72.53 110.518 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.78 -16.94 43.0 Favored Glycine 0 N--CA 1.471 0.984 0 N-CA-C 111.349 -0.7 . . . . 75.15 111.349 -173.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.411 ' HD2' HG21 ' A' ' 227' ' ' THR . 76.1 mtt85 -71.02 -178.96 2.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.247 1.019 . . . . 74.44 109.91 167.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.4 ptmt -167.05 159.97 13.61 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.191 0.307 . . . . 75.54 110.773 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.56 ' HG ' HD22 ' A' ' 197' ' ' LEU . 85.5 mt -88.19 147.29 24.94 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.35 -0.611 . . . . 74.43 109.35 168.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -113.68 107.17 15.4 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 124.675 1.235 . . . . 74.31 107.733 166.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.526 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 70.4 mt -110.07 110.72 21.71 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.482 0.713 . . . . 74.44 109.45 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -83.41 121.07 26.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.015 -0.993 . . . . 72.41 111.078 -167.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.8 2.53 88.56 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.236 -0.893 . . . . 71.44 113.341 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.526 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 48.2 mmtm -94.05 4.68 53.56 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.618 0.767 . . . . 73.4 111.814 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.97 -175.37 49.95 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.479 -1.048 . . . . 62.23 110.479 166.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -62.77 136.54 96.38 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-N 117.579 0.689 . . . . 74.34 110.906 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.544 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 55.9 Cg_endo -69.51 143.88 53.53 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.307 2.005 . . . . 74.31 112.21 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.21 167.29 23.47 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 119.471 -0.627 . . . . 71.02 112.489 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.77 -22.22 32.32 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 123.157 2.571 . . . . 75.12 113.887 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.2 1.05 16.02 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.278 0.631 . . . . 70.14 111.684 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.54 159.6 8.46 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.517 -0.633 . . . . 75.51 111.517 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 51.9 mtm180 -83.35 169.79 15.25 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.374 0.67 . . . . 75.21 111.438 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.74 -174.79 35.21 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.366 -0.834 . . . . 71.05 111.684 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -126.12 150.55 48.15 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.144 0.497 . . . . 73.32 110.209 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 37.6 tp -109.09 108.72 19.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.818 0.847 . . . . 73.2 109.95 -171.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.542 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 54.1 m-85 -104.29 116.32 31.95 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.402 1.081 . . . . 75.31 108.458 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.2 pp -130.08 115.19 16.73 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.386 0.884 . . . . 72.22 113.386 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -68.82 119.52 13.31 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.834 1.254 . . . . 74.11 112.061 -170.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 232' ' ' LYS . 66.6 t -65.13 124.92 21.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 CA-C-N 114.558 -1.201 . . . . 73.52 110.649 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . 0.47 ' HG2' HG21 ' A' ' 196' ' ' THR . 14.1 mmm180 -119.41 135.27 54.82 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.062 1.345 . . . . 72.01 108.539 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.41 111.12 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 107.888 -1.153 . . . . 74.03 107.888 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.564 1.517 0 CA-C-O 117.644 -1.169 . . . . 75.42 108.819 -171.819 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 11.7 m . . . . . 0 CA--C 1.551 1.001 0 CA-C-O 121.198 0.523 . . . . 71.14 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -90.34 143.23 26.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.532 0.733 . . . . 72.45 111.104 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.29 -75.6 0.42 Allowed Glycine 0 C--N 1.344 0.98 0 O-C-N 123.912 0.758 . . . . 73.3 112.358 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -158.14 171.27 20.53 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.906 0.882 . . . . 70.42 111.085 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.512 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 16.0 m95 . . . . . 0 CA--C 1.542 0.659 0 CA-C-N 114.811 -1.086 . . . . 73.54 108.661 168.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.0 p-10 . . . . . 0 N--CA 1.447 -0.583 0 CA-C-O 120.958 0.408 . . . . 74.5 111.672 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.8 mt -123.45 132.79 54.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.204 -0.907 . . . . 70.12 110.215 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -93.32 129.99 39.23 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.579 -0.897 . . . . 71.22 108.579 167.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -138.65 -171.85 3.16 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.12 -0.696 . . . . 62.2 109.12 175.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.1 m -127.74 119.45 25.81 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.423 0.689 . . . . 74.31 110.778 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.511 HD22 ' HG ' ' A' ' 233' ' ' LEU . 17.3 tp -81.47 105.25 12.48 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.152 -1.055 . . . . 71.12 108.152 171.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -92.36 99.5 12.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.825 0.821 . . . . 73.24 108.85 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.637 HG21 HG21 ' A' ' 210' ' ' VAL . 22.8 t -101.15 121.71 51.04 Favored Pre-proline 0 C--N 1.347 0.465 0 N-CA-C 107.645 -1.242 . . . . 75.23 107.645 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.97 149.52 71.99 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 121.76 1.64 . . . . 71.4 110.243 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.61 -45.95 85.55 Favored Pre-proline 0 CA--C 1.56 1.365 0 O-C-N 124.2 0.937 . . . . 74.25 113.075 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.9 Cg_endo -57.47 -48.83 15.61 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 121.979 1.786 . . . . 70.51 113.67 176.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.413 HG21 HG13 ' A' ' 210' ' ' VAL . 47.9 mt -66.91 -32.47 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 122.813 0.445 . . . . 74.01 110.632 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.8 95.2 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.228 -0.442 . . . . 71.54 110.725 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.23 -51.68 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.612 0.765 . . . . 74.14 111.816 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.5 p -78.95 -22.42 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 120.753 0.311 . . . . 70.33 110.871 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 75.64 62.18 2.75 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 115.635 -0.711 . . . . 63.14 111.902 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.26 -120.68 2.73 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.25 -0.34 . . . . 72.22 112.25 -175.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -146.94 140.84 25.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.691 0.796 . . . . 72.44 109.259 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.637 HG21 HG21 ' A' ' 199' ' ' VAL . 19.1 m -137.19 152.61 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.301 0.64 . . . . 62.33 110.58 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -77.8 140.6 39.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.752 0.821 . . . . 74.53 110.75 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.03 115.8 29.51 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.497 -1.298 . . . . 75.53 107.497 172.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.9 tpt -63.49 127.55 31.81 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.229 0.612 . . . . 64.11 110.894 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.29 -170.23 2.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.786 1.234 . . . . 75.44 109.696 -175.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.04 -68.79 0.52 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.27 1.033 . . . . 74.43 111.224 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.19 -37.64 5.5 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 113.265 -1.789 . . . . 72.41 110.765 -165.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -133.31 119.25 2.3 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 118.566 -1.13 . . . . 65.12 110.669 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.09 141.44 52.79 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.53 2.153 . . . . 73.41 112.833 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 71.0 t -92.62 165.9 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.056 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -146.75 136.88 23.51 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 108.028 -1.101 . . . . 62.12 108.028 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.483 HG21 HD23 ' A' ' 233' ' ' LEU . 14.5 p -130.17 142.18 44.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.446 0.698 . . . . 75.31 110.809 -172.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.22 113.45 12.6 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.154 -0.684 . . . . 71.32 109.154 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.9 t -74.09 136.6 76.07 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 123.562 0.745 . . . . 72.33 109.146 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.86 154.04 67.78 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.259 1.973 . . . . 72.21 111.575 170.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.87 132.35 36.8 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.531 2.154 . . . . 75.04 111.916 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 49.56 72.84 0.28 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.139 1.375 . . . . 75.3 112.378 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.534 HG21 ' HD2' ' A' ' 231' ' ' ARG . 67.8 m -82.8 141.95 31.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.307 -1.315 . . . . 63.24 110.923 174.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.433 ' H ' HH11 ' A' ' 231' ' ' ARG . 27.0 mp0 -100.42 151.62 21.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.997 0.919 . . . . 73.42 110.314 171.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -75.94 156.84 33.84 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.049 -0.978 . . . . 42.02 111.078 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.57 -2.42 62.6 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.242 -0.435 . . . . 75.2 112.291 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.534 ' HD2' HG21 ' A' ' 227' ' ' THR . 28.3 mtt85 -77.17 -175.22 3.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.513 0.725 . . . . 63.41 109.737 168.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.572 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 9.3 ptmt -167.38 154.75 8.76 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 110.488 -0.189 . . . . 73.24 110.488 170.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.634 HD11 HD12 ' A' ' 251' ' ' LEU . 48.8 mt -80.0 143.58 33.99 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 110.118 -0.326 . . . . 73.2 110.118 167.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -109.89 108.39 18.67 Favored 'General case' 0 C--O 1.243 0.716 0 O-C-N 125.299 1.624 . . . . 75.11 108.39 166.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.493 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 65.9 mt -115.03 138.85 50.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.228 -0.896 . . . . 74.24 109.31 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -108.96 141.05 41.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.201 0.6 . . . . 73.12 109.44 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 68.58 24.16 75.28 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 124.194 0.934 . . . . 70.43 112.956 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.493 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 45.5 mmtm -117.43 -11.07 10.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.429 0.692 . . . . 75.43 112.331 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.85 -168.83 40.14 Favored Glycine 0 N--CA 1.479 1.531 0 CA-C-O 119.627 -0.541 . . . . 75.11 111.911 171.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -66.64 142.48 97.6 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-N 117.811 0.805 . . . . 74.42 111.651 -173.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.22 141.79 48.46 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.3 2.666 . . . . 74.51 112.647 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -135.82 172.23 22.36 Favored Glycine 0 N--CA 1.476 1.346 0 C-N-CA 123.243 0.449 . . . . 75.34 113.123 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.02 -25.51 44.2 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.031 2.487 . . . . 65.15 112.409 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.99 21.71 8.37 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.526 0.73 . . . . 72.42 111.623 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 103.03 -172.2 21.36 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 110.495 -1.042 . . . . 75.42 110.495 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.45 149.57 22.55 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 117.693 0.746 . . . . 74.21 110.633 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.1 -173.59 44.19 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.907 0.754 . . . . 71.43 114.394 -173.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 6.9 p-10 -105.07 167.5 9.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.348 0.659 . . . . 63.01 110.917 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.472 HD21 HD11 ' A' ' 235' ' ' LEU . 42.2 tp -137.98 110.62 7.57 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.524 0.73 . . . . 73.22 109.381 -174.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.572 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 20.8 m-85 -108.75 118.86 37.89 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.886 -0.783 . . . . 75.55 108.886 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.634 HD12 HD11 ' A' ' 233' ' ' LEU . 1.6 pp -130.7 114.83 15.87 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.064 0.764 . . . . 75.33 113.064 -175.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -69.04 124.44 23.76 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 124.232 1.013 . . . . 75.32 113.204 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 232' ' ' LYS . 65.5 t -73.72 131.62 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 113.573 -1.649 . . . . 72.35 111.689 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -121.09 139.2 53.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.447 1.499 . . . . 71.52 108.15 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 35.0 mm -105.04 103.63 15.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.657 -1.238 . . . . 74.32 107.657 173.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.557 1.247 0 CA-C-O 117.741 -1.123 . . . . 72.02 108.625 -174.185 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 121.469 0.652 . . . . 73.33 109.804 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -86.91 148.68 25.25 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.469 -0.787 . . . . 64.43 111.067 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -67.63 -100.54 0.03 OUTLIER Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.167 -0.773 . . . . 64.22 111.167 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -130.11 173.6 10.59 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.946 0.499 . . . . 73.04 109.861 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.515 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 16.1 m95 . . . . . 0 C--O 1.244 0.771 0 CA-C-N 115.152 -0.931 . . . . 74.44 108.997 168.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 120.946 0.403 . . . . 72.33 110.839 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.4 mt -135.14 142.48 46.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.478 0.711 . . . . 72.52 110.408 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -106.77 111.2 23.62 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.144 -1.428 . . . . 74.11 107.144 165.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.598 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . . . -123.67 -171.33 2.29 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.698 0.799 . . . . 72.53 110.167 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.1 m -113.64 145.87 40.63 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.483 1.113 . . . . 63.52 110.434 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 253' ' ' VAL . 18.4 tp -113.32 104.94 12.82 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.695 -1.595 . . . . 73.31 106.695 167.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.58 100.18 9.99 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.704 -0.85 . . . . 74.2 108.704 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.641 ' HA ' HG12 ' A' ' 210' ' ' VAL . 20.9 t -110.88 103.01 54.05 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.281 -1.007 . . . . 75.25 108.281 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.05 144.87 77.53 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.522 1.481 . . . . 74.23 109.876 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.407 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.03 -41.2 78.62 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 117.743 -1.122 . . . . 74.41 113.08 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.4 Cg_endo -55.28 -46.22 34.33 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.828 1.685 . . . . 71.15 113.06 173.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.413 HG21 HG13 ' A' ' 210' ' ' VAL . 52.0 mt -69.73 -34.82 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.35 0.66 . . . . 64.41 110.616 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.13 91.11 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 122.756 0.422 . . . . 72.34 110.593 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.89 -49.6 62.0 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 O-C-N 124.543 1.152 . . . . 74.4 111.481 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.7 p -79.0 -23.88 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 122.474 0.31 . . . . 72.22 110.738 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.51 71.62 1.11 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.466 -0.654 . . . . 75.22 111.466 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.27 -129.57 6.74 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.765 -0.534 . . . . 64.41 111.765 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -138.85 144.53 39.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.778 0.831 . . . . 73.31 109.537 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 199' ' ' VAL . 27.0 m -137.02 153.73 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 115.665 -0.698 . . . . 74.04 110.564 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -74.9 143.51 43.75 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.515 0.726 . . . . 74.4 110.569 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.511 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -116.04 113.15 22.8 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.146 1.378 . . . . 72.5 107.946 172.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.5 tpt -64.87 122.88 17.99 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.342 1.057 . . . . 63.43 111.002 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 215' ' ' LEU . 0.2 OUTLIER -124.09 -171.07 2.25 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.787 1.235 . . . . 75.22 109.084 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.502 ' H ' HG22 ' A' ' 214' ' ' THR . 7.0 mt -60.27 -67.26 0.41 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.632 1.173 . . . . 75.23 111.42 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -109.48 -42.53 4.31 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.105 -1.861 . . . . 72.32 110.918 -163.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -131.86 157.42 22.4 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-O 118.916 -0.936 . . . . 75.12 111.308 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -86.3 143.31 7.63 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.966 1.778 . . . . 74.21 113.064 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 64.4 t -98.43 167.57 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 114.256 -1.338 . . . . 75.11 108.038 174.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -143.53 145.46 32.58 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.444 -0.947 . . . . 75.01 108.444 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.86 141.24 42.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.404 0.681 . . . . 75.15 110.123 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.84 112.74 10.25 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.565 -0.902 . . . . 73.34 108.565 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.7 t -73.27 132.46 81.98 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 108.558 -0.905 . . . . 75.11 108.558 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.6 153.25 76.16 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.667 2.244 . . . . 65.23 111.525 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -64.57 136.07 48.5 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 121.89 1.727 . . . . 73.13 111.979 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 53.24 54.11 10.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.469 1.508 . . . . 74.11 113.275 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.491 HG21 ' HD2' ' A' ' 231' ' ' ARG . 19.4 m -80.02 138.2 36.97 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.92 -0.582 . . . . 75.01 111.403 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -96.16 160.04 14.64 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.124 0.969 . . . . 75.04 111.135 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -79.88 156.02 27.52 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.314 -1.312 . . . . 74.55 110.858 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.64 -18.61 43.77 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 111.958 -0.457 . . . . 73.24 111.958 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.491 ' HD2' HG21 ' A' ' 227' ' ' THR . 78.0 mtt85 -68.48 178.79 1.87 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.039 0.935 . . . . 75.0 109.986 167.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.567 ' HA ' HG22 ' A' ' 253' ' ' VAL . 11.2 ptmt -167.02 154.94 9.45 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.142 0.276 . . . . 74.11 110.492 173.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.565 HD12 HD13 ' A' ' 251' ' ' LEU . 82.3 mt -81.66 146.09 30.22 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 108.811 -0.811 . . . . 74.11 108.811 167.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -116.1 106.99 14.36 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.808 -1.182 . . . . 75.02 107.808 165.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.485 HD13 HD21 ' A' ' 249' ' ' LEU . 58.6 mt -107.97 108.44 19.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.788 -1.097 . . . . 73.23 109.202 -173.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -82.88 121.92 27.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.822 -1.081 . . . . 72.1 110.337 -170.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.06 9.93 79.44 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 124.307 1.004 . . . . 73.21 113.894 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 46.5 mmtm -99.46 6.25 46.0 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.75 0.775 . . . . 73.34 112.542 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.35 -174.75 50.24 Favored Glycine 0 N--CA 1.472 1.099 0 O-C-N 123.319 0.387 . . . . 73.03 112.291 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -58.35 142.55 81.53 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 123.857 0.863 . . . . 75.32 112.993 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.445 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 48.9 Cg_endo -67.23 132.32 27.38 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.301 2.668 . . . . 74.21 112.791 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.07 -178.37 15.51 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 115.213 -0.903 . . . . 75.22 112.913 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.15 -25.78 21.98 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 123.101 2.534 . . . . 74.31 112.686 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.24 22.11 16.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.308 1.043 . . . . 43.33 111.006 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 98.98 -172.88 26.07 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.142 -0.783 . . . . 74.22 111.142 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.445 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 68.7 mtm180 -85.41 156.93 20.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.899 0.479 . . . . 72.22 111.722 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.8 -154.86 6.05 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 123.941 0.776 . . . . 70.43 111.799 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -121.75 166.36 14.44 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.899 0.85 . . . . 73.02 110.825 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.485 HD21 HD13 ' A' ' 235' ' ' LEU . 46.6 tp -126.78 107.22 9.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.496 0.718 . . . . 74.13 109.194 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -105.08 111.3 24.02 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.966 -1.124 . . . . 75.33 107.966 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 195' ' ' ALA . 1.8 pp -125.9 120.9 31.64 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.709 1.003 . . . . 75.44 113.709 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -69.26 123.81 22.16 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.733 1.613 . . . . 74.42 112.624 -171.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 232' ' ' LYS . 90.4 t -71.86 119.23 18.01 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 C-N-CA 124.821 1.249 . . . . 75.42 111.077 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -113.82 115.41 27.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.626 1.57 . . . . 73.43 107.883 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 36.2 mm -86.87 96.0 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.868 -1.16 . . . . 74.52 107.868 175.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.556 1.202 0 C-N-CA 124.539 1.135 . . . . 71.33 109.076 -171.91 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.055 0.455 . . . . 71.2 112.0 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.0 166.8 18.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.781 0.832 . . . . 61.14 111.713 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.16 -80.96 1.15 Allowed Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.886 -1.052 . . . . 71.53 111.011 172.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.9 175.27 13.55 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.165 0.586 . . . . 71.44 111.464 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.441 ' CZ3' HG23 ' A' ' 253' ' ' VAL . 23.7 m95 . . . . . 0 C--O 1.239 0.501 0 CA-C-N 114.846 -1.07 . . . . 64.45 110.743 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 5.5 p-10 . . . . . 0 C--O 1.235 0.333 0 CA-C-O 120.682 0.277 . . . . 73.35 110.639 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.454 ' HB2' HD12 ' A' ' 249' ' ' LEU . 84.2 mt -119.3 147.55 44.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.328 0.651 . . . . 74.34 110.092 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 9.0 t80 -109.31 114.93 29.03 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.882 -1.155 . . . . 75.14 107.882 171.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -127.42 -173.69 2.98 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.729 0.812 . . . . 75.21 110.441 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 60.3 m -121.52 137.93 54.52 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.519 0.728 . . . . 73.44 111.071 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.527 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.5 tp -108.1 108.81 20.05 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.973 1.309 . . . . 62.31 107.69 169.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.04 99.35 12.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.42 0.629 . . . . 75.51 109.611 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.596 HG22 HG21 ' A' ' 210' ' ' VAL . 15.1 t -101.59 111.03 63.34 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.675 -1.231 . . . . 71.24 107.675 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.55 154.38 74.56 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.85 1.7 . . . . 74.02 110.418 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.72 -45.37 79.31 Favored Pre-proline 0 CA--C 1.573 1.847 0 CA-C-O 117.809 -1.091 . . . . 63.52 113.394 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.79 -48.89 13.05 Favored 'Trans proline' 0 C--N 1.402 3.351 0 C-N-CA 121.828 1.685 . . . . 74.41 112.484 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.468 HG21 HG12 ' A' ' 210' ' ' VAL . 44.4 mt -68.28 -31.2 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.539 0.736 . . . . 63.22 110.762 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.81 -46.72 77.59 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.0 0.52 . . . . 74.15 110.585 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.56 -48.33 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 124.417 1.073 . . . . 73.42 111.954 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.15 -28.58 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 120.678 0.275 . . . . 75.34 110.715 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.11 76.46 1.0 Allowed Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.626 -0.589 . . . . 72.14 111.626 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.5 -129.4 6.68 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-O 120.049 -0.306 . . . . 72.3 112.817 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.72 135.19 29.57 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.965 0.906 . . . . 74.52 109.132 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.596 HG21 HG22 ' A' ' 199' ' ' VAL . 31.6 m -134.21 149.3 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.573 0.749 . . . . 74.44 110.547 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -75.95 150.4 37.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.945 0.898 . . . . 74.24 110.624 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.529 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -122.57 121.58 36.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.838 1.255 . . . . 72.11 108.442 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.23 123.4 19.01 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.732 0.813 . . . . 74.22 110.217 176.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.454 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.3 OUTLIER -126.47 -171.87 2.5 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.552 1.141 . . . . 72.14 110.206 -176.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.53 -70.34 0.22 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 122.243 1.021 . . . . 74.12 111.268 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -110.22 -41.59 4.37 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 113.461 -1.7 . . . . 64.23 110.947 -162.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -132.55 145.86 17.7 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 118.348 -1.251 . . . . 53.44 110.549 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.82 152.72 64.05 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.125 1.883 . . . . 75.22 112.628 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 54.1 t -104.09 167.67 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.927 1.291 . . . . 75.31 108.029 174.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -148.64 146.28 28.13 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 107.815 -1.18 . . . . 75.13 107.815 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.419 HG13 HD13 ' A' ' 233' ' ' LEU . 9.6 p -138.5 144.27 30.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 C-N-CA 122.946 0.498 . . . . 63.23 110.8 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.59 112.89 12.41 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 124.035 0.835 . . . . 74.14 109.675 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.56 134.81 75.71 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.017 0.927 . . . . 74.51 109.45 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.52 154.34 50.08 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.465 2.11 . . . . 70.13 111.533 169.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.93 136.97 64.58 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 121.988 1.792 . . . . 73.42 111.756 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 51.51 70.37 0.55 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.231 1.413 . . . . 75.01 113.434 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.46 HG21 ' HD2' ' A' ' 231' ' ' ARG . 80.8 m -89.01 143.09 27.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.803 -1.089 . . . . 54.24 110.655 173.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -107.61 154.85 20.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.294 1.037 . . . . 71.12 110.35 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.431 ' HB1' ' H ' ' A' ' 255' ' ' ILE . . . -80.28 150.82 29.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.053 -0.976 . . . . 74.33 110.823 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.1 -21.3 27.3 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.931 -0.868 . . . . 71.52 110.931 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.46 ' HD2' HG21 ' A' ' 227' ' ' THR . 72.2 mtt85 -65.34 179.79 0.71 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.09 0.956 . . . . 70.11 110.525 170.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.712 ' HD3' ' HB3' ' A' ' 250' ' ' TYR . 9.9 ptpt -166.77 159.72 14.03 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.225 0.21 . . . . 74.12 111.033 171.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.507 HD12 HD13 ' A' ' 251' ' ' LEU . 71.2 mt -87.22 154.16 20.93 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.898 -0.408 . . . . 74.31 109.898 170.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -117.84 106.75 13.33 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.791 1.307 . . . . 73.45 108.04 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 44.8 mt -118.13 112.98 20.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.96 -0.564 . . . . 75.52 110.947 -172.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -90.78 127.4 36.33 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.159 -0.473 . . . . 75.13 109.935 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 88.23 11.57 66.79 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 123.981 0.8 . . . . 74.42 112.672 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.498 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.3 mmtt -113.79 -4.93 13.29 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.42 0.688 . . . . 74.33 111.867 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.72 -176.41 51.43 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.277 -0.729 . . . . 75.13 111.277 166.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.3 139.96 94.6 Favored Pre-proline 0 N--CA 1.487 1.375 0 CA-C-N 117.718 0.759 . . . . 75.21 111.405 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.458 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 34.8 Cg_endo -63.26 137.86 63.28 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.838 2.359 . . . . 75.53 112.516 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.99 169.51 22.89 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.126 -0.488 . . . . 65.31 113.875 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -71.35 -20.26 27.96 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 123.202 2.601 . . . . 65.41 112.077 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.1 17.46 15.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.279 1.032 . . . . 53.42 110.462 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.51 169.35 45.49 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.29 -0.724 . . . . 72.52 111.29 -170.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 95.5 mtt180 -65.34 158.2 27.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.877 0.871 . . . . 71.24 111.414 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.47 -164.61 40.46 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.715 -0.675 . . . . 64.31 112.333 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 8.7 p-10 -110.04 170.99 7.72 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.695 0.76 . . . . 71.44 110.574 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.662 ' HG ' HD23 ' A' ' 251' ' ' LEU . 33.5 tp -135.02 109.68 8.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.024 -0.989 . . . . 72.42 109.123 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.712 ' HB3' ' HD3' ' A' ' 232' ' ' LYS . 12.3 m-30 -98.29 112.04 24.17 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.37 -1.344 . . . . 73.32 107.37 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.662 HD23 ' HG ' ' A' ' 249' ' ' LEU . 3.5 pp -124.82 113.52 18.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.673 0.749 . . . . 75.02 112.863 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.51 119.37 12.2 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.826 1.25 . . . . 75.15 112.543 -170.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 232' ' ' LYS . 58.5 t -68.07 131.79 33.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 113.858 -1.519 . . . . 74.03 110.862 174.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -127.35 133.98 50.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.353 1.461 . . . . 75.43 107.913 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 34.6 mm -103.36 101.37 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.122 -1.066 . . . . 75.22 108.122 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.561 1.374 0 CA-C-N 115.045 -0.98 . . . . 73.24 108.634 -170.429 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 121.451 0.643 . . . . 74.14 110.102 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.5 178.34 4.71 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.068 0.947 . . . . 71.25 111.162 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.04 -86.05 1.79 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.059 -1.616 . . . . 74.41 109.059 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.29 164.89 29.44 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.389 1.076 . . . . 62.41 109.651 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.545 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.6 m95 . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 108.484 -0.932 . . . . 73.33 108.484 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 11.4 p-10 . . . . . 0 CA--C 1.542 0.646 0 N-CA-C 110.013 -0.365 . . . . 74.52 110.013 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.9 mt -124.54 159.01 31.57 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.383 0.611 . . . . 72.22 111.691 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 8.7 t80 -116.04 109.13 17.1 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.54 -1.209 . . . . 73.35 108.774 174.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . . . -118.59 -170.42 1.9 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.502 1.121 . . . . 53.21 109.913 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 98.3 m -117.53 127.77 54.31 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.732 0.813 . . . . 73.31 110.761 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.646 HD22 ' HG ' ' A' ' 233' ' ' LEU . 17.0 tp -87.84 105.88 17.71 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.866 -1.161 . . . . 71.12 107.866 165.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -87.1 107.52 18.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.096 -1.076 . . . . 72.33 108.096 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.607 ' HA ' HG13 ' A' ' 210' ' ' VAL . 19.2 t -117.58 115.94 37.12 Favored Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 108.83 -0.804 . . . . 75.01 108.83 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.01 149.61 77.29 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 121.571 1.514 . . . . 64.13 110.371 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.437 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.38 -43.96 92.64 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-O 117.75 -1.119 . . . . 73.01 112.571 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.2 Cg_endo -54.42 -52.57 7.91 Favored 'Trans proline' 0 C--N 1.403 3.446 0 C-N-CA 122.291 1.994 . . . . 71.32 113.077 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.437 HG21 HG11 ' A' ' 210' ' ' VAL . 51.2 mt -64.63 -33.61 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.207 0.603 . . . . 71.23 111.009 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.48 -46.58 85.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.829 0.452 . . . . 73.43 110.837 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.86 -50.62 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.004 0.922 . . . . 74.15 112.316 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.19 -27.01 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-O 120.614 0.245 . . . . 72.23 110.708 -174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.96 76.7 0.88 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.021 -0.536 . . . . 70.13 111.764 -175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.46 -130.23 6.77 Favored Glycine 0 N--CA 1.476 1.346 0 N-CA-C 111.018 -0.833 . . . . 74.54 111.018 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -133.13 152.91 51.93 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.568 0.747 . . . . 73.43 110.434 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 199' ' ' VAL . 30.7 m -139.9 149.77 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.323 -0.853 . . . . 64.4 109.402 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -73.42 152.62 40.73 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.516 -0.765 . . . . 71.51 110.673 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -130.73 114.27 15.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.147 1.379 . . . . 75.44 108.635 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 12.8 tpt -63.91 123.8 19.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.696 1.198 . . . . 75.25 111.435 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.521 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -121.83 -172.82 2.51 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.709 1.203 . . . . 75.3 109.371 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.52 ' H ' HG21 ' A' ' 214' ' ' THR . 4.8 mt -64.88 -65.96 0.6 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.191 1.396 . . . . 73.53 110.254 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -93.17 -37.4 12.12 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 112.227 -2.26 . . . . 72.12 110.155 -166.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -145.49 -162.43 9.64 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.237 -0.892 . . . . 53.14 112.429 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -100.66 174.73 0.31 Allowed 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 123.145 2.564 . . . . 72.23 113.936 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 43.7 t -130.49 167.78 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 126.06 1.744 . . . . 65.32 106.322 172.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -145.68 120.26 9.76 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.388 -0.967 . . . . 74.23 108.388 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.422 HG11 HD12 ' A' ' 233' ' ' LEU . 15.0 p -112.53 141.37 28.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 123.99 0.916 . . . . 72.23 110.095 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.06 115.91 15.21 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.538 -0.912 . . . . 51.33 108.538 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.92 132.53 74.12 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 108.559 -0.904 . . . . 74.41 108.559 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.73 149.59 78.79 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.939 2.426 . . . . 73.15 111.536 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -56.64 129.99 37.61 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.374 2.049 . . . . 73.43 112.572 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 54.58 68.25 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.456 1.502 . . . . 73.45 113.478 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 54.0 m -95.05 139.27 31.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.901 -1.045 . . . . 70.53 110.184 172.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -104.07 163.87 12.1 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.453 1.101 . . . . 74.43 110.765 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.418 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.4 155.73 24.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.336 -1.302 . . . . 72.01 110.924 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.95 -5.17 57.84 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 111.878 -0.489 . . . . 71.55 111.878 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -81.38 -174.96 5.23 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.998 0.919 . . . . 74.23 109.308 168.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.561 ' HA ' HG22 ' A' ' 253' ' ' VAL . 10.6 ptpt -165.98 161.99 17.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.08 0.552 . . . . 72.24 109.692 169.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.675 HD11 HD11 ' A' ' 251' ' ' LEU . 87.0 mt -85.92 150.71 24.32 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.49 -0.93 . . . . 74.43 108.49 164.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -116.94 106.39 13.38 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.876 -1.157 . . . . 75.15 107.876 160.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 43.3 mt -102.2 104.39 14.97 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.41 -1.268 . . . . 74.33 108.76 -174.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -79.47 118.81 21.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.164 -1.38 . . . . 75.22 110.295 -167.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.94 9.59 82.34 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.436 1.085 . . . . 54.25 114.044 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.527 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.4 mmtt -96.29 -0.04 50.19 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 118.249 1.024 . . . . 74.15 112.772 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.53 -177.35 50.46 Favored Glycine 0 N--CA 1.472 1.066 0 N-CA-C 111.716 -0.553 . . . . 75.42 111.716 170.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -55.46 126.18 62.1 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 123.568 0.747 . . . . 73.25 111.29 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.539 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 35.2 Cg_endo -65.05 134.72 40.82 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.7 2.267 . . . . 73.22 111.918 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -117.4 177.34 16.58 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.244 -0.889 . . . . 51.5 112.356 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.39 -33.36 23.57 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.824 2.349 . . . . 61.41 113.073 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.55 -33.62 12.34 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.137 0.575 . . . . 71.35 111.122 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 177.63 174.86 44.36 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.242 -0.89 . . . . 74.41 111.163 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.539 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 65.9 mtt180 -88.05 160.56 17.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.233 0.613 . . . . 73.32 111.47 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.54 -176.38 50.98 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.688 -0.965 . . . . 75.25 110.688 168.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 27.1 m-20 -110.33 -178.99 3.65 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.118 0.567 . . . . 74.3 110.163 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 55.7 tp -136.38 105.47 5.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.887 0.851 . . . . 75.01 109.499 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 58.9 m-85 -99.56 108.8 21.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.703 -1.221 . . . . 72.55 107.703 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.675 HD11 HD11 ' A' ' 233' ' ' LEU . 1.5 pp -125.49 115.0 19.54 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.965 1.098 . . . . 64.53 113.965 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.65 126.46 29.43 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 113.656 -1.611 . . . . 74.23 113.1 -170.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 232' ' ' LYS . 63.3 t -75.01 124.83 33.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 CA-C-N 113.522 -1.672 . . . . 74.23 110.622 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -121.04 122.06 39.27 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.817 1.247 . . . . 72.13 107.788 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.418 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 32.7 mm -92.51 103.73 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.04 -1.096 . . . . 74.33 108.04 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.562 1.42 0 CA-C-O 117.484 -1.246 . . . . 71.41 108.751 -169.384 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 CA--C 1.556 1.188 0 CA-C-O 121.31 0.576 . . . . 71.53 111.097 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.17 167.57 20.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.866 0.866 . . . . 72.13 112.746 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -89.74 -91.53 1.21 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 110.102 -1.199 . . . . 53.41 110.102 169.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -141.19 170.05 16.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.211 1.004 . . . . 74.12 110.495 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.588 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 15.3 m95 . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 123.542 0.737 . . . . 73.4 109.946 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 12.2 p-10 . . . . . 0 CA--C 1.547 0.84 0 CA-C-O 122.021 0.915 . . . . 72.4 108.757 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.2 mt -91.5 170.33 10.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.859 -1.064 . . . . 72.32 112.981 -168.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 24.8 t80 -124.84 140.32 53.03 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 113.41 -1.723 . . . . 73.25 107.621 171.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.606 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -154.43 -170.91 3.68 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.291 0.637 . . . . 73.41 110.176 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 91.0 m -117.82 138.27 52.19 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.09 0.956 . . . . 72.35 110.809 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.546 HD22 HG23 ' A' ' 253' ' ' VAL . 17.3 tp -98.55 108.92 21.72 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.727 -1.212 . . . . 73.32 107.727 166.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -82.73 100.6 10.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.211 -0.662 . . . . 71.42 109.211 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.617 HG21 HG23 ' A' ' 210' ' ' VAL . 21.5 t -108.11 109.43 61.9 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 108.715 -0.846 . . . . 72.25 108.715 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.42 145.56 65.51 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.257 1.305 . . . . 74.23 109.597 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.447 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -51.66 -40.53 70.8 Favored Pre-proline 0 CA--C 1.56 1.337 0 N-CA-C 113.979 1.103 . . . . 65.42 113.979 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.2 Cg_endo -56.16 -48.65 18.44 Favored 'Trans proline' 0 C--N 1.397 3.13 0 C-N-CA 122.037 1.825 . . . . 73.44 112.751 174.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.449 HG21 HG11 ' A' ' 210' ' ' VAL . 37.4 mt -67.74 -35.15 71.65 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 C-N-CA 122.905 0.482 . . . . 72.32 110.833 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.419 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -61.21 -46.3 91.02 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.072 0.549 . . . . 75.42 110.817 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.4 t -71.12 -48.1 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.889 0.876 . . . . 62.53 112.119 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.43 -23.58 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 120.607 0.241 . . . . 75.45 110.726 -173.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.26 68.75 1.48 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.759 -0.655 . . . . 51.3 111.791 -175.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.6 -136.83 9.31 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-O 119.741 -0.477 . . . . 73.05 112.308 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 5.3 ttmt -129.57 139.41 51.49 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.014 -0.736 . . . . 74.35 109.014 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.617 HG23 HG21 ' A' ' 199' ' ' VAL . 27.6 m -131.76 146.94 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 122.861 0.464 . . . . 70.12 110.929 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -74.34 144.35 44.51 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.948 -1.024 . . . . 73.1 110.297 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.617 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -117.24 122.35 43.73 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.92 1.288 . . . . 74.34 108.07 172.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.79 119.43 9.94 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.344 0.657 . . . . 65.4 110.037 175.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.96 -170.41 2.1 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.437 1.095 . . . . 72.51 109.378 -175.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.99 -70.24 0.25 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.844 0.83 . . . . 70.2 110.77 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -114.0 -41.29 3.56 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-N 113.719 -1.582 . . . . 61.34 111.445 -166.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -130.49 129.0 5.72 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-O 118.465 -1.186 . . . . 72.15 110.513 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.27 152.96 61.84 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.184 1.923 . . . . 74.33 113.212 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.617 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 55.1 t -97.43 166.39 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.255 -1.339 . . . . 65.3 108.691 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -149.77 135.1 18.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.614 -0.884 . . . . 72.52 108.614 172.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 14.3 p -131.11 142.56 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.526 0.73 . . . . 75.25 110.812 -172.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.1 108.19 5.85 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.93 0.492 . . . . 71.24 109.721 170.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 204' ' ' ALA . 70.6 t -69.58 134.37 88.54 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.84 0.856 . . . . 71.55 109.137 172.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.37 154.56 71.69 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.386 2.057 . . . . 70.15 111.286 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.4 131.18 37.09 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.161 1.907 . . . . 73.22 112.072 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 53.81 69.76 0.68 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.265 1.426 . . . . 74.22 113.389 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.41 HG21 ' HD2' ' A' ' 231' ' ' ARG . 87.1 m -88.2 142.42 27.77 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.666 -1.152 . . . . 74.34 110.908 173.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -103.7 164.78 11.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.047 0.939 . . . . 74.14 110.614 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -86.87 149.57 24.73 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.196 -0.911 . . . . 73.12 111.17 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.8 -12.28 32.36 Favored Glycine 0 N--CA 1.473 1.123 0 CA-C-N 115.922 -0.581 . . . . 74.15 111.965 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.41 ' HD2' HG21 ' A' ' 227' ' ' THR . 62.0 mtt85 -74.4 -175.49 2.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.24 1.016 . . . . 75.35 110.336 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.52 ' HA ' HG22 ' A' ' 253' ' ' VAL . 10.2 ptmt -168.37 165.21 12.85 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 111.752 0.278 . . . . 74.13 111.752 174.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.599 HD12 HD13 ' A' ' 251' ' ' LEU . 84.5 mt -95.57 150.56 20.2 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 123.514 0.509 . . . . 73.11 109.713 167.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -114.15 107.09 15.16 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.659 -1.237 . . . . 73.43 107.659 162.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 57.0 mt -106.99 110.75 22.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.317 -0.856 . . . . 72.41 109.748 -174.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -77.75 118.68 20.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.761 -1.109 . . . . 74.23 110.8 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.35 3.61 89.92 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 114.948 -1.024 . . . . 73.22 114.386 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -95.27 2.67 54.88 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 112.804 0.668 . . . . 75.52 112.804 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.42 -173.12 47.62 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.693 -0.963 . . . . 63.34 110.693 166.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 15.4 m-85 -58.9 134.8 87.11 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 117.737 0.769 . . . . 63.24 110.759 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 3.5 Cg_exo -76.96 139.44 19.4 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.575 2.183 . . . . 73.4 110.763 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -107.36 -167.93 22.0 Favored Glycine 0 C--O 1.238 0.345 0 CA-C-O 119.132 -0.815 . . . . 73.21 111.73 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.55 -50.44 10.72 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.693 2.262 . . . . 73.15 112.763 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.63 -25.0 5.61 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.159 0.584 . . . . 74.14 112.225 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -133.82 158.87 23.5 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-O 119.925 -0.375 . . . . 74.43 112.349 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 92.7 mtt180 -113.32 157.82 21.34 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.606 0.763 . . . . 74.43 110.763 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.46 175.73 37.77 Favored Glycine 0 N--CA 1.468 0.798 0 CA-C-N 115.528 -0.76 . . . . 53.2 111.556 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 40.2 m-20 -102.67 176.78 5.05 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.762 -0.459 . . . . 72.44 109.762 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.6 tp -134.09 108.84 8.55 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.327 0.584 . . . . 70.24 110.41 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 34.3 m-85 -102.33 103.56 14.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.032 -1.099 . . . . 74.41 108.032 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.4 pp -121.38 114.55 21.46 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.837 1.051 . . . . 72.43 113.837 -172.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.08 118.32 11.84 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.071 -1.422 . . . . 72.41 113.215 -172.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.588 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 98.2 t -62.36 122.34 12.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 113.73 -1.577 . . . . 74.11 111.701 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -121.43 122.81 40.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.912 -1.04 . . . . 74.1 108.236 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 30.5 mm -88.78 96.55 6.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 108.993 -0.743 . . . . 74.11 108.993 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.561 1.384 0 C-N-CA 125.077 1.351 . . . . 73.41 108.819 -175.311 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.485 HG23 HG21 ' A' ' 219' ' ' VAL . 3.6 m . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 108.304 -0.999 . . . . 74.54 108.304 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.84 174.49 10.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.328 -0.851 . . . . 70.23 110.914 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -101.97 -85.29 1.86 Allowed Glycine 0 C--N 1.336 0.573 0 N-CA-C 109.323 -1.511 . . . . 60.14 109.323 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -151.82 174.94 12.96 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.453 0.701 . . . . 73.21 110.811 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.426 ' HZ2' HG22 ' A' ' 223' ' ' VAL . 18.5 m95 . . . . . 0 CA--C 1.548 0.888 0 CA-C-N 115.239 -0.892 . . . . 75.21 110.96 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 C--O 1.238 0.473 0 CA-C-O 120.725 0.298 . . . . 72.34 110.248 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 58.6 mt -107.01 150.75 26.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.951 -0.759 . . . . 65.35 108.951 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 1.8 t80 -125.86 108.77 11.77 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.19 -1.041 . . . . 75.12 108.19 173.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.69 -174.86 2.77 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.082 0.953 . . . . 62.23 109.575 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 85.0 m -126.79 116.02 20.26 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.746 0.818 . . . . 72.53 109.944 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.537 HD21 HG21 ' A' ' 253' ' ' VAL . 15.7 tp -82.08 105.48 13.21 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.618 -0.882 . . . . 73.14 108.618 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.56 100.32 12.99 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.774 -0.825 . . . . 72.43 108.774 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.583 HG23 HG21 ' A' ' 210' ' ' VAL . 21.4 t -102.87 114.76 65.06 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.22 -1.03 . . . . 74.04 108.22 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.39 145.89 73.01 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 121.515 1.477 . . . . 72.5 110.342 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.76 -43.41 82.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-O 117.696 -1.145 . . . . 72.54 112.717 -176.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.2 Cg_endo -54.42 -50.06 14.78 Favored 'Trans proline' 0 C--N 1.398 3.179 0 C-N-CA 121.948 1.765 . . . . 75.11 112.703 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.458 HG21 HG12 ' A' ' 210' ' ' VAL . 17.3 mt -65.4 -35.65 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.404 0.682 . . . . 75.02 111.011 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.26 93.8 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.847 0.459 . . . . 54.41 111.012 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.5 t -70.58 -50.84 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.626 1.17 . . . . 64.21 111.975 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.41 -15.81 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.852 0.461 . . . . 72.01 110.671 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 70.79 75.57 0.61 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 111.403 -0.679 . . . . 71.41 111.403 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.16 -132.82 7.84 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.842 0.321 . . . . 71.45 112.446 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -142.95 135.42 27.52 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.983 0.913 . . . . 74.21 109.077 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.583 HG21 HG23 ' A' ' 199' ' ' VAL . 23.3 m -132.74 145.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.182 0.593 . . . . 75.33 110.18 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -71.01 142.02 50.94 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.413 0.685 . . . . 70.31 110.758 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.512 ' HB1' ' HB ' ' A' ' 219' ' ' VAL . . . -118.35 120.18 36.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.763 1.225 . . . . 74.34 109.02 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -65.32 136.98 57.23 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.053 0.941 . . . . 74.4 111.77 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.591 HG22 ' HD2' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -139.88 -174.26 3.86 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.0 0.92 . . . . 71.32 110.288 -179.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.571 ' H ' HG21 ' A' ' 214' ' ' THR . 10.6 mt -52.95 -68.4 0.17 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.656 1.582 . . . . 71.41 112.683 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -111.65 -41.23 4.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.714 -1.585 . . . . 74.11 111.352 -165.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -130.94 158.58 22.7 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-O 119.108 -0.829 . . . . 72.24 112.514 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.25 143.4 8.93 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.567 2.178 . . . . 74.41 113.416 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.512 ' HB ' ' HB1' ' A' ' 212' ' ' ALA . 78.0 t -97.22 166.13 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.902 1.281 . . . . 64.12 108.245 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -147.72 135.65 21.16 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.463 -1.31 . . . . 74.32 107.463 170.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.493 HG12 HD13 ' A' ' 233' ' ' LEU . 11.3 p -128.46 140.74 48.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 C-N-CA 123.184 0.594 . . . . 74.53 110.931 -170.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.41 108.82 5.71 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.84 0.856 . . . . 71.33 109.384 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.426 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 86.5 t -72.33 130.62 85.86 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.89 -0.782 . . . . 72.35 108.89 174.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.04 155.56 61.47 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.759 2.306 . . . . 74.02 111.202 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.92 139.52 85.36 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.402 2.068 . . . . 74.5 112.403 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 41.44 73.93 0.12 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.703 1.601 . . . . 64.13 113.653 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 231' ' ' ARG . 92.8 m -84.6 139.12 32.31 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.011 -0.995 . . . . 73.23 110.998 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.425 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 24.8 mp0 -101.75 147.31 26.62 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.208 1.003 . . . . 74.31 109.175 171.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.26 155.91 39.02 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.129 -0.941 . . . . 72.53 110.854 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.62 -19.62 30.84 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.63 -0.588 . . . . 75.15 111.63 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.52 ' HD2' HG21 ' A' ' 227' ' ' THR . 80.5 mtt85 -66.34 177.95 1.34 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.867 0.867 . . . . 74.44 110.276 167.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.615 ' HA ' HG23 ' A' ' 253' ' ' VAL . 2.2 ptmt -167.62 158.04 10.89 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.218 0.324 . . . . 75.54 110.653 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.568 HD12 HD13 ' A' ' 251' ' ' LEU . 67.9 mt -86.02 136.41 33.26 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.995 -0.743 . . . . 74.43 108.995 171.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -103.56 104.77 14.87 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.957 -1.497 . . . . 74.31 106.957 164.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 48.1 mt -107.88 106.8 17.25 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.411 -0.813 . . . . 74.44 109.257 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -80.62 116.76 20.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.736 -1.12 . . . . 72.41 111.076 -168.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 88.37 4.25 77.41 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.79 -0.641 . . . . 71.44 113.652 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.591 ' HD2' HG22 ' A' ' 214' ' ' THR . 46.2 mmtm -93.93 4.84 53.33 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.846 0.684 . . . . 73.4 112.846 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.25 -177.48 50.73 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.429 -0.65 . . . . 62.23 111.554 171.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -60.59 142.78 91.05 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 117.45 0.625 . . . . 74.34 111.636 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.571 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 38.3 Cg_endo -66.68 139.75 53.91 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.709 2.272 . . . . 74.31 113.112 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.77 170.91 22.24 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.399 -0.819 . . . . 71.02 112.548 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.11 -21.01 27.89 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.096 2.531 . . . . 75.12 113.205 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.4 -11.64 17.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.842 0.857 . . . . 70.14 111.297 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 141.28 163.66 9.64 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.717 -0.953 . . . . 75.51 110.717 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.571 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 42.0 mtm180 -69.15 170.66 9.63 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.515 0.726 . . . . 75.21 111.776 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.74 -164.26 39.9 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 112.089 -0.404 . . . . 71.05 112.089 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -121.59 152.03 39.72 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.148 -0.686 . . . . 73.32 109.148 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 23.7 tp -112.19 108.38 17.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.651 0.78 . . . . 73.2 109.227 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 53.7 m-85 -101.58 119.26 38.5 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.788 -1.19 . . . . 75.31 107.788 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.3 pp -131.79 115.7 16.29 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.786 0.803 . . . . 72.22 112.99 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -68.76 118.8 12.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.174 1.39 . . . . 74.11 112.855 -169.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 232' ' ' LYS . 67.9 t -69.6 127.1 30.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-N 114.156 -1.384 . . . . 73.52 111.31 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -124.24 130.49 52.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.591 1.556 . . . . 72.01 108.126 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.3 mm -100.18 98.44 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.336 -0.986 . . . . 74.03 108.336 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.258 1.526 0 C-N-CA 124.637 1.175 . . . . 75.42 108.386 -172.407 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 121.691 0.757 . . . . 74.23 110.196 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.61 175.32 6.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.767 -1.106 . . . . 74.44 111.421 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -105.49 -108.52 3.32 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.183 -0.917 . . . . 74.32 110.901 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.91 153.09 36.4 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.857 0.863 . . . . 72.41 109.98 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.506 ' CZ3' HG23 ' A' ' 227' ' ' THR . 23.2 m95 . . . . . 0 N--CA 1.469 0.506 0 CA-C-N 115.715 -0.675 . . . . 75.02 110.101 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 108.862 -0.792 . . . . 61.01 108.862 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.0 mt -122.72 139.32 54.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.353 0.661 . . . . 73.45 110.987 -170.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -103.62 133.49 48.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.138 -1.06 . . . . 65.23 108.138 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . . . -139.15 -172.19 3.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.523 0.729 . . . . 72.11 110.059 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.4 m -118.08 158.61 24.69 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.126 0.97 . . . . 75.4 109.919 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.527 HD21 HG22 ' A' ' 253' ' ' VAL . 16.8 tp -126.52 114.47 18.16 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.585 1.554 . . . . 72.42 107.479 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.47 99.03 12.11 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.066 -0.716 . . . . 75.25 109.066 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.636 ' HA ' HG12 ' A' ' 210' ' ' VAL . 21.4 t -109.01 108.96 60.94 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 108.161 -1.051 . . . . 73.31 108.161 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.426 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 35.9 Cg_endo -66.68 146.14 77.97 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.575 1.517 . . . . 75.44 110.329 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -46.67 -46.91 50.7 Favored Pre-proline 0 CA--C 1.563 1.453 0 O-C-N 124.198 0.936 . . . . 72.23 113.258 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 33.4 Cg_exo -57.5 -47.88 19.78 Favored 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 121.645 1.564 . . . . 72.31 113.679 177.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.6 mt -65.97 -34.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.707 0.403 . . . . 72.31 110.765 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.35 -43.07 99.68 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.411 0.444 . . . . 75.34 110.421 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.0 t -73.24 -51.2 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 124.221 0.951 . . . . 74.11 111.919 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.33 -25.97 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 120.822 0.344 . . . . 74.54 111.02 -172.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.7 75.28 1.13 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.866 -0.606 . . . . 72.2 112.431 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.99 -135.51 7.66 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 112.176 -0.37 . . . . 75.22 112.176 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.572 ' HB2' ' HZ3' ' A' ' 209' ' ' LYS . 3.5 mtmp? -130.89 150.63 51.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.068 0.947 . . . . 75.42 110.026 173.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 199' ' ' VAL . 34.8 m -140.59 157.4 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.584 0.754 . . . . 72.42 110.882 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -79.5 141.26 36.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.116 0.566 . . . . 75.32 110.944 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.476 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -119.08 118.68 32.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.2 1.4 . . . . 75.52 108.112 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 12.9 tpt -64.85 132.02 48.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.169 0.587 . . . . 74.12 111.11 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.86 -169.52 2.74 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.577 1.151 . . . . 75.1 109.783 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.457 ' HB2' ' HG2' ' A' ' 216' ' ' GLU . 4.7 mt -77.33 -66.67 0.8 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.294 1.438 . . . . 71.24 110.185 -173.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 215' ' ' LEU . 21.6 mm-40 -87.88 -31.0 19.71 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 112.268 -2.242 . . . . 72.11 110.491 -164.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -164.11 -178.85 37.96 Favored Glycine 0 C--N 1.33 0.218 0 CA-C-N 114.964 -1.017 . . . . 73.24 111.702 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.08 136.6 5.03 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.212 1.941 . . . . 75.31 112.713 172.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 49.7 t -90.41 162.64 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.402 -1.272 . . . . 72.44 107.899 173.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -142.51 129.41 20.63 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.14 -1.059 . . . . 74.53 108.14 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.448 HG22 HD22 ' A' ' 233' ' ' LEU . 14.9 p -120.69 138.96 49.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 123.552 0.741 . . . . 75.35 110.855 -174.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.7 102.99 2.93 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.037 0.935 . . . . 65.52 109.048 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.97 130.73 91.3 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.414 0.686 . . . . 71.23 109.7 176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.95 154.42 56.64 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.796 2.33 . . . . 73.42 111.827 172.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.91 130.58 29.73 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.131 1.888 . . . . 72.24 111.202 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 51.54 71.8 0.42 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.62 1.568 . . . . 73.51 112.577 -177.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.506 HG23 ' CZ3' ' A' ' 176' ' ' TRP . 92.9 m -96.03 139.89 31.56 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.078 -0.965 . . . . 65.13 110.705 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -99.44 152.21 20.24 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.047 0.939 . . . . 65.11 110.664 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -75.51 155.46 36.11 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.683 -1.144 . . . . 72.54 110.391 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.68 5.08 61.66 Favored Glycine 0 N--CA 1.471 0.98 0 CA-C-N 115.747 -0.66 . . . . 75.44 112.576 -174.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.403 ' HD2' HG21 ' A' ' 227' ' ' THR . 67.9 mtt85 -84.36 -175.58 5.85 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.155 0.982 . . . . 72.04 108.589 164.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.581 ' HA ' HG21 ' A' ' 253' ' ' VAL . 0.0 OUTLIER -167.46 149.11 5.67 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 110.123 -0.325 . . . . 74.54 110.123 169.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.688 HD13 HD13 ' A' ' 251' ' ' LEU . 62.4 mt -75.97 139.37 41.51 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.628 -0.508 . . . . 74.42 109.628 171.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -105.34 105.05 14.91 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.088 -1.078 . . . . 75.34 108.088 165.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.419 HD13 HD21 ' A' ' 249' ' ' LEU . 49.1 mt -109.81 110.85 21.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.556 -1.202 . . . . 74.15 109.56 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -88.25 123.56 32.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.243 -0.89 . . . . 75.34 110.098 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.36 4.51 83.49 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.176 -0.92 . . . . 72.13 113.601 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -101.01 9.0 42.71 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.789 0.795 . . . . 75.44 112.414 -176.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.21 -179.03 45.59 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.435 -1.066 . . . . 73.43 110.435 165.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -56.11 137.79 73.55 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 123.073 0.549 . . . . 74.14 112.177 -172.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.03 140.52 72.73 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.816 2.344 . . . . 74.11 111.707 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.28 175.0 20.08 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 116.108 -0.496 . . . . 65.41 113.387 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.41 -34.91 32.94 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 123.425 2.75 . . . . 74.34 114.001 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.47 -0.84 31.74 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.638 0.375 . . . . 63.34 111.783 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 144.11 175.97 17.72 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.497 -0.641 . . . . 75.03 111.497 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -80.91 163.48 23.33 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.425 0.69 . . . . 63.04 111.967 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.66 -175.05 45.84 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.86 -0.896 . . . . 71.22 110.86 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -111.62 168.84 9.24 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 117.969 0.884 . . . . 73.21 110.122 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.419 HD21 HD13 ' A' ' 235' ' ' LEU . 69.5 tp -134.69 108.94 8.29 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.637 0.775 . . . . 71.1 109.786 -172.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 23.2 m-85 -106.9 109.14 20.97 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.028 -1.101 . . . . 73.15 108.028 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.688 HD13 HD13 ' A' ' 233' ' ' LEU . 3.7 pp -118.74 121.93 41.26 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.602 0.715 . . . . 74.2 112.506 -172.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -69.08 130.0 41.5 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 126.501 1.92 . . . . 72.44 112.571 -169.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 232' ' ' LYS . 84.8 t -81.73 120.58 33.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 122.904 0.482 . . . . 74.34 110.958 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -114.47 120.05 38.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.055 1.342 . . . . 74.34 108.611 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.54 100.52 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.116 -1.068 . . . . 72.11 108.116 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.254 1.326 0 C-N-CA 124.816 1.247 . . . . 73.41 108.598 -173.734 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.448 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 6.6 m . . . . . 0 CA--C 1.553 1.058 0 CA-C-O 121.56 0.695 . . . . 74.53 109.624 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -104.24 179.77 4.18 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.456 -0.793 . . . . 64.45 111.641 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -102.86 -85.6 1.88 Allowed Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.416 -0.811 . . . . 73.41 111.999 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.69 158.38 43.89 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.807 0.843 . . . . 74.12 111.584 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 30.2 m95 . . . . . 0 CA--C 1.55 0.95 0 C-N-CA 124.413 1.085 . . . . 75.03 110.664 176.003 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 121.136 0.493 . . . . 65.15 111.096 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.432 ' HG ' ' HA2' ' A' ' 239' ' ' GLY . 63.2 mt -128.22 103.14 7.02 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.509 -0.923 . . . . 74.14 108.509 164.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -83.15 106.49 14.99 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.753 -1.203 . . . . 74.23 107.753 164.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.27 -173.6 2.6 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.053 0.541 . . . . 73.15 110.095 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.3 m -119.95 150.82 39.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.646 0.778 . . . . 75.45 110.009 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.607 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.5 tp -113.7 105.68 13.59 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.845 -1.539 . . . . 72.43 106.845 168.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.55 101.43 12.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.698 -1.223 . . . . 72.33 107.698 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 210' ' ' VAL . 30.9 t -110.83 118.65 47.96 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.197 -1.038 . . . . 71.11 108.197 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.02 149.91 82.69 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 121.654 1.569 . . . . 71.03 110.166 171.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.438 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.95 -41.07 83.55 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 113.061 0.763 . . . . 75.42 113.061 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 9.4 Cg_endo -54.7 -57.22 1.86 Allowed 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 121.907 1.738 . . . . 71.53 113.71 171.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.84 -31.98 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 123.206 0.602 . . . . 73.25 111.121 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -50.43 68.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.68 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.52 -48.39 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 124.023 0.827 . . . . 74.12 111.746 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.77 -32.5 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 117.824 0.284 . . . . 74.33 111.403 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.33 101.48 0.85 Allowed Glycine 0 C--N 1.343 0.946 0 N-CA-C 111.793 -0.523 . . . . 73.41 111.793 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.76 -129.49 2.95 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.603 -0.554 . . . . 74.23 112.24 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -138.33 151.64 47.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.805 0.803 . . . . 74.21 109.546 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 199' ' ' VAL . 22.6 m -145.58 158.01 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.719 0.807 . . . . 70.12 110.352 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -74.33 154.06 39.05 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.411 1.084 . . . . 72.45 111.36 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.541 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -132.13 113.93 13.9 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.208 1.003 . . . . 72.34 108.648 177.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.7 tpt -65.64 131.46 46.41 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.454 0.701 . . . . 70.42 111.771 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.64 HG23 HD21 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -130.97 -170.68 2.4 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.708 1.203 . . . . 72.44 108.586 176.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.442 ' H ' HG21 ' A' ' 214' ' ' THR . 10.5 mt -59.32 -70.14 0.17 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.583 0.706 . . . . 73.4 111.018 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -111.57 -42.2 3.91 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.019 -1.446 . . . . 75.41 111.446 -168.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -122.42 120.59 4.36 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 118.854 -0.97 . . . . 62.02 111.469 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.28 154.85 46.49 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.058 1.839 . . . . 72.11 112.935 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 39.5 t -101.84 168.71 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.109 1.364 . . . . 75.55 108.136 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.448 ' H ' ' HB ' ' A' ' 172' ' ' THR . 8.9 tt0 -141.19 134.7 29.91 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.425 -1.324 . . . . 73.24 107.425 171.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.509 HG13 HD12 ' A' ' 233' ' ' LEU . 14.6 p -131.2 141.46 45.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 122.937 0.495 . . . . 72.45 110.414 -173.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.03 117.3 15.66 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.395 -0.594 . . . . 44.33 109.395 173.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.7 t -78.91 128.66 75.89 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 109.407 -0.59 . . . . 73.15 109.407 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.07 157.32 60.14 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.763 2.309 . . . . 71.43 111.619 173.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.97 133.5 38.89 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.353 2.035 . . . . 75.43 112.455 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 54.4 68.72 0.81 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.919 1.688 . . . . 73.54 113.04 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.461 HG21 ' HD2' ' A' ' 231' ' ' ARG . 75.9 m -89.25 138.33 31.52 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.806 -1.088 . . . . 75.32 111.264 175.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -103.31 149.66 24.52 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.988 0.915 . . . . 74.01 110.746 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.87 155.29 40.05 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.227 0.954 . . . . 65.25 110.946 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 101.33 -16.82 56.48 Favored Glycine 0 N--CA 1.476 1.322 0 N-CA-C 111.081 -0.807 . . . . 55.13 111.081 -174.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.461 ' HD2' HG21 ' A' ' 227' ' ' THR . 65.4 mtt85 -65.87 172.16 3.82 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.108 0.563 . . . . 73.33 109.834 163.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.546 ' HA ' HG22 ' A' ' 253' ' ' VAL . 11.4 ptmt -168.03 151.49 5.93 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.359 0.412 . . . . 73.33 110.688 174.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.533 HD11 HD13 ' A' ' 251' ' ' LEU . 85.6 mt -83.48 152.85 24.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 110.318 -0.253 . . . . 75.11 110.318 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -120.93 106.93 12.09 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.751 1.282 . . . . 74.12 107.957 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.467 HD11 HD23 ' A' ' 249' ' ' LEU . 59.4 mt -117.03 127.99 54.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.764 0.826 . . . . 74.41 109.673 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.418 ' HD3' ' HB3' ' A' ' 248' ' ' ASP . 32.5 mmtp -101.36 138.75 37.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.692 0.397 . . . . 74.21 110.126 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.01 13.5 83.3 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 124.279 0.987 . . . . 65.42 113.167 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.634 ' HE3' HG22 ' A' ' 214' ' ' THR . 27.6 mmmt -108.87 -14.32 14.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.467 0.634 . . . . 75.5 112.632 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.432 ' HA2' ' HG ' ' A' ' 193' ' ' LEU . . . -74.66 -170.92 26.09 Favored Glycine 0 N--CA 1.478 1.443 0 CA-C-O 119.855 -0.414 . . . . 74.14 113.349 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -58.56 147.1 71.15 Favored Pre-proline 0 N--CA 1.487 1.425 0 C-N-CA 123.41 0.684 . . . . 73.0 111.806 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -63.7 137.82 60.88 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.707 2.271 . . . . 74.4 111.871 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.9 175.13 20.49 Favored Glycine 0 N--CA 1.468 0.828 0 CA-C-N 115.179 -0.919 . . . . 64.1 113.606 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.76 -28.54 20.31 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 123.149 2.566 . . . . 75.53 112.285 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.7 23.38 7.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.613 0.765 . . . . 62.0 110.92 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 117.84 -95.83 0.66 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.482 -0.647 . . . . 74.22 111.482 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 40.9 mtm-85 -148.53 165.44 31.22 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.571 1.148 . . . . 74.41 109.683 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -90.86 -155.09 31.17 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.621 0.575 . . . . 55.23 112.981 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.418 ' HB3' ' HD3' ' A' ' 236' ' ' LYS . 31.9 p30 -127.17 163.51 23.68 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.991 0.9 . . . . 72.35 112.234 -176.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.64 HD21 HG23 ' A' ' 214' ' ' THR . 12.6 tp -130.32 109.42 10.74 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.027 -1.442 . . . . 73.01 109.697 -171.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 25.6 m-85 -107.63 110.07 21.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.421 -0.955 . . . . 73.01 108.421 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 233' ' ' LEU . 3.7 pp -120.43 114.78 22.32 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.687 0.625 . . . . 73.31 112.687 -170.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.0 113.34 6.29 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.67 1.188 . . . . 74.32 112.706 -171.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.607 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 53.1 t -64.08 127.3 24.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.54 1.136 . . . . 74.42 110.893 173.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -126.27 129.7 49.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.986 1.314 . . . . 74.32 108.769 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.9 mm -99.55 107.46 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.33 -0.989 . . . . 74.22 108.33 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.56 1.337 0 CA-C-N 114.861 -1.063 . . . . 74.41 109.029 -169.419 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.428 HG22 HG21 ' A' ' 219' ' ' VAL . 18.2 m . . . . . 0 CA--C 1.55 0.975 0 CA-C-O 121.44 0.638 . . . . 73.25 109.718 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.22 149.39 23.13 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.19 -0.914 . . . . 63.3 111.139 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -69.79 -89.1 0.09 OUTLIER Glycine 0 C--N 1.347 1.147 0 O-C-N 124.026 0.829 . . . . 73.33 111.393 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.97 -178.36 5.89 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.896 0.879 . . . . 74.25 110.209 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.455 ' HZ2' HG23 ' A' ' 223' ' ' VAL . 23.5 m95 . . . . . 0 C--O 1.244 0.772 0 CA-C-N 115.549 -0.751 . . . . 74.2 109.579 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 . . . . . 0 C--O 1.239 0.506 0 CA-C-O 120.63 0.252 . . . . 74.5 110.753 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 79.5 mt -117.01 137.13 52.43 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.054 0.541 . . . . 73.2 110.3 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -103.38 108.87 20.28 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.952 -1.129 . . . . 65.22 107.952 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.602 ' HB1' ' HB3' ' A' ' 251' ' ' LEU . . . -120.27 -172.12 2.3 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.412 1.085 . . . . 74.11 109.243 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 90.8 m -124.9 139.37 53.9 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.673 0.789 . . . . 71.34 110.164 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 16.0 tp -97.23 105.84 18.06 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.664 -0.865 . . . . 74.35 108.664 170.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -86.77 101.59 13.46 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.999 -0.741 . . . . 72.33 108.999 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.553 ' HA ' HG13 ' A' ' 210' ' ' VAL . 1.4 p -119.46 113.68 34.93 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.703 0.801 . . . . 73.12 109.351 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.4 145.7 78.08 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.945 1.763 . . . . 64.55 111.054 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -44.35 -47.68 25.2 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.334 1.053 . . . . 71.34 113.625 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.5 -48.09 23.32 Favored 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 121.935 1.757 . . . . 75.32 113.976 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.46 HG21 HG11 ' A' ' 210' ' ' VAL . 60.5 mt -65.84 -33.74 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 122.938 0.495 . . . . 72.22 110.471 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.47 93.73 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.914 0.485 . . . . 75.45 111.16 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 226' ' ' ARG . 58.9 t -72.94 -45.88 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.39 1.076 . . . . 74.1 111.912 -175.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.62 -29.66 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 120.71 0.29 . . . . 73.34 110.255 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.65 73.21 1.18 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.415 -0.674 . . . . 70.44 111.415 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.01 -127.2 6.04 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 120.135 -0.258 . . . . 74.45 112.457 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -143.75 137.59 28.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.647 0.779 . . . . 64.14 109.752 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.553 HG13 ' HA ' ' A' ' 199' ' ' VAL . 31.5 m -137.29 154.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.833 0.453 . . . . 73.41 111.108 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -76.13 142.93 41.49 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.758 -1.11 . . . . 73.12 111.192 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.573 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -113.97 117.39 31.2 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.917 1.287 . . . . 71.2 108.283 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.0 tpt -63.82 121.08 13.16 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.057 0.943 . . . . 71.22 111.498 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.445 HG21 ' H ' ' A' ' 215' ' ' LEU . 0.2 OUTLIER -123.82 -171.25 2.28 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.053 1.341 . . . . 73.44 109.653 -178.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.445 ' H ' HG21 ' A' ' 214' ' ' THR . 9.2 mt -59.58 -69.4 0.21 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.583 1.153 . . . . 73.52 112.044 -175.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.92 -42.11 3.45 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 113.94 -1.482 . . . . 74.34 111.445 -166.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -119.33 167.3 13.28 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.283 -0.871 . . . . 63.53 111.172 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.41 154.81 10.67 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.987 1.792 . . . . 71.23 113.202 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 69.5 t -106.3 166.26 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 107.086 -1.45 . . . . 72.23 107.086 165.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.28 140.2 25.05 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.32 -0.992 . . . . 64.12 108.32 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.451 HG12 HD11 ' A' ' 233' ' ' LEU . 8.7 p -134.18 142.24 41.54 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 C-N-CA 123.162 0.585 . . . . 74.14 110.86 -172.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.97 108.23 8.71 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.961 0.904 . . . . 74.3 109.187 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.455 HG23 ' HZ2' ' A' ' 176' ' ' TRP . 59.5 t -71.54 132.61 85.43 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.132 0.973 . . . . 73.51 109.279 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -64.02 155.44 64.52 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.794 2.329 . . . . 75.22 112.483 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.51 130.48 31.89 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.273 1.982 . . . . 71.24 111.804 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 205' ' ' VAL . 33.3 mtp-105 49.7 71.23 0.41 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.514 1.526 . . . . 71.11 113.266 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.425 HG22 ' HD2' ' A' ' 231' ' ' ARG . 98.7 m -87.45 142.74 27.64 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.884 -1.053 . . . . 75.23 111.1 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -103.06 154.67 19.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.001 0.92 . . . . 74.41 110.604 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.72 155.41 29.4 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.452 -1.249 . . . . 71.15 110.615 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.03 -13.02 52.69 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 111.594 -0.602 . . . . 63.45 111.594 -173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.425 ' HD2' HG22 ' A' ' 227' ' ' THR . 68.0 mtt85 -70.43 -176.34 1.21 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.04 0.936 . . . . 72.33 110.55 170.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.593 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 10.3 ptmt -167.57 156.32 9.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.341 0.256 . . . . 72.14 110.573 171.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.495 HD13 HD12 ' A' ' 251' ' ' LEU . 73.5 mt -87.51 151.58 22.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.509 -0.552 . . . . 75.25 109.509 168.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -119.85 105.87 11.52 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.335 -1.357 . . . . 75.42 107.335 168.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 67.6 mt -114.19 117.04 30.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.281 0.633 . . . . 74.44 110.698 -170.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -84.99 133.36 34.26 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 116.275 -0.42 . . . . 75.24 111.287 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.27 1.11 89.89 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 114.884 -1.053 . . . . 74.13 113.77 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -98.02 -0.38 44.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.384 0.674 . . . . 72.24 112.523 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.86 -172.35 48.36 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 111.18 -0.768 . . . . 71.43 111.18 167.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -65.17 142.61 98.61 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-N 117.24 0.52 . . . . 75.33 111.541 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.431 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.5 Cg_endo -65.92 133.7 34.59 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.853 2.368 . . . . 74.01 112.093 172.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.42 172.92 21.65 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 119.436 -0.647 . . . . 45.51 113.192 -176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.68 -23.33 26.72 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.097 2.531 . . . . 63.32 112.543 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.71 22.26 8.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.958 0.903 . . . . 74.32 110.751 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 94.9 -173.36 31.87 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 110.471 -1.052 . . . . 70.12 110.471 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.431 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 80.8 mtm180 -84.11 158.35 21.41 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 117.417 0.608 . . . . 73.31 110.883 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.78 -164.66 38.61 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.502 -0.772 . . . . 64.44 111.933 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -124.57 164.47 19.75 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.583 0.706 . . . . 64.32 110.634 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.0 tp -123.01 108.56 13.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.078 -0.964 . . . . 73.44 108.613 -171.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.593 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 33.3 m-85 -100.53 112.75 25.16 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.091 -1.448 . . . . 73.42 107.091 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.602 ' HB3' ' HB1' ' A' ' 195' ' ' ALA . 2.6 pp -127.86 115.81 19.18 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.498 0.925 . . . . 74.15 113.498 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -67.64 117.65 9.86 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.556 -1.202 . . . . 73.15 112.05 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 232' ' ' LYS . 95.1 t -68.82 116.73 9.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 125.167 1.387 . . . . 75.14 111.509 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -106.65 117.03 32.99 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.355 -1.293 . . . . 73.0 108.803 170.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.426 HD11 HG12 ' A' ' 199' ' ' VAL . 42.3 mm -79.1 96.28 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 106.529 -1.656 . . . . 75.33 106.529 168.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.26 1.651 0 CA-C-O 117.31 -1.329 . . . . 74.41 108.64 -174.718 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.572 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 16.8 m . . . . . 0 CA--C 1.556 1.174 0 CA-C-O 121.745 0.783 . . . . 73.14 110.78 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.54 -176.0 6.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.298 1.039 . . . . 71.4 113.045 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -106.15 -88.95 2.07 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 114.473 -1.24 . . . . 73.01 110.269 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -146.98 153.66 40.32 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 112.734 0.642 . . . . 75.41 112.734 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.441 ' HA ' HD23 ' A' ' 233' ' ' LEU . 34.3 m95 . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 124.275 1.03 . . . . 74.41 109.993 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 C--O 1.238 0.496 0 CA-C-O 120.734 0.302 . . . . 73.32 110.976 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 74.5 mt -120.9 145.33 47.78 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.572 0.749 . . . . 74.43 110.89 -176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 31.2 t80 -102.26 132.39 48.24 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.68 0.792 . . . . 72.34 109.082 172.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.578 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -138.05 -171.84 3.12 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.383 0.673 . . . . 71.54 109.536 173.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 95.8 m -131.04 109.2 10.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.457 0.703 . . . . 72.24 111.14 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.586 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 16.3 tp -72.88 105.29 4.33 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.171 -1.048 . . . . 63.12 108.171 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -80.26 99.58 7.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.968 -1.015 . . . . 71.41 108.867 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.626 HG21 HG23 ' A' ' 210' ' ' VAL . 13.6 t -113.96 106.44 53.41 Favored Pre-proline 0 N--CA 1.472 0.666 0 N-CA-C 108.362 -0.977 . . . . 72.3 108.362 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.29 152.77 78.78 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.414 1.41 . . . . 73.43 110.495 174.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.18 -45.86 75.95 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 114.017 1.117 . . . . 74.11 114.017 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.72 -48.2 17.87 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 121.76 1.64 . . . . 72.23 112.9 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.455 HG21 HG12 ' A' ' 210' ' ' VAL . 50.0 mt -67.75 -33.68 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.332 0.653 . . . . 75.43 110.973 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.31 87.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.045 -0.525 . . . . 73.44 110.473 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.05 -47.74 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.415 1.086 . . . . 63.32 111.495 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.99 -32.19 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-O 120.775 0.321 . . . . 75.24 110.729 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.84 68.58 1.41 Allowed Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.789 -0.642 . . . . 72.52 112.047 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.91 -123.99 5.33 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 112.523 -0.231 . . . . 75.14 112.523 -175.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -142.49 143.68 32.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.747 0.819 . . . . 75.04 109.713 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.626 HG23 HG21 ' A' ' 199' ' ' VAL . 28.8 m -140.79 151.66 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.423 0.689 . . . . 75.32 111.114 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -78.22 150.22 33.5 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.862 0.865 . . . . 73.2 111.399 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -130.63 114.21 15.15 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.375 1.47 . . . . 63.21 109.001 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -64.11 124.03 20.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.653 0.781 . . . . 75.32 110.781 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.451 HG21 ' H ' ' A' ' 215' ' ' LEU . 0.2 OUTLIER -111.54 -169.66 1.5 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.936 1.294 . . . . 73.44 108.095 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.451 ' H ' HG21 ' A' ' 214' ' ' THR . 7.8 mt -45.81 -70.33 0.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.863 1.265 . . . . 75.24 112.001 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -113.29 -43.56 3.34 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 113.892 -1.504 . . . . 74.24 110.84 -168.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -114.9 -179.25 18.72 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 115.646 -0.706 . . . . 63.41 112.426 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -92.65 164.07 2.81 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.213 1.942 . . . . 72.14 113.968 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 12.7 t -121.47 168.79 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 106.173 -1.788 . . . . 72.25 106.173 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.572 ' H ' ' HB ' ' A' ' 172' ' ' THR . 13.5 tt0 -148.67 143.28 26.39 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.116 -1.068 . . . . 72.03 108.116 173.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.412 HG12 HD23 ' A' ' 197' ' ' LEU . 13.3 p -136.35 143.12 36.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 C-N-CA 123.256 0.623 . . . . 75.35 111.475 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.14 110.29 8.32 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.408 1.083 . . . . 74.33 109.73 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 79.9 t -77.16 134.92 66.87 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 123.888 0.875 . . . . 54.32 109.852 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.0 155.64 61.5 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.904 2.402 . . . . 62.53 112.249 169.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.35 132.34 45.88 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.978 2.452 . . . . 73.22 112.134 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 49.58 73.27 0.25 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.376 1.47 . . . . 72.2 113.105 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 231' ' ' ARG . 97.0 m -89.56 142.26 27.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.504 -1.226 . . . . 71.31 111.069 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -105.45 158.37 16.71 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.107 0.963 . . . . 75.35 110.383 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -82.26 148.73 28.22 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.22 -1.354 . . . . 73.12 110.411 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.46 -28.74 8.03 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 110.843 -0.903 . . . . 72.22 110.843 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.414 ' HD2' HG21 ' A' ' 227' ' ' THR . 75.1 mtt85 -58.92 171.72 0.64 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.078 0.951 . . . . 73.32 110.645 165.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.488 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.9 ptmt -165.89 149.84 7.98 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.126 0.266 . . . . 75.3 110.691 172.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.677 HD11 HD11 ' A' ' 251' ' ' LEU . 84.1 mt -79.49 155.64 28.17 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 123.532 0.52 . . . . 74.34 109.715 171.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -126.58 106.66 9.58 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.405 -1.332 . . . . 74.11 107.405 169.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 39.4 mt -105.32 112.21 25.23 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.531 -0.759 . . . . 71.41 110.045 -172.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -77.18 117.44 18.72 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.429 -1.26 . . . . 64.03 111.0 -171.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 92.55 -4.73 76.67 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.329 1.018 . . . . 72.53 113.612 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.435 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 33.9 mmtp -95.58 5.62 51.02 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.588 0.755 . . . . 74.14 112.518 -172.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.95 -178.28 50.04 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 110.81 -0.916 . . . . 45.32 110.81 166.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.48 138.22 96.44 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-N 117.402 0.601 . . . . 72.32 111.476 -174.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.49 143.62 69.98 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.316 2.677 . . . . 75.5 112.949 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.67 -178.67 15.82 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 115.844 -0.616 . . . . 73.32 113.61 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.04 -49.76 3.56 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.598 2.865 . . . . 73.21 113.393 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.28 -34.01 37.3 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 122.92 0.488 . . . . 72.44 110.989 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.32 179.88 46.14 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 114.766 -1.107 . . . . 75.24 111.391 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -79.0 168.37 19.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.523 0.729 . . . . 75.4 110.899 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.21 -167.58 39.93 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.608 -0.724 . . . . 72.34 112.063 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -119.91 171.0 8.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 122.238 -0.566 . . . . 73.41 109.873 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.653 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 43.8 tp -129.41 108.73 10.51 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.57 0.7 . . . . 65.12 110.682 -174.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 46.0 m-85 -100.11 110.5 22.78 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.141 -1.059 . . . . 70.0 108.141 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.677 HD11 HD11 ' A' ' 233' ' ' LEU . 3.1 pp -125.66 114.99 19.4 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.435 0.636 . . . . 74.23 112.417 -173.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -70.15 120.29 15.63 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 114.689 -1.141 . . . . 63.42 113.452 -170.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.586 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 48.4 t -65.1 126.83 24.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 113.89 -1.505 . . . . 75.04 110.031 174.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -129.67 128.23 42.14 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.045 1.338 . . . . 74.31 108.975 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 29.2 mm -95.92 104.4 15.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.183 -1.043 . . . . 74.53 108.183 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.293 0 CA-C-O 117.386 -1.292 . . . . 72.22 108.783 -168.878 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 19.1 m . . . . . 0 CA--C 1.554 1.123 0 CA-C-O 120.863 0.363 . . . . 73.2 111.395 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.79 160.85 14.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.854 0.862 . . . . 75.04 111.904 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.46 ' H ' HD23 ' A' ' 235' ' ' LEU . . . -73.35 -108.41 0.07 OUTLIER Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.31 -0.859 . . . . 65.34 111.203 166.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -138.77 176.74 8.44 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.749 0.774 . . . . 70.44 111.716 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.421 ' HZ2' HG22 ' A' ' 223' ' ' VAL . 29.6 m95 . . . . . 0 C--O 1.239 0.527 0 CA-C-N 114.601 -1.181 . . . . 64.32 110.25 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 110.143 -0.317 . . . . 75.12 110.143 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.3 mt -119.35 160.62 21.92 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.656 0.782 . . . . 75.13 110.914 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 4.4 t80 -121.77 108.33 13.37 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.188 -0.671 . . . . 74.2 109.188 171.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . . . -116.8 -170.85 1.91 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.42 1.088 . . . . 63.03 109.5 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.9 m -119.12 126.04 50.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.985 0.914 . . . . 72.14 110.429 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.589 ' HB2' HD12 ' A' ' 251' ' ' LEU . 25.2 tp -84.51 104.76 14.79 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 107.769 -1.197 . . . . 75.24 107.769 166.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -86.95 106.39 17.77 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.165 -0.68 . . . . 74.33 109.165 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 210' ' ' VAL . 21.7 t -114.13 120.76 37.92 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.65 -0.87 . . . . 72.11 108.65 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.89 150.61 61.63 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 121.77 1.646 . . . . 75.11 110.217 170.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.67 -45.24 96.6 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 117.808 -1.091 . . . . 64.11 112.834 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -56.26 -50.36 12.33 Favored 'Trans proline' 0 C--N 1.401 3.294 0 C-N-CA 122.077 1.851 . . . . 74.22 112.87 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.432 HG21 HG13 ' A' ' 210' ' ' VAL . 28.1 mt -64.74 -34.49 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.41 0.684 . . . . 74.4 110.626 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.403 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -64.53 -42.61 95.65 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.072 -0.513 . . . . 71.02 111.137 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.4 t -73.92 -49.78 32.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 123.982 0.913 . . . . 70.5 111.844 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.2 -28.45 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.373 0.269 . . . . 74.3 110.878 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.15 77.79 1.18 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.993 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.01 -137.28 8.2 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.725 -0.486 . . . . 75.21 112.0 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -133.77 139.84 46.58 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.801 0.8 . . . . 73.21 109.806 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 199' ' ' VAL . 35.6 m -133.4 153.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.229 0.612 . . . . 73.54 111.064 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 212' ' ' ALA . 22.9 ttm180 -75.73 154.54 36.34 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.905 0.882 . . . . 74.42 110.716 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -132.23 120.76 22.63 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.521 1.528 . . . . 74.41 108.383 176.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.06 132.23 48.65 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.766 0.827 . . . . 75.12 110.467 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.644 HG23 ' HD2' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -136.14 -172.72 3.2 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.663 0.785 . . . . 75.22 110.162 -175.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.6 ' H ' HG22 ' A' ' 214' ' ' THR . 6.4 mt -63.78 -67.41 0.43 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.298 1.439 . . . . 73.12 110.671 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -103.74 -41.55 5.89 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 113.322 -1.763 . . . . 73.34 111.554 -162.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -150.7 154.02 25.36 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.046 -0.863 . . . . 63.24 111.76 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.16 142.0 30.11 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.603 2.202 . . . . 73.11 113.55 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 73.1 t -95.62 163.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 114.471 -1.241 . . . . 72.33 108.286 175.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -142.81 136.92 29.29 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.371 -1.344 . . . . 74.32 107.371 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.451 HG12 HD12 ' A' ' 233' ' ' LEU . 12.3 p -132.26 140.38 47.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.481 0.712 . . . . 65.41 110.688 -172.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.31 109.42 9.99 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.063 0.945 . . . . 75.34 109.323 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.421 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 93.1 t -73.73 131.02 82.52 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.212 1.005 . . . . 73.54 109.388 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.88 155.2 58.16 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.433 2.089 . . . . 65.05 111.05 171.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.55 136.23 53.33 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.314 2.009 . . . . 63.13 112.7 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 51.66 69.25 0.68 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.646 1.579 . . . . 73.44 112.706 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.423 HG22 ' HD2' ' A' ' 231' ' ' ARG . 69.8 m -85.03 141.08 30.54 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.85 -1.068 . . . . 72.52 110.613 174.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -102.16 155.63 18.08 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.78 0.832 . . . . 65.02 110.1 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -83.91 154.83 23.18 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.652 -1.158 . . . . 62.21 111.212 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.88 -6.78 57.06 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.935 -0.575 . . . . 51.55 111.933 -173.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.423 ' HD2' HG22 ' A' ' 227' ' ' THR . 65.9 mtt85 -72.09 179.47 3.28 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.916 0.886 . . . . 74.01 109.722 168.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.486 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.2 ptpt -168.27 150.94 5.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.882 0.473 . . . . 74.33 110.464 169.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.502 ' HG ' HD22 ' A' ' 197' ' ' LEU . 56.9 mt -85.18 156.03 21.18 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.751 -0.833 . . . . 73.03 108.751 169.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -115.32 123.74 49.51 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 106.459 -1.682 . . . . 75.45 106.459 157.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 46.5 mt -112.21 108.18 17.33 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.898 -0.779 . . . . 72.31 108.898 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -70.41 113.2 7.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.136 -1.393 . . . . 74.45 111.443 -170.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 91.74 -5.88 79.71 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.248 -0.887 . . . . 62.11 113.771 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.644 ' HD2' HG23 ' A' ' 214' ' ' THR . 48.4 mmtm -86.87 10.08 17.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.405 0.682 . . . . 74.42 112.213 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.16 169.56 24.07 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.786 -1.326 . . . . 74.02 109.786 164.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 41.4 m-85 -57.22 139.51 79.57 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 123.363 0.665 . . . . 62.54 112.129 -173.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 11.7 Cg_exo -69.6 150.04 68.69 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.907 2.405 . . . . 73.3 113.076 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.68 171.95 21.8 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.801 -0.999 . . . . 65.32 111.018 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -61.66 -48.22 9.57 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.988 2.459 . . . . 74.23 113.393 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.57 -19.07 28.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.287 0.635 . . . . 72.32 111.863 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 171.31 169.43 34.24 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.944 -0.462 . . . . 72.11 111.944 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -85.51 170.22 12.84 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.788 0.835 . . . . 74.43 110.864 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.95 179.95 48.73 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.299 -0.864 . . . . 64.32 111.224 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -122.69 153.16 39.78 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.578 -0.527 . . . . 75.53 109.578 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.632 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.8 tp -106.2 106.75 17.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.352 -0.61 . . . . 73.33 109.352 -172.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 48.8 m-85 -98.98 109.12 21.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.998 -1.482 . . . . 74.15 106.998 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -126.55 117.49 22.93 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.95 1.092 . . . . 65.53 113.95 -177.198 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.86 118.78 10.18 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 113.133 -1.849 . . . . 72.1 112.518 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.527 HG21 HD21 ' A' ' 197' ' ' LEU . 52.3 t -69.68 109.49 2.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 114.329 -1.305 . . . . 75.31 110.68 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -100.25 118.17 35.98 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.53 1.132 . . . . 74.41 108.824 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.26 107.94 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.462 -1.31 . . . . 62.44 107.462 170.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.329 0 C-N-CA 124.301 1.04 . . . . 63.21 108.258 -174.096 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.417 HG23 HG22 ' A' ' 219' ' ' VAL . 17.0 m . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 121.315 0.578 . . . . 75.31 110.633 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.9 -168.79 0.95 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.861 0.865 . . . . 70.32 112.59 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.07 -87.52 1.03 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 110.194 -1.163 . . . . 63.4 110.194 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.27 174.51 10.47 Favored 'General case' 0 C--O 1.248 0.98 0 C-N-CA 123.477 0.711 . . . . 75.51 109.917 172.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.446 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 19.1 m95 . . . . . 0 C--O 1.243 0.751 0 CA-C-N 115.313 -0.858 . . . . 73.14 109.744 167.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 109.692 -0.484 . . . . 65.14 109.692 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 80.5 mt -129.0 166.52 19.05 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.424 0.63 . . . . 74.02 111.747 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 25.4 t80 -120.26 139.37 52.81 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.612 -1.176 . . . . 75.0 109.267 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -151.72 -170.44 3.65 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.003 0.921 . . . . 72.23 109.819 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.4 m -119.72 140.99 49.83 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.695 0.798 . . . . 74.34 110.964 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 19.5 tp -100.48 108.23 20.14 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.105 0.962 . . . . 73.34 108.413 168.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -83.46 100.1 10.52 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.26 -0.645 . . . . 73.41 109.26 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.597 ' HA ' HG12 ' A' ' 210' ' ' VAL . 21.7 t -108.39 115.17 58.42 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 108.334 -0.987 . . . . 72.03 108.334 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.81 145.0 49.94 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 121.571 1.514 . . . . 75.15 110.6 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.27 -47.91 56.35 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 114.252 1.204 . . . . 73.52 114.252 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.79 -45.85 33.64 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 122.235 1.957 . . . . 73.51 113.768 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.2 mt -65.87 -34.92 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.942 0.497 . . . . 72.33 110.535 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.13 -44.39 92.33 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.07 -0.514 . . . . 73.13 111.385 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.3 t -71.03 -46.4 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.99 0.916 . . . . 72.2 112.028 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.03 -28.33 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 120.561 0.219 . . . . 73.1 110.623 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.89 72.3 1.23 Allowed Glycine 0 C--N 1.346 1.084 0 N-CA-C 111.233 -0.747 . . . . 62.41 111.233 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.7 -126.59 5.74 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 112.33 -0.308 . . . . 72.34 112.33 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -142.33 148.02 37.27 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.266 1.027 . . . . 74.44 108.849 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 199' ' ' VAL . 27.8 m -142.43 158.89 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 123.134 0.573 . . . . 73.52 110.69 174.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -75.8 151.11 37.59 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.776 0.83 . . . . 75.34 110.18 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.495 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -128.2 114.59 17.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 75.05 108.576 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.6 tpt -64.51 109.58 2.01 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.129 0.572 . . . . 73.44 110.933 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.486 ' OG1' HG21 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -93.45 -169.1 2.04 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.247 1.419 . . . . 73.13 108.933 175.174 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.55 -69.16 0.12 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.464 1.126 . . . . 75.42 110.581 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.76 -42.52 3.41 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 112.793 -2.003 . . . . 72.32 110.746 -170.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -101.77 176.78 26.38 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.507 -0.769 . . . . 65.32 112.607 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -102.4 145.94 0.22 Allowed 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 122.882 2.388 . . . . 61.44 114.234 168.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 50.2 t -104.06 168.79 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.158 1.383 . . . . 71.45 108.055 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -142.04 139.23 32.27 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.094 -1.076 . . . . 74.22 108.094 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.456 HG12 HD12 ' A' ' 233' ' ' LEU . 12.7 p -134.25 144.64 34.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 123.627 0.771 . . . . 73.05 110.153 -173.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.04 113.12 19.02 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.421 0.688 . . . . 64.52 109.373 174.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 89.8 t -76.77 132.14 72.3 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.707 0.803 . . . . 74.25 109.512 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.83 161.34 44.36 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.803 2.335 . . . . 72.52 112.376 171.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.37 131.9 22.78 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.135 1.89 . . . . 74.45 112.315 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 52.79 72.21 0.43 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.998 1.319 . . . . 75.54 112.63 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 97.3 m -91.51 143.59 26.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.636 -1.166 . . . . 74.31 110.915 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -108.51 160.49 15.86 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.264 1.025 . . . . 73.35 110.635 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -80.07 155.17 27.66 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.991 -1.004 . . . . 72.45 111.264 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.6 -20.95 35.79 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 112.141 -0.384 . . . . 62.01 112.141 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -65.68 178.11 1.09 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.11 0.964 . . . . 72.25 110.551 167.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.567 ' HA ' HG22 ' A' ' 253' ' ' VAL . 12.4 ptmt -167.13 153.95 8.54 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 116.703 -0.226 . . . . 74.13 110.955 173.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.623 HD11 HD12 ' A' ' 251' ' ' LEU . 75.2 mt -84.23 152.03 24.45 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.862 -0.422 . . . . 72.01 109.862 170.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -117.8 107.18 13.83 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.354 -1.35 . . . . 73.3 107.354 161.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.671 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 65.4 mt -102.97 107.92 18.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.085 -0.961 . . . . 74.34 109.725 -173.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -78.61 120.7 23.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.635 -1.166 . . . . 74.13 111.426 -165.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.91 18.98 80.14 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.502 1.126 . . . . 74.24 113.761 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.402 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 43.4 mmtm -105.09 3.34 30.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.047 0.539 . . . . 75.51 111.842 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -83.75 -172.57 48.99 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 111.087 -0.805 . . . . 74.11 111.087 168.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 10.2 m-85 -62.04 137.0 95.49 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 117.213 0.506 . . . . 74.43 111.802 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.578 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 15.0 Cg_exo -69.64 143.72 52.37 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.038 2.492 . . . . 72.35 112.257 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.57 173.33 20.9 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.109 -0.95 . . . . 73.34 112.12 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.83 -14.29 26.74 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 123.106 2.537 . . . . 73.12 113.415 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.61 -17.94 12.91 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.837 0.855 . . . . 74.51 111.957 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 162.46 -162.13 34.16 Favored Glycine 0 C--O 1.221 -0.719 0 N-CA-C 109.52 -1.432 . . . . 61.12 109.52 -173.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.578 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 99.0 mtt180 -115.61 160.37 20.09 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 118.511 1.156 . . . . 72.22 110.67 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 177.28 54.34 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.348 -0.842 . . . . 55.11 111.765 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -119.31 143.14 47.53 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.367 0.603 . . . . 75.14 109.72 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 51.7 tp -102.4 108.04 19.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.438 -0.801 . . . . 74.1 110.006 -168.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 53.6 m-85 -100.58 106.6 18.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.916 -1.038 . . . . 75.41 108.776 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.623 HD12 HD11 ' A' ' 233' ' ' LEU . 1.8 pp -124.47 118.57 26.93 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.58 0.955 . . . . 73.53 113.58 -174.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.77 116.13 8.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.405 1.482 . . . . 75.45 112.488 -172.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 232' ' ' LYS . 59.4 t -64.24 118.85 7.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-N 114.092 -1.413 . . . . 75.43 111.081 175.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -114.32 117.51 31.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.431 1.492 . . . . 72.43 108.576 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.6 mm -87.82 106.75 16.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.088 -1.079 . . . . 74.35 108.088 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.259 1.581 0 C-N-CA 124.615 1.166 . . . . 72.22 108.131 -171.833 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.7 m . . . . . 0 CA--C 1.548 0.892 0 CA-C-O 121.78 0.8 . . . . 75.02 108.904 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -91.86 164.03 13.82 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.013 -0.994 . . . . 72.34 110.871 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -99.08 -88.82 1.97 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 111.34 -0.704 . . . . 74.54 111.34 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.23 159.67 41.77 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.114 0.966 . . . . 73.42 110.232 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.504 ' HA ' HD23 ' A' ' 233' ' ' LEU . 26.0 m95 . . . . . 0 CA--C 1.544 0.728 0 CA-C-N 115.473 -0.785 . . . . 75.24 109.201 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 C--O 1.239 0.543 0 N-CA-C 110.097 -0.335 . . . . 73.22 110.097 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.5 mt -121.2 146.05 47.19 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.917 0.487 . . . . 75.13 111.762 -171.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -99.56 111.0 23.4 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.005 -0.998 . . . . 74.22 108.487 171.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 251' ' ' LEU . . . -120.39 -170.45 1.98 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.416 1.086 . . . . 75.14 109.752 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.3 m -120.87 138.92 53.84 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 124.274 1.03 . . . . 74.0 111.07 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.517 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.8 tp -94.56 107.0 19.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.2 -1.037 . . . . 72.31 108.2 168.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.411 ' O ' ' HB ' ' A' ' 210' ' ' VAL . 14.3 t70 -80.52 109.08 14.7 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.983 -0.747 . . . . 72.3 108.983 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.481 ' HB ' HG23 ' A' ' 210' ' ' VAL . 0.9 OUTLIER -132.23 118.36 16.12 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 122.68 0.392 . . . . 75.23 110.191 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 53.9 Cg_endo -70.62 148.08 58.73 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.982 1.788 . . . . 64.22 111.373 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.37 -45.6 83.82 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.495 1.118 . . . . 74.31 113.945 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.9 Cg_exo -56.07 -47.48 24.45 Favored 'Trans proline' 0 C--N 1.396 3.052 0 C-N-CA 122.065 1.844 . . . . 55.42 113.034 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.57 -37.33 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.406 0.682 . . . . 72.42 110.717 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.81 -43.74 97.79 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.045 0.538 . . . . 63.3 110.867 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.3 -48.69 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.405 1.082 . . . . 74.24 112.031 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.5 p -79.48 -32.09 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 117.955 0.343 . . . . 73.14 111.192 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.86 106.17 1.35 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.474 -0.65 . . . . 64.22 111.474 -171.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.48 -138.13 3.6 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 119.518 -0.601 . . . . 72.33 111.883 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -138.98 137.3 36.25 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.693 0.797 . . . . 74.54 109.402 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.481 HG23 ' HB ' ' A' ' 199' ' ' VAL . 24.3 m -137.54 153.3 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.92 0.488 . . . . 60.44 111.19 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -76.91 139.05 40.08 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.559 -0.746 . . . . 74.31 111.132 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -111.76 111.43 22.4 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.154 -1.425 . . . . 73.0 107.154 170.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -69.13 114.12 7.12 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.071 0.548 . . . . 61.43 109.888 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.554 HG21 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -108.38 -173.12 2.2 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.311 1.044 . . . . 73.41 109.432 178.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.501 ' H ' HG22 ' A' ' 214' ' ' THR . 7.3 mt -56.42 -69.06 0.16 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.505 1.522 . . . . 74.15 111.7 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.83 -43.59 3.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 113.67 -1.605 . . . . 73.24 110.843 -168.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -123.9 133.65 8.9 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.545 -1.141 . . . . 65.34 111.132 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.49 150.65 58.1 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.342 2.028 . . . . 75.14 112.57 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 53.2 t -104.31 168.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.121 1.368 . . . . 75.45 107.856 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -148.64 135.23 19.67 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.438 -0.949 . . . . 75.44 108.438 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 p -126.56 139.34 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.509 0.724 . . . . 73.35 110.6 -173.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.02 104.35 3.53 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.522 -0.763 . . . . 65.12 109.076 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.43 123.99 90.22 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.141 -0.936 . . . . 74.41 108.789 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.03 158.67 42.36 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.773 2.316 . . . . 73.32 111.552 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.45 142.44 90.55 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.222 1.948 . . . . 70.4 111.932 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 46.67 64.9 1.35 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.8 1.64 . . . . 75.33 113.545 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.437 HG22 ' HD2' ' A' ' 231' ' ' ARG . 90.9 m -93.87 137.98 32.51 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.532 -1.213 . . . . 74.53 110.501 175.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -104.25 163.58 12.32 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.854 0.862 . . . . 75.5 110.24 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . 0.42 ' HB1' ' H ' ' A' ' 255' ' ' ILE . . . -84.27 154.84 22.74 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.29 -1.323 . . . . 71.42 111.002 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.62 -15.59 49.08 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 123.459 0.474 . . . . 71.22 111.93 -172.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.437 ' HD2' HG22 ' A' ' 227' ' ' THR . 81.1 mtt85 -68.57 -179.35 1.35 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.974 0.909 . . . . 71.22 109.553 164.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.517 ' HA ' HG22 ' A' ' 253' ' ' VAL . 4.8 ptmt -169.24 147.74 3.81 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 119.288 -0.387 . . . . 75.55 110.323 176.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.575 HD11 HD12 ' A' ' 251' ' ' LEU . 88.7 mt -79.34 152.79 30.25 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.671 -0.492 . . . . 73.14 109.671 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -115.88 113.42 23.31 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 107.156 -1.424 . . . . 75.24 107.156 160.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 57.3 mt -113.3 109.96 19.59 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.908 -0.775 . . . . 74.4 108.908 -177.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . 0.528 ' HZ2' ' HB3' ' A' ' 236' ' ' LYS . 3.9 mmmp? -86.91 117.08 25.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.316 -0.856 . . . . 74.15 110.879 -167.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 89.83 10.84 64.38 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.197 0.936 . . . . 53.42 113.598 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.482 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 39.1 mmtm -98.54 -5.01 32.96 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.814 1.042 . . . . 74.22 113.814 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -83.49 -172.23 48.53 Favored Glycine 0 N--CA 1.479 1.505 0 CA-C-O 119.79 -0.45 . . . . 73.11 112.586 171.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -56.89 133.48 79.5 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.458 0.703 . . . . 74.23 111.964 -175.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.13 145.37 72.81 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.988 2.458 . . . . 72.24 111.944 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.4 177.08 19.04 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.971 -0.559 . . . . 72.32 112.899 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.09 -26.32 18.31 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 123.213 2.608 . . . . 74.42 113.41 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.73 -30.87 14.66 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.518 0.727 . . . . 74.02 111.699 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.07 -132.03 1.59 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 111.214 -0.755 . . . . 74.23 111.214 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -140.22 147.03 39.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.786 1.235 . . . . 72.3 108.784 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.93 177.31 42.13 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.897 0.748 . . . . 75.3 111.585 174.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -108.12 -177.64 3.39 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.144 0.577 . . . . 75.13 110.424 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.1 tp -141.3 106.21 4.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.514 0.673 . . . . 75.34 110.454 -176.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 38.3 m-85 -103.6 111.71 24.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.784 -1.561 . . . . 75.53 106.784 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.582 ' HB3' ' HB1' ' A' ' 195' ' ' ALA . 1.9 pp -124.08 118.06 26.08 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.57 0.952 . . . . 74.15 113.57 -173.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.61 119.24 12.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.751 1.62 . . . . 73.35 112.002 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.517 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 97.9 t -67.74 122.83 19.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 125.125 1.37 . . . . 74.53 111.073 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -118.67 111.54 18.65 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.2 1.4 . . . . 75.02 108.652 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.457 HD13 HG13 ' A' ' 199' ' ' VAL . 24.1 mm -81.84 96.81 3.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 107.586 -1.264 . . . . 61.14 107.586 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.252 1.228 0 C-N-CA 124.922 1.289 . . . . 71.44 108.451 -178.088 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.05 0.453 . . . . 72.34 111.942 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.02 158.22 26.57 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.5 0.72 . . . . 73.51 112.073 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.92 -82.4 0.85 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 110.609 -0.997 . . . . 65.32 110.609 170.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.45 170.6 22.06 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.435 0.694 . . . . 74.35 111.147 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 233' ' ' LEU . 48.2 m95 . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 107.827 -1.175 . . . . 75.5 107.827 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 5.9 p-10 . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 120.816 0.341 . . . . 71.04 110.315 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.1 mt -113.5 164.36 13.73 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.436 0.636 . . . . 75.12 112.648 -164.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -114.49 125.53 53.92 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.611 -1.177 . . . . 74.3 108.523 167.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -135.66 -171.53 2.87 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.977 0.911 . . . . 74.03 109.467 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.1 m -117.93 138.49 52.11 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.945 0.898 . . . . 73.1 110.494 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 251' ' ' LEU . 21.8 tp -93.74 128.82 40.16 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.06 -1.089 . . . . 73.55 108.06 165.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.08 100.37 11.69 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.611 -0.514 . . . . 73.23 109.611 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.594 HG21 HG21 ' A' ' 210' ' ' VAL . 21.9 t -111.1 108.81 57.26 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 108.444 -0.947 . . . . 74.44 108.444 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.17 144.57 63.5 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 121.491 1.461 . . . . 74.35 110.082 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.16 -45.9 65.48 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 114.083 1.142 . . . . 73.44 114.083 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.08 -47.16 24.15 Favored 'Trans proline' 0 C--N 1.392 2.851 0 C-N-CA 122.104 1.869 . . . . 71.11 113.744 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.2 mt -64.19 -36.96 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 122.736 0.414 . . . . 74.22 110.567 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.37 94.43 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.951 0.501 . . . . 60.1 111.088 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.0 t -72.3 -50.69 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 124.32 1.013 . . . . 74.54 112.097 -175.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.78 -21.54 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-O 120.851 0.358 . . . . 73.13 110.899 -176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.36 84.87 0.53 Allowed Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.996 -0.547 . . . . 74.04 112.1 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.94 -136.82 5.99 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.839 -0.504 . . . . 75.2 111.839 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -127.54 151.33 49.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.862 0.865 . . . . 73.13 109.212 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.594 HG21 HG21 ' A' ' 199' ' ' VAL . 28.3 m -140.36 150.18 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.294 0.638 . . . . 73.41 110.31 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -77.24 138.89 39.68 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 123.621 0.575 . . . . 72.31 110.426 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -109.26 114.71 28.63 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.748 -1.575 . . . . 65.1 106.748 171.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.0 tpt -64.69 126.12 26.91 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.035 0.534 . . . . 62.52 109.691 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.98 -168.98 2.08 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.687 1.195 . . . . 71.14 109.74 -172.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.4 mt -82.22 -68.73 0.67 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.141 0.972 . . . . 72.25 109.904 -171.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -98.24 -40.78 8.19 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 112.972 -1.922 . . . . 74.42 109.845 -165.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -145.34 134.29 5.45 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-O 118.448 -1.196 . . . . 70.32 110.242 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.0 144.21 52.01 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.764 2.31 . . . . 75.42 112.345 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 55.3 t -96.79 168.5 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 125.231 1.413 . . . . 72.51 108.994 -177.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -148.26 127.92 13.32 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.869 -0.789 . . . . 74.11 108.869 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.6 p -118.13 143.3 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.472 0.709 . . . . 75.34 109.892 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.46 108.64 7.36 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.853 -0.795 . . . . 73.51 108.853 170.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.489 ' HA ' ' HZ2' ' A' ' 176' ' ' TRP . 71.1 t -73.61 128.33 87.21 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.737 0.815 . . . . 73.11 109.821 173.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.62 157.47 60.56 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.704 2.269 . . . . 73.42 111.411 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.18 134.6 56.87 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.466 2.11 . . . . 74.25 112.509 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 51.24 67.32 0.97 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.76 1.624 . . . . 74.42 112.823 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.454 HG21 ' HD2' ' A' ' 231' ' ' ARG . 54.9 m -88.79 140.16 29.73 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.694 -1.139 . . . . 71.43 110.549 173.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -100.78 157.52 16.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.074 0.95 . . . . 73.41 111.156 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -80.2 155.28 27.46 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.447 -1.251 . . . . 45.4 110.239 176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.48 29.86 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 111.649 -0.58 . . . . 64.33 111.649 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.454 ' HD2' HG21 ' A' ' 227' ' ' THR . 73.7 mtt85 -62.23 178.18 0.41 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.688 0.795 . . . . 74.12 110.559 168.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.4 ptmt -166.17 147.24 6.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.752 -0.462 . . . . 74.44 109.752 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 251' ' ' LEU . 88.8 mt -79.32 147.63 32.39 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.911 -0.774 . . . . 73.12 108.911 169.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -108.57 121.39 44.89 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.006 -1.479 . . . . 73.35 107.006 158.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 80.4 mt -118.28 110.92 18.1 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.365 -0.606 . . . . 63.52 109.365 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -79.02 119.28 21.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 73.43 110.922 -167.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.34 13.78 77.93 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.454 1.096 . . . . 75.32 113.948 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.44 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.3 mmtt -102.65 8.57 39.63 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 117.512 0.656 . . . . 73.01 112.665 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.82 172.55 32.66 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 110.644 -0.982 . . . . 71.43 110.644 168.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -55.42 146.09 44.81 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-N 117.652 0.726 . . . . 65.3 112.31 -173.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.475 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 24.5 Cg_exo -60.31 141.29 95.43 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.933 2.422 . . . . 74.21 112.272 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -130.26 171.72 20.49 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.958 -1.019 . . . . 71.11 111.842 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.68 -32.21 38.46 Favored 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 123.014 2.476 . . . . 73.12 112.793 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.57 -7.36 41.3 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.583 0.753 . . . . 73.44 111.387 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 135.55 177.08 14.71 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.218 -0.753 . . . . 65.15 111.218 -177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 61.8 mtm-85 -69.44 155.77 39.91 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.406 0.682 . . . . 74.45 112.206 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.12 -172.04 47.04 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.525 -0.761 . . . . 75.12 111.976 173.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.484 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 12.7 m-20 -115.12 149.08 38.15 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.366 0.666 . . . . 55.51 110.115 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.2 tp -106.53 108.47 19.99 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.348 0.594 . . . . 73.23 109.84 -170.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 54.0 m-85 -101.65 101.85 12.44 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.213 -1.032 . . . . 75.33 108.213 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.2 pp -118.68 119.34 34.15 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.429 0.9 . . . . 75.21 113.429 -173.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -67.68 116.96 8.97 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.118 0.967 . . . . 74.04 111.936 -174.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.567 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 94.1 t -63.93 116.77 3.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 113.691 -1.595 . . . . 74.23 110.717 174.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -111.9 125.16 53.74 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.343 -1.298 . . . . 74.45 108.645 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 29.8 mm -91.15 108.83 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.455 -1.313 . . . . 73.52 107.455 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.253 1.257 0 CA-C-O 117.766 -1.112 . . . . 73.33 108.551 -171.458 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.425 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 7.5 m . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 121.55 0.691 . . . . 71.31 111.595 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.85 176.27 6.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.03 0.932 . . . . 74.11 111.851 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.19 -129.23 6.18 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.25 -0.74 . . . . 62.34 111.25 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.57 158.05 17.81 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.087 0.555 . . . . 64.21 111.124 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.488 ' CZ3' HG23 ' A' ' 227' ' ' THR . 31.1 m95 . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 108.581 -0.896 . . . . 74.33 108.581 165.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.635 -0.506 . . . . 73.02 109.635 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 77.0 mt -128.43 158.67 37.67 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.375 0.607 . . . . 75.22 112.261 -177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 11.6 t80 -121.14 126.0 48.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.687 -1.142 . . . . 74.1 108.679 171.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 251' ' ' LEU . . . -136.18 -173.81 3.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.953 0.901 . . . . 73.4 109.274 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.8 m -126.37 117.47 23.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.548 0.739 . . . . 75.23 110.599 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.547 ' HB2' HD11 ' A' ' 251' ' ' LEU . 18.4 tp -76.92 105.88 8.26 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.58 -0.896 . . . . 72.23 108.58 171.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.21 101.86 12.19 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.658 -0.867 . . . . 63.43 108.658 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.622 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.3 t -110.64 115.03 54.24 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.089 -1.078 . . . . 73.45 108.089 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.03 148.93 70.88 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.558 1.506 . . . . 75.43 110.194 171.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.45 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -54.11 -40.07 79.05 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 124.014 0.926 . . . . 74.23 113.4 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 10.9 Cg_endo -54.14 -51.4 10.73 Favored 'Trans proline' 0 C--N 1.395 3.013 0 C-N-CA 122.17 1.913 . . . . 75.23 113.534 172.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . 0.45 HG21 HG12 ' A' ' 210' ' ' VAL . 49.3 mt -64.8 -36.2 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.25 0.62 . . . . 74.32 110.979 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.424 ' HA ' HG12 ' A' ' 223' ' ' VAL . . . -65.13 -44.08 89.86 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.936 -0.575 . . . . 74.11 111.656 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.71 -51.03 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.767 0.827 . . . . 73.42 111.805 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.93 -23.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 120.494 0.188 . . . . 64.3 110.932 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.97 77.95 1.07 Allowed Glycine 0 C--N 1.349 1.305 0 N-CA-C 111.346 -0.702 . . . . 62.43 111.346 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.13 -139.78 8.41 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.907 -0.477 . . . . 73.14 111.907 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -132.1 146.27 51.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.286 0.634 . . . . 75.12 109.458 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 199' ' ' VAL . 28.5 m -134.97 152.9 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 123.658 0.599 . . . . 75.51 109.819 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 218' ' ' PRO . 40.4 ttt-85 -79.15 143.67 35.22 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.593 0.757 . . . . 72.43 109.772 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.59 ' HB1' ' HB ' ' A' ' 219' ' ' VAL . . . -112.75 114.28 26.77 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.677 -1.231 . . . . 74.04 107.677 171.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.91 135.07 54.28 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.866 1.266 . . . . 74.4 111.193 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' THR . . . . . 0.673 HG22 ' HE3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -141.48 -170.83 3.18 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.703 0.801 . . . . 75.14 110.515 173.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.537 ' H ' HG21 ' A' ' 214' ' ' THR . 7.1 mt -55.69 -69.54 0.14 Allowed 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.613 1.165 . . . . 72.33 110.815 -172.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -116.37 -42.69 3.0 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.251 -1.795 . . . . 73.51 110.929 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -113.02 132.88 10.96 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 118.656 -1.08 . . . . 72.22 111.717 -175.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . 0.423 ' HB3' ' HE ' ' A' ' 211' ' ' ARG . 74.6 Cg_endo -73.68 -173.95 1.52 Allowed 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.525 2.15 . . . . 72.22 112.682 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.59 ' HB ' ' HB1' ' A' ' 212' ' ' ALA . 8.5 t -140.05 164.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.36 1.464 . . . . 74.24 107.523 168.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.425 ' H ' ' HB ' ' A' ' 172' ' ' THR . 5.0 tt0 -142.16 127.75 19.07 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.043 -1.095 . . . . 74.15 108.043 170.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.465 HG11 HD12 ' A' ' 233' ' ' LEU . 13.8 p -120.22 139.75 46.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 123.6 0.76 . . . . 74.11 110.603 -173.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.17 104.87 5.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.818 0.847 . . . . 74.24 109.419 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 204' ' ' ALA . 61.5 t -69.38 128.37 92.38 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.449 0.7 . . . . 73.12 109.335 173.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.51 154.25 74.57 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.057 2.505 . . . . 73.13 112.063 171.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.78 129.38 27.45 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.306 2.004 . . . . 72.11 112.189 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 55.56 74.21 0.39 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.547 1.539 . . . . 72.21 113.081 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' THR . . . . . 0.488 HG23 ' CZ3' ' A' ' 176' ' ' TRP . 64.8 m -97.22 144.15 27.32 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.662 -1.154 . . . . 75.34 111.204 175.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -108.53 163.89 12.83 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.561 1.144 . . . . 72.41 110.972 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -88.15 152.47 21.96 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.642 -1.163 . . . . 73.3 111.427 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.02 -12.84 52.67 Favored Glycine 0 N--CA 1.476 1.31 0 CA-C-N 116.342 -0.39 . . . . 71.34 112.25 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.431 ' HD2' HG21 ' A' ' 227' ' ' THR . 73.3 mtt85 -69.58 178.17 2.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.636 0.774 . . . . 75.21 109.762 166.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.629 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 10.9 ptmt -168.37 157.02 8.77 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.319 0.104 . . . . 72.0 111.15 172.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.554 HD11 HD13 ' A' ' 251' ' ' LEU . 73.0 mt -93.62 158.8 15.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.003 0.521 . . . . 62.25 109.807 170.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -132.61 109.55 9.82 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.914 1.285 . . . . 73.41 108.363 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 49.5 mt -120.42 117.15 26.96 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.393 0.677 . . . . 74.22 111.339 -166.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -84.94 134.35 34.25 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.709 -0.678 . . . . 75.43 110.695 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 76.22 10.14 85.47 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 124.219 0.949 . . . . 73.2 113.513 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.673 ' HE3' HG22 ' A' ' 214' ' ' THR . 29.3 mmmt -97.68 -25.15 15.2 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 117.142 0.471 . . . . 72.43 112.232 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -66.09 -172.0 4.19 Favored Glycine 0 CA--C 1.538 1.519 0 O-C-N 123.103 0.252 . . . . 75.03 113.151 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -59.06 138.68 87.82 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 122.696 0.399 . . . . 71.22 111.235 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . 0.561 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 32.2 Cg_exo -59.29 152.66 58.79 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.93 2.42 . . . . 74.11 112.622 175.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.6 -177.77 15.15 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.708 -0.678 . . . . 64.15 112.509 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.12 -40.67 4.52 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 122.732 2.288 . . . . 75.1 112.537 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.47 -10.65 14.88 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.683 0.793 . . . . 63.41 111.854 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.41 166.49 27.56 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 111.467 -0.653 . . . . 72.31 111.467 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.561 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 16.5 mtp180 -85.66 165.58 16.88 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.204 0.602 . . . . 72.31 110.871 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.72 -176.61 46.86 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.342 -0.844 . . . . 62.11 112.826 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.74 169.21 8.65 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.014 0.525 . . . . 72.51 110.935 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 62.7 tp -131.95 108.98 9.73 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.571 -0.74 . . . . 71.32 110.201 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.629 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 13.8 m-30 -98.8 116.91 32.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.125 -1.065 . . . . 71.11 108.125 173.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.595 ' HB3' ' HB1' ' A' ' 195' ' ' ALA . 1.6 pp -129.5 116.31 18.76 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.34 0.867 . . . . 71.21 113.34 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.34 123.34 20.5 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 114.751 -1.113 . . . . 75.21 112.506 -174.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.518 HG23 HD21 ' A' ' 197' ' ' LEU . 60.5 t -70.09 125.23 27.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 114.19 -1.368 . . . . 73.5 110.953 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.92 129.9 55.43 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.551 1.14 . . . . 74.43 108.484 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.6 mm -99.97 99.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.552 -1.277 . . . . 74.32 107.552 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.561 1.366 0 CA-C-N 114.37 -1.286 . . . . 70.21 108.952 -167.59 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.469 HG23 HG21 ' A' ' 219' ' ' VAL . 3.4 m . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.026 0.441 . . . . 75.32 109.892 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.03 152.24 18.71 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.634 0.773 . . . . 62.13 111.184 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.64 -102.29 0.06 OUTLIER Glycine 0 C--N 1.351 1.363 0 O-C-N 124.207 0.942 . . . . 74.21 111.482 165.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -136.51 175.77 9.3 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.537 0.735 . . . . 73.43 109.84 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . 0.492 ' HZ2' HG21 ' A' ' 223' ' ' VAL . 14.2 m95 . . . . . 0 C--O 1.24 0.565 0 CA-C-N 115.156 -0.929 . . . . 74.01 109.539 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 9.2 p-10 . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 109.464 -0.569 . . . . 61.12 109.464 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.6 mt -113.71 165.4 12.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.538 0.735 . . . . 64.45 111.757 -169.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -118.0 122.18 42.56 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 114.741 -1.118 . . . . 75.24 108.24 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . . . -131.43 -172.98 2.99 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.829 0.852 . . . . 74.34 110.052 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 52.9 m -119.29 149.77 41.24 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.122 0.969 . . . . 75.42 109.706 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.572 ' HB2' HD12 ' A' ' 251' ' ' LEU . 22.2 tp -119.95 104.57 10.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.106 1.362 . . . . 72.24 108.462 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -91.44 99.71 12.61 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.892 0.853 . . . . 70.02 109.109 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.558 ' HA ' HG13 ' A' ' 210' ' ' VAL . 23.2 t -94.99 119.85 65.28 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 114.555 -1.202 . . . . 73.05 108.282 174.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.68 144.95 61.83 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 121.539 1.493 . . . . 72.34 109.859 173.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.42 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.48 -42.44 75.1 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.501 -1.238 . . . . 50.42 113.147 -175.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.7 Cg_endo -55.96 -51.62 9.18 Favored 'Trans proline' 0 C--N 1.406 3.602 0 C-N-CA 121.94 1.76 . . . . 71.42 112.71 174.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 54.5 mt -65.01 -33.55 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.236 0.615 . . . . 73.43 110.674 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.67 77.14 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.407 0.683 . . . . 62.43 110.898 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.7 t -70.3 -47.12 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.351 1.06 . . . . 73.4 112.281 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.56 -35.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 120.507 0.194 . . . . 71.32 110.761 -174.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.47 105.79 1.13 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.539 -1.024 . . . . 53.22 110.539 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.93 -129.0 2.29 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.689 -0.506 . . . . 65.42 111.859 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 4.9 ttmt -145.15 137.7 26.06 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.608 0.763 . . . . 75.31 109.75 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.558 HG13 ' HA ' ' A' ' 199' ' ' VAL . 33.6 m -135.23 155.16 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 122.766 0.427 . . . . 73.34 110.763 175.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -70.65 146.2 50.13 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.016 0.822 . . . . 73.04 110.427 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -123.64 120.75 33.68 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.014 1.326 . . . . 74.33 107.882 172.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -64.76 129.23 39.02 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.987 0.915 . . . . 73.34 110.899 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 -170.91 2.82 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.207 1.003 . . . . 64.24 110.265 -172.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.4 mt -84.87 -66.76 0.86 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.61 1.195 . . . . 73.33 109.639 -171.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -95.65 -33.3 12.4 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 112.675 -2.057 . . . . 74.22 110.856 -165.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -160.68 141.97 7.79 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.354 -1.248 . . . . 72.4 111.294 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.6 142.99 60.72 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.694 2.263 . . . . 51.12 113.001 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 61.6 t -94.06 166.47 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.92 1.288 . . . . 75.13 109.031 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -144.3 136.68 26.59 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.243 -1.391 . . . . 75.51 107.243 171.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' VAL . . . . . 0.492 HG12 HD11 ' A' ' 233' ' ' LEU . 14.4 p -132.88 140.71 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.253 0.621 . . . . 74.34 111.347 -169.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.09 101.17 2.69 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.302 1.041 . . . . 72.21 110.331 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.492 HG21 ' HZ2' ' A' ' 176' ' ' TRP . 92.9 t -72.25 121.66 85.32 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 118.141 -0.933 . . . . 73.23 109.226 175.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.67 154.72 72.57 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.592 2.195 . . . . 75.51 111.783 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.72 130.93 37.3 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.532 2.154 . . . . 74.4 112.769 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 56.15 74.65 0.38 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.813 1.645 . . . . 70.42 112.762 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 97.0 m -90.7 142.09 28.11 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.714 -1.13 . . . . 73.54 111.064 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -107.6 149.71 27.73 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.586 1.154 . . . . 70.02 109.947 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.68 155.28 37.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.188 -0.914 . . . . 73.03 110.545 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.1 -19.84 39.56 Favored Glycine 0 N--CA 1.476 1.311 0 N-CA-C 111.162 -0.775 . . . . 75.44 111.162 -172.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -65.9 179.83 0.83 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.257 1.023 . . . . 74.51 110.599 168.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.542 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.0 ptmt -166.81 152.89 8.27 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 116.176 -0.465 . . . . 74.42 109.992 172.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LEU . . . . . 0.573 HD13 HD11 ' A' ' 251' ' ' LEU . 61.6 mt -81.29 142.71 32.85 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.035 -0.728 . . . . 74.53 109.035 169.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -103.22 104.06 14.16 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.177 -1.416 . . . . 75.45 107.177 158.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.55 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 50.6 mt -102.43 113.51 26.9 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 114.939 -1.028 . . . . 74.52 109.009 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -82.18 125.79 31.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.316 -0.856 . . . . 74.51 110.142 -172.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.64 25.3 75.67 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 124.448 1.092 . . . . 73.25 113.804 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.55 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 74.3 mmtt -107.54 -3.17 19.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 112.671 0.619 . . . . 73.31 112.671 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.93 176.89 50.89 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.825 -1.31 . . . . 74.24 109.825 164.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -56.65 131.69 77.88 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 117.335 0.567 . . . . 71.42 111.894 -171.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.23 138.93 69.31 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.97 2.447 . . . . 74.14 111.519 174.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.22 177.77 18.49 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.561 -0.745 . . . . 74.44 113.472 -174.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.61 -33.52 66.93 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.973 2.448 . . . . 72.4 112.75 177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.48 -8.97 59.6 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.419 0.688 . . . . 65.23 111.901 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 144.42 -101.18 0.25 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 110.872 -0.891 . . . . 73.15 110.872 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -148.35 165.78 30.04 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.788 1.235 . . . . 74.42 110.176 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.65 174.08 30.23 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 110.792 -0.923 . . . . 75.12 110.792 167.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 45.7 m-20 -102.85 -179.15 3.88 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.105 0.562 . . . . 71.42 109.944 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 46.0 tp -141.68 107.63 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.603 0.716 . . . . 73.32 109.128 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' TYR . . . . . 0.464 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 54.3 m-85 -100.99 107.6 19.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.882 -1.525 . . . . 75.14 106.882 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 195' ' ' ALA . 2.7 pp -122.94 118.09 27.04 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.759 0.79 . . . . 62.13 113.086 -175.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -69.75 120.63 15.79 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 125.3 1.44 . . . . 70.11 112.252 -171.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' A' ' 232' ' ' LYS . 58.9 t -68.8 116.56 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 114.09 -1.414 . . . . 74.42 110.979 177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -103.35 131.24 50.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.112 1.765 . . . . 74.02 108.866 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.0 mm -97.46 110.22 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.966 -1.124 . . . . 70.43 107.966 170.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.257 1.45 0 C-N-CA 124.335 1.054 . . . . 74.54 108.627 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' A' ' 168' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.985 -0.376 . . . . 63.15 109.985 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.29 162.18 25.8 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.381 0.672 . . . . 74.3 110.106 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.7 p -57.81 -32.81 67.94 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.333 1.053 . . . . 74.23 112.411 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.95 54.16 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.451 0.7 . . . . 44.44 110.978 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.442 HG21 HG22 ' A' ' 219' ' ' VAL . 11.6 m -75.15 -10.76 59.77 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.675 0.79 . . . . 74.31 110.976 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -111.95 151.6 29.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.621 0.768 . . . . 75.32 110.657 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.34 -113.37 0.07 OUTLIER Glycine 0 C--N 1.349 1.251 0 O-C-N 123.659 0.599 . . . . 72.33 111.71 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -112.5 177.69 4.55 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.406 0.683 . . . . 74.31 110.047 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 179' ' ' LYS . 13.6 m95 -85.26 -76.09 0.34 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.176 -0.92 . . . . 75.3 109.732 170.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -168.92 34.8 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.06 0.944 . . . . 75.42 109.101 -174.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.7 -41.08 1.49 Allowed Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.144 -1.182 . . . . 55.34 110.144 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 176' ' ' TRP . 44.7 mmtm -63.81 141.3 58.82 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.819 0.848 . . . . 71.12 111.37 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 86.12 -69.7 3.13 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 109.895 -1.282 . . . . 53.42 109.895 -168.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.4 p -166.53 139.29 3.8 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.576 1.15 . . . . 70.22 108.712 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -72.41 79.22 0.67 Allowed Glycine 0 C--N 1.346 1.102 0 N-CA-C 110.664 -0.974 . . . . 71.12 110.664 172.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -67.94 -58.12 7.89 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 123.307 0.479 . . . . 63.44 112.114 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.2 p -164.71 99.65 0.79 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.583 0.753 . . . . 73.1 109.759 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -76.84 81.54 1.14 Allowed Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.835 -0.62 . . . . 71.13 112.221 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -157.67 101.43 0.2 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 112.33 -0.308 . . . . 75.43 112.33 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.1 m -90.35 102.62 15.35 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.569 0.748 . . . . 61.2 109.732 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 174.49 142.06 3.86 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.405 -1.078 . . . . 75.24 110.405 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 176.52 -143.84 6.62 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.713 -0.555 . . . . 64.45 111.713 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.6 m -157.74 167.8 29.04 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.849 1.259 . . . . 74.12 109.064 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 58.74 24.62 12.46 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.882 0.873 . . . . 73.0 110.704 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.06 163.39 24.21 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.621 0.769 . . . . 55.43 112.882 -166.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.1 mt -130.88 147.3 52.51 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.653 -1.158 . . . . 73.51 110.157 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -114.71 122.81 47.58 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.587 -0.894 . . . . 71.44 108.587 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.506 ' HB1' ' HB3' ' A' ' 251' ' ' LEU . . . -133.14 -173.24 3.15 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.558 0.536 . . . . 73.22 110.532 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.5 m -123.81 135.88 54.06 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.797 0.839 . . . . 73.3 110.146 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.3 tp -96.01 109.18 21.61 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.746 -1.205 . . . . 74.55 107.746 170.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -85.43 99.69 11.37 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.664 -0.865 . . . . 71.34 108.664 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.625 ' HA ' HG12 ' A' ' 210' ' ' VAL . 18.9 t -111.61 112.31 54.0 Favored Pre-proline 0 C--N 1.344 0.342 0 N-CA-C 107.988 -1.115 . . . . 74.52 107.988 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.3 151.59 80.53 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.538 1.492 . . . . 74.33 110.693 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.82 -42.2 88.47 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 123.755 0.822 . . . . 74.33 113.203 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 11.1 Cg_endo -55.24 -56.67 2.14 Favored 'Trans proline' 0 C--N 1.392 2.828 0 C-N-CA 122.004 1.803 . . . . 71.25 113.824 172.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.412 HG21 HG13 ' A' ' 210' ' ' VAL . 59.4 mt -62.57 -31.28 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 122.942 0.497 . . . . 75.11 111.001 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.33 80.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.076 -0.511 . . . . 63.3 111.045 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.9 t -67.27 -50.41 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.987 0.915 . . . . 71.02 111.801 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.6 p -79.28 -25.89 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 120.813 0.34 . . . . 75.1 110.723 -172.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.95 73.0 1.07 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.92 -0.582 . . . . 75.24 111.778 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.13 -130.22 6.8 Favored Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.59 -0.604 . . . . 65.25 111.59 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -131.9 156.09 46.74 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.519 0.728 . . . . 74.15 110.104 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.625 HG12 ' HA ' ' A' ' 199' ' ' VAL . 26.8 m -144.79 158.05 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.064 0.853 . . . . 75.24 110.145 173.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -81.41 146.65 30.18 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.523 -0.762 . . . . 71.52 111.017 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 219' ' ' VAL . . . -121.84 125.68 47.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.727 1.211 . . . . 75.12 108.347 170.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.5 tpt -64.32 131.44 47.3 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.946 0.498 . . . . 75.01 110.851 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.32 -170.78 2.67 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.789 1.236 . . . . 73.52 108.888 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.447 ' HB2' ' HG3' ' A' ' 216' ' ' GLU . 7.1 mt -63.54 -68.65 0.33 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 122.39 1.091 . . . . 73.22 111.869 -172.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 33.9 mt-10 -97.42 -39.83 8.99 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 112.707 -2.042 . . . . 75.13 109.266 -163.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -147.0 -165.39 11.69 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 113.981 -1.463 . . . . 72.14 111.565 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -96.89 151.46 1.07 Allowed 'Trans proline' 0 CA--C 1.551 1.35 0 C-N-CA 122.728 2.285 . . . . 72.13 114.907 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.555 ' HB ' ' HB1' ' A' ' 212' ' ' ALA . 54.0 t -97.86 162.88 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 114.195 -1.366 . . . . 75.43 107.535 165.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -144.65 119.23 9.74 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.18 -1.044 . . . . 65.31 108.18 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.408 HG11 HD11 ' A' ' 233' ' ' LEU . 12.7 p -112.07 142.66 23.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.56 0.744 . . . . 75.14 110.207 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.28 112.53 10.54 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.824 -0.806 . . . . 70.44 108.824 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.3 133.02 81.26 Favored Pre-proline 0 CA--C 1.553 1.075 0 N-CA-C 109.211 -0.663 . . . . 74.44 109.211 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.57 157.58 61.23 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.252 2.635 . . . . 65.34 111.237 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.57 135.11 40.86 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 121.98 1.786 . . . . 74.42 112.08 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.7 mtp-105 53.19 65.46 1.51 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.913 1.685 . . . . 71.14 113.34 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.504 HG22 ' HD2' ' A' ' 231' ' ' ARG . 77.7 m -87.95 139.01 30.95 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.87 -1.059 . . . . 73.42 111.711 176.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.621 ' HB2' HH12 ' A' ' 231' ' ' ARG . 25.9 mp0 -104.33 159.02 16.06 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.003 0.921 . . . . 74.21 110.086 172.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -86.19 152.32 22.92 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.111 -0.95 . . . . 74.3 111.46 -177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.11 -15.21 30.86 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 115.934 -0.575 . . . . 71.43 111.744 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.621 HH12 ' HB2' ' A' ' 228' ' ' GLN . 69.5 mtt85 -69.72 179.26 2.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.959 0.904 . . . . 72.21 109.769 166.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HA ' HG21 ' A' ' 253' ' ' VAL . 11.1 ptmt -166.0 155.66 12.1 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.917 -0.401 . . . . 74.45 109.917 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.555 HD13 HD13 ' A' ' 251' ' ' LEU . 79.8 mt -84.37 147.08 27.35 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.617 -0.512 . . . . 74.44 109.617 170.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -114.21 107.36 15.51 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.66 1.225 . . . . 72.23 107.958 167.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 63.3 mt -116.53 118.32 32.31 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.931 0.492 . . . . 74.01 110.863 -173.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -92.86 126.0 37.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.127 -0.488 . . . . 75.54 110.184 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.23 12.91 72.37 Favored Glycine 0 N--CA 1.471 1.022 0 O-C-N 124.264 0.978 . . . . 54.33 113.021 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -114.11 -3.32 13.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.689 0.796 . . . . 75.5 111.446 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.88 -177.34 51.47 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 110.556 -1.018 . . . . 53.04 110.556 166.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -57.5 141.52 78.43 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.753 0.649 . . . . 74.43 112.753 -171.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.45 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 7.8 Cg_exo -69.47 133.72 26.81 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.622 2.214 . . . . 70.04 110.512 171.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -135.31 174.63 21.13 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.888 -1.051 . . . . 63.14 112.621 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.62 -9.98 23.16 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.903 2.402 . . . . 74.21 112.71 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -105.29 11.07 33.32 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.094 0.958 . . . . 72.51 111.407 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 121.83 -113.02 2.16 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.187 -0.765 . . . . 72.32 111.187 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 65.0 mtt180 -143.87 164.06 31.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.276 1.03 . . . . 74.32 110.567 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -98.29 -163.87 30.79 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 114.748 -1.115 . . . . 63.43 113.29 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -115.6 160.21 20.3 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.183 0.993 . . . . 74.31 110.679 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.59 ' HG ' HD23 ' A' ' 251' ' ' LEU . 27.7 tp -131.47 109.66 10.45 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.469 0.708 . . . . 74.32 109.641 -171.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.442 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 20.2 m-85 -102.8 116.3 32.3 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.482 -0.932 . . . . 75.45 108.482 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.59 HD23 ' HG ' ' A' ' 249' ' ' LEU . 3.0 pp -127.76 114.47 17.33 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.384 0.611 . . . . 73.11 112.42 -173.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -68.74 119.73 13.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.923 1.289 . . . . 72.44 112.984 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.583 HG21 ' HA ' ' A' ' 232' ' ' LYS . 64.1 t -70.82 126.12 30.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-N 114.342 -1.299 . . . . 72.13 110.897 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -116.24 133.14 56.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.988 1.315 . . . . 72.31 108.34 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 43.0 mm -104.94 100.53 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 107.874 -1.158 . . . . 73.32 107.874 175.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.557 1.227 0 CA-C-O 117.773 -1.108 . . . . 74.54 109.506 -171.857 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.6 ptm . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.824 0.345 . . . . 63.14 111.119 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -162.29 163.93 27.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.54 1.136 . . . . 74.35 108.251 -167.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 63.6 p -54.73 -38.92 67.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.512 0.725 . . . . 61.5 111.219 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -131.02 91.39 3.04 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.123 -1.066 . . . . 74.12 108.123 167.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 10.3 m -78.0 -23.97 48.11 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.931 -0.577 . . . . 74.44 111.114 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.52 151.13 38.0 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.911 -0.586 . . . . 75.34 111.703 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -77.05 -66.3 1.83 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.425 -0.807 . . . . 61.51 111.944 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -162.7 167.91 22.36 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 123.924 0.889 . . . . 64.44 111.096 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.551 ' CZ3' HG23 ' A' ' 253' ' ' VAL . 26.8 m95 -77.51 -67.92 0.67 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.516 -1.22 . . . . 75.33 108.613 167.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 168.7 -131.56 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.818 2.047 . . . . 73.11 105.676 -168.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.86 20.82 42.95 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.242 -0.754 . . . . 63.24 112.011 160.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 51.9 pttt 31.99 48.97 0.12 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 126.852 2.061 . . . . 75.51 113.257 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.95 -47.37 0.31 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.163 -1.575 . . . . 72.43 109.163 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.7 m -75.66 95.36 3.37 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.107 -0.701 . . . . 72.31 109.107 170.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -75.47 75.34 1.41 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.09 -0.959 . . . . 63.14 112.671 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -125.9 49.58 0.91 Allowed Glycine 0 C--N 1.344 0.982 0 C-N-CA 123.312 0.482 . . . . 73.34 111.922 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.494 ' HA ' ' NH2' ' A' ' 234' ' ' ARG . 45.4 t -85.73 -74.14 0.42 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.188 0.595 . . . . 75.24 110.178 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.9 -172.02 44.23 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 112.514 -0.234 . . . . 54.13 112.514 -171.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 176.96 -123.07 0.87 Allowed Glycine 0 N--CA 1.469 0.842 0 CA-C-O 119.695 -0.503 . . . . 74.02 112.065 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.2 m 63.62 92.32 0.07 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.929 1.291 . . . . 54.21 112.268 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -120.03 -95.06 1.51 Allowed Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.07 -0.812 . . . . 70.54 111.07 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 179.05 83.94 0.06 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.61 -0.55 . . . . 72.3 111.915 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.3 t 78.5 -41.1 0.29 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 125.785 1.634 . . . . 73.41 113.773 173.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.17 -55.59 23.84 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.607 1.163 . . . . 72.12 110.176 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -63.53 140.89 58.92 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.369 -1.287 . . . . 72.02 109.499 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.19 159.59 29.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.38 0.61 . . . . 75.43 111.046 -172.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 11.9 t80 -125.59 110.47 13.88 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.654 -1.157 . . . . 74.32 107.884 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.602 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . . . -118.96 -171.87 2.18 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.034 0.934 . . . . 54.32 110.056 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 69.2 m -127.26 118.52 24.39 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.438 0.695 . . . . 64.43 110.95 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.505 HD22 HG22 ' A' ' 253' ' ' VAL . 13.8 tp -78.71 111.37 14.74 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.732 -0.84 . . . . 75.14 108.732 169.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.75 109.6 18.75 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.949 -1.13 . . . . 74.05 107.949 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.6 ' HA ' HG12 ' A' ' 210' ' ' VAL . 21.5 t -118.36 114.19 36.57 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.602 -1.259 . . . . 74.32 107.602 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.96 146.05 76.18 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 121.214 1.276 . . . . 74.12 109.971 171.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.46 -44.54 82.99 Favored Pre-proline 0 CA--C 1.563 1.451 0 CA-C-O 117.869 -1.063 . . . . 71.21 112.817 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 16.5 Cg_endo -54.89 -48.93 18.55 Favored 'Trans proline' 0 C--N 1.399 3.2 0 C-N-CA 122.19 1.927 . . . . 75.22 112.754 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.471 HG21 HG13 ' A' ' 210' ' ' VAL . 50.8 mt -65.99 -35.3 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.006 0.523 . . . . 73.04 110.649 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.73 99.5 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.06 0.544 . . . . 74.22 111.14 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 201' ' ' ALA . 90.0 t -72.93 -50.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.156 0.982 . . . . 71.43 112.078 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 12.4 p -77.72 -27.93 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.703 0.401 . . . . 72.43 110.52 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.83 70.18 1.36 Allowed Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.336 -0.706 . . . . 51.31 111.336 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.69 -130.02 6.86 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.902 -0.479 . . . . 64.51 111.902 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -143.49 137.19 28.34 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.231 0.613 . . . . 73.51 109.921 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 199' ' ' VAL . 35.4 m -132.55 151.02 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.409 0.684 . . . . 64.51 110.235 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -75.23 140.04 42.97 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.941 0.497 . . . . 74.42 110.856 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -112.12 113.71 26.13 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.982 -1.488 . . . . 74.43 106.982 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 11.0 tpt -65.54 131.0 45.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.037 0.535 . . . . 72.34 111.489 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.479 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -133.71 -171.69 2.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.545 1.138 . . . . 74.34 110.644 -172.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mt -83.5 -64.22 1.21 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.777 1.275 . . . . 75.34 109.679 -168.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.8 -32.07 12.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 112.067 -2.333 . . . . 72.21 110.93 -166.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -164.44 144.29 9.27 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-O 118.672 -1.071 . . . . 51.42 111.442 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.33 143.88 71.99 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.686 2.257 . . . . 72.13 113.278 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.421 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 66.0 t -96.54 163.23 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.177 -1.374 . . . . 74.24 108.159 174.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.412 ' H ' ' HB ' ' A' ' 172' ' ' THR . 9.5 tt0 -147.08 134.06 20.28 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.767 -1.197 . . . . 74.24 107.767 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.451 HG22 HD21 ' A' ' 233' ' ' LEU . 12.0 p -126.49 135.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 C-N-CA 123.48 0.712 . . . . 73.43 110.951 -173.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.75 104.4 2.42 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.85 -1.068 . . . . 63.44 108.95 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.4 t -71.75 132.79 84.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 108.551 -0.907 . . . . 73.3 108.551 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.5 157.39 60.82 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.541 2.161 . . . . 74.44 111.839 171.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -64.71 137.48 54.29 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.103 1.868 . . . . 74.54 111.96 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 50.5 65.19 1.53 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.327 1.451 . . . . 72.34 113.192 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.417 HG21 ' HD2' ' A' ' 231' ' ' ARG . 68.1 m -82.87 144.55 30.0 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.947 -1.024 . . . . 74.24 111.071 174.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -105.79 155.92 18.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.749 0.82 . . . . 74.11 110.398 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -76.61 153.59 35.14 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.618 -1.174 . . . . 75.01 110.369 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.3 -10.93 59.97 Favored Glycine 0 N--CA 1.472 1.099 0 N-CA-C 112.351 -0.3 . . . . 64.55 112.351 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.417 ' HD2' HG21 ' A' ' 227' ' ' THR . 65.8 mtt85 -72.1 -177.23 2.0 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.126 0.97 . . . . 74.33 109.586 165.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.531 ' HA ' HG21 ' A' ' 253' ' ' VAL . 7.5 ptmt -167.25 161.83 14.63 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 111.275 0.102 . . . . 75.01 111.275 172.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.591 HD12 HD11 ' A' ' 251' ' ' LEU . 73.1 mt -88.49 151.28 22.64 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.468 -0.567 . . . . 74.33 109.468 166.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.494 ' NH2' ' HA ' ' A' ' 184' ' ' SER . 4.3 ptp180 -111.85 109.33 19.09 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.49 -1.3 . . . . 73.42 107.49 162.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.474 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 64.0 mt -110.11 102.43 11.14 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.854 0.835 . . . . 70.3 109.784 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -76.68 119.1 20.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.095 -1.411 . . . . 74.43 110.853 -169.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.62 -3.95 86.6 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 124.072 0.858 . . . . 62.23 113.981 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.479 ' HD2' HG21 ' A' ' 214' ' ' THR . 32.6 mmtp -87.09 5.79 35.89 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.645 0.723 . . . . 64.03 112.565 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.98 174.02 49.24 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.123 -0.791 . . . . 74.42 111.123 166.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.04 148.16 88.98 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.85 0.46 . . . . 75.24 111.753 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 11.7 Cg_exo -68.69 133.32 27.29 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.659 2.239 . . . . 65.15 112.429 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -128.89 173.78 19.26 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.793 -1.094 . . . . 75.42 112.552 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.02 -24.82 20.17 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.92 2.413 . . . . 73.43 112.195 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.22 22.46 14.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.058 0.943 . . . . 72.11 110.833 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 101.16 -177.74 27.67 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.957 -0.857 . . . . 71.42 110.957 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.565 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 32.9 mtp180 -81.81 155.49 25.39 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.113 0.457 . . . . 73.52 111.161 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.2 -179.12 52.72 Favored Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.436 -0.802 . . . . 65.44 112.222 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -117.37 138.26 51.92 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.208 0.528 . . . . 75.21 109.789 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 38.8 tp -101.91 105.57 16.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.973 -1.012 . . . . 73.34 109.116 -170.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 60.5 m-85 -102.15 114.13 27.99 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.146 -1.057 . . . . 73.13 108.146 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 195' ' ' ALA . 2.5 pp -125.88 114.74 18.94 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.593 0.96 . . . . 73.35 113.593 -171.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -67.74 125.8 27.37 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.799 1.24 . . . . 74.2 112.766 -173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.551 HG23 ' CZ3' ' A' ' 176' ' ' TRP . 89.1 t -74.25 131.3 35.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-N 113.55 -1.659 . . . . 75.44 110.936 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -123.81 125.33 44.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.456 1.503 . . . . 75.12 107.851 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 33.1 mm -97.01 105.91 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.566 -1.272 . . . . 75.02 107.566 176.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.564 1.495 0 CA-C-O 118.022 -0.99 . . . . 73.43 109.507 -169.724 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.485 ' N ' ' SD ' ' A' ' 168' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.524 -0.547 . . . . 63.15 109.524 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -85.38 161.93 19.25 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.461 0.704 . . . . 74.3 110.606 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.8 p -59.63 -35.44 74.38 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.454 1.102 . . . . 74.23 111.433 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.05 141.32 40.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.377 -0.601 . . . . 44.44 109.377 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.407 HG21 HG22 ' A' ' 219' ' ' VAL . 13.4 m -70.88 -19.64 62.6 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.351 0.66 . . . . 74.31 110.959 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.74 166.17 12.58 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.744 0.817 . . . . 75.32 111.874 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.68 -96.56 0.92 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.525 -1.03 . . . . 72.33 110.525 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.14 174.86 9.61 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.982 0.513 . . . . 74.31 109.716 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.458 ' CZ3' HG23 ' A' ' 253' ' ' VAL . 9.9 m95 -87.29 -73.1 0.49 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.266 -0.879 . . . . 75.3 110.097 170.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.559 HE22 ' HG2' ' A' ' 231' ' ' ARG . 3.8 pt20 -169.51 32.43 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.241 0.617 . . . . 75.42 110.033 -170.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.09 69.15 1.25 Allowed Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.923 -0.58 . . . . 55.34 111.7 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -124.54 113.25 17.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.631 1.172 . . . . 71.12 107.915 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.02 -60.05 4.23 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 110.918 -0.873 . . . . 53.42 110.918 -170.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.0 p -139.68 149.86 44.19 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.566 1.146 . . . . 70.22 108.71 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -120.88 135.62 10.87 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.044 -0.823 . . . . 71.12 111.044 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -76.62 -58.84 3.42 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 111.81 -0.516 . . . . 63.44 111.81 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.0 p -162.6 149.24 13.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.268 0.627 . . . . 73.1 110.172 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.47 65.99 2.07 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.29 0.369 . . . . 71.13 112.553 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.67 143.84 6.32 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 112.168 -0.373 . . . . 75.43 112.168 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.6 m -138.45 139.39 38.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.665 0.786 . . . . 61.2 110.644 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 159.52 83.62 0.05 OUTLIER Glycine 0 C--N 1.342 0.915 0 N-CA-C 110.525 -1.03 . . . . 75.24 110.525 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -106.0 -159.32 22.46 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 113.929 0.332 . . . . 64.45 113.929 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.2 m -130.08 152.28 49.71 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.338 1.055 . . . . 74.12 109.521 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 58.92 21.1 8.8 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 124.185 0.994 . . . . 73.0 110.89 -174.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 7.9 p-10 -76.67 154.6 34.11 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 114.741 -1.118 . . . . 55.43 112.366 -169.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.414 ' HB2' HD12 ' A' ' 249' ' ' LEU . 87.4 mt -116.75 147.22 42.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.391 1.076 . . . . 73.51 109.594 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -115.55 117.6 30.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.18 -1.045 . . . . 71.44 108.18 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.551 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -130.17 -173.61 3.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.456 0.702 . . . . 73.22 109.878 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.0 m -124.33 120.63 32.71 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.43 0.692 . . . . 73.3 110.311 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.508 HD21 HG22 ' A' ' 253' ' ' VAL . 18.3 tp -78.6 105.55 9.96 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.003 -1.11 . . . . 74.55 108.003 172.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -86.29 101.0 12.67 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.788 -0.819 . . . . 71.34 108.788 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.611 ' HA ' HG12 ' A' ' 210' ' ' VAL . 18.1 t -112.67 113.86 50.12 Favored Pre-proline 0 N--CA 1.47 0.556 0 N-CA-C 108.884 -0.784 . . . . 74.52 108.884 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.38 151.17 83.85 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 121.611 1.541 . . . . 74.33 110.642 171.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.19 -43.77 95.7 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-O 118.01 -0.995 . . . . 74.33 113.096 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.3 Cg_endo -55.37 -51.76 9.28 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 122.152 1.901 . . . . 71.25 112.98 174.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.471 HG21 HG13 ' A' ' 210' ' ' VAL . 38.6 mt -63.76 -34.85 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.07 0.548 . . . . 75.11 111.016 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.44 87.24 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.19 -0.459 . . . . 63.3 111.017 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.9 t -72.84 -49.03 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.826 0.85 . . . . 71.02 111.833 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.81 -24.72 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 122.329 0.252 . . . . 75.1 110.714 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.06 75.9 1.03 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.95 -0.568 . . . . 75.24 111.776 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.99 -144.78 10.9 Favored Glycine 0 N--CA 1.474 1.209 0 N-CA-C 110.815 -0.914 . . . . 65.25 110.815 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -122.29 150.73 41.94 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.107 0.953 . . . . 74.15 110.762 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.611 HG12 ' HA ' ' A' ' 199' ' ' VAL . 24.8 m -141.06 149.21 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 115.354 -0.839 . . . . 75.24 109.978 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -73.83 145.13 45.18 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.292 0.568 . . . . 71.52 111.124 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -119.8 115.95 24.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.256 1.422 . . . . 75.12 107.281 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 15.9 tpt -64.26 130.88 45.6 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.27 0.628 . . . . 75.01 111.529 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.404 ' HG1' HG21 ' A' ' 219' ' ' VAL . 0.0 OUTLIER -131.88 -172.41 2.87 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.166 1.386 . . . . 73.52 109.691 -179.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.04 -70.18 0.26 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.074 0.94 . . . . 73.22 110.668 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -114.88 -41.52 3.35 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 113.63 -1.623 . . . . 75.13 111.387 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -116.3 102.97 1.11 Allowed Glycine 0 C--N 1.349 1.294 0 CA-C-O 118.468 -1.184 . . . . 72.14 111.652 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.33 137.99 78.14 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.251 2.634 . . . . 72.13 112.625 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 91.0 t -90.37 163.46 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.451 1.1 . . . . 75.43 108.955 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -146.19 127.9 15.25 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.704 -1.221 . . . . 65.31 107.704 170.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.454 HG12 HD11 ' A' ' 233' ' ' LEU . 14.0 p -116.94 140.99 37.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 C-N-CA 123.722 0.809 . . . . 75.14 110.276 -174.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.93 106.82 5.81 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.59 -0.732 . . . . 70.44 109.052 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.91 128.61 92.75 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.755 0.822 . . . . 74.44 109.253 173.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -59.39 149.58 80.5 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.956 2.438 . . . . 65.34 111.961 170.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.39 132.18 39.78 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 121.751 1.634 . . . . 74.42 110.77 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 52.92 69.88 0.64 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.287 1.435 . . . . 71.14 112.672 -173.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.481 HG23 ' HD2' ' A' ' 231' ' ' ARG . 32.5 m -92.06 138.42 31.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.222 -1.354 . . . . 73.42 110.135 170.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.3 mp0 -103.55 162.31 13.15 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.555 0.742 . . . . 74.21 111.044 176.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -82.76 155.88 24.02 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.187 -1.37 . . . . 74.3 111.741 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.07 -10.03 59.98 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 111.847 -0.501 . . . . 71.43 111.847 -173.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.559 ' HG2' HE22 ' A' ' 177' ' ' GLN . 71.4 mtt85 -72.38 -179.52 2.98 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.067 0.947 . . . . 72.21 110.307 168.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.535 ' HA ' HG21 ' A' ' 253' ' ' VAL . 8.4 ptmt -167.8 153.23 7.1 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.88 -0.6 . . . . 74.45 109.909 171.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.548 HD13 HD13 ' A' ' 251' ' ' LEU . 85.4 mt -83.58 152.48 24.82 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.358 -0.608 . . . . 74.44 109.358 169.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -118.65 110.08 16.89 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 124.833 1.333 . . . . 72.23 107.593 168.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 58.6 mt -116.98 117.8 30.66 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.728 -0.669 . . . . 74.01 110.07 -171.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.484 ' HD3' ' HB3' ' A' ' 248' ' ' ASP . 27.2 mmtp -93.03 132.39 37.17 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.702 -0.481 . . . . 75.54 109.702 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.81 20.72 73.11 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 124.261 0.976 . . . . 54.33 112.912 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.441 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 26.6 mmtp -116.86 -5.47 11.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.178 0.807 . . . . 75.5 113.178 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.61 -172.32 46.78 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-O 119.794 -0.448 . . . . 53.04 112.124 166.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -58.77 139.14 86.56 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.077 0.551 . . . . 74.43 111.765 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 6.3 Cg_exo -76.61 136.8 17.61 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.728 2.285 . . . . 70.04 111.508 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -130.93 170.16 21.35 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.952 -0.567 . . . . 63.14 112.764 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.52 -28.9 21.03 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.892 2.395 . . . . 74.21 112.26 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.59 22.17 12.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.855 0.862 . . . . 72.51 110.849 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.91 169.44 24.26 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 111.115 -0.794 . . . . 72.32 111.115 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 96.6 mtt180 -73.78 175.1 7.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.711 0.767 . . . . 74.32 111.994 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.46 -167.43 33.93 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.193 -1.367 . . . . 63.43 112.147 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.484 ' HB3' ' HD3' ' A' ' 236' ' ' LYS . 2.2 p-10 -118.69 176.94 5.03 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.682 0.793 . . . . 74.31 110.41 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 27.2 tp -145.82 109.55 4.8 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.236 0.541 . . . . 74.32 110.973 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 16.9 m-85 -102.16 116.14 32.03 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.449 -0.945 . . . . 75.45 108.449 174.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.0 pp -127.91 115.24 18.27 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.138 0.792 . . . . 73.11 113.138 -175.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.42 119.6 13.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.392 1.477 . . . . 72.44 112.856 -170.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.535 HG21 ' HA ' ' A' ' 232' ' ' LYS . 57.4 t -70.82 120.75 19.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-N 114.57 -1.196 . . . . 72.13 111.105 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -113.59 129.01 56.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.564 1.146 . . . . 72.31 108.908 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 31.9 mm -94.88 99.59 9.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.643 -1.243 . . . . 73.32 107.643 173.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 124.877 1.271 . . . . 74.54 108.436 -171.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.501 ' N ' ' SD ' ' A' ' 168' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 108.393 -0.966 . . . . 71.44 108.393 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -76.22 139.27 41.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.656 -0.702 . . . . 72.33 110.389 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.591 HG21 ' HA2' ' A' ' 174' ' ' GLY . 82.2 p -89.28 120.62 30.8 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.117 -0.947 . . . . 75.14 109.39 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.12 74.82 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.551 -0.907 . . . . 75.33 108.551 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.453 HG23 HG21 ' A' ' 219' ' ' VAL . 1.1 m -147.14 -40.76 0.19 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.592 -1.262 . . . . 74.54 107.592 162.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.96 159.73 14.97 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.719 0.808 . . . . 70.23 111.681 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.591 ' HA2' HG21 ' A' ' 170' ' ' THR . . . -92.08 -88.95 1.48 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 114.885 -1.052 . . . . 60.14 111.994 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.85 165.61 33.07 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.588 0.709 . . . . 73.21 112.801 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.494 ' CZ3' HG23 ' A' ' 227' ' ' THR . 34.5 m95 -87.03 -86.74 0.15 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 113.654 -1.612 . . . . 75.21 110.577 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -127.53 15.59 7.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.794 0.838 . . . . 75.35 110.548 -168.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.02 86.9 0.58 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.462 -1.455 . . . . 65.24 109.462 -168.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -64.02 100.0 0.29 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.607 -0.886 . . . . 73.54 108.607 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.08 -40.52 0.42 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 114.827 -1.079 . . . . 63.42 110.67 -171.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.5 t -162.48 -52.32 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.613 0.765 . . . . 73.42 109.329 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 145.22 -166.73 27.54 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.264 -0.88 . . . . 72.43 111.712 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 143.64 -96.67 0.19 Allowed Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.435 -0.666 . . . . 52.12 111.435 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 69.0 p -158.77 132.67 7.65 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.433 1.093 . . . . 75.13 108.961 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -87.87 -43.07 5.82 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-O 121.22 0.344 . . . . 73.34 112.797 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 113.3 162.11 14.9 Favored Glycine 0 N--CA 1.467 0.736 0 O-C-N 122.49 -0.418 . . . . 54.11 112.063 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.1 t -163.89 128.3 2.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.726 0.81 . . . . 75.23 109.0 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.15 161.55 10.89 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-O 120.231 -0.205 . . . . 73.54 112.592 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 140.51 -158.01 25.89 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.094 0.378 . . . . 71.33 112.262 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 58.0 p -118.8 151.84 37.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.968 0.907 . . . . 63.33 108.651 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.97 8.82 4.16 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.054 0.942 . . . . 72.33 112.347 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -90.1 148.3 23.1 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.106 0.962 . . . . 72.34 110.292 -169.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.0 mt -111.59 143.39 42.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.196 0.599 . . . . 65.35 110.653 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -113.41 114.82 27.13 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.594 -0.891 . . . . 75.12 108.594 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.577 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -128.13 -172.56 2.72 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.238 1.015 . . . . 62.23 109.603 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . 0.47 HG21 ' HG2' ' A' ' 254' ' ' ARG . 88.0 m -111.69 150.19 30.54 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.997 0.919 . . . . 72.53 110.442 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.56 HD22 ' HG ' ' A' ' 233' ' ' LEU . 16.7 tp -110.29 103.29 11.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.61 -1.626 . . . . 73.14 106.61 162.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.85 99.44 12.12 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.676 -0.861 . . . . 72.43 108.676 -173.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.61 ' HA ' HG11 ' A' ' 210' ' ' VAL . 15.6 t -106.73 113.02 63.29 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.118 -0.946 . . . . 74.04 108.518 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.31 148.37 88.39 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.531 1.487 . . . . 72.5 110.325 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -51.69 -44.28 89.9 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 117.725 -1.131 . . . . 72.54 112.579 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.1 Cg_endo -56.49 -49.94 13.41 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 122.052 1.835 . . . . 75.11 112.665 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.468 HG21 HG12 ' A' ' 210' ' ' VAL . 38.2 mt -65.36 -32.94 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.225 0.61 . . . . 75.02 110.818 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.84 -47.35 78.29 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.031 0.532 . . . . 54.41 110.344 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -70.25 -49.21 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.25 1.02 . . . . 64.21 111.945 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.0 p -79.68 -27.4 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.375 0.27 . . . . 72.01 110.715 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.3 70.6 1.34 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 112.217 -0.353 . . . . 71.41 112.217 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.33 -123.48 5.2 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 120.031 -0.316 . . . . 71.45 112.797 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -150.22 137.12 19.29 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.97 0.908 . . . . 74.21 110.052 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.61 HG11 ' HA ' ' A' ' 199' ' ' VAL . 29.6 m -139.17 156.68 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 123.427 0.691 . . . . 75.33 111.317 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -77.6 141.47 39.47 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.007 0.923 . . . . 70.31 111.535 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.424 ' HB3' HD21 ' A' ' 251' ' ' LEU . . . -116.4 116.59 27.98 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.421 1.488 . . . . 74.34 108.477 172.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -66.21 130.64 43.93 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.864 0.865 . . . . 74.4 111.189 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.2 -171.2 2.69 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.323 1.049 . . . . 71.32 110.132 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.1 mt -68.28 -66.83 0.52 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.881 1.273 . . . . 71.41 111.205 -175.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -105.5 -42.32 5.25 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 113.229 -1.805 . . . . 74.11 111.385 -165.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -137.49 145.16 16.79 Favored Glycine 0 N--CA 1.467 0.765 0 CA-C-O 118.695 -1.059 . . . . 72.24 111.716 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.65 137.92 23.24 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.165 1.91 . . . . 74.41 112.38 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.453 HG21 HG23 ' A' ' 172' ' ' THR . 50.5 t -95.39 164.67 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 114.475 -1.239 . . . . 64.12 108.104 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -144.41 144.32 31.35 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.416 -1.327 . . . . 74.32 107.416 175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.431 HG12 HD23 ' A' ' 197' ' ' LEU . 15.0 p -135.65 140.39 44.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 123.223 0.609 . . . . 74.53 110.824 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.56 112.6 9.79 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.803 0.841 . . . . 71.33 109.392 172.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 83.8 t -76.74 132.61 71.43 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.533 0.733 . . . . 72.35 109.406 176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.3 155.58 68.76 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.803 2.336 . . . . 74.02 111.353 169.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -65.63 136.22 45.2 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.001 1.801 . . . . 74.5 111.865 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 49.4 69.53 0.58 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.571 1.549 . . . . 64.13 112.773 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.494 HG23 ' CZ3' ' A' ' 176' ' ' TRP . 86.2 m -90.4 144.39 25.86 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.527 -1.215 . . . . 73.23 110.703 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -107.56 156.95 18.45 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.427 1.091 . . . . 74.31 110.556 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.05 155.45 30.63 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.481 -1.236 . . . . 72.53 110.518 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.78 -16.94 43.0 Favored Glycine 0 N--CA 1.471 0.984 0 N-CA-C 111.349 -0.7 . . . . 75.15 111.349 -173.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.411 ' HD2' HG21 ' A' ' 227' ' ' THR . 76.1 mtt85 -71.02 -178.96 2.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.247 1.019 . . . . 74.44 109.91 167.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.4 ptmt -167.05 159.97 13.61 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.191 0.307 . . . . 75.54 110.773 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.56 ' HG ' HD22 ' A' ' 197' ' ' LEU . 85.5 mt -88.19 147.29 24.94 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.35 -0.611 . . . . 74.43 109.35 168.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -113.68 107.17 15.4 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 124.675 1.235 . . . . 74.31 107.733 166.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.526 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 70.4 mt -110.07 110.72 21.71 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.482 0.713 . . . . 74.44 109.45 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -83.41 121.07 26.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.015 -0.993 . . . . 72.41 111.078 -167.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.8 2.53 88.56 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.236 -0.893 . . . . 71.44 113.341 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.526 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 48.2 mmtm -94.05 4.68 53.56 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.618 0.767 . . . . 73.4 111.814 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.97 -175.37 49.95 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.479 -1.048 . . . . 62.23 110.479 166.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -62.77 136.54 96.38 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-N 117.579 0.689 . . . . 74.34 110.906 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.544 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 55.9 Cg_endo -69.51 143.88 53.53 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.307 2.005 . . . . 74.31 112.21 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.21 167.29 23.47 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 119.471 -0.627 . . . . 71.02 112.489 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.77 -22.22 32.32 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 123.157 2.571 . . . . 75.12 113.887 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.2 1.05 16.02 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.278 0.631 . . . . 70.14 111.684 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.54 159.6 8.46 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.517 -0.633 . . . . 75.51 111.517 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 51.9 mtm180 -83.35 169.79 15.25 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.374 0.67 . . . . 75.21 111.438 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.74 -174.79 35.21 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.366 -0.834 . . . . 71.05 111.684 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -126.12 150.55 48.15 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.144 0.497 . . . . 73.32 110.209 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.517 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 37.6 tp -109.09 108.72 19.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.818 0.847 . . . . 73.2 109.95 -171.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.542 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 54.1 m-85 -104.29 116.32 31.95 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.402 1.081 . . . . 75.31 108.458 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.2 pp -130.08 115.19 16.73 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.386 0.884 . . . . 72.22 113.386 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -68.82 119.52 13.31 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.834 1.254 . . . . 74.11 112.061 -170.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 232' ' ' LYS . 66.6 t -65.13 124.92 21.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 CA-C-N 114.558 -1.201 . . . . 73.52 110.649 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . 0.47 ' HG2' HG21 ' A' ' 196' ' ' THR . 14.1 mmm180 -119.41 135.27 54.82 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.062 1.345 . . . . 72.01 108.539 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.41 111.12 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 107.888 -1.153 . . . . 74.03 107.888 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.564 1.517 0 CA-C-O 117.644 -1.169 . . . . 75.42 108.819 -171.819 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 53.0 mtm . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.133 -0.691 . . . . 72.52 109.133 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.46 -175.71 2.8 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.628 0.771 . . . . 74.03 109.599 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 8.1 t -80.79 68.61 7.09 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 122.122 0.963 . . . . 74.14 110.491 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -172.42 155.38 3.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.33 1.052 . . . . 62.52 109.188 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 11.7 m -76.87 -26.61 54.44 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.56 0.744 . . . . 71.14 110.064 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -90.34 143.23 26.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.532 0.733 . . . . 72.45 111.104 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.29 -75.6 0.42 Allowed Glycine 0 C--N 1.344 0.98 0 O-C-N 123.912 0.758 . . . . 73.3 112.358 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -158.14 171.27 20.53 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.906 0.882 . . . . 70.42 111.085 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.6 ' HB2' ' HB3' ' A' ' 179' ' ' LYS . 16.0 m95 -85.27 -69.56 0.65 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.811 -1.086 . . . . 73.54 108.661 168.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -173.19 -131.99 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 105.808 -1.923 . . . . 72.41 105.808 -175.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -80.0 66.08 3.65 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 110.279 -1.128 . . . . 73.4 110.279 162.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.6 ' HB3' ' HB2' ' A' ' 176' ' ' TRP . 20.6 pttp -58.33 117.39 4.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.265 1.026 . . . . 71.3 111.817 -172.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 127.77 -28.13 4.49 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.194 -0.912 . . . . 72.31 112.279 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.2 p -141.35 -54.46 0.47 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.117 0.567 . . . . 73.12 110.702 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -67.17 140.84 38.35 Favored Glycine 0 C--N 1.353 1.513 0 CA-C-O 119.726 -0.485 . . . . 72.23 112.235 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.489 ' HA2' ' HG2' ' A' ' 231' ' ' ARG . . . -135.49 -3.86 2.61 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 117.391 0.595 . . . . 72.54 114.481 -172.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 50.0 m -93.91 118.3 31.29 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 117.818 0.809 . . . . 74.42 111.084 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.52 159.27 16.16 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.942 -0.863 . . . . 75.51 110.942 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.71 170.28 33.46 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 114.737 0.655 . . . . 55.24 114.737 -171.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 37.3 p -76.13 165.26 25.18 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.276 1.03 . . . . 72.04 110.83 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -57.93 146.13 39.44 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 123.756 0.66 . . . . 71.21 114.527 -172.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.17 -87.47 1.72 Allowed Glycine 0 C--N 1.347 1.187 0 CA-C-N 116.848 0.324 . . . . 73.43 113.402 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.3 m -154.27 129.64 9.79 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.169 0.988 . . . . 73.24 109.288 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.423 ' HB2' ' HA3' ' A' ' 247' ' ' GLY . 22.8 mt-30 59.83 20.02 8.9 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.342 1.057 . . . . 63.23 110.346 -174.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.466 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.0 p-10 -80.54 155.98 26.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 113.746 -1.57 . . . . 74.5 111.672 -164.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.8 mt -123.45 132.79 54.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.204 -0.907 . . . . 70.12 110.215 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -93.32 129.99 39.23 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.579 -0.897 . . . . 71.22 108.579 167.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.611 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -138.65 -171.85 3.16 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.12 -0.696 . . . . 62.2 109.12 175.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.1 m -127.74 119.45 25.81 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.423 0.689 . . . . 74.31 110.778 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.511 HD22 ' HG ' ' A' ' 233' ' ' LEU . 17.3 tp -81.47 105.25 12.48 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.152 -1.055 . . . . 71.12 108.152 171.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -92.36 99.5 12.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.825 0.821 . . . . 73.24 108.85 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.637 HG21 HG21 ' A' ' 210' ' ' VAL . 22.8 t -101.15 121.71 51.04 Favored Pre-proline 0 C--N 1.347 0.465 0 N-CA-C 107.645 -1.242 . . . . 75.23 107.645 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.97 149.52 71.99 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 121.76 1.64 . . . . 71.4 110.243 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.413 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.61 -45.95 85.55 Favored Pre-proline 0 CA--C 1.56 1.365 0 O-C-N 124.2 0.937 . . . . 74.25 113.075 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.9 Cg_endo -57.47 -48.83 15.61 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 121.979 1.786 . . . . 70.51 113.67 176.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.413 HG21 HG13 ' A' ' 210' ' ' VAL . 47.9 mt -66.91 -32.47 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 122.813 0.445 . . . . 74.01 110.632 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.8 95.2 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.228 -0.442 . . . . 71.54 110.725 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.23 -51.68 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.612 0.765 . . . . 74.14 111.816 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.5 p -78.95 -22.42 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 120.753 0.311 . . . . 70.33 110.871 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 75.64 62.18 2.75 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 115.635 -0.711 . . . . 63.14 111.902 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.26 -120.68 2.73 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.25 -0.34 . . . . 72.22 112.25 -175.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -146.94 140.84 25.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.691 0.796 . . . . 72.44 109.259 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.637 HG21 HG21 ' A' ' 199' ' ' VAL . 19.1 m -137.19 152.61 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.301 0.64 . . . . 62.33 110.58 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -77.8 140.6 39.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.752 0.821 . . . . 74.53 110.75 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.503 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.03 115.8 29.51 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.497 -1.298 . . . . 75.53 107.497 172.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.9 tpt -63.49 127.55 31.81 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.229 0.612 . . . . 64.11 110.894 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.29 -170.23 2.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.786 1.234 . . . . 75.44 109.696 -175.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.04 -68.79 0.52 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.27 1.033 . . . . 74.43 111.224 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.19 -37.64 5.5 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 113.265 -1.789 . . . . 72.41 110.765 -165.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -133.31 119.25 2.3 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 118.566 -1.13 . . . . 65.12 110.669 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.09 141.44 52.79 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.53 2.153 . . . . 73.41 112.833 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 71.0 t -92.62 165.9 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 114.466 -1.243 . . . . 75.21 109.056 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -146.75 136.88 23.51 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 108.028 -1.101 . . . . 62.12 108.028 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.483 HG21 HD23 ' A' ' 233' ' ' LEU . 14.5 p -130.17 142.18 44.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.446 0.698 . . . . 75.31 110.809 -172.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.22 113.45 12.6 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.154 -0.684 . . . . 71.32 109.154 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.9 t -74.09 136.6 76.07 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 123.562 0.745 . . . . 72.33 109.146 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.86 154.04 67.78 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.259 1.973 . . . . 72.21 111.575 170.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.87 132.35 36.8 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.531 2.154 . . . . 75.04 111.916 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 49.56 72.84 0.28 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.139 1.375 . . . . 75.3 112.378 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.534 HG21 ' HD2' ' A' ' 231' ' ' ARG . 67.8 m -82.8 141.95 31.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.307 -1.315 . . . . 63.24 110.923 174.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.433 ' H ' HH11 ' A' ' 231' ' ' ARG . 27.0 mp0 -100.42 151.62 21.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.997 0.919 . . . . 73.42 110.314 171.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -75.94 156.84 33.84 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.049 -0.978 . . . . 42.02 111.078 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.57 -2.42 62.6 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.242 -0.435 . . . . 75.2 112.291 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.534 ' HD2' HG21 ' A' ' 227' ' ' THR . 28.3 mtt85 -77.17 -175.22 3.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.513 0.725 . . . . 63.41 109.737 168.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.572 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 9.3 ptmt -167.38 154.75 8.76 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 110.488 -0.189 . . . . 73.24 110.488 170.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.634 HD11 HD12 ' A' ' 251' ' ' LEU . 48.8 mt -80.0 143.58 33.99 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 110.118 -0.326 . . . . 73.2 110.118 167.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -109.89 108.39 18.67 Favored 'General case' 0 C--O 1.243 0.716 0 O-C-N 125.299 1.624 . . . . 75.11 108.39 166.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.493 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 65.9 mt -115.03 138.85 50.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.228 -0.896 . . . . 74.24 109.31 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -108.96 141.05 41.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.201 0.6 . . . . 73.12 109.44 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 68.58 24.16 75.28 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 124.194 0.934 . . . . 70.43 112.956 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.493 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 45.5 mmtm -117.43 -11.07 10.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.429 0.692 . . . . 75.43 112.331 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.85 -168.83 40.14 Favored Glycine 0 N--CA 1.479 1.531 0 CA-C-O 119.627 -0.541 . . . . 75.11 111.911 171.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -66.64 142.48 97.6 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-N 117.811 0.805 . . . . 74.42 111.651 -173.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.22 141.79 48.46 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.3 2.666 . . . . 74.51 112.647 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -135.82 172.23 22.36 Favored Glycine 0 N--CA 1.476 1.346 0 C-N-CA 123.243 0.449 . . . . 75.34 113.123 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.02 -25.51 44.2 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.031 2.487 . . . . 65.15 112.409 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.99 21.71 8.37 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.526 0.73 . . . . 72.42 111.623 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 103.03 -172.2 21.36 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 110.495 -1.042 . . . . 75.42 110.495 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.45 149.57 22.55 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 117.693 0.746 . . . . 74.21 110.633 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 191' ' ' GLN . . . -79.1 -173.59 44.19 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.907 0.754 . . . . 71.43 114.394 -173.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.466 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 6.9 p-10 -105.07 167.5 9.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.348 0.659 . . . . 63.01 110.917 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.472 HD21 HD11 ' A' ' 235' ' ' LEU . 42.2 tp -137.98 110.62 7.57 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.524 0.73 . . . . 73.22 109.381 -174.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.572 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 20.8 m-85 -108.75 118.86 37.89 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.886 -0.783 . . . . 75.55 108.886 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.634 HD12 HD11 ' A' ' 233' ' ' LEU . 1.6 pp -130.7 114.83 15.87 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.064 0.764 . . . . 75.33 113.064 -175.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -69.04 124.44 23.76 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 124.232 1.013 . . . . 75.32 113.204 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 232' ' ' LYS . 65.5 t -73.72 131.62 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 113.573 -1.649 . . . . 72.35 111.689 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -121.09 139.2 53.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.447 1.499 . . . . 71.52 108.15 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 35.0 mm -105.04 103.63 15.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.657 -1.238 . . . . 74.32 107.657 173.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.557 1.247 0 CA-C-O 117.741 -1.123 . . . . 72.02 108.625 -174.185 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.444 -0.206 . . . . 74.11 110.444 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -171.32 143.02 1.79 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.178 0.991 . . . . 64.41 109.19 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 34.7 p -63.98 -36.18 83.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.763 0.825 . . . . 72.41 111.935 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.96 139.81 36.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.006 0.522 . . . . 75.2 110.9 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.6 m -81.67 -22.66 37.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.905 0.882 . . . . 73.33 109.804 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -86.91 148.68 25.25 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.469 -0.787 . . . . 64.43 111.067 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -67.63 -100.54 0.03 OUTLIER Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.167 -0.773 . . . . 64.22 111.167 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -130.11 173.6 10.59 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.946 0.499 . . . . 73.04 109.861 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.515 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 16.1 m95 -72.32 -81.52 0.05 Allowed 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.152 -0.931 . . . . 74.44 108.997 168.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -172.12 121.46 0.46 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.215 0.606 . . . . 74.14 109.664 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.47 7.55 88.4 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 114.195 0.438 . . . . 72.33 114.195 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.04 -33.01 39.43 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.686 0.794 . . . . 74.53 109.904 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -112.63 -98.59 2.38 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.827 -0.624 . . . . 70.44 111.645 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -73.05 122.99 22.66 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 122.983 0.513 . . . . 61.35 111.859 -171.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -83.67 59.97 4.91 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.899 -0.481 . . . . 73.42 111.899 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -168.33 151.95 19.43 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.987 -0.445 . . . . 64.54 111.987 -175.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.1 t -166.11 97.47 0.62 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.447 1.099 . . . . 72.24 108.857 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.73 64.79 0.05 OUTLIER Glycine 0 C--N 1.345 1.071 0 N-CA-C 112.084 -0.406 . . . . 64.04 112.084 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -166.31 62.66 0.22 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.715 -0.554 . . . . 74.25 111.715 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.3 p -86.63 92.51 8.94 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.528 0.731 . . . . 64.31 110.426 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -79.77 85.9 1.27 Allowed Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.617 -0.593 . . . . 62.34 111.617 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 86.23 -129.07 9.18 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 110.827 -0.909 . . . . 63.03 110.827 -171.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.8 m -146.24 -89.99 0.09 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.016 0.526 . . . . 73.14 109.753 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 54.61 16.58 1.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.591 1.156 . . . . 75.44 113.007 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -100.14 172.79 6.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.202 0.601 . . . . 72.33 110.839 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.4 mt -135.14 142.48 46.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.478 0.711 . . . . 72.52 110.408 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -106.77 111.2 23.62 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.144 -1.428 . . . . 74.11 107.144 165.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.598 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . . . -123.67 -171.33 2.29 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.698 0.799 . . . . 72.53 110.167 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.1 m -113.64 145.87 40.63 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.483 1.113 . . . . 63.52 110.434 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 253' ' ' VAL . 18.4 tp -113.32 104.94 12.82 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.695 -1.595 . . . . 73.31 106.695 167.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.58 100.18 9.99 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.704 -0.85 . . . . 74.2 108.704 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.641 ' HA ' HG12 ' A' ' 210' ' ' VAL . 20.9 t -110.88 103.01 54.05 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.281 -1.007 . . . . 75.25 108.281 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.05 144.87 77.53 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.522 1.481 . . . . 74.23 109.876 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.407 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.03 -41.2 78.62 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 117.743 -1.122 . . . . 74.41 113.08 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.4 Cg_endo -55.28 -46.22 34.33 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.828 1.685 . . . . 71.15 113.06 173.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.413 HG21 HG13 ' A' ' 210' ' ' VAL . 52.0 mt -69.73 -34.82 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.35 0.66 . . . . 64.41 110.616 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.13 91.11 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 122.756 0.422 . . . . 72.34 110.593 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.89 -49.6 62.0 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 O-C-N 124.543 1.152 . . . . 74.4 111.481 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.7 p -79.0 -23.88 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 122.474 0.31 . . . . 72.22 110.738 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.51 71.62 1.11 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.466 -0.654 . . . . 75.22 111.466 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.27 -129.57 6.74 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.765 -0.534 . . . . 64.41 111.765 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -138.85 144.53 39.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.778 0.831 . . . . 73.31 109.537 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.641 HG12 ' HA ' ' A' ' 199' ' ' VAL . 27.0 m -137.02 153.73 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 115.665 -0.698 . . . . 74.04 110.564 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -74.9 143.51 43.75 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.515 0.726 . . . . 74.4 110.569 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.511 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -116.04 113.15 22.8 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.146 1.378 . . . . 72.5 107.946 172.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.5 tpt -64.87 122.88 17.99 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.342 1.057 . . . . 63.43 111.002 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 215' ' ' LEU . 0.2 OUTLIER -124.09 -171.07 2.25 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.787 1.235 . . . . 75.22 109.084 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.502 ' H ' HG22 ' A' ' 214' ' ' THR . 7.0 mt -60.27 -67.26 0.41 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.632 1.173 . . . . 75.23 111.42 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -109.48 -42.53 4.31 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.105 -1.861 . . . . 72.32 110.918 -163.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -131.86 157.42 22.4 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-O 118.916 -0.936 . . . . 75.12 111.308 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -86.3 143.31 7.63 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.966 1.778 . . . . 74.21 113.064 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 64.4 t -98.43 167.57 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 114.256 -1.338 . . . . 75.11 108.038 174.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -143.53 145.46 32.58 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.444 -0.947 . . . . 75.01 108.444 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.86 141.24 42.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.404 0.681 . . . . 75.15 110.123 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.84 112.74 10.25 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.565 -0.902 . . . . 73.34 108.565 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.7 t -73.27 132.46 81.98 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 108.558 -0.905 . . . . 75.11 108.558 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.6 153.25 76.16 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.667 2.244 . . . . 65.23 111.525 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -64.57 136.07 48.5 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 121.89 1.727 . . . . 73.13 111.979 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 53.24 54.11 10.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.469 1.508 . . . . 74.11 113.275 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.491 HG21 ' HD2' ' A' ' 231' ' ' ARG . 19.4 m -80.02 138.2 36.97 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.92 -0.582 . . . . 75.01 111.403 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -96.16 160.04 14.64 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.124 0.969 . . . . 75.04 111.135 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -79.88 156.02 27.52 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.314 -1.312 . . . . 74.55 110.858 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.64 -18.61 43.77 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 111.958 -0.457 . . . . 73.24 111.958 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.491 ' HD2' HG21 ' A' ' 227' ' ' THR . 78.0 mtt85 -68.48 178.79 1.87 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.039 0.935 . . . . 75.0 109.986 167.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.567 ' HA ' HG22 ' A' ' 253' ' ' VAL . 11.2 ptmt -167.02 154.94 9.45 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.142 0.276 . . . . 74.11 110.492 173.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.565 HD12 HD13 ' A' ' 251' ' ' LEU . 82.3 mt -81.66 146.09 30.22 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 108.811 -0.811 . . . . 74.11 108.811 167.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -116.1 106.99 14.36 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.808 -1.182 . . . . 75.02 107.808 165.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.485 HD13 HD21 ' A' ' 249' ' ' LEU . 58.6 mt -107.97 108.44 19.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.788 -1.097 . . . . 73.23 109.202 -173.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -82.88 121.92 27.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.822 -1.081 . . . . 72.1 110.337 -170.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.06 9.93 79.44 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 124.307 1.004 . . . . 73.21 113.894 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.461 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 46.5 mmtm -99.46 6.25 46.0 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.75 0.775 . . . . 73.34 112.542 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.35 -174.75 50.24 Favored Glycine 0 N--CA 1.472 1.099 0 O-C-N 123.319 0.387 . . . . 73.03 112.291 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -58.35 142.55 81.53 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 123.857 0.863 . . . . 75.32 112.993 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.445 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 48.9 Cg_endo -67.23 132.32 27.38 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.301 2.668 . . . . 74.21 112.791 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.07 -178.37 15.51 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 115.213 -0.903 . . . . 75.22 112.913 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.15 -25.78 21.98 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 123.101 2.534 . . . . 74.31 112.686 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.24 22.11 16.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.308 1.043 . . . . 43.33 111.006 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 98.98 -172.88 26.07 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.142 -0.783 . . . . 74.22 111.142 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.445 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 68.7 mtm180 -85.41 156.93 20.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.899 0.479 . . . . 72.22 111.722 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.8 -154.86 6.05 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 123.941 0.776 . . . . 70.43 111.799 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -121.75 166.36 14.44 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.899 0.85 . . . . 73.02 110.825 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.485 HD21 HD13 ' A' ' 235' ' ' LEU . 46.6 tp -126.78 107.22 9.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.496 0.718 . . . . 74.13 109.194 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -105.08 111.3 24.02 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.966 -1.124 . . . . 75.33 107.966 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.598 ' HB3' ' HB2' ' A' ' 195' ' ' ALA . 1.8 pp -125.9 120.9 31.64 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.709 1.003 . . . . 75.44 113.709 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -69.26 123.81 22.16 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.733 1.613 . . . . 74.42 112.624 -171.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 232' ' ' LYS . 90.4 t -71.86 119.23 18.01 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 C-N-CA 124.821 1.249 . . . . 75.42 111.077 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -113.82 115.41 27.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.626 1.57 . . . . 73.43 107.883 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 36.2 mm -86.87 96.0 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.868 -1.16 . . . . 74.52 107.868 175.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.556 1.202 0 C-N-CA 124.539 1.135 . . . . 71.33 109.076 -171.91 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 121.416 0.627 . . . . 72.14 109.456 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.21 96.6 10.61 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.877 -1.157 . . . . 71.14 107.877 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.4 m -136.39 135.41 38.74 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.365 -0.834 . . . . 75.43 109.227 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.01 163.64 14.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.298 0.639 . . . . 72.52 110.251 173.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.2 m -62.24 -21.33 65.08 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.432 0.693 . . . . 71.2 112.0 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.0 166.8 18.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.781 0.832 . . . . 61.14 111.713 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.16 -80.96 1.15 Allowed Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.886 -1.052 . . . . 71.53 111.011 172.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.537 ' HB2' ' HD3' ' A' ' 179' ' ' LYS . 12.7 pt-20 -153.9 175.27 13.55 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.165 0.586 . . . . 71.44 111.464 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.441 ' CZ3' HG23 ' A' ' 253' ' ' VAL . 23.7 m95 -84.9 -94.9 0.07 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.846 -1.07 . . . . 64.45 110.743 177.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 179.91 165.47 1.19 Allowed 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.131 0.973 . . . . 74.5 109.014 -170.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.07 -47.17 3.65 Favored Glycine 0 N--CA 1.476 1.341 0 N-CA-C 111.765 -0.534 . . . . 74.42 111.765 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.537 ' HD3' ' HB2' ' A' ' 175' ' ' GLU . 13.3 ptmm? -69.09 -11.34 60.7 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.978 0.911 . . . . 74.21 111.301 165.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.41 86.3 0.08 OUTLIER Glycine 0 C--N 1.348 1.197 0 N-CA-C 110.884 -0.886 . . . . 71.41 110.884 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.3 m -156.79 172.25 18.95 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.63 1.172 . . . . 72.31 110.419 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 173.03 -171.31 44.36 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.611 -0.595 . . . . 72.15 111.611 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.51 75.38 2.32 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.357 -0.697 . . . . 75.52 111.357 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.3 t -163.63 138.23 6.05 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.382 0.673 . . . . 74.32 109.694 -176.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -152.81 178.51 29.89 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.672 -0.571 . . . . 63.21 111.672 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -71.71 157.03 53.02 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 116.679 0.24 . . . . 53.45 113.537 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.8 p -154.38 145.66 22.94 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.81 0.844 . . . . 74.14 110.649 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.77 -117.92 4.52 Favored Glycine 0 C--N 1.35 1.307 0 N-CA-C 112.168 -0.373 . . . . 73.21 112.168 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.3 59.03 4.47 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.125 -0.79 . . . . 62.21 111.125 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.2 m -68.9 -41.69 77.92 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.935 0.894 . . . . 74.12 112.216 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 63.88 16.44 9.85 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 124.313 1.008 . . . . 72.11 112.119 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 5.5 p-10 -75.35 148.37 39.32 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 123.742 0.817 . . . . 73.35 110.639 -174.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.454 ' HB2' HD12 ' A' ' 249' ' ' LEU . 84.2 mt -119.3 147.55 44.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.328 0.651 . . . . 74.34 110.092 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 9.0 t80 -109.31 114.93 29.03 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.882 -1.155 . . . . 75.14 107.882 171.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.418 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -127.42 -173.69 2.98 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.729 0.812 . . . . 75.21 110.441 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 60.3 m -121.52 137.93 54.52 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.519 0.728 . . . . 73.44 111.071 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.527 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.5 tp -108.1 108.81 20.05 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.973 1.309 . . . . 62.31 107.69 169.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.04 99.35 12.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.42 0.629 . . . . 75.51 109.611 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.596 HG22 HG21 ' A' ' 210' ' ' VAL . 15.1 t -101.59 111.03 63.34 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.675 -1.231 . . . . 71.24 107.675 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.55 154.38 74.56 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.85 1.7 . . . . 74.02 110.418 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.72 -45.37 79.31 Favored Pre-proline 0 CA--C 1.573 1.847 0 CA-C-O 117.809 -1.091 . . . . 63.52 113.394 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.79 -48.89 13.05 Favored 'Trans proline' 0 C--N 1.402 3.351 0 C-N-CA 121.828 1.685 . . . . 74.41 112.484 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.468 HG21 HG12 ' A' ' 210' ' ' VAL . 44.4 mt -68.28 -31.2 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.539 0.736 . . . . 63.22 110.762 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.81 -46.72 77.59 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.0 0.52 . . . . 74.15 110.585 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.56 -48.33 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 124.417 1.073 . . . . 73.42 111.954 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.15 -28.58 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 120.678 0.275 . . . . 75.34 110.715 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.11 76.46 1.0 Allowed Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.626 -0.589 . . . . 72.14 111.626 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.5 -129.4 6.68 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-O 120.049 -0.306 . . . . 72.3 112.817 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.72 135.19 29.57 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.965 0.906 . . . . 74.52 109.132 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.596 HG21 HG22 ' A' ' 199' ' ' VAL . 31.6 m -134.21 149.3 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.573 0.749 . . . . 74.44 110.547 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -75.95 150.4 37.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.945 0.898 . . . . 74.24 110.624 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.529 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -122.57 121.58 36.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.838 1.255 . . . . 72.11 108.442 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.23 123.4 19.01 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.732 0.813 . . . . 74.22 110.217 176.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.454 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.3 OUTLIER -126.47 -171.87 2.5 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.552 1.141 . . . . 72.14 110.206 -176.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.53 -70.34 0.22 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 122.243 1.021 . . . . 74.12 111.268 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -110.22 -41.59 4.37 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 113.461 -1.7 . . . . 64.23 110.947 -162.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -132.55 145.86 17.7 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 118.348 -1.251 . . . . 53.44 110.549 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.82 152.72 64.05 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.125 1.883 . . . . 75.22 112.628 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 54.1 t -104.09 167.67 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.927 1.291 . . . . 75.31 108.029 174.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -148.64 146.28 28.13 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 107.815 -1.18 . . . . 75.13 107.815 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.419 HG13 HD13 ' A' ' 233' ' ' LEU . 9.6 p -138.5 144.27 30.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 C-N-CA 122.946 0.498 . . . . 63.23 110.8 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.59 112.89 12.41 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 124.035 0.835 . . . . 74.14 109.675 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.56 134.81 75.71 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.017 0.927 . . . . 74.51 109.45 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.52 154.34 50.08 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.465 2.11 . . . . 70.13 111.533 169.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.93 136.97 64.58 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 121.988 1.792 . . . . 73.42 111.756 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 51.51 70.37 0.55 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.231 1.413 . . . . 75.01 113.434 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.46 HG21 ' HD2' ' A' ' 231' ' ' ARG . 80.8 m -89.01 143.09 27.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.803 -1.089 . . . . 54.24 110.655 173.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -107.61 154.85 20.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.294 1.037 . . . . 71.12 110.35 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.431 ' HB1' ' H ' ' A' ' 255' ' ' ILE . . . -80.28 150.82 29.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.053 -0.976 . . . . 74.33 110.823 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.1 -21.3 27.3 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.931 -0.868 . . . . 71.52 110.931 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.46 ' HD2' HG21 ' A' ' 227' ' ' THR . 72.2 mtt85 -65.34 179.79 0.71 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.09 0.956 . . . . 70.11 110.525 170.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.712 ' HD3' ' HB3' ' A' ' 250' ' ' TYR . 9.9 ptpt -166.77 159.72 14.03 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.225 0.21 . . . . 74.12 111.033 171.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.507 HD12 HD13 ' A' ' 251' ' ' LEU . 71.2 mt -87.22 154.16 20.93 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.898 -0.408 . . . . 74.31 109.898 170.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -117.84 106.75 13.33 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.791 1.307 . . . . 73.45 108.04 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.532 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 44.8 mt -118.13 112.98 20.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.96 -0.564 . . . . 75.52 110.947 -172.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -90.78 127.4 36.33 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.159 -0.473 . . . . 75.13 109.935 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 88.23 11.57 66.79 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 123.981 0.8 . . . . 74.42 112.672 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.498 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.3 mmtt -113.79 -4.93 13.29 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.42 0.688 . . . . 74.33 111.867 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.72 -176.41 51.43 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.277 -0.729 . . . . 75.13 111.277 166.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.3 139.96 94.6 Favored Pre-proline 0 N--CA 1.487 1.375 0 CA-C-N 117.718 0.759 . . . . 75.21 111.405 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.458 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 34.8 Cg_endo -63.26 137.86 63.28 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.838 2.359 . . . . 75.53 112.516 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.99 169.51 22.89 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.126 -0.488 . . . . 65.31 113.875 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -71.35 -20.26 27.96 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 123.202 2.601 . . . . 65.41 112.077 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.1 17.46 15.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.279 1.032 . . . . 53.42 110.462 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.51 169.35 45.49 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.29 -0.724 . . . . 72.52 111.29 -170.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.458 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 95.5 mtt180 -65.34 158.2 27.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.877 0.871 . . . . 71.24 111.414 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.47 -164.61 40.46 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.715 -0.675 . . . . 64.31 112.333 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 8.7 p-10 -110.04 170.99 7.72 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.695 0.76 . . . . 71.44 110.574 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.662 ' HG ' HD23 ' A' ' 251' ' ' LEU . 33.5 tp -135.02 109.68 8.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.024 -0.989 . . . . 72.42 109.123 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.712 ' HB3' ' HD3' ' A' ' 232' ' ' LYS . 12.3 m-30 -98.29 112.04 24.17 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.37 -1.344 . . . . 73.32 107.37 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.662 HD23 ' HG ' ' A' ' 249' ' ' LEU . 3.5 pp -124.82 113.52 18.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.673 0.749 . . . . 75.02 112.863 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.51 119.37 12.2 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.826 1.25 . . . . 75.15 112.543 -170.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.532 HG21 ' HA ' ' A' ' 232' ' ' LYS . 58.5 t -68.07 131.79 33.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 113.858 -1.519 . . . . 74.03 110.862 174.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -127.35 133.98 50.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.353 1.461 . . . . 75.43 107.913 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 34.6 mm -103.36 101.37 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.122 -1.066 . . . . 75.22 108.122 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.561 1.374 0 CA-C-N 115.045 -0.98 . . . . 73.24 108.634 -170.429 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.445 ' N ' ' SD ' ' A' ' 168' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 108.482 -0.933 . . . . 75.53 108.482 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -127.61 151.5 48.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.553 0.741 . . . . 74.31 110.428 -173.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.8 p -134.84 130.35 35.89 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.298 1.039 . . . . 62.21 108.714 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 63.78 14.96 8.67 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.663 1.185 . . . . 43.51 113.652 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 23.6 m -65.03 -26.94 68.48 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.314 0.645 . . . . 74.14 110.102 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.5 178.34 4.71 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.068 0.947 . . . . 71.25 111.162 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.04 -86.05 1.79 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.059 -1.616 . . . . 74.41 109.059 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.29 164.89 29.44 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.389 1.076 . . . . 62.41 109.651 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.545 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.6 m95 -70.24 -61.67 1.68 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.484 -0.932 . . . . 73.33 108.484 170.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -174.27 -165.08 0.21 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.502 -1.226 . . . . 71.02 108.209 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -69.62 78.57 0.35 Allowed Glycine 0 C--N 1.34 0.753 0 N-CA-C 109.484 -1.446 . . . . 71.43 109.484 163.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -71.1 89.84 0.84 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.215 1.006 . . . . 74.5 109.562 -170.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.67 -50.5 0.34 Allowed Glycine 0 C--O 1.239 0.466 0 CA-C-N 114.059 -1.428 . . . . 45.32 110.708 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 19.2 t -164.41 143.06 7.14 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.462 0.705 . . . . 75.45 109.689 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.28 156.17 12.07 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.151 0.282 . . . . 73.51 112.899 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -90.47 -156.33 32.29 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 122.832 0.254 . . . . 60.31 112.741 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.5 m -99.75 169.15 9.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.843 0.857 . . . . 74.24 110.356 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 122.73 141.58 5.98 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 111.99 -0.444 . . . . 72.12 111.99 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 159.65 62.0 0.01 OUTLIER Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.987 -0.845 . . . . 72.32 110.987 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.1 t -154.01 129.63 9.99 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.862 0.865 . . . . 71.32 108.902 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -135.85 -130.81 2.96 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.046 0.216 . . . . 73.04 112.984 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.34 30.53 4.42 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.403 -0.665 . . . . 71.45 114.627 -170.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.2 t 71.72 -7.82 1.18 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.812 1.245 . . . . 72.42 113.26 172.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -69.31 -42.69 75.06 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 108.449 -0.945 . . . . 71.41 108.449 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 11.4 p-10 -64.97 145.79 55.86 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.585 -1.189 . . . . 74.52 110.013 171.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.9 mt -124.54 159.01 31.57 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.383 0.611 . . . . 72.22 111.691 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 8.7 t80 -116.04 109.13 17.1 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.54 -1.209 . . . . 73.35 108.774 174.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . . . -118.59 -170.42 1.9 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.502 1.121 . . . . 53.21 109.913 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 98.3 m -117.53 127.77 54.31 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.732 0.813 . . . . 73.31 110.761 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.646 HD22 ' HG ' ' A' ' 233' ' ' LEU . 17.0 tp -87.84 105.88 17.71 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.866 -1.161 . . . . 71.12 107.866 165.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -87.1 107.52 18.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.096 -1.076 . . . . 72.33 108.096 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.607 ' HA ' HG13 ' A' ' 210' ' ' VAL . 19.2 t -117.58 115.94 37.12 Favored Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 108.83 -0.804 . . . . 75.01 108.83 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.01 149.61 77.29 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 121.571 1.514 . . . . 64.13 110.371 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.437 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.38 -43.96 92.64 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-O 117.75 -1.119 . . . . 73.01 112.571 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.2 Cg_endo -54.42 -52.57 7.91 Favored 'Trans proline' 0 C--N 1.403 3.446 0 C-N-CA 122.291 1.994 . . . . 71.32 113.077 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.437 HG21 HG11 ' A' ' 210' ' ' VAL . 51.2 mt -64.63 -33.61 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.207 0.603 . . . . 71.23 111.009 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.48 -46.58 85.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.829 0.452 . . . . 73.43 110.837 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.86 -50.62 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.004 0.922 . . . . 74.15 112.316 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.19 -27.01 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-O 120.614 0.245 . . . . 72.23 110.708 -174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.96 76.7 0.88 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.021 -0.536 . . . . 70.13 111.764 -175.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.46 -130.23 6.77 Favored Glycine 0 N--CA 1.476 1.346 0 N-CA-C 111.018 -0.833 . . . . 74.54 111.018 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -133.13 152.91 51.93 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.568 0.747 . . . . 73.43 110.434 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.607 HG13 ' HA ' ' A' ' 199' ' ' VAL . 30.7 m -139.9 149.77 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.323 -0.853 . . . . 64.4 109.402 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -73.42 152.62 40.73 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.516 -0.765 . . . . 71.51 110.673 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.572 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -130.73 114.27 15.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.147 1.379 . . . . 75.44 108.635 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 12.8 tpt -63.91 123.8 19.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.696 1.198 . . . . 75.25 111.435 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.521 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -121.83 -172.82 2.51 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.709 1.203 . . . . 75.3 109.371 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.52 ' H ' HG21 ' A' ' 214' ' ' THR . 4.8 mt -64.88 -65.96 0.6 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.191 1.396 . . . . 73.53 110.254 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -93.17 -37.4 12.12 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 112.227 -2.26 . . . . 72.12 110.155 -166.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -145.49 -162.43 9.64 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.237 -0.892 . . . . 53.14 112.429 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -100.66 174.73 0.31 Allowed 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 123.145 2.564 . . . . 72.23 113.936 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.572 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 43.7 t -130.49 167.78 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 126.06 1.744 . . . . 65.32 106.322 172.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -145.68 120.26 9.76 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.388 -0.967 . . . . 74.23 108.388 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.422 HG11 HD12 ' A' ' 233' ' ' LEU . 15.0 p -112.53 141.37 28.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 123.99 0.916 . . . . 72.23 110.095 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.06 115.91 15.21 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.538 -0.912 . . . . 51.33 108.538 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.92 132.53 74.12 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 108.559 -0.904 . . . . 74.41 108.559 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.73 149.59 78.79 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.939 2.426 . . . . 73.15 111.536 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -56.64 129.99 37.61 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.374 2.049 . . . . 73.43 112.572 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 54.58 68.25 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.456 1.502 . . . . 73.45 113.478 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 54.0 m -95.05 139.27 31.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.901 -1.045 . . . . 70.53 110.184 172.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -104.07 163.87 12.1 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.453 1.101 . . . . 74.43 110.765 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.418 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.4 155.73 24.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.336 -1.302 . . . . 72.01 110.924 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.95 -5.17 57.84 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 111.878 -0.489 . . . . 71.55 111.878 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -81.38 -174.96 5.23 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.998 0.919 . . . . 74.23 109.308 168.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.561 ' HA ' HG22 ' A' ' 253' ' ' VAL . 10.6 ptpt -165.98 161.99 17.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.08 0.552 . . . . 72.24 109.692 169.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.675 HD11 HD11 ' A' ' 251' ' ' LEU . 87.0 mt -85.92 150.71 24.32 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.49 -0.93 . . . . 74.43 108.49 164.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -116.94 106.39 13.38 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.876 -1.157 . . . . 75.15 107.876 160.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 43.3 mt -102.2 104.39 14.97 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.41 -1.268 . . . . 74.33 108.76 -174.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -79.47 118.81 21.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.164 -1.38 . . . . 75.22 110.295 -167.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.94 9.59 82.34 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.436 1.085 . . . . 54.25 114.044 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.527 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.4 mmtt -96.29 -0.04 50.19 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 118.249 1.024 . . . . 74.15 112.772 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.53 -177.35 50.46 Favored Glycine 0 N--CA 1.472 1.066 0 N-CA-C 111.716 -0.553 . . . . 75.42 111.716 170.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -55.46 126.18 62.1 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 123.568 0.747 . . . . 73.25 111.29 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.539 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 35.2 Cg_endo -65.05 134.72 40.82 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.7 2.267 . . . . 73.22 111.918 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -117.4 177.34 16.58 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.244 -0.889 . . . . 51.5 112.356 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.39 -33.36 23.57 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.824 2.349 . . . . 61.41 113.073 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.55 -33.62 12.34 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.137 0.575 . . . . 71.35 111.122 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 177.63 174.86 44.36 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.242 -0.89 . . . . 74.41 111.163 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.539 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 65.9 mtt180 -88.05 160.56 17.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.233 0.613 . . . . 73.32 111.47 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.54 -176.38 50.98 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.688 -0.965 . . . . 75.25 110.688 168.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 27.1 m-20 -110.33 -178.99 3.65 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.118 0.567 . . . . 74.3 110.163 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 55.7 tp -136.38 105.47 5.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.887 0.851 . . . . 75.01 109.499 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.487 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 58.9 m-85 -99.56 108.8 21.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.703 -1.221 . . . . 72.55 107.703 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.675 HD11 HD11 ' A' ' 233' ' ' LEU . 1.5 pp -125.49 115.0 19.54 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.965 1.098 . . . . 64.53 113.965 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.65 126.46 29.43 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 113.656 -1.611 . . . . 74.23 113.1 -170.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 232' ' ' LYS . 63.3 t -75.01 124.83 33.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 CA-C-N 113.522 -1.672 . . . . 74.23 110.622 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -121.04 122.06 39.27 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.817 1.247 . . . . 72.13 107.788 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.418 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 32.7 mm -92.51 103.73 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.04 -1.096 . . . . 74.33 108.04 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.562 1.42 0 CA-C-O 117.484 -1.246 . . . . 71.41 108.751 -169.384 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 75.9 mtp . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 121.198 0.523 . . . . 70.11 109.757 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 170' ' ' THR . 29.7 tt0 -167.88 -177.29 3.36 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 108.528 -0.916 . . . . 74.01 108.528 -174.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.417 ' H ' ' HG2' ' A' ' 169' ' ' GLU . 11.0 t -56.71 -30.59 63.65 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.573 0.749 . . . . 74.54 111.704 170.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.34 133.65 47.15 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.509 -0.552 . . . . 75.55 109.509 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.5 m -66.68 -15.38 63.46 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.818 0.847 . . . . 71.53 111.097 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.17 167.57 20.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.866 0.866 . . . . 72.13 112.746 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -89.74 -91.53 1.21 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 110.102 -1.199 . . . . 53.41 110.102 169.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -141.19 170.05 16.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.211 1.004 . . . . 74.12 110.495 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.588 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 15.3 m95 -70.88 -77.66 0.09 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.542 0.737 . . . . 73.4 109.946 173.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -173.71 -162.32 0.15 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.388 -0.968 . . . . 75.14 108.388 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -67.13 76.85 0.17 Allowed Glycine 0 C--N 1.347 1.164 0 N-CA-C 110.309 -1.116 . . . . 71.53 110.309 164.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.21 84.64 1.38 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 122.442 1.115 . . . . 74.53 110.773 -167.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -162.38 -116.07 0.37 Allowed Glycine 0 C--N 1.339 0.722 0 CA-C-N 114.3 -1.318 . . . . 73.41 111.228 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.9 p -79.08 -30.06 43.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.504 0.722 . . . . 73.23 111.69 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 131.94 -124.85 4.11 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.839 -0.504 . . . . 62.14 111.839 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 171.84 -157.68 28.0 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.059 -0.816 . . . . 71.31 111.059 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 59.0 p -82.43 -29.45 30.69 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 117.468 0.634 . . . . 72.31 110.927 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 141.03 -144.17 14.27 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.183 -0.462 . . . . 73.3 112.292 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.28 168.33 40.82 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.533 -0.627 . . . . 64.03 111.533 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.0 t -128.67 162.64 26.88 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.473 0.709 . . . . 73.15 110.486 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -137.9 130.03 4.87 Favored Glycine 0 C--N 1.345 1.057 0 N-CA-C 110.586 -1.006 . . . . 73.33 110.586 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -117.01 -121.06 3.18 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 117.182 0.491 . . . . 72.23 112.772 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.2 m -91.66 -73.43 0.54 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.865 0.466 . . . . 71.43 111.198 -175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.485 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.0 mt-30 -75.67 -39.83 56.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.099 0.56 . . . . 64.55 110.049 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 12.2 p-10 -73.92 103.83 4.57 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.021 0.915 . . . . 72.4 108.757 175.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.2 mt -91.5 170.33 10.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.859 -1.064 . . . . 72.32 112.981 -168.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 24.8 t80 -124.84 140.32 53.03 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 113.41 -1.723 . . . . 73.25 107.621 171.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.606 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -154.43 -170.91 3.68 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.291 0.637 . . . . 73.41 110.176 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 91.0 m -117.82 138.27 52.19 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.09 0.956 . . . . 72.35 110.809 177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.546 HD22 HG23 ' A' ' 253' ' ' VAL . 17.3 tp -98.55 108.92 21.72 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.727 -1.212 . . . . 73.32 107.727 166.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -82.73 100.6 10.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.211 -0.662 . . . . 71.42 109.211 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.617 HG21 HG23 ' A' ' 210' ' ' VAL . 21.5 t -108.11 109.43 61.9 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 108.715 -0.846 . . . . 72.25 108.715 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.42 145.56 65.51 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.257 1.305 . . . . 74.23 109.597 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.447 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -51.66 -40.53 70.8 Favored Pre-proline 0 CA--C 1.56 1.337 0 N-CA-C 113.979 1.103 . . . . 65.42 113.979 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.2 Cg_endo -56.16 -48.65 18.44 Favored 'Trans proline' 0 C--N 1.397 3.13 0 C-N-CA 122.037 1.825 . . . . 73.44 112.751 174.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.449 HG21 HG11 ' A' ' 210' ' ' VAL . 37.4 mt -67.74 -35.15 71.65 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 C-N-CA 122.905 0.482 . . . . 72.32 110.833 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.419 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -61.21 -46.3 91.02 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.072 0.549 . . . . 75.42 110.817 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.4 t -71.12 -48.1 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.889 0.876 . . . . 62.53 112.119 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.43 -23.58 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 120.607 0.241 . . . . 75.45 110.726 -173.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.26 68.75 1.48 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.759 -0.655 . . . . 51.3 111.791 -175.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.6 -136.83 9.31 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-O 119.741 -0.477 . . . . 73.05 112.308 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 5.3 ttmt -129.57 139.41 51.49 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.014 -0.736 . . . . 74.35 109.014 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.617 HG23 HG21 ' A' ' 199' ' ' VAL . 27.6 m -131.76 146.94 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 122.861 0.464 . . . . 70.12 110.929 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -74.34 144.35 44.51 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.948 -1.024 . . . . 73.1 110.297 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.617 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -117.24 122.35 43.73 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.92 1.288 . . . . 74.34 108.07 172.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.79 119.43 9.94 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.344 0.657 . . . . 65.4 110.037 175.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.96 -170.41 2.1 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.437 1.095 . . . . 72.51 109.378 -175.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.99 -70.24 0.25 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.844 0.83 . . . . 70.2 110.77 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -114.0 -41.29 3.56 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-N 113.719 -1.582 . . . . 61.34 111.445 -166.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -130.49 129.0 5.72 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-O 118.465 -1.186 . . . . 72.15 110.513 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.27 152.96 61.84 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.184 1.923 . . . . 74.33 113.212 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.617 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 55.1 t -97.43 166.39 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.255 -1.339 . . . . 65.3 108.691 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -149.77 135.1 18.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.614 -0.884 . . . . 72.52 108.614 172.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 14.3 p -131.11 142.56 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.526 0.73 . . . . 75.25 110.812 -172.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.1 108.19 5.85 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.93 0.492 . . . . 71.24 109.721 170.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' A' ' 204' ' ' ALA . 70.6 t -69.58 134.37 88.54 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.84 0.856 . . . . 71.55 109.137 172.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.37 154.56 71.69 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.386 2.057 . . . . 70.15 111.286 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.4 131.18 37.09 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.161 1.907 . . . . 73.22 112.072 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 53.81 69.76 0.68 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.265 1.426 . . . . 74.22 113.389 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.41 HG21 ' HD2' ' A' ' 231' ' ' ARG . 87.1 m -88.2 142.42 27.77 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.666 -1.152 . . . . 74.34 110.908 173.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -103.7 164.78 11.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.047 0.939 . . . . 74.14 110.614 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -86.87 149.57 24.73 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.196 -0.911 . . . . 73.12 111.17 -178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.8 -12.28 32.36 Favored Glycine 0 N--CA 1.473 1.123 0 CA-C-N 115.922 -0.581 . . . . 74.15 111.965 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.41 ' HD2' HG21 ' A' ' 227' ' ' THR . 62.0 mtt85 -74.4 -175.49 2.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.24 1.016 . . . . 75.35 110.336 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.52 ' HA ' HG22 ' A' ' 253' ' ' VAL . 10.2 ptmt -168.37 165.21 12.85 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 111.752 0.278 . . . . 74.13 111.752 174.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.599 HD12 HD13 ' A' ' 251' ' ' LEU . 84.5 mt -95.57 150.56 20.2 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 123.514 0.509 . . . . 73.11 109.713 167.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -114.15 107.09 15.16 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.659 -1.237 . . . . 73.43 107.659 162.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 57.0 mt -106.99 110.75 22.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.317 -0.856 . . . . 72.41 109.748 -174.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -77.75 118.68 20.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.761 -1.109 . . . . 74.23 110.8 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.35 3.61 89.92 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 114.948 -1.024 . . . . 73.22 114.386 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -95.27 2.67 54.88 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 112.804 0.668 . . . . 75.52 112.804 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.42 -173.12 47.62 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.693 -0.963 . . . . 63.34 110.693 166.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.485 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 15.4 m-85 -58.9 134.8 87.11 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 117.737 0.769 . . . . 63.24 110.759 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.461 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 3.5 Cg_exo -76.96 139.44 19.4 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.575 2.183 . . . . 73.4 110.763 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -107.36 -167.93 22.0 Favored Glycine 0 C--O 1.238 0.345 0 CA-C-O 119.132 -0.815 . . . . 73.21 111.73 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.55 -50.44 10.72 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.693 2.262 . . . . 73.15 112.763 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.63 -25.0 5.61 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.159 0.584 . . . . 74.14 112.225 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -133.82 158.87 23.5 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-O 119.925 -0.375 . . . . 74.43 112.349 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.461 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 92.7 mtt180 -113.32 157.82 21.34 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.606 0.763 . . . . 74.43 110.763 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.46 175.73 37.77 Favored Glycine 0 N--CA 1.468 0.798 0 CA-C-N 115.528 -0.76 . . . . 53.2 111.556 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.407 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 40.2 m-20 -102.67 176.78 5.05 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.762 -0.459 . . . . 72.44 109.762 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.6 tp -134.09 108.84 8.55 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.327 0.584 . . . . 70.24 110.41 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 34.3 m-85 -102.33 103.56 14.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.032 -1.099 . . . . 74.41 108.032 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.606 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.4 pp -121.38 114.55 21.46 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.837 1.051 . . . . 72.43 113.837 -172.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.08 118.32 11.84 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.071 -1.422 . . . . 72.41 113.215 -172.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.588 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 98.2 t -62.36 122.34 12.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 113.73 -1.577 . . . . 74.11 111.701 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 17.3 mmm180 -121.43 122.81 40.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.912 -1.04 . . . . 74.1 108.236 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 30.5 mm -88.78 96.55 6.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 108.993 -0.743 . . . . 74.11 108.993 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.561 1.384 0 C-N-CA 125.077 1.351 . . . . 73.41 108.819 -175.311 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 168' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 109.513 -0.551 . . . . 71.44 109.513 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -74.69 128.23 35.06 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.791 0.437 . . . . 72.33 110.237 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 40.5 p -104.2 115.04 29.7 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.117 -0.947 . . . . 75.14 108.957 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.19 -53.9 52.19 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 109.448 -0.575 . . . . 75.33 109.448 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.485 HG23 HG21 ' A' ' 219' ' ' VAL . 3.6 m -153.17 -41.36 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.304 -0.999 . . . . 74.54 108.304 169.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.84 174.49 10.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.328 -0.851 . . . . 70.23 110.914 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -101.97 -85.29 1.86 Allowed Glycine 0 C--N 1.336 0.573 0 N-CA-C 109.323 -1.511 . . . . 60.14 109.323 177.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.479 ' HB2' ' HB2' ' A' ' 179' ' ' LYS . 14.1 pt-20 -151.82 174.94 12.96 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.453 0.701 . . . . 73.21 110.811 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.426 ' HZ2' HG22 ' A' ' 223' ' ' VAL . 18.5 m95 -85.78 -90.5 0.1 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.239 -0.892 . . . . 75.21 110.96 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -126.97 -15.63 5.3 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.839 0.856 . . . . 75.35 110.724 -170.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 168.83 74.33 0.04 OUTLIER Glycine 0 C--N 1.345 1.06 0 N-CA-C 110.342 -1.103 . . . . 65.24 110.342 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 175' ' ' GLU . 12.8 tmtt? -70.82 99.64 1.77 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 108.608 -0.886 . . . . 73.54 108.608 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 144.61 -38.22 1.31 Allowed Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.01 -0.995 . . . . 63.42 111.344 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.9 t -147.7 -64.94 0.26 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.371 0.669 . . . . 73.42 109.484 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 158.22 -178.64 34.39 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.797 -0.638 . . . . 72.43 112.177 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 155.71 -146.95 15.1 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.194 -0.763 . . . . 52.12 111.194 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.2 p -159.14 124.32 4.19 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.557 0.743 . . . . 75.13 109.306 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -79.71 178.59 53.67 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.411 -0.359 . . . . 73.34 113.347 -175.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.05 178.03 44.8 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 112.483 -0.247 . . . . 54.11 112.483 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t -147.01 19.83 1.25 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.099 0.56 . . . . 75.23 110.375 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -149.08 175.27 28.39 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.551 -0.295 . . . . 73.54 112.438 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 150.01 -129.67 3.04 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.941 -0.863 . . . . 71.33 110.941 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.6 p -152.02 137.91 18.07 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.138 0.975 . . . . 63.33 108.693 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 63.57 12.78 6.74 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.492 1.117 . . . . 72.33 111.34 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -85.45 145.22 27.54 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 123.827 0.851 . . . . 72.34 110.248 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 58.6 mt -107.01 150.75 26.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.951 -0.759 . . . . 65.35 108.951 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 1.8 t80 -125.86 108.77 11.77 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.19 -1.041 . . . . 75.12 108.19 173.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.69 -174.86 2.77 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.082 0.953 . . . . 62.23 109.575 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 85.0 m -126.79 116.02 20.26 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.746 0.818 . . . . 72.53 109.944 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.537 HD21 HG21 ' A' ' 253' ' ' VAL . 15.7 tp -82.08 105.48 13.21 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.618 -0.882 . . . . 73.14 108.618 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.56 100.32 12.99 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.774 -0.825 . . . . 72.43 108.774 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.583 HG23 HG21 ' A' ' 210' ' ' VAL . 21.4 t -102.87 114.76 65.06 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.22 -1.03 . . . . 74.04 108.22 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.39 145.89 73.01 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 121.515 1.477 . . . . 72.5 110.342 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.76 -43.41 82.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-O 117.696 -1.145 . . . . 72.54 112.717 -176.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.2 Cg_endo -54.42 -50.06 14.78 Favored 'Trans proline' 0 C--N 1.398 3.179 0 C-N-CA 121.948 1.765 . . . . 75.11 112.703 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.458 HG21 HG12 ' A' ' 210' ' ' VAL . 17.3 mt -65.4 -35.65 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.404 0.682 . . . . 75.02 111.011 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.26 93.8 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.847 0.459 . . . . 54.41 111.012 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.5 t -70.58 -50.84 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.626 1.17 . . . . 64.21 111.975 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.41 -15.81 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.852 0.461 . . . . 72.01 110.671 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 70.79 75.57 0.61 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 111.403 -0.679 . . . . 71.41 111.403 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.16 -132.82 7.84 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.842 0.321 . . . . 71.45 112.446 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -142.95 135.42 27.52 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.983 0.913 . . . . 74.21 109.077 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.583 HG21 HG23 ' A' ' 199' ' ' VAL . 23.3 m -132.74 145.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.182 0.593 . . . . 75.33 110.18 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -71.01 142.02 50.94 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.413 0.685 . . . . 70.31 110.758 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.512 ' HB1' ' HB ' ' A' ' 219' ' ' VAL . . . -118.35 120.18 36.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.763 1.225 . . . . 74.34 109.02 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -65.32 136.98 57.23 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.053 0.941 . . . . 74.4 111.77 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.591 HG22 ' HD2' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -139.88 -174.26 3.86 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.0 0.92 . . . . 71.32 110.288 -179.694 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.571 ' H ' HG21 ' A' ' 214' ' ' THR . 10.6 mt -52.95 -68.4 0.17 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.656 1.582 . . . . 71.41 112.683 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -111.65 -41.23 4.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.714 -1.585 . . . . 74.11 111.352 -165.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -130.94 158.58 22.7 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-O 119.108 -0.829 . . . . 72.24 112.514 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.25 143.4 8.93 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.567 2.178 . . . . 74.41 113.416 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.512 ' HB ' ' HB1' ' A' ' 212' ' ' ALA . 78.0 t -97.22 166.13 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.902 1.281 . . . . 64.12 108.245 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -147.72 135.65 21.16 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.463 -1.31 . . . . 74.32 107.463 170.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.493 HG12 HD13 ' A' ' 233' ' ' LEU . 11.3 p -128.46 140.74 48.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 C-N-CA 123.184 0.594 . . . . 74.53 110.931 -170.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.41 108.82 5.71 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.84 0.856 . . . . 71.33 109.384 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.426 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 86.5 t -72.33 130.62 85.86 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.89 -0.782 . . . . 72.35 108.89 174.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.04 155.56 61.47 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.759 2.306 . . . . 74.02 111.202 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.92 139.52 85.36 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.402 2.068 . . . . 74.5 112.403 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 41.44 73.93 0.12 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.703 1.601 . . . . 64.13 113.653 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.52 HG21 ' HD2' ' A' ' 231' ' ' ARG . 92.8 m -84.6 139.12 32.31 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.011 -0.995 . . . . 73.23 110.998 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.425 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 24.8 mp0 -101.75 147.31 26.62 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.208 1.003 . . . . 74.31 109.175 171.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -73.26 155.91 39.02 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.129 -0.941 . . . . 72.53 110.854 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.62 -19.62 30.84 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.63 -0.588 . . . . 75.15 111.63 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.52 ' HD2' HG21 ' A' ' 227' ' ' THR . 80.5 mtt85 -66.34 177.95 1.34 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.867 0.867 . . . . 74.44 110.276 167.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.615 ' HA ' HG23 ' A' ' 253' ' ' VAL . 2.2 ptmt -167.62 158.04 10.89 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.218 0.324 . . . . 75.54 110.653 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.568 HD12 HD13 ' A' ' 251' ' ' LEU . 67.9 mt -86.02 136.41 33.26 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.995 -0.743 . . . . 74.43 108.995 171.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -103.56 104.77 14.87 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.957 -1.497 . . . . 74.31 106.957 164.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 48.1 mt -107.88 106.8 17.25 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.411 -0.813 . . . . 74.44 109.257 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -80.62 116.76 20.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.736 -1.12 . . . . 72.41 111.076 -168.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 88.37 4.25 77.41 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.79 -0.641 . . . . 71.44 113.652 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.591 ' HD2' HG22 ' A' ' 214' ' ' THR . 46.2 mmtm -93.93 4.84 53.33 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.846 0.684 . . . . 73.4 112.846 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.25 -177.48 50.73 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.429 -0.65 . . . . 62.23 111.554 171.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -60.59 142.78 91.05 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 117.45 0.625 . . . . 74.34 111.636 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.571 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 38.3 Cg_endo -66.68 139.75 53.91 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.709 2.272 . . . . 74.31 113.112 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.77 170.91 22.24 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.399 -0.819 . . . . 71.02 112.548 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.11 -21.01 27.89 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.096 2.531 . . . . 75.12 113.205 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.4 -11.64 17.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.842 0.857 . . . . 70.14 111.297 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 141.28 163.66 9.64 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.717 -0.953 . . . . 75.51 110.717 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.571 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 42.0 mtm180 -69.15 170.66 9.63 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.515 0.726 . . . . 75.21 111.776 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.74 -164.26 39.9 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 112.089 -0.404 . . . . 71.05 112.089 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -121.59 152.03 39.72 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.148 -0.686 . . . . 73.32 109.148 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 23.7 tp -112.19 108.38 17.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.651 0.78 . . . . 73.2 109.227 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 53.7 m-85 -101.58 119.26 38.5 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.788 -1.19 . . . . 75.31 107.788 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.594 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.3 pp -131.79 115.7 16.29 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.786 0.803 . . . . 72.22 112.99 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -68.76 118.8 12.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.174 1.39 . . . . 74.11 112.855 -169.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 232' ' ' LYS . 67.9 t -69.6 127.1 30.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-N 114.156 -1.384 . . . . 73.52 111.31 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -124.24 130.49 52.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.591 1.556 . . . . 72.01 108.126 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.3 mm -100.18 98.44 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.336 -0.986 . . . . 74.03 108.336 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.258 1.526 0 C-N-CA 124.637 1.175 . . . . 75.42 108.386 -172.407 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 111.284 0.105 . . . . 72.32 111.284 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -73.71 115.34 13.01 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.836 0.855 . . . . 71.42 109.268 -176.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.0 t -159.38 136.04 9.29 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.035 -0.728 . . . . 70.33 109.035 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 61.46 25.73 15.62 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.539 1.136 . . . . 71.34 110.934 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.4 m -77.48 -21.82 52.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.9 0.88 . . . . 74.23 110.196 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.61 175.32 6.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.767 -1.106 . . . . 74.44 111.421 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -105.49 -108.52 3.32 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.183 -0.917 . . . . 74.32 110.901 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.91 153.09 36.4 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.857 0.863 . . . . 72.41 109.98 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.506 ' CZ3' HG23 ' A' ' 227' ' ' THR . 23.2 m95 -77.79 -83.56 0.08 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.715 -0.675 . . . . 75.02 110.101 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.452 ' HG3' ' HG2' ' A' ' 231' ' ' ARG . 23.4 mm-40 -131.25 -59.63 0.97 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.076 -1.083 . . . . 71.35 108.076 -172.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 69.91 -74.69 0.47 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 110.824 -0.91 . . . . 75.45 110.824 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -123.77 147.54 47.44 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.47 1.108 . . . . 75.24 109.234 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -171.93 102.44 0.18 Allowed Glycine 0 C--N 1.338 0.667 0 N-CA-C 110.962 -0.855 . . . . 31.12 110.962 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 19.0 m -72.18 -6.2 41.1 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.422 0.689 . . . . 62.1 112.012 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 96.61 57.17 1.12 Allowed Glycine 0 C--N 1.352 1.462 0 C-N-CA 122.959 0.314 . . . . 65.04 112.518 172.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.62 110.46 0.34 Allowed Glycine 0 C--N 1.344 0.992 0 N-CA-C 111.665 -0.574 . . . . 71.42 111.665 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 27.8 p -164.25 -17.59 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.746 0.818 . . . . 73.42 111.729 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 78.29 -82.1 1.28 Allowed Glycine 0 C--N 1.347 1.139 0 O-C-N 123.282 0.364 . . . . 75.24 112.85 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 69.66 55.34 9.94 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 112.103 -0.399 . . . . 73.32 112.103 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.8 m -107.75 -29.23 9.23 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.375 0.67 . . . . 75.14 111.007 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.95 178.44 16.73 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.341 -0.391 . . . . 63.22 113.297 176.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -146.5 -135.19 2.71 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.046 -1.222 . . . . 65.22 110.046 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.4 m -81.87 -70.91 0.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 117.544 0.672 . . . . 72.33 109.466 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -88.15 -26.51 22.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.602 0.761 . . . . 65.03 110.063 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.14 128.26 35.72 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.209 -0.905 . . . . 61.01 108.862 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.0 mt -122.72 139.32 54.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.353 0.661 . . . . 73.45 110.987 -170.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -103.62 133.49 48.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.138 -1.06 . . . . 65.23 108.138 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . . . -139.15 -172.19 3.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.523 0.729 . . . . 72.11 110.059 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.4 m -118.08 158.61 24.69 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.126 0.97 . . . . 75.4 109.919 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.527 HD21 HG22 ' A' ' 253' ' ' VAL . 16.8 tp -126.52 114.47 18.16 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.585 1.554 . . . . 72.42 107.479 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.47 99.03 12.11 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.066 -0.716 . . . . 75.25 109.066 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.636 ' HA ' HG12 ' A' ' 210' ' ' VAL . 21.4 t -109.01 108.96 60.94 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 108.161 -1.051 . . . . 73.31 108.161 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.426 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 35.9 Cg_endo -66.68 146.14 77.97 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.575 1.517 . . . . 75.44 110.329 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -46.67 -46.91 50.7 Favored Pre-proline 0 CA--C 1.563 1.453 0 O-C-N 124.198 0.936 . . . . 72.23 113.258 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.426 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 33.4 Cg_exo -57.5 -47.88 19.78 Favored 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 121.645 1.564 . . . . 72.31 113.679 177.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.6 mt -65.97 -34.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.707 0.403 . . . . 72.31 110.765 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.35 -43.07 99.68 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.411 0.444 . . . . 75.34 110.421 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.0 t -73.24 -51.2 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 124.221 0.951 . . . . 74.11 111.919 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.33 -25.97 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 120.822 0.344 . . . . 74.54 111.02 -172.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.7 75.28 1.13 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.866 -0.606 . . . . 72.2 112.431 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.99 -135.51 7.66 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 112.176 -0.37 . . . . 75.22 112.176 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.572 ' HB2' ' HZ3' ' A' ' 209' ' ' LYS . 3.5 mtmp? -130.89 150.63 51.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.068 0.947 . . . . 75.42 110.026 173.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.636 HG12 ' HA ' ' A' ' 199' ' ' VAL . 34.8 m -140.59 157.4 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.584 0.754 . . . . 72.42 110.882 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -79.5 141.26 36.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.116 0.566 . . . . 75.32 110.944 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.476 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -119.08 118.68 32.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.2 1.4 . . . . 75.52 108.112 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 12.9 tpt -64.85 132.02 48.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.169 0.587 . . . . 74.12 111.11 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.86 -169.52 2.74 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.577 1.151 . . . . 75.1 109.783 -174.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.457 ' HB2' ' HG2' ' A' ' 216' ' ' GLU . 4.7 mt -77.33 -66.67 0.8 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.294 1.438 . . . . 71.24 110.185 -173.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.457 ' HG2' ' HB2' ' A' ' 215' ' ' LEU . 21.6 mm-40 -87.88 -31.0 19.71 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 112.268 -2.242 . . . . 72.11 110.491 -164.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -164.11 -178.85 37.96 Favored Glycine 0 C--N 1.33 0.218 0 CA-C-N 114.964 -1.017 . . . . 73.24 111.702 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.08 136.6 5.03 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.212 1.941 . . . . 75.31 112.713 172.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 49.7 t -90.41 162.64 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.402 -1.272 . . . . 72.44 107.899 173.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -142.51 129.41 20.63 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.14 -1.059 . . . . 74.53 108.14 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.448 HG22 HD22 ' A' ' 233' ' ' LEU . 14.9 p -120.69 138.96 49.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 123.552 0.741 . . . . 75.35 110.855 -174.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.7 102.99 2.93 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.037 0.935 . . . . 65.52 109.048 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.97 130.73 91.3 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.414 0.686 . . . . 71.23 109.7 176.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.95 154.42 56.64 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.796 2.33 . . . . 73.42 111.827 172.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.91 130.58 29.73 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.131 1.888 . . . . 72.24 111.202 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 51.54 71.8 0.42 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.62 1.568 . . . . 73.51 112.577 -177.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.506 HG23 ' CZ3' ' A' ' 176' ' ' TRP . 92.9 m -96.03 139.89 31.56 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.078 -0.965 . . . . 65.13 110.705 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -99.44 152.21 20.24 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.047 0.939 . . . . 65.11 110.664 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -75.51 155.46 36.11 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.683 -1.144 . . . . 72.54 110.391 175.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.68 5.08 61.66 Favored Glycine 0 N--CA 1.471 0.98 0 CA-C-N 115.747 -0.66 . . . . 75.44 112.576 -174.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.452 ' HG2' ' HG3' ' A' ' 177' ' ' GLN . 67.9 mtt85 -84.36 -175.58 5.85 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.155 0.982 . . . . 72.04 108.589 164.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.581 ' HA ' HG21 ' A' ' 253' ' ' VAL . 0.0 OUTLIER -167.46 149.11 5.67 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 110.123 -0.325 . . . . 74.54 110.123 169.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.688 HD13 HD13 ' A' ' 251' ' ' LEU . 62.4 mt -75.97 139.37 41.51 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.628 -0.508 . . . . 74.42 109.628 171.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.1 ptt180 -105.34 105.05 14.91 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.088 -1.078 . . . . 75.34 108.088 165.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.419 HD13 HD21 ' A' ' 249' ' ' LEU . 49.1 mt -109.81 110.85 21.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.556 -1.202 . . . . 74.15 109.56 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -88.25 123.56 32.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.243 -0.89 . . . . 75.34 110.098 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.36 4.51 83.49 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.176 -0.92 . . . . 72.13 113.601 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -101.01 9.0 42.71 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.789 0.795 . . . . 75.44 112.414 -176.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.21 -179.03 45.59 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.435 -1.066 . . . . 73.43 110.435 165.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -56.11 137.79 73.55 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 123.073 0.549 . . . . 74.14 112.177 -172.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.03 140.52 72.73 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.816 2.344 . . . . 74.11 111.707 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.28 175.0 20.08 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 116.108 -0.496 . . . . 65.41 113.387 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.41 -34.91 32.94 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 123.425 2.75 . . . . 74.34 114.001 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.47 -0.84 31.74 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.638 0.375 . . . . 63.34 111.783 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 144.11 175.97 17.72 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.497 -0.641 . . . . 75.03 111.497 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -80.91 163.48 23.33 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.425 0.69 . . . . 63.04 111.967 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.66 -175.05 45.84 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.86 -0.896 . . . . 71.22 110.86 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -111.62 168.84 9.24 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 117.969 0.884 . . . . 73.21 110.122 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.419 HD21 HD13 ' A' ' 235' ' ' LEU . 69.5 tp -134.69 108.94 8.29 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.637 0.775 . . . . 71.1 109.786 -172.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 23.2 m-85 -106.9 109.14 20.97 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.028 -1.101 . . . . 73.15 108.028 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.688 HD13 HD13 ' A' ' 233' ' ' LEU . 3.7 pp -118.74 121.93 41.26 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.602 0.715 . . . . 74.2 112.506 -172.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -69.08 130.0 41.5 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 126.501 1.92 . . . . 72.44 112.571 -169.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 232' ' ' LYS . 84.8 t -81.73 120.58 33.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 122.904 0.482 . . . . 74.34 110.958 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -114.47 120.05 38.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.055 1.342 . . . . 74.34 108.611 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 38.6 mm -91.54 100.52 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.116 -1.068 . . . . 72.11 108.116 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.254 1.326 0 C-N-CA 124.816 1.247 . . . . 73.41 108.598 -173.734 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 48.9 tpp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 109.013 -0.736 . . . . 70.44 109.013 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -141.1 -160.38 1.07 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.243 1.017 . . . . 74.1 109.408 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.5 p -57.02 95.77 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.387 0.675 . . . . 74.32 112.165 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -178.74 150.73 0.52 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.169 1.388 . . . . 63.43 108.574 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.448 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 6.6 m -86.27 -19.02 30.54 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.56 0.695 . . . . 74.53 109.624 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -104.24 179.77 4.18 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.456 -0.793 . . . . 64.45 111.641 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -102.86 -85.6 1.88 Allowed Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.416 -0.811 . . . . 73.41 111.999 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.69 158.38 43.89 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.807 0.843 . . . . 74.12 111.584 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 30.2 m95 -92.0 -102.99 0.11 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.413 1.085 . . . . 75.03 110.664 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.413 ' NE2' ' H ' ' A' ' 232' ' ' LYS . 9.7 pt20 165.21 161.68 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.855 2.062 . . . . 73.34 107.312 -167.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.4 -27.44 5.0 Favored Glycine 0 N--CA 1.473 1.124 0 N-CA-C 110.534 -1.026 . . . . 74.34 110.534 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -83.98 9.71 11.66 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.627 0.771 . . . . 72.03 111.008 168.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.62 148.97 20.73 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.351 -0.699 . . . . 71.21 111.351 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.1 p -81.99 137.92 35.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.573 0.749 . . . . 61.41 111.068 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 105.95 143.73 11.79 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.488 0.492 . . . . 75.11 113.48 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -121.73 10.73 9.63 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 123.142 0.401 . . . . 74.55 112.686 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.3 m -88.55 83.19 6.8 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.584 0.692 . . . . 74.43 109.778 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.45 85.3 1.47 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.193 -1.163 . . . . 74.23 110.193 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.62 121.9 17.0 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.202 0.589 . . . . 75.52 114.213 -173.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.0 m -119.41 140.87 49.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.698 0.799 . . . . 70.42 110.035 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 122.69 46.53 0.28 Allowed Glycine 0 N--CA 1.468 0.773 0 CA-C-N 116.123 -0.489 . . . . 72.42 112.009 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -71.43 -80.22 0.36 Allowed Glycine 0 C--N 1.346 1.098 0 N-CA-C 112.348 -0.301 . . . . 63.03 112.348 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 64.6 p -162.01 -56.46 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.025 -0.731 . . . . 73.13 109.025 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -98.13 26.83 4.99 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.307 1.043 . . . . 71.31 109.363 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.71 155.64 37.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.428 -1.26 . . . . 65.15 111.096 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.432 ' HG ' ' HA2' ' A' ' 239' ' ' GLY . 63.2 mt -128.22 103.14 7.02 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.509 -0.923 . . . . 74.14 108.509 164.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -83.15 106.49 14.99 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.753 -1.203 . . . . 74.23 107.753 164.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.495 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.27 -173.6 2.6 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.053 0.541 . . . . 73.15 110.095 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.3 m -119.95 150.82 39.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.646 0.778 . . . . 75.45 110.009 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.607 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.5 tp -113.7 105.68 13.59 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.845 -1.539 . . . . 72.43 106.845 168.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.55 101.43 12.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.698 -1.223 . . . . 72.33 107.698 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.591 ' HA ' HG12 ' A' ' 210' ' ' VAL . 30.9 t -110.83 118.65 47.96 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.197 -1.038 . . . . 71.11 108.197 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.02 149.91 82.69 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 121.654 1.569 . . . . 71.03 110.166 171.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.438 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.95 -41.07 83.55 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 113.061 0.763 . . . . 75.42 113.061 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 9.4 Cg_endo -54.7 -57.22 1.86 Allowed 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 121.907 1.738 . . . . 71.53 113.71 171.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.84 -31.98 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 123.206 0.602 . . . . 73.25 111.121 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -50.43 68.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.68 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.52 -48.39 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 124.023 0.827 . . . . 74.12 111.746 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.77 -32.5 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 117.824 0.284 . . . . 74.33 111.403 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.33 101.48 0.85 Allowed Glycine 0 C--N 1.343 0.946 0 N-CA-C 111.793 -0.523 . . . . 73.41 111.793 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.76 -129.49 2.95 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.603 -0.554 . . . . 74.23 112.24 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -138.33 151.64 47.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.805 0.803 . . . . 74.21 109.546 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 199' ' ' VAL . 22.6 m -145.58 158.01 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.719 0.807 . . . . 70.12 110.352 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -74.33 154.06 39.05 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.411 1.084 . . . . 72.45 111.36 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.541 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -132.13 113.93 13.9 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.208 1.003 . . . . 72.34 108.648 177.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.7 tpt -65.64 131.46 46.41 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.454 0.701 . . . . 70.42 111.771 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.64 HG23 HD21 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -130.97 -170.68 2.4 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.708 1.203 . . . . 72.44 108.586 176.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.442 ' H ' HG21 ' A' ' 214' ' ' THR . 10.5 mt -59.32 -70.14 0.17 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.583 0.706 . . . . 73.4 111.018 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -111.57 -42.2 3.91 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.019 -1.446 . . . . 75.41 111.446 -168.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -122.42 120.59 4.36 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 118.854 -0.97 . . . . 62.02 111.469 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.28 154.85 46.49 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.058 1.839 . . . . 72.11 112.935 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 39.5 t -101.84 168.71 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.109 1.364 . . . . 75.55 108.136 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.448 ' H ' ' HB ' ' A' ' 172' ' ' THR . 8.9 tt0 -141.19 134.7 29.91 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.425 -1.324 . . . . 73.24 107.425 171.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.509 HG13 HD12 ' A' ' 233' ' ' LEU . 14.6 p -131.2 141.46 45.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 122.937 0.495 . . . . 72.45 110.414 -173.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.03 117.3 15.66 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.395 -0.594 . . . . 44.33 109.395 173.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.7 t -78.91 128.66 75.89 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 109.407 -0.59 . . . . 73.15 109.407 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.07 157.32 60.14 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.763 2.309 . . . . 71.43 111.619 173.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.97 133.5 38.89 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.353 2.035 . . . . 75.43 112.455 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 54.4 68.72 0.81 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.919 1.688 . . . . 73.54 113.04 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.461 HG21 ' HD2' ' A' ' 231' ' ' ARG . 75.9 m -89.25 138.33 31.52 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.806 -1.088 . . . . 75.32 111.264 175.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -103.31 149.66 24.52 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.988 0.915 . . . . 74.01 110.746 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.87 155.29 40.05 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.227 0.954 . . . . 65.25 110.946 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 101.33 -16.82 56.48 Favored Glycine 0 N--CA 1.476 1.322 0 N-CA-C 111.081 -0.807 . . . . 55.13 111.081 -174.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.461 ' HD2' HG21 ' A' ' 227' ' ' THR . 65.4 mtt85 -65.87 172.16 3.82 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.108 0.563 . . . . 73.33 109.834 163.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.546 ' HA ' HG22 ' A' ' 253' ' ' VAL . 11.4 ptmt -168.03 151.49 5.93 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.359 0.412 . . . . 73.33 110.688 174.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.533 HD11 HD13 ' A' ' 251' ' ' LEU . 85.6 mt -83.48 152.85 24.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 110.318 -0.253 . . . . 75.11 110.318 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -120.93 106.93 12.09 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.751 1.282 . . . . 74.12 107.957 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.467 HD11 HD23 ' A' ' 249' ' ' LEU . 59.4 mt -117.03 127.99 54.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.764 0.826 . . . . 74.41 109.673 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.418 ' HD3' ' HB3' ' A' ' 248' ' ' ASP . 32.5 mmtp -101.36 138.75 37.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.692 0.397 . . . . 74.21 110.126 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.01 13.5 83.3 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 124.279 0.987 . . . . 65.42 113.167 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.634 ' HE3' HG22 ' A' ' 214' ' ' THR . 27.6 mmmt -108.87 -14.32 14.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.467 0.634 . . . . 75.5 112.632 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.432 ' HA2' ' HG ' ' A' ' 193' ' ' LEU . . . -74.66 -170.92 26.09 Favored Glycine 0 N--CA 1.478 1.443 0 CA-C-O 119.855 -0.414 . . . . 74.14 113.349 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -58.56 147.1 71.15 Favored Pre-proline 0 N--CA 1.487 1.425 0 C-N-CA 123.41 0.684 . . . . 73.0 111.806 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -63.7 137.82 60.88 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.707 2.271 . . . . 74.4 111.871 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.9 175.13 20.49 Favored Glycine 0 N--CA 1.468 0.828 0 CA-C-N 115.179 -0.919 . . . . 64.1 113.606 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.76 -28.54 20.31 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 123.149 2.566 . . . . 75.53 112.285 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.7 23.38 7.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.613 0.765 . . . . 62.0 110.92 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 117.84 -95.83 0.66 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.482 -0.647 . . . . 74.22 111.482 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 40.9 mtm-85 -148.53 165.44 31.22 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.571 1.148 . . . . 74.41 109.683 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -90.86 -155.09 31.17 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.621 0.575 . . . . 55.23 112.981 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.418 ' HB3' ' HD3' ' A' ' 236' ' ' LYS . 31.9 p30 -127.17 163.51 23.68 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.991 0.9 . . . . 72.35 112.234 -176.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.64 HD21 HG23 ' A' ' 214' ' ' THR . 12.6 tp -130.32 109.42 10.74 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.027 -1.442 . . . . 73.01 109.697 -171.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 25.6 m-85 -107.63 110.07 21.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.421 -0.955 . . . . 73.01 108.421 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.533 HD13 HD11 ' A' ' 233' ' ' LEU . 3.7 pp -120.43 114.78 22.32 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.687 0.625 . . . . 73.31 112.687 -170.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.0 113.34 6.29 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.67 1.188 . . . . 74.32 112.706 -171.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.607 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 53.1 t -64.08 127.3 24.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.54 1.136 . . . . 74.42 110.893 173.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -126.27 129.7 49.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.986 1.314 . . . . 74.32 108.769 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.9 mm -99.55 107.46 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.33 -0.989 . . . . 74.22 108.33 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.56 1.337 0 CA-C-N 114.861 -1.063 . . . . 74.41 109.029 -169.419 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 120.71 0.29 . . . . 74.24 110.629 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.32 -160.52 0.38 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.593 0.757 . . . . 73.02 111.421 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 18.3 m -57.38 -49.87 74.81 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 124.063 0.945 . . . . 75.43 111.969 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.31 139.83 57.27 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.01 0.524 . . . . 75.1 109.894 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.428 HG22 HG21 ' A' ' 219' ' ' VAL . 18.2 m -69.35 -25.69 64.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.65 0.78 . . . . 73.25 109.718 175.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.22 149.39 23.13 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.19 -0.914 . . . . 63.3 111.139 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -69.79 -89.1 0.09 OUTLIER Glycine 0 C--N 1.347 1.147 0 O-C-N 124.026 0.829 . . . . 73.33 111.393 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.97 -178.36 5.89 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.896 0.879 . . . . 74.25 110.209 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.455 ' HZ2' HG23 ' A' ' 223' ' ' VAL . 23.5 m95 -80.58 -91.9 0.05 Allowed 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.549 -0.751 . . . . 74.2 109.579 168.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -174.83 80.77 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.981 0.913 . . . . 75.32 108.677 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -78.89 64.29 3.69 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.792 -0.923 . . . . 72.55 110.792 173.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -115.34 5.04 14.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.707 0.803 . . . . 71.32 111.694 -169.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.31 -71.77 2.86 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 123.173 0.295 . . . . 72.33 112.922 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.9 p -82.67 56.56 3.41 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.217 1.007 . . . . 71.41 110.518 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 65.24 -91.97 0.13 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 110.845 -0.902 . . . . 71.33 110.845 -169.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 132.9 12.82 1.66 Allowed Glycine 0 C--N 1.345 1.029 0 C-N-CA 123.097 0.38 . . . . 73.31 112.546 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.0 t -65.1 102.28 0.61 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.788 0.835 . . . . 75.12 109.736 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.08 -173.06 29.23 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 115.513 -0.767 . . . . 74.01 111.572 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 67.1 54.83 18.93 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.779 -0.528 . . . . 71.11 111.779 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.2 m -63.77 -32.97 74.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.062 0.545 . . . . 55.32 110.793 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -149.77 147.81 18.45 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 115.068 -0.969 . . . . 74.42 111.132 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.03 -103.07 0.27 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.282 -0.727 . . . . 52.53 111.282 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 42.8 p -152.9 119.18 5.53 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.533 0.733 . . . . 74.01 109.692 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 61.8 12.96 5.05 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.33 1.052 . . . . 73.51 111.945 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -83.33 151.24 25.66 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.483 1.113 . . . . 74.5 110.753 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 79.5 mt -117.01 137.13 52.43 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.054 0.541 . . . . 73.2 110.3 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -103.38 108.87 20.28 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.952 -1.129 . . . . 65.22 107.952 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.602 ' HB1' ' HB3' ' A' ' 251' ' ' LEU . . . -120.27 -172.12 2.3 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.412 1.085 . . . . 74.11 109.243 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 90.8 m -124.9 139.37 53.9 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.673 0.789 . . . . 71.34 110.164 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 16.0 tp -97.23 105.84 18.06 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.664 -0.865 . . . . 74.35 108.664 170.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -86.77 101.59 13.46 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.999 -0.741 . . . . 72.33 108.999 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.553 ' HA ' HG13 ' A' ' 210' ' ' VAL . 1.4 p -119.46 113.68 34.93 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.703 0.801 . . . . 73.12 109.351 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.4 145.7 78.08 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.945 1.763 . . . . 64.55 111.054 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -44.35 -47.68 25.2 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.334 1.053 . . . . 71.34 113.625 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.5 -48.09 23.32 Favored 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 121.935 1.757 . . . . 75.32 113.976 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.46 HG21 HG11 ' A' ' 210' ' ' VAL . 60.5 mt -65.84 -33.74 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 122.938 0.495 . . . . 72.22 110.471 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.47 93.73 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.914 0.485 . . . . 75.45 111.16 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 226' ' ' ARG . 58.9 t -72.94 -45.88 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.39 1.076 . . . . 74.1 111.912 -175.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.62 -29.66 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 120.71 0.29 . . . . 73.34 110.255 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.65 73.21 1.18 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.415 -0.674 . . . . 70.44 111.415 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.01 -127.2 6.04 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 120.135 -0.258 . . . . 74.45 112.457 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -143.75 137.59 28.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.647 0.779 . . . . 64.14 109.752 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.553 HG13 ' HA ' ' A' ' 199' ' ' VAL . 31.5 m -137.29 154.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.833 0.453 . . . . 73.41 111.108 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -76.13 142.93 41.49 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.758 -1.11 . . . . 73.12 111.192 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.573 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -113.97 117.39 31.2 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.917 1.287 . . . . 71.2 108.283 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.0 tpt -63.82 121.08 13.16 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.057 0.943 . . . . 71.22 111.498 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.445 HG21 ' H ' ' A' ' 215' ' ' LEU . 0.2 OUTLIER -123.82 -171.25 2.28 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.053 1.341 . . . . 73.44 109.653 -178.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.445 ' H ' HG21 ' A' ' 214' ' ' THR . 9.2 mt -59.58 -69.4 0.21 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.583 1.153 . . . . 73.52 112.044 -175.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.92 -42.11 3.45 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 113.94 -1.482 . . . . 74.34 111.445 -166.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -119.33 167.3 13.28 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.283 -0.871 . . . . 63.53 111.172 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.41 154.81 10.67 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.987 1.792 . . . . 71.23 113.202 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 69.5 t -106.3 166.26 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 107.086 -1.45 . . . . 72.23 107.086 165.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.28 140.2 25.05 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.32 -0.992 . . . . 64.12 108.32 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.451 HG12 HD11 ' A' ' 233' ' ' LEU . 8.7 p -134.18 142.24 41.54 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 C-N-CA 123.162 0.585 . . . . 74.14 110.86 -172.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.97 108.23 8.71 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.961 0.904 . . . . 74.3 109.187 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.455 HG23 ' HZ2' ' A' ' 176' ' ' TRP . 59.5 t -71.54 132.61 85.43 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.132 0.973 . . . . 73.51 109.279 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -64.02 155.44 64.52 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.794 2.329 . . . . 75.22 112.483 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.51 130.48 31.89 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.273 1.982 . . . . 71.24 111.804 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 205' ' ' VAL . 33.3 mtp-105 49.7 71.23 0.41 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.514 1.526 . . . . 71.11 113.266 -176.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.425 HG22 ' HD2' ' A' ' 231' ' ' ARG . 98.7 m -87.45 142.74 27.64 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.884 -1.053 . . . . 75.23 111.1 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -103.06 154.67 19.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.001 0.92 . . . . 74.41 110.604 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.72 155.41 29.4 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.452 -1.249 . . . . 71.15 110.615 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.03 -13.02 52.69 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 111.594 -0.602 . . . . 63.45 111.594 -173.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.425 ' HD2' HG22 ' A' ' 227' ' ' THR . 68.0 mtt85 -70.43 -176.34 1.21 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.04 0.936 . . . . 72.33 110.55 170.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.593 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 10.3 ptmt -167.57 156.32 9.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.341 0.256 . . . . 72.14 110.573 171.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.495 HD13 HD12 ' A' ' 251' ' ' LEU . 73.5 mt -87.51 151.58 22.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.509 -0.552 . . . . 75.25 109.509 168.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -119.85 105.87 11.52 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.335 -1.357 . . . . 75.42 107.335 168.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 67.6 mt -114.19 117.04 30.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.281 0.633 . . . . 74.44 110.698 -170.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -84.99 133.36 34.26 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 116.275 -0.42 . . . . 75.24 111.287 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.27 1.11 89.89 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 114.884 -1.053 . . . . 74.13 113.77 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -98.02 -0.38 44.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.384 0.674 . . . . 72.24 112.523 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.86 -172.35 48.36 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 111.18 -0.768 . . . . 71.43 111.18 167.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -65.17 142.61 98.61 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-N 117.24 0.52 . . . . 75.33 111.541 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.431 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 37.5 Cg_endo -65.92 133.7 34.59 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.853 2.368 . . . . 74.01 112.093 172.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.42 172.92 21.65 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 119.436 -0.647 . . . . 45.51 113.192 -176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.68 -23.33 26.72 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.097 2.531 . . . . 63.32 112.543 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.71 22.26 8.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.958 0.903 . . . . 74.32 110.751 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 94.9 -173.36 31.87 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 110.471 -1.052 . . . . 70.12 110.471 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.431 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 80.8 mtm180 -84.11 158.35 21.41 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 117.417 0.608 . . . . 73.31 110.883 178.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.78 -164.66 38.61 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.502 -0.772 . . . . 64.44 111.933 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -124.57 164.47 19.75 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.583 0.706 . . . . 64.32 110.634 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.0 tp -123.01 108.56 13.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.078 -0.964 . . . . 73.44 108.613 -171.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.593 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 33.3 m-85 -100.53 112.75 25.16 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.091 -1.448 . . . . 73.42 107.091 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.602 ' HB3' ' HB1' ' A' ' 195' ' ' ALA . 2.6 pp -127.86 115.81 19.18 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.498 0.925 . . . . 74.15 113.498 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -67.64 117.65 9.86 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.556 -1.202 . . . . 73.15 112.05 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 232' ' ' LYS . 95.1 t -68.82 116.73 9.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 125.167 1.387 . . . . 75.14 111.509 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 24.7 mmt85 -106.65 117.03 32.99 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.355 -1.293 . . . . 73.0 108.803 170.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.426 HD11 HG12 ' A' ' 199' ' ' VAL . 42.3 mm -79.1 96.28 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 106.529 -1.656 . . . . 75.33 106.529 168.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.26 1.651 0 CA-C-O 117.31 -1.329 . . . . 74.41 108.64 -174.718 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 17.1 tmm? . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.184 0.516 . . . . 75.13 109.79 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.23 172.02 13.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.881 1.273 . . . . 72.12 110.244 -170.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 46.1 p -90.66 26.64 1.97 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.045 0.938 . . . . 70.2 111.819 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.47 ' HB3' ' HA ' ' A' ' 221' ' ' VAL . . . -151.44 155.88 39.49 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.833 0.853 . . . . 75.3 110.173 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.572 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 16.8 m -71.76 -19.93 61.96 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.741 0.816 . . . . 73.14 110.78 175.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.54 -176.0 6.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.298 1.039 . . . . 71.4 113.045 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -106.15 -88.95 2.07 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 114.473 -1.24 . . . . 73.01 110.269 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -146.98 153.66 40.32 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 112.734 0.642 . . . . 75.41 112.734 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.441 ' HA ' HD23 ' A' ' 233' ' ' LEU . 34.3 m95 -82.99 -83.56 0.13 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.275 1.03 . . . . 74.41 109.993 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.557 ' HG3' ' HA3' ' A' ' 182' ' ' GLY . 19.4 mm-40 -113.5 29.58 7.89 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 106.793 -1.558 . . . . 75.35 106.793 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.44 -72.55 0.43 Allowed Glycine 0 C--N 1.35 1.31 0 N-CA-C 108.402 -1.879 . . . . 64.21 108.402 -156.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -177.94 -175.22 0.48 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.257 1.423 . . . . 72.12 109.826 174.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 74.31 -88.01 0.7 Allowed Glycine 0 C--N 1.346 1.119 0 O-C-N 123.198 0.311 . . . . 63.5 112.51 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.1 t -162.48 179.91 7.43 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 123.586 0.754 . . . . 61.41 109.502 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.557 ' HA3' ' HG3' ' A' ' 177' ' ' GLN . . . 177.65 -142.73 5.8 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-O 119.811 -0.438 . . . . 55.11 112.112 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -154.1 -34.79 0.03 OUTLIER Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.612 -0.549 . . . . 72.21 113.34 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.4 t -149.57 -79.99 0.13 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.637 0.718 . . . . 74.14 110.535 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.99 178.93 15.19 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.026 0.37 . . . . 74.43 114.026 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 65.85 94.97 0.03 OUTLIER Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.161 0.41 . . . . 62.23 113.7 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.3 t -82.77 -167.85 1.8 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.556 0.742 . . . . 72.3 110.18 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -83.28 -175.06 50.8 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 119.904 -0.387 . . . . 75.13 112.176 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -167.49 -136.04 1.97 Allowed Glycine 0 C--N 1.342 0.89 0 CA-C-N 117.703 0.751 . . . . 71.34 113.107 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.1 m -142.57 133.21 25.28 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.744 1.218 . . . . 62.4 107.959 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 62.75 16.04 8.65 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.774 0.829 . . . . 74.12 111.654 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -87.41 151.72 22.83 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.1 -0.954 . . . . 73.32 110.976 -169.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 74.5 mt -120.9 145.33 47.78 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.572 0.749 . . . . 74.43 110.89 -176.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.437 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 31.2 t80 -102.26 132.39 48.24 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.68 0.792 . . . . 72.34 109.082 172.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.578 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -138.05 -171.84 3.12 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.383 0.673 . . . . 71.54 109.536 173.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 95.8 m -131.04 109.2 10.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.457 0.703 . . . . 72.24 111.14 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.586 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 16.3 tp -72.88 105.29 4.33 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.171 -1.048 . . . . 63.12 108.171 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -80.26 99.58 7.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.968 -1.015 . . . . 71.41 108.867 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.626 HG21 HG23 ' A' ' 210' ' ' VAL . 13.6 t -113.96 106.44 53.41 Favored Pre-proline 0 N--CA 1.472 0.666 0 N-CA-C 108.362 -0.977 . . . . 72.3 108.362 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.29 152.77 78.78 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.414 1.41 . . . . 73.43 110.495 174.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.18 -45.86 75.95 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 114.017 1.117 . . . . 74.11 114.017 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.72 -48.2 17.87 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 121.76 1.64 . . . . 72.23 112.9 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.455 HG21 HG12 ' A' ' 210' ' ' VAL . 50.0 mt -67.75 -33.68 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.332 0.653 . . . . 75.43 110.973 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.31 87.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.045 -0.525 . . . . 73.44 110.473 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.05 -47.74 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.415 1.086 . . . . 63.32 111.495 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.99 -32.19 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-O 120.775 0.321 . . . . 75.24 110.729 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.84 68.58 1.41 Allowed Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.789 -0.642 . . . . 72.52 112.047 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.91 -123.99 5.33 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 112.523 -0.231 . . . . 75.14 112.523 -175.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -142.49 143.68 32.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.747 0.819 . . . . 75.04 109.713 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.626 HG23 HG21 ' A' ' 199' ' ' VAL . 28.8 m -140.79 151.66 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.423 0.689 . . . . 75.32 111.114 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -78.22 150.22 33.5 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.862 0.865 . . . . 73.2 111.399 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -130.63 114.21 15.15 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.375 1.47 . . . . 63.21 109.001 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -64.11 124.03 20.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.653 0.781 . . . . 75.32 110.781 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.451 HG21 ' H ' ' A' ' 215' ' ' LEU . 0.2 OUTLIER -111.54 -169.66 1.5 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.936 1.294 . . . . 73.44 108.095 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.451 ' H ' HG21 ' A' ' 214' ' ' THR . 7.8 mt -45.81 -70.33 0.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.863 1.265 . . . . 75.24 112.001 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -113.29 -43.56 3.34 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 113.892 -1.504 . . . . 74.24 110.84 -168.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -114.9 -179.25 18.72 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 115.646 -0.706 . . . . 63.41 112.426 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -92.65 164.07 2.81 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.213 1.942 . . . . 72.14 113.968 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 12.7 t -121.47 168.79 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 106.173 -1.788 . . . . 72.25 106.173 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.572 ' H ' ' HB ' ' A' ' 172' ' ' THR . 13.5 tt0 -148.67 143.28 26.39 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.116 -1.068 . . . . 72.03 108.116 173.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.47 ' HA ' ' HB3' ' A' ' 171' ' ' ALA . 13.3 p -136.35 143.12 36.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 C-N-CA 123.256 0.623 . . . . 75.35 111.475 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.14 110.29 8.32 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.408 1.083 . . . . 74.33 109.73 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 79.9 t -77.16 134.92 66.87 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 123.888 0.875 . . . . 54.32 109.852 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.0 155.64 61.5 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.904 2.402 . . . . 62.53 112.249 169.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.35 132.34 45.88 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.978 2.452 . . . . 73.22 112.134 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 49.58 73.27 0.25 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.376 1.47 . . . . 72.2 113.105 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.414 HG21 ' HD2' ' A' ' 231' ' ' ARG . 97.0 m -89.56 142.26 27.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.504 -1.226 . . . . 71.31 111.069 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -105.45 158.37 16.71 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.107 0.963 . . . . 75.35 110.383 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -82.26 148.73 28.22 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.22 -1.354 . . . . 73.12 110.411 176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.46 -28.74 8.03 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 110.843 -0.903 . . . . 72.22 110.843 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.414 ' HD2' HG21 ' A' ' 227' ' ' THR . 75.1 mtt85 -58.92 171.72 0.64 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.078 0.951 . . . . 73.32 110.645 165.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.488 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.9 ptmt -165.89 149.84 7.98 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.126 0.266 . . . . 75.3 110.691 172.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.677 HD11 HD11 ' A' ' 251' ' ' LEU . 84.1 mt -79.49 155.64 28.17 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 123.532 0.52 . . . . 74.34 109.715 171.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -126.58 106.66 9.58 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.405 -1.332 . . . . 74.11 107.405 169.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.653 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 39.4 mt -105.32 112.21 25.23 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.531 -0.759 . . . . 71.41 110.045 -172.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -77.18 117.44 18.72 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.429 -1.26 . . . . 64.03 111.0 -171.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 92.55 -4.73 76.67 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.329 1.018 . . . . 72.53 113.612 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.435 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 33.9 mmtp -95.58 5.62 51.02 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.588 0.755 . . . . 74.14 112.518 -172.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.95 -178.28 50.04 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 110.81 -0.916 . . . . 45.32 110.81 166.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.48 138.22 96.44 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-N 117.402 0.601 . . . . 72.32 111.476 -174.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.49 143.62 69.98 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.316 2.677 . . . . 75.5 112.949 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.67 -178.67 15.82 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 115.844 -0.616 . . . . 73.32 113.61 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.04 -49.76 3.56 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.598 2.865 . . . . 73.21 113.393 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.28 -34.01 37.3 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 122.92 0.488 . . . . 72.44 110.989 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.32 179.88 46.14 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 114.766 -1.107 . . . . 75.24 111.391 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -79.0 168.37 19.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.523 0.729 . . . . 75.4 110.899 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.21 -167.58 39.93 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.608 -0.724 . . . . 72.34 112.063 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -119.91 171.0 8.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 122.238 -0.566 . . . . 73.41 109.873 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.653 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 43.8 tp -129.41 108.73 10.51 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.57 0.7 . . . . 65.12 110.682 -174.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 46.0 m-85 -100.11 110.5 22.78 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.141 -1.059 . . . . 70.0 108.141 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.677 HD11 HD11 ' A' ' 233' ' ' LEU . 3.1 pp -125.66 114.99 19.4 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.435 0.636 . . . . 74.23 112.417 -173.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -70.15 120.29 15.63 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 114.689 -1.141 . . . . 63.42 113.452 -170.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.586 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 48.4 t -65.1 126.83 24.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 113.89 -1.505 . . . . 75.04 110.031 174.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -129.67 128.23 42.14 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.045 1.338 . . . . 74.31 108.975 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 199' ' ' VAL . 29.2 mm -95.92 104.4 15.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.183 -1.043 . . . . 74.53 108.183 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.293 0 CA-C-O 117.386 -1.292 . . . . 72.22 108.783 -168.878 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.414 ' HB3' ' HA2' ' A' ' 174' ' ' GLY . 20.1 ptp . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 122.087 0.946 . . . . 74.1 109.726 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.18 -150.09 0.06 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.888 -1.051 . . . . 70.04 109.534 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.0 p -63.08 80.84 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 121.427 0.632 . . . . 70.44 110.529 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -168.98 136.87 1.95 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.533 1.533 . . . . 71.42 107.554 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 19.1 m -72.52 -13.77 61.49 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.473 0.709 . . . . 73.2 111.395 -178.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.79 160.85 14.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.854 0.862 . . . . 75.04 111.904 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.46 ' H ' HD23 ' A' ' 235' ' ' LEU . . . -73.35 -108.41 0.07 OUTLIER Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.31 -0.859 . . . . 65.34 111.203 166.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -138.77 176.74 8.44 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.749 0.774 . . . . 70.44 111.716 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.421 ' HZ2' HG22 ' A' ' 223' ' ' VAL . 29.6 m95 -80.82 126.8 31.78 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.601 -1.181 . . . . 64.32 110.25 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 75.87 -40.95 0.42 Allowed 'General case' 0 C--O 1.248 0.99 0 C-N-CA 126.34 1.856 . . . . 73.42 112.206 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.427 ' HA3' ' HG2' ' A' ' 234' ' ' ARG . . . 78.51 90.39 0.37 Allowed Glycine 0 C--N 1.35 1.343 0 N-CA-C 110.768 -0.933 . . . . 60.4 110.768 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -60.09 104.79 0.34 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.971 0.908 . . . . 73.33 111.261 -172.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.62 -54.89 0.16 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.327 -0.851 . . . . 75.24 111.534 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.8 m -133.87 75.86 1.62 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.452 0.701 . . . . 62.3 110.078 -177.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -94.28 35.6 4.12 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.463 -0.789 . . . . 72.04 112.071 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -79.61 173.98 55.15 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 112.597 -0.201 . . . . 64.13 112.597 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.3 t -96.58 93.84 7.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.98 -0.748 . . . . 74.31 108.98 178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.56 158.45 31.14 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.951 -0.568 . . . . 74.13 112.481 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.21 -170.22 39.35 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 119.656 -0.524 . . . . 74.1 111.806 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.8 t 71.1 108.01 0.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.077 1.351 . . . . 55.53 110.613 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.81 119.76 2.79 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.228 -0.749 . . . . 63.45 111.228 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 162.36 126.63 0.83 Allowed Glycine 0 C--N 1.344 1.019 0 N-CA-C 111.117 -0.793 . . . . 73.33 111.117 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 45.6 m -91.09 -65.6 1.0 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.174 0.59 . . . . 73.13 110.638 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -72.53 -50.3 26.68 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.489 -0.778 . . . . 73.2 109.704 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -68.03 140.19 56.32 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.193 -0.912 . . . . 75.12 110.143 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.3 mt -119.35 160.62 21.92 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.656 0.782 . . . . 75.13 110.914 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 4.4 t80 -121.77 108.33 13.37 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.188 -0.671 . . . . 74.2 109.188 171.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.608 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . . . -116.8 -170.85 1.91 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.42 1.088 . . . . 63.03 109.5 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.9 m -119.12 126.04 50.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.985 0.914 . . . . 72.14 110.429 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.589 ' HB2' HD12 ' A' ' 251' ' ' LEU . 25.2 tp -84.51 104.76 14.79 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 107.769 -1.197 . . . . 75.24 107.769 166.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -86.95 106.39 17.77 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.165 -0.68 . . . . 74.33 109.165 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 210' ' ' VAL . 21.7 t -114.13 120.76 37.92 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.65 -0.87 . . . . 72.11 108.65 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.89 150.61 61.63 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 121.77 1.646 . . . . 75.11 110.217 170.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -52.67 -45.24 96.6 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 117.808 -1.091 . . . . 64.11 112.834 -178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -56.26 -50.36 12.33 Favored 'Trans proline' 0 C--N 1.401 3.294 0 C-N-CA 122.077 1.851 . . . . 74.22 112.87 177.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.432 HG21 HG13 ' A' ' 210' ' ' VAL . 28.1 mt -64.74 -34.49 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.41 0.684 . . . . 74.4 110.626 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.403 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -64.53 -42.61 95.65 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.072 -0.513 . . . . 71.02 111.137 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.4 t -73.92 -49.78 32.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 123.982 0.913 . . . . 70.5 111.844 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.2 -28.45 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.373 0.269 . . . . 74.3 110.878 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.15 77.79 1.18 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.993 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.01 -137.28 8.2 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.725 -0.486 . . . . 75.21 112.0 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -133.77 139.84 46.58 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.801 0.8 . . . . 73.21 109.806 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.577 HG22 HG22 ' A' ' 199' ' ' VAL . 35.6 m -133.4 153.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.229 0.612 . . . . 73.54 111.064 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 212' ' ' ALA . 22.9 ttm180 -75.73 154.54 36.34 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.905 0.882 . . . . 74.42 110.716 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -132.23 120.76 22.63 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.521 1.528 . . . . 74.41 108.383 176.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.06 132.23 48.65 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.766 0.827 . . . . 75.12 110.467 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.644 HG23 ' HD2' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -136.14 -172.72 3.2 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.663 0.785 . . . . 75.22 110.162 -175.129 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.6 ' H ' HG22 ' A' ' 214' ' ' THR . 6.4 mt -63.78 -67.41 0.43 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.298 1.439 . . . . 73.12 110.671 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -103.74 -41.55 5.89 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 113.322 -1.763 . . . . 73.34 111.554 -162.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -150.7 154.02 25.36 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.046 -0.863 . . . . 63.24 111.76 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.16 142.0 30.11 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.603 2.202 . . . . 73.11 113.55 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 73.1 t -95.62 163.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 114.471 -1.241 . . . . 72.33 108.286 175.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -142.81 136.92 29.29 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.371 -1.344 . . . . 74.32 107.371 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.451 HG12 HD12 ' A' ' 233' ' ' LEU . 12.3 p -132.26 140.38 47.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.481 0.712 . . . . 65.41 110.688 -172.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.31 109.42 9.99 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.063 0.945 . . . . 75.34 109.323 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.421 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 93.1 t -73.73 131.02 82.52 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.212 1.005 . . . . 73.54 109.388 176.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.88 155.2 58.16 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.433 2.089 . . . . 65.05 111.05 171.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.55 136.23 53.33 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.314 2.009 . . . . 63.13 112.7 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 51.66 69.25 0.68 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.646 1.579 . . . . 73.44 112.706 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.423 HG22 ' HD2' ' A' ' 231' ' ' ARG . 69.8 m -85.03 141.08 30.54 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.85 -1.068 . . . . 72.52 110.613 174.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -102.16 155.63 18.08 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.78 0.832 . . . . 65.02 110.1 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -83.91 154.83 23.18 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.652 -1.158 . . . . 62.21 111.212 -177.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.88 -6.78 57.06 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.935 -0.575 . . . . 51.55 111.933 -173.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.423 ' HD2' HG22 ' A' ' 227' ' ' THR . 65.9 mtt85 -72.09 179.47 3.28 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.916 0.886 . . . . 74.01 109.722 168.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.486 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.2 ptpt -168.27 150.94 5.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.882 0.473 . . . . 74.33 110.464 169.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.502 ' HG ' HD22 ' A' ' 197' ' ' LEU . 56.9 mt -85.18 156.03 21.18 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.751 -0.833 . . . . 73.03 108.751 169.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.427 ' HG2' ' HA3' ' A' ' 178' ' ' GLY . 12.1 ptp180 -115.32 123.74 49.51 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 106.459 -1.682 . . . . 75.45 106.459 157.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.632 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 46.5 mt -112.21 108.18 17.33 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.898 -0.779 . . . . 72.31 108.898 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -70.41 113.2 7.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.136 -1.393 . . . . 74.45 111.443 -170.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 91.74 -5.88 79.71 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.248 -0.887 . . . . 62.11 113.771 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.644 ' HD2' HG23 ' A' ' 214' ' ' THR . 48.4 mmtm -86.87 10.08 17.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.405 0.682 . . . . 74.42 112.213 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.16 169.56 24.07 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.786 -1.326 . . . . 74.02 109.786 164.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.419 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 41.4 m-85 -57.22 139.51 79.57 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 123.363 0.665 . . . . 62.54 112.129 -173.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 11.7 Cg_exo -69.6 150.04 68.69 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.907 2.405 . . . . 73.3 113.076 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.68 171.95 21.8 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.801 -0.999 . . . . 65.32 111.018 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -61.66 -48.22 9.57 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.988 2.459 . . . . 74.23 113.393 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.57 -19.07 28.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.287 0.635 . . . . 72.32 111.863 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 171.31 169.43 34.24 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.944 -0.462 . . . . 72.11 111.944 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -85.51 170.22 12.84 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.788 0.835 . . . . 74.43 110.864 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.95 179.95 48.73 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.299 -0.864 . . . . 64.32 111.224 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -122.69 153.16 39.78 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.578 -0.527 . . . . 75.53 109.578 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.632 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.8 tp -106.2 106.75 17.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.352 -0.61 . . . . 73.33 109.352 -172.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 48.8 m-85 -98.98 109.12 21.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.998 -1.482 . . . . 74.15 106.998 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -126.55 117.49 22.93 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.95 1.092 . . . . 65.53 113.95 -177.198 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.86 118.78 10.18 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 113.133 -1.849 . . . . 72.1 112.518 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.527 HG21 HD21 ' A' ' 197' ' ' LEU . 52.3 t -69.68 109.49 2.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 114.329 -1.305 . . . . 75.31 110.68 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -100.25 118.17 35.98 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.53 1.132 . . . . 74.41 108.824 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 39.8 mm -87.26 107.94 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.462 -1.31 . . . . 62.44 107.462 170.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.329 0 C-N-CA 124.301 1.04 . . . . 63.21 108.258 -174.096 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.417 0.627 . . . . 74.52 109.315 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.04 -168.5 3.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.51 1.124 . . . . 73.11 108.884 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.7 t -73.85 75.15 1.62 Allowed 'General case' 0 CA--C 1.565 1.543 0 CA-C-O 122.284 1.04 . . . . 74.22 110.646 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -163.48 158.67 21.21 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.221 1.009 . . . . 75.21 109.669 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.417 HG23 HG22 ' A' ' 219' ' ' VAL . 17.0 m -78.0 -26.46 48.57 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.374 -0.83 . . . . 75.31 110.633 176.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.9 -168.79 0.95 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.861 0.865 . . . . 70.32 112.59 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.07 -87.52 1.03 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 110.194 -1.163 . . . . 63.4 110.194 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.27 174.51 10.47 Favored 'General case' 0 C--O 1.248 0.98 0 C-N-CA 123.477 0.711 . . . . 75.51 109.917 172.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.446 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 19.1 m95 -82.33 -84.78 0.12 Allowed 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.313 -0.858 . . . . 73.14 109.744 167.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 176.25 -173.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.864 1.265 . . . . 75.45 109.121 -171.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -73.86 -90.36 0.16 Allowed Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.243 -0.743 . . . . 64.35 111.243 170.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -144.02 113.61 7.08 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.119 -1.067 . . . . 75.32 108.119 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -60.12 119.46 18.5 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 123.833 0.708 . . . . 73.04 112.616 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.7 t -147.58 148.15 30.83 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.995 0.518 . . . . 74.02 110.549 -172.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 78.8 -143.51 26.71 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.925 -0.58 . . . . 71.22 112.848 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -101.45 -176.93 28.67 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 112.096 -0.402 . . . . 64.33 112.096 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.9 p -72.77 114.95 11.48 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.93 0.492 . . . . 71.1 110.171 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -65.92 139.9 39.3 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-O 119.705 -0.497 . . . . 61.13 112.901 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -64.32 117.01 9.79 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 120.035 -0.314 . . . . 70.03 112.333 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.4 t -135.5 140.61 44.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.76 0.824 . . . . 73.4 109.855 -175.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -86.48 -152.72 21.66 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.569 0.543 . . . . 61.54 111.898 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -170.46 77.48 0.1 OUTLIER Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.938 -0.465 . . . . 72.24 111.938 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 47.6 t -89.44 -95.0 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 109.098 -0.704 . . . . 74.1 109.098 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -83.01 -33.98 26.41 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.99 -0.745 . . . . 71.43 108.99 168.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.38 142.49 56.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.661 -1.154 . . . . 65.14 109.692 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 80.5 mt -129.0 166.52 19.05 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.424 0.63 . . . . 74.02 111.747 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 25.4 t80 -120.26 139.37 52.81 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.612 -1.176 . . . . 75.0 109.267 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.612 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -151.72 -170.44 3.65 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.003 0.921 . . . . 72.23 109.819 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.4 m -119.72 140.99 49.83 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.695 0.798 . . . . 74.34 110.964 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 19.5 tp -100.48 108.23 20.14 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.105 0.962 . . . . 73.34 108.413 168.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -83.46 100.1 10.52 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.26 -0.645 . . . . 73.41 109.26 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.597 ' HA ' HG12 ' A' ' 210' ' ' VAL . 21.7 t -108.39 115.17 58.42 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 108.334 -0.987 . . . . 72.03 108.334 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.81 145.0 49.94 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 121.571 1.514 . . . . 75.15 110.6 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.27 -47.91 56.35 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 114.252 1.204 . . . . 73.52 114.252 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.79 -45.85 33.64 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 122.235 1.957 . . . . 73.51 113.768 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.2 mt -65.87 -34.92 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.942 0.497 . . . . 72.33 110.535 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.13 -44.39 92.33 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.07 -0.514 . . . . 73.13 111.385 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.3 t -71.03 -46.4 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.99 0.916 . . . . 72.2 112.028 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.03 -28.33 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 120.561 0.219 . . . . 73.1 110.623 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.89 72.3 1.23 Allowed Glycine 0 C--N 1.346 1.084 0 N-CA-C 111.233 -0.747 . . . . 62.41 111.233 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.7 -126.59 5.74 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 112.33 -0.308 . . . . 72.34 112.33 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -142.33 148.02 37.27 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.266 1.027 . . . . 74.44 108.849 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.597 HG12 ' HA ' ' A' ' 199' ' ' VAL . 27.8 m -142.43 158.89 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 123.134 0.573 . . . . 73.52 110.69 174.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -75.8 151.11 37.59 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.776 0.83 . . . . 75.34 110.18 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.495 ' HB2' ' HB ' ' A' ' 219' ' ' VAL . . . -128.2 114.59 17.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 75.05 108.576 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.6 tpt -64.51 109.58 2.01 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.129 0.572 . . . . 73.44 110.933 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.486 ' OG1' HG21 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -93.45 -169.1 2.04 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.247 1.419 . . . . 73.13 108.933 175.174 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.55 -69.16 0.12 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.464 1.126 . . . . 75.42 110.581 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.76 -42.52 3.41 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 112.793 -2.003 . . . . 72.32 110.746 -170.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -101.77 176.78 26.38 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.507 -0.769 . . . . 65.32 112.607 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -102.4 145.94 0.22 Allowed 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 122.882 2.388 . . . . 61.44 114.234 168.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' A' ' 212' ' ' ALA . 50.2 t -104.06 168.79 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.158 1.383 . . . . 71.45 108.055 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -142.04 139.23 32.27 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.094 -1.076 . . . . 74.22 108.094 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.456 HG12 HD12 ' A' ' 233' ' ' LEU . 12.7 p -134.25 144.64 34.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 123.627 0.771 . . . . 73.05 110.153 -173.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.04 113.12 19.02 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.421 0.688 . . . . 64.52 109.373 174.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 89.8 t -76.77 132.14 72.3 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.707 0.803 . . . . 74.25 109.512 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.83 161.34 44.36 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.803 2.335 . . . . 72.52 112.376 171.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.37 131.9 22.78 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.135 1.89 . . . . 74.45 112.315 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 52.79 72.21 0.43 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.998 1.319 . . . . 75.54 112.63 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 97.3 m -91.51 143.59 26.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.636 -1.166 . . . . 74.31 110.915 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -108.51 160.49 15.86 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.264 1.025 . . . . 73.35 110.635 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -80.07 155.17 27.66 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.991 -1.004 . . . . 72.45 111.264 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.6 -20.95 35.79 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 112.141 -0.384 . . . . 62.01 112.141 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -65.68 178.11 1.09 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.11 0.964 . . . . 72.25 110.551 167.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.567 ' HA ' HG22 ' A' ' 253' ' ' VAL . 12.4 ptmt -167.13 153.95 8.54 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 116.703 -0.226 . . . . 74.13 110.955 173.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.623 HD11 HD12 ' A' ' 251' ' ' LEU . 75.2 mt -84.23 152.03 24.45 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.862 -0.422 . . . . 72.01 109.862 170.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -117.8 107.18 13.83 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.354 -1.35 . . . . 73.3 107.354 161.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.671 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 65.4 mt -102.97 107.92 18.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.085 -0.961 . . . . 74.34 109.725 -173.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -78.61 120.7 23.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.635 -1.166 . . . . 74.13 111.426 -165.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.91 18.98 80.14 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.502 1.126 . . . . 74.24 113.761 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.402 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 43.4 mmtm -105.09 3.34 30.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.047 0.539 . . . . 75.51 111.842 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -83.75 -172.57 48.99 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 111.087 -0.805 . . . . 74.11 111.087 168.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.423 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 10.2 m-85 -62.04 137.0 95.49 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 117.213 0.506 . . . . 74.43 111.802 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.578 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 15.0 Cg_exo -69.64 143.72 52.37 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.038 2.492 . . . . 72.35 112.257 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.57 173.33 20.9 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.109 -0.95 . . . . 73.34 112.12 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.83 -14.29 26.74 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 123.106 2.537 . . . . 73.12 113.415 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.61 -17.94 12.91 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.837 0.855 . . . . 74.51 111.957 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 162.46 -162.13 34.16 Favored Glycine 0 C--O 1.221 -0.719 0 N-CA-C 109.52 -1.432 . . . . 61.12 109.52 -173.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.578 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 99.0 mtt180 -115.61 160.37 20.09 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 118.511 1.156 . . . . 72.22 110.67 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 177.28 54.34 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.348 -0.842 . . . . 55.11 111.765 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -119.31 143.14 47.53 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.367 0.603 . . . . 75.14 109.72 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 51.7 tp -102.4 108.04 19.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.438 -0.801 . . . . 74.1 110.006 -168.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 53.6 m-85 -100.58 106.6 18.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.916 -1.038 . . . . 75.41 108.776 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.623 HD12 HD11 ' A' ' 233' ' ' LEU . 1.8 pp -124.47 118.57 26.93 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.58 0.955 . . . . 73.53 113.58 -174.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.77 116.13 8.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.405 1.482 . . . . 75.45 112.488 -172.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 232' ' ' LYS . 59.4 t -64.24 118.85 7.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-N 114.092 -1.413 . . . . 75.43 111.081 175.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -114.32 117.51 31.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.431 1.492 . . . . 72.43 108.576 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.6 mm -87.82 106.75 16.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.088 -1.079 . . . . 74.35 108.088 172.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.259 1.581 0 C-N-CA 124.615 1.166 . . . . 72.22 108.131 -171.833 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 91.7 mtp . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.589 0.233 . . . . 72.43 110.373 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -78.31 133.68 37.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.119 0.968 . . . . 73.01 108.969 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.2 t -64.47 100.4 0.36 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.42 0.688 . . . . 74.24 111.433 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -167.89 148.59 5.14 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.715 0.806 . . . . 71.3 110.41 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.7 m -78.76 -26.17 44.54 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.78 0.8 . . . . 75.02 108.904 169.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -91.86 164.03 13.82 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.013 -0.994 . . . . 72.34 110.871 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -99.08 -88.82 1.97 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 111.34 -0.704 . . . . 74.54 111.34 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.23 159.67 41.77 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.114 0.966 . . . . 73.42 110.232 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.504 ' HA ' HD23 ' A' ' 233' ' ' LEU . 26.0 m95 -76.11 -87.72 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.473 -0.785 . . . . 75.24 109.201 175.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.07 37.24 4.19 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 106.048 -1.834 . . . . 72.32 106.048 174.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.39 -68.31 3.17 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 108.019 -2.033 . . . . 44.23 108.019 -152.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? 170.02 101.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.628 2.371 . . . . 74.54 105.237 164.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.07 -120.73 0.97 Allowed Glycine 0 C--N 1.341 0.828 0 C-N-CA 121.307 -0.473 . . . . 73.25 112.979 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.5 t -150.47 141.28 22.78 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.505 0.722 . . . . 74.13 109.956 -168.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.95 -134.86 3.96 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 111.116 -0.794 . . . . 73.23 111.116 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 146.49 61.86 0.01 OUTLIER Glycine 0 C--N 1.347 1.179 0 CA-C-N 117.226 0.513 . . . . 75.52 112.349 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 78.3 p -165.36 162.13 19.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.715 0.806 . . . . 71.13 110.731 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -82.8 -103.51 0.48 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.187 -1.165 . . . . 71.42 110.187 167.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.82 -64.45 3.34 Favored Glycine 0 C--N 1.351 1.368 0 C-N-CA 123.305 0.479 . . . . 74.44 113.476 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.402 ' HB3' ' CZ ' ' A' ' 250' ' ' TYR . 21.0 m -71.11 -14.66 62.37 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.92 1.288 . . . . 71.53 113.634 -175.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -74.81 99.67 1.15 Allowed Glycine 0 C--N 1.352 1.451 0 O-C-N 123.618 0.574 . . . . 72.45 112.614 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -115.6 -100.33 2.25 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.431 -0.65 . . . . 74.34 112.623 -177.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -145.66 -62.11 0.33 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 117.926 0.863 . . . . 75.4 111.944 -171.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.65 -33.88 75.84 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 120.65 0.262 . . . . 75.43 110.414 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.83 146.42 49.7 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.868 -0.605 . . . . 73.22 110.097 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.5 mt -121.2 146.05 47.19 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.917 0.487 . . . . 75.13 111.762 -171.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -99.56 111.0 23.4 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.005 -0.998 . . . . 74.22 108.487 171.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 251' ' ' LEU . . . -120.39 -170.45 1.98 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.416 1.086 . . . . 75.14 109.752 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.3 m -120.87 138.92 53.84 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 124.274 1.03 . . . . 74.0 111.07 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.517 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.8 tp -94.56 107.0 19.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.2 -1.037 . . . . 72.31 108.2 168.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.411 ' O ' ' HB ' ' A' ' 210' ' ' VAL . 14.3 t70 -80.52 109.08 14.7 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.983 -0.747 . . . . 72.3 108.983 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.481 ' HB ' HG23 ' A' ' 210' ' ' VAL . 0.9 OUTLIER -132.23 118.36 16.12 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 122.68 0.392 . . . . 75.23 110.191 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.457 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 53.9 Cg_endo -70.62 148.08 58.73 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.982 1.788 . . . . 64.22 111.373 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.37 -45.6 83.82 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.495 1.118 . . . . 74.31 113.945 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.9 Cg_exo -56.07 -47.48 24.45 Favored 'Trans proline' 0 C--N 1.396 3.052 0 C-N-CA 122.065 1.844 . . . . 55.42 113.034 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.57 -37.33 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.406 0.682 . . . . 72.42 110.717 177.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.81 -43.74 97.79 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.045 0.538 . . . . 63.3 110.867 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.3 -48.69 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.405 1.082 . . . . 74.24 112.031 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.5 p -79.48 -32.09 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 117.955 0.343 . . . . 73.14 111.192 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.86 106.17 1.35 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.474 -0.65 . . . . 64.22 111.474 -171.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.48 -138.13 3.6 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 119.518 -0.601 . . . . 72.33 111.883 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -138.98 137.3 36.25 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.693 0.797 . . . . 74.54 109.402 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.481 HG23 ' HB ' ' A' ' 199' ' ' VAL . 24.3 m -137.54 153.3 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.92 0.488 . . . . 60.44 111.19 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -76.91 139.05 40.08 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.559 -0.746 . . . . 74.31 111.132 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -111.76 111.43 22.4 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.154 -1.425 . . . . 73.0 107.154 170.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -69.13 114.12 7.12 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.071 0.548 . . . . 61.43 109.888 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.554 HG21 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -108.38 -173.12 2.2 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.311 1.044 . . . . 73.41 109.432 178.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.501 ' H ' HG22 ' A' ' 214' ' ' THR . 7.3 mt -56.42 -69.06 0.16 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.505 1.522 . . . . 74.15 111.7 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.83 -43.59 3.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 113.67 -1.605 . . . . 73.24 110.843 -168.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -123.9 133.65 8.9 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.545 -1.141 . . . . 65.34 111.132 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.49 150.65 58.1 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.342 2.028 . . . . 75.14 112.57 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.472 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 53.2 t -104.31 168.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.121 1.368 . . . . 75.45 107.856 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -148.64 135.23 19.67 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.438 -0.949 . . . . 75.44 108.438 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.8 p -126.56 139.34 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.509 0.724 . . . . 73.35 110.6 -173.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.02 104.35 3.53 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.522 -0.763 . . . . 65.12 109.076 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.43 123.99 90.22 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.141 -0.936 . . . . 74.41 108.789 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.03 158.67 42.36 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.773 2.316 . . . . 73.32 111.552 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.45 142.44 90.55 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.222 1.948 . . . . 70.4 111.932 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 46.67 64.9 1.35 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.8 1.64 . . . . 75.33 113.545 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.437 HG22 ' HD2' ' A' ' 231' ' ' ARG . 90.9 m -93.87 137.98 32.51 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.532 -1.213 . . . . 74.53 110.501 175.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -104.25 163.58 12.32 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.854 0.862 . . . . 75.5 110.24 175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . 0.42 ' HB1' ' H ' ' A' ' 255' ' ' ILE . . . -84.27 154.84 22.74 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.29 -1.323 . . . . 71.42 111.002 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.62 -15.59 49.08 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 123.459 0.474 . . . . 71.22 111.93 -172.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.437 ' HD2' HG22 ' A' ' 227' ' ' THR . 81.1 mtt85 -68.57 -179.35 1.35 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.974 0.909 . . . . 71.22 109.553 164.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.517 ' HA ' HG22 ' A' ' 253' ' ' VAL . 4.8 ptmt -169.24 147.74 3.81 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 119.288 -0.387 . . . . 75.55 110.323 176.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.575 HD11 HD12 ' A' ' 251' ' ' LEU . 88.7 mt -79.34 152.79 30.25 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.671 -0.492 . . . . 73.14 109.671 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -115.88 113.42 23.31 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 107.156 -1.424 . . . . 75.24 107.156 160.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 57.3 mt -113.3 109.96 19.59 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.908 -0.775 . . . . 74.4 108.908 -177.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . 0.528 ' HZ2' ' HB3' ' A' ' 236' ' ' LYS . 3.9 mmmp? -86.91 117.08 25.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.316 -0.856 . . . . 74.15 110.879 -167.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 89.83 10.84 64.38 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.197 0.936 . . . . 53.42 113.598 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.482 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 39.1 mmtm -98.54 -5.01 32.96 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.814 1.042 . . . . 74.22 113.814 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -83.49 -172.23 48.53 Favored Glycine 0 N--CA 1.479 1.505 0 CA-C-O 119.79 -0.45 . . . . 73.11 112.586 171.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -56.89 133.48 79.5 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.458 0.703 . . . . 74.23 111.964 -175.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.13 145.37 72.81 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.988 2.458 . . . . 72.24 111.944 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.4 177.08 19.04 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.971 -0.559 . . . . 72.32 112.899 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.09 -26.32 18.31 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 123.213 2.608 . . . . 74.42 113.41 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.73 -30.87 14.66 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.518 0.727 . . . . 74.02 111.699 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.07 -132.03 1.59 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 111.214 -0.755 . . . . 74.23 111.214 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -140.22 147.03 39.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.786 1.235 . . . . 72.3 108.784 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.93 177.31 42.13 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.897 0.748 . . . . 75.3 111.585 174.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -108.12 -177.64 3.39 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.144 0.577 . . . . 75.13 110.424 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.1 tp -141.3 106.21 4.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.514 0.673 . . . . 75.34 110.454 -176.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 38.3 m-85 -103.6 111.71 24.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.784 -1.561 . . . . 75.53 106.784 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.582 ' HB3' ' HB1' ' A' ' 195' ' ' ALA . 1.9 pp -124.08 118.06 26.08 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.57 0.952 . . . . 74.15 113.57 -173.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.61 119.24 12.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.751 1.62 . . . . 73.35 112.002 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.517 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 97.9 t -67.74 122.83 19.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 125.125 1.37 . . . . 74.53 111.073 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -118.67 111.54 18.65 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.2 1.4 . . . . 75.02 108.652 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.457 HD13 HG13 ' A' ' 199' ' ' VAL . 24.1 mm -81.84 96.81 3.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 107.586 -1.264 . . . . 61.14 107.586 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.252 1.228 0 C-N-CA 124.922 1.289 . . . . 71.44 108.451 -178.088 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 173' ' ' ALA . 14.1 ptt? . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 111.82 0.304 . . . . 63.14 111.82 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.442 ' HG2' ' H ' ' A' ' 170' ' ' THR . 19.8 tt0 -156.7 -154.54 0.47 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 108.251 -1.018 . . . . 74.4 108.251 -161.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.442 ' H ' ' HG2' ' A' ' 169' ' ' GLU . 12.1 t -57.91 -25.07 60.37 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.103 0.561 . . . . 72.01 110.805 167.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.66 129.0 34.26 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 123.508 0.723 . . . . 71.42 109.535 168.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 27.2 m -67.37 -18.38 65.12 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.288 1.035 . . . . 72.34 111.942 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.463 ' O ' ' HG2' ' A' ' 168' ' ' MET . . . -80.02 158.22 26.57 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.5 0.72 . . . . 73.51 112.073 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.92 -82.4 0.85 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 110.609 -0.997 . . . . 65.32 110.609 170.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.45 170.6 22.06 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.435 0.694 . . . . 74.35 111.147 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 233' ' ' LEU . 48.2 m95 -70.53 -62.93 1.2 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.827 -1.175 . . . . 75.5 107.827 171.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.47 173.52 9.79 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 113.748 -1.569 . . . . 72.31 108.482 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -69.64 74.54 0.44 Allowed Glycine 0 C--N 1.343 0.957 0 N-CA-C 109.214 -1.555 . . . . 65.2 109.214 164.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.09 107.7 2.0 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.76 1.224 . . . . 75.01 110.874 -158.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.39 -115.44 0.33 Allowed Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.881 -0.6 . . . . 34.42 112.812 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.1 m -83.01 -32.62 26.82 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.313 0.645 . . . . 72.41 111.634 -175.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -63.89 123.47 28.52 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.416 -0.811 . . . . 74.2 113.596 -175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -134.49 28.64 3.11 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 123.046 0.355 . . . . 73.2 112.72 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.2 m -85.87 138.16 32.24 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.075 0.55 . . . . 74.55 110.017 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -90.37 -148.46 20.37 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 111.567 -0.613 . . . . 52.51 111.567 173.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -167.61 148.73 13.31 Favored Glycine 0 C--O 1.242 0.644 0 N-CA-C 111.773 -0.531 . . . . 64.44 111.773 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.6 t -70.82 -45.69 64.1 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.928 0.891 . . . . 73.41 110.383 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.36 -163.31 21.86 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 111.344 -0.702 . . . . 64.4 111.344 -172.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.48 -162.26 12.72 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.704 -0.558 . . . . 53.42 111.704 -176.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.1 m -70.82 -51.01 29.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.018 0.527 . . . . 50.53 110.501 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -74.85 -62.61 1.48 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.697 0.799 . . . . 74.44 109.218 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.484 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 5.9 p-10 -73.57 126.74 30.94 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.901 -1.045 . . . . 71.04 110.315 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.1 mt -113.5 164.36 13.73 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.436 0.636 . . . . 75.12 112.648 -164.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -114.49 125.53 53.92 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.611 -1.177 . . . . 74.3 108.523 167.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.633 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -135.66 -171.53 2.87 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.977 0.911 . . . . 74.03 109.467 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.1 m -117.93 138.49 52.11 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.945 0.898 . . . . 73.1 110.494 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 251' ' ' LEU . 21.8 tp -93.74 128.82 40.16 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.06 -1.089 . . . . 73.55 108.06 165.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.08 100.37 11.69 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.611 -0.514 . . . . 73.23 109.611 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.594 HG21 HG21 ' A' ' 210' ' ' VAL . 21.9 t -111.1 108.81 57.26 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 108.444 -0.947 . . . . 74.44 108.444 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.17 144.57 63.5 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 121.491 1.461 . . . . 74.35 110.082 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.16 -45.9 65.48 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 114.083 1.142 . . . . 73.44 114.083 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.08 -47.16 24.15 Favored 'Trans proline' 0 C--N 1.392 2.851 0 C-N-CA 122.104 1.869 . . . . 71.11 113.744 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.2 mt -64.19 -36.96 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 122.736 0.414 . . . . 74.22 110.567 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.37 94.43 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.951 0.501 . . . . 60.1 111.088 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.0 t -72.3 -50.69 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 124.32 1.013 . . . . 74.54 112.097 -175.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.78 -21.54 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-O 120.851 0.358 . . . . 73.13 110.899 -176.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.36 84.87 0.53 Allowed Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.996 -0.547 . . . . 74.04 112.1 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.94 -136.82 5.99 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.839 -0.504 . . . . 75.2 111.839 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -127.54 151.33 49.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.862 0.865 . . . . 73.13 109.212 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.594 HG21 HG21 ' A' ' 199' ' ' VAL . 28.3 m -140.36 150.18 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.294 0.638 . . . . 73.41 110.31 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -77.24 138.89 39.68 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 123.621 0.575 . . . . 72.31 110.426 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -109.26 114.71 28.63 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.748 -1.575 . . . . 65.1 106.748 171.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.0 tpt -64.69 126.12 26.91 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.035 0.534 . . . . 62.52 109.691 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.98 -168.98 2.08 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.687 1.195 . . . . 71.14 109.74 -172.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.4 mt -82.22 -68.73 0.67 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.141 0.972 . . . . 72.25 109.904 -171.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -98.24 -40.78 8.19 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 112.972 -1.922 . . . . 74.42 109.845 -165.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -145.34 134.29 5.45 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-O 118.448 -1.196 . . . . 70.32 110.242 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.0 144.21 52.01 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.764 2.31 . . . . 75.42 112.345 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 55.3 t -96.79 168.5 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 125.231 1.413 . . . . 72.51 108.994 -177.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -148.26 127.92 13.32 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.869 -0.789 . . . . 74.11 108.869 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.6 p -118.13 143.3 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.472 0.709 . . . . 75.34 109.892 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.46 108.64 7.36 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.853 -0.795 . . . . 73.51 108.853 170.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.489 ' HA ' ' HZ2' ' A' ' 176' ' ' TRP . 71.1 t -73.61 128.33 87.21 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.737 0.815 . . . . 73.11 109.821 173.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.62 157.47 60.56 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.704 2.269 . . . . 73.42 111.411 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.18 134.6 56.87 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.466 2.11 . . . . 74.25 112.509 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 51.24 67.32 0.97 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.76 1.624 . . . . 74.42 112.823 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.454 HG21 ' HD2' ' A' ' 231' ' ' ARG . 54.9 m -88.79 140.16 29.73 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.694 -1.139 . . . . 71.43 110.549 173.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 28.2 mp0 -100.78 157.52 16.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.074 0.95 . . . . 73.41 111.156 177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -80.2 155.28 27.46 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.447 -1.251 . . . . 45.4 110.239 176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.48 29.86 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 111.649 -0.58 . . . . 64.33 111.649 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.454 ' HD2' HG21 ' A' ' 227' ' ' THR . 73.7 mtt85 -62.23 178.18 0.41 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.688 0.795 . . . . 74.12 110.559 168.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.4 ptmt -166.17 147.24 6.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.752 -0.462 . . . . 74.44 109.752 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.547 HD11 HD11 ' A' ' 251' ' ' LEU . 88.8 mt -79.32 147.63 32.39 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.911 -0.774 . . . . 73.12 108.911 169.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -108.57 121.39 44.89 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.006 -1.479 . . . . 73.35 107.006 158.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 80.4 mt -118.28 110.92 18.1 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.365 -0.606 . . . . 63.52 109.365 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -79.02 119.28 21.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 73.43 110.922 -167.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.34 13.78 77.93 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.454 1.096 . . . . 75.32 113.948 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.44 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.3 mmtt -102.65 8.57 39.63 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 117.512 0.656 . . . . 73.01 112.665 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.82 172.55 32.66 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 110.644 -0.982 . . . . 71.43 110.644 168.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -55.42 146.09 44.81 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-N 117.652 0.726 . . . . 65.3 112.31 -173.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.475 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 24.5 Cg_exo -60.31 141.29 95.43 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.933 2.422 . . . . 74.21 112.272 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -130.26 171.72 20.49 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.958 -1.019 . . . . 71.11 111.842 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.68 -32.21 38.46 Favored 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 123.014 2.476 . . . . 73.12 112.793 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.57 -7.36 41.3 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.583 0.753 . . . . 73.44 111.387 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 135.55 177.08 14.71 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.218 -0.753 . . . . 65.15 111.218 -177.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.475 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 61.8 mtm-85 -69.44 155.77 39.91 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.406 0.682 . . . . 74.45 112.206 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.12 -172.04 47.04 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.525 -0.761 . . . . 75.12 111.976 173.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.484 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 12.7 m-20 -115.12 149.08 38.15 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.366 0.666 . . . . 55.51 110.115 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.571 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.2 tp -106.53 108.47 19.99 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.348 0.594 . . . . 73.23 109.84 -170.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 54.0 m-85 -101.65 101.85 12.44 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.213 -1.032 . . . . 75.33 108.213 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.2 pp -118.68 119.34 34.15 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.429 0.9 . . . . 75.21 113.429 -173.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -67.68 116.96 8.97 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.118 0.967 . . . . 74.04 111.936 -174.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.567 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 94.1 t -63.93 116.77 3.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 113.691 -1.595 . . . . 74.23 110.717 174.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -111.9 125.16 53.74 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.343 -1.298 . . . . 74.45 108.645 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 29.8 mm -91.15 108.83 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.455 -1.313 . . . . 73.52 107.455 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.253 1.257 0 CA-C-O 117.766 -1.112 . . . . 73.33 108.551 -171.458 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.634 -0.506 . . . . 74.12 109.634 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -154.36 172.83 17.07 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.925 0.89 . . . . 75.54 110.193 -175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.5 p 47.59 80.66 0.05 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.781 1.232 . . . . 75.24 113.082 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.47 113.78 15.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.948 -0.76 . . . . 63.11 108.948 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.425 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 7.5 m -66.64 -18.4 65.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.238 1.015 . . . . 71.31 111.595 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.85 176.27 6.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.03 0.932 . . . . 74.11 111.851 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.19 -129.23 6.18 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.25 -0.74 . . . . 62.34 111.25 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.57 158.05 17.81 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.087 0.555 . . . . 64.21 111.124 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.488 ' CZ3' HG23 ' A' ' 227' ' ' THR . 31.1 m95 -88.12 -80.59 0.27 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.581 -0.896 . . . . 74.33 108.581 165.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -131.42 39.22 3.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.131 0.972 . . . . 73.04 109.559 -173.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.78 -42.93 99.6 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 116.277 -0.419 . . . . 72.11 112.494 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.32 -78.25 0.39 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.093 -1.077 . . . . 75.34 108.093 174.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 146.67 135.13 2.68 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-N 115.624 -0.716 . . . . 74.22 111.646 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.542 ' HB3' ' HD2' ' A' ' 234' ' ' ARG . 33.9 t -151.7 122.68 7.6 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.003 -0.74 . . . . 70.12 109.003 176.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . 0.458 ' HA2' ' HH ' ' A' ' 250' ' ' TYR . . . -177.07 103.77 0.18 Allowed Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.178 -0.769 . . . . 74.52 111.178 -175.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 169.08 145.39 4.59 Favored Glycine 0 C--O 1.241 0.578 0 CA-C-O 119.869 -0.406 . . . . 75.24 112.117 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.0 t 60.81 19.69 9.88 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.775 1.23 . . . . 73.1 112.269 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -66.52 -41.38 94.21 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 111.533 -0.627 . . . . 74.32 111.533 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.63 71.42 2.7 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 112.316 -0.314 . . . . 32.33 112.316 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.0 m -81.51 -43.62 18.52 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.548 0.739 . . . . 72.03 110.42 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 161.29 -71.48 0.22 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 110.814 -0.914 . . . . 71.11 110.814 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -65.9 101.45 0.6 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 110.922 -0.871 . . . . 73.51 110.922 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.1 m -71.97 93.57 1.38 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.448 0.699 . . . . 75.3 110.598 -171.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . 0.58 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 24.3 mt-30 -115.65 -35.69 4.46 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.747 -1.115 . . . . 72.44 108.455 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -55.65 137.55 49.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.412 -1.267 . . . . 73.02 109.635 165.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 77.0 mt -128.43 158.67 37.67 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.375 0.607 . . . . 75.22 112.261 -177.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.42 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 11.6 t80 -121.14 126.0 48.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.687 -1.142 . . . . 74.1 108.679 171.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.595 ' HB1' ' HB3' ' A' ' 251' ' ' LEU . . . -136.18 -173.81 3.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.953 0.901 . . . . 73.4 109.274 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.8 m -126.37 117.47 23.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.548 0.739 . . . . 75.23 110.599 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.547 ' HB2' HD11 ' A' ' 251' ' ' LEU . 18.4 tp -76.92 105.88 8.26 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.58 -0.896 . . . . 72.23 108.58 171.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.21 101.86 12.19 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.658 -0.867 . . . . 63.43 108.658 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.622 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.3 t -110.64 115.03 54.24 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.089 -1.078 . . . . 73.45 108.089 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.03 148.93 70.88 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.558 1.506 . . . . 75.43 110.194 171.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.45 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -54.11 -40.07 79.05 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 124.014 0.926 . . . . 74.23 113.4 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 10.9 Cg_endo -54.14 -51.4 10.73 Favored 'Trans proline' 0 C--N 1.395 3.013 0 C-N-CA 122.17 1.913 . . . . 75.23 113.534 172.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.45 HG21 HG12 ' A' ' 210' ' ' VAL . 49.3 mt -64.8 -36.2 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.25 0.62 . . . . 74.32 110.979 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.424 ' HA ' HG12 ' A' ' 223' ' ' VAL . . . -65.13 -44.08 89.86 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.936 -0.575 . . . . 74.11 111.656 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.71 -51.03 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.767 0.827 . . . . 73.42 111.805 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.93 -23.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 120.494 0.188 . . . . 64.3 110.932 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.97 77.95 1.07 Allowed Glycine 0 C--N 1.349 1.305 0 N-CA-C 111.346 -0.702 . . . . 62.43 111.346 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.13 -139.78 8.41 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.907 -0.477 . . . . 73.14 111.907 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -132.1 146.27 51.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.286 0.634 . . . . 75.12 109.458 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.622 HG11 ' HA ' ' A' ' 199' ' ' VAL . 28.5 m -134.97 152.9 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 123.658 0.599 . . . . 75.51 109.819 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 218' ' ' PRO . 40.4 ttt-85 -79.15 143.67 35.22 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.593 0.757 . . . . 72.43 109.772 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.59 ' HB1' ' HB ' ' A' ' 219' ' ' VAL . . . -112.75 114.28 26.77 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.677 -1.231 . . . . 74.04 107.677 171.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.91 135.07 54.28 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.866 1.266 . . . . 74.4 111.193 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.673 HG22 ' HE3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -141.48 -170.83 3.18 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.703 0.801 . . . . 75.14 110.515 173.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.537 ' H ' HG21 ' A' ' 214' ' ' THR . 7.1 mt -55.69 -69.54 0.14 Allowed 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.613 1.165 . . . . 72.33 110.815 -172.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -116.37 -42.69 3.0 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.251 -1.795 . . . . 73.51 110.929 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -113.02 132.88 10.96 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 118.656 -1.08 . . . . 72.22 111.717 -175.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . 0.423 ' HB3' ' HE ' ' A' ' 211' ' ' ARG . 74.6 Cg_endo -73.68 -173.95 1.52 Allowed 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.525 2.15 . . . . 72.22 112.682 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.59 ' HB ' ' HB1' ' A' ' 212' ' ' ALA . 8.5 t -140.05 164.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.36 1.464 . . . . 74.24 107.523 168.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.425 ' H ' ' HB ' ' A' ' 172' ' ' THR . 5.0 tt0 -142.16 127.75 19.07 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.043 -1.095 . . . . 74.15 108.043 170.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.465 HG11 HD12 ' A' ' 233' ' ' LEU . 13.8 p -120.22 139.75 46.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 123.6 0.76 . . . . 74.11 110.603 -173.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.17 104.87 5.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.818 0.847 . . . . 74.24 109.419 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 204' ' ' ALA . 61.5 t -69.38 128.37 92.38 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.449 0.7 . . . . 73.12 109.335 173.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.51 154.25 74.57 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.057 2.505 . . . . 73.13 112.063 171.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.78 129.38 27.45 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.306 2.004 . . . . 72.11 112.189 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 55.56 74.21 0.39 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.547 1.539 . . . . 72.21 113.081 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' THR . . . . . 0.488 HG23 ' CZ3' ' A' ' 176' ' ' TRP . 64.8 m -97.22 144.15 27.32 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.662 -1.154 . . . . 75.34 111.204 175.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -108.53 163.89 12.83 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.561 1.144 . . . . 72.41 110.972 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -88.15 152.47 21.96 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.642 -1.163 . . . . 73.3 111.427 -177.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.02 -12.84 52.67 Favored Glycine 0 N--CA 1.476 1.31 0 CA-C-N 116.342 -0.39 . . . . 71.34 112.25 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.431 ' HD2' HG21 ' A' ' 227' ' ' THR . 73.3 mtt85 -69.58 178.17 2.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.636 0.774 . . . . 75.21 109.762 166.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.629 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 10.9 ptmt -168.37 157.02 8.77 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.319 0.104 . . . . 72.0 111.15 172.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.554 HD11 HD13 ' A' ' 251' ' ' LEU . 73.0 mt -93.62 158.8 15.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.003 0.521 . . . . 62.25 109.807 170.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . 0.542 ' HD2' ' HB3' ' A' ' 181' ' ' SER . 8.1 ptt-85 -132.61 109.55 9.82 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.914 1.285 . . . . 73.41 108.363 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.606 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 49.5 mt -120.42 117.15 26.96 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.393 0.677 . . . . 74.22 111.339 -166.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -84.94 134.35 34.25 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.709 -0.678 . . . . 75.43 110.695 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 76.22 10.14 85.47 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 124.219 0.949 . . . . 73.2 113.513 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.673 ' HE3' HG22 ' A' ' 214' ' ' THR . 29.3 mmmt -97.68 -25.15 15.2 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 117.142 0.471 . . . . 72.43 112.232 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -66.09 -172.0 4.19 Favored Glycine 0 CA--C 1.538 1.519 0 O-C-N 123.103 0.252 . . . . 75.03 113.151 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . 0.58 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 17.5 m-30 -59.06 138.68 87.82 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 122.696 0.399 . . . . 71.22 111.235 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . 0.561 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 32.2 Cg_exo -59.29 152.66 58.79 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.93 2.42 . . . . 74.11 112.622 175.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.6 -177.77 15.15 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.708 -0.678 . . . . 64.15 112.509 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.12 -40.67 4.52 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 122.732 2.288 . . . . 75.1 112.537 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.47 -10.65 14.88 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.683 0.793 . . . . 63.41 111.854 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.41 166.49 27.56 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 111.467 -0.653 . . . . 72.31 111.467 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.561 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 16.5 mtp180 -85.66 165.58 16.88 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.204 0.602 . . . . 72.31 110.871 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.72 -176.61 46.86 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.342 -0.844 . . . . 62.11 112.826 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.74 169.21 8.65 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.014 0.525 . . . . 72.51 110.935 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.606 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 62.7 tp -131.95 108.98 9.73 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.571 -0.74 . . . . 71.32 110.201 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.629 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 13.8 m-30 -98.8 116.91 32.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.125 -1.065 . . . . 71.11 108.125 173.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.595 ' HB3' ' HB1' ' A' ' 195' ' ' ALA . 1.6 pp -129.5 116.31 18.76 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.34 0.867 . . . . 71.21 113.34 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.34 123.34 20.5 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 114.751 -1.113 . . . . 75.21 112.506 -174.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.518 HG23 HD21 ' A' ' 197' ' ' LEU . 60.5 t -70.09 125.23 27.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 114.19 -1.368 . . . . 73.5 110.953 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.92 129.9 55.43 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.551 1.14 . . . . 74.43 108.484 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 40.6 mm -99.97 99.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.552 -1.277 . . . . 74.32 107.552 177.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.561 1.366 0 CA-C-N 114.37 -1.286 . . . . 70.21 108.952 -167.59 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 59.4 mtt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.95 -0.759 . . . . 72.25 108.95 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.48 -168.88 0.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.229 1.011 . . . . 65.13 111.855 -173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.0 t -65.59 -13.44 59.05 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.413 0.685 . . . . 74.13 112.477 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -105.34 162.03 13.79 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.626 0.77 . . . . 74.01 110.086 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.469 HG23 HG21 ' A' ' 219' ' ' VAL . 3.4 m -71.78 -27.04 62.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.836 -0.62 . . . . 75.32 109.892 175.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.03 152.24 18.71 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.634 0.773 . . . . 62.13 111.184 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.64 -102.29 0.06 OUTLIER Glycine 0 C--N 1.351 1.363 0 O-C-N 124.207 0.942 . . . . 74.21 111.482 165.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -136.51 175.77 9.3 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.537 0.735 . . . . 73.43 109.84 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.492 ' HZ2' HG21 ' A' ' 223' ' ' VAL . 14.2 m95 -79.52 -82.33 0.1 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.156 -0.929 . . . . 74.01 109.539 170.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -143.01 138.45 30.02 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 106.84 -1.541 . . . . 74.34 106.84 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.98 94.52 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.373 -1.091 . . . . 72.11 110.373 166.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.51 163.07 10.3 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.43 1.492 . . . . 75.02 108.716 174.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -97.78 57.29 1.12 Allowed Glycine 0 N--CA 1.473 1.14 0 N-CA-C 111.685 -0.566 . . . . 55.45 111.685 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.5 p -82.11 -41.52 20.38 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.517 0.727 . . . . 74.44 111.941 -174.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -170.78 142.1 6.91 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 121.437 -0.411 . . . . 72.42 112.485 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -88.82 59.12 4.0 Favored Glycine 0 C--N 1.348 1.209 0 C-N-CA 122.938 0.304 . . . . 73.21 112.639 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.0 p -90.44 151.05 21.57 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.779 0.831 . . . . 74.34 110.291 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.36 170.86 32.72 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.854 -0.612 . . . . 74.15 112.094 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -68.17 -32.48 76.48 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-O 119.864 -0.409 . . . . 53.2 112.718 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.7 m 64.74 24.35 12.86 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.718 1.207 . . . . 63.34 112.508 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 160.65 72.47 0.02 OUTLIER Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.047 -0.821 . . . . 35.25 111.047 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -88.5 -154.88 28.87 Favored Glycine 0 C--N 1.341 0.845 0 C-N-CA 123.144 0.402 . . . . 72.42 112.888 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.4 m -112.58 -65.83 1.14 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.52 0.728 . . . . 74.54 109.81 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -87.36 -40.17 14.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.557 -0.747 . . . . 72.22 109.659 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 9.2 p-10 -71.56 129.4 38.66 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.62 -0.718 . . . . 61.12 109.464 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.6 mt -113.71 165.4 12.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.538 0.735 . . . . 64.45 111.757 -169.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -118.0 122.18 42.56 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 114.741 -1.118 . . . . 75.24 108.24 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.611 ' HB2' ' HB3' ' A' ' 251' ' ' LEU . . . -131.43 -172.98 2.99 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.829 0.852 . . . . 74.34 110.052 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 52.9 m -119.29 149.77 41.24 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.122 0.969 . . . . 75.42 109.706 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.572 ' HB2' HD12 ' A' ' 251' ' ' LEU . 22.2 tp -119.95 104.57 10.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.106 1.362 . . . . 72.24 108.462 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -91.44 99.71 12.61 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.892 0.853 . . . . 70.02 109.109 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.558 ' HA ' HG13 ' A' ' 210' ' ' VAL . 23.2 t -94.99 119.85 65.28 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 114.555 -1.202 . . . . 73.05 108.282 174.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.68 144.95 61.83 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 121.539 1.493 . . . . 72.34 109.859 173.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.42 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.48 -42.44 75.1 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.501 -1.238 . . . . 50.42 113.147 -175.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.7 Cg_endo -55.96 -51.62 9.18 Favored 'Trans proline' 0 C--N 1.406 3.602 0 C-N-CA 121.94 1.76 . . . . 71.42 112.71 174.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 54.5 mt -65.01 -33.55 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.236 0.615 . . . . 73.43 110.674 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.67 77.14 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.407 0.683 . . . . 62.43 110.898 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.7 t -70.3 -47.12 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.351 1.06 . . . . 73.4 112.281 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.56 -35.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 120.507 0.194 . . . . 71.32 110.761 -174.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.47 105.79 1.13 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.539 -1.024 . . . . 53.22 110.539 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.93 -129.0 2.29 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.689 -0.506 . . . . 65.42 111.859 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 4.9 ttmt -145.15 137.7 26.06 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.608 0.763 . . . . 75.31 109.75 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.558 HG13 ' HA ' ' A' ' 199' ' ' VAL . 33.6 m -135.23 155.16 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 122.766 0.427 . . . . 73.34 110.763 175.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -70.65 146.2 50.13 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.016 0.822 . . . . 73.04 110.427 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -123.64 120.75 33.68 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.014 1.326 . . . . 74.33 107.882 172.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -64.76 129.23 39.02 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.987 0.915 . . . . 73.34 110.899 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 -170.91 2.82 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.207 1.003 . . . . 64.24 110.265 -172.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.4 mt -84.87 -66.76 0.86 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.61 1.195 . . . . 73.33 109.639 -171.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -95.65 -33.3 12.4 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 112.675 -2.057 . . . . 74.22 110.856 -165.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -160.68 141.97 7.79 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.354 -1.248 . . . . 72.4 111.294 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.6 142.99 60.72 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.694 2.263 . . . . 51.12 113.001 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.552 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 61.6 t -94.06 166.47 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.92 1.288 . . . . 75.13 109.031 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -144.3 136.68 26.59 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.243 -1.391 . . . . 75.51 107.243 171.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' VAL . . . . . 0.492 HG12 HD11 ' A' ' 233' ' ' LEU . 14.4 p -132.88 140.71 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.253 0.621 . . . . 74.34 111.347 -169.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.09 101.17 2.69 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.302 1.041 . . . . 72.21 110.331 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.492 HG21 ' HZ2' ' A' ' 176' ' ' TRP . 92.9 t -72.25 121.66 85.32 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 118.141 -0.933 . . . . 73.23 109.226 175.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.67 154.72 72.57 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.592 2.195 . . . . 75.51 111.783 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.72 130.93 37.3 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.532 2.154 . . . . 74.4 112.769 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 56.15 74.65 0.38 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.813 1.645 . . . . 70.42 112.762 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 97.0 m -90.7 142.09 28.11 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.714 -1.13 . . . . 73.54 111.064 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -107.6 149.71 27.73 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.586 1.154 . . . . 70.02 109.947 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.68 155.28 37.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.188 -0.914 . . . . 73.03 110.545 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.1 -19.84 39.56 Favored Glycine 0 N--CA 1.476 1.311 0 N-CA-C 111.162 -0.775 . . . . 75.44 111.162 -172.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -65.9 179.83 0.83 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.257 1.023 . . . . 74.51 110.599 168.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.542 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.0 ptmt -166.81 152.89 8.27 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 116.176 -0.465 . . . . 74.42 109.992 172.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LEU . . . . . 0.573 HD13 HD11 ' A' ' 251' ' ' LEU . 61.6 mt -81.29 142.71 32.85 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.035 -0.728 . . . . 74.53 109.035 169.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -103.22 104.06 14.16 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.177 -1.416 . . . . 75.45 107.177 158.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.55 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 50.6 mt -102.43 113.51 26.9 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 114.939 -1.028 . . . . 74.52 109.009 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -82.18 125.79 31.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.316 -0.856 . . . . 74.51 110.142 -172.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.64 25.3 75.67 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 124.448 1.092 . . . . 73.25 113.804 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.55 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 74.3 mmtt -107.54 -3.17 19.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 112.671 0.619 . . . . 73.31 112.671 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.93 176.89 50.89 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.825 -1.31 . . . . 74.24 109.825 164.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -56.65 131.69 77.88 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 117.335 0.567 . . . . 71.42 111.894 -171.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.23 138.93 69.31 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.97 2.447 . . . . 74.14 111.519 174.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.22 177.77 18.49 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.561 -0.745 . . . . 74.44 113.472 -174.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.61 -33.52 66.93 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.973 2.448 . . . . 72.4 112.75 177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.48 -8.97 59.6 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.419 0.688 . . . . 65.23 111.901 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 144.42 -101.18 0.25 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 110.872 -0.891 . . . . 73.15 110.872 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.3 mtt180 -148.35 165.78 30.04 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.788 1.235 . . . . 74.42 110.176 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.65 174.08 30.23 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 110.792 -0.923 . . . . 75.12 110.792 167.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 45.7 m-20 -102.85 -179.15 3.88 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.105 0.562 . . . . 71.42 109.944 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 46.0 tp -141.68 107.63 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.603 0.716 . . . . 73.32 109.128 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' TYR . . . . . 0.464 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 54.3 m-85 -100.99 107.6 19.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.882 -1.525 . . . . 75.14 106.882 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 195' ' ' ALA . 2.7 pp -122.94 118.09 27.04 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.759 0.79 . . . . 62.13 113.086 -175.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -69.75 120.63 15.79 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 125.3 1.44 . . . . 70.11 112.252 -171.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' A' ' 232' ' ' LYS . 58.9 t -68.8 116.56 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 114.09 -1.414 . . . . 74.42 110.979 177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -103.35 131.24 50.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.112 1.765 . . . . 74.02 108.866 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.0 mm -97.46 110.22 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.966 -1.124 . . . . 70.43 107.966 170.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.257 1.45 0 C-N-CA 124.335 1.054 . . . . 74.54 108.627 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 219' ' ' VAL . 11.6 m . . . . . 0 CA--C 1.557 1.226 0 CA-C-O 121.484 0.659 . . . . 61.43 110.976 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -111.95 151.6 29.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.621 0.768 . . . . 75.200000000000003 110.657 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.34 -113.37 0.07 OUTLIER Glycine 0 C--N 1.349 1.251 0 O-C-N 123.659 0.599 . . . . 72.329999999999998 111.71 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -112.5 177.69 4.55 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.406 0.683 . . . . 63.32 110.047 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.506 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 13.6 m95 . . . . . 0 CA--C 1.54 0.57 0 CA-C-N 115.176 -0.92 . . . . 72.120000000000005 109.732 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 C--O 1.238 0.485 0 CA-C-O 121.616 0.722 . . . . 51.340000000000003 112.882 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.1 mt -130.88 147.3 52.51 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.653 -1.158 . . . . 70.140000000000001 110.157 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -114.71 122.81 47.58 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.587 -0.894 . . . . 71.439999999999998 108.587 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -133.14 -173.24 3.15 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.558 0.536 . . . . 73.219999999999999 110.532 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.5 m -123.81 135.88 54.06 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.797 0.839 . . . . 71.019999999999996 110.146 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.3 tp -96.01 109.18 21.61 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.746 -1.205 . . . . 54.130000000000003 107.746 170.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -85.43 99.69 11.37 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.664 -0.865 . . . . 61.420000000000002 108.664 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.682 ' HA ' HG11 ' A' ' 210' ' ' VAL . 18.9 t -111.61 112.31 54.0 Favored Pre-proline 0 C--N 1.344 0.342 0 N-CA-C 107.988 -1.115 . . . . 63.240000000000002 107.988 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.3 151.59 80.53 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.538 1.492 . . . . 72.349999999999994 110.693 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.424 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.82 -42.2 88.47 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 123.755 0.822 . . . . 74.329999999999998 113.203 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 11.1 Cg_endo -55.24 -56.67 2.14 Favored 'Trans proline' 0 C--N 1.392 2.828 0 C-N-CA 122.004 1.803 . . . . 71.25 113.824 172.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.57 -31.28 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 122.942 0.497 . . . . 75.109999999999999 111.001 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.33 80.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.076 -0.511 . . . . 43.439999999999998 111.045 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.9 t -67.27 -50.41 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.987 0.915 . . . . 71.019999999999996 111.801 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.6 p -79.28 -25.89 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 120.813 0.34 . . . . 75.099999999999994 110.723 -172.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.95 73.0 1.07 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.92 -0.582 . . . . 75.239999999999995 111.778 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.13 -130.22 6.8 Favored Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.59 -0.604 . . . . 65.25 111.59 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -131.9 156.09 46.74 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.519 0.728 . . . . 52.049999999999997 110.104 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.682 HG11 ' HA ' ' A' ' 199' ' ' VAL . 26.8 m -144.79 158.05 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.064 0.853 . . . . 75.239999999999995 110.145 173.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -81.41 146.65 30.18 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.523 -0.762 . . . . 71.219999999999999 111.017 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -121.84 125.68 47.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.727 1.211 . . . . 75.120000000000005 108.347 170.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.5 tpt -64.32 131.44 47.3 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.946 0.498 . . . . 75.010000000000005 110.851 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.424 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -135.32 -170.78 2.67 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.789 1.236 . . . . 73.519999999999996 108.888 -177.112 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 216' ' ' GLU . 7.1 mt -63.54 -68.65 0.33 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 122.39 1.091 . . . . 61.009999999999998 111.869 -172.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 33.9 mt-10 -97.42 -39.83 8.99 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 112.707 -2.042 . . . . 75.129999999999995 109.266 -163.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -147.0 -165.39 11.69 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 113.981 -1.463 . . . . 22.120000000000001 111.565 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -96.89 151.46 1.07 Allowed 'Trans proline' 0 CA--C 1.551 1.35 0 C-N-CA 122.728 2.285 . . . . 71.409999999999997 114.907 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 54.0 t -97.86 162.88 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 114.195 -1.366 . . . . 74.010000000000005 107.535 165.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -144.65 119.23 9.74 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.18 -1.044 . . . . 65.310000000000002 108.18 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 233' ' ' LEU . 12.7 p -112.07 142.66 23.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.56 0.744 . . . . 64.140000000000001 110.207 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.28 112.53 10.54 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.824 -0.806 . . . . 63.200000000000003 108.824 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.3 133.02 81.26 Favored Pre-proline 0 CA--C 1.553 1.075 0 N-CA-C 109.211 -0.663 . . . . 74.209999999999994 109.211 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.57 157.58 61.23 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.252 2.635 . . . . 65.340000000000003 111.237 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.57 135.11 40.86 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 121.98 1.786 . . . . 70.409999999999997 112.08 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.7 mtp-105 53.19 65.46 1.51 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.913 1.685 . . . . 64.430000000000007 113.34 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.526 HG23 ' HD2' ' A' ' 231' ' ' ARG . 77.7 m -87.95 139.01 30.95 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.87 -1.059 . . . . 61.409999999999997 111.711 176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.643 ' HB2' HH12 ' A' ' 231' ' ' ARG . 25.9 mp0 -104.33 159.02 16.06 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.003 0.921 . . . . 74.209999999999994 110.086 172.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.45 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -86.19 152.32 22.92 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.111 -0.95 . . . . 74.299999999999997 111.46 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.11 -15.21 30.86 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 115.934 -0.575 . . . . 71.400000000000006 111.744 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.643 HH12 ' HB2' ' A' ' 228' ' ' GLN . 69.5 mtt85 -69.72 179.26 2.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.959 0.904 . . . . 62.109999999999999 109.769 166.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.1 ptmt -166.0 155.66 12.1 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.917 -0.401 . . . . 74.450000000000003 109.917 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.585 HD12 HD11 ' A' ' 251' ' ' LEU . 79.8 mt -84.37 147.08 27.35 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.617 -0.512 . . . . 61.450000000000003 109.617 170.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -114.21 107.36 15.51 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.66 1.225 . . . . 63.32 107.958 167.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 63.3 mt -116.53 118.32 32.31 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.931 0.492 . . . . 74.010000000000005 110.863 -173.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -92.86 126.0 37.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.127 -0.488 . . . . 74.200000000000003 110.184 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.23 12.91 72.37 Favored Glycine 0 N--CA 1.471 1.022 0 O-C-N 124.264 0.978 . . . . 54.329999999999998 113.021 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -114.11 -3.32 13.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.689 0.796 . . . . 74.420000000000002 111.446 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.88 -177.34 51.47 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 110.556 -1.018 . . . . 53.039999999999999 110.556 166.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -57.5 141.52 78.43 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.753 0.649 . . . . 74.430000000000007 112.753 -171.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 7.8 Cg_exo -69.47 133.72 26.81 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.622 2.214 . . . . 70.040000000000006 110.512 171.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -135.31 174.63 21.13 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.888 -1.051 . . . . 54.140000000000001 112.621 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.62 -9.98 23.16 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.903 2.402 . . . . 71.430000000000007 112.71 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -105.29 11.07 33.32 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.094 0.958 . . . . 72.030000000000001 111.407 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 121.83 -113.02 2.16 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.187 -0.765 . . . . 72.319999999999993 111.187 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 65.0 mtt180 -143.87 164.06 31.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.276 1.03 . . . . 73.140000000000001 110.567 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -98.29 -163.87 30.79 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 114.748 -1.115 . . . . 63.43 113.29 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -115.6 160.21 20.3 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.183 0.993 . . . . 74.310000000000002 110.679 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.572 ' HG ' HD23 ' A' ' 251' ' ' LEU . 27.7 tp -131.47 109.66 10.45 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.469 0.708 . . . . 74.319999999999993 109.641 -171.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.461 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 20.2 m-85 -102.8 116.3 32.3 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.482 -0.932 . . . . 64.450000000000003 108.482 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.585 HD11 HD12 ' A' ' 233' ' ' LEU . 3.0 pp -127.76 114.47 17.33 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.384 0.611 . . . . 54.020000000000003 112.42 -173.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -68.74 119.73 13.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.923 1.289 . . . . 72.439999999999998 112.984 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 232' ' ' LYS . 64.1 t -70.82 126.12 30.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-N 114.342 -1.299 . . . . 72.129999999999995 110.897 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -116.24 133.14 56.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.988 1.315 . . . . 63.509999999999998 108.34 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.45 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 43.0 mm -104.94 100.53 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 107.874 -1.158 . . . . 73.319999999999993 107.874 175.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.557 1.227 0 CA-C-O 117.773 -1.108 . . . . 73.109999999999999 109.506 -171.857 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 10.3 m . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.079 0.466 . . . . 74.439999999999998 111.114 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.52 151.13 38.0 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.911 -0.586 . . . . 64.030000000000001 111.703 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -77.05 -66.3 1.83 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.425 -0.807 . . . . 61.509999999999998 111.944 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -162.7 167.91 22.36 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 123.924 0.889 . . . . 64.439999999999998 111.096 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.616 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.8 m95 . . . . . 0 CA--C 1.543 0.688 0 CA-C-N 114.516 -1.22 . . . . 71.219999999999999 108.613 167.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 C--O 1.239 0.542 0 N-CA-C 109.499 -0.556 . . . . 72.019999999999996 109.499 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.19 159.59 29.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.38 0.61 . . . . 63.350000000000001 111.046 -172.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 11.9 t80 -125.59 110.47 13.88 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.654 -1.157 . . . . 64.200000000000003 107.884 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.96 -171.87 2.18 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.034 0.934 . . . . 54.32 110.056 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 69.2 m -127.26 118.52 24.39 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.438 0.695 . . . . 64.430000000000007 110.95 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.521 HD23 HG22 ' A' ' 253' ' ' VAL . 13.8 tp -78.71 111.37 14.74 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.732 -0.84 . . . . 75.129999999999995 108.732 169.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.75 109.6 18.75 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.949 -1.13 . . . . 74.049999999999997 107.949 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.638 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.5 t -118.36 114.19 36.57 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.602 -1.259 . . . . 55.340000000000003 107.602 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.96 146.05 76.18 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 121.214 1.276 . . . . 74.120000000000005 109.971 171.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.46 -44.54 82.99 Favored Pre-proline 0 CA--C 1.563 1.451 0 CA-C-O 117.869 -1.063 . . . . 62.229999999999997 112.817 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 16.5 Cg_endo -54.89 -48.93 18.55 Favored 'Trans proline' 0 C--N 1.399 3.2 0 C-N-CA 122.19 1.927 . . . . 63.520000000000003 112.754 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.489 HG21 HG13 ' A' ' 210' ' ' VAL . 50.8 mt -65.99 -35.3 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.006 0.523 . . . . 73.040000000000006 110.649 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.73 99.5 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.06 0.544 . . . . 71.439999999999998 111.14 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.0 t -72.93 -50.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.156 0.982 . . . . 60.119999999999997 112.078 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 12.4 p -77.72 -27.93 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.703 0.401 . . . . 72.430000000000007 110.52 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.83 70.18 1.36 Allowed Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.336 -0.706 . . . . 51.310000000000002 111.336 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.69 -130.02 6.86 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.902 -0.479 . . . . 64.510000000000005 111.902 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -143.49 137.19 28.34 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.231 0.613 . . . . 61.140000000000001 109.921 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.638 HG11 ' HA ' ' A' ' 199' ' ' VAL . 35.4 m -132.55 151.02 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.409 0.684 . . . . 53.149999999999999 110.235 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -75.23 140.04 42.97 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.941 0.497 . . . . 74.420000000000002 110.856 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.12 113.71 26.13 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.982 -1.488 . . . . 74.430000000000007 106.982 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 11.0 tpt -65.54 131.0 45.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.037 0.535 . . . . 65.239999999999995 111.489 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -133.71 -171.69 2.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.545 1.138 . . . . 72.209999999999994 110.644 -172.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mt -83.5 -64.22 1.21 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.777 1.275 . . . . 75.340000000000003 109.679 -168.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.8 -32.07 12.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 112.067 -2.333 . . . . 72.209999999999994 110.93 -166.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -164.44 144.29 9.27 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-O 118.672 -1.071 . . . . 51.420000000000002 111.442 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.33 143.88 71.99 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.686 2.257 . . . . 72.129999999999995 113.278 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 66.0 t -96.54 163.23 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.177 -1.374 . . . . 73.200000000000003 108.159 174.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.401 ' H ' ' HB ' ' A' ' 172' ' ' THR . 9.5 tt0 -147.08 134.06 20.28 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.767 -1.197 . . . . 74.010000000000005 107.767 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.51 HG21 HD21 ' A' ' 233' ' ' LEU . 12.0 p -126.49 135.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 C-N-CA 123.48 0.712 . . . . 71.340000000000003 110.951 -173.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.75 104.4 2.42 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.85 -1.068 . . . . 63.439999999999998 108.95 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.4 t -71.75 132.79 84.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 108.551 -0.907 . . . . 63.329999999999998 108.551 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.5 157.39 60.82 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.541 2.161 . . . . 74.420000000000002 111.839 171.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -64.71 137.48 54.29 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.103 1.868 . . . . 74.310000000000002 111.96 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 50.5 65.19 1.53 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.327 1.451 . . . . 72.340000000000003 113.192 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.444 HG23 ' HD2' ' A' ' 231' ' ' ARG . 68.1 m -82.87 144.55 30.0 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.947 -1.024 . . . . 70.109999999999999 111.071 174.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -105.79 155.92 18.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.749 0.82 . . . . 72.209999999999994 110.398 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.439 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -76.61 153.59 35.14 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.618 -1.174 . . . . 74.010000000000005 110.369 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.3 -10.93 59.97 Favored Glycine 0 N--CA 1.472 1.099 0 N-CA-C 112.351 -0.3 . . . . 60.100000000000001 112.351 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.444 ' HD2' HG23 ' A' ' 227' ' ' THR . 65.8 mtt85 -72.1 -177.23 2.0 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.126 0.97 . . . . 74.0 109.586 165.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.526 ' HA ' HG23 ' A' ' 253' ' ' VAL . 7.5 ptmt -167.25 161.83 14.63 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 111.275 0.102 . . . . 64.040000000000006 111.275 172.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.632 HD12 HD11 ' A' ' 251' ' ' LEU . 73.1 mt -88.49 151.28 22.64 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.468 -0.567 . . . . 74.0 109.468 166.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -111.85 109.33 19.09 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.49 -1.3 . . . . 73.420000000000002 107.49 162.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 64.0 mt -110.11 102.43 11.14 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.854 0.835 . . . . 70.299999999999997 109.784 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -76.68 119.1 20.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.095 -1.411 . . . . 62.329999999999998 110.853 -169.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.62 -3.95 86.6 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 124.072 0.858 . . . . 54.030000000000001 113.981 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.486 ' HD2' HG21 ' A' ' 214' ' ' THR . 32.6 mmtp -87.09 5.79 35.89 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.645 0.723 . . . . 64.030000000000001 112.565 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.98 174.02 49.24 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.123 -0.791 . . . . 74.420000000000002 111.123 166.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.04 148.16 88.98 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.85 0.46 . . . . 74.439999999999998 111.753 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.519 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 11.7 Cg_exo -68.69 133.32 27.29 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.659 2.239 . . . . 64.219999999999999 112.429 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -128.89 173.78 19.26 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.793 -1.094 . . . . 75.420000000000002 112.552 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.02 -24.82 20.17 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.92 2.413 . . . . 73.430000000000007 112.195 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.22 22.46 14.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.058 0.943 . . . . 72.109999999999999 110.833 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 101.16 -177.74 27.67 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.957 -0.857 . . . . 71.420000000000002 110.957 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 32.9 mtp180 -81.81 155.49 25.39 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.113 0.457 . . . . 63.549999999999997 111.161 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.2 -179.12 52.72 Favored Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.436 -0.802 . . . . 65.439999999999998 112.222 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -117.37 138.26 51.92 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.208 0.528 . . . . 75.209999999999994 109.789 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 38.8 tp -101.91 105.57 16.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.973 -1.012 . . . . 61.439999999999998 109.116 -170.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 60.5 m-85 -102.15 114.13 27.99 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.146 -1.057 . . . . 73.129999999999995 108.146 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 233' ' ' LEU . 2.5 pp -125.88 114.74 18.94 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.593 0.96 . . . . 62.399999999999999 113.593 -171.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -67.74 125.8 27.37 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.799 1.24 . . . . 74.019999999999996 112.766 -173.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.616 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 89.1 t -74.25 131.3 35.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-N 113.55 -1.659 . . . . 75.439999999999998 110.936 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -123.81 125.33 44.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.456 1.503 . . . . 75.120000000000005 107.851 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.439 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 33.1 mm -97.01 105.91 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.566 -1.272 . . . . 54.140000000000001 107.566 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.564 1.495 0 CA-C-O 118.022 -0.99 . . . . 62.140000000000001 109.507 -169.724 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.407 HG22 HG22 ' A' ' 219' ' ' VAL . 13.4 m . . . . . 0 CA--C 1.555 1.156 0 CA-C-O 121.207 0.527 . . . . 61.43 110.959 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.74 166.17 12.58 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.744 0.817 . . . . 75.200000000000003 111.874 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.68 -96.56 0.92 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.525 -1.03 . . . . 72.329999999999998 110.525 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.14 174.86 9.61 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.982 0.513 . . . . 63.32 109.716 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.523 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 9.9 m95 . . . . . 0 CA--C 1.539 0.53 0 CA-C-N 115.266 -0.879 . . . . 72.120000000000005 110.097 170.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 7.9 p-10 . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 112.366 0.506 . . . . 51.340000000000003 112.366 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.46 ' HB2' HD13 ' A' ' 249' ' ' LEU . 87.4 mt -116.75 147.22 42.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.391 1.076 . . . . 70.140000000000001 109.594 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -115.55 117.6 30.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.18 -1.045 . . . . 71.439999999999998 108.18 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.577 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -130.17 -173.61 3.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.456 0.702 . . . . 73.219999999999999 109.878 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.0 m -124.33 120.63 32.71 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.43 0.692 . . . . 71.019999999999996 110.311 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.503 HD23 HG22 ' A' ' 253' ' ' VAL . 18.3 tp -78.6 105.55 9.96 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.003 -1.11 . . . . 54.130000000000003 108.003 172.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -86.29 101.0 12.67 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.788 -0.819 . . . . 61.420000000000002 108.788 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 210' ' ' VAL . 18.1 t -112.67 113.86 50.12 Favored Pre-proline 0 N--CA 1.47 0.556 0 N-CA-C 108.884 -0.784 . . . . 63.240000000000002 108.884 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.38 151.17 83.85 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 121.611 1.541 . . . . 72.349999999999994 110.642 171.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.436 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.19 -43.77 95.7 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-O 118.01 -0.995 . . . . 74.329999999999998 113.096 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.3 Cg_endo -55.37 -51.76 9.28 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 122.152 1.901 . . . . 71.25 112.98 174.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.48 HG21 HG13 ' A' ' 210' ' ' VAL . 38.6 mt -63.76 -34.85 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.07 0.548 . . . . 75.109999999999999 111.016 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.44 87.24 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.19 -0.459 . . . . 43.439999999999998 111.017 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.9 t -72.84 -49.03 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.826 0.85 . . . . 71.019999999999996 111.833 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.81 -24.72 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 122.329 0.252 . . . . 75.099999999999994 110.714 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.06 75.9 1.03 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.95 -0.568 . . . . 75.239999999999995 111.776 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.99 -144.78 10.9 Favored Glycine 0 N--CA 1.474 1.209 0 N-CA-C 110.815 -0.914 . . . . 65.25 110.815 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -122.29 150.73 41.94 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.107 0.953 . . . . 52.049999999999997 110.762 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.661 HG21 HG22 ' A' ' 199' ' ' VAL . 24.8 m -141.06 149.21 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 115.354 -0.839 . . . . 75.239999999999995 109.978 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -73.83 145.13 45.18 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.292 0.568 . . . . 71.219999999999999 111.124 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.623 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -119.8 115.95 24.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.256 1.422 . . . . 75.120000000000005 107.281 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 15.9 tpt -64.26 130.88 45.6 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.27 0.628 . . . . 75.010000000000005 111.529 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.88 -172.41 2.87 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.166 1.386 . . . . 73.519999999999996 109.691 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.04 -70.18 0.26 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.074 0.94 . . . . 61.009999999999998 110.668 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -114.88 -41.52 3.35 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 113.63 -1.623 . . . . 75.129999999999995 111.387 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -116.3 102.97 1.11 Allowed Glycine 0 C--N 1.349 1.294 0 CA-C-O 118.468 -1.184 . . . . 22.120000000000001 111.652 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.33 137.99 78.14 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.251 2.634 . . . . 71.409999999999997 112.625 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.623 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 91.0 t -90.37 163.46 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.451 1.1 . . . . 74.010000000000005 108.955 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -146.19 127.9 15.25 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.704 -1.221 . . . . 65.310000000000002 107.704 170.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.453 HG11 HD11 ' A' ' 233' ' ' LEU . 14.0 p -116.94 140.99 37.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 C-N-CA 123.722 0.809 . . . . 64.140000000000001 110.276 -174.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.93 106.82 5.81 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.59 -0.732 . . . . 63.200000000000003 109.052 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.91 128.61 92.75 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.755 0.822 . . . . 74.209999999999994 109.253 173.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -59.39 149.58 80.5 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.956 2.438 . . . . 65.340000000000003 111.961 170.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.39 132.18 39.78 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 121.751 1.634 . . . . 70.409999999999997 110.77 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 52.92 69.88 0.64 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.287 1.435 . . . . 64.430000000000007 112.672 -173.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.502 HG23 ' HD2' ' A' ' 231' ' ' ARG . 32.5 m -92.06 138.42 31.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.222 -1.354 . . . . 61.409999999999997 110.135 170.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.422 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 26.3 mp0 -103.55 162.31 13.15 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.555 0.742 . . . . 74.209999999999994 111.044 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.455 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.76 155.88 24.02 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.187 -1.37 . . . . 74.299999999999997 111.741 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.07 -10.03 59.98 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 111.847 -0.501 . . . . 71.400000000000006 111.847 -173.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.502 ' HD2' HG23 ' A' ' 227' ' ' THR . 71.4 mtt85 -72.38 -179.52 2.98 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.067 0.947 . . . . 62.109999999999999 110.307 168.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.504 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.4 ptmt -167.8 153.23 7.1 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.88 -0.6 . . . . 74.450000000000003 109.909 171.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.574 HD12 HD11 ' A' ' 251' ' ' LEU . 85.4 mt -83.58 152.48 24.82 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.358 -0.608 . . . . 61.450000000000003 109.358 169.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -118.65 110.08 16.89 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 124.833 1.333 . . . . 63.32 107.593 168.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 58.6 mt -116.98 117.8 30.66 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.728 -0.669 . . . . 74.010000000000005 110.07 -171.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' ' 248' ' ' ASP . 27.2 mmtp -93.03 132.39 37.17 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.702 -0.481 . . . . 74.200000000000003 109.702 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.81 20.72 73.11 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 124.261 0.976 . . . . 54.329999999999998 112.912 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 26.6 mmtp -116.86 -5.47 11.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.178 0.807 . . . . 74.420000000000002 113.178 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.61 -172.32 46.78 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-O 119.794 -0.448 . . . . 53.039999999999999 112.124 166.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -58.77 139.14 86.56 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.077 0.551 . . . . 74.430000000000007 111.765 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.485 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 6.3 Cg_exo -76.61 136.8 17.61 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.728 2.285 . . . . 70.040000000000006 111.508 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -130.93 170.16 21.35 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.952 -0.567 . . . . 54.140000000000001 112.764 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.52 -28.9 21.03 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.892 2.395 . . . . 71.430000000000007 112.26 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.59 22.17 12.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.855 0.862 . . . . 72.030000000000001 110.849 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.91 169.44 24.26 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 111.115 -0.794 . . . . 72.319999999999993 111.115 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 96.6 mtt180 -73.78 175.1 7.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.711 0.767 . . . . 73.140000000000001 111.994 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.46 -167.43 33.93 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.193 -1.367 . . . . 63.43 112.147 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.524 ' HB3' ' HD3' ' A' ' 236' ' ' LYS . 2.2 p-10 -118.69 176.94 5.03 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.682 0.793 . . . . 74.310000000000002 110.41 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 27.2 tp -145.82 109.55 4.8 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.236 0.541 . . . . 74.319999999999993 110.973 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 16.9 m-85 -102.16 116.14 32.03 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.449 -0.945 . . . . 64.450000000000003 108.449 174.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.0 pp -127.91 115.24 18.27 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.138 0.792 . . . . 54.020000000000003 113.138 -175.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.42 119.6 13.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.392 1.477 . . . . 72.439999999999998 112.856 -170.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.523 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 57.4 t -70.82 120.75 19.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-N 114.57 -1.196 . . . . 72.129999999999995 111.105 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -113.59 129.01 56.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.564 1.146 . . . . 63.509999999999998 108.908 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.455 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 31.9 mm -94.88 99.59 9.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.643 -1.243 . . . . 73.319999999999993 107.643 173.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 124.877 1.271 . . . . 73.109999999999999 108.436 -171.89 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.472 HG22 HG22 ' A' ' 219' ' ' VAL . 1.1 m . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 107.592 -1.262 . . . . 61.119999999999997 107.592 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.96 159.73 14.97 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.719 0.808 . . . . 64.010000000000005 111.681 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -92.08 -88.95 1.48 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 114.885 -1.052 . . . . 52.130000000000003 111.994 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.85 165.61 33.07 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.588 0.709 . . . . 73.209999999999994 112.801 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.512 ' CZ3' HG21 ' A' ' 227' ' ' THR . 34.5 m95 . . . . . 0 CA--C 1.541 0.601 0 CA-C-N 113.654 -1.612 . . . . 75.209999999999994 110.577 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 120.752 0.311 . . . . 72.340000000000003 110.292 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.0 mt -111.59 143.39 42.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.196 0.599 . . . . 51.229999999999997 110.653 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -113.41 114.82 27.13 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.594 -0.891 . . . . 61.229999999999997 108.594 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -128.13 -172.56 2.72 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.238 1.015 . . . . 55.219999999999999 109.603 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.504 HG23 ' HG2' ' A' ' 254' ' ' ARG . 88.0 m -111.69 150.19 30.54 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.997 0.919 . . . . 72.530000000000001 110.442 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.558 HD22 ' HG ' ' A' ' 233' ' ' LEU . 16.7 tp -110.29 103.29 11.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.61 -1.626 . . . . 73.140000000000001 106.61 162.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.85 99.44 12.12 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.676 -0.861 . . . . 72.430000000000007 108.676 -173.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.651 HG22 HG21 ' A' ' 210' ' ' VAL . 15.6 t -106.73 113.02 63.29 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.118 -0.946 . . . . 74.040000000000006 108.518 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.31 148.37 88.39 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.531 1.487 . . . . 62.119999999999997 110.325 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.415 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -51.69 -44.28 89.9 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 117.725 -1.131 . . . . 72.540000000000006 112.579 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.1 Cg_endo -56.49 -49.94 13.41 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 122.052 1.835 . . . . 45.310000000000002 112.665 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.467 HG21 HG13 ' A' ' 210' ' ' VAL . 38.2 mt -65.36 -32.94 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.225 0.61 . . . . 74.030000000000001 110.818 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.84 -47.35 78.29 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.031 0.532 . . . . 43.210000000000001 110.344 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -70.25 -49.21 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.25 1.02 . . . . 52.420000000000002 111.945 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.0 p -79.68 -27.4 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.375 0.27 . . . . 72.010000000000005 110.715 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.3 70.6 1.34 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 112.217 -0.353 . . . . 71.409999999999997 112.217 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.33 -123.48 5.2 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 120.031 -0.316 . . . . 71.450000000000003 112.797 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -150.22 137.12 19.29 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.97 0.908 . . . . 73.239999999999995 110.052 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.651 HG21 HG22 ' A' ' 199' ' ' VAL . 29.6 m -139.17 156.68 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 123.427 0.691 . . . . 75.329999999999998 111.317 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -77.6 141.47 39.47 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.007 0.923 . . . . 63.140000000000001 111.535 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.504 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -116.4 116.59 27.98 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.421 1.488 . . . . 72.030000000000001 108.477 172.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -66.21 130.64 43.93 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.864 0.865 . . . . 74.400000000000006 111.189 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.2 -171.2 2.69 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.323 1.049 . . . . 62.420000000000002 110.132 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 215' ' ' LEU . 7.1 mt -68.28 -66.83 0.52 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.881 1.273 . . . . 60.5 111.205 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -105.5 -42.32 5.25 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 113.229 -1.805 . . . . 71.409999999999997 111.385 -165.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -137.49 145.16 16.79 Favored Glycine 0 N--CA 1.467 0.765 0 CA-C-O 118.695 -1.059 . . . . 63.539999999999999 111.716 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.65 137.92 23.24 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.165 1.91 . . . . 74.409999999999997 112.38 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 172' ' ' THR . 50.5 t -95.39 164.67 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 114.475 -1.239 . . . . 64.120000000000005 108.104 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -144.41 144.32 31.35 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.416 -1.327 . . . . 74.319999999999993 107.416 175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.459 HG11 HD21 ' A' ' 197' ' ' LEU . 15.0 p -135.65 140.39 44.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 123.223 0.609 . . . . 74.530000000000001 110.824 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.56 112.6 9.79 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.803 0.841 . . . . 45.119999999999997 109.392 172.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 176' ' ' TRP . 83.8 t -76.74 132.61 71.43 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.533 0.733 . . . . 72.349999999999994 109.406 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.3 155.58 68.76 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.803 2.336 . . . . 74.019999999999996 111.353 169.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -65.63 136.22 45.2 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.001 1.801 . . . . 74.5 111.865 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 49.4 69.53 0.58 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.571 1.549 . . . . 63.340000000000003 112.773 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.512 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 86.2 m -90.4 144.39 25.86 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.527 -1.215 . . . . 72.430000000000007 110.703 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -107.56 156.95 18.45 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.427 1.091 . . . . 63.409999999999997 110.556 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.05 155.45 30.63 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.481 -1.236 . . . . 50.299999999999997 110.518 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.78 -16.94 43.0 Favored Glycine 0 N--CA 1.471 0.984 0 N-CA-C 111.349 -0.7 . . . . 75.150000000000006 111.349 -173.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 227' ' ' THR . 76.1 mtt85 -71.02 -178.96 2.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.247 1.019 . . . . 74.439999999999998 109.91 167.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.56 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 8.4 ptmt -167.05 159.97 13.61 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.191 0.307 . . . . 74.010000000000005 110.773 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.581 HD12 HD11 ' A' ' 251' ' ' LEU . 85.5 mt -88.19 147.29 24.94 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.35 -0.611 . . . . 73.310000000000002 109.35 168.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -113.68 107.17 15.4 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 124.675 1.235 . . . . 73.239999999999995 107.733 166.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.553 HD12 HD23 ' A' ' 249' ' ' LEU . 70.4 mt -110.07 110.72 21.71 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.482 0.713 . . . . 74.439999999999998 109.45 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -83.41 121.07 26.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.015 -0.993 . . . . 72.409999999999997 111.078 -167.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.8 2.53 88.56 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.236 -0.893 . . . . 64.409999999999997 113.341 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.546 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 48.2 mmtm -94.05 4.68 53.56 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.618 0.767 . . . . 73.400000000000006 111.814 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.97 -175.37 49.95 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.479 -1.048 . . . . 55.149999999999999 110.479 166.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -62.77 136.54 96.38 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-N 117.579 0.689 . . . . 74.340000000000003 110.906 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.499 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 55.9 Cg_endo -69.51 143.88 53.53 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.307 2.005 . . . . 74.310000000000002 112.21 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.21 167.29 23.47 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 119.471 -0.627 . . . . 71.019999999999996 112.489 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.77 -22.22 32.32 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 123.157 2.571 . . . . 72.310000000000002 113.887 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.2 1.05 16.02 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.278 0.631 . . . . 54.030000000000001 111.684 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.54 159.6 8.46 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.517 -0.633 . . . . 75.510000000000005 111.517 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 51.9 mtm180 -83.35 169.79 15.25 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.374 0.67 . . . . 75.209999999999994 111.438 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.74 -174.79 35.21 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.366 -0.834 . . . . 32.049999999999997 111.684 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -126.12 150.55 48.15 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.144 0.497 . . . . 64.519999999999996 110.209 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.553 HD23 HD12 ' A' ' 235' ' ' LEU . 37.6 tp -109.09 108.72 19.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.818 0.847 . . . . 73.200000000000003 109.95 -171.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.56 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 54.1 m-85 -104.29 116.32 31.95 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.402 1.081 . . . . 74.299999999999997 108.458 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.2 pp -130.08 115.19 16.73 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.386 0.884 . . . . 72.219999999999999 113.386 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -68.82 119.52 13.31 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.834 1.254 . . . . 74.109999999999999 112.061 -170.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.543 HG23 ' HA ' ' A' ' 232' ' ' LYS . 66.6 t -65.13 124.92 21.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 CA-C-N 114.558 -1.201 . . . . 73.519999999999996 110.649 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.504 ' HG2' HG23 ' A' ' 196' ' ' THR . 14.1 mmm180 -119.41 135.27 54.82 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.062 1.345 . . . . 71.340000000000003 108.539 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.41 111.12 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 107.888 -1.153 . . . . 74.030000000000001 107.888 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.564 1.517 0 CA-C-O 117.644 -1.169 . . . . 75.420000000000002 108.819 -171.819 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 11.7 m . . . . . 0 CA--C 1.551 1.001 0 CA-C-O 121.198 0.523 . . . . 71.140000000000001 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -90.34 143.23 26.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.532 0.733 . . . . 72.450000000000003 111.104 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.29 -75.6 0.42 Allowed Glycine 0 C--N 1.344 0.98 0 O-C-N 123.912 0.758 . . . . 73.299999999999997 112.358 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -158.14 171.27 20.53 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.906 0.882 . . . . 70.420000000000002 111.085 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.581 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 16.0 m95 . . . . . 0 CA--C 1.542 0.659 0 CA-C-N 114.811 -1.086 . . . . 73.420000000000002 108.661 168.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.0 p-10 . . . . . 0 N--CA 1.447 -0.583 0 CA-C-O 120.958 0.408 . . . . 74.5 111.672 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.8 mt -123.45 132.79 54.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.204 -0.907 . . . . 61.299999999999997 110.215 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -93.32 129.99 39.23 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.579 -0.897 . . . . 71.219999999999999 108.579 167.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -138.65 -171.85 3.16 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.12 -0.696 . . . . 62.200000000000003 109.12 175.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.1 m -127.74 119.45 25.81 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.423 0.689 . . . . 55.509999999999998 110.778 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.516 HD22 ' HG ' ' A' ' 233' ' ' LEU . 17.3 tp -81.47 105.25 12.48 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.152 -1.055 . . . . 71.120000000000005 108.152 171.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -92.36 99.5 12.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.825 0.821 . . . . 73.239999999999995 108.85 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.682 HG22 HG21 ' A' ' 210' ' ' VAL . 22.8 t -101.15 121.71 51.04 Favored Pre-proline 0 C--N 1.347 0.465 0 N-CA-C 107.645 -1.242 . . . . 75.230000000000004 107.645 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.97 149.52 71.99 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 121.76 1.64 . . . . 71.400000000000006 110.243 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.423 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.61 -45.95 85.55 Favored Pre-proline 0 CA--C 1.56 1.365 0 O-C-N 124.2 0.937 . . . . 74.25 113.075 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.9 Cg_endo -57.47 -48.83 15.61 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 121.979 1.786 . . . . 61.43 113.67 176.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.435 HG21 HG13 ' A' ' 210' ' ' VAL . 47.9 mt -66.91 -32.47 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 122.813 0.445 . . . . 74.010000000000005 110.632 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.8 95.2 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.228 -0.442 . . . . 40.229999999999997 110.725 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.23 -51.68 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.612 0.765 . . . . 74.140000000000001 111.816 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.5 p -78.95 -22.42 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 120.753 0.311 . . . . 70.329999999999998 110.871 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 75.64 62.18 2.75 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 115.635 -0.711 . . . . 63.100000000000001 111.902 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.26 -120.68 2.73 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.25 -0.34 . . . . 70.040000000000006 112.25 -175.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -146.94 140.84 25.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.691 0.796 . . . . 70.349999999999994 109.259 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.682 HG21 HG22 ' A' ' 199' ' ' VAL . 19.1 m -137.19 152.61 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.301 0.64 . . . . 61.439999999999998 110.58 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -77.8 140.6 39.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.752 0.821 . . . . 73.129999999999995 110.75 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.03 115.8 29.51 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.497 -1.298 . . . . 73.230000000000004 107.497 172.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.9 tpt -63.49 127.55 31.81 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.229 0.612 . . . . 64.109999999999999 110.894 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.29 -170.23 2.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.786 1.234 . . . . 70.540000000000006 109.696 -175.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.04 -68.79 0.52 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.27 1.033 . . . . 72.010000000000005 111.224 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.19 -37.64 5.5 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 113.265 -1.789 . . . . 72.409999999999997 110.765 -165.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -133.31 119.25 2.3 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 118.566 -1.13 . . . . 51.539999999999999 110.669 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.09 141.44 52.79 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.53 2.153 . . . . 73.209999999999994 112.833 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 71.0 t -92.62 165.9 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 114.466 -1.243 . . . . 74.420000000000002 109.056 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -146.75 136.88 23.51 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 108.028 -1.101 . . . . 55.32 108.028 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.541 HG21 HD21 ' A' ' 233' ' ' LEU . 14.5 p -130.17 142.18 44.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.446 0.698 . . . . 75.310000000000002 110.809 -172.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.22 113.45 12.6 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.154 -0.684 . . . . 44.439999999999998 109.154 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.9 t -74.09 136.6 76.07 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 123.562 0.745 . . . . 65.420000000000002 109.146 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.86 154.04 67.78 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.259 1.973 . . . . 72.209999999999994 111.575 170.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.87 132.35 36.8 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.531 2.154 . . . . 64.310000000000002 111.916 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 49.56 72.84 0.28 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.139 1.375 . . . . 75.299999999999997 112.378 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.564 HG23 ' HD2' ' A' ' 231' ' ' ARG . 67.8 m -82.8 141.95 31.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.307 -1.315 . . . . 44.450000000000003 110.923 174.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.494 ' H ' HH11 ' A' ' 231' ' ' ARG . 27.0 mp0 -100.42 151.62 21.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.997 0.919 . . . . 73.420000000000002 110.314 171.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -75.94 156.84 33.84 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.049 -0.978 . . . . 42.020000000000003 111.078 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.57 -2.42 62.6 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.242 -0.435 . . . . 73.019999999999996 112.291 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.564 ' HD2' HG23 ' A' ' 227' ' ' THR . 28.3 mtt85 -77.17 -175.22 3.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.513 0.725 . . . . 32.350000000000001 109.737 168.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 9.3 ptmt -167.38 154.75 8.76 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 110.488 -0.189 . . . . 54.509999999999998 110.488 170.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.647 HD12 HD11 ' A' ' 251' ' ' LEU . 48.8 mt -80.0 143.58 33.99 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 110.118 -0.326 . . . . 51.399999999999999 110.118 167.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 250' ' ' TYR . 7.8 ptp85 -109.89 108.39 18.67 Favored 'General case' 0 C--O 1.243 0.716 0 O-C-N 125.299 1.624 . . . . 63.020000000000003 108.39 166.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.519 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 65.9 mt -115.03 138.85 50.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.228 -0.896 . . . . 60.530000000000001 109.31 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -108.96 141.05 41.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.201 0.6 . . . . 72.400000000000006 109.44 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 68.58 24.16 75.28 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 124.194 0.934 . . . . 70.430000000000007 112.956 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 45.5 mmtm -117.43 -11.07 10.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.429 0.692 . . . . 75.430000000000007 112.331 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.85 -168.83 40.14 Favored Glycine 0 N--CA 1.479 1.531 0 CA-C-O 119.627 -0.541 . . . . 75.109999999999999 111.911 171.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -66.64 142.48 97.6 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-N 117.811 0.805 . . . . 74.420000000000002 111.651 -173.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.22 141.79 48.46 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.3 2.666 . . . . 74.510000000000005 112.647 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -135.82 172.23 22.36 Favored Glycine 0 N--CA 1.476 1.346 0 C-N-CA 123.243 0.449 . . . . 75.340000000000003 113.123 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.02 -25.51 44.2 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.031 2.487 . . . . 65.150000000000006 112.409 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.99 21.71 8.37 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.526 0.73 . . . . 71.310000000000002 111.623 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 103.03 -172.2 21.36 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 110.495 -1.042 . . . . 75.420000000000002 110.495 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.45 149.57 22.55 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 117.693 0.746 . . . . 74.209999999999994 110.633 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.1 -173.59 44.19 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.907 0.754 . . . . 71.430000000000007 114.394 -173.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 6.9 p-10 -105.07 167.5 9.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.348 0.659 . . . . 55.210000000000001 110.917 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.486 HD23 HD12 ' A' ' 235' ' ' LEU . 42.2 tp -137.98 110.62 7.57 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.524 0.73 . . . . 73.219999999999999 109.381 -174.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.583 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 20.8 m-85 -108.75 118.86 37.89 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.886 -0.783 . . . . 75.549999999999997 108.886 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.647 HD11 HD12 ' A' ' 233' ' ' LEU . 1.6 pp -130.7 114.83 15.87 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.064 0.764 . . . . 64.099999999999994 113.064 -175.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -69.04 124.44 23.76 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 124.232 1.013 . . . . 75.319999999999993 113.204 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.581 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 65.5 t -73.72 131.62 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 113.573 -1.649 . . . . 72.349999999999994 111.689 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -121.09 139.2 53.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.447 1.499 . . . . 71.519999999999996 108.15 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 35.0 mm -105.04 103.63 15.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.657 -1.238 . . . . 74.319999999999993 107.657 173.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.557 1.247 0 CA-C-O 117.741 -1.123 . . . . 72.019999999999996 108.625 -174.185 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 121.469 0.652 . . . . 73.109999999999999 109.804 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -86.91 148.68 25.25 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.469 -0.787 . . . . 64.430000000000007 111.067 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -67.63 -100.54 0.03 OUTLIER Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.167 -0.773 . . . . 64.219999999999999 111.167 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -130.11 173.6 10.59 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.946 0.499 . . . . 72.510000000000005 109.861 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.619 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 16.1 m95 . . . . . 0 C--O 1.244 0.771 0 CA-C-N 115.152 -0.931 . . . . 62.210000000000001 108.997 168.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 120.946 0.403 . . . . 72.329999999999998 110.839 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.4 mt -135.14 142.48 46.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.478 0.711 . . . . 63.350000000000001 110.408 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -106.77 111.2 23.62 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.144 -1.428 . . . . 74.109999999999999 107.144 165.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.623 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -123.67 -171.33 2.29 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.698 0.799 . . . . 44.039999999999999 110.167 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.1 m -113.64 145.87 40.63 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.483 1.113 . . . . 62.210000000000001 110.434 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.561 HD23 HG22 ' A' ' 253' ' ' VAL . 18.4 tp -113.32 104.94 12.82 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.695 -1.595 . . . . 70.239999999999995 106.695 167.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.58 100.18 9.99 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.704 -0.85 . . . . 74.200000000000003 108.704 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.686 ' HA ' HG11 ' A' ' 210' ' ' VAL . 20.9 t -110.88 103.01 54.05 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.281 -1.007 . . . . 72.420000000000002 108.281 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.05 144.87 77.53 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.522 1.481 . . . . 74.230000000000004 109.876 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.41 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.03 -41.2 78.62 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 117.743 -1.122 . . . . 72.420000000000002 113.08 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.4 Cg_endo -55.28 -46.22 34.33 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.828 1.685 . . . . 71.150000000000006 113.06 173.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.413 HG21 HG13 ' A' ' 210' ' ' VAL . 52.0 mt -69.73 -34.82 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.35 0.66 . . . . 53.340000000000003 110.616 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.13 91.11 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 122.756 0.422 . . . . 72.340000000000003 110.593 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.89 -49.6 62.0 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 O-C-N 124.543 1.152 . . . . 72.420000000000002 111.481 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.7 p -79.0 -23.88 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 122.474 0.31 . . . . 62.240000000000002 110.738 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.51 71.62 1.11 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.466 -0.654 . . . . 75.219999999999999 111.466 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.27 -129.57 6.74 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.765 -0.534 . . . . 64.409999999999997 111.765 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -138.85 144.53 39.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.778 0.831 . . . . 45.030000000000001 109.537 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.0 m -137.02 153.73 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 115.665 -0.698 . . . . 73.239999999999995 110.564 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -74.9 143.51 43.75 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.515 0.726 . . . . 74.400000000000006 110.569 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.572 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -116.04 113.15 22.8 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.146 1.378 . . . . 72.329999999999998 107.946 172.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.5 tpt -64.87 122.88 17.99 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.342 1.057 . . . . 62.420000000000002 111.002 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.521 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -124.09 -171.07 2.25 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.787 1.235 . . . . 75.219999999999999 109.084 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.506 ' H ' HG22 ' A' ' 214' ' ' THR . 7.0 mt -60.27 -67.26 0.41 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.632 1.173 . . . . 72.319999999999993 111.42 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -109.48 -42.53 4.31 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.105 -1.861 . . . . 61.32 110.918 -163.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -131.86 157.42 22.4 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-O 118.916 -0.936 . . . . 75.120000000000005 111.308 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -86.3 143.31 7.63 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.966 1.778 . . . . 73.129999999999995 113.064 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 64.4 t -98.43 167.57 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 114.256 -1.338 . . . . 74.129999999999995 108.038 174.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -143.53 145.46 32.58 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.444 -0.947 . . . . 73.109999999999999 108.444 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.86 141.24 42.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.404 0.681 . . . . 73.420000000000002 110.123 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.84 112.74 10.25 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.565 -0.902 . . . . 72.209999999999994 108.565 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.7 t -73.27 132.46 81.98 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 108.558 -0.905 . . . . 75.109999999999999 108.558 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.6 153.25 76.16 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.667 2.244 . . . . 65.230000000000004 111.525 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -64.57 136.07 48.5 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 121.89 1.727 . . . . 73.129999999999995 111.979 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 53.24 54.11 10.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.469 1.508 . . . . 71.219999999999999 113.275 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.518 HG23 ' HD2' ' A' ' 231' ' ' ARG . 19.4 m -80.02 138.2 36.97 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.92 -0.582 . . . . 64.030000000000001 111.403 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -96.16 160.04 14.64 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.124 0.969 . . . . 55.039999999999999 111.135 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -79.88 156.02 27.52 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.314 -1.312 . . . . 74.549999999999997 110.858 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.64 -18.61 43.77 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 111.958 -0.457 . . . . 65.349999999999994 111.958 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.518 ' HD2' HG23 ' A' ' 227' ' ' THR . 78.0 mtt85 -68.48 178.79 1.87 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.039 0.935 . . . . 52.119999999999997 109.986 167.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.562 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.2 ptmt -167.02 154.94 9.45 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.142 0.276 . . . . 64.109999999999999 110.492 173.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.595 HD12 HD11 ' A' ' 251' ' ' LEU . 82.3 mt -81.66 146.09 30.22 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 108.811 -0.811 . . . . 74.109999999999999 108.811 167.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -116.1 106.99 14.36 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.808 -1.182 . . . . 73.140000000000001 107.808 165.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 249' ' ' LEU . 58.6 mt -107.97 108.44 19.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.788 -1.097 . . . . 73.230000000000004 109.202 -173.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -82.88 121.92 27.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.822 -1.081 . . . . 72.099999999999994 110.337 -170.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.06 9.93 79.44 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 124.307 1.004 . . . . 23.550000000000001 113.894 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.501 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 46.5 mmtm -99.46 6.25 46.0 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.75 0.775 . . . . 71.239999999999995 112.542 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.35 -174.75 50.24 Favored Glycine 0 N--CA 1.472 1.099 0 O-C-N 123.319 0.387 . . . . 73.030000000000001 112.291 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -58.35 142.55 81.53 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 123.857 0.863 . . . . 75.319999999999993 112.993 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.416 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 48.9 Cg_endo -67.23 132.32 27.38 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.301 2.668 . . . . 74.209999999999994 112.791 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.07 -178.37 15.51 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 115.213 -0.903 . . . . 75.219999999999999 112.913 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.15 -25.78 21.98 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 123.101 2.534 . . . . 72.019999999999996 112.686 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.24 22.11 16.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.308 1.043 . . . . 33.329999999999998 111.006 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 98.98 -172.88 26.07 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.142 -0.783 . . . . 51.299999999999997 111.142 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 68.7 mtm180 -85.41 156.93 20.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.899 0.479 . . . . 72.219999999999999 111.722 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.8 -154.86 6.05 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 123.941 0.776 . . . . 70.430000000000007 111.799 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -121.75 166.36 14.44 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.899 0.85 . . . . 73.019999999999996 110.825 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.541 HD23 HD12 ' A' ' 235' ' ' LEU . 46.6 tp -126.78 107.22 9.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.496 0.718 . . . . 71.140000000000001 109.194 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -105.08 111.3 24.02 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.966 -1.124 . . . . 75.329999999999998 107.966 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.8 pp -125.9 120.9 31.64 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.709 1.003 . . . . 74.530000000000001 113.709 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -69.26 123.81 22.16 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.733 1.613 . . . . 74.420000000000002 112.624 -171.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.619 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 90.4 t -71.86 119.23 18.01 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 C-N-CA 124.821 1.249 . . . . 75.420000000000002 111.077 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -113.82 115.41 27.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.626 1.57 . . . . 73.430000000000007 107.883 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.87 96.0 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.868 -1.16 . . . . 74.519999999999996 107.868 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.556 1.202 0 C-N-CA 124.539 1.135 . . . . 43.399999999999999 109.076 -171.91 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.055 0.455 . . . . 71.200000000000003 112.0 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.0 166.8 18.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.781 0.832 . . . . 54.450000000000003 111.713 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.16 -80.96 1.15 Allowed Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.886 -1.052 . . . . 53.149999999999999 111.011 172.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.9 175.27 13.55 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.165 0.586 . . . . 71.439999999999998 111.464 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.519 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 23.7 m95 . . . . . 0 C--O 1.239 0.501 0 CA-C-N 114.846 -1.07 . . . . 61.439999999999998 110.743 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 5.5 p-10 . . . . . 0 C--O 1.235 0.333 0 CA-C-O 120.682 0.277 . . . . 73.349999999999994 110.639 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.47 ' HB2' HD13 ' A' ' 249' ' ' LEU . 84.2 mt -119.3 147.55 44.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.328 0.651 . . . . 72.040000000000006 110.092 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 9.0 t80 -109.31 114.93 29.03 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.882 -1.155 . . . . 74.109999999999999 107.882 171.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -127.42 -173.69 2.98 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.729 0.812 . . . . 75.209999999999994 110.441 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 60.3 m -121.52 137.93 54.52 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.519 0.728 . . . . 73.439999999999998 111.071 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.5 tp -108.1 108.81 20.05 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.973 1.309 . . . . 53.310000000000002 107.69 169.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.04 99.35 12.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.42 0.629 . . . . 75.510000000000005 109.611 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.66 HG22 HG21 ' A' ' 210' ' ' VAL . 15.1 t -101.59 111.03 63.34 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.675 -1.231 . . . . 71.239999999999995 107.675 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.55 154.38 74.56 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.85 1.7 . . . . 74.019999999999996 110.418 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.72 -45.37 79.31 Favored Pre-proline 0 CA--C 1.573 1.847 0 CA-C-O 117.809 -1.091 . . . . 63.520000000000003 113.394 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.79 -48.89 13.05 Favored 'Trans proline' 0 C--N 1.402 3.351 0 C-N-CA 121.828 1.685 . . . . 73.310000000000002 112.484 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.475 HG21 HG13 ' A' ' 210' ' ' VAL . 44.4 mt -68.28 -31.2 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.539 0.736 . . . . 62.299999999999997 110.762 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.81 -46.72 77.59 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.0 0.52 . . . . 71.400000000000006 110.585 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.56 -48.33 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 124.417 1.073 . . . . 73.420000000000002 111.954 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.15 -28.58 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 120.678 0.275 . . . . 74.420000000000002 110.715 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.11 76.46 1.0 Allowed Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.626 -0.589 . . . . 72.140000000000001 111.626 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.5 -129.4 6.68 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-O 120.049 -0.306 . . . . 72.299999999999997 112.817 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.72 135.19 29.57 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.965 0.906 . . . . 73.219999999999999 109.132 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.66 HG21 HG22 ' A' ' 199' ' ' VAL . 31.6 m -134.21 149.3 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.573 0.749 . . . . 73.209999999999994 110.547 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -75.95 150.4 37.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.945 0.898 . . . . 74.239999999999995 110.624 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -122.57 121.58 36.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.838 1.255 . . . . 64.239999999999995 108.442 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.23 123.4 19.01 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.732 0.813 . . . . 74.219999999999999 110.217 176.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.3 OUTLIER -126.47 -171.87 2.5 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.552 1.141 . . . . 72.140000000000001 110.206 -176.344 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.53 -70.34 0.22 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 122.243 1.021 . . . . 72.340000000000003 111.268 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -110.22 -41.59 4.37 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 113.461 -1.7 . . . . 64.230000000000004 110.947 -162.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -132.55 145.86 17.7 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 118.348 -1.251 . . . . 53.439999999999998 110.549 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.82 152.72 64.05 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.125 1.883 . . . . 60.130000000000003 112.628 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 54.1 t -104.09 167.67 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.927 1.291 . . . . 75.310000000000002 108.029 174.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -148.64 146.28 28.13 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 107.815 -1.18 . . . . 75.129999999999995 107.815 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 233' ' ' LEU . 9.6 p -138.5 144.27 30.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 C-N-CA 122.946 0.498 . . . . 61.5 110.8 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.59 112.89 12.41 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 124.035 0.835 . . . . 74.140000000000001 109.675 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.56 134.81 75.71 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.017 0.927 . . . . 41.530000000000001 109.45 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.52 154.34 50.08 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.465 2.11 . . . . 52.439999999999998 111.533 169.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.93 136.97 64.58 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 121.988 1.792 . . . . 72.209999999999994 111.756 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 51.51 70.37 0.55 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.231 1.413 . . . . 75.010000000000005 113.434 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.478 HG23 ' HD2' ' A' ' 231' ' ' ARG . 80.8 m -89.01 143.09 27.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.803 -1.089 . . . . 54.240000000000002 110.655 173.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -107.61 154.85 20.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.294 1.037 . . . . 71.120000000000005 110.35 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.495 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -80.28 150.82 29.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.053 -0.976 . . . . 74.329999999999998 110.823 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.1 -21.3 27.3 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.931 -0.868 . . . . 71.519999999999996 110.931 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.478 ' HD2' HG23 ' A' ' 227' ' ' THR . 72.2 mtt85 -65.34 179.79 0.71 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.09 0.956 . . . . 53.520000000000003 110.525 170.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.729 ' HD3' ' HB3' ' A' ' 250' ' ' TYR . 9.9 ptpt -166.77 159.72 14.03 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.225 0.21 . . . . 74.120000000000005 111.033 171.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.565 HD12 HD11 ' A' ' 251' ' ' LEU . 71.2 mt -87.22 154.16 20.93 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.898 -0.408 . . . . 74.230000000000004 109.898 170.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -117.84 106.75 13.33 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.791 1.307 . . . . 73.450000000000003 108.04 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 44.8 mt -118.13 112.98 20.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.96 -0.564 . . . . 73.129999999999995 110.947 -172.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -90.78 127.4 36.33 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.159 -0.473 . . . . 62.299999999999997 109.935 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 88.23 11.57 66.79 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 123.981 0.8 . . . . 34.530000000000001 112.672 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.515 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.3 mmtt -113.79 -4.93 13.29 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.42 0.688 . . . . 74.329999999999998 111.867 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.72 -176.41 51.43 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.277 -0.729 . . . . 71.120000000000005 111.277 166.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.3 139.96 94.6 Favored Pre-proline 0 N--CA 1.487 1.375 0 CA-C-N 117.718 0.759 . . . . 75.209999999999994 111.405 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.403 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 34.8 Cg_endo -63.26 137.86 63.28 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.838 2.359 . . . . 75.530000000000001 112.516 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.99 169.51 22.89 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.126 -0.488 . . . . 65.310000000000002 113.875 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -71.35 -20.26 27.96 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 123.202 2.601 . . . . 54.219999999999999 112.077 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.1 17.46 15.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.279 1.032 . . . . 41.109999999999999 110.462 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.51 169.35 45.49 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.29 -0.724 . . . . 72.519999999999996 111.29 -170.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 95.5 mtt180 -65.34 158.2 27.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.877 0.871 . . . . 71.230000000000004 111.414 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.47 -164.61 40.46 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.715 -0.675 . . . . 42.229999999999997 112.333 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 8.7 p-10 -110.04 170.99 7.72 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.695 0.76 . . . . 71.439999999999998 110.574 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.66 ' HG ' HD23 ' A' ' 251' ' ' LEU . 33.5 tp -135.02 109.68 8.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.024 -0.989 . . . . 71.0 109.123 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.729 ' HB3' ' HD3' ' A' ' 232' ' ' LYS . 12.3 m-30 -98.29 112.04 24.17 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.37 -1.344 . . . . 63.130000000000003 107.37 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.66 HD23 ' HG ' ' A' ' 249' ' ' LEU . 3.5 pp -124.82 113.52 18.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.673 0.749 . . . . 75.019999999999996 112.863 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.51 119.37 12.2 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.826 1.25 . . . . 64.239999999999995 112.543 -170.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 232' ' ' LYS . 58.5 t -68.07 131.79 33.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 113.858 -1.519 . . . . 73.019999999999996 110.862 174.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -127.35 133.98 50.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.353 1.461 . . . . 74.319999999999993 107.913 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.495 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 34.6 mm -103.36 101.37 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.122 -1.066 . . . . 75.219999999999999 108.122 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.561 1.374 0 CA-C-N 115.045 -0.98 . . . . 37.219999999999999 108.634 -170.429 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 121.451 0.643 . . . . 74.140000000000001 110.102 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.5 178.34 4.71 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.068 0.947 . . . . 71.109999999999999 111.162 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.04 -86.05 1.79 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.059 -1.616 . . . . 74.099999999999994 109.059 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.29 164.89 29.44 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.389 1.076 . . . . 62.409999999999997 109.651 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.647 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.6 m95 . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 108.484 -0.932 . . . . 72.420000000000002 108.484 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 11.4 p-10 . . . . . 0 CA--C 1.542 0.646 0 N-CA-C 110.013 -0.365 . . . . 74.519999999999996 110.013 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.9 mt -124.54 159.01 31.57 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.383 0.611 . . . . 72.219999999999999 111.691 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 8.7 t80 -116.04 109.13 17.1 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.54 -1.209 . . . . 73.349999999999994 108.774 174.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.59 -170.42 1.9 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.502 1.121 . . . . 51.25 109.913 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 98.3 m -117.53 127.77 54.31 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.732 0.813 . . . . 73.310000000000002 110.761 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.648 HD22 ' HG ' ' A' ' 233' ' ' LEU . 17.0 tp -87.84 105.88 17.71 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.866 -1.161 . . . . 43.539999999999999 107.866 165.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -87.1 107.52 18.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.096 -1.076 . . . . 62.43 108.096 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.642 ' HA ' HG11 ' A' ' 210' ' ' VAL . 19.2 t -117.58 115.94 37.12 Favored Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 108.83 -0.804 . . . . 71.109999999999999 108.83 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.01 149.61 77.29 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 121.571 1.514 . . . . 40.130000000000003 110.371 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.441 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.38 -43.96 92.64 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-O 117.75 -1.119 . . . . 62.43 112.571 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.2 Cg_endo -54.42 -52.57 7.91 Favored 'Trans proline' 0 C--N 1.403 3.446 0 C-N-CA 122.291 1.994 . . . . 51.119999999999997 113.077 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.438 HG21 HG13 ' A' ' 210' ' ' VAL . 51.2 mt -64.63 -33.61 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.207 0.603 . . . . 71.230000000000004 111.009 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.48 -46.58 85.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.829 0.452 . . . . 61.530000000000001 110.837 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.86 -50.62 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.004 0.922 . . . . 74.150000000000006 112.316 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.19 -27.01 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-O 120.614 0.245 . . . . 64.299999999999997 110.708 -174.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.96 76.7 0.88 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.021 -0.536 . . . . 54.130000000000003 111.764 -175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.46 -130.23 6.77 Favored Glycine 0 N--CA 1.476 1.346 0 N-CA-C 111.018 -0.833 . . . . 74.540000000000006 111.018 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -133.13 152.91 51.93 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.568 0.747 . . . . 64.430000000000007 110.434 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 199' ' ' VAL . 30.7 m -139.9 149.77 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.323 -0.853 . . . . 64.400000000000006 109.402 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -73.42 152.62 40.73 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.516 -0.765 . . . . 71.510000000000005 110.673 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -130.73 114.27 15.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.147 1.379 . . . . 75.439999999999998 108.635 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 12.8 tpt -63.91 123.8 19.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.696 1.198 . . . . 74.040000000000006 111.435 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.542 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -121.83 -172.82 2.51 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.709 1.203 . . . . 75.299999999999997 109.371 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.521 ' H ' HG22 ' A' ' 214' ' ' THR . 4.8 mt -64.88 -65.96 0.6 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.191 1.396 . . . . 73.530000000000001 110.254 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -93.17 -37.4 12.12 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 112.227 -2.26 . . . . 62.340000000000003 110.155 -166.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -145.49 -162.43 9.64 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.237 -0.892 . . . . 53.140000000000001 112.429 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -100.66 174.73 0.31 Allowed 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 123.145 2.564 . . . . 72.230000000000004 113.936 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 43.7 t -130.49 167.78 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 126.06 1.744 . . . . 62.340000000000003 106.322 172.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -145.68 120.26 9.76 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.388 -0.967 . . . . 64.430000000000007 108.388 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.449 HG11 HD11 ' A' ' 233' ' ' LEU . 15.0 p -112.53 141.37 28.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 123.99 0.916 . . . . 72.230000000000004 110.095 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.06 115.91 15.21 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.538 -0.912 . . . . 42.340000000000003 108.538 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.92 132.53 74.12 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 108.559 -0.904 . . . . 74.409999999999997 108.559 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.73 149.59 78.79 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.939 2.426 . . . . 64.129999999999995 111.536 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -56.64 129.99 37.61 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.374 2.049 . . . . 51.329999999999998 112.572 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 54.58 68.25 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.456 1.502 . . . . 72.420000000000002 113.478 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.403 HG21 ' CH2' ' A' ' 176' ' ' TRP . 54.0 m -95.05 139.27 31.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.901 -1.045 . . . . 70.530000000000001 110.184 172.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -104.07 163.87 12.1 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.453 1.101 . . . . 74.430000000000007 110.765 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.523 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.4 155.73 24.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.336 -1.302 . . . . 72.010000000000005 110.924 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.95 -5.17 57.84 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 111.878 -0.489 . . . . 71.549999999999997 111.878 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -81.38 -174.96 5.23 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.998 0.919 . . . . 74.230000000000004 109.308 168.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.537 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.6 ptpt -165.98 161.99 17.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.08 0.552 . . . . 62.32 109.692 169.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 251' ' ' LEU . 87.0 mt -85.92 150.71 24.32 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.49 -0.93 . . . . 65.5 108.49 164.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -116.94 106.39 13.38 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.876 -1.157 . . . . 75.150000000000006 107.876 160.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 43.3 mt -102.2 104.39 14.97 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.41 -1.268 . . . . 52.32 108.76 -174.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -79.47 118.81 21.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.164 -1.38 . . . . 74.400000000000006 110.295 -167.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.94 9.59 82.34 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.436 1.085 . . . . 54.25 114.044 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.555 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.4 mmtt -96.29 -0.04 50.19 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 118.249 1.024 . . . . 73.510000000000005 112.772 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.53 -177.35 50.46 Favored Glycine 0 N--CA 1.472 1.066 0 N-CA-C 111.716 -0.553 . . . . 75.420000000000002 111.716 170.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -55.46 126.18 62.1 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 123.568 0.747 . . . . 73.25 111.29 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.502 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 35.2 Cg_endo -65.05 134.72 40.82 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.7 2.267 . . . . 73.219999999999999 111.918 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -117.4 177.34 16.58 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.244 -0.889 . . . . 51.5 112.356 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.39 -33.36 23.57 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.824 2.349 . . . . 61.409999999999997 113.073 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.55 -33.62 12.34 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.137 0.575 . . . . 71.349999999999994 111.122 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 177.63 174.86 44.36 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.242 -0.89 . . . . 74.409999999999997 111.163 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.502 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 65.9 mtt180 -88.05 160.56 17.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.233 0.613 . . . . 73.319999999999993 111.47 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.54 -176.38 50.98 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.688 -0.965 . . . . 75.25 110.688 168.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 27.1 m-20 -110.33 -178.99 3.65 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.118 0.567 . . . . 74.299999999999997 110.163 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 55.7 tp -136.38 105.47 5.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.887 0.851 . . . . 55.399999999999999 109.499 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 58.9 m-85 -99.56 108.8 21.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.703 -1.221 . . . . 72.549999999999997 107.703 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.765 HD11 HD12 ' A' ' 233' ' ' LEU . 1.5 pp -125.49 115.0 19.54 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.965 1.098 . . . . 64.530000000000001 113.965 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.65 126.46 29.43 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 113.656 -1.611 . . . . 71.409999999999997 113.1 -170.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.647 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 63.3 t -75.01 124.83 33.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 CA-C-N 113.522 -1.672 . . . . 74.010000000000005 110.622 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -121.04 122.06 39.27 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.817 1.247 . . . . 72.129999999999995 107.788 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.523 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 32.7 mm -92.51 103.73 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.04 -1.096 . . . . 64.319999999999993 108.04 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.562 1.42 0 CA-C-O 117.484 -1.246 . . . . 70.239999999999995 108.751 -169.384 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 CA--C 1.556 1.188 0 CA-C-O 121.31 0.576 . . . . 63.25 111.097 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.17 167.57 20.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.866 0.866 . . . . 61.119999999999997 112.746 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -89.74 -91.53 1.21 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 110.102 -1.199 . . . . 51.520000000000003 110.102 169.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -141.19 170.05 16.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.211 1.004 . . . . 72.299999999999997 110.495 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.626 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 15.3 m95 . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 123.542 0.737 . . . . 63.43 109.946 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 12.2 p-10 . . . . . 0 CA--C 1.547 0.84 0 CA-C-O 122.021 0.915 . . . . 72.400000000000006 108.757 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.2 mt -91.5 170.33 10.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.859 -1.064 . . . . 63.109999999999999 112.981 -168.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 24.8 t80 -124.84 140.32 53.03 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 113.41 -1.723 . . . . 71.400000000000006 107.621 171.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -154.43 -170.91 3.68 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.291 0.637 . . . . 64.200000000000003 110.176 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 254' ' ' ARG . 91.0 m -117.82 138.27 52.19 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.09 0.956 . . . . 72.349999999999994 110.809 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.634 HD23 HG22 ' A' ' 253' ' ' VAL . 17.3 tp -98.55 108.92 21.72 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.727 -1.212 . . . . 64.319999999999993 107.727 166.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -82.73 100.6 10.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.211 -0.662 . . . . 71.420000000000002 109.211 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.673 HG22 HG21 ' A' ' 210' ' ' VAL . 21.5 t -108.11 109.43 61.9 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 108.715 -0.846 . . . . 52.549999999999997 108.715 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.42 145.56 65.51 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.257 1.305 . . . . 72.5 109.597 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.455 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -51.66 -40.53 70.8 Favored Pre-proline 0 CA--C 1.56 1.337 0 N-CA-C 113.979 1.103 . . . . 51.119999999999997 113.979 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.2 Cg_endo -56.16 -48.65 18.44 Favored 'Trans proline' 0 C--N 1.397 3.13 0 C-N-CA 122.037 1.825 . . . . 72.239999999999995 112.751 174.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.483 HG21 HG13 ' A' ' 210' ' ' VAL . 37.4 mt -67.74 -35.15 71.65 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 C-N-CA 122.905 0.482 . . . . 72.319999999999993 110.833 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.409 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -61.21 -46.3 91.02 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.072 0.549 . . . . 64.230000000000004 110.817 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.4 t -71.12 -48.1 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.889 0.876 . . . . 35.140000000000001 112.119 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.43 -23.58 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 120.607 0.241 . . . . 73.530000000000001 110.726 -173.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.26 68.75 1.48 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.759 -0.655 . . . . 34.240000000000002 111.791 -175.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.6 -136.83 9.31 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-O 119.741 -0.477 . . . . 52.039999999999999 112.308 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 5.3 ttmt -129.57 139.41 51.49 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.014 -0.736 . . . . 74.349999999999994 109.014 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.673 HG21 HG22 ' A' ' 199' ' ' VAL . 27.6 m -131.76 146.94 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 122.861 0.464 . . . . 64.140000000000001 110.929 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -74.34 144.35 44.51 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.948 -1.024 . . . . 73.099999999999994 110.297 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.689 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -117.24 122.35 43.73 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.92 1.288 . . . . 74.340000000000003 108.07 172.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.79 119.43 9.94 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.344 0.657 . . . . 60.140000000000001 110.037 175.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.96 -170.41 2.1 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.437 1.095 . . . . 72.510000000000005 109.378 -175.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.99 -70.24 0.25 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.844 0.83 . . . . 63.439999999999998 110.77 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -114.0 -41.29 3.56 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-N 113.719 -1.582 . . . . 61.340000000000003 111.445 -166.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -130.49 129.0 5.72 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-O 118.465 -1.186 . . . . 72.150000000000006 110.513 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.27 152.96 61.84 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.184 1.923 . . . . 74.329999999999998 113.212 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.689 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 55.1 t -97.43 166.39 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.255 -1.339 . . . . 61.240000000000002 108.691 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -149.77 135.1 18.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.614 -0.884 . . . . 71.510000000000005 108.614 172.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 14.3 p -131.11 142.56 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.526 0.73 . . . . 63.219999999999999 110.812 -172.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.1 108.19 5.85 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.93 0.492 . . . . 71.239999999999995 109.721 170.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 204' ' ' ALA . 70.6 t -69.58 134.37 88.54 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.84 0.856 . . . . 71.549999999999997 109.137 172.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.37 154.56 71.69 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.386 2.057 . . . . 70.150000000000006 111.286 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.4 131.18 37.09 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.161 1.907 . . . . 73.0 112.072 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 53.81 69.76 0.68 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.265 1.426 . . . . 74.219999999999999 113.389 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.431 HG23 ' HD2' ' A' ' 231' ' ' ARG . 87.1 m -88.2 142.42 27.77 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.666 -1.152 . . . . 62.229999999999997 110.908 173.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -103.7 164.78 11.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.047 0.939 . . . . 74.140000000000001 110.614 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.468 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -86.87 149.57 24.73 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.196 -0.911 . . . . 73.120000000000005 111.17 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.8 -12.28 32.36 Favored Glycine 0 N--CA 1.473 1.123 0 CA-C-N 115.922 -0.581 . . . . 35.200000000000003 111.965 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.431 ' HD2' HG23 ' A' ' 227' ' ' THR . 62.0 mtt85 -74.4 -175.49 2.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.24 1.016 . . . . 75.349999999999994 110.336 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.536 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.2 ptmt -168.37 165.21 12.85 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 111.752 0.278 . . . . 74.129999999999995 111.752 174.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.677 HD12 HD11 ' A' ' 251' ' ' LEU . 84.5 mt -95.57 150.56 20.2 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 123.514 0.509 . . . . 63.43 109.713 167.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -114.15 107.09 15.16 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.659 -1.237 . . . . 70.409999999999997 107.659 162.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 57.0 mt -106.99 110.75 22.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.317 -0.856 . . . . 72.409999999999997 109.748 -174.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -77.75 118.68 20.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.761 -1.109 . . . . 63.32 110.8 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.35 3.61 89.92 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 114.948 -1.024 . . . . 61.149999999999999 114.386 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -95.27 2.67 54.88 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 112.804 0.668 . . . . 75.430000000000007 112.804 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.42 -173.12 47.62 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.693 -0.963 . . . . 63.340000000000003 110.693 166.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 15.4 m-85 -58.9 134.8 87.11 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 117.737 0.769 . . . . 60.409999999999997 110.759 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.442 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 3.5 Cg_exo -76.96 139.44 19.4 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.575 2.183 . . . . 63.039999999999999 110.763 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -107.36 -167.93 22.0 Favored Glycine 0 C--O 1.238 0.345 0 CA-C-O 119.132 -0.815 . . . . 44.219999999999999 111.73 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.55 -50.44 10.72 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.693 2.262 . . . . 63.229999999999997 112.763 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.63 -25.0 5.61 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.159 0.584 . . . . 64.5 112.225 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -133.82 158.87 23.5 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-O 119.925 -0.375 . . . . 54.219999999999999 112.349 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 92.7 mtt180 -113.32 157.82 21.34 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.606 0.763 . . . . 74.430000000000007 110.763 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.46 175.73 37.77 Favored Glycine 0 N--CA 1.468 0.798 0 CA-C-N 115.528 -0.76 . . . . 53.200000000000003 111.556 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 40.2 m-20 -102.67 176.78 5.05 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.762 -0.459 . . . . 72.439999999999998 109.762 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.6 tp -134.09 108.84 8.55 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.327 0.584 . . . . 70.239999999999995 110.41 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 34.3 m-85 -102.33 103.56 14.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.032 -1.099 . . . . 74.409999999999997 108.032 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 233' ' ' LEU . 2.4 pp -121.38 114.55 21.46 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.837 1.051 . . . . 64.420000000000002 113.837 -172.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.08 118.32 11.84 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.071 -1.422 . . . . 63.420000000000002 113.215 -172.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.634 HG22 HD23 ' A' ' 197' ' ' LEU . 98.2 t -62.36 122.34 12.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 113.73 -1.577 . . . . 55.149999999999999 111.701 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.41 ' HG2' HG23 ' A' ' 196' ' ' THR . 17.3 mmm180 -121.43 122.81 40.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.912 -1.04 . . . . 74.099999999999994 108.236 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.468 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 30.5 mm -88.78 96.55 6.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 108.993 -0.743 . . . . 60.140000000000001 108.993 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.561 1.384 0 C-N-CA 125.077 1.351 . . . . 73.409999999999997 108.819 -175.311 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.493 HG22 HG22 ' A' ' 219' ' ' VAL . 3.6 m . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 108.304 -0.999 . . . . 61.119999999999997 108.304 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.84 174.49 10.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.328 -0.851 . . . . 64.010000000000005 110.914 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.414 ' H ' ' CD2' ' A' ' 235' ' ' LEU . . . -101.97 -85.29 1.86 Allowed Glycine 0 C--N 1.336 0.573 0 N-CA-C 109.323 -1.511 . . . . 52.130000000000003 109.323 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -151.82 174.94 12.96 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.453 0.701 . . . . 73.209999999999994 110.811 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.519 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 18.5 m95 . . . . . 0 CA--C 1.548 0.888 0 CA-C-N 115.239 -0.892 . . . . 75.209999999999994 110.96 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 C--O 1.238 0.473 0 CA-C-O 120.725 0.298 . . . . 72.340000000000003 110.248 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 58.6 mt -107.01 150.75 26.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.951 -0.759 . . . . 51.229999999999997 108.951 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 1.8 t80 -125.86 108.77 11.77 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.19 -1.041 . . . . 61.229999999999997 108.19 173.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.69 -174.86 2.77 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.082 0.953 . . . . 55.219999999999999 109.575 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 85.0 m -126.79 116.02 20.26 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.746 0.818 . . . . 72.530000000000001 109.944 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.545 HD23 HG22 ' A' ' 253' ' ' VAL . 15.7 tp -82.08 105.48 13.21 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.618 -0.882 . . . . 73.140000000000001 108.618 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.56 100.32 12.99 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.774 -0.825 . . . . 72.430000000000007 108.774 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.621 HG22 HG21 ' A' ' 210' ' ' VAL . 21.4 t -102.87 114.76 65.06 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.22 -1.03 . . . . 74.040000000000006 108.22 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.39 145.89 73.01 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 121.515 1.477 . . . . 62.119999999999997 110.342 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.76 -43.41 82.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-O 117.696 -1.145 . . . . 72.540000000000006 112.717 -176.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.2 Cg_endo -54.42 -50.06 14.78 Favored 'Trans proline' 0 C--N 1.398 3.179 0 C-N-CA 121.948 1.765 . . . . 45.310000000000002 112.703 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.455 HG21 HG13 ' A' ' 210' ' ' VAL . 17.3 mt -65.4 -35.65 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.404 0.682 . . . . 74.030000000000001 111.011 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.26 93.8 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.847 0.459 . . . . 43.210000000000001 111.012 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.5 t -70.58 -50.84 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.626 1.17 . . . . 52.420000000000002 111.975 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.41 -15.81 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.852 0.461 . . . . 72.010000000000005 110.671 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 70.79 75.57 0.61 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 111.403 -0.679 . . . . 71.409999999999997 111.403 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.16 -132.82 7.84 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.842 0.321 . . . . 71.450000000000003 112.446 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -142.95 135.42 27.52 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.983 0.913 . . . . 73.239999999999995 109.077 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.621 HG21 HG22 ' A' ' 199' ' ' VAL . 23.3 m -132.74 145.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.182 0.593 . . . . 75.329999999999998 110.18 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -71.01 142.02 50.94 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.413 0.685 . . . . 63.140000000000001 110.758 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -118.35 120.18 36.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.763 1.225 . . . . 72.030000000000001 109.02 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' MET . . . . . 0.401 ' O ' HD21 ' A' ' 249' ' ' LEU . 13.4 tpt -65.32 136.98 57.23 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.053 0.941 . . . . 74.400000000000006 111.77 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.633 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -139.88 -174.26 3.86 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.0 0.92 . . . . 62.420000000000002 110.288 -179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.589 ' H ' HG22 ' A' ' 214' ' ' THR . 10.6 mt -52.95 -68.4 0.17 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.656 1.582 . . . . 60.5 112.683 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -111.65 -41.23 4.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.714 -1.585 . . . . 71.409999999999997 111.352 -165.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -130.94 158.58 22.7 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-O 119.108 -0.829 . . . . 63.539999999999999 112.514 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.25 143.4 8.93 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.567 2.178 . . . . 74.409999999999997 113.416 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 78.0 t -97.22 166.13 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.902 1.281 . . . . 64.120000000000005 108.245 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -147.72 135.65 21.16 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.463 -1.31 . . . . 74.319999999999993 107.463 170.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.512 HG11 HD11 ' A' ' 233' ' ' LEU . 11.3 p -128.46 140.74 48.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 C-N-CA 123.184 0.594 . . . . 74.530000000000001 110.931 -170.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.41 108.82 5.71 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.84 0.856 . . . . 45.119999999999997 109.384 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.404 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 86.5 t -72.33 130.62 85.86 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.89 -0.782 . . . . 72.349999999999994 108.89 174.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.04 155.56 61.47 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.759 2.306 . . . . 74.019999999999996 111.202 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.92 139.52 85.36 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.402 2.068 . . . . 74.5 112.403 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 41.44 73.93 0.12 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.703 1.601 . . . . 63.340000000000003 113.653 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.545 HG23 ' HD2' ' A' ' 231' ' ' ARG . 92.8 m -84.6 139.12 32.31 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.011 -0.995 . . . . 72.430000000000007 110.998 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.51 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 24.8 mp0 -101.75 147.31 26.62 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.208 1.003 . . . . 63.409999999999997 109.175 171.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.431 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -73.26 155.91 39.02 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.129 -0.941 . . . . 50.299999999999997 110.854 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.62 -19.62 30.84 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.63 -0.588 . . . . 75.150000000000006 111.63 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.545 ' HD2' HG23 ' A' ' 227' ' ' THR . 80.5 mtt85 -66.34 177.95 1.34 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.867 0.867 . . . . 74.439999999999998 110.276 167.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.613 ' HA ' HG23 ' A' ' 253' ' ' VAL . 2.2 ptmt -167.62 158.04 10.89 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.218 0.324 . . . . 74.010000000000005 110.653 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.627 HD12 HD11 ' A' ' 251' ' ' LEU . 67.9 mt -86.02 136.41 33.26 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.995 -0.743 . . . . 73.310000000000002 108.995 171.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -103.56 104.77 14.87 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.957 -1.497 . . . . 73.239999999999995 106.957 164.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 48.1 mt -107.88 106.8 17.25 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.411 -0.813 . . . . 74.439999999999998 109.257 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -80.62 116.76 20.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.736 -1.12 . . . . 72.409999999999997 111.076 -168.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 88.37 4.25 77.41 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.79 -0.641 . . . . 64.409999999999997 113.652 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.633 ' HD2' HG21 ' A' ' 214' ' ' THR . 46.2 mmtm -93.93 4.84 53.33 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.846 0.684 . . . . 73.400000000000006 112.846 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.25 -177.48 50.73 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.429 -0.65 . . . . 55.149999999999999 111.554 171.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -60.59 142.78 91.05 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 117.45 0.625 . . . . 74.340000000000003 111.636 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.52 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 38.3 Cg_endo -66.68 139.75 53.91 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.709 2.272 . . . . 74.310000000000002 113.112 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.77 170.91 22.24 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.399 -0.819 . . . . 71.019999999999996 112.548 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.11 -21.01 27.89 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.096 2.531 . . . . 72.310000000000002 113.205 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.4 -11.64 17.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.842 0.857 . . . . 54.030000000000001 111.297 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 141.28 163.66 9.64 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.717 -0.953 . . . . 75.510000000000005 110.717 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.52 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 42.0 mtm180 -69.15 170.66 9.63 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.515 0.726 . . . . 75.209999999999994 111.776 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.74 -164.26 39.9 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 112.089 -0.404 . . . . 32.049999999999997 112.089 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -121.59 152.03 39.72 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.148 -0.686 . . . . 64.519999999999996 109.148 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 23.7 tp -112.19 108.38 17.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.651 0.78 . . . . 73.200000000000003 109.227 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 53.7 m-85 -101.58 119.26 38.5 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.788 -1.19 . . . . 74.299999999999997 107.788 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.3 pp -131.79 115.7 16.29 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.786 0.803 . . . . 72.219999999999999 112.99 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -68.76 118.8 12.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.174 1.39 . . . . 74.109999999999999 112.855 -169.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 232' ' ' LYS . 67.9 t -69.6 127.1 30.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-N 114.156 -1.384 . . . . 73.519999999999996 111.31 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -124.24 130.49 52.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.591 1.556 . . . . 71.340000000000003 108.126 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.431 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 36.3 mm -100.18 98.44 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.336 -0.986 . . . . 74.030000000000001 108.336 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.258 1.526 0 C-N-CA 124.637 1.175 . . . . 75.420000000000002 108.386 -172.407 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 121.691 0.757 . . . . 72.0 110.196 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.61 175.32 6.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.767 -1.106 . . . . 63.119999999999997 111.421 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -105.49 -108.52 3.32 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.183 -0.917 . . . . 74.319999999999993 110.901 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.91 153.09 36.4 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.857 0.863 . . . . 72.409999999999997 109.98 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.52 ' CZ3' HG21 ' A' ' 227' ' ' THR . 23.2 m95 . . . . . 0 N--CA 1.469 0.506 0 CA-C-N 115.715 -0.675 . . . . 52.109999999999999 110.101 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 108.862 -0.792 . . . . 61.009999999999998 108.862 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.0 mt -122.72 139.32 54.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.353 0.661 . . . . 63.43 110.987 -170.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -103.62 133.49 48.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.138 -1.06 . . . . 65.230000000000004 108.138 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -139.15 -172.19 3.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.523 0.729 . . . . 52.240000000000002 110.059 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.4 m -118.08 158.61 24.69 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.126 0.97 . . . . 75.400000000000006 109.919 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.554 HD23 HG22 ' A' ' 253' ' ' VAL . 16.8 tp -126.52 114.47 18.16 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.585 1.554 . . . . 71.040000000000006 107.479 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.47 99.03 12.11 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.066 -0.716 . . . . 75.25 109.066 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.71 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.4 t -109.01 108.96 60.94 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 108.161 -1.051 . . . . 73.219999999999999 108.161 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.427 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 35.9 Cg_endo -66.68 146.14 77.97 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.575 1.517 . . . . 72.420000000000002 110.329 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -46.67 -46.91 50.7 Favored Pre-proline 0 CA--C 1.563 1.453 0 O-C-N 124.198 0.936 . . . . 72.230000000000004 113.258 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 33.4 Cg_exo -57.5 -47.88 19.78 Favored 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 121.645 1.564 . . . . 72.310000000000002 113.679 177.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.6 mt -65.97 -34.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.707 0.403 . . . . 70.519999999999996 110.765 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.35 -43.07 99.68 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.411 0.444 . . . . 75.340000000000003 110.421 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.0 t -73.24 -51.2 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 124.221 0.951 . . . . 50.43 111.919 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.33 -25.97 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 120.822 0.344 . . . . 72.209999999999994 111.02 -172.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.7 75.28 1.13 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.866 -0.606 . . . . 72.200000000000003 112.431 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.99 -135.51 7.66 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 112.176 -0.37 . . . . 75.219999999999999 112.176 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -130.89 150.63 51.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.068 0.947 . . . . 64.230000000000004 110.026 173.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 199' ' ' VAL . 34.8 m -140.59 157.4 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.584 0.754 . . . . 72.420000000000002 110.882 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -79.5 141.26 36.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.116 0.566 . . . . 75.319999999999993 110.944 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.517 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -119.08 118.68 32.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.2 1.4 . . . . 75.519999999999996 108.112 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 12.9 tpt -64.85 132.02 48.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.169 0.587 . . . . 64.439999999999998 111.11 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.438 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -139.86 -169.52 2.74 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.577 1.151 . . . . 61.149999999999999 109.783 -174.218 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.451 ' HB2' ' HG2' ' A' ' 216' ' ' GLU . 4.7 mt -77.33 -66.67 0.8 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.294 1.438 . . . . 61.210000000000001 110.185 -173.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 215' ' ' LEU . 21.6 mm-40 -87.88 -31.0 19.71 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 112.268 -2.242 . . . . 45.32 110.491 -164.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -164.11 -178.85 37.96 Favored Glycine 0 C--N 1.33 0.218 0 CA-C-N 114.964 -1.017 . . . . 62.409999999999997 111.702 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.08 136.6 5.03 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.212 1.941 . . . . 74.430000000000007 112.713 172.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 49.7 t -90.41 162.64 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.402 -1.272 . . . . 72.439999999999998 107.899 173.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -142.51 129.41 20.63 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.14 -1.059 . . . . 74.530000000000001 108.14 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 233' ' ' LEU . 14.9 p -120.69 138.96 49.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 123.552 0.741 . . . . 53.240000000000002 110.855 -174.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.7 102.99 2.93 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.037 0.935 . . . . 65.519999999999996 109.048 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.97 130.73 91.3 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.414 0.686 . . . . 65.5 109.7 176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.95 154.42 56.64 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.796 2.33 . . . . 73.420000000000002 111.827 172.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.91 130.58 29.73 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.131 1.888 . . . . 72.239999999999995 111.202 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 51.54 71.8 0.42 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.62 1.568 . . . . 73.510000000000005 112.577 -177.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.52 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 92.9 m -96.03 139.89 31.56 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.078 -0.965 . . . . 65.129999999999995 110.705 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -99.44 152.21 20.24 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.047 0.939 . . . . 65.109999999999999 110.664 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -75.51 155.46 36.11 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.683 -1.144 . . . . 72.540000000000006 110.391 175.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.68 5.08 61.66 Favored Glycine 0 N--CA 1.471 0.98 0 CA-C-N 115.747 -0.66 . . . . 42.439999999999998 112.576 -174.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.401 ' HD2' HG23 ' A' ' 227' ' ' THR . 67.9 mtt85 -84.36 -175.58 5.85 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.155 0.982 . . . . 70.25 108.589 164.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 253' ' ' VAL . 0.0 OUTLIER -167.46 149.11 5.67 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 110.123 -0.325 . . . . 63.130000000000003 110.123 169.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.725 HD12 HD11 ' A' ' 251' ' ' LEU . 62.4 mt -75.97 139.37 41.51 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.628 -0.508 . . . . 63.409999999999997 109.628 171.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 250' ' ' TYR . 13.1 ptt180 -105.34 105.05 14.91 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.088 -1.078 . . . . 64.450000000000003 108.088 165.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 249' ' ' LEU . 49.1 mt -109.81 110.85 21.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.556 -1.202 . . . . 73.310000000000002 109.56 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -88.25 123.56 32.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.243 -0.89 . . . . 62.43 110.098 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.36 4.51 83.49 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.176 -0.92 . . . . 72.129999999999995 113.601 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -101.01 9.0 42.71 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.789 0.795 . . . . 62.310000000000002 112.414 -176.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.21 -179.03 45.59 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.435 -1.066 . . . . 55.119999999999997 110.435 165.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -56.11 137.79 73.55 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 123.073 0.549 . . . . 64.5 112.177 -172.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.03 140.52 72.73 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.816 2.344 . . . . 53.200000000000003 111.707 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.28 175.0 20.08 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 116.108 -0.496 . . . . 65.409999999999997 113.387 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.41 -34.91 32.94 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 123.425 2.75 . . . . 74.340000000000003 114.001 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.47 -0.84 31.74 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.638 0.375 . . . . 61.109999999999999 111.783 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 144.11 175.97 17.72 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.497 -0.641 . . . . 75.030000000000001 111.497 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -80.91 163.48 23.33 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.425 0.69 . . . . 63.039999999999999 111.967 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.66 -175.05 45.84 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.86 -0.896 . . . . 71.219999999999999 110.86 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -111.62 168.84 9.24 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 117.969 0.884 . . . . 73.030000000000001 110.122 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 235' ' ' LEU . 69.5 tp -134.69 108.94 8.29 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.637 0.775 . . . . 64.129999999999995 109.786 -172.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.409 ' HD2' ' HA ' ' A' ' 234' ' ' ARG . 23.2 m-85 -106.9 109.14 20.97 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.028 -1.101 . . . . 73.150000000000006 108.028 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.725 HD11 HD12 ' A' ' 233' ' ' LEU . 3.7 pp -118.74 121.93 41.26 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.602 0.715 . . . . 60.310000000000002 112.506 -172.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -69.08 130.0 41.5 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 126.501 1.92 . . . . 72.219999999999999 112.571 -169.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 232' ' ' LYS . 84.8 t -81.73 120.58 33.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 122.904 0.482 . . . . 74.25 110.958 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -114.47 120.05 38.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.055 1.342 . . . . 74.340000000000003 108.611 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.42 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 38.6 mm -91.54 100.52 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.116 -1.068 . . . . 62.219999999999999 108.116 173.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.254 1.326 0 C-N-CA 124.816 1.247 . . . . 70.150000000000006 108.598 -173.734 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.482 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 6.6 m . . . . . 0 CA--C 1.553 1.058 0 CA-C-O 121.56 0.695 . . . . 61.420000000000002 109.624 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -104.24 179.77 4.18 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.456 -0.793 . . . . 31.5 111.641 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -102.86 -85.6 1.88 Allowed Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.416 -0.811 . . . . 73.409999999999997 111.999 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.69 158.38 43.89 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.807 0.843 . . . . 71.519999999999996 111.584 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.42 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 30.2 m95 . . . . . 0 CA--C 1.55 0.95 0 C-N-CA 124.413 1.085 . . . . 73.5 110.664 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 121.136 0.493 . . . . 65.150000000000006 111.096 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.432 ' HG ' ' HA2' ' A' ' 239' ' ' GLY . 63.2 mt -128.22 103.14 7.02 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.509 -0.923 . . . . 64.129999999999995 108.509 164.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -83.15 106.49 14.99 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.753 -1.203 . . . . 72.409999999999997 107.753 164.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.27 -173.6 2.6 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.053 0.541 . . . . 73.030000000000001 110.095 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.3 m -119.95 150.82 39.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.646 0.778 . . . . 73.510000000000005 110.009 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.5 tp -113.7 105.68 13.59 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.845 -1.539 . . . . 53.219999999999999 106.845 168.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.55 101.43 12.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.698 -1.223 . . . . 72.329999999999998 107.698 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.622 HG22 HG21 ' A' ' 210' ' ' VAL . 30.9 t -110.83 118.65 47.96 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.197 -1.038 . . . . 71.0 108.197 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.02 149.91 82.69 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 121.654 1.569 . . . . 65.239999999999995 110.166 171.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.95 -41.07 83.55 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 113.061 0.763 . . . . 73.230000000000004 113.061 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 9.4 Cg_endo -54.7 -57.22 1.86 Allowed 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 121.907 1.738 . . . . 53.0 113.71 171.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.84 -31.98 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 123.206 0.602 . . . . 73.25 111.121 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -50.43 68.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.15 -0.477 . . . . 74.109999999999999 110.68 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.52 -48.39 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 124.023 0.827 . . . . 64.109999999999999 111.746 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.77 -32.5 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 117.824 0.284 . . . . 61.210000000000001 111.403 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.33 101.48 0.85 Allowed Glycine 0 C--N 1.343 0.946 0 N-CA-C 111.793 -0.523 . . . . 73.409999999999997 111.793 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.76 -129.49 2.95 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.603 -0.554 . . . . 70.219999999999999 112.24 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -138.33 151.64 47.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.805 0.803 . . . . 73.319999999999993 109.546 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.622 HG21 HG22 ' A' ' 199' ' ' VAL . 22.6 m -145.58 158.01 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.719 0.807 . . . . 70.120000000000005 110.352 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -74.33 154.06 39.05 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.411 1.084 . . . . 72.450000000000003 111.36 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.62 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -132.13 113.93 13.9 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.208 1.003 . . . . 72.340000000000003 108.648 177.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.7 tpt -65.64 131.46 46.41 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.454 0.701 . . . . 70.420000000000002 111.771 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.663 HG21 ' HE3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -130.97 -170.68 2.4 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.708 1.203 . . . . 72.439999999999998 108.586 176.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.444 ' H ' HG22 ' A' ' 214' ' ' THR . 10.5 mt -59.32 -70.14 0.17 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.583 0.706 . . . . 62.240000000000002 111.018 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -111.57 -42.2 3.91 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.019 -1.446 . . . . 75.409999999999997 111.446 -168.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -122.42 120.59 4.36 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 118.854 -0.97 . . . . 41.130000000000003 111.469 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.28 154.85 46.49 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.058 1.839 . . . . 64.439999999999998 112.935 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 39.5 t -101.84 168.71 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.109 1.364 . . . . 75.319999999999993 108.136 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.482 ' H ' ' HB ' ' A' ' 172' ' ' THR . 8.9 tt0 -141.19 134.7 29.91 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.425 -1.324 . . . . 73.239999999999995 107.425 171.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.509 HG11 HD11 ' A' ' 233' ' ' LEU . 14.6 p -131.2 141.46 45.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 122.937 0.495 . . . . 53.130000000000003 110.414 -173.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.03 117.3 15.66 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.395 -0.594 . . . . 44.329999999999998 109.395 173.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.7 t -78.91 128.66 75.89 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 109.407 -0.59 . . . . 73.150000000000006 109.407 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.07 157.32 60.14 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.763 2.309 . . . . 61.310000000000002 111.619 173.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.97 133.5 38.89 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.353 2.035 . . . . 62.439999999999998 112.455 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 54.4 68.72 0.81 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.919 1.688 . . . . 73.319999999999993 113.04 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.472 HG23 ' HD2' ' A' ' 231' ' ' ARG . 75.9 m -89.25 138.33 31.52 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.806 -1.088 . . . . 75.319999999999993 111.264 175.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -103.31 149.66 24.52 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.988 0.915 . . . . 74.010000000000005 110.746 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.87 155.29 40.05 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.227 0.954 . . . . 65.25 110.946 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 101.33 -16.82 56.48 Favored Glycine 0 N--CA 1.476 1.322 0 N-CA-C 111.081 -0.807 . . . . 55.130000000000003 111.081 -174.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.472 ' HD2' HG23 ' A' ' 227' ' ' THR . 65.4 mtt85 -65.87 172.16 3.82 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.108 0.563 . . . . 73.329999999999998 109.834 163.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.536 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.4 ptmt -168.03 151.49 5.93 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.359 0.412 . . . . 73.230000000000004 110.688 174.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.543 HD12 HD11 ' A' ' 251' ' ' LEU . 85.6 mt -83.48 152.85 24.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 110.318 -0.253 . . . . 75.109999999999999 110.318 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -120.93 106.93 12.09 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.751 1.282 . . . . 74.120000000000005 107.957 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.512 HD12 HD23 ' A' ' 249' ' ' LEU . 59.4 mt -117.03 127.99 54.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.764 0.826 . . . . 74.409999999999997 109.673 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . 0.442 ' HD3' ' HB3' ' A' ' 248' ' ' ASP . 32.5 mmtp -101.36 138.75 37.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.692 0.397 . . . . 73.519999999999996 110.126 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.01 13.5 83.3 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 124.279 0.987 . . . . 65.420000000000002 113.167 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.663 ' HE3' HG21 ' A' ' 214' ' ' THR . 27.6 mmmt -108.87 -14.32 14.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.467 0.634 . . . . 73.239999999999995 112.632 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.432 ' HA2' ' HG ' ' A' ' 193' ' ' LEU . . . -74.66 -170.92 26.09 Favored Glycine 0 N--CA 1.478 1.443 0 CA-C-O 119.855 -0.414 . . . . 74.140000000000001 113.349 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -58.56 147.1 71.15 Favored Pre-proline 0 N--CA 1.487 1.425 0 C-N-CA 123.41 0.684 . . . . 64.230000000000004 111.806 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -63.7 137.82 60.88 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.707 2.271 . . . . 74.400000000000006 111.871 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.9 175.13 20.49 Favored Glycine 0 N--CA 1.468 0.828 0 CA-C-N 115.179 -0.919 . . . . 64.099999999999994 113.606 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.76 -28.54 20.31 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 123.149 2.566 . . . . 62.539999999999999 112.285 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.7 23.38 7.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.613 0.765 . . . . 60.130000000000003 110.92 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 117.84 -95.83 0.66 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.482 -0.647 . . . . 74.219999999999999 111.482 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 40.9 mtm-85 -148.53 165.44 31.22 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.571 1.148 . . . . 65.319999999999993 109.683 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -90.86 -155.09 31.17 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.621 0.575 . . . . 55.229999999999997 112.981 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.442 ' HB3' ' HD3' ' A' ' 236' ' ' LYS . 31.9 p30 -127.17 163.51 23.68 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.991 0.9 . . . . 72.329999999999998 112.234 -176.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.662 HD22 HG23 ' A' ' 214' ' ' THR . 12.6 tp -130.32 109.42 10.74 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.027 -1.442 . . . . 43.340000000000003 109.697 -171.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 25.6 m-85 -107.63 110.07 21.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.421 -0.955 . . . . 73.010000000000005 108.421 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.543 HD11 HD12 ' A' ' 233' ' ' LEU . 3.7 pp -120.43 114.78 22.32 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.687 0.625 . . . . 73.310000000000002 112.687 -170.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.0 113.34 6.29 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.67 1.188 . . . . 60.240000000000002 112.706 -171.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.604 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 53.1 t -64.08 127.3 24.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.54 1.136 . . . . 63.350000000000001 110.893 173.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -126.27 129.7 49.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.986 1.314 . . . . 74.030000000000001 108.769 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.9 mm -99.55 107.46 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.33 -0.989 . . . . 74.109999999999999 108.33 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.56 1.337 0 CA-C-N 114.861 -1.063 . . . . 74.129999999999995 109.029 -169.419 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.41 HG22 HG22 ' A' ' 219' ' ' VAL . 18.2 m . . . . . 0 CA--C 1.55 0.975 0 CA-C-O 121.44 0.638 . . . . 62.219999999999999 109.718 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.22 149.39 23.13 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.19 -0.914 . . . . 63.299999999999997 111.139 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -69.79 -89.1 0.09 OUTLIER Glycine 0 C--N 1.347 1.147 0 O-C-N 124.026 0.829 . . . . 64.230000000000004 111.393 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.97 -178.36 5.89 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.896 0.879 . . . . 74.25 110.209 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.531 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 23.5 m95 . . . . . 0 C--O 1.244 0.772 0 CA-C-N 115.549 -0.751 . . . . 62.100000000000001 109.579 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 . . . . . 0 C--O 1.239 0.506 0 CA-C-O 120.63 0.252 . . . . 74.5 110.753 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 79.5 mt -117.01 137.13 52.43 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.054 0.541 . . . . 73.200000000000003 110.3 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -103.38 108.87 20.28 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.952 -1.129 . . . . 65.219999999999999 107.952 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.27 -172.12 2.3 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.412 1.085 . . . . 74.109999999999999 109.243 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' THR . . . . . 0.418 HG23 ' HG2' ' A' ' 254' ' ' ARG . 90.8 m -124.9 139.37 53.9 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.673 0.789 . . . . 71.040000000000006 110.164 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 16.0 tp -97.23 105.84 18.06 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.664 -0.865 . . . . 72.5 108.664 170.144 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -86.77 101.59 13.46 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.999 -0.741 . . . . 72.329999999999998 108.999 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.574 ' HA ' HG11 ' A' ' 210' ' ' VAL . 1.4 p -119.46 113.68 34.93 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.703 0.801 . . . . 65.030000000000001 109.351 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.4 145.7 78.08 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.945 1.763 . . . . 64.549999999999997 111.054 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -44.35 -47.68 25.2 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.334 1.053 . . . . 71.340000000000003 113.625 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.5 -48.09 23.32 Favored 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 121.935 1.757 . . . . 75.319999999999993 113.976 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.502 HG21 HG13 ' A' ' 210' ' ' VAL . 60.5 mt -65.84 -33.74 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 122.938 0.495 . . . . 64.519999999999996 110.471 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.47 93.73 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.914 0.485 . . . . 74.230000000000004 111.16 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.94 -45.88 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.39 1.076 . . . . 74.099999999999994 111.912 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.62 -29.66 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 120.71 0.29 . . . . 73.209999999999994 110.255 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.65 73.21 1.18 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.415 -0.674 . . . . 70.439999999999998 111.415 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.01 -127.2 6.04 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 120.135 -0.258 . . . . 74.209999999999994 112.457 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -143.75 137.59 28.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.647 0.779 . . . . 64.140000000000001 109.752 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.574 HG11 ' HA ' ' A' ' 199' ' ' VAL . 31.5 m -137.29 154.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.833 0.453 . . . . 55.5 111.108 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -76.13 142.93 41.49 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.758 -1.11 . . . . 72.109999999999999 111.192 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -113.97 117.39 31.2 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.917 1.287 . . . . 71.200000000000003 108.283 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.0 tpt -63.82 121.08 13.16 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.057 0.943 . . . . 71.150000000000006 111.498 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.475 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -123.82 -171.25 2.28 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.053 1.341 . . . . 72.030000000000001 109.653 -178.802 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.45 ' H ' HG22 ' A' ' 214' ' ' THR . 9.2 mt -59.58 -69.4 0.21 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.583 1.153 . . . . 73.519999999999996 112.044 -175.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.92 -42.11 3.45 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 113.94 -1.482 . . . . 74.340000000000003 111.445 -166.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -119.33 167.3 13.28 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.283 -0.871 . . . . 63.530000000000001 111.172 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.41 154.81 10.67 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.987 1.792 . . . . 60.240000000000002 113.202 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.653 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 69.5 t -106.3 166.26 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 107.086 -1.45 . . . . 61.119999999999997 107.086 165.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.28 140.2 25.05 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.32 -0.992 . . . . 61.240000000000002 108.32 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.459 HG11 HD11 ' A' ' 233' ' ' LEU . 8.7 p -134.18 142.24 41.54 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 C-N-CA 123.162 0.585 . . . . 53.539999999999999 110.86 -172.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.97 108.23 8.71 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.961 0.904 . . . . 74.019999999999996 109.187 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.459 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 59.5 t -71.54 132.61 85.43 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.132 0.973 . . . . 73.239999999999995 109.279 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -64.02 155.44 64.52 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.794 2.329 . . . . 73.200000000000003 112.483 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.51 130.48 31.89 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.273 1.982 . . . . 61.509999999999998 111.804 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.3 mtp-105 49.7 71.23 0.41 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.514 1.526 . . . . 64.120000000000005 113.266 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.442 HG23 ' HD2' ' A' ' 231' ' ' ARG . 98.7 m -87.45 142.74 27.64 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.884 -1.053 . . . . 65.549999999999997 111.1 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -103.06 154.67 19.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.001 0.92 . . . . 74.409999999999997 110.604 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.529 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -78.72 155.41 29.4 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.452 -1.249 . . . . 71.150000000000006 110.615 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.03 -13.02 52.69 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 111.594 -0.602 . . . . 63.450000000000003 111.594 -173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.442 ' HD2' HG23 ' A' ' 227' ' ' THR . 68.0 mtt85 -70.43 -176.34 1.21 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.04 0.936 . . . . 72.329999999999998 110.55 170.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.608 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 10.3 ptmt -167.57 156.32 9.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.341 0.256 . . . . 72.140000000000001 110.573 171.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.559 HD12 HD11 ' A' ' 251' ' ' LEU . 73.5 mt -87.51 151.58 22.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.509 -0.552 . . . . 63.229999999999997 109.509 168.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -119.85 105.87 11.52 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.335 -1.357 . . . . 73.450000000000003 107.335 168.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 67.6 mt -114.19 117.04 30.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.281 0.633 . . . . 74.439999999999998 110.698 -170.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -84.99 133.36 34.26 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 116.275 -0.42 . . . . 43.119999999999997 111.287 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.27 1.11 89.89 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 114.884 -1.053 . . . . 74.129999999999995 113.77 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 47.6 mmtm -98.02 -0.38 44.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.384 0.674 . . . . 70.420000000000002 112.523 -174.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.86 -172.35 48.36 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 111.18 -0.768 . . . . 71.430000000000007 111.18 167.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -65.17 142.61 98.61 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-N 117.24 0.52 . . . . 75.329999999999998 111.541 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.92 133.7 34.59 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.853 2.368 . . . . 54.43 112.093 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.42 172.92 21.65 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 119.436 -0.647 . . . . 45.509999999999998 113.192 -176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.68 -23.33 26.72 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.097 2.531 . . . . 63.32 112.543 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.71 22.26 8.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.958 0.903 . . . . 74.319999999999993 110.751 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 94.9 -173.36 31.87 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 110.471 -1.052 . . . . 70.120000000000005 110.471 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -84.11 158.35 21.41 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 117.417 0.608 . . . . 73.310000000000002 110.883 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.78 -164.66 38.61 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.502 -0.772 . . . . 64.439999999999998 111.933 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -124.57 164.47 19.75 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.583 0.706 . . . . 64.219999999999999 110.634 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.0 tp -123.01 108.56 13.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.078 -0.964 . . . . 73.420000000000002 108.613 -171.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.608 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 33.3 m-85 -100.53 112.75 25.16 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.091 -1.448 . . . . 73.420000000000002 107.091 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.627 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.6 pp -127.86 115.81 19.18 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.498 0.925 . . . . 74.150000000000006 113.498 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -67.64 117.65 9.86 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.556 -1.202 . . . . 73.040000000000006 112.05 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.599 HG23 ' HA ' ' A' ' 232' ' ' LYS . 95.1 t -68.82 116.73 9.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 125.167 1.387 . . . . 75.140000000000001 111.509 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ARG . . . . . 0.418 ' HG2' HG23 ' A' ' 196' ' ' THR . 24.7 mmt85 -106.65 117.03 32.99 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.355 -1.293 . . . . 64.299999999999997 108.803 170.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.542 HD13 HG13 ' A' ' 199' ' ' VAL . 42.3 mm -79.1 96.28 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 106.529 -1.656 . . . . 51.420000000000002 106.529 168.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.26 1.651 0 CA-C-O 117.31 -1.329 . . . . 60.43 108.64 -174.718 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.57 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 16.8 m . . . . . 0 CA--C 1.556 1.174 0 CA-C-O 121.745 0.783 . . . . 62.420000000000002 110.78 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.54 -176.0 6.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.298 1.039 . . . . 71.400000000000006 113.045 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -106.15 -88.95 2.07 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 114.473 -1.24 . . . . 73.010000000000005 110.269 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -146.98 153.66 40.32 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 112.734 0.642 . . . . 72.409999999999997 112.734 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.454 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 34.3 m95 . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 124.275 1.03 . . . . 74.230000000000004 109.993 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 C--O 1.238 0.496 0 CA-C-O 120.734 0.302 . . . . 73.319999999999993 110.976 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 74.5 mt -120.9 145.33 47.78 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.572 0.749 . . . . 74.310000000000002 110.89 -176.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 31.2 t80 -102.26 132.39 48.24 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.68 0.792 . . . . 72.129999999999995 109.082 172.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -138.05 -171.84 3.12 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.383 0.673 . . . . 71.540000000000006 109.536 173.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 95.8 m -131.04 109.2 10.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.457 0.703 . . . . 72.239999999999995 111.14 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.584 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 16.3 tp -72.88 105.29 4.33 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.171 -1.048 . . . . 63.119999999999997 108.171 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -80.26 99.58 7.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.968 -1.015 . . . . 71.25 108.867 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 210' ' ' VAL . 13.6 t -113.96 106.44 53.41 Favored Pre-proline 0 N--CA 1.472 0.666 0 N-CA-C 108.362 -0.977 . . . . 61.049999999999997 108.362 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.29 152.77 78.78 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.414 1.41 . . . . 72.439999999999998 110.495 174.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.18 -45.86 75.95 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 114.017 1.117 . . . . 24.52 114.017 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.72 -48.2 17.87 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 121.76 1.64 . . . . 72.230000000000004 112.9 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.463 HG21 HG13 ' A' ' 210' ' ' VAL . 50.0 mt -67.75 -33.68 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.332 0.653 . . . . 54.329999999999998 110.973 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.31 87.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.045 -0.525 . . . . 73.439999999999998 110.473 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.05 -47.74 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.415 1.086 . . . . 53.32 111.495 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.99 -32.19 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-O 120.775 0.321 . . . . 64.540000000000006 110.729 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.84 68.58 1.41 Allowed Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.789 -0.642 . . . . 72.519999999999996 112.047 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.91 -123.99 5.33 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 112.523 -0.231 . . . . 75.140000000000001 112.523 -175.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -142.49 143.68 32.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.747 0.819 . . . . 61.210000000000001 109.713 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.721 HG21 HG22 ' A' ' 199' ' ' VAL . 28.8 m -140.79 151.66 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.423 0.689 . . . . 72.340000000000003 111.114 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -78.22 150.22 33.5 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.862 0.865 . . . . 61.219999999999999 111.399 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -130.63 114.21 15.15 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.375 1.47 . . . . 52.200000000000003 109.001 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -64.11 124.03 20.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.653 0.781 . . . . 75.319999999999993 110.781 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 215' ' ' LEU . 0.2 OUTLIER -111.54 -169.66 1.5 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.936 1.294 . . . . 71.0 108.095 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.466 ' H ' HG22 ' A' ' 214' ' ' THR . 7.8 mt -45.81 -70.33 0.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.863 1.265 . . . . 63.219999999999999 112.001 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -113.29 -43.56 3.34 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 113.892 -1.504 . . . . 45.039999999999999 110.84 -168.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -114.9 -179.25 18.72 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 115.646 -0.706 . . . . 52.240000000000002 112.426 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -92.65 164.07 2.81 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.213 1.942 . . . . 52.149999999999999 113.968 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 12.7 t -121.47 168.79 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 106.173 -1.788 . . . . 72.25 106.173 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.57 ' H ' ' HB ' ' A' ' 172' ' ' THR . 13.5 tt0 -148.67 143.28 26.39 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.116 -1.068 . . . . 72.030000000000001 108.116 173.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.409 HG11 HD21 ' A' ' 197' ' ' LEU . 13.3 p -136.35 143.12 36.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 C-N-CA 123.256 0.623 . . . . 75.349999999999994 111.475 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.14 110.29 8.32 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.408 1.083 . . . . 74.329999999999998 109.73 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 79.9 t -77.16 134.92 66.87 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 123.888 0.875 . . . . 54.32 109.852 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.0 155.64 61.5 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.904 2.402 . . . . 54.200000000000003 112.249 169.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.35 132.34 45.88 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.978 2.452 . . . . 73.219999999999999 112.134 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 49.58 73.27 0.25 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.376 1.47 . . . . 72.200000000000003 113.105 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.0 m -89.56 142.26 27.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.504 -1.226 . . . . 52.229999999999997 111.069 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -105.45 158.37 16.71 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.107 0.963 . . . . 70.340000000000003 110.383 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.455 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.26 148.73 28.22 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.22 -1.354 . . . . 64.239999999999995 110.411 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.46 -28.74 8.03 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 110.843 -0.903 . . . . 72.219999999999999 110.843 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.433 ' HD2' HG23 ' A' ' 227' ' ' THR . 75.1 mtt85 -58.92 171.72 0.64 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.078 0.951 . . . . 73.319999999999993 110.645 165.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.467 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.9 ptmt -165.89 149.84 7.98 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.126 0.266 . . . . 73.150000000000006 110.691 172.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.713 HD12 HD11 ' A' ' 251' ' ' LEU . 84.1 mt -79.49 155.64 28.17 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 123.532 0.52 . . . . 74.340000000000003 109.715 171.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -126.58 106.66 9.58 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.405 -1.332 . . . . 74.109999999999999 107.405 169.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 39.4 mt -105.32 112.21 25.23 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.531 -0.759 . . . . 61.310000000000002 110.045 -172.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -77.18 117.44 18.72 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.429 -1.26 . . . . 60.299999999999997 111.0 -171.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 92.55 -4.73 76.67 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.329 1.018 . . . . 72.530000000000001 113.612 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.459 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 33.9 mmtp -95.58 5.62 51.02 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.588 0.755 . . . . 61.130000000000003 112.518 -172.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.95 -178.28 50.04 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 110.81 -0.916 . . . . 45.32 110.81 166.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.48 138.22 96.44 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-N 117.402 0.601 . . . . 65.450000000000003 111.476 -174.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.49 143.62 69.98 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.316 2.677 . . . . 75.5 112.949 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.67 -178.67 15.82 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 115.844 -0.616 . . . . 73.319999999999993 113.61 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.04 -49.76 3.56 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.598 2.865 . . . . 62.130000000000003 113.393 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.28 -34.01 37.3 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 122.92 0.488 . . . . 72.439999999999998 110.989 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.32 179.88 46.14 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 114.766 -1.107 . . . . 52.399999999999999 111.391 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -79.0 168.37 19.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.523 0.729 . . . . 73.439999999999998 110.899 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.21 -167.58 39.93 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.608 -0.724 . . . . 40.049999999999997 112.063 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -119.91 171.0 8.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 122.238 -0.566 . . . . 65.310000000000002 109.873 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 43.8 tp -129.41 108.73 10.51 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.57 0.7 . . . . 65.120000000000005 110.682 -174.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 46.0 m-85 -100.11 110.5 22.78 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.141 -1.059 . . . . 65.010000000000005 108.141 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 233' ' ' LEU . 3.1 pp -125.66 114.99 19.4 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.435 0.636 . . . . 74.230000000000004 112.417 -173.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -70.15 120.29 15.63 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 114.689 -1.141 . . . . 63.420000000000002 113.452 -170.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.584 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 48.4 t -65.1 126.83 24.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 113.89 -1.505 . . . . 65.420000000000002 110.031 174.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -129.67 128.23 42.14 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.045 1.338 . . . . 74.310000000000002 108.975 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.455 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 29.2 mm -95.92 104.4 15.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.183 -1.043 . . . . 74.530000000000001 108.183 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.293 0 CA-C-O 117.386 -1.292 . . . . 62.130000000000003 108.783 -168.878 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 19.1 m . . . . . 0 CA--C 1.554 1.123 0 CA-C-O 120.863 0.363 . . . . 52.340000000000003 111.395 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.79 160.85 14.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.854 0.862 . . . . 74.299999999999997 111.904 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . 0.51 ' H ' HD22 ' A' ' 235' ' ' LEU . . . -73.35 -108.41 0.07 OUTLIER Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.31 -0.859 . . . . 65.340000000000003 111.203 166.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -138.77 176.74 8.44 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.749 0.774 . . . . 42.240000000000002 111.716 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 29.6 m95 . . . . . 0 C--O 1.239 0.527 0 CA-C-N 114.601 -1.181 . . . . 64.219999999999999 110.25 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 110.143 -0.317 . . . . 63.420000000000002 110.143 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.3 mt -119.35 160.62 21.92 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.656 0.782 . . . . 74.299999999999997 110.914 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 4.4 t80 -121.77 108.33 13.37 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.188 -0.671 . . . . 74.040000000000006 109.188 171.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -116.8 -170.85 1.91 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.42 1.088 . . . . 52.25 109.5 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.9 m -119.12 126.04 50.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.985 0.914 . . . . 72.140000000000001 110.429 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.601 ' HB2' HD13 ' A' ' 251' ' ' LEU . 25.2 tp -84.51 104.76 14.79 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 107.769 -1.197 . . . . 54.109999999999999 107.769 166.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -86.95 106.39 17.77 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.165 -0.68 . . . . 74.329999999999998 109.165 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.652 HG22 HG21 ' A' ' 210' ' ' VAL . 21.7 t -114.13 120.76 37.92 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.65 -0.87 . . . . 71.439999999999998 108.65 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.89 150.61 61.63 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 121.77 1.646 . . . . 52.119999999999997 110.217 170.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.67 -45.24 96.6 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 117.808 -1.091 . . . . 64.109999999999999 112.834 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.2 Cg_endo -56.26 -50.36 12.33 Favored 'Trans proline' 0 C--N 1.401 3.294 0 C-N-CA 122.077 1.851 . . . . 60.109999999999999 112.87 177.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.449 HG21 HG13 ' A' ' 210' ' ' VAL . 28.1 mt -64.74 -34.49 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.41 0.684 . . . . 74.400000000000006 110.626 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.61 95.65 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.072 -0.513 . . . . 44.030000000000001 111.137 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.4 t -73.92 -49.78 32.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 123.982 0.913 . . . . 70.5 111.844 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.2 -28.45 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.373 0.269 . . . . 74.299999999999997 110.878 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.15 77.79 1.18 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.993 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.01 -137.28 8.2 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.725 -0.486 . . . . 64.219999999999999 112.0 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -133.77 139.84 46.58 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.801 0.8 . . . . 73.209999999999994 109.806 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.652 HG21 HG22 ' A' ' 199' ' ' VAL . 35.6 m -133.4 153.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.229 0.612 . . . . 53.520000000000003 111.064 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.428 ' HG2' ' N ' ' A' ' 212' ' ' ALA . 22.9 ttm180 -75.73 154.54 36.34 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.905 0.882 . . . . 73.25 110.716 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -132.23 120.76 22.63 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.521 1.528 . . . . 64.319999999999993 108.383 176.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.06 132.23 48.65 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.766 0.827 . . . . 74.099999999999994 110.467 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.661 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -136.14 -172.72 3.2 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.663 0.785 . . . . 54.539999999999999 110.162 -175.129 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.618 ' H ' HG22 ' A' ' 214' ' ' THR . 6.4 mt -63.78 -67.41 0.43 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.298 1.439 . . . . 73.120000000000005 110.671 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -103.74 -41.55 5.89 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 113.322 -1.763 . . . . 73.340000000000003 111.554 -162.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -150.7 154.02 25.36 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.046 -0.863 . . . . 61.340000000000003 111.76 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.16 142.0 30.11 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.603 2.202 . . . . 70.129999999999995 113.55 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 73.1 t -95.62 163.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 114.471 -1.241 . . . . 63.229999999999997 108.286 175.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -142.81 136.92 29.29 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.371 -1.344 . . . . 74.319999999999993 107.371 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.457 HG11 HD11 ' A' ' 233' ' ' LEU . 12.3 p -132.26 140.38 47.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.481 0.712 . . . . 64.25 110.688 -172.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.31 109.42 9.99 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.063 0.945 . . . . 75.340000000000003 109.323 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.1 t -73.73 131.02 82.52 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.212 1.005 . . . . 63.549999999999997 109.388 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.88 155.2 58.16 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.433 2.089 . . . . 52.340000000000003 111.05 171.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.55 136.23 53.33 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.314 2.009 . . . . 61.219999999999999 112.7 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 51.66 69.25 0.68 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.646 1.579 . . . . 73.439999999999998 112.706 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.443 HG23 ' HD2' ' A' ' 231' ' ' ARG . 69.8 m -85.03 141.08 30.54 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.85 -1.068 . . . . 72.519999999999996 110.613 174.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -102.16 155.63 18.08 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.78 0.832 . . . . 54.200000000000003 110.1 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.495 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -83.91 154.83 23.18 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.652 -1.158 . . . . 62.210000000000001 111.212 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.88 -6.78 57.06 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.935 -0.575 . . . . 51.549999999999997 111.933 -173.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.443 ' HD2' HG23 ' A' ' 227' ' ' THR . 65.9 mtt85 -72.09 179.47 3.28 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.916 0.886 . . . . 71.430000000000007 109.722 168.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.462 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.2 ptpt -168.27 150.94 5.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.882 0.473 . . . . 62.119999999999997 110.464 169.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.489 ' HG ' HD22 ' A' ' 197' ' ' LEU . 56.9 mt -85.18 156.03 21.18 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.751 -0.833 . . . . 65.239999999999995 108.751 169.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -115.32 123.74 49.51 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 106.459 -1.682 . . . . 53.229999999999997 106.459 157.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.659 HD12 HD23 ' A' ' 249' ' ' LEU . 46.5 mt -112.21 108.18 17.33 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.898 -0.779 . . . . 72.310000000000002 108.898 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -70.41 113.2 7.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.136 -1.393 . . . . 74.450000000000003 111.443 -170.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 91.74 -5.88 79.71 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.248 -0.887 . . . . 52.240000000000002 113.771 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.661 ' HD2' HG21 ' A' ' 214' ' ' THR . 48.4 mmtm -86.87 10.08 17.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.405 0.682 . . . . 72.129999999999995 112.213 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.16 169.56 24.07 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.786 -1.326 . . . . 74.019999999999996 109.786 164.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 41.4 m-85 -57.22 139.51 79.57 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 123.363 0.665 . . . . 52.140000000000001 112.129 -173.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 11.7 Cg_exo -69.6 150.04 68.69 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.907 2.405 . . . . 54.340000000000003 113.076 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.68 171.95 21.8 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.801 -0.999 . . . . 54.32 111.018 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -61.66 -48.22 9.57 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.988 2.459 . . . . 74.230000000000004 113.393 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.57 -19.07 28.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.287 0.635 . . . . 64.239999999999995 111.863 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 171.31 169.43 34.24 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.944 -0.462 . . . . 72.109999999999999 111.944 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -85.51 170.22 12.84 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.788 0.835 . . . . 64.430000000000007 110.864 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.95 179.95 48.73 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.299 -0.864 . . . . 53.539999999999999 111.224 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -122.69 153.16 39.78 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.578 -0.527 . . . . 75.530000000000001 109.578 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.659 HD23 HD12 ' A' ' 235' ' ' LEU . 48.8 tp -106.2 106.75 17.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.352 -0.61 . . . . 73.329999999999998 109.352 -172.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 48.8 m-85 -98.98 109.12 21.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.998 -1.482 . . . . 74.140000000000001 106.998 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.647 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -126.55 117.49 22.93 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.95 1.092 . . . . 64.140000000000001 113.95 -177.198 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.86 118.78 10.18 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 113.133 -1.849 . . . . 51.299999999999997 112.518 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.543 HG22 HD23 ' A' ' 197' ' ' LEU . 52.3 t -69.68 109.49 2.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 114.329 -1.305 . . . . 71.219999999999999 110.68 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -100.25 118.17 35.98 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.53 1.132 . . . . 74.340000000000003 108.824 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.495 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 39.8 mm -87.26 107.94 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.462 -1.31 . . . . 53.049999999999997 107.462 170.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.329 0 C-N-CA 124.301 1.04 . . . . 44.409999999999997 108.258 -174.096 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.401 HG22 HG22 ' A' ' 219' ' ' VAL . 17.0 m . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 121.315 0.578 . . . . 75.310000000000002 110.633 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.9 -168.79 0.95 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.861 0.865 . . . . 52.039999999999999 112.59 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.07 -87.52 1.03 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 110.194 -1.163 . . . . 63.399999999999999 110.194 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.27 174.51 10.47 Favored 'General case' 0 C--O 1.248 0.98 0 C-N-CA 123.477 0.711 . . . . 64.549999999999997 109.917 172.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.526 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 19.1 m95 . . . . . 0 C--O 1.243 0.751 0 CA-C-N 115.313 -0.858 . . . . 73.140000000000001 109.744 167.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 109.692 -0.484 . . . . 63.210000000000001 109.692 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 80.5 mt -129.0 166.52 19.05 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.424 0.63 . . . . 71.310000000000002 111.747 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 25.4 t80 -120.26 139.37 52.81 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.612 -1.176 . . . . 73.329999999999998 109.267 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -151.72 -170.44 3.65 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.003 0.921 . . . . 72.230000000000004 109.819 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.4 m -119.72 140.99 49.83 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.695 0.798 . . . . 64.430000000000007 110.964 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.536 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 19.5 tp -100.48 108.23 20.14 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.105 0.962 . . . . 73.340000000000003 108.413 168.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -83.46 100.1 10.52 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.26 -0.645 . . . . 73.409999999999997 109.26 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.652 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.7 t -108.39 115.17 58.42 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 108.334 -0.987 . . . . 54.219999999999999 108.334 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.81 145.0 49.94 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 121.571 1.514 . . . . 43.009999999999998 110.6 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.27 -47.91 56.35 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 114.252 1.204 . . . . 42.229999999999997 114.252 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.79 -45.85 33.64 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 122.235 1.957 . . . . 73.510000000000005 113.768 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.2 mt -65.87 -34.92 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.942 0.497 . . . . 72.329999999999998 110.535 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.13 -44.39 92.33 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.07 -0.514 . . . . 72.299999999999997 111.385 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.3 t -71.03 -46.4 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.99 0.916 . . . . 72.200000000000003 112.028 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.03 -28.33 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 120.561 0.219 . . . . 73.099999999999994 110.623 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.89 72.3 1.23 Allowed Glycine 0 C--N 1.346 1.084 0 N-CA-C 111.233 -0.747 . . . . 62.409999999999997 111.233 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.7 -126.59 5.74 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 112.33 -0.308 . . . . 53.229999999999997 112.33 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -142.33 148.02 37.27 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.266 1.027 . . . . 74.439999999999998 108.849 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.8 m -142.43 158.89 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 123.134 0.573 . . . . 73.519999999999996 110.69 174.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -75.8 151.11 37.59 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.776 0.83 . . . . 75.340000000000003 110.18 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -128.2 114.59 17.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 73.340000000000003 108.576 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.6 tpt -64.51 109.58 2.01 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.129 0.572 . . . . 73.439999999999998 110.933 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.553 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -93.45 -169.1 2.04 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.247 1.419 . . . . 62.100000000000001 108.933 175.174 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.55 -69.16 0.12 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.464 1.126 . . . . 64.010000000000005 110.581 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.76 -42.52 3.41 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 112.793 -2.003 . . . . 72.319999999999993 110.746 -170.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -101.77 176.78 26.38 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.507 -0.769 . . . . 64.120000000000005 112.607 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -102.4 145.94 0.22 Allowed 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 122.882 2.388 . . . . 61.439999999999998 114.234 168.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.553 HG23 ' OG1' ' A' ' 214' ' ' THR . 50.2 t -104.06 168.79 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.158 1.383 . . . . 55.439999999999998 108.055 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -142.04 139.23 32.27 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.094 -1.076 . . . . 71.540000000000006 108.094 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.54 HG11 HD11 ' A' ' 233' ' ' LEU . 12.7 p -134.25 144.64 34.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 123.627 0.771 . . . . 62.340000000000003 110.153 -173.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.04 113.12 19.02 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.421 0.688 . . . . 62.0 109.373 174.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 89.8 t -76.77 132.14 72.3 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.707 0.803 . . . . 71.120000000000005 109.512 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.83 161.34 44.36 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.803 2.335 . . . . 72.519999999999996 112.376 171.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.37 131.9 22.78 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.135 1.89 . . . . 74.450000000000003 112.315 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 52.79 72.21 0.43 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.998 1.319 . . . . 75.540000000000006 112.63 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 97.3 m -91.51 143.59 26.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.636 -1.166 . . . . 41.130000000000003 110.915 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -108.51 160.49 15.86 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.264 1.025 . . . . 72.120000000000005 110.635 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.528 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -80.07 155.17 27.66 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.991 -1.004 . . . . 65.420000000000002 111.264 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.6 -20.95 35.79 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 112.141 -0.384 . . . . 62.009999999999998 112.141 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -65.68 178.11 1.09 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.11 0.964 . . . . 72.25 110.551 167.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.574 ' HA ' HG23 ' A' ' 253' ' ' VAL . 12.4 ptmt -167.13 153.95 8.54 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 116.703 -0.226 . . . . 74.129999999999995 110.955 173.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.706 HD12 HD11 ' A' ' 251' ' ' LEU . 75.2 mt -84.23 152.03 24.45 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.862 -0.422 . . . . 71.510000000000005 109.862 170.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -117.8 107.18 13.83 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.354 -1.35 . . . . 73.129999999999995 107.354 161.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 65.4 mt -102.97 107.92 18.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.085 -0.961 . . . . 74.340000000000003 109.725 -173.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -78.61 120.7 23.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.635 -1.166 . . . . 74.129999999999995 111.426 -165.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.91 18.98 80.14 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.502 1.126 . . . . 74.239999999999995 113.761 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.44 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 43.4 mmtm -105.09 3.34 30.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.047 0.539 . . . . 73.439999999999998 111.842 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -83.75 -172.57 48.99 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 111.087 -0.805 . . . . 74.109999999999999 111.087 168.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 10.2 m-85 -62.04 137.0 95.49 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 117.213 0.506 . . . . 71.209999999999994 111.802 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.55 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 15.0 Cg_exo -69.64 143.72 52.37 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.038 2.492 . . . . 62.240000000000002 112.257 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.57 173.33 20.9 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.109 -0.95 . . . . 73.340000000000003 112.12 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.83 -14.29 26.74 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 123.106 2.537 . . . . 73.120000000000005 113.415 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.61 -17.94 12.91 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.837 0.855 . . . . 51.25 111.957 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 162.46 -162.13 34.16 Favored Glycine 0 C--O 1.221 -0.719 0 N-CA-C 109.52 -1.432 . . . . 61.119999999999997 109.52 -173.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.55 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 99.0 mtt180 -115.61 160.37 20.09 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 118.511 1.156 . . . . 71.430000000000007 110.67 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 177.28 54.34 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.348 -0.842 . . . . 55.109999999999999 111.765 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -119.31 143.14 47.53 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.367 0.603 . . . . 75.140000000000001 109.72 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 51.7 tp -102.4 108.04 19.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.438 -0.801 . . . . 74.099999999999994 110.006 -168.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 53.6 m-85 -100.58 106.6 18.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.916 -1.038 . . . . 75.409999999999997 108.776 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.706 HD11 HD12 ' A' ' 233' ' ' LEU . 1.8 pp -124.47 118.57 26.93 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.58 0.955 . . . . 25.41 113.58 -174.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.77 116.13 8.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.405 1.482 . . . . 72.340000000000003 112.488 -172.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 232' ' ' LYS . 59.4 t -64.24 118.85 7.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-N 114.092 -1.413 . . . . 75.430000000000007 111.081 175.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -114.32 117.51 31.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.431 1.492 . . . . 71.219999999999999 108.576 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.528 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 36.6 mm -87.82 106.75 16.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.088 -1.079 . . . . 45.420000000000002 108.088 172.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.259 1.581 0 C-N-CA 124.615 1.166 . . . . 64.140000000000001 108.131 -171.833 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.7 m . . . . . 0 CA--C 1.548 0.892 0 CA-C-O 121.78 0.8 . . . . 62.25 108.904 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -91.86 164.03 13.82 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.013 -0.994 . . . . 72.340000000000003 110.871 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -99.08 -88.82 1.97 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 111.34 -0.704 . . . . 51.030000000000001 111.34 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.23 159.67 41.77 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.114 0.966 . . . . 72.049999999999997 110.232 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.545 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.0 m95 . . . . . 0 CA--C 1.544 0.728 0 CA-C-N 115.473 -0.785 . . . . 64.019999999999996 109.201 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 C--O 1.239 0.543 0 N-CA-C 110.097 -0.335 . . . . 71.340000000000003 110.097 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.5 mt -121.2 146.05 47.19 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.917 0.487 . . . . 75.129999999999995 111.762 -171.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -99.56 111.0 23.4 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.005 -0.998 . . . . 74.219999999999999 108.487 171.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.39 -170.45 1.98 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.416 1.086 . . . . 74.140000000000001 109.752 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.3 m -120.87 138.92 53.84 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 124.274 1.03 . . . . 74.0 111.07 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.8 tp -94.56 107.0 19.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.2 -1.037 . . . . 64.439999999999998 108.2 168.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 210' ' ' VAL . 14.3 t70 -80.52 109.08 14.7 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.983 -0.747 . . . . 61.399999999999999 108.983 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 255' ' ' ILE . 0.9 OUTLIER -132.23 118.36 16.12 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 122.68 0.392 . . . . 74.049999999999997 110.191 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 53.9 Cg_endo -70.62 148.08 58.73 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.982 1.788 . . . . 50.32 111.373 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.37 -45.6 83.82 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.495 1.118 . . . . 74.310000000000002 113.945 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.9 Cg_exo -56.07 -47.48 24.45 Favored 'Trans proline' 0 C--N 1.396 3.052 0 C-N-CA 122.065 1.844 . . . . 55.420000000000002 113.034 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.41 HG21 HG13 ' A' ' 210' ' ' VAL . 25.8 mt -64.57 -37.33 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.406 0.682 . . . . 72.310000000000002 110.717 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.81 -43.74 97.79 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.045 0.538 . . . . 53.130000000000003 110.867 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.3 -48.69 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.405 1.082 . . . . 74.239999999999995 112.031 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.5 p -79.48 -32.09 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 117.955 0.343 . . . . 73.140000000000001 111.192 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.86 106.17 1.35 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.474 -0.65 . . . . 33.310000000000002 111.474 -171.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.48 -138.13 3.6 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 119.518 -0.601 . . . . 72.329999999999998 111.883 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -138.98 137.3 36.25 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.693 0.797 . . . . 74.540000000000006 109.402 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.502 HG21 ' HB ' ' A' ' 199' ' ' VAL . 24.3 m -137.54 153.3 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.92 0.488 . . . . 33.100000000000001 111.19 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -76.91 139.05 40.08 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.559 -0.746 . . . . 61.299999999999997 111.132 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.561 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -111.76 111.43 22.4 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.154 -1.425 . . . . 73.0 107.154 170.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -69.13 114.12 7.12 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.071 0.548 . . . . 61.43 109.888 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.562 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -108.38 -173.12 2.2 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.311 1.044 . . . . 73.409999999999997 109.432 178.683 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.519 ' H ' HG22 ' A' ' 214' ' ' THR . 7.3 mt -56.42 -69.06 0.16 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.505 1.522 . . . . 74.150000000000006 111.7 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.83 -43.59 3.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 113.67 -1.605 . . . . 73.239999999999995 110.843 -168.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -123.9 133.65 8.9 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.545 -1.141 . . . . 65.340000000000003 111.132 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.49 150.65 58.1 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.342 2.028 . . . . 75.140000000000001 112.57 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 53.2 t -104.31 168.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.121 1.368 . . . . 75.450000000000003 107.856 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -148.64 135.23 19.67 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.438 -0.949 . . . . 75.439999999999998 108.438 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.434 HG21 HD21 ' A' ' 233' ' ' LEU . 11.8 p -126.56 139.34 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.509 0.724 . . . . 71.340000000000003 110.6 -173.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.02 104.35 3.53 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.522 -0.763 . . . . 64.530000000000001 109.076 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.43 123.99 90.22 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.141 -0.936 . . . . 74.120000000000005 108.789 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.03 158.67 42.36 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.773 2.316 . . . . 71.5 111.552 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.45 142.44 90.55 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.222 1.948 . . . . 70.400000000000006 111.932 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 46.67 64.9 1.35 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.8 1.64 . . . . 75.329999999999998 113.545 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.464 HG23 ' HD2' ' A' ' 231' ' ' ARG . 90.9 m -93.87 137.98 32.51 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.532 -1.213 . . . . 72.099999999999994 110.501 175.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.464 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 25.9 mp0 -104.25 163.58 12.32 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.854 0.862 . . . . 60.219999999999999 110.24 175.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.538 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -84.27 154.84 22.74 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.29 -1.323 . . . . 52.43 111.002 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.62 -15.59 49.08 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 123.459 0.474 . . . . 71.219999999999999 111.93 -172.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.464 ' HD2' HG23 ' A' ' 227' ' ' THR . 81.1 mtt85 -68.57 -179.35 1.35 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.974 0.909 . . . . 64.340000000000003 109.553 164.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.484 ' HA ' HG23 ' A' ' 253' ' ' VAL . 4.8 ptmt -169.24 147.74 3.81 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 119.288 -0.387 . . . . 75.549999999999997 110.323 176.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.601 HD12 HD11 ' A' ' 251' ' ' LEU . 88.7 mt -79.34 152.79 30.25 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.671 -0.492 . . . . 73.140000000000001 109.671 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -115.88 113.42 23.31 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 107.156 -1.424 . . . . 75.239999999999995 107.156 160.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 57.3 mt -113.3 109.96 19.59 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.908 -0.775 . . . . 74.400000000000006 108.908 -177.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -86.91 117.08 25.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.316 -0.856 . . . . 74.150000000000006 110.879 -167.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 89.83 10.84 64.38 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.197 0.936 . . . . 44.43 113.598 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 39.1 mmtm -98.54 -5.01 32.96 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.814 1.042 . . . . 74.219999999999999 113.814 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -83.49 -172.23 48.53 Favored Glycine 0 N--CA 1.479 1.505 0 CA-C-O 119.79 -0.45 . . . . 73.109999999999999 112.586 171.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -56.89 133.48 79.5 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.458 0.703 . . . . 73.019999999999996 111.964 -175.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.13 145.37 72.81 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.988 2.458 . . . . 72.239999999999995 111.944 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.4 177.08 19.04 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.971 -0.559 . . . . 72.319999999999993 112.899 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.09 -26.32 18.31 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 123.213 2.608 . . . . 73.25 113.41 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.73 -30.87 14.66 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.518 0.727 . . . . 74.019999999999996 111.699 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.07 -132.03 1.59 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 111.214 -0.755 . . . . 70.099999999999994 111.214 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -140.22 147.03 39.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.786 1.235 . . . . 70.230000000000004 108.784 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.93 177.31 42.13 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.897 0.748 . . . . 75.299999999999997 111.585 174.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -108.12 -177.64 3.39 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.144 0.577 . . . . 75.129999999999995 110.424 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.1 tp -141.3 106.21 4.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.514 0.673 . . . . 63.020000000000003 110.454 -176.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 38.3 m-85 -103.6 111.71 24.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.784 -1.561 . . . . 73.439999999999998 106.784 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.9 pp -124.08 118.06 26.08 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.57 0.952 . . . . 71.310000000000002 113.57 -173.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.61 119.24 12.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.751 1.62 . . . . 64.549999999999997 112.002 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.545 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 97.9 t -67.74 122.83 19.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 125.125 1.37 . . . . 74.530000000000001 111.073 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -118.67 111.54 18.65 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.2 1.4 . . . . 73.340000000000003 108.652 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.538 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 24.1 mm -81.84 96.81 3.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 107.586 -1.264 . . . . 60.119999999999997 107.586 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.252 1.228 0 C-N-CA 124.922 1.289 . . . . 64.099999999999994 108.451 -178.088 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.05 0.453 . . . . 54.299999999999997 111.942 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.02 158.22 26.57 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.5 0.72 . . . . 70.010000000000005 112.073 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.92 -82.4 0.85 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 110.609 -0.997 . . . . 54.399999999999999 110.609 170.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.45 170.6 22.06 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.435 0.694 . . . . 74.349999999999994 111.147 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.614 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 48.2 m95 . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 107.827 -1.175 . . . . 75.5 107.827 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 5.9 p-10 . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 120.816 0.341 . . . . 65.010000000000005 110.315 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.1 mt -113.5 164.36 13.73 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.436 0.636 . . . . 71.230000000000004 112.648 -164.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -114.49 125.53 53.92 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.611 -1.177 . . . . 74.299999999999997 108.523 167.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -135.66 -171.53 2.87 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.977 0.911 . . . . 70.400000000000006 109.467 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.1 m -117.93 138.49 52.11 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.945 0.898 . . . . 54.399999999999999 110.494 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.613 ' HB2' HD13 ' A' ' 251' ' ' LEU . 21.8 tp -93.74 128.82 40.16 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.06 -1.089 . . . . 13.24 108.06 165.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.08 100.37 11.69 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.611 -0.514 . . . . 73.230000000000004 109.611 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.634 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.9 t -111.1 108.81 57.26 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 108.444 -0.947 . . . . 74.439999999999998 108.444 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.17 144.57 63.5 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 121.491 1.461 . . . . 74.349999999999994 110.082 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.16 -45.9 65.48 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 114.083 1.142 . . . . 73.439999999999998 114.083 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.08 -47.16 24.15 Favored 'Trans proline' 0 C--N 1.392 2.851 0 C-N-CA 122.104 1.869 . . . . 62.299999999999997 113.744 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.2 mt -64.19 -36.96 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 122.736 0.414 . . . . 74.150000000000006 110.567 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.37 94.43 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.951 0.501 . . . . 43.409999999999997 111.088 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.0 t -72.3 -50.69 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 124.32 1.013 . . . . 74.540000000000006 112.097 -175.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.78 -21.54 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-O 120.851 0.358 . . . . 42.340000000000003 110.899 -176.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.36 84.87 0.53 Allowed Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.996 -0.547 . . . . 72.049999999999997 112.1 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.94 -136.82 5.99 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.839 -0.504 . . . . 64.209999999999994 111.839 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -127.54 151.33 49.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.862 0.865 . . . . 61.210000000000001 109.212 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.634 HG11 ' HA ' ' A' ' 199' ' ' VAL . 28.3 m -140.36 150.18 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.294 0.638 . . . . 73.230000000000004 110.31 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -77.24 138.89 39.68 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 123.621 0.575 . . . . 72.310000000000002 110.426 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.645 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -109.26 114.71 28.63 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.748 -1.575 . . . . 65.099999999999994 106.748 171.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.0 tpt -64.69 126.12 26.91 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.035 0.534 . . . . 62.43 109.691 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.98 -168.98 2.08 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.687 1.195 . . . . 71.140000000000001 109.74 -172.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.4 mt -82.22 -68.73 0.67 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.141 0.972 . . . . 72.25 109.904 -171.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -98.24 -40.78 8.19 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 112.972 -1.922 . . . . 74.230000000000004 109.845 -165.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -145.34 134.29 5.45 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-O 118.448 -1.196 . . . . 62.32 110.242 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.0 144.21 52.01 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.764 2.31 . . . . 75.420000000000002 112.345 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 55.3 t -96.79 168.5 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 125.231 1.413 . . . . 63.140000000000001 108.994 -177.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -148.26 127.92 13.32 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.869 -0.789 . . . . 74.109999999999999 108.869 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.6 p -118.13 143.3 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.472 0.709 . . . . 52.5 109.892 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.46 108.64 7.36 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.853 -0.795 . . . . 73.510000000000005 108.853 170.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.497 ' HA ' ' HZ2' ' A' ' 176' ' ' TRP . 71.1 t -73.61 128.33 87.21 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.737 0.815 . . . . 61.310000000000002 109.821 173.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.62 157.47 60.56 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.704 2.269 . . . . 73.420000000000002 111.411 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.18 134.6 56.87 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.466 2.11 . . . . 53.219999999999999 112.509 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 51.24 67.32 0.97 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.76 1.624 . . . . 74.420000000000002 112.823 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.47 HG23 ' HD2' ' A' ' 231' ' ' ARG . 54.9 m -88.79 140.16 29.73 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.694 -1.139 . . . . 54.509999999999998 110.549 173.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.444 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 28.2 mp0 -100.78 157.52 16.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.074 0.95 . . . . 73.409999999999997 111.156 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.494 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -80.2 155.28 27.46 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.447 -1.251 . . . . 44.420000000000002 110.239 176.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.48 29.86 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 111.649 -0.58 . . . . 64.329999999999998 111.649 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.47 ' HD2' HG23 ' A' ' 227' ' ' THR . 73.7 mtt85 -62.23 178.18 0.41 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.688 0.795 . . . . 71.209999999999994 110.559 168.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.4 ptmt -166.17 147.24 6.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.752 -0.462 . . . . 74.439999999999998 109.752 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.581 HD12 HD11 ' A' ' 251' ' ' LEU . 88.8 mt -79.32 147.63 32.39 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.911 -0.774 . . . . 73.120000000000005 108.911 169.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -108.57 121.39 44.89 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.006 -1.479 . . . . 73.349999999999994 107.006 158.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 80.4 mt -118.28 110.92 18.1 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.365 -0.606 . . . . 63.32 109.365 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -79.02 119.28 21.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 73.400000000000006 110.922 -167.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.34 13.78 77.93 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.454 1.096 . . . . 44.119999999999997 113.948 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.3 mmtt -102.65 8.57 39.63 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 117.512 0.656 . . . . 61.119999999999997 112.665 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.82 172.55 32.66 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 110.644 -0.982 . . . . 63.240000000000002 110.644 168.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -55.42 146.09 44.81 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-N 117.652 0.726 . . . . 65.299999999999997 112.31 -173.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 24.5 Cg_exo -60.31 141.29 95.43 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.933 2.422 . . . . 74.209999999999994 112.272 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -130.26 171.72 20.49 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.958 -1.019 . . . . 71.109999999999999 111.842 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.68 -32.21 38.46 Favored 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 123.014 2.476 . . . . 60.420000000000002 112.793 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.57 -7.36 41.3 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.583 0.753 . . . . 73.439999999999998 111.387 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 135.55 177.08 14.71 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.218 -0.753 . . . . 33.200000000000003 111.218 -177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 61.8 mtm-85 -69.44 155.77 39.91 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.406 0.682 . . . . 61.149999999999999 112.206 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.12 -172.04 47.04 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.525 -0.761 . . . . 35.049999999999997 111.976 173.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.525 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 12.7 m-20 -115.12 149.08 38.15 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.366 0.666 . . . . 55.509999999999998 110.115 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.2 tp -106.53 108.47 19.99 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.348 0.594 . . . . 62.020000000000003 109.84 -170.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 54.0 m-85 -101.65 101.85 12.44 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.213 -1.032 . . . . 75.329999999999998 108.213 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.2 pp -118.68 119.34 34.15 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.429 0.9 . . . . 73.439999999999998 113.429 -173.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -67.68 116.96 8.97 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.118 0.967 . . . . 72.439999999999998 111.936 -174.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.614 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 94.1 t -63.93 116.77 3.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 113.691 -1.595 . . . . 53.219999999999999 110.717 174.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -111.9 125.16 53.74 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.343 -1.298 . . . . 74.450000000000003 108.645 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.494 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 29.8 mm -91.15 108.83 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.455 -1.313 . . . . 73.519999999999996 107.455 173.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.253 1.257 0 CA-C-O 117.766 -1.112 . . . . 73.329999999999998 108.551 -171.458 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.445 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 7.5 m . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 121.55 0.691 . . . . 71.310000000000002 111.595 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.85 176.27 6.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.03 0.932 . . . . 64.010000000000005 111.851 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.19 -129.23 6.18 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.25 -0.74 . . . . 21.210000000000001 111.25 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.57 158.05 17.81 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.087 0.555 . . . . 64.209999999999994 111.124 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.515 ' CZ3' HG21 ' A' ' 227' ' ' THR . 31.1 m95 . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 108.581 -0.896 . . . . 74.329999999999998 108.581 165.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.635 -0.506 . . . . 73.019999999999996 109.635 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 77.0 mt -128.43 158.67 37.67 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.375 0.607 . . . . 64.340000000000003 112.261 -177.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 11.6 t80 -121.14 126.0 48.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.687 -1.142 . . . . 65.040000000000006 108.679 171.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -136.18 -173.81 3.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.953 0.901 . . . . 73.400000000000006 109.274 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.8 m -126.37 117.47 23.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.548 0.739 . . . . 73.439999999999998 110.599 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.55 HD23 HG22 ' A' ' 253' ' ' VAL . 18.4 tp -76.92 105.88 8.26 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.58 -0.896 . . . . 72.209999999999994 108.58 171.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.21 101.86 12.19 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.658 -0.867 . . . . 63.43 108.658 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.667 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.3 t -110.64 115.03 54.24 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.089 -1.078 . . . . 73.109999999999999 108.089 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.03 148.93 70.88 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.558 1.506 . . . . 75.430000000000007 110.194 171.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.455 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -54.11 -40.07 79.05 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 124.014 0.926 . . . . 64.310000000000002 113.4 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 10.9 Cg_endo -54.14 -51.4 10.73 Favored 'Trans proline' 0 C--N 1.395 3.013 0 C-N-CA 122.17 1.913 . . . . 75.230000000000004 113.534 172.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.459 HG21 HG13 ' A' ' 210' ' ' VAL . 49.3 mt -64.8 -36.2 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.25 0.62 . . . . 72.219999999999999 110.979 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.401 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -65.13 -44.08 89.86 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.936 -0.575 . . . . 71.109999999999999 111.656 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.71 -51.03 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.767 0.827 . . . . 73.230000000000004 111.805 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.93 -23.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 120.494 0.188 . . . . 64.209999999999994 110.932 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.97 77.95 1.07 Allowed Glycine 0 C--N 1.349 1.305 0 N-CA-C 111.346 -0.702 . . . . 62.43 111.346 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.13 -139.78 8.41 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.907 -0.477 . . . . 73.140000000000001 111.907 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -132.1 146.27 51.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.286 0.634 . . . . 61.229999999999997 109.458 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' A' ' 199' ' ' VAL . 28.5 m -134.97 152.9 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 123.658 0.599 . . . . 75.510000000000005 109.819 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ARG . . . . . 0.511 ' HE ' ' HB3' ' A' ' 218' ' ' PRO . 40.4 ttt-85 -79.15 143.67 35.22 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.593 0.757 . . . . 70.310000000000002 109.772 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.75 114.28 26.77 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.677 -1.231 . . . . 74.040000000000006 107.677 171.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.91 135.07 54.28 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.866 1.266 . . . . 74.400000000000006 111.193 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.686 HG21 ' HE3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -141.48 -170.83 3.18 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.703 0.801 . . . . 75.140000000000001 110.515 173.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.535 ' H ' HG22 ' A' ' 214' ' ' THR . 7.1 mt -55.69 -69.54 0.14 Allowed 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.613 1.165 . . . . 72.329999999999998 110.815 -172.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -116.37 -42.69 3.0 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.251 -1.795 . . . . 73.510000000000005 110.929 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -113.02 132.88 10.96 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 118.656 -1.08 . . . . 72.219999999999999 111.717 -175.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' PRO . . . . . 0.511 ' HB3' ' HE ' ' A' ' 211' ' ' ARG . 74.6 Cg_endo -73.68 -173.95 1.52 Allowed 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.525 2.15 . . . . 72.219999999999999 112.682 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 8.5 t -140.05 164.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.36 1.464 . . . . 73.019999999999996 107.523 168.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.445 ' H ' ' HB ' ' A' ' 172' ' ' THR . 5.0 tt0 -142.16 127.75 19.07 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.043 -1.095 . . . . 74.109999999999999 108.043 170.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 233' ' ' LEU . 13.8 p -120.22 139.75 46.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 123.6 0.76 . . . . 72.109999999999999 110.603 -173.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.17 104.87 5.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.818 0.847 . . . . 74.239999999999995 109.419 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 204' ' ' ALA . 61.5 t -69.38 128.37 92.38 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.449 0.7 . . . . 72.340000000000003 109.335 173.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.51 154.25 74.57 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.057 2.505 . . . . 53.229999999999997 112.063 171.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.78 129.38 27.45 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.306 2.004 . . . . 72.109999999999999 112.189 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 55.56 74.21 0.39 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.547 1.539 . . . . 72.209999999999994 113.081 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' THR . . . . . 0.515 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 64.8 m -97.22 144.15 27.32 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.662 -1.154 . . . . 75.340000000000003 111.204 175.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -108.53 163.89 12.83 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.561 1.144 . . . . 72.409999999999997 110.972 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ALA . . . . . 0.472 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -88.15 152.47 21.96 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.642 -1.163 . . . . 71.510000000000005 111.427 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.02 -12.84 52.67 Favored Glycine 0 N--CA 1.476 1.31 0 CA-C-N 116.342 -0.39 . . . . 60.530000000000001 112.25 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.456 ' HD2' HG23 ' A' ' 227' ' ' THR . 73.3 mtt85 -69.58 178.17 2.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.636 0.774 . . . . 75.209999999999994 109.762 166.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.629 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 10.9 ptmt -168.37 157.02 8.77 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.319 0.104 . . . . 71.519999999999996 111.15 172.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 251' ' ' LEU . 73.0 mt -93.62 158.8 15.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.003 0.521 . . . . 62.25 109.807 170.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -132.61 109.55 9.82 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.914 1.285 . . . . 73.329999999999998 108.363 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 49.5 mt -120.42 117.15 26.96 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.393 0.677 . . . . 74.030000000000001 111.339 -166.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -84.94 134.35 34.25 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.709 -0.678 . . . . 74.439999999999998 110.695 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 76.22 10.14 85.47 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 124.219 0.949 . . . . 64.120000000000005 113.513 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.686 ' HE3' HG21 ' A' ' 214' ' ' THR . 29.3 mmmt -97.68 -25.15 15.2 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 117.142 0.471 . . . . 72.430000000000007 112.232 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -66.09 -172.0 4.19 Favored Glycine 0 CA--C 1.538 1.519 0 O-C-N 123.103 0.252 . . . . 50.119999999999997 113.151 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -59.06 138.68 87.82 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 122.696 0.399 . . . . 71.219999999999999 111.235 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.535 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 32.2 Cg_exo -59.29 152.66 58.79 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.93 2.42 . . . . 74.109999999999999 112.622 175.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.6 -177.77 15.15 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.708 -0.678 . . . . 42.240000000000002 112.509 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.12 -40.67 4.52 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 122.732 2.288 . . . . 75.099999999999994 112.537 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.47 -10.65 14.88 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.683 0.793 . . . . 63.109999999999999 111.854 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.41 166.49 27.56 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 111.467 -0.653 . . . . 72.310000000000002 111.467 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.535 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 16.5 mtp180 -85.66 165.58 16.88 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.204 0.602 . . . . 72.310000000000002 110.871 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.72 -176.61 46.86 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.342 -0.844 . . . . 62.109999999999999 112.826 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.74 169.21 8.65 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.014 0.525 . . . . 72.510000000000005 110.935 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 62.7 tp -131.95 108.98 9.73 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.571 -0.74 . . . . 71.239999999999995 110.201 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.629 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 13.8 m-30 -98.8 116.91 32.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.125 -1.065 . . . . 71.109999999999999 108.125 173.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.6 pp -129.5 116.31 18.76 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.34 0.867 . . . . 63.43 113.34 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.34 123.34 20.5 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 114.751 -1.113 . . . . 75.209999999999994 112.506 -174.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.55 HG22 HD23 ' A' ' 197' ' ' LEU . 60.5 t -70.09 125.23 27.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 114.19 -1.368 . . . . 73.0 110.953 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.92 129.9 55.43 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.551 1.14 . . . . 73.340000000000003 108.484 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.472 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 40.6 mm -99.97 99.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.552 -1.277 . . . . 74.319999999999993 107.552 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.561 1.366 0 CA-C-N 114.37 -1.286 . . . . 70.209999999999994 108.952 -167.59 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.488 HG22 HG22 ' A' ' 219' ' ' VAL . 3.4 m . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.026 0.441 . . . . 75.319999999999993 109.892 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.03 152.24 18.71 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.634 0.773 . . . . 51.32 111.184 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.64 -102.29 0.06 OUTLIER Glycine 0 C--N 1.351 1.363 0 O-C-N 124.207 0.942 . . . . 74.209999999999994 111.482 165.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -136.51 175.77 9.3 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.537 0.735 . . . . 73.430000000000007 109.84 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TRP . . . . . 0.549 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 14.2 m95 . . . . . 0 C--O 1.24 0.565 0 CA-C-N 115.156 -0.929 . . . . 71.430000000000007 109.539 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 9.2 p-10 . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 109.464 -0.569 . . . . 50.329999999999998 109.464 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.6 mt -113.71 165.4 12.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.538 0.735 . . . . 51.509999999999998 111.757 -169.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -118.0 122.18 42.56 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 114.741 -1.118 . . . . 74.219999999999999 108.24 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -131.43 -172.98 2.99 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.829 0.852 . . . . 74.340000000000003 110.052 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 52.9 m -119.29 149.77 41.24 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.122 0.969 . . . . 75.420000000000002 109.706 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.534 ' HB2' HD13 ' A' ' 251' ' ' LEU . 22.2 tp -119.95 104.57 10.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.106 1.362 . . . . 72.239999999999995 108.462 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -91.44 99.71 12.61 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.892 0.853 . . . . 62.329999999999998 109.109 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.609 HG22 HG21 ' A' ' 210' ' ' VAL . 23.2 t -94.99 119.85 65.28 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 114.555 -1.202 . . . . 72.030000000000001 108.282 174.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.68 144.95 61.83 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 121.539 1.493 . . . . 72.340000000000003 109.859 173.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.427 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.48 -42.44 75.1 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.501 -1.238 . . . . 50.420000000000002 113.147 -175.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.7 Cg_endo -55.96 -51.62 9.18 Favored 'Trans proline' 0 C--N 1.406 3.602 0 C-N-CA 121.94 1.76 . . . . 71.420000000000002 112.71 174.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 54.5 mt -65.01 -33.55 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.236 0.615 . . . . 71.129999999999995 110.674 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.67 77.14 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.407 0.683 . . . . 62.43 110.898 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.7 t -70.3 -47.12 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.351 1.06 . . . . 62.43 112.281 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.56 -35.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 120.507 0.194 . . . . 45.43 110.761 -174.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.47 105.79 1.13 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.539 -1.024 . . . . 53.210000000000001 110.539 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.93 -129.0 2.29 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.689 -0.506 . . . . 65.420000000000002 111.859 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 4.9 ttmt -145.15 137.7 26.06 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.608 0.763 . . . . 72.019999999999996 109.75 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 199' ' ' VAL . 33.6 m -135.23 155.16 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 122.766 0.427 . . . . 71.099999999999994 110.763 175.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -70.65 146.2 50.13 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.016 0.822 . . . . 72.329999999999998 110.427 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -123.64 120.75 33.68 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.014 1.326 . . . . 74.329999999999998 107.882 172.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -64.76 129.23 39.02 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.987 0.915 . . . . 73.340000000000003 110.899 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 -170.91 2.82 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.207 1.003 . . . . 52.43 110.265 -172.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.4 mt -84.87 -66.76 0.86 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.61 1.195 . . . . 61.32 109.639 -171.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -95.65 -33.3 12.4 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 112.675 -2.057 . . . . 71.329999999999998 110.856 -165.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -160.68 141.97 7.79 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.354 -1.248 . . . . 72.239999999999995 111.294 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.6 142.99 60.72 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.694 2.263 . . . . 51.0 113.001 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 61.6 t -94.06 166.47 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.92 1.288 . . . . 75.129999999999995 109.031 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -144.3 136.68 26.59 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.243 -1.391 . . . . 75.510000000000005 107.243 171.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' VAL . . . . . 0.555 HG11 HD11 ' A' ' 233' ' ' LEU . 14.4 p -132.88 140.71 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.253 0.621 . . . . 74.340000000000003 111.347 -169.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.09 101.17 2.69 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.302 1.041 . . . . 72.209999999999994 110.331 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.484 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 92.9 t -72.25 121.66 85.32 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 118.141 -0.933 . . . . 73.230000000000004 109.226 175.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.67 154.72 72.57 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.592 2.195 . . . . 75.510000000000005 111.783 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.72 130.93 37.3 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.532 2.154 . . . . 74.400000000000006 112.769 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 56.15 74.65 0.38 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.813 1.645 . . . . 63.409999999999997 112.762 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 97.0 m -90.7 142.09 28.11 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.714 -1.13 . . . . 72.519999999999996 111.064 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -107.6 149.71 27.73 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.586 1.154 . . . . 53.219999999999999 109.947 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.68 155.28 37.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.188 -0.914 . . . . 73.030000000000001 110.545 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.1 -19.84 39.56 Favored Glycine 0 N--CA 1.476 1.311 0 N-CA-C 111.162 -0.775 . . . . 72.430000000000007 111.162 -172.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -65.9 179.83 0.83 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.257 1.023 . . . . 74.510000000000005 110.599 168.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.515 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.0 ptmt -166.81 152.89 8.27 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 116.176 -0.465 . . . . 74.420000000000002 109.992 172.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LEU . . . . . 0.65 HD12 HD11 ' A' ' 251' ' ' LEU . 61.6 mt -81.29 142.71 32.85 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.035 -0.728 . . . . 64.400000000000006 109.035 169.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -103.22 104.06 14.16 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.177 -1.416 . . . . 75.450000000000003 107.177 158.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LEU . . . . . 0.566 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 50.6 mt -102.43 113.51 26.9 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 114.939 -1.028 . . . . 74.519999999999996 109.009 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -82.18 125.79 31.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.316 -0.856 . . . . 71.239999999999995 110.142 -172.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.64 25.3 75.67 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 124.448 1.092 . . . . 45.009999999999998 113.804 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.566 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 74.3 mmtt -107.54 -3.17 19.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 112.671 0.619 . . . . 72.230000000000004 112.671 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.93 176.89 50.89 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.825 -1.31 . . . . 74.239999999999995 109.825 164.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -56.65 131.69 77.88 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 117.335 0.567 . . . . 53.299999999999997 111.894 -171.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 28.0 Cg_endo -63.23 138.93 69.31 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.97 2.447 . . . . 74.140000000000001 111.519 174.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.22 177.77 18.49 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.561 -0.745 . . . . 74.439999999999998 113.472 -174.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.61 -33.52 66.93 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.973 2.448 . . . . 62.210000000000001 112.75 177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.48 -8.97 59.6 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.419 0.688 . . . . 62.310000000000002 111.901 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 144.42 -101.18 0.25 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 110.872 -0.891 . . . . 40.039999999999999 110.872 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 59.3 mtt180 -148.35 165.78 30.04 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.788 1.235 . . . . 71.450000000000003 110.176 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.65 174.08 30.23 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 110.792 -0.923 . . . . 70.549999999999997 110.792 167.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 45.7 m-20 -102.85 -179.15 3.88 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.105 0.562 . . . . 71.420000000000002 109.944 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 46.0 tp -141.68 107.63 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.603 0.716 . . . . 73.319999999999993 109.128 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' TYR . . . . . 0.488 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 54.3 m-85 -100.99 107.6 19.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.882 -1.525 . . . . 75.140000000000001 106.882 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 233' ' ' LEU . 2.7 pp -122.94 118.09 27.04 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.759 0.79 . . . . 62.130000000000003 113.086 -175.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -69.75 120.63 15.79 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 125.3 1.44 . . . . 70.109999999999999 112.252 -171.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' VAL . . . . . 0.549 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 58.9 t -68.8 116.56 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 114.09 -1.414 . . . . 74.230000000000004 110.979 177.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -103.35 131.24 50.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.112 1.765 . . . . 72.420000000000002 108.866 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.0 mm -97.46 110.22 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.966 -1.124 . . . . 64.510000000000005 107.966 170.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.257 1.45 0 C-N-CA 124.335 1.054 . . . . 74.540000000000006 108.627 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 168' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.985 -0.376 . . . . 61.530000000000001 109.985 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.29 162.18 25.8 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.381 0.672 . . . . 74.299999999999997 110.106 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.7 p -57.81 -32.81 67.94 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.333 1.053 . . . . 63.32 112.411 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.95 54.16 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.451 0.7 . . . . 34.119999999999997 110.978 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 219' ' ' VAL . 11.6 m -75.15 -10.76 59.77 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.675 0.79 . . . . 61.43 110.976 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -111.95 151.6 29.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.621 0.768 . . . . 75.200000000000003 110.657 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.34 -113.37 0.07 OUTLIER Glycine 0 C--N 1.349 1.251 0 O-C-N 123.659 0.599 . . . . 72.329999999999998 111.71 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -112.5 177.69 4.55 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.406 0.683 . . . . 63.32 110.047 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.506 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 13.6 m95 -85.26 -76.09 0.34 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.176 -0.92 . . . . 72.120000000000005 109.732 170.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -168.92 34.8 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.06 0.944 . . . . 64.519999999999996 109.101 -174.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.7 -41.08 1.49 Allowed Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.144 -1.182 . . . . 53.130000000000003 110.144 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 176' ' ' TRP . 44.7 mmtm -63.81 141.3 58.82 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.819 0.848 . . . . 61.450000000000003 111.37 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 86.12 -69.7 3.13 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 109.895 -1.282 . . . . 51.299999999999997 109.895 -168.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.4 p -166.53 139.29 3.8 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.576 1.15 . . . . 62.109999999999999 108.712 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -72.41 79.22 0.67 Allowed Glycine 0 C--N 1.346 1.102 0 N-CA-C 110.664 -0.974 . . . . 71.120000000000005 110.664 172.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -67.94 -58.12 7.89 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 123.307 0.479 . . . . 63.439999999999998 112.114 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.2 p -164.71 99.65 0.79 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.583 0.753 . . . . 52.350000000000001 109.759 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -76.84 81.54 1.14 Allowed Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.835 -0.62 . . . . 71.129999999999995 112.221 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -157.67 101.43 0.2 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 112.33 -0.308 . . . . 75.430000000000007 112.33 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.1 m -90.35 102.62 15.35 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.569 0.748 . . . . 61.200000000000003 109.732 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 174.49 142.06 3.86 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.405 -1.078 . . . . 63.25 110.405 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 176.52 -143.84 6.62 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.713 -0.555 . . . . 54.539999999999999 111.713 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.6 m -157.74 167.8 29.04 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.849 1.259 . . . . 62.130000000000003 109.064 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 58.74 24.62 12.46 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.882 0.873 . . . . 61.539999999999999 110.704 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.06 163.39 24.21 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.621 0.769 . . . . 51.340000000000003 112.882 -166.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.1 mt -130.88 147.3 52.51 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.653 -1.158 . . . . 70.140000000000001 110.157 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -114.71 122.81 47.58 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.587 -0.894 . . . . 71.439999999999998 108.587 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -133.14 -173.24 3.15 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.558 0.536 . . . . 73.219999999999999 110.532 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.5 m -123.81 135.88 54.06 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.797 0.839 . . . . 71.019999999999996 110.146 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.3 tp -96.01 109.18 21.61 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.746 -1.205 . . . . 54.130000000000003 107.746 170.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -85.43 99.69 11.37 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.664 -0.865 . . . . 61.420000000000002 108.664 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.682 ' HA ' HG11 ' A' ' 210' ' ' VAL . 18.9 t -111.61 112.31 54.0 Favored Pre-proline 0 C--N 1.344 0.342 0 N-CA-C 107.988 -1.115 . . . . 63.240000000000002 107.988 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.3 151.59 80.53 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.538 1.492 . . . . 72.349999999999994 110.693 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.424 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.82 -42.2 88.47 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 123.755 0.822 . . . . 74.329999999999998 113.203 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 11.1 Cg_endo -55.24 -56.67 2.14 Favored 'Trans proline' 0 C--N 1.392 2.828 0 C-N-CA 122.004 1.803 . . . . 71.25 113.824 172.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.57 -31.28 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 122.942 0.497 . . . . 75.109999999999999 111.001 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.33 80.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.076 -0.511 . . . . 43.439999999999998 111.045 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.9 t -67.27 -50.41 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.987 0.915 . . . . 71.019999999999996 111.801 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.6 p -79.28 -25.89 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 120.813 0.34 . . . . 75.099999999999994 110.723 -172.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.95 73.0 1.07 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.92 -0.582 . . . . 75.239999999999995 111.778 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.13 -130.22 6.8 Favored Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.59 -0.604 . . . . 65.25 111.59 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -131.9 156.09 46.74 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.519 0.728 . . . . 52.049999999999997 110.104 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.682 HG11 ' HA ' ' A' ' 199' ' ' VAL . 26.8 m -144.79 158.05 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.064 0.853 . . . . 75.239999999999995 110.145 173.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -81.41 146.65 30.18 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.523 -0.762 . . . . 71.219999999999999 111.017 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -121.84 125.68 47.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.727 1.211 . . . . 75.120000000000005 108.347 170.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.5 tpt -64.32 131.44 47.3 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.946 0.498 . . . . 75.010000000000005 110.851 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.424 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -135.32 -170.78 2.67 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.789 1.236 . . . . 73.519999999999996 108.888 -177.112 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 216' ' ' GLU . 7.1 mt -63.54 -68.65 0.33 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 122.39 1.091 . . . . 61.009999999999998 111.869 -172.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 33.9 mt-10 -97.42 -39.83 8.99 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 112.707 -2.042 . . . . 75.129999999999995 109.266 -163.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -147.0 -165.39 11.69 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 113.981 -1.463 . . . . 22.120000000000001 111.565 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -96.89 151.46 1.07 Allowed 'Trans proline' 0 CA--C 1.551 1.35 0 C-N-CA 122.728 2.285 . . . . 71.409999999999997 114.907 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 54.0 t -97.86 162.88 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 114.195 -1.366 . . . . 74.010000000000005 107.535 165.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -144.65 119.23 9.74 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.18 -1.044 . . . . 65.310000000000002 108.18 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 233' ' ' LEU . 12.7 p -112.07 142.66 23.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.56 0.744 . . . . 64.140000000000001 110.207 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.28 112.53 10.54 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.824 -0.806 . . . . 63.200000000000003 108.824 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.3 133.02 81.26 Favored Pre-proline 0 CA--C 1.553 1.075 0 N-CA-C 109.211 -0.663 . . . . 74.209999999999994 109.211 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.57 157.58 61.23 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.252 2.635 . . . . 65.340000000000003 111.237 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.57 135.11 40.86 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 121.98 1.786 . . . . 70.409999999999997 112.08 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.7 mtp-105 53.19 65.46 1.51 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.913 1.685 . . . . 64.430000000000007 113.34 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.526 HG23 ' HD2' ' A' ' 231' ' ' ARG . 77.7 m -87.95 139.01 30.95 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.87 -1.059 . . . . 61.409999999999997 111.711 176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.643 ' HB2' HH12 ' A' ' 231' ' ' ARG . 25.9 mp0 -104.33 159.02 16.06 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.003 0.921 . . . . 74.209999999999994 110.086 172.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.45 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -86.19 152.32 22.92 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.111 -0.95 . . . . 74.299999999999997 111.46 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.11 -15.21 30.86 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 115.934 -0.575 . . . . 71.400000000000006 111.744 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.643 HH12 ' HB2' ' A' ' 228' ' ' GLN . 69.5 mtt85 -69.72 179.26 2.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.959 0.904 . . . . 62.109999999999999 109.769 166.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.1 ptmt -166.0 155.66 12.1 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.917 -0.401 . . . . 74.450000000000003 109.917 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.585 HD12 HD11 ' A' ' 251' ' ' LEU . 79.8 mt -84.37 147.08 27.35 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.617 -0.512 . . . . 61.450000000000003 109.617 170.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -114.21 107.36 15.51 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.66 1.225 . . . . 63.32 107.958 167.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 63.3 mt -116.53 118.32 32.31 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.931 0.492 . . . . 74.010000000000005 110.863 -173.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -92.86 126.0 37.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.127 -0.488 . . . . 74.200000000000003 110.184 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.23 12.91 72.37 Favored Glycine 0 N--CA 1.471 1.022 0 O-C-N 124.264 0.978 . . . . 54.329999999999998 113.021 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -114.11 -3.32 13.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.689 0.796 . . . . 74.420000000000002 111.446 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.88 -177.34 51.47 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 110.556 -1.018 . . . . 53.039999999999999 110.556 166.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -57.5 141.52 78.43 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.753 0.649 . . . . 74.430000000000007 112.753 -171.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 7.8 Cg_exo -69.47 133.72 26.81 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.622 2.214 . . . . 70.040000000000006 110.512 171.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -135.31 174.63 21.13 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.888 -1.051 . . . . 54.140000000000001 112.621 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.62 -9.98 23.16 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.903 2.402 . . . . 71.430000000000007 112.71 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -105.29 11.07 33.32 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.094 0.958 . . . . 72.030000000000001 111.407 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 121.83 -113.02 2.16 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.187 -0.765 . . . . 72.319999999999993 111.187 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 65.0 mtt180 -143.87 164.06 31.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.276 1.03 . . . . 73.140000000000001 110.567 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -98.29 -163.87 30.79 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 114.748 -1.115 . . . . 63.43 113.29 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -115.6 160.21 20.3 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.183 0.993 . . . . 74.310000000000002 110.679 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.572 ' HG ' HD23 ' A' ' 251' ' ' LEU . 27.7 tp -131.47 109.66 10.45 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.469 0.708 . . . . 74.319999999999993 109.641 -171.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.461 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 20.2 m-85 -102.8 116.3 32.3 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.482 -0.932 . . . . 64.450000000000003 108.482 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.585 HD11 HD12 ' A' ' 233' ' ' LEU . 3.0 pp -127.76 114.47 17.33 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.384 0.611 . . . . 54.020000000000003 112.42 -173.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -68.74 119.73 13.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.923 1.289 . . . . 72.439999999999998 112.984 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 232' ' ' LYS . 64.1 t -70.82 126.12 30.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-N 114.342 -1.299 . . . . 72.129999999999995 110.897 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -116.24 133.14 56.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.988 1.315 . . . . 63.509999999999998 108.34 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.45 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 43.0 mm -104.94 100.53 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 107.874 -1.158 . . . . 73.319999999999993 107.874 175.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.557 1.227 0 CA-C-O 117.773 -1.108 . . . . 73.109999999999999 109.506 -171.857 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.6 ptm . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.824 0.345 . . . . 63.140000000000001 111.119 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 171' ' ' ALA . 11.6 tp10 -162.29 163.93 27.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.54 1.136 . . . . 72.540000000000006 108.251 -167.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 63.6 p -54.73 -38.92 67.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.512 0.725 . . . . 61.5 111.219 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.438 ' H ' ' HG3' ' A' ' 169' ' ' GLU . . . -131.02 91.39 3.04 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.123 -1.066 . . . . 62.439999999999998 108.123 167.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 10.3 m -78.0 -23.97 48.11 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.931 -0.577 . . . . 74.439999999999998 111.114 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.52 151.13 38.0 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.911 -0.586 . . . . 64.030000000000001 111.703 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -77.05 -66.3 1.83 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.425 -0.807 . . . . 61.509999999999998 111.944 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -162.7 167.91 22.36 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 123.924 0.889 . . . . 64.439999999999998 111.096 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.616 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.8 m95 -77.51 -67.92 0.67 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.516 -1.22 . . . . 71.219999999999999 108.613 167.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 168.7 -131.56 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.818 2.047 . . . . 73.109999999999999 105.676 -168.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.86 20.82 42.95 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.242 -0.754 . . . . 63.219999999999999 112.011 160.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 51.9 pttt 31.99 48.97 0.12 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 126.852 2.061 . . . . 74.310000000000002 113.257 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.95 -47.37 0.31 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.163 -1.575 . . . . 72.430000000000007 109.163 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.7 m -75.66 95.36 3.37 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.107 -0.701 . . . . 51.439999999999998 109.107 170.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -75.47 75.34 1.41 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.09 -0.959 . . . . 62.219999999999999 112.671 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -125.9 49.58 0.91 Allowed Glycine 0 C--N 1.344 0.982 0 C-N-CA 123.312 0.482 . . . . 72.030000000000001 111.922 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.489 ' HA ' ' NH2' ' A' ' 234' ' ' ARG . 45.4 t -85.73 -74.14 0.42 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.188 0.595 . . . . 75.239999999999995 110.178 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.9 -172.02 44.23 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 112.514 -0.234 . . . . 54.130000000000003 112.514 -171.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 176.96 -123.07 0.87 Allowed Glycine 0 N--CA 1.469 0.842 0 CA-C-O 119.695 -0.503 . . . . 74.019999999999996 112.065 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.2 m 63.62 92.32 0.07 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.929 1.291 . . . . 50.409999999999997 112.268 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -120.03 -95.06 1.51 Allowed Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.07 -0.812 . . . . 65.420000000000002 111.07 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 179.05 83.94 0.06 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.61 -0.55 . . . . 72.299999999999997 111.915 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.3 t 78.5 -41.1 0.29 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 125.785 1.634 . . . . 73.409999999999997 113.773 173.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -63.17 -55.59 23.84 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.607 1.163 . . . . 72.120000000000005 110.176 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -63.53 140.89 58.92 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.369 -1.287 . . . . 72.019999999999996 109.499 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.19 159.59 29.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.38 0.61 . . . . 63.350000000000001 111.046 -172.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 11.9 t80 -125.59 110.47 13.88 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.654 -1.157 . . . . 64.200000000000003 107.884 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.96 -171.87 2.18 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.034 0.934 . . . . 54.32 110.056 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 69.2 m -127.26 118.52 24.39 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.438 0.695 . . . . 64.430000000000007 110.95 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.521 HD23 HG22 ' A' ' 253' ' ' VAL . 13.8 tp -78.71 111.37 14.74 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.732 -0.84 . . . . 75.129999999999995 108.732 169.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.75 109.6 18.75 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.949 -1.13 . . . . 74.049999999999997 107.949 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.638 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.5 t -118.36 114.19 36.57 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.602 -1.259 . . . . 55.340000000000003 107.602 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.96 146.05 76.18 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 121.214 1.276 . . . . 74.120000000000005 109.971 171.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.46 -44.54 82.99 Favored Pre-proline 0 CA--C 1.563 1.451 0 CA-C-O 117.869 -1.063 . . . . 62.229999999999997 112.817 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 16.5 Cg_endo -54.89 -48.93 18.55 Favored 'Trans proline' 0 C--N 1.399 3.2 0 C-N-CA 122.19 1.927 . . . . 63.520000000000003 112.754 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.489 HG21 HG13 ' A' ' 210' ' ' VAL . 50.8 mt -65.99 -35.3 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.006 0.523 . . . . 73.040000000000006 110.649 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.73 99.5 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.06 0.544 . . . . 71.439999999999998 111.14 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.0 t -72.93 -50.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.156 0.982 . . . . 60.119999999999997 112.078 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 12.4 p -77.72 -27.93 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.703 0.401 . . . . 72.430000000000007 110.52 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.83 70.18 1.36 Allowed Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.336 -0.706 . . . . 51.310000000000002 111.336 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.69 -130.02 6.86 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.902 -0.479 . . . . 64.510000000000005 111.902 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -143.49 137.19 28.34 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.231 0.613 . . . . 61.140000000000001 109.921 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.638 HG11 ' HA ' ' A' ' 199' ' ' VAL . 35.4 m -132.55 151.02 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.409 0.684 . . . . 53.149999999999999 110.235 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -75.23 140.04 42.97 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.941 0.497 . . . . 74.420000000000002 110.856 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.12 113.71 26.13 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.982 -1.488 . . . . 74.430000000000007 106.982 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 11.0 tpt -65.54 131.0 45.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.037 0.535 . . . . 65.239999999999995 111.489 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -133.71 -171.69 2.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.545 1.138 . . . . 72.209999999999994 110.644 -172.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mt -83.5 -64.22 1.21 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.777 1.275 . . . . 75.340000000000003 109.679 -168.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.8 -32.07 12.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 112.067 -2.333 . . . . 72.209999999999994 110.93 -166.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -164.44 144.29 9.27 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-O 118.672 -1.071 . . . . 51.420000000000002 111.442 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.33 143.88 71.99 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.686 2.257 . . . . 72.129999999999995 113.278 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 66.0 t -96.54 163.23 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.177 -1.374 . . . . 73.200000000000003 108.159 174.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.401 ' H ' ' HB ' ' A' ' 172' ' ' THR . 9.5 tt0 -147.08 134.06 20.28 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.767 -1.197 . . . . 74.010000000000005 107.767 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.51 HG21 HD21 ' A' ' 233' ' ' LEU . 12.0 p -126.49 135.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 C-N-CA 123.48 0.712 . . . . 71.340000000000003 110.951 -173.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.75 104.4 2.42 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.85 -1.068 . . . . 63.439999999999998 108.95 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.4 t -71.75 132.79 84.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 108.551 -0.907 . . . . 63.329999999999998 108.551 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.5 157.39 60.82 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.541 2.161 . . . . 74.420000000000002 111.839 171.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -64.71 137.48 54.29 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.103 1.868 . . . . 74.310000000000002 111.96 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 50.5 65.19 1.53 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.327 1.451 . . . . 72.340000000000003 113.192 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.444 HG23 ' HD2' ' A' ' 231' ' ' ARG . 68.1 m -82.87 144.55 30.0 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.947 -1.024 . . . . 70.109999999999999 111.071 174.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -105.79 155.92 18.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.749 0.82 . . . . 72.209999999999994 110.398 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.439 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -76.61 153.59 35.14 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.618 -1.174 . . . . 74.010000000000005 110.369 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.3 -10.93 59.97 Favored Glycine 0 N--CA 1.472 1.099 0 N-CA-C 112.351 -0.3 . . . . 60.100000000000001 112.351 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.444 ' HD2' HG23 ' A' ' 227' ' ' THR . 65.8 mtt85 -72.1 -177.23 2.0 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.126 0.97 . . . . 74.0 109.586 165.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.526 ' HA ' HG23 ' A' ' 253' ' ' VAL . 7.5 ptmt -167.25 161.83 14.63 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 111.275 0.102 . . . . 64.040000000000006 111.275 172.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.632 HD12 HD11 ' A' ' 251' ' ' LEU . 73.1 mt -88.49 151.28 22.64 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.468 -0.567 . . . . 74.0 109.468 166.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.489 ' NH2' ' HA ' ' A' ' 184' ' ' SER . 4.3 ptp180 -111.85 109.33 19.09 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.49 -1.3 . . . . 73.420000000000002 107.49 162.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 64.0 mt -110.11 102.43 11.14 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.854 0.835 . . . . 70.299999999999997 109.784 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -76.68 119.1 20.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.095 -1.411 . . . . 62.329999999999998 110.853 -169.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.62 -3.95 86.6 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 124.072 0.858 . . . . 54.030000000000001 113.981 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.486 ' HD2' HG21 ' A' ' 214' ' ' THR . 32.6 mmtp -87.09 5.79 35.89 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.645 0.723 . . . . 64.030000000000001 112.565 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.98 174.02 49.24 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.123 -0.791 . . . . 74.420000000000002 111.123 166.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.04 148.16 88.98 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.85 0.46 . . . . 74.439999999999998 111.753 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.519 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 11.7 Cg_exo -68.69 133.32 27.29 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.659 2.239 . . . . 64.219999999999999 112.429 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -128.89 173.78 19.26 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.793 -1.094 . . . . 75.420000000000002 112.552 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.02 -24.82 20.17 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.92 2.413 . . . . 73.430000000000007 112.195 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.22 22.46 14.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.058 0.943 . . . . 72.109999999999999 110.833 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 101.16 -177.74 27.67 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.957 -0.857 . . . . 71.420000000000002 110.957 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 32.9 mtp180 -81.81 155.49 25.39 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.113 0.457 . . . . 63.549999999999997 111.161 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.2 -179.12 52.72 Favored Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.436 -0.802 . . . . 65.439999999999998 112.222 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -117.37 138.26 51.92 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.208 0.528 . . . . 75.209999999999994 109.789 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 38.8 tp -101.91 105.57 16.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.973 -1.012 . . . . 61.439999999999998 109.116 -170.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 60.5 m-85 -102.15 114.13 27.99 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.146 -1.057 . . . . 73.129999999999995 108.146 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 233' ' ' LEU . 2.5 pp -125.88 114.74 18.94 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.593 0.96 . . . . 62.399999999999999 113.593 -171.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -67.74 125.8 27.37 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.799 1.24 . . . . 74.019999999999996 112.766 -173.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.616 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 89.1 t -74.25 131.3 35.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-N 113.55 -1.659 . . . . 75.439999999999998 110.936 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -123.81 125.33 44.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.456 1.503 . . . . 75.120000000000005 107.851 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.439 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 33.1 mm -97.01 105.91 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.566 -1.272 . . . . 54.140000000000001 107.566 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.564 1.495 0 CA-C-O 118.022 -0.99 . . . . 62.140000000000001 109.507 -169.724 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.498 ' N ' ' SD ' ' A' ' 168' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.524 -0.547 . . . . 61.530000000000001 109.524 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -85.38 161.93 19.25 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.461 0.704 . . . . 74.299999999999997 110.606 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.8 p -59.63 -35.44 74.38 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.454 1.102 . . . . 63.32 111.433 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.05 141.32 40.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.377 -0.601 . . . . 34.119999999999997 109.377 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.407 HG22 HG22 ' A' ' 219' ' ' VAL . 13.4 m -70.88 -19.64 62.6 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.351 0.66 . . . . 61.43 110.959 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.74 166.17 12.58 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.744 0.817 . . . . 75.200000000000003 111.874 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.68 -96.56 0.92 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.525 -1.03 . . . . 72.329999999999998 110.525 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.14 174.86 9.61 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.982 0.513 . . . . 63.32 109.716 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.523 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 9.9 m95 -87.29 -73.1 0.49 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.266 -0.879 . . . . 72.120000000000005 110.097 170.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.419 ' NE2' ' HE ' ' A' ' 231' ' ' ARG . 11.6 pt20 -169.51 32.43 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.241 0.617 . . . . 64.519999999999996 110.033 -170.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.09 69.15 1.25 Allowed Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.923 -0.58 . . . . 53.130000000000003 111.7 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -124.54 113.25 17.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.631 1.172 . . . . 61.450000000000003 107.915 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.02 -60.05 4.23 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 110.918 -0.873 . . . . 51.299999999999997 110.918 -170.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.0 p -139.68 149.86 44.19 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.566 1.146 . . . . 62.109999999999999 108.71 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -120.88 135.62 10.87 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.044 -0.823 . . . . 71.120000000000005 111.044 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -76.62 -58.84 3.42 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 111.81 -0.516 . . . . 63.439999999999998 111.81 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.0 p -162.6 149.24 13.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.268 0.627 . . . . 52.350000000000001 110.172 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.47 65.99 2.07 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.29 0.369 . . . . 71.129999999999995 112.553 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.67 143.84 6.32 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 112.168 -0.373 . . . . 75.430000000000007 112.168 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.6 m -138.45 139.39 38.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.665 0.786 . . . . 61.200000000000003 110.644 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 159.52 83.62 0.05 OUTLIER Glycine 0 C--N 1.342 0.915 0 N-CA-C 110.525 -1.03 . . . . 63.25 110.525 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -106.0 -159.32 22.46 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 113.929 0.332 . . . . 54.539999999999999 113.929 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.2 m -130.08 152.28 49.71 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.338 1.055 . . . . 62.130000000000003 109.521 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 58.92 21.1 8.8 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 124.185 0.994 . . . . 61.539999999999999 110.89 -174.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 7.9 p-10 -76.67 154.6 34.11 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 114.741 -1.118 . . . . 51.340000000000003 112.366 -169.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.46 ' HB2' HD13 ' A' ' 249' ' ' LEU . 87.4 mt -116.75 147.22 42.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.391 1.076 . . . . 70.140000000000001 109.594 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -115.55 117.6 30.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.18 -1.045 . . . . 71.439999999999998 108.18 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.577 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -130.17 -173.61 3.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.456 0.702 . . . . 73.219999999999999 109.878 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.0 m -124.33 120.63 32.71 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.43 0.692 . . . . 71.019999999999996 110.311 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.503 HD23 HG22 ' A' ' 253' ' ' VAL . 18.3 tp -78.6 105.55 9.96 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.003 -1.11 . . . . 54.130000000000003 108.003 172.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -86.29 101.0 12.67 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.788 -0.819 . . . . 61.420000000000002 108.788 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 210' ' ' VAL . 18.1 t -112.67 113.86 50.12 Favored Pre-proline 0 N--CA 1.47 0.556 0 N-CA-C 108.884 -0.784 . . . . 63.240000000000002 108.884 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.38 151.17 83.85 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 121.611 1.541 . . . . 72.349999999999994 110.642 171.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.436 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.19 -43.77 95.7 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-O 118.01 -0.995 . . . . 74.329999999999998 113.096 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.3 Cg_endo -55.37 -51.76 9.28 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 122.152 1.901 . . . . 71.25 112.98 174.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.48 HG21 HG13 ' A' ' 210' ' ' VAL . 38.6 mt -63.76 -34.85 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.07 0.548 . . . . 75.109999999999999 111.016 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.44 87.24 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.19 -0.459 . . . . 43.439999999999998 111.017 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.9 t -72.84 -49.03 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.826 0.85 . . . . 71.019999999999996 111.833 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.81 -24.72 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 122.329 0.252 . . . . 75.099999999999994 110.714 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.06 75.9 1.03 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.95 -0.568 . . . . 75.239999999999995 111.776 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.99 -144.78 10.9 Favored Glycine 0 N--CA 1.474 1.209 0 N-CA-C 110.815 -0.914 . . . . 65.25 110.815 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -122.29 150.73 41.94 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.107 0.953 . . . . 52.049999999999997 110.762 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.661 HG21 HG22 ' A' ' 199' ' ' VAL . 24.8 m -141.06 149.21 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 115.354 -0.839 . . . . 75.239999999999995 109.978 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -73.83 145.13 45.18 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.292 0.568 . . . . 71.219999999999999 111.124 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.623 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -119.8 115.95 24.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.256 1.422 . . . . 75.120000000000005 107.281 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 15.9 tpt -64.26 130.88 45.6 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.27 0.628 . . . . 75.010000000000005 111.529 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.88 -172.41 2.87 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.166 1.386 . . . . 73.519999999999996 109.691 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.04 -70.18 0.26 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.074 0.94 . . . . 61.009999999999998 110.668 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -114.88 -41.52 3.35 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 113.63 -1.623 . . . . 75.129999999999995 111.387 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -116.3 102.97 1.11 Allowed Glycine 0 C--N 1.349 1.294 0 CA-C-O 118.468 -1.184 . . . . 22.120000000000001 111.652 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.33 137.99 78.14 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.251 2.634 . . . . 71.409999999999997 112.625 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.623 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 91.0 t -90.37 163.46 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.451 1.1 . . . . 74.010000000000005 108.955 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -146.19 127.9 15.25 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.704 -1.221 . . . . 65.310000000000002 107.704 170.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.453 HG11 HD11 ' A' ' 233' ' ' LEU . 14.0 p -116.94 140.99 37.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 C-N-CA 123.722 0.809 . . . . 64.140000000000001 110.276 -174.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.93 106.82 5.81 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.59 -0.732 . . . . 63.200000000000003 109.052 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.91 128.61 92.75 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.755 0.822 . . . . 74.209999999999994 109.253 173.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -59.39 149.58 80.5 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.956 2.438 . . . . 65.340000000000003 111.961 170.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.39 132.18 39.78 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 121.751 1.634 . . . . 70.409999999999997 110.77 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 52.92 69.88 0.64 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.287 1.435 . . . . 64.430000000000007 112.672 -173.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.502 HG23 ' HD2' ' A' ' 231' ' ' ARG . 32.5 m -92.06 138.42 31.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.222 -1.354 . . . . 61.409999999999997 110.135 170.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.422 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 26.3 mp0 -103.55 162.31 13.15 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.555 0.742 . . . . 74.209999999999994 111.044 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.455 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.76 155.88 24.02 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.187 -1.37 . . . . 74.299999999999997 111.741 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.07 -10.03 59.98 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 111.847 -0.501 . . . . 71.400000000000006 111.847 -173.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.502 ' HD2' HG23 ' A' ' 227' ' ' THR . 71.4 mtt85 -72.38 -179.52 2.98 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.067 0.947 . . . . 62.109999999999999 110.307 168.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.504 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.4 ptmt -167.8 153.23 7.1 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.88 -0.6 . . . . 74.450000000000003 109.909 171.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.574 HD12 HD11 ' A' ' 251' ' ' LEU . 85.4 mt -83.58 152.48 24.82 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.358 -0.608 . . . . 61.450000000000003 109.358 169.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -118.65 110.08 16.89 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 124.833 1.333 . . . . 63.32 107.593 168.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 58.6 mt -116.98 117.8 30.66 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.728 -0.669 . . . . 74.010000000000005 110.07 -171.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' ' 248' ' ' ASP . 27.2 mmtp -93.03 132.39 37.17 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.702 -0.481 . . . . 74.200000000000003 109.702 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.81 20.72 73.11 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 124.261 0.976 . . . . 54.329999999999998 112.912 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 26.6 mmtp -116.86 -5.47 11.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.178 0.807 . . . . 74.420000000000002 113.178 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.61 -172.32 46.78 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-O 119.794 -0.448 . . . . 53.039999999999999 112.124 166.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -58.77 139.14 86.56 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.077 0.551 . . . . 74.430000000000007 111.765 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.485 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 6.3 Cg_exo -76.61 136.8 17.61 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.728 2.285 . . . . 70.040000000000006 111.508 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -130.93 170.16 21.35 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.952 -0.567 . . . . 54.140000000000001 112.764 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.52 -28.9 21.03 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.892 2.395 . . . . 71.430000000000007 112.26 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.59 22.17 12.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.855 0.862 . . . . 72.030000000000001 110.849 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.91 169.44 24.26 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 111.115 -0.794 . . . . 72.319999999999993 111.115 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 96.6 mtt180 -73.78 175.1 7.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.711 0.767 . . . . 73.140000000000001 111.994 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.46 -167.43 33.93 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.193 -1.367 . . . . 63.43 112.147 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.524 ' HB3' ' HD3' ' A' ' 236' ' ' LYS . 2.2 p-10 -118.69 176.94 5.03 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.682 0.793 . . . . 74.310000000000002 110.41 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 27.2 tp -145.82 109.55 4.8 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.236 0.541 . . . . 74.319999999999993 110.973 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 16.9 m-85 -102.16 116.14 32.03 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.449 -0.945 . . . . 64.450000000000003 108.449 174.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.0 pp -127.91 115.24 18.27 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.138 0.792 . . . . 54.020000000000003 113.138 -175.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.42 119.6 13.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.392 1.477 . . . . 72.439999999999998 112.856 -170.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.523 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 57.4 t -70.82 120.75 19.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-N 114.57 -1.196 . . . . 72.129999999999995 111.105 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -113.59 129.01 56.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.564 1.146 . . . . 63.509999999999998 108.908 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.455 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 31.9 mm -94.88 99.59 9.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.643 -1.243 . . . . 73.319999999999993 107.643 173.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 124.877 1.271 . . . . 73.109999999999999 108.436 -171.89 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.501 ' N ' ' SD ' ' A' ' 168' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 108.393 -0.966 . . . . 61.140000000000001 108.393 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -76.22 139.27 41.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.656 -0.702 . . . . 72.329999999999998 110.389 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.614 HG22 ' HA2' ' A' ' 174' ' ' GLY . 82.2 p -89.28 120.62 30.8 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.117 -0.947 . . . . 75.140000000000001 109.39 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.12 74.82 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.551 -0.907 . . . . 75.329999999999998 108.551 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.472 HG22 HG22 ' A' ' 219' ' ' VAL . 1.1 m -147.14 -40.76 0.19 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.592 -1.262 . . . . 61.119999999999997 107.592 162.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.96 159.73 14.97 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.719 0.808 . . . . 64.010000000000005 111.681 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.614 ' HA2' HG22 ' A' ' 170' ' ' THR . . . -92.08 -88.95 1.48 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 114.885 -1.052 . . . . 52.130000000000003 111.994 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.408 ' CB ' ' HB2' ' A' ' 179' ' ' LYS . 12.8 pt-20 -150.85 165.61 33.07 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.588 0.709 . . . . 73.209999999999994 112.801 -175.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.512 ' CZ3' HG21 ' A' ' 227' ' ' THR . 34.5 m95 -87.03 -86.74 0.15 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 113.654 -1.612 . . . . 75.209999999999994 110.577 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -127.53 15.59 7.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.794 0.838 . . . . 74.319999999999993 110.548 -168.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.02 86.9 0.58 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.462 -1.455 . . . . 65.239999999999995 109.462 -168.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.408 ' HB2' ' CB ' ' A' ' 175' ' ' GLU . 14.4 tmtt? -64.02 100.0 0.29 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.607 -0.886 . . . . 73.540000000000006 108.607 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.08 -40.52 0.42 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 114.827 -1.079 . . . . 63.420000000000002 110.67 -171.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.5 t -162.48 -52.32 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.613 0.765 . . . . 73.420000000000002 109.329 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 145.22 -166.73 27.54 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.264 -0.88 . . . . 72.430000000000007 111.712 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 143.64 -96.67 0.19 Allowed Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.435 -0.666 . . . . 52.119999999999997 111.435 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 69.0 p -158.77 132.67 7.65 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.433 1.093 . . . . 75.129999999999995 108.961 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 234' ' ' ARG . . . -87.87 -43.07 5.82 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-O 121.22 0.344 . . . . 73.340000000000003 112.797 -176.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 113.3 162.11 14.9 Favored Glycine 0 N--CA 1.467 0.736 0 O-C-N 122.49 -0.418 . . . . 54.109999999999999 112.063 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.1 t -163.89 128.3 2.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.726 0.81 . . . . 65.200000000000003 109.0 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.15 161.55 10.89 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-O 120.231 -0.205 . . . . 73.540000000000006 112.592 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 140.51 -158.01 25.89 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.094 0.378 . . . . 71.329999999999998 112.262 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 58.0 p -118.8 151.84 37.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.968 0.907 . . . . 63.329999999999998 108.651 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.97 8.82 4.16 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.054 0.942 . . . . 72.329999999999998 112.347 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -90.1 148.3 23.1 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.106 0.962 . . . . 72.340000000000003 110.292 -169.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.0 mt -111.59 143.39 42.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.196 0.599 . . . . 51.229999999999997 110.653 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -113.41 114.82 27.13 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.594 -0.891 . . . . 61.229999999999997 108.594 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -128.13 -172.56 2.72 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.238 1.015 . . . . 55.219999999999999 109.603 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.504 HG23 ' HG2' ' A' ' 254' ' ' ARG . 88.0 m -111.69 150.19 30.54 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.997 0.919 . . . . 72.530000000000001 110.442 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.558 HD22 ' HG ' ' A' ' 233' ' ' LEU . 16.7 tp -110.29 103.29 11.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.61 -1.626 . . . . 73.140000000000001 106.61 162.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.85 99.44 12.12 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.676 -0.861 . . . . 72.430000000000007 108.676 -173.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.651 HG22 HG21 ' A' ' 210' ' ' VAL . 15.6 t -106.73 113.02 63.29 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.118 -0.946 . . . . 74.040000000000006 108.518 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.31 148.37 88.39 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.531 1.487 . . . . 62.119999999999997 110.325 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.415 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -51.69 -44.28 89.9 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 117.725 -1.131 . . . . 72.540000000000006 112.579 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.1 Cg_endo -56.49 -49.94 13.41 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 122.052 1.835 . . . . 45.310000000000002 112.665 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.467 HG21 HG13 ' A' ' 210' ' ' VAL . 38.2 mt -65.36 -32.94 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.225 0.61 . . . . 74.030000000000001 110.818 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.84 -47.35 78.29 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.031 0.532 . . . . 43.210000000000001 110.344 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -70.25 -49.21 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.25 1.02 . . . . 52.420000000000002 111.945 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.0 p -79.68 -27.4 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.375 0.27 . . . . 72.010000000000005 110.715 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.3 70.6 1.34 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 112.217 -0.353 . . . . 71.409999999999997 112.217 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.33 -123.48 5.2 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 120.031 -0.316 . . . . 71.450000000000003 112.797 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -150.22 137.12 19.29 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.97 0.908 . . . . 73.239999999999995 110.052 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.651 HG21 HG22 ' A' ' 199' ' ' VAL . 29.6 m -139.17 156.68 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 123.427 0.691 . . . . 75.329999999999998 111.317 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -77.6 141.47 39.47 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.007 0.923 . . . . 63.140000000000001 111.535 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.504 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -116.4 116.59 27.98 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.421 1.488 . . . . 72.030000000000001 108.477 172.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -66.21 130.64 43.93 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.864 0.865 . . . . 74.400000000000006 111.189 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.2 -171.2 2.69 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.323 1.049 . . . . 62.420000000000002 110.132 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 215' ' ' LEU . 7.1 mt -68.28 -66.83 0.52 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.881 1.273 . . . . 60.5 111.205 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -105.5 -42.32 5.25 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 113.229 -1.805 . . . . 71.409999999999997 111.385 -165.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -137.49 145.16 16.79 Favored Glycine 0 N--CA 1.467 0.765 0 CA-C-O 118.695 -1.059 . . . . 63.539999999999999 111.716 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.65 137.92 23.24 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.165 1.91 . . . . 74.409999999999997 112.38 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 172' ' ' THR . 50.5 t -95.39 164.67 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 114.475 -1.239 . . . . 64.120000000000005 108.104 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -144.41 144.32 31.35 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.416 -1.327 . . . . 74.319999999999993 107.416 175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.459 HG11 HD21 ' A' ' 197' ' ' LEU . 15.0 p -135.65 140.39 44.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 123.223 0.609 . . . . 74.530000000000001 110.824 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.56 112.6 9.79 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.803 0.841 . . . . 45.119999999999997 109.392 172.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 176' ' ' TRP . 83.8 t -76.74 132.61 71.43 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.533 0.733 . . . . 72.349999999999994 109.406 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.3 155.58 68.76 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.803 2.336 . . . . 74.019999999999996 111.353 169.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -65.63 136.22 45.2 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.001 1.801 . . . . 74.5 111.865 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 49.4 69.53 0.58 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.571 1.549 . . . . 63.340000000000003 112.773 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.512 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 86.2 m -90.4 144.39 25.86 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.527 -1.215 . . . . 72.430000000000007 110.703 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -107.56 156.95 18.45 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.427 1.091 . . . . 63.409999999999997 110.556 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.05 155.45 30.63 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.481 -1.236 . . . . 50.299999999999997 110.518 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.78 -16.94 43.0 Favored Glycine 0 N--CA 1.471 0.984 0 N-CA-C 111.349 -0.7 . . . . 75.150000000000006 111.349 -173.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 227' ' ' THR . 76.1 mtt85 -71.02 -178.96 2.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.247 1.019 . . . . 74.439999999999998 109.91 167.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.56 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 8.4 ptmt -167.05 159.97 13.61 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.191 0.307 . . . . 74.010000000000005 110.773 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.581 HD12 HD11 ' A' ' 251' ' ' LEU . 85.5 mt -88.19 147.29 24.94 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.35 -0.611 . . . . 73.310000000000002 109.35 168.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 185' ' ' GLY . 16.1 ptt180 -113.68 107.17 15.4 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 124.675 1.235 . . . . 73.239999999999995 107.733 166.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.553 HD12 HD23 ' A' ' 249' ' ' LEU . 70.4 mt -110.07 110.72 21.71 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.482 0.713 . . . . 74.439999999999998 109.45 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -83.41 121.07 26.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.015 -0.993 . . . . 72.409999999999997 111.078 -167.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.8 2.53 88.56 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.236 -0.893 . . . . 64.409999999999997 113.341 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.546 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 48.2 mmtm -94.05 4.68 53.56 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.618 0.767 . . . . 73.400000000000006 111.814 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.97 -175.37 49.95 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.479 -1.048 . . . . 55.149999999999999 110.479 166.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -62.77 136.54 96.38 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-N 117.579 0.689 . . . . 74.340000000000003 110.906 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.499 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 55.9 Cg_endo -69.51 143.88 53.53 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.307 2.005 . . . . 74.310000000000002 112.21 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.21 167.29 23.47 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 119.471 -0.627 . . . . 71.019999999999996 112.489 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.77 -22.22 32.32 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 123.157 2.571 . . . . 72.310000000000002 113.887 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.2 1.05 16.02 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.278 0.631 . . . . 54.030000000000001 111.684 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.54 159.6 8.46 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.517 -0.633 . . . . 75.510000000000005 111.517 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 51.9 mtm180 -83.35 169.79 15.25 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.374 0.67 . . . . 75.209999999999994 111.438 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.74 -174.79 35.21 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.366 -0.834 . . . . 32.049999999999997 111.684 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -126.12 150.55 48.15 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.144 0.497 . . . . 64.519999999999996 110.209 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.553 HD23 HD12 ' A' ' 235' ' ' LEU . 37.6 tp -109.09 108.72 19.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.818 0.847 . . . . 73.200000000000003 109.95 -171.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.56 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 54.1 m-85 -104.29 116.32 31.95 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.402 1.081 . . . . 74.299999999999997 108.458 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.2 pp -130.08 115.19 16.73 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.386 0.884 . . . . 72.219999999999999 113.386 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -68.82 119.52 13.31 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.834 1.254 . . . . 74.109999999999999 112.061 -170.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.543 HG23 ' HA ' ' A' ' 232' ' ' LYS . 66.6 t -65.13 124.92 21.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 CA-C-N 114.558 -1.201 . . . . 73.519999999999996 110.649 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.504 ' HG2' HG23 ' A' ' 196' ' ' THR . 14.1 mmm180 -119.41 135.27 54.82 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.062 1.345 . . . . 71.340000000000003 108.539 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.41 111.12 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 107.888 -1.153 . . . . 74.030000000000001 107.888 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.564 1.517 0 CA-C-O 117.644 -1.169 . . . . 75.420000000000002 108.819 -171.819 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 53.0 mtm . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.133 -0.691 . . . . 72.519999999999996 109.133 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.46 -175.71 2.8 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.628 0.771 . . . . 74.030000000000001 109.599 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 8.1 t -80.79 68.61 7.09 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 122.122 0.963 . . . . 71.329999999999998 110.491 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -172.42 155.38 3.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.33 1.052 . . . . 43.450000000000003 109.188 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 11.7 m -76.87 -26.61 54.44 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.56 0.744 . . . . 71.140000000000001 110.064 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -90.34 143.23 26.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.532 0.733 . . . . 72.450000000000003 111.104 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.29 -75.6 0.42 Allowed Glycine 0 C--N 1.344 0.98 0 O-C-N 123.912 0.758 . . . . 73.299999999999997 112.358 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -158.14 171.27 20.53 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.906 0.882 . . . . 70.420000000000002 111.085 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.592 ' HB2' ' HB3' ' A' ' 179' ' ' LYS . 16.0 m95 -85.27 -69.56 0.65 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.811 -1.086 . . . . 73.420000000000002 108.661 168.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.441 ' HA ' ' NH1' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -173.19 -131.99 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 105.808 -1.923 . . . . 50.130000000000003 105.808 -175.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -80.0 66.08 3.65 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 110.279 -1.128 . . . . 53.310000000000002 110.279 162.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 176' ' ' TRP . 20.6 pttp -58.33 117.39 4.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.265 1.026 . . . . 71.299999999999997 111.817 -172.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 127.77 -28.13 4.49 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.194 -0.912 . . . . 72.310000000000002 112.279 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.2 p -141.35 -54.46 0.47 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.117 0.567 . . . . 73.120000000000005 110.702 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -67.17 140.84 38.35 Favored Glycine 0 C--N 1.353 1.513 0 CA-C-O 119.726 -0.485 . . . . 72.230000000000004 112.235 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.481 ' HA2' ' HG2' ' A' ' 231' ' ' ARG . . . -135.49 -3.86 2.61 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 117.391 0.595 . . . . 72.540000000000006 114.481 -172.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 50.0 m -93.91 118.3 31.29 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 117.818 0.809 . . . . 72.340000000000003 111.084 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.52 159.27 16.16 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.942 -0.863 . . . . 75.510000000000005 110.942 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.71 170.28 33.46 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 114.737 0.655 . . . . 55.240000000000002 114.737 -171.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 37.3 p -76.13 165.26 25.18 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.276 1.03 . . . . 72.040000000000006 110.83 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -57.93 146.13 39.44 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 123.756 0.66 . . . . 71.209999999999994 114.527 -172.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.17 -87.47 1.72 Allowed Glycine 0 C--N 1.347 1.187 0 CA-C-N 116.848 0.324 . . . . 73.430000000000007 113.402 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.3 m -154.27 129.64 9.79 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.169 0.988 . . . . 72.120000000000005 109.288 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.469 ' HB2' ' HA3' ' A' ' 247' ' ' GLY . 22.8 mt-30 59.83 20.02 8.9 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.342 1.057 . . . . 63.229999999999997 110.346 -174.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.0 p-10 -80.54 155.98 26.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 113.746 -1.57 . . . . 74.5 111.672 -164.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.8 mt -123.45 132.79 54.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.204 -0.907 . . . . 61.299999999999997 110.215 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -93.32 129.99 39.23 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.579 -0.897 . . . . 71.219999999999999 108.579 167.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -138.65 -171.85 3.16 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.12 -0.696 . . . . 62.200000000000003 109.12 175.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.1 m -127.74 119.45 25.81 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.423 0.689 . . . . 55.509999999999998 110.778 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.516 HD22 ' HG ' ' A' ' 233' ' ' LEU . 17.3 tp -81.47 105.25 12.48 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.152 -1.055 . . . . 71.120000000000005 108.152 171.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -92.36 99.5 12.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.825 0.821 . . . . 73.239999999999995 108.85 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.682 HG22 HG21 ' A' ' 210' ' ' VAL . 22.8 t -101.15 121.71 51.04 Favored Pre-proline 0 C--N 1.347 0.465 0 N-CA-C 107.645 -1.242 . . . . 75.230000000000004 107.645 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.97 149.52 71.99 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 121.76 1.64 . . . . 71.400000000000006 110.243 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.423 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.61 -45.95 85.55 Favored Pre-proline 0 CA--C 1.56 1.365 0 O-C-N 124.2 0.937 . . . . 74.25 113.075 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.9 Cg_endo -57.47 -48.83 15.61 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 121.979 1.786 . . . . 61.43 113.67 176.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.435 HG21 HG13 ' A' ' 210' ' ' VAL . 47.9 mt -66.91 -32.47 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 122.813 0.445 . . . . 74.010000000000005 110.632 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.8 95.2 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.228 -0.442 . . . . 40.229999999999997 110.725 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.23 -51.68 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.612 0.765 . . . . 74.140000000000001 111.816 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.5 p -78.95 -22.42 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 120.753 0.311 . . . . 70.329999999999998 110.871 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 75.64 62.18 2.75 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 115.635 -0.711 . . . . 63.100000000000001 111.902 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.26 -120.68 2.73 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.25 -0.34 . . . . 70.040000000000006 112.25 -175.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -146.94 140.84 25.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.691 0.796 . . . . 70.349999999999994 109.259 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.682 HG21 HG22 ' A' ' 199' ' ' VAL . 19.1 m -137.19 152.61 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.301 0.64 . . . . 61.439999999999998 110.58 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -77.8 140.6 39.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.752 0.821 . . . . 73.129999999999995 110.75 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.03 115.8 29.51 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.497 -1.298 . . . . 73.230000000000004 107.497 172.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.9 tpt -63.49 127.55 31.81 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.229 0.612 . . . . 64.109999999999999 110.894 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.29 -170.23 2.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.786 1.234 . . . . 70.540000000000006 109.696 -175.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.04 -68.79 0.52 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.27 1.033 . . . . 72.010000000000005 111.224 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.19 -37.64 5.5 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 113.265 -1.789 . . . . 72.409999999999997 110.765 -165.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -133.31 119.25 2.3 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 118.566 -1.13 . . . . 51.539999999999999 110.669 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.09 141.44 52.79 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.53 2.153 . . . . 73.209999999999994 112.833 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 71.0 t -92.62 165.9 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 114.466 -1.243 . . . . 74.420000000000002 109.056 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -146.75 136.88 23.51 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 108.028 -1.101 . . . . 55.32 108.028 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.541 HG21 HD21 ' A' ' 233' ' ' LEU . 14.5 p -130.17 142.18 44.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.446 0.698 . . . . 75.310000000000002 110.809 -172.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.22 113.45 12.6 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.154 -0.684 . . . . 44.439999999999998 109.154 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.9 t -74.09 136.6 76.07 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 123.562 0.745 . . . . 65.420000000000002 109.146 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.86 154.04 67.78 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.259 1.973 . . . . 72.209999999999994 111.575 170.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.87 132.35 36.8 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.531 2.154 . . . . 64.310000000000002 111.916 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 49.56 72.84 0.28 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.139 1.375 . . . . 75.299999999999997 112.378 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.564 HG23 ' HD2' ' A' ' 231' ' ' ARG . 67.8 m -82.8 141.95 31.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.307 -1.315 . . . . 44.450000000000003 110.923 174.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.494 ' H ' HH11 ' A' ' 231' ' ' ARG . 27.0 mp0 -100.42 151.62 21.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.997 0.919 . . . . 73.420000000000002 110.314 171.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -75.94 156.84 33.84 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.049 -0.978 . . . . 42.020000000000003 111.078 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.57 -2.42 62.6 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.242 -0.435 . . . . 73.019999999999996 112.291 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.564 ' HD2' HG23 ' A' ' 227' ' ' THR . 28.3 mtt85 -77.17 -175.22 3.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.513 0.725 . . . . 32.350000000000001 109.737 168.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 9.3 ptmt -167.38 154.75 8.76 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 110.488 -0.189 . . . . 54.509999999999998 110.488 170.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.647 HD12 HD11 ' A' ' 251' ' ' LEU . 48.8 mt -80.0 143.58 33.99 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 110.118 -0.326 . . . . 51.399999999999999 110.118 167.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.441 ' NH1' ' HA ' ' A' ' 177' ' ' GLN . 7.8 ptp85 -109.89 108.39 18.67 Favored 'General case' 0 C--O 1.243 0.716 0 O-C-N 125.299 1.624 . . . . 63.020000000000003 108.39 166.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.519 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 65.9 mt -115.03 138.85 50.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.228 -0.896 . . . . 60.530000000000001 109.31 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -108.96 141.05 41.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.201 0.6 . . . . 72.400000000000006 109.44 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 68.58 24.16 75.28 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 124.194 0.934 . . . . 70.430000000000007 112.956 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 45.5 mmtm -117.43 -11.07 10.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.429 0.692 . . . . 75.430000000000007 112.331 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.85 -168.83 40.14 Favored Glycine 0 N--CA 1.479 1.531 0 CA-C-O 119.627 -0.541 . . . . 75.109999999999999 111.911 171.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -66.64 142.48 97.6 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-N 117.811 0.805 . . . . 74.420000000000002 111.651 -173.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.22 141.79 48.46 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.3 2.666 . . . . 74.510000000000005 112.647 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -135.82 172.23 22.36 Favored Glycine 0 N--CA 1.476 1.346 0 C-N-CA 123.243 0.449 . . . . 75.340000000000003 113.123 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.02 -25.51 44.2 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.031 2.487 . . . . 65.150000000000006 112.409 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.99 21.71 8.37 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.526 0.73 . . . . 71.310000000000002 111.623 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 103.03 -172.2 21.36 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 110.495 -1.042 . . . . 75.420000000000002 110.495 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.45 149.57 22.55 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 117.693 0.746 . . . . 74.209999999999994 110.633 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 191' ' ' GLN . . . -79.1 -173.59 44.19 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.907 0.754 . . . . 71.430000000000007 114.394 -173.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 6.9 p-10 -105.07 167.5 9.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.348 0.659 . . . . 55.210000000000001 110.917 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.486 HD23 HD12 ' A' ' 235' ' ' LEU . 42.2 tp -137.98 110.62 7.57 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.524 0.73 . . . . 73.219999999999999 109.381 -174.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.583 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 20.8 m-85 -108.75 118.86 37.89 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.886 -0.783 . . . . 75.549999999999997 108.886 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.647 HD11 HD12 ' A' ' 233' ' ' LEU . 1.6 pp -130.7 114.83 15.87 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.064 0.764 . . . . 64.099999999999994 113.064 -175.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -69.04 124.44 23.76 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 124.232 1.013 . . . . 75.319999999999993 113.204 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.581 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 65.5 t -73.72 131.62 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 113.573 -1.649 . . . . 72.349999999999994 111.689 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -121.09 139.2 53.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.447 1.499 . . . . 71.519999999999996 108.15 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 35.0 mm -105.04 103.63 15.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.657 -1.238 . . . . 74.319999999999993 107.657 173.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.557 1.247 0 CA-C-O 117.741 -1.123 . . . . 72.019999999999996 108.625 -174.185 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.444 -0.206 . . . . 63.039999999999999 110.444 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.425 ' HG2' ' H ' ' A' ' 171' ' ' ALA . 38.6 tt0 -171.32 143.02 1.79 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.178 0.991 . . . . 64.409999999999997 109.19 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 34.7 p -63.98 -36.18 83.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.763 0.825 . . . . 72.409999999999997 111.935 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.425 ' H ' ' HG2' ' A' ' 169' ' ' GLU . . . -79.96 139.81 36.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.006 0.522 . . . . 73.420000000000002 110.9 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.6 m -81.67 -22.66 37.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.905 0.882 . . . . 73.109999999999999 109.804 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -86.91 148.68 25.25 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.469 -0.787 . . . . 64.430000000000007 111.067 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -67.63 -100.54 0.03 OUTLIER Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.167 -0.773 . . . . 64.219999999999999 111.167 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -130.11 173.6 10.59 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.946 0.499 . . . . 72.510000000000005 109.861 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.619 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 16.1 m95 -72.32 -81.52 0.05 Allowed 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.152 -0.931 . . . . 62.210000000000001 108.997 168.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -172.12 121.46 0.46 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.215 0.606 . . . . 70.109999999999999 109.664 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.47 7.55 88.4 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 114.195 0.438 . . . . 72.329999999999998 114.195 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.404 ' HE2' ' HA ' ' A' ' 179' ' ' LYS . 0.4 OUTLIER -80.04 -33.01 39.43 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.686 0.794 . . . . 71.340000000000003 109.904 177.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -112.63 -98.59 2.38 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.827 -0.624 . . . . 55.420000000000002 111.645 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -73.05 122.99 22.66 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 122.983 0.513 . . . . 61.350000000000001 111.859 -171.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -83.67 59.97 4.91 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.899 -0.481 . . . . 73.420000000000002 111.899 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -168.33 151.95 19.43 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.987 -0.445 . . . . 64.540000000000006 111.987 -175.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.1 t -166.11 97.47 0.62 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.447 1.099 . . . . 61.109999999999999 108.857 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.73 64.79 0.05 OUTLIER Glycine 0 C--N 1.345 1.071 0 N-CA-C 112.084 -0.406 . . . . 64.030000000000001 112.084 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -166.31 62.66 0.22 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.715 -0.554 . . . . 74.25 111.715 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.3 p -86.63 92.51 8.94 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.528 0.731 . . . . 64.310000000000002 110.426 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -79.77 85.9 1.27 Allowed Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.617 -0.593 . . . . 62.340000000000003 111.617 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 86.23 -129.07 9.18 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 110.827 -0.909 . . . . 54.450000000000003 110.827 -171.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.8 m -146.24 -89.99 0.09 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.016 0.526 . . . . 65.239999999999995 109.753 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 54.61 16.58 1.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.591 1.156 . . . . 75.439999999999998 113.007 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -100.14 172.79 6.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.202 0.601 . . . . 72.329999999999998 110.839 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.4 mt -135.14 142.48 46.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.478 0.711 . . . . 63.350000000000001 110.408 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -106.77 111.2 23.62 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.144 -1.428 . . . . 74.109999999999999 107.144 165.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.623 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -123.67 -171.33 2.29 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.698 0.799 . . . . 44.039999999999999 110.167 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.1 m -113.64 145.87 40.63 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.483 1.113 . . . . 62.210000000000001 110.434 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.561 HD23 HG22 ' A' ' 253' ' ' VAL . 18.4 tp -113.32 104.94 12.82 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.695 -1.595 . . . . 70.239999999999995 106.695 167.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.58 100.18 9.99 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.704 -0.85 . . . . 74.200000000000003 108.704 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.686 ' HA ' HG11 ' A' ' 210' ' ' VAL . 20.9 t -110.88 103.01 54.05 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.281 -1.007 . . . . 72.420000000000002 108.281 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.05 144.87 77.53 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.522 1.481 . . . . 74.230000000000004 109.876 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.41 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.03 -41.2 78.62 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 117.743 -1.122 . . . . 72.420000000000002 113.08 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.4 Cg_endo -55.28 -46.22 34.33 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.828 1.685 . . . . 71.150000000000006 113.06 173.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.413 HG21 HG13 ' A' ' 210' ' ' VAL . 52.0 mt -69.73 -34.82 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.35 0.66 . . . . 53.340000000000003 110.616 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.13 91.11 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 122.756 0.422 . . . . 72.340000000000003 110.593 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.89 -49.6 62.0 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 O-C-N 124.543 1.152 . . . . 72.420000000000002 111.481 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.7 p -79.0 -23.88 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 122.474 0.31 . . . . 62.240000000000002 110.738 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.51 71.62 1.11 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.466 -0.654 . . . . 75.219999999999999 111.466 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.27 -129.57 6.74 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.765 -0.534 . . . . 64.409999999999997 111.765 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -138.85 144.53 39.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.778 0.831 . . . . 45.030000000000001 109.537 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.0 m -137.02 153.73 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 115.665 -0.698 . . . . 73.239999999999995 110.564 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -74.9 143.51 43.75 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.515 0.726 . . . . 74.400000000000006 110.569 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.572 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -116.04 113.15 22.8 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.146 1.378 . . . . 72.329999999999998 107.946 172.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.5 tpt -64.87 122.88 17.99 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.342 1.057 . . . . 62.420000000000002 111.002 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.521 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -124.09 -171.07 2.25 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.787 1.235 . . . . 75.219999999999999 109.084 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.506 ' H ' HG22 ' A' ' 214' ' ' THR . 7.0 mt -60.27 -67.26 0.41 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.632 1.173 . . . . 72.319999999999993 111.42 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -109.48 -42.53 4.31 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.105 -1.861 . . . . 61.32 110.918 -163.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -131.86 157.42 22.4 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-O 118.916 -0.936 . . . . 75.120000000000005 111.308 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -86.3 143.31 7.63 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.966 1.778 . . . . 73.129999999999995 113.064 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 64.4 t -98.43 167.57 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 114.256 -1.338 . . . . 74.129999999999995 108.038 174.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -143.53 145.46 32.58 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.444 -0.947 . . . . 73.109999999999999 108.444 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.86 141.24 42.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.404 0.681 . . . . 73.420000000000002 110.123 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.84 112.74 10.25 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.565 -0.902 . . . . 72.209999999999994 108.565 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.7 t -73.27 132.46 81.98 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 108.558 -0.905 . . . . 75.109999999999999 108.558 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.6 153.25 76.16 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.667 2.244 . . . . 65.230000000000004 111.525 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -64.57 136.07 48.5 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 121.89 1.727 . . . . 73.129999999999995 111.979 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 53.24 54.11 10.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.469 1.508 . . . . 71.219999999999999 113.275 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.518 HG23 ' HD2' ' A' ' 231' ' ' ARG . 19.4 m -80.02 138.2 36.97 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.92 -0.582 . . . . 64.030000000000001 111.403 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -96.16 160.04 14.64 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.124 0.969 . . . . 55.039999999999999 111.135 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -79.88 156.02 27.52 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.314 -1.312 . . . . 74.549999999999997 110.858 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.64 -18.61 43.77 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 111.958 -0.457 . . . . 65.349999999999994 111.958 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.518 ' HD2' HG23 ' A' ' 227' ' ' THR . 78.0 mtt85 -68.48 178.79 1.87 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.039 0.935 . . . . 52.119999999999997 109.986 167.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.562 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.2 ptmt -167.02 154.94 9.45 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.142 0.276 . . . . 64.109999999999999 110.492 173.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.595 HD12 HD11 ' A' ' 251' ' ' LEU . 82.3 mt -81.66 146.09 30.22 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 108.811 -0.811 . . . . 74.109999999999999 108.811 167.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -116.1 106.99 14.36 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.808 -1.182 . . . . 73.140000000000001 107.808 165.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 249' ' ' LEU . 58.6 mt -107.97 108.44 19.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.788 -1.097 . . . . 73.230000000000004 109.202 -173.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -82.88 121.92 27.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.822 -1.081 . . . . 72.099999999999994 110.337 -170.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.06 9.93 79.44 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 124.307 1.004 . . . . 23.550000000000001 113.894 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.501 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 46.5 mmtm -99.46 6.25 46.0 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.75 0.775 . . . . 71.239999999999995 112.542 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.35 -174.75 50.24 Favored Glycine 0 N--CA 1.472 1.099 0 O-C-N 123.319 0.387 . . . . 73.030000000000001 112.291 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -58.35 142.55 81.53 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 123.857 0.863 . . . . 75.319999999999993 112.993 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.416 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 48.9 Cg_endo -67.23 132.32 27.38 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.301 2.668 . . . . 74.209999999999994 112.791 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.07 -178.37 15.51 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 115.213 -0.903 . . . . 75.219999999999999 112.913 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.15 -25.78 21.98 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 123.101 2.534 . . . . 72.019999999999996 112.686 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.24 22.11 16.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.308 1.043 . . . . 33.329999999999998 111.006 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 98.98 -172.88 26.07 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.142 -0.783 . . . . 51.299999999999997 111.142 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 68.7 mtm180 -85.41 156.93 20.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.899 0.479 . . . . 72.219999999999999 111.722 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.8 -154.86 6.05 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 123.941 0.776 . . . . 70.430000000000007 111.799 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -121.75 166.36 14.44 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.899 0.85 . . . . 73.019999999999996 110.825 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.541 HD23 HD12 ' A' ' 235' ' ' LEU . 46.6 tp -126.78 107.22 9.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.496 0.718 . . . . 71.140000000000001 109.194 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -105.08 111.3 24.02 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.966 -1.124 . . . . 75.329999999999998 107.966 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.8 pp -125.9 120.9 31.64 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.709 1.003 . . . . 74.530000000000001 113.709 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -69.26 123.81 22.16 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.733 1.613 . . . . 74.420000000000002 112.624 -171.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.619 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 90.4 t -71.86 119.23 18.01 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 C-N-CA 124.821 1.249 . . . . 75.420000000000002 111.077 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -113.82 115.41 27.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.626 1.57 . . . . 73.430000000000007 107.883 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.87 96.0 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.868 -1.16 . . . . 74.519999999999996 107.868 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.556 1.202 0 C-N-CA 124.539 1.135 . . . . 43.399999999999999 109.076 -171.91 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 121.416 0.627 . . . . 63.439999999999998 109.456 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.21 96.6 10.61 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.877 -1.157 . . . . 71.140000000000001 107.877 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.4 m -136.39 135.41 38.74 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.365 -0.834 . . . . 72.430000000000007 109.227 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.01 163.64 14.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.298 0.639 . . . . 72.109999999999999 110.251 173.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.2 m -62.24 -21.33 65.08 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.432 0.693 . . . . 71.200000000000003 112.0 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.0 166.8 18.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.781 0.832 . . . . 54.450000000000003 111.713 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.16 -80.96 1.15 Allowed Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.886 -1.052 . . . . 53.149999999999999 111.011 172.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.536 ' HB2' ' HD3' ' A' ' 179' ' ' LYS . 12.7 pt-20 -153.9 175.27 13.55 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.165 0.586 . . . . 71.439999999999998 111.464 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.519 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 23.7 m95 -84.9 -94.9 0.07 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.846 -1.07 . . . . 61.439999999999998 110.743 177.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 179.91 165.47 1.19 Allowed 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.131 0.973 . . . . 72.120000000000005 109.014 -170.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.07 -47.17 3.65 Favored Glycine 0 N--CA 1.476 1.341 0 N-CA-C 111.765 -0.534 . . . . 74.420000000000002 111.765 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.536 ' HD3' ' HB2' ' A' ' 175' ' ' GLU . 13.3 ptmm? -69.09 -11.34 60.7 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.978 0.911 . . . . 74.200000000000003 111.301 165.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.41 86.3 0.08 OUTLIER Glycine 0 C--N 1.348 1.197 0 N-CA-C 110.884 -0.886 . . . . 64.340000000000003 110.884 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.3 m -156.79 172.25 18.95 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.63 1.172 . . . . 44.009999999999998 110.419 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 173.03 -171.31 44.36 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.611 -0.595 . . . . 64.310000000000002 111.611 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.51 75.38 2.32 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.357 -0.697 . . . . 74.230000000000004 111.357 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.3 t -163.63 138.23 6.05 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.382 0.673 . . . . 74.319999999999993 109.694 -176.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -152.81 178.51 29.89 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.672 -0.571 . . . . 63.210000000000001 111.672 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -71.71 157.03 53.02 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 116.679 0.24 . . . . 52.130000000000003 113.537 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.8 p -154.38 145.66 22.94 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.81 0.844 . . . . 61.030000000000001 110.649 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.77 -117.92 4.52 Favored Glycine 0 C--N 1.35 1.307 0 N-CA-C 112.168 -0.373 . . . . 32.310000000000002 112.168 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.3 59.03 4.47 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.125 -0.79 . . . . 62.210000000000001 111.125 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.2 m -68.9 -41.69 77.92 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.935 0.894 . . . . 74.120000000000005 112.216 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 63.88 16.44 9.85 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 124.313 1.008 . . . . 71.340000000000003 112.119 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 5.5 p-10 -75.35 148.37 39.32 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 123.742 0.817 . . . . 73.349999999999994 110.639 -174.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.47 ' HB2' HD13 ' A' ' 249' ' ' LEU . 84.2 mt -119.3 147.55 44.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.328 0.651 . . . . 72.040000000000006 110.092 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 9.0 t80 -109.31 114.93 29.03 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.882 -1.155 . . . . 74.109999999999999 107.882 171.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -127.42 -173.69 2.98 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.729 0.812 . . . . 75.209999999999994 110.441 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 60.3 m -121.52 137.93 54.52 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.519 0.728 . . . . 73.439999999999998 111.071 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.5 tp -108.1 108.81 20.05 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.973 1.309 . . . . 53.310000000000002 107.69 169.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.04 99.35 12.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.42 0.629 . . . . 75.510000000000005 109.611 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.66 HG22 HG21 ' A' ' 210' ' ' VAL . 15.1 t -101.59 111.03 63.34 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.675 -1.231 . . . . 71.239999999999995 107.675 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.55 154.38 74.56 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.85 1.7 . . . . 74.019999999999996 110.418 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.72 -45.37 79.31 Favored Pre-proline 0 CA--C 1.573 1.847 0 CA-C-O 117.809 -1.091 . . . . 63.520000000000003 113.394 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.79 -48.89 13.05 Favored 'Trans proline' 0 C--N 1.402 3.351 0 C-N-CA 121.828 1.685 . . . . 73.310000000000002 112.484 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.475 HG21 HG13 ' A' ' 210' ' ' VAL . 44.4 mt -68.28 -31.2 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.539 0.736 . . . . 62.299999999999997 110.762 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.81 -46.72 77.59 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.0 0.52 . . . . 71.400000000000006 110.585 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.56 -48.33 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 124.417 1.073 . . . . 73.420000000000002 111.954 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.15 -28.58 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 120.678 0.275 . . . . 74.420000000000002 110.715 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.11 76.46 1.0 Allowed Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.626 -0.589 . . . . 72.140000000000001 111.626 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.5 -129.4 6.68 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-O 120.049 -0.306 . . . . 72.299999999999997 112.817 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.72 135.19 29.57 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.965 0.906 . . . . 73.219999999999999 109.132 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.66 HG21 HG22 ' A' ' 199' ' ' VAL . 31.6 m -134.21 149.3 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.573 0.749 . . . . 73.209999999999994 110.547 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -75.95 150.4 37.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.945 0.898 . . . . 74.239999999999995 110.624 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -122.57 121.58 36.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.838 1.255 . . . . 64.239999999999995 108.442 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.23 123.4 19.01 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.732 0.813 . . . . 74.219999999999999 110.217 176.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.3 OUTLIER -126.47 -171.87 2.5 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.552 1.141 . . . . 72.140000000000001 110.206 -176.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.53 -70.34 0.22 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 122.243 1.021 . . . . 72.340000000000003 111.268 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -110.22 -41.59 4.37 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 113.461 -1.7 . . . . 64.230000000000004 110.947 -162.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -132.55 145.86 17.7 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 118.348 -1.251 . . . . 53.439999999999998 110.549 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.82 152.72 64.05 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.125 1.883 . . . . 60.130000000000003 112.628 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 54.1 t -104.09 167.67 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.927 1.291 . . . . 75.310000000000002 108.029 174.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -148.64 146.28 28.13 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 107.815 -1.18 . . . . 75.129999999999995 107.815 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 233' ' ' LEU . 9.6 p -138.5 144.27 30.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 C-N-CA 122.946 0.498 . . . . 61.5 110.8 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.59 112.89 12.41 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 124.035 0.835 . . . . 74.140000000000001 109.675 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.56 134.81 75.71 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.017 0.927 . . . . 41.530000000000001 109.45 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.52 154.34 50.08 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.465 2.11 . . . . 52.439999999999998 111.533 169.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.93 136.97 64.58 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 121.988 1.792 . . . . 72.209999999999994 111.756 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 51.51 70.37 0.55 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.231 1.413 . . . . 75.010000000000005 113.434 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.478 HG23 ' HD2' ' A' ' 231' ' ' ARG . 80.8 m -89.01 143.09 27.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.803 -1.089 . . . . 54.240000000000002 110.655 173.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -107.61 154.85 20.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.294 1.037 . . . . 71.120000000000005 110.35 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.495 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -80.28 150.82 29.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.053 -0.976 . . . . 74.329999999999998 110.823 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.1 -21.3 27.3 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.931 -0.868 . . . . 71.519999999999996 110.931 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.478 ' HD2' HG23 ' A' ' 227' ' ' THR . 72.2 mtt85 -65.34 179.79 0.71 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.09 0.956 . . . . 53.520000000000003 110.525 170.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.729 ' HD3' ' HB3' ' A' ' 250' ' ' TYR . 9.9 ptpt -166.77 159.72 14.03 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.225 0.21 . . . . 74.120000000000005 111.033 171.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.565 HD12 HD11 ' A' ' 251' ' ' LEU . 71.2 mt -87.22 154.16 20.93 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.898 -0.408 . . . . 74.230000000000004 109.898 170.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -117.84 106.75 13.33 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.791 1.307 . . . . 73.450000000000003 108.04 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 44.8 mt -118.13 112.98 20.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.96 -0.564 . . . . 73.129999999999995 110.947 -172.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -90.78 127.4 36.33 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.159 -0.473 . . . . 62.299999999999997 109.935 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 88.23 11.57 66.79 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 123.981 0.8 . . . . 34.530000000000001 112.672 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.515 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.3 mmtt -113.79 -4.93 13.29 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.42 0.688 . . . . 74.329999999999998 111.867 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.72 -176.41 51.43 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.277 -0.729 . . . . 71.120000000000005 111.277 166.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.3 139.96 94.6 Favored Pre-proline 0 N--CA 1.487 1.375 0 CA-C-N 117.718 0.759 . . . . 75.209999999999994 111.405 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.403 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 34.8 Cg_endo -63.26 137.86 63.28 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.838 2.359 . . . . 75.530000000000001 112.516 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.99 169.51 22.89 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.126 -0.488 . . . . 65.310000000000002 113.875 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -71.35 -20.26 27.96 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 123.202 2.601 . . . . 54.219999999999999 112.077 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.1 17.46 15.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.279 1.032 . . . . 41.109999999999999 110.462 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.51 169.35 45.49 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.29 -0.724 . . . . 72.519999999999996 111.29 -170.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 95.5 mtt180 -65.34 158.2 27.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.877 0.871 . . . . 71.230000000000004 111.414 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.47 -164.61 40.46 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.715 -0.675 . . . . 42.229999999999997 112.333 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 8.7 p-10 -110.04 170.99 7.72 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.695 0.76 . . . . 71.439999999999998 110.574 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.66 ' HG ' HD23 ' A' ' 251' ' ' LEU . 33.5 tp -135.02 109.68 8.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.024 -0.989 . . . . 71.0 109.123 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.729 ' HB3' ' HD3' ' A' ' 232' ' ' LYS . 12.3 m-30 -98.29 112.04 24.17 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.37 -1.344 . . . . 63.130000000000003 107.37 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.66 HD23 ' HG ' ' A' ' 249' ' ' LEU . 3.5 pp -124.82 113.52 18.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.673 0.749 . . . . 75.019999999999996 112.863 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.51 119.37 12.2 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.826 1.25 . . . . 64.239999999999995 112.543 -170.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 232' ' ' LYS . 58.5 t -68.07 131.79 33.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 113.858 -1.519 . . . . 73.019999999999996 110.862 174.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -127.35 133.98 50.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.353 1.461 . . . . 74.319999999999993 107.913 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.495 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 34.6 mm -103.36 101.37 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.122 -1.066 . . . . 75.219999999999999 108.122 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.561 1.374 0 CA-C-N 115.045 -0.98 . . . . 37.219999999999999 108.634 -170.429 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' A' ' 168' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 108.482 -0.933 . . . . 71.120000000000005 108.482 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -127.61 151.5 48.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.553 0.741 . . . . 65.519999999999996 110.428 -173.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.8 p -134.84 130.35 35.89 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.298 1.039 . . . . 62.210000000000001 108.714 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 63.78 14.96 8.67 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.663 1.185 . . . . 43.509999999999998 113.652 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 23.6 m -65.03 -26.94 68.48 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.314 0.645 . . . . 74.140000000000001 110.102 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.5 178.34 4.71 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.068 0.947 . . . . 71.109999999999999 111.162 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.04 -86.05 1.79 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.059 -1.616 . . . . 74.099999999999994 109.059 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.29 164.89 29.44 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.389 1.076 . . . . 62.409999999999997 109.651 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.647 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.6 m95 -70.24 -61.67 1.68 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.484 -0.932 . . . . 72.420000000000002 108.484 170.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -174.27 -165.08 0.21 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.502 -1.226 . . . . 70.409999999999997 108.209 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -69.62 78.57 0.35 Allowed Glycine 0 C--N 1.34 0.753 0 N-CA-C 109.484 -1.446 . . . . 71.430000000000007 109.484 163.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -71.1 89.84 0.84 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.215 1.006 . . . . 74.120000000000005 109.562 -170.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.67 -50.5 0.34 Allowed Glycine 0 C--O 1.239 0.466 0 CA-C-N 114.059 -1.428 . . . . 45.32 110.708 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 19.2 t -164.41 143.06 7.14 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.462 0.705 . . . . 71.340000000000003 109.689 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.28 156.17 12.07 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.151 0.282 . . . . 73.510000000000005 112.899 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -90.47 -156.33 32.29 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 122.832 0.254 . . . . 42.509999999999998 112.741 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.5 m -99.75 169.15 9.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.843 0.857 . . . . 73.129999999999995 110.356 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 122.73 141.58 5.98 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 111.99 -0.444 . . . . 72.120000000000005 111.99 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 159.65 62.0 0.01 OUTLIER Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.987 -0.845 . . . . 72.319999999999993 110.987 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.1 t -154.01 129.63 9.99 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.862 0.865 . . . . 62.310000000000002 108.902 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -135.85 -130.81 2.96 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.046 0.216 . . . . 73.040000000000006 112.984 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.34 30.53 4.42 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.403 -0.665 . . . . 71.450000000000003 114.627 -170.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.2 t 71.72 -7.82 1.18 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.812 1.245 . . . . 43.450000000000003 113.26 172.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -69.31 -42.69 75.06 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 108.449 -0.945 . . . . 71.409999999999997 108.449 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 11.4 p-10 -64.97 145.79 55.86 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.585 -1.189 . . . . 74.519999999999996 110.013 171.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.9 mt -124.54 159.01 31.57 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.383 0.611 . . . . 72.219999999999999 111.691 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 8.7 t80 -116.04 109.13 17.1 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.54 -1.209 . . . . 73.349999999999994 108.774 174.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.59 -170.42 1.9 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.502 1.121 . . . . 51.25 109.913 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 98.3 m -117.53 127.77 54.31 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.732 0.813 . . . . 73.310000000000002 110.761 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.648 HD22 ' HG ' ' A' ' 233' ' ' LEU . 17.0 tp -87.84 105.88 17.71 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.866 -1.161 . . . . 43.539999999999999 107.866 165.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -87.1 107.52 18.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.096 -1.076 . . . . 62.43 108.096 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.642 ' HA ' HG11 ' A' ' 210' ' ' VAL . 19.2 t -117.58 115.94 37.12 Favored Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 108.83 -0.804 . . . . 71.109999999999999 108.83 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.01 149.61 77.29 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 121.571 1.514 . . . . 40.130000000000003 110.371 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.441 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.38 -43.96 92.64 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-O 117.75 -1.119 . . . . 62.43 112.571 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.2 Cg_endo -54.42 -52.57 7.91 Favored 'Trans proline' 0 C--N 1.403 3.446 0 C-N-CA 122.291 1.994 . . . . 51.119999999999997 113.077 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.438 HG21 HG13 ' A' ' 210' ' ' VAL . 51.2 mt -64.63 -33.61 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.207 0.603 . . . . 71.230000000000004 111.009 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.48 -46.58 85.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.829 0.452 . . . . 61.530000000000001 110.837 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.86 -50.62 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.004 0.922 . . . . 74.150000000000006 112.316 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.19 -27.01 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-O 120.614 0.245 . . . . 64.299999999999997 110.708 -174.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.96 76.7 0.88 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.021 -0.536 . . . . 54.130000000000003 111.764 -175.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.46 -130.23 6.77 Favored Glycine 0 N--CA 1.476 1.346 0 N-CA-C 111.018 -0.833 . . . . 74.540000000000006 111.018 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -133.13 152.91 51.93 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.568 0.747 . . . . 64.430000000000007 110.434 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 199' ' ' VAL . 30.7 m -139.9 149.77 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.323 -0.853 . . . . 64.400000000000006 109.402 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -73.42 152.62 40.73 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.516 -0.765 . . . . 71.510000000000005 110.673 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -130.73 114.27 15.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.147 1.379 . . . . 75.439999999999998 108.635 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 12.8 tpt -63.91 123.8 19.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.696 1.198 . . . . 74.040000000000006 111.435 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.542 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -121.83 -172.82 2.51 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.709 1.203 . . . . 75.299999999999997 109.371 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.521 ' H ' HG22 ' A' ' 214' ' ' THR . 4.8 mt -64.88 -65.96 0.6 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.191 1.396 . . . . 73.530000000000001 110.254 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -93.17 -37.4 12.12 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 112.227 -2.26 . . . . 62.340000000000003 110.155 -166.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -145.49 -162.43 9.64 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.237 -0.892 . . . . 53.140000000000001 112.429 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -100.66 174.73 0.31 Allowed 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 123.145 2.564 . . . . 72.230000000000004 113.936 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 43.7 t -130.49 167.78 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 126.06 1.744 . . . . 62.340000000000003 106.322 172.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -145.68 120.26 9.76 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.388 -0.967 . . . . 64.430000000000007 108.388 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.449 HG11 HD11 ' A' ' 233' ' ' LEU . 15.0 p -112.53 141.37 28.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 123.99 0.916 . . . . 72.230000000000004 110.095 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.06 115.91 15.21 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.538 -0.912 . . . . 42.340000000000003 108.538 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.92 132.53 74.12 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 108.559 -0.904 . . . . 74.409999999999997 108.559 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.73 149.59 78.79 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.939 2.426 . . . . 64.129999999999995 111.536 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -56.64 129.99 37.61 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.374 2.049 . . . . 51.329999999999998 112.572 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 54.58 68.25 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.456 1.502 . . . . 72.420000000000002 113.478 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.403 HG21 ' CH2' ' A' ' 176' ' ' TRP . 54.0 m -95.05 139.27 31.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.901 -1.045 . . . . 70.530000000000001 110.184 172.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -104.07 163.87 12.1 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.453 1.101 . . . . 74.430000000000007 110.765 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.523 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.4 155.73 24.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.336 -1.302 . . . . 72.010000000000005 110.924 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.95 -5.17 57.84 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 111.878 -0.489 . . . . 71.549999999999997 111.878 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -81.38 -174.96 5.23 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.998 0.919 . . . . 74.230000000000004 109.308 168.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.537 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.6 ptpt -165.98 161.99 17.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.08 0.552 . . . . 62.32 109.692 169.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 251' ' ' LEU . 87.0 mt -85.92 150.71 24.32 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.49 -0.93 . . . . 65.5 108.49 164.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -116.94 106.39 13.38 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.876 -1.157 . . . . 75.150000000000006 107.876 160.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 43.3 mt -102.2 104.39 14.97 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.41 -1.268 . . . . 52.32 108.76 -174.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -79.47 118.81 21.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.164 -1.38 . . . . 74.400000000000006 110.295 -167.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.94 9.59 82.34 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.436 1.085 . . . . 54.25 114.044 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.555 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.4 mmtt -96.29 -0.04 50.19 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 118.249 1.024 . . . . 73.510000000000005 112.772 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.53 -177.35 50.46 Favored Glycine 0 N--CA 1.472 1.066 0 N-CA-C 111.716 -0.553 . . . . 75.420000000000002 111.716 170.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -55.46 126.18 62.1 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 123.568 0.747 . . . . 73.25 111.29 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.502 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 35.2 Cg_endo -65.05 134.72 40.82 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.7 2.267 . . . . 73.219999999999999 111.918 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -117.4 177.34 16.58 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.244 -0.889 . . . . 51.5 112.356 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.39 -33.36 23.57 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.824 2.349 . . . . 61.409999999999997 113.073 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.55 -33.62 12.34 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.137 0.575 . . . . 71.349999999999994 111.122 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 177.63 174.86 44.36 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.242 -0.89 . . . . 74.409999999999997 111.163 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.502 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 65.9 mtt180 -88.05 160.56 17.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.233 0.613 . . . . 73.319999999999993 111.47 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.54 -176.38 50.98 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.688 -0.965 . . . . 75.25 110.688 168.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 27.1 m-20 -110.33 -178.99 3.65 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.118 0.567 . . . . 74.299999999999997 110.163 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 55.7 tp -136.38 105.47 5.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.887 0.851 . . . . 55.399999999999999 109.499 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 58.9 m-85 -99.56 108.8 21.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.703 -1.221 . . . . 72.549999999999997 107.703 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.765 HD11 HD12 ' A' ' 233' ' ' LEU . 1.5 pp -125.49 115.0 19.54 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.965 1.098 . . . . 64.530000000000001 113.965 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.65 126.46 29.43 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 113.656 -1.611 . . . . 71.409999999999997 113.1 -170.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.647 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 63.3 t -75.01 124.83 33.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 CA-C-N 113.522 -1.672 . . . . 74.010000000000005 110.622 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -121.04 122.06 39.27 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.817 1.247 . . . . 72.129999999999995 107.788 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.523 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 32.7 mm -92.51 103.73 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.04 -1.096 . . . . 64.319999999999993 108.04 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.562 1.42 0 CA-C-O 117.484 -1.246 . . . . 70.239999999999995 108.751 -169.384 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 75.9 mtp . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 121.198 0.523 . . . . 61.439999999999998 109.757 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.46 ' HG2' ' H ' ' A' ' 170' ' ' THR . 29.7 tt0 -167.88 -177.29 3.36 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 108.528 -0.916 . . . . 74.010000000000005 108.528 -174.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.46 ' H ' ' HG2' ' A' ' 169' ' ' GLU . 11.0 t -56.71 -30.59 63.65 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.573 0.749 . . . . 74.540000000000006 111.704 170.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.34 133.65 47.15 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.509 -0.552 . . . . 71.430000000000007 109.509 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.5 m -66.68 -15.38 63.46 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.818 0.847 . . . . 63.25 111.097 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.17 167.57 20.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.866 0.866 . . . . 61.119999999999997 112.746 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -89.74 -91.53 1.21 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 110.102 -1.199 . . . . 51.520000000000003 110.102 169.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -141.19 170.05 16.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.211 1.004 . . . . 72.299999999999997 110.495 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.626 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 15.3 m95 -70.88 -77.66 0.09 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.542 0.737 . . . . 63.43 109.946 173.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -173.71 -162.32 0.15 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.388 -0.968 . . . . 75.140000000000001 108.388 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -67.13 76.85 0.17 Allowed Glycine 0 C--N 1.347 1.164 0 N-CA-C 110.309 -1.116 . . . . 63.210000000000001 110.309 164.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.21 84.64 1.38 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 122.442 1.115 . . . . 61.039999999999999 110.773 -167.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -162.38 -116.07 0.37 Allowed Glycine 0 C--N 1.339 0.722 0 CA-C-N 114.3 -1.318 . . . . 73.409999999999997 111.228 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.9 p -79.08 -30.06 43.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.504 0.722 . . . . 73.230000000000004 111.69 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 131.94 -124.85 4.11 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.839 -0.504 . . . . 62.140000000000001 111.839 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 171.84 -157.68 28.0 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.059 -0.816 . . . . 65.129999999999995 111.059 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 59.0 p -82.43 -29.45 30.69 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 117.468 0.634 . . . . 62.450000000000003 110.927 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 141.03 -144.17 14.27 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.183 -0.462 . . . . 73.040000000000006 112.292 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.28 168.33 40.82 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.533 -0.627 . . . . 64.030000000000001 111.533 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.0 t -128.67 162.64 26.88 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.473 0.709 . . . . 41.310000000000002 110.486 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -137.9 130.03 4.87 Favored Glycine 0 C--N 1.345 1.057 0 N-CA-C 110.586 -1.006 . . . . 73.329999999999998 110.586 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -117.01 -121.06 3.18 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 117.182 0.491 . . . . 52.240000000000002 112.772 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.2 m -91.66 -73.43 0.54 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.865 0.466 . . . . 54.340000000000003 111.198 -175.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.0 mt-30 -75.67 -39.83 56.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.099 0.56 . . . . 64.549999999999997 110.049 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 12.2 p-10 -73.92 103.83 4.57 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.021 0.915 . . . . 72.400000000000006 108.757 175.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.2 mt -91.5 170.33 10.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.859 -1.064 . . . . 63.109999999999999 112.981 -168.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 24.8 t80 -124.84 140.32 53.03 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 113.41 -1.723 . . . . 71.400000000000006 107.621 171.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -154.43 -170.91 3.68 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.291 0.637 . . . . 64.200000000000003 110.176 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 254' ' ' ARG . 91.0 m -117.82 138.27 52.19 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.09 0.956 . . . . 72.349999999999994 110.809 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.634 HD23 HG22 ' A' ' 253' ' ' VAL . 17.3 tp -98.55 108.92 21.72 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.727 -1.212 . . . . 64.319999999999993 107.727 166.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -82.73 100.6 10.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.211 -0.662 . . . . 71.420000000000002 109.211 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.673 HG22 HG21 ' A' ' 210' ' ' VAL . 21.5 t -108.11 109.43 61.9 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 108.715 -0.846 . . . . 52.549999999999997 108.715 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.42 145.56 65.51 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.257 1.305 . . . . 72.5 109.597 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.455 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -51.66 -40.53 70.8 Favored Pre-proline 0 CA--C 1.56 1.337 0 N-CA-C 113.979 1.103 . . . . 51.119999999999997 113.979 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.2 Cg_endo -56.16 -48.65 18.44 Favored 'Trans proline' 0 C--N 1.397 3.13 0 C-N-CA 122.037 1.825 . . . . 72.239999999999995 112.751 174.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.483 HG21 HG13 ' A' ' 210' ' ' VAL . 37.4 mt -67.74 -35.15 71.65 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 C-N-CA 122.905 0.482 . . . . 72.319999999999993 110.833 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.409 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -61.21 -46.3 91.02 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.072 0.549 . . . . 64.230000000000004 110.817 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.4 t -71.12 -48.1 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.889 0.876 . . . . 35.140000000000001 112.119 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.43 -23.58 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 120.607 0.241 . . . . 73.530000000000001 110.726 -173.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.26 68.75 1.48 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.759 -0.655 . . . . 34.240000000000002 111.791 -175.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.6 -136.83 9.31 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-O 119.741 -0.477 . . . . 52.039999999999999 112.308 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 5.3 ttmt -129.57 139.41 51.49 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.014 -0.736 . . . . 74.349999999999994 109.014 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.673 HG21 HG22 ' A' ' 199' ' ' VAL . 27.6 m -131.76 146.94 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 122.861 0.464 . . . . 64.140000000000001 110.929 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -74.34 144.35 44.51 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.948 -1.024 . . . . 73.099999999999994 110.297 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.689 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -117.24 122.35 43.73 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.92 1.288 . . . . 74.340000000000003 108.07 172.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.79 119.43 9.94 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.344 0.657 . . . . 60.140000000000001 110.037 175.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.96 -170.41 2.1 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.437 1.095 . . . . 72.510000000000005 109.378 -175.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.99 -70.24 0.25 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.844 0.83 . . . . 63.439999999999998 110.77 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -114.0 -41.29 3.56 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-N 113.719 -1.582 . . . . 61.340000000000003 111.445 -166.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -130.49 129.0 5.72 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-O 118.465 -1.186 . . . . 72.150000000000006 110.513 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.27 152.96 61.84 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.184 1.923 . . . . 74.329999999999998 113.212 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.689 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 55.1 t -97.43 166.39 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.255 -1.339 . . . . 61.240000000000002 108.691 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -149.77 135.1 18.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.614 -0.884 . . . . 71.510000000000005 108.614 172.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 14.3 p -131.11 142.56 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.526 0.73 . . . . 63.219999999999999 110.812 -172.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.1 108.19 5.85 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.93 0.492 . . . . 71.239999999999995 109.721 170.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 204' ' ' ALA . 70.6 t -69.58 134.37 88.54 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.84 0.856 . . . . 71.549999999999997 109.137 172.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.37 154.56 71.69 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.386 2.057 . . . . 70.150000000000006 111.286 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.4 131.18 37.09 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.161 1.907 . . . . 73.0 112.072 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 53.81 69.76 0.68 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.265 1.426 . . . . 74.219999999999999 113.389 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.431 HG23 ' HD2' ' A' ' 231' ' ' ARG . 87.1 m -88.2 142.42 27.77 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.666 -1.152 . . . . 62.229999999999997 110.908 173.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -103.7 164.78 11.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.047 0.939 . . . . 74.140000000000001 110.614 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.468 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -86.87 149.57 24.73 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.196 -0.911 . . . . 73.120000000000005 111.17 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.8 -12.28 32.36 Favored Glycine 0 N--CA 1.473 1.123 0 CA-C-N 115.922 -0.581 . . . . 35.200000000000003 111.965 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.431 ' HD2' HG23 ' A' ' 227' ' ' THR . 62.0 mtt85 -74.4 -175.49 2.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.24 1.016 . . . . 75.349999999999994 110.336 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.536 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.2 ptmt -168.37 165.21 12.85 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 111.752 0.278 . . . . 74.129999999999995 111.752 174.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.677 HD12 HD11 ' A' ' 251' ' ' LEU . 84.5 mt -95.57 150.56 20.2 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 123.514 0.509 . . . . 63.43 109.713 167.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -114.15 107.09 15.16 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.659 -1.237 . . . . 70.409999999999997 107.659 162.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 57.0 mt -106.99 110.75 22.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.317 -0.856 . . . . 72.409999999999997 109.748 -174.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -77.75 118.68 20.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.761 -1.109 . . . . 63.32 110.8 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.35 3.61 89.92 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 114.948 -1.024 . . . . 61.149999999999999 114.386 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -95.27 2.67 54.88 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 112.804 0.668 . . . . 75.430000000000007 112.804 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.42 -173.12 47.62 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.693 -0.963 . . . . 63.340000000000003 110.693 166.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.494 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 15.4 m-85 -58.9 134.8 87.11 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 117.737 0.769 . . . . 60.409999999999997 110.759 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.442 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 3.5 Cg_exo -76.96 139.44 19.4 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.575 2.183 . . . . 63.039999999999999 110.763 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -107.36 -167.93 22.0 Favored Glycine 0 C--O 1.238 0.345 0 CA-C-O 119.132 -0.815 . . . . 44.219999999999999 111.73 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.55 -50.44 10.72 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.693 2.262 . . . . 63.229999999999997 112.763 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.63 -25.0 5.61 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.159 0.584 . . . . 64.5 112.225 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -133.82 158.87 23.5 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-O 119.925 -0.375 . . . . 54.219999999999999 112.349 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 92.7 mtt180 -113.32 157.82 21.34 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.606 0.763 . . . . 74.430000000000007 110.763 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.46 175.73 37.77 Favored Glycine 0 N--CA 1.468 0.798 0 CA-C-N 115.528 -0.76 . . . . 53.200000000000003 111.556 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 40.2 m-20 -102.67 176.78 5.05 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.762 -0.459 . . . . 72.439999999999998 109.762 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.6 tp -134.09 108.84 8.55 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.327 0.584 . . . . 70.239999999999995 110.41 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 34.3 m-85 -102.33 103.56 14.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.032 -1.099 . . . . 74.409999999999997 108.032 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 233' ' ' LEU . 2.4 pp -121.38 114.55 21.46 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.837 1.051 . . . . 64.420000000000002 113.837 -172.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.08 118.32 11.84 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.071 -1.422 . . . . 63.420000000000002 113.215 -172.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.634 HG22 HD23 ' A' ' 197' ' ' LEU . 98.2 t -62.36 122.34 12.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 113.73 -1.577 . . . . 55.149999999999999 111.701 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.41 ' HG2' HG23 ' A' ' 196' ' ' THR . 17.3 mmm180 -121.43 122.81 40.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.912 -1.04 . . . . 74.099999999999994 108.236 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.468 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 30.5 mm -88.78 96.55 6.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 108.993 -0.743 . . . . 60.140000000000001 108.993 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.561 1.384 0 C-N-CA 125.077 1.351 . . . . 73.409999999999997 108.819 -175.311 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 168' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 109.513 -0.551 . . . . 61.140000000000001 109.513 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -74.69 128.23 35.06 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.791 0.437 . . . . 72.329999999999998 110.237 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 40.5 p -104.2 115.04 29.7 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.117 -0.947 . . . . 75.140000000000001 108.957 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.19 -53.9 52.19 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 109.448 -0.575 . . . . 75.329999999999998 109.448 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.493 HG22 HG22 ' A' ' 219' ' ' VAL . 3.6 m -153.17 -41.36 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.304 -0.999 . . . . 61.119999999999997 108.304 169.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.84 174.49 10.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.328 -0.851 . . . . 64.010000000000005 110.914 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.414 ' H ' ' CD2' ' A' ' 235' ' ' LEU . . . -101.97 -85.29 1.86 Allowed Glycine 0 C--N 1.336 0.573 0 N-CA-C 109.323 -1.511 . . . . 52.130000000000003 109.323 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 179' ' ' LYS . 14.1 pt-20 -151.82 174.94 12.96 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.453 0.701 . . . . 73.209999999999994 110.811 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.519 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 18.5 m95 -85.78 -90.5 0.1 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.239 -0.892 . . . . 75.209999999999994 110.96 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -126.97 -15.63 5.3 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.839 0.856 . . . . 74.319999999999993 110.724 -170.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 168.83 74.33 0.04 OUTLIER Glycine 0 C--N 1.345 1.06 0 N-CA-C 110.342 -1.103 . . . . 65.239999999999995 110.342 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 175' ' ' GLU . 12.8 tmtt? -70.82 99.64 1.77 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 108.608 -0.886 . . . . 73.540000000000006 108.608 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 144.61 -38.22 1.31 Allowed Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.01 -0.995 . . . . 63.420000000000002 111.344 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.9 t -147.7 -64.94 0.26 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.371 0.669 . . . . 73.420000000000002 109.484 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 158.22 -178.64 34.39 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.797 -0.638 . . . . 72.430000000000007 112.177 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 155.71 -146.95 15.1 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.194 -0.763 . . . . 52.119999999999997 111.194 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.2 p -159.14 124.32 4.19 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.557 0.743 . . . . 75.129999999999995 109.306 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -79.71 178.59 53.67 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.411 -0.359 . . . . 73.340000000000003 113.347 -175.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.05 178.03 44.8 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 112.483 -0.247 . . . . 54.109999999999999 112.483 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t -147.01 19.83 1.25 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.099 0.56 . . . . 65.200000000000003 110.375 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -149.08 175.27 28.39 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.551 -0.295 . . . . 73.540000000000006 112.438 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 150.01 -129.67 3.04 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.941 -0.863 . . . . 71.329999999999998 110.941 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.6 p -152.02 137.91 18.07 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.138 0.975 . . . . 63.329999999999998 108.693 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 63.57 12.78 6.74 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.492 1.117 . . . . 72.329999999999998 111.34 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -85.45 145.22 27.54 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 123.827 0.851 . . . . 72.340000000000003 110.248 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 58.6 mt -107.01 150.75 26.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.951 -0.759 . . . . 51.229999999999997 108.951 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 1.8 t80 -125.86 108.77 11.77 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.19 -1.041 . . . . 61.229999999999997 108.19 173.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.69 -174.86 2.77 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.082 0.953 . . . . 55.219999999999999 109.575 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 85.0 m -126.79 116.02 20.26 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.746 0.818 . . . . 72.530000000000001 109.944 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.545 HD23 HG22 ' A' ' 253' ' ' VAL . 15.7 tp -82.08 105.48 13.21 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.618 -0.882 . . . . 73.140000000000001 108.618 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.56 100.32 12.99 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.774 -0.825 . . . . 72.430000000000007 108.774 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.621 HG22 HG21 ' A' ' 210' ' ' VAL . 21.4 t -102.87 114.76 65.06 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.22 -1.03 . . . . 74.040000000000006 108.22 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.39 145.89 73.01 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 121.515 1.477 . . . . 62.119999999999997 110.342 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.76 -43.41 82.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-O 117.696 -1.145 . . . . 72.540000000000006 112.717 -176.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.2 Cg_endo -54.42 -50.06 14.78 Favored 'Trans proline' 0 C--N 1.398 3.179 0 C-N-CA 121.948 1.765 . . . . 45.310000000000002 112.703 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.455 HG21 HG13 ' A' ' 210' ' ' VAL . 17.3 mt -65.4 -35.65 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.404 0.682 . . . . 74.030000000000001 111.011 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.26 93.8 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.847 0.459 . . . . 43.210000000000001 111.012 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.5 t -70.58 -50.84 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.626 1.17 . . . . 52.420000000000002 111.975 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.41 -15.81 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.852 0.461 . . . . 72.010000000000005 110.671 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 70.79 75.57 0.61 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 111.403 -0.679 . . . . 71.409999999999997 111.403 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.16 -132.82 7.84 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.842 0.321 . . . . 71.450000000000003 112.446 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -142.95 135.42 27.52 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.983 0.913 . . . . 73.239999999999995 109.077 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.621 HG21 HG22 ' A' ' 199' ' ' VAL . 23.3 m -132.74 145.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.182 0.593 . . . . 75.329999999999998 110.18 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -71.01 142.02 50.94 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.413 0.685 . . . . 63.140000000000001 110.758 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -118.35 120.18 36.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.763 1.225 . . . . 72.030000000000001 109.02 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.401 ' O ' HD21 ' A' ' 249' ' ' LEU . 13.4 tpt -65.32 136.98 57.23 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.053 0.941 . . . . 74.400000000000006 111.77 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.633 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -139.88 -174.26 3.86 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.0 0.92 . . . . 62.420000000000002 110.288 -179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.589 ' H ' HG22 ' A' ' 214' ' ' THR . 10.6 mt -52.95 -68.4 0.17 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.656 1.582 . . . . 60.5 112.683 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -111.65 -41.23 4.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.714 -1.585 . . . . 71.409999999999997 111.352 -165.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -130.94 158.58 22.7 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-O 119.108 -0.829 . . . . 63.539999999999999 112.514 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.25 143.4 8.93 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.567 2.178 . . . . 74.409999999999997 113.416 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 78.0 t -97.22 166.13 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.902 1.281 . . . . 64.120000000000005 108.245 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -147.72 135.65 21.16 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.463 -1.31 . . . . 74.319999999999993 107.463 170.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.512 HG11 HD11 ' A' ' 233' ' ' LEU . 11.3 p -128.46 140.74 48.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 C-N-CA 123.184 0.594 . . . . 74.530000000000001 110.931 -170.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.41 108.82 5.71 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.84 0.856 . . . . 45.119999999999997 109.384 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.404 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 86.5 t -72.33 130.62 85.86 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.89 -0.782 . . . . 72.349999999999994 108.89 174.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.04 155.56 61.47 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.759 2.306 . . . . 74.019999999999996 111.202 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.92 139.52 85.36 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.402 2.068 . . . . 74.5 112.403 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 41.44 73.93 0.12 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.703 1.601 . . . . 63.340000000000003 113.653 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.545 HG23 ' HD2' ' A' ' 231' ' ' ARG . 92.8 m -84.6 139.12 32.31 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.011 -0.995 . . . . 72.430000000000007 110.998 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.51 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 24.8 mp0 -101.75 147.31 26.62 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.208 1.003 . . . . 63.409999999999997 109.175 171.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.431 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -73.26 155.91 39.02 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.129 -0.941 . . . . 50.299999999999997 110.854 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.62 -19.62 30.84 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.63 -0.588 . . . . 75.150000000000006 111.63 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.545 ' HD2' HG23 ' A' ' 227' ' ' THR . 80.5 mtt85 -66.34 177.95 1.34 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.867 0.867 . . . . 74.439999999999998 110.276 167.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.613 ' HA ' HG23 ' A' ' 253' ' ' VAL . 2.2 ptmt -167.62 158.04 10.89 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.218 0.324 . . . . 74.010000000000005 110.653 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.627 HD12 HD11 ' A' ' 251' ' ' LEU . 67.9 mt -86.02 136.41 33.26 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.995 -0.743 . . . . 73.310000000000002 108.995 171.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -103.56 104.77 14.87 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.957 -1.497 . . . . 73.239999999999995 106.957 164.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 48.1 mt -107.88 106.8 17.25 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.411 -0.813 . . . . 74.439999999999998 109.257 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -80.62 116.76 20.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.736 -1.12 . . . . 72.409999999999997 111.076 -168.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 88.37 4.25 77.41 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.79 -0.641 . . . . 64.409999999999997 113.652 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.633 ' HD2' HG21 ' A' ' 214' ' ' THR . 46.2 mmtm -93.93 4.84 53.33 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.846 0.684 . . . . 73.400000000000006 112.846 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.25 -177.48 50.73 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.429 -0.65 . . . . 55.149999999999999 111.554 171.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -60.59 142.78 91.05 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 117.45 0.625 . . . . 74.340000000000003 111.636 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.52 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 38.3 Cg_endo -66.68 139.75 53.91 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.709 2.272 . . . . 74.310000000000002 113.112 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.77 170.91 22.24 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.399 -0.819 . . . . 71.019999999999996 112.548 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.11 -21.01 27.89 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.096 2.531 . . . . 72.310000000000002 113.205 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.4 -11.64 17.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.842 0.857 . . . . 54.030000000000001 111.297 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 141.28 163.66 9.64 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.717 -0.953 . . . . 75.510000000000005 110.717 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.52 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 42.0 mtm180 -69.15 170.66 9.63 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.515 0.726 . . . . 75.209999999999994 111.776 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.74 -164.26 39.9 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 112.089 -0.404 . . . . 32.049999999999997 112.089 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -121.59 152.03 39.72 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.148 -0.686 . . . . 64.519999999999996 109.148 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 23.7 tp -112.19 108.38 17.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.651 0.78 . . . . 73.200000000000003 109.227 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 53.7 m-85 -101.58 119.26 38.5 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.788 -1.19 . . . . 74.299999999999997 107.788 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.3 pp -131.79 115.7 16.29 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.786 0.803 . . . . 72.219999999999999 112.99 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -68.76 118.8 12.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.174 1.39 . . . . 74.109999999999999 112.855 -169.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 232' ' ' LYS . 67.9 t -69.6 127.1 30.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-N 114.156 -1.384 . . . . 73.519999999999996 111.31 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -124.24 130.49 52.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.591 1.556 . . . . 71.340000000000003 108.126 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.431 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 36.3 mm -100.18 98.44 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.336 -0.986 . . . . 74.030000000000001 108.336 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.258 1.526 0 C-N-CA 124.637 1.175 . . . . 75.420000000000002 108.386 -172.407 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 111.284 0.105 . . . . 63.109999999999999 111.284 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -73.71 115.34 13.01 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.836 0.855 . . . . 71.420000000000002 109.268 -176.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.0 t -159.38 136.04 9.29 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.035 -0.728 . . . . 70.310000000000002 109.035 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 61.46 25.73 15.62 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.539 1.136 . . . . 71.340000000000003 110.934 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.4 m -77.48 -21.82 52.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.9 0.88 . . . . 72.0 110.196 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.61 175.32 6.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.767 -1.106 . . . . 63.119999999999997 111.421 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -105.49 -108.52 3.32 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.183 -0.917 . . . . 74.319999999999993 110.901 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.91 153.09 36.4 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.857 0.863 . . . . 72.409999999999997 109.98 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.52 ' CZ3' HG21 ' A' ' 227' ' ' THR . 23.2 m95 -77.79 -83.56 0.08 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.715 -0.675 . . . . 52.109999999999999 110.101 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.441 ' HG3' ' HG2' ' A' ' 231' ' ' ARG . 23.4 mm-40 -131.25 -59.63 0.97 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.076 -1.083 . . . . 71.349999999999994 108.076 -172.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 69.91 -74.69 0.47 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 110.824 -0.91 . . . . 75.450000000000003 110.824 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -123.77 147.54 47.44 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.47 1.108 . . . . 61.32 109.234 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -171.93 102.44 0.18 Allowed Glycine 0 C--N 1.338 0.667 0 N-CA-C 110.962 -0.855 . . . . 23.030000000000001 110.962 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 19.0 m -72.18 -6.2 41.1 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.422 0.689 . . . . 50.210000000000001 112.012 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 96.61 57.17 1.12 Allowed Glycine 0 C--N 1.352 1.462 0 C-N-CA 122.959 0.314 . . . . 65.040000000000006 112.518 172.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.62 110.46 0.34 Allowed Glycine 0 C--N 1.344 0.992 0 N-CA-C 111.665 -0.574 . . . . 62.149999999999999 111.665 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 27.8 p -164.25 -17.59 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.746 0.818 . . . . 73.299999999999997 111.729 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 78.29 -82.1 1.28 Allowed Glycine 0 C--N 1.347 1.139 0 O-C-N 123.282 0.364 . . . . 75.239999999999995 112.85 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 69.66 55.34 9.94 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 112.103 -0.399 . . . . 73.319999999999993 112.103 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.8 m -107.75 -29.23 9.23 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.375 0.67 . . . . 75.140000000000001 111.007 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.95 178.44 16.73 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.341 -0.391 . . . . 62.409999999999997 113.297 176.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -146.5 -135.19 2.71 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.046 -1.222 . . . . 62.420000000000002 110.046 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.4 m -81.87 -70.91 0.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 117.544 0.672 . . . . 72.329999999999998 109.466 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -88.15 -26.51 22.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.602 0.761 . . . . 63.200000000000003 110.063 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.14 128.26 35.72 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.209 -0.905 . . . . 61.009999999999998 108.862 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.0 mt -122.72 139.32 54.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.353 0.661 . . . . 63.43 110.987 -170.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -103.62 133.49 48.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.138 -1.06 . . . . 65.230000000000004 108.138 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -139.15 -172.19 3.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.523 0.729 . . . . 52.240000000000002 110.059 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.4 m -118.08 158.61 24.69 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.126 0.97 . . . . 75.400000000000006 109.919 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.554 HD23 HG22 ' A' ' 253' ' ' VAL . 16.8 tp -126.52 114.47 18.16 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.585 1.554 . . . . 71.040000000000006 107.479 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.47 99.03 12.11 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.066 -0.716 . . . . 75.25 109.066 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.71 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.4 t -109.01 108.96 60.94 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 108.161 -1.051 . . . . 73.219999999999999 108.161 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.427 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 35.9 Cg_endo -66.68 146.14 77.97 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.575 1.517 . . . . 72.420000000000002 110.329 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -46.67 -46.91 50.7 Favored Pre-proline 0 CA--C 1.563 1.453 0 O-C-N 124.198 0.936 . . . . 72.230000000000004 113.258 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 33.4 Cg_exo -57.5 -47.88 19.78 Favored 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 121.645 1.564 . . . . 72.310000000000002 113.679 177.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.6 mt -65.97 -34.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.707 0.403 . . . . 70.519999999999996 110.765 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.35 -43.07 99.68 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.411 0.444 . . . . 75.340000000000003 110.421 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.0 t -73.24 -51.2 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 124.221 0.951 . . . . 50.43 111.919 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.33 -25.97 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 120.822 0.344 . . . . 72.209999999999994 111.02 -172.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.7 75.28 1.13 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.866 -0.606 . . . . 72.200000000000003 112.431 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.99 -135.51 7.66 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 112.176 -0.37 . . . . 75.219999999999999 112.176 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -130.89 150.63 51.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.068 0.947 . . . . 64.230000000000004 110.026 173.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 199' ' ' VAL . 34.8 m -140.59 157.4 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.584 0.754 . . . . 72.420000000000002 110.882 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -79.5 141.26 36.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.116 0.566 . . . . 75.319999999999993 110.944 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.517 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -119.08 118.68 32.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.2 1.4 . . . . 75.519999999999996 108.112 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 12.9 tpt -64.85 132.02 48.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.169 0.587 . . . . 64.439999999999998 111.11 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.438 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -139.86 -169.52 2.74 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.577 1.151 . . . . 61.149999999999999 109.783 -174.218 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.451 ' HB2' ' HG2' ' A' ' 216' ' ' GLU . 4.7 mt -77.33 -66.67 0.8 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.294 1.438 . . . . 61.210000000000001 110.185 -173.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 215' ' ' LEU . 21.6 mm-40 -87.88 -31.0 19.71 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 112.268 -2.242 . . . . 45.32 110.491 -164.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -164.11 -178.85 37.96 Favored Glycine 0 C--N 1.33 0.218 0 CA-C-N 114.964 -1.017 . . . . 62.409999999999997 111.702 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.08 136.6 5.03 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.212 1.941 . . . . 74.430000000000007 112.713 172.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 49.7 t -90.41 162.64 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.402 -1.272 . . . . 72.439999999999998 107.899 173.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -142.51 129.41 20.63 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.14 -1.059 . . . . 74.530000000000001 108.14 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 233' ' ' LEU . 14.9 p -120.69 138.96 49.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 123.552 0.741 . . . . 53.240000000000002 110.855 -174.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.7 102.99 2.93 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.037 0.935 . . . . 65.519999999999996 109.048 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.97 130.73 91.3 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.414 0.686 . . . . 65.5 109.7 176.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.95 154.42 56.64 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.796 2.33 . . . . 73.420000000000002 111.827 172.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.91 130.58 29.73 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.131 1.888 . . . . 72.239999999999995 111.202 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 51.54 71.8 0.42 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.62 1.568 . . . . 73.510000000000005 112.577 -177.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.52 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 92.9 m -96.03 139.89 31.56 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.078 -0.965 . . . . 65.129999999999995 110.705 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -99.44 152.21 20.24 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.047 0.939 . . . . 65.109999999999999 110.664 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -75.51 155.46 36.11 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.683 -1.144 . . . . 72.540000000000006 110.391 175.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.68 5.08 61.66 Favored Glycine 0 N--CA 1.471 0.98 0 CA-C-N 115.747 -0.66 . . . . 42.439999999999998 112.576 -174.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.441 ' HG2' ' HG3' ' A' ' 177' ' ' GLN . 67.9 mtt85 -84.36 -175.58 5.85 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.155 0.982 . . . . 70.25 108.589 164.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 253' ' ' VAL . 0.0 OUTLIER -167.46 149.11 5.67 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 110.123 -0.325 . . . . 63.130000000000003 110.123 169.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.725 HD12 HD11 ' A' ' 251' ' ' LEU . 62.4 mt -75.97 139.37 41.51 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.628 -0.508 . . . . 63.409999999999997 109.628 171.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 250' ' ' TYR . 13.1 ptt180 -105.34 105.05 14.91 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.088 -1.078 . . . . 64.450000000000003 108.088 165.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 249' ' ' LEU . 49.1 mt -109.81 110.85 21.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.556 -1.202 . . . . 73.310000000000002 109.56 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -88.25 123.56 32.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.243 -0.89 . . . . 62.43 110.098 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.36 4.51 83.49 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.176 -0.92 . . . . 72.129999999999995 113.601 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -101.01 9.0 42.71 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.789 0.795 . . . . 62.310000000000002 112.414 -176.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.21 -179.03 45.59 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.435 -1.066 . . . . 55.119999999999997 110.435 165.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -56.11 137.79 73.55 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 123.073 0.549 . . . . 64.5 112.177 -172.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.03 140.52 72.73 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.816 2.344 . . . . 53.200000000000003 111.707 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.28 175.0 20.08 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 116.108 -0.496 . . . . 65.409999999999997 113.387 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.41 -34.91 32.94 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 123.425 2.75 . . . . 74.340000000000003 114.001 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.47 -0.84 31.74 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.638 0.375 . . . . 61.109999999999999 111.783 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 144.11 175.97 17.72 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.497 -0.641 . . . . 75.030000000000001 111.497 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -80.91 163.48 23.33 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.425 0.69 . . . . 63.039999999999999 111.967 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.66 -175.05 45.84 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.86 -0.896 . . . . 71.219999999999999 110.86 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -111.62 168.84 9.24 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 117.969 0.884 . . . . 73.030000000000001 110.122 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 235' ' ' LEU . 69.5 tp -134.69 108.94 8.29 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.637 0.775 . . . . 64.129999999999995 109.786 -172.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.409 ' HD2' ' HA ' ' A' ' 234' ' ' ARG . 23.2 m-85 -106.9 109.14 20.97 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.028 -1.101 . . . . 73.150000000000006 108.028 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.725 HD11 HD12 ' A' ' 233' ' ' LEU . 3.7 pp -118.74 121.93 41.26 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.602 0.715 . . . . 60.310000000000002 112.506 -172.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -69.08 130.0 41.5 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 126.501 1.92 . . . . 72.219999999999999 112.571 -169.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 232' ' ' LYS . 84.8 t -81.73 120.58 33.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 122.904 0.482 . . . . 74.25 110.958 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -114.47 120.05 38.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.055 1.342 . . . . 74.340000000000003 108.611 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.42 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 38.6 mm -91.54 100.52 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.116 -1.068 . . . . 62.219999999999999 108.116 173.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.254 1.326 0 C-N-CA 124.816 1.247 . . . . 70.150000000000006 108.598 -173.734 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 48.9 tpp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 109.013 -0.736 . . . . 70.329999999999998 109.013 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -141.1 -160.38 1.07 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.243 1.017 . . . . 61.43 109.408 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.5 p -57.02 95.77 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.387 0.675 . . . . 74.319999999999993 112.165 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -178.74 150.73 0.52 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.169 1.388 . . . . 63.43 108.574 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.482 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 6.6 m -86.27 -19.02 30.54 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.56 0.695 . . . . 61.420000000000002 109.624 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -104.24 179.77 4.18 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.456 -0.793 . . . . 31.5 111.641 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -102.86 -85.6 1.88 Allowed Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.416 -0.811 . . . . 73.409999999999997 111.999 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.69 158.38 43.89 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.807 0.843 . . . . 71.519999999999996 111.584 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.42 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 30.2 m95 -92.0 -102.99 0.11 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.413 1.085 . . . . 73.5 110.664 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 165.21 161.68 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.855 2.062 . . . . 73.340000000000003 107.312 -167.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.4 -27.44 5.0 Favored Glycine 0 N--CA 1.473 1.124 0 N-CA-C 110.534 -1.026 . . . . 74.340000000000003 110.534 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -83.98 9.71 11.66 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.627 0.771 . . . . 72.030000000000001 111.008 168.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.62 148.97 20.73 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.351 -0.699 . . . . 71.209999999999994 111.351 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.1 p -81.99 137.92 35.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.573 0.749 . . . . 42.420000000000002 111.068 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 105.95 143.73 11.79 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.488 0.492 . . . . 75.109999999999999 113.48 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -121.73 10.73 9.63 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 123.142 0.401 . . . . 74.549999999999997 112.686 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.3 m -88.55 83.19 6.8 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.584 0.692 . . . . 65.409999999999997 109.778 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.45 85.3 1.47 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.193 -1.163 . . . . 64.140000000000001 110.193 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.62 121.9 17.0 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.202 0.589 . . . . 75.519999999999996 114.213 -173.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.0 m -119.41 140.87 49.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.698 0.799 . . . . 63.119999999999997 110.035 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 122.69 46.53 0.28 Allowed Glycine 0 N--CA 1.468 0.773 0 CA-C-N 116.123 -0.489 . . . . 71.439999999999998 112.009 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -71.43 -80.22 0.36 Allowed Glycine 0 C--N 1.346 1.098 0 N-CA-C 112.348 -0.301 . . . . 63.030000000000001 112.348 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 64.6 p -162.01 -56.46 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.025 -0.731 . . . . 43.340000000000003 109.025 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -98.13 26.83 4.99 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.307 1.043 . . . . 71.310000000000002 109.363 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.71 155.64 37.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.428 -1.26 . . . . 65.150000000000006 111.096 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.432 ' HG ' ' HA2' ' A' ' 239' ' ' GLY . 63.2 mt -128.22 103.14 7.02 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.509 -0.923 . . . . 64.129999999999995 108.509 164.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -83.15 106.49 14.99 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.753 -1.203 . . . . 72.409999999999997 107.753 164.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.27 -173.6 2.6 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.053 0.541 . . . . 73.030000000000001 110.095 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.3 m -119.95 150.82 39.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.646 0.778 . . . . 73.510000000000005 110.009 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.5 tp -113.7 105.68 13.59 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.845 -1.539 . . . . 53.219999999999999 106.845 168.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.55 101.43 12.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.698 -1.223 . . . . 72.329999999999998 107.698 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.622 HG22 HG21 ' A' ' 210' ' ' VAL . 30.9 t -110.83 118.65 47.96 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.197 -1.038 . . . . 71.0 108.197 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.02 149.91 82.69 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 121.654 1.569 . . . . 65.239999999999995 110.166 171.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.95 -41.07 83.55 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 113.061 0.763 . . . . 73.230000000000004 113.061 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 9.4 Cg_endo -54.7 -57.22 1.86 Allowed 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 121.907 1.738 . . . . 53.0 113.71 171.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.84 -31.98 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 123.206 0.602 . . . . 73.25 111.121 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -50.43 68.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.15 -0.477 . . . . 74.109999999999999 110.68 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.52 -48.39 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 124.023 0.827 . . . . 64.109999999999999 111.746 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.77 -32.5 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 117.824 0.284 . . . . 61.210000000000001 111.403 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.33 101.48 0.85 Allowed Glycine 0 C--N 1.343 0.946 0 N-CA-C 111.793 -0.523 . . . . 73.409999999999997 111.793 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.76 -129.49 2.95 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.603 -0.554 . . . . 70.219999999999999 112.24 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -138.33 151.64 47.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.805 0.803 . . . . 73.319999999999993 109.546 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.622 HG21 HG22 ' A' ' 199' ' ' VAL . 22.6 m -145.58 158.01 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.719 0.807 . . . . 70.120000000000005 110.352 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -74.33 154.06 39.05 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.411 1.084 . . . . 72.450000000000003 111.36 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.62 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -132.13 113.93 13.9 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.208 1.003 . . . . 72.340000000000003 108.648 177.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.7 tpt -65.64 131.46 46.41 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.454 0.701 . . . . 70.420000000000002 111.771 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.663 HG21 ' HE3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -130.97 -170.68 2.4 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.708 1.203 . . . . 72.439999999999998 108.586 176.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.444 ' H ' HG22 ' A' ' 214' ' ' THR . 10.5 mt -59.32 -70.14 0.17 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.583 0.706 . . . . 62.240000000000002 111.018 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -111.57 -42.2 3.91 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.019 -1.446 . . . . 75.409999999999997 111.446 -168.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -122.42 120.59 4.36 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 118.854 -0.97 . . . . 41.130000000000003 111.469 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.28 154.85 46.49 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.058 1.839 . . . . 64.439999999999998 112.935 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 39.5 t -101.84 168.71 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.109 1.364 . . . . 75.319999999999993 108.136 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.482 ' H ' ' HB ' ' A' ' 172' ' ' THR . 8.9 tt0 -141.19 134.7 29.91 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.425 -1.324 . . . . 73.239999999999995 107.425 171.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.509 HG11 HD11 ' A' ' 233' ' ' LEU . 14.6 p -131.2 141.46 45.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 122.937 0.495 . . . . 53.130000000000003 110.414 -173.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.03 117.3 15.66 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.395 -0.594 . . . . 44.329999999999998 109.395 173.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.7 t -78.91 128.66 75.89 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 109.407 -0.59 . . . . 73.150000000000006 109.407 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.07 157.32 60.14 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.763 2.309 . . . . 61.310000000000002 111.619 173.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.97 133.5 38.89 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.353 2.035 . . . . 62.439999999999998 112.455 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 54.4 68.72 0.81 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.919 1.688 . . . . 73.319999999999993 113.04 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.472 HG23 ' HD2' ' A' ' 231' ' ' ARG . 75.9 m -89.25 138.33 31.52 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.806 -1.088 . . . . 75.319999999999993 111.264 175.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -103.31 149.66 24.52 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.988 0.915 . . . . 74.010000000000005 110.746 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.87 155.29 40.05 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.227 0.954 . . . . 65.25 110.946 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 101.33 -16.82 56.48 Favored Glycine 0 N--CA 1.476 1.322 0 N-CA-C 111.081 -0.807 . . . . 55.130000000000003 111.081 -174.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.472 ' HD2' HG23 ' A' ' 227' ' ' THR . 65.4 mtt85 -65.87 172.16 3.82 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.108 0.563 . . . . 73.329999999999998 109.834 163.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.536 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.4 ptmt -168.03 151.49 5.93 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.359 0.412 . . . . 73.230000000000004 110.688 174.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.543 HD12 HD11 ' A' ' 251' ' ' LEU . 85.6 mt -83.48 152.85 24.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 110.318 -0.253 . . . . 75.109999999999999 110.318 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -120.93 106.93 12.09 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.751 1.282 . . . . 74.120000000000005 107.957 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.512 HD12 HD23 ' A' ' 249' ' ' LEU . 59.4 mt -117.03 127.99 54.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.764 0.826 . . . . 74.409999999999997 109.673 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . 0.442 ' HD3' ' HB3' ' A' ' 248' ' ' ASP . 32.5 mmtp -101.36 138.75 37.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.692 0.397 . . . . 73.519999999999996 110.126 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.01 13.5 83.3 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 124.279 0.987 . . . . 65.420000000000002 113.167 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.663 ' HE3' HG21 ' A' ' 214' ' ' THR . 27.6 mmmt -108.87 -14.32 14.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.467 0.634 . . . . 73.239999999999995 112.632 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.432 ' HA2' ' HG ' ' A' ' 193' ' ' LEU . . . -74.66 -170.92 26.09 Favored Glycine 0 N--CA 1.478 1.443 0 CA-C-O 119.855 -0.414 . . . . 74.140000000000001 113.349 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -58.56 147.1 71.15 Favored Pre-proline 0 N--CA 1.487 1.425 0 C-N-CA 123.41 0.684 . . . . 64.230000000000004 111.806 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -63.7 137.82 60.88 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.707 2.271 . . . . 74.400000000000006 111.871 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.9 175.13 20.49 Favored Glycine 0 N--CA 1.468 0.828 0 CA-C-N 115.179 -0.919 . . . . 64.099999999999994 113.606 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.76 -28.54 20.31 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 123.149 2.566 . . . . 62.539999999999999 112.285 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.7 23.38 7.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.613 0.765 . . . . 60.130000000000003 110.92 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 117.84 -95.83 0.66 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.482 -0.647 . . . . 74.219999999999999 111.482 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 40.9 mtm-85 -148.53 165.44 31.22 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.571 1.148 . . . . 65.319999999999993 109.683 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -90.86 -155.09 31.17 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.621 0.575 . . . . 55.229999999999997 112.981 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.442 ' HB3' ' HD3' ' A' ' 236' ' ' LYS . 31.9 p30 -127.17 163.51 23.68 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.991 0.9 . . . . 72.329999999999998 112.234 -176.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.662 HD22 HG23 ' A' ' 214' ' ' THR . 12.6 tp -130.32 109.42 10.74 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.027 -1.442 . . . . 43.340000000000003 109.697 -171.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 25.6 m-85 -107.63 110.07 21.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.421 -0.955 . . . . 73.010000000000005 108.421 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.543 HD11 HD12 ' A' ' 233' ' ' LEU . 3.7 pp -120.43 114.78 22.32 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.687 0.625 . . . . 73.310000000000002 112.687 -170.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.0 113.34 6.29 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.67 1.188 . . . . 60.240000000000002 112.706 -171.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.604 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 53.1 t -64.08 127.3 24.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.54 1.136 . . . . 63.350000000000001 110.893 173.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -126.27 129.7 49.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.986 1.314 . . . . 74.030000000000001 108.769 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.9 mm -99.55 107.46 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.33 -0.989 . . . . 74.109999999999999 108.33 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.56 1.337 0 CA-C-N 114.861 -1.063 . . . . 74.129999999999995 109.029 -169.419 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 120.71 0.29 . . . . 74.239999999999995 110.629 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.32 -160.52 0.38 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.593 0.757 . . . . 73.019999999999996 111.421 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 18.3 m -57.38 -49.87 74.81 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 124.063 0.945 . . . . 65.030000000000001 111.969 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.31 139.83 57.27 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.01 0.524 . . . . 61.310000000000002 109.894 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.41 HG22 HG22 ' A' ' 219' ' ' VAL . 18.2 m -69.35 -25.69 64.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.65 0.78 . . . . 62.219999999999999 109.718 175.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.22 149.39 23.13 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.19 -0.914 . . . . 63.299999999999997 111.139 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -69.79 -89.1 0.09 OUTLIER Glycine 0 C--N 1.347 1.147 0 O-C-N 124.026 0.829 . . . . 64.230000000000004 111.393 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.97 -178.36 5.89 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.896 0.879 . . . . 74.25 110.209 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.531 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 23.5 m95 -80.58 -91.9 0.05 Allowed 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.549 -0.751 . . . . 62.100000000000001 109.579 168.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -174.83 80.77 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.981 0.913 . . . . 74.510000000000005 108.677 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -78.89 64.29 3.69 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.792 -0.923 . . . . 44.25 110.792 173.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -115.34 5.04 14.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.707 0.803 . . . . 61.200000000000003 111.694 -169.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.31 -71.77 2.86 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 123.173 0.295 . . . . 72.329999999999998 112.922 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.9 p -82.67 56.56 3.41 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.217 1.007 . . . . 71.409999999999997 110.518 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 65.24 -91.97 0.13 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 110.845 -0.902 . . . . 71.329999999999998 110.845 -169.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 132.9 12.82 1.66 Allowed Glycine 0 C--N 1.345 1.029 0 C-N-CA 123.097 0.38 . . . . 64.140000000000001 112.546 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.0 t -65.1 102.28 0.61 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.788 0.835 . . . . 64.519999999999996 109.736 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.08 -173.06 29.23 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 115.513 -0.767 . . . . 73.310000000000002 111.572 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 67.1 54.83 18.93 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.779 -0.528 . . . . 71.109999999999999 111.779 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.2 m -63.77 -32.97 74.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.062 0.545 . . . . 55.32 110.793 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -149.77 147.81 18.45 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 115.068 -0.969 . . . . 74.420000000000002 111.132 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.03 -103.07 0.27 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.282 -0.727 . . . . 41.219999999999999 111.282 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 42.8 p -152.9 119.18 5.53 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.533 0.733 . . . . 74.010000000000005 109.692 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 61.8 12.96 5.05 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.33 1.052 . . . . 72.340000000000003 111.945 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -83.33 151.24 25.66 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.483 1.113 . . . . 74.5 110.753 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 79.5 mt -117.01 137.13 52.43 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.054 0.541 . . . . 73.200000000000003 110.3 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -103.38 108.87 20.28 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.952 -1.129 . . . . 65.219999999999999 107.952 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.27 -172.12 2.3 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.412 1.085 . . . . 74.109999999999999 109.243 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' THR . . . . . 0.418 HG23 ' HG2' ' A' ' 254' ' ' ARG . 90.8 m -124.9 139.37 53.9 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.673 0.789 . . . . 71.040000000000006 110.164 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 16.0 tp -97.23 105.84 18.06 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.664 -0.865 . . . . 72.5 108.664 170.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -86.77 101.59 13.46 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.999 -0.741 . . . . 72.329999999999998 108.999 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.574 ' HA ' HG11 ' A' ' 210' ' ' VAL . 1.4 p -119.46 113.68 34.93 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.703 0.801 . . . . 65.030000000000001 109.351 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.4 145.7 78.08 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.945 1.763 . . . . 64.549999999999997 111.054 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -44.35 -47.68 25.2 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.334 1.053 . . . . 71.340000000000003 113.625 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.5 -48.09 23.32 Favored 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 121.935 1.757 . . . . 75.319999999999993 113.976 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.502 HG21 HG13 ' A' ' 210' ' ' VAL . 60.5 mt -65.84 -33.74 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 122.938 0.495 . . . . 64.519999999999996 110.471 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.47 93.73 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.914 0.485 . . . . 74.230000000000004 111.16 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.94 -45.88 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.39 1.076 . . . . 74.099999999999994 111.912 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.62 -29.66 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 120.71 0.29 . . . . 73.209999999999994 110.255 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.65 73.21 1.18 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.415 -0.674 . . . . 70.439999999999998 111.415 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.01 -127.2 6.04 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 120.135 -0.258 . . . . 74.209999999999994 112.457 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -143.75 137.59 28.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.647 0.779 . . . . 64.140000000000001 109.752 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.574 HG11 ' HA ' ' A' ' 199' ' ' VAL . 31.5 m -137.29 154.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.833 0.453 . . . . 55.5 111.108 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -76.13 142.93 41.49 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.758 -1.11 . . . . 72.109999999999999 111.192 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -113.97 117.39 31.2 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.917 1.287 . . . . 71.200000000000003 108.283 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.0 tpt -63.82 121.08 13.16 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.057 0.943 . . . . 71.150000000000006 111.498 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.475 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -123.82 -171.25 2.28 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.053 1.341 . . . . 72.030000000000001 109.653 -178.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.45 ' H ' HG22 ' A' ' 214' ' ' THR . 9.2 mt -59.58 -69.4 0.21 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.583 1.153 . . . . 73.519999999999996 112.044 -175.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.92 -42.11 3.45 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 113.94 -1.482 . . . . 74.340000000000003 111.445 -166.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -119.33 167.3 13.28 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.283 -0.871 . . . . 63.530000000000001 111.172 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.41 154.81 10.67 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.987 1.792 . . . . 60.240000000000002 113.202 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.653 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 69.5 t -106.3 166.26 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 107.086 -1.45 . . . . 61.119999999999997 107.086 165.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.28 140.2 25.05 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.32 -0.992 . . . . 61.240000000000002 108.32 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.459 HG11 HD11 ' A' ' 233' ' ' LEU . 8.7 p -134.18 142.24 41.54 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 C-N-CA 123.162 0.585 . . . . 53.539999999999999 110.86 -172.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.97 108.23 8.71 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.961 0.904 . . . . 74.019999999999996 109.187 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.459 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 59.5 t -71.54 132.61 85.43 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.132 0.973 . . . . 73.239999999999995 109.279 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -64.02 155.44 64.52 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.794 2.329 . . . . 73.200000000000003 112.483 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.51 130.48 31.89 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.273 1.982 . . . . 61.509999999999998 111.804 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.3 mtp-105 49.7 71.23 0.41 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.514 1.526 . . . . 64.120000000000005 113.266 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.442 HG23 ' HD2' ' A' ' 231' ' ' ARG . 98.7 m -87.45 142.74 27.64 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.884 -1.053 . . . . 65.549999999999997 111.1 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -103.06 154.67 19.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.001 0.92 . . . . 74.409999999999997 110.604 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.529 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -78.72 155.41 29.4 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.452 -1.249 . . . . 71.150000000000006 110.615 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.03 -13.02 52.69 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 111.594 -0.602 . . . . 63.450000000000003 111.594 -173.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.442 ' HD2' HG23 ' A' ' 227' ' ' THR . 68.0 mtt85 -70.43 -176.34 1.21 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.04 0.936 . . . . 72.329999999999998 110.55 170.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.608 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 10.3 ptmt -167.57 156.32 9.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.341 0.256 . . . . 72.140000000000001 110.573 171.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.559 HD12 HD11 ' A' ' 251' ' ' LEU . 73.5 mt -87.51 151.58 22.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.509 -0.552 . . . . 63.229999999999997 109.509 168.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -119.85 105.87 11.52 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.335 -1.357 . . . . 73.450000000000003 107.335 168.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 67.6 mt -114.19 117.04 30.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.281 0.633 . . . . 74.439999999999998 110.698 -170.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -84.99 133.36 34.26 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 116.275 -0.42 . . . . 43.119999999999997 111.287 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.27 1.11 89.89 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 114.884 -1.053 . . . . 74.129999999999995 113.77 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 47.6 mmtm -98.02 -0.38 44.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.384 0.674 . . . . 70.420000000000002 112.523 -174.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.86 -172.35 48.36 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 111.18 -0.768 . . . . 71.430000000000007 111.18 167.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -65.17 142.61 98.61 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-N 117.24 0.52 . . . . 75.329999999999998 111.541 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.92 133.7 34.59 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.853 2.368 . . . . 54.43 112.093 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.42 172.92 21.65 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 119.436 -0.647 . . . . 45.509999999999998 113.192 -176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.68 -23.33 26.72 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.097 2.531 . . . . 63.32 112.543 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.71 22.26 8.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.958 0.903 . . . . 74.319999999999993 110.751 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 94.9 -173.36 31.87 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 110.471 -1.052 . . . . 70.120000000000005 110.471 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -84.11 158.35 21.41 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 117.417 0.608 . . . . 73.310000000000002 110.883 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.78 -164.66 38.61 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.502 -0.772 . . . . 64.439999999999998 111.933 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -124.57 164.47 19.75 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.583 0.706 . . . . 64.219999999999999 110.634 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.0 tp -123.01 108.56 13.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.078 -0.964 . . . . 73.420000000000002 108.613 -171.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.608 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 33.3 m-85 -100.53 112.75 25.16 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.091 -1.448 . . . . 73.420000000000002 107.091 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.627 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.6 pp -127.86 115.81 19.18 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.498 0.925 . . . . 74.150000000000006 113.498 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -67.64 117.65 9.86 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.556 -1.202 . . . . 73.040000000000006 112.05 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.599 HG23 ' HA ' ' A' ' 232' ' ' LYS . 95.1 t -68.82 116.73 9.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 125.167 1.387 . . . . 75.140000000000001 111.509 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ARG . . . . . 0.418 ' HG2' HG23 ' A' ' 196' ' ' THR . 24.7 mmt85 -106.65 117.03 32.99 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.355 -1.293 . . . . 64.299999999999997 108.803 170.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.542 HD13 HG13 ' A' ' 199' ' ' VAL . 42.3 mm -79.1 96.28 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 106.529 -1.656 . . . . 51.420000000000002 106.529 168.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.26 1.651 0 CA-C-O 117.31 -1.329 . . . . 60.43 108.64 -174.718 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 17.1 tmm? . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.184 0.516 . . . . 54.200000000000003 109.79 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.23 172.02 13.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.881 1.273 . . . . 72.120000000000005 110.244 -170.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 46.1 p -90.66 26.64 1.97 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.045 0.938 . . . . 70.200000000000003 111.819 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 221' ' ' VAL . . . -151.44 155.88 39.49 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.833 0.853 . . . . 73.140000000000001 110.173 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.57 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 16.8 m -71.76 -19.93 61.96 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.741 0.816 . . . . 62.420000000000002 110.78 175.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.54 -176.0 6.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.298 1.039 . . . . 71.400000000000006 113.045 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -106.15 -88.95 2.07 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 114.473 -1.24 . . . . 73.010000000000005 110.269 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -146.98 153.66 40.32 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 112.734 0.642 . . . . 72.409999999999997 112.734 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.454 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 34.3 m95 -82.99 -83.56 0.13 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.275 1.03 . . . . 74.230000000000004 109.993 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.543 ' HG3' ' HA3' ' A' ' 182' ' ' GLY . 19.4 mm-40 -113.5 29.58 7.89 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 106.793 -1.558 . . . . 75.349999999999994 106.793 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.44 -72.55 0.43 Allowed Glycine 0 C--N 1.35 1.31 0 N-CA-C 108.402 -1.879 . . . . 64.209999999999994 108.402 -156.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -177.94 -175.22 0.48 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.257 1.423 . . . . 71.420000000000002 109.826 174.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 74.31 -88.01 0.7 Allowed Glycine 0 C--N 1.346 1.119 0 O-C-N 123.198 0.311 . . . . 20.440000000000001 112.51 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.1 t -162.48 179.91 7.43 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 123.586 0.754 . . . . 61.409999999999997 109.502 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLY . . . . . 0.543 ' HA3' ' HG3' ' A' ' 177' ' ' GLN . . . 177.65 -142.73 5.8 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-O 119.811 -0.438 . . . . 44.530000000000001 112.112 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -154.1 -34.79 0.03 OUTLIER Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.612 -0.549 . . . . 60.149999999999999 113.34 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.4 t -149.57 -79.99 0.13 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.637 0.718 . . . . 74.129999999999995 110.535 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.99 178.93 15.19 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.026 0.37 . . . . 74.430000000000007 114.026 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 65.85 94.97 0.03 OUTLIER Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.161 0.41 . . . . 32.049999999999997 113.7 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.3 t -82.77 -167.85 1.8 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.556 0.742 . . . . 62.340000000000003 110.18 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -83.28 -175.06 50.8 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 119.904 -0.387 . . . . 54.530000000000001 112.176 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -167.49 -136.04 1.97 Allowed Glycine 0 C--N 1.342 0.89 0 CA-C-N 117.703 0.751 . . . . 71.340000000000003 113.107 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.1 m -142.57 133.21 25.28 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.744 1.218 . . . . 62.399999999999999 107.959 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 62.75 16.04 8.65 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.774 0.829 . . . . 74.120000000000005 111.654 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -87.41 151.72 22.83 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.1 -0.954 . . . . 73.319999999999993 110.976 -169.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 74.5 mt -120.9 145.33 47.78 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.572 0.749 . . . . 74.310000000000002 110.89 -176.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 31.2 t80 -102.26 132.39 48.24 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.68 0.792 . . . . 72.129999999999995 109.082 172.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -138.05 -171.84 3.12 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.383 0.673 . . . . 71.540000000000006 109.536 173.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 95.8 m -131.04 109.2 10.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.457 0.703 . . . . 72.239999999999995 111.14 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.584 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 16.3 tp -72.88 105.29 4.33 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.171 -1.048 . . . . 63.119999999999997 108.171 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -80.26 99.58 7.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.968 -1.015 . . . . 71.25 108.867 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 210' ' ' VAL . 13.6 t -113.96 106.44 53.41 Favored Pre-proline 0 N--CA 1.472 0.666 0 N-CA-C 108.362 -0.977 . . . . 61.049999999999997 108.362 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.29 152.77 78.78 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.414 1.41 . . . . 72.439999999999998 110.495 174.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.18 -45.86 75.95 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 114.017 1.117 . . . . 24.52 114.017 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.72 -48.2 17.87 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 121.76 1.64 . . . . 72.230000000000004 112.9 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.463 HG21 HG13 ' A' ' 210' ' ' VAL . 50.0 mt -67.75 -33.68 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.332 0.653 . . . . 54.329999999999998 110.973 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.31 87.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.045 -0.525 . . . . 73.439999999999998 110.473 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.05 -47.74 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.415 1.086 . . . . 53.32 111.495 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.99 -32.19 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-O 120.775 0.321 . . . . 64.540000000000006 110.729 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.84 68.58 1.41 Allowed Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.789 -0.642 . . . . 72.519999999999996 112.047 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.91 -123.99 5.33 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 112.523 -0.231 . . . . 75.140000000000001 112.523 -175.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -142.49 143.68 32.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.747 0.819 . . . . 61.210000000000001 109.713 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.721 HG21 HG22 ' A' ' 199' ' ' VAL . 28.8 m -140.79 151.66 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.423 0.689 . . . . 72.340000000000003 111.114 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -78.22 150.22 33.5 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.862 0.865 . . . . 61.219999999999999 111.399 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -130.63 114.21 15.15 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.375 1.47 . . . . 52.200000000000003 109.001 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -64.11 124.03 20.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.653 0.781 . . . . 75.319999999999993 110.781 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 215' ' ' LEU . 0.2 OUTLIER -111.54 -169.66 1.5 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.936 1.294 . . . . 71.0 108.095 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.466 ' H ' HG22 ' A' ' 214' ' ' THR . 7.8 mt -45.81 -70.33 0.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.863 1.265 . . . . 63.219999999999999 112.001 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -113.29 -43.56 3.34 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 113.892 -1.504 . . . . 45.039999999999999 110.84 -168.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -114.9 -179.25 18.72 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 115.646 -0.706 . . . . 52.240000000000002 112.426 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -92.65 164.07 2.81 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.213 1.942 . . . . 52.149999999999999 113.968 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 12.7 t -121.47 168.79 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 106.173 -1.788 . . . . 72.25 106.173 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.57 ' H ' ' HB ' ' A' ' 172' ' ' THR . 13.5 tt0 -148.67 143.28 26.39 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.116 -1.068 . . . . 72.030000000000001 108.116 173.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.473 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 13.3 p -136.35 143.12 36.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 C-N-CA 123.256 0.623 . . . . 75.349999999999994 111.475 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.14 110.29 8.32 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.408 1.083 . . . . 74.329999999999998 109.73 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 79.9 t -77.16 134.92 66.87 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 123.888 0.875 . . . . 54.32 109.852 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.0 155.64 61.5 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.904 2.402 . . . . 54.200000000000003 112.249 169.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.35 132.34 45.88 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.978 2.452 . . . . 73.219999999999999 112.134 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 49.58 73.27 0.25 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.376 1.47 . . . . 72.200000000000003 113.105 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.0 m -89.56 142.26 27.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.504 -1.226 . . . . 52.229999999999997 111.069 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -105.45 158.37 16.71 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.107 0.963 . . . . 70.340000000000003 110.383 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.455 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.26 148.73 28.22 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.22 -1.354 . . . . 64.239999999999995 110.411 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.46 -28.74 8.03 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 110.843 -0.903 . . . . 72.219999999999999 110.843 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.433 ' HD2' HG23 ' A' ' 227' ' ' THR . 75.1 mtt85 -58.92 171.72 0.64 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.078 0.951 . . . . 73.319999999999993 110.645 165.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.467 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.9 ptmt -165.89 149.84 7.98 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.126 0.266 . . . . 73.150000000000006 110.691 172.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.713 HD12 HD11 ' A' ' 251' ' ' LEU . 84.1 mt -79.49 155.64 28.17 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 123.532 0.52 . . . . 74.340000000000003 109.715 171.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -126.58 106.66 9.58 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.405 -1.332 . . . . 74.109999999999999 107.405 169.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 39.4 mt -105.32 112.21 25.23 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.531 -0.759 . . . . 61.310000000000002 110.045 -172.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -77.18 117.44 18.72 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.429 -1.26 . . . . 60.299999999999997 111.0 -171.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 92.55 -4.73 76.67 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.329 1.018 . . . . 72.530000000000001 113.612 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.459 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 33.9 mmtp -95.58 5.62 51.02 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.588 0.755 . . . . 61.130000000000003 112.518 -172.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.95 -178.28 50.04 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 110.81 -0.916 . . . . 45.32 110.81 166.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.48 138.22 96.44 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-N 117.402 0.601 . . . . 65.450000000000003 111.476 -174.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.49 143.62 69.98 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.316 2.677 . . . . 75.5 112.949 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.67 -178.67 15.82 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 115.844 -0.616 . . . . 73.319999999999993 113.61 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.04 -49.76 3.56 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.598 2.865 . . . . 62.130000000000003 113.393 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.28 -34.01 37.3 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 122.92 0.488 . . . . 72.439999999999998 110.989 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.32 179.88 46.14 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 114.766 -1.107 . . . . 52.399999999999999 111.391 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -79.0 168.37 19.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.523 0.729 . . . . 73.439999999999998 110.899 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.21 -167.58 39.93 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.608 -0.724 . . . . 40.049999999999997 112.063 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -119.91 171.0 8.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 122.238 -0.566 . . . . 65.310000000000002 109.873 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 43.8 tp -129.41 108.73 10.51 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.57 0.7 . . . . 65.120000000000005 110.682 -174.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 46.0 m-85 -100.11 110.5 22.78 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.141 -1.059 . . . . 65.010000000000005 108.141 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 233' ' ' LEU . 3.1 pp -125.66 114.99 19.4 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.435 0.636 . . . . 74.230000000000004 112.417 -173.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -70.15 120.29 15.63 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 114.689 -1.141 . . . . 63.420000000000002 113.452 -170.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.584 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 48.4 t -65.1 126.83 24.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 113.89 -1.505 . . . . 65.420000000000002 110.031 174.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -129.67 128.23 42.14 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.045 1.338 . . . . 74.310000000000002 108.975 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.455 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 29.2 mm -95.92 104.4 15.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.183 -1.043 . . . . 74.530000000000001 108.183 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.293 0 CA-C-O 117.386 -1.292 . . . . 62.130000000000003 108.783 -168.878 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.437 ' HB3' ' HA2' ' A' ' 174' ' ' GLY . 20.1 ptp . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 122.087 0.946 . . . . 74.099999999999994 109.726 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.18 -150.09 0.06 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.888 -1.051 . . . . 70.040000000000006 109.534 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.0 p -63.08 80.84 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 121.427 0.632 . . . . 70.439999999999998 110.529 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -168.98 136.87 1.95 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.533 1.533 . . . . 63.240000000000002 107.554 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 19.1 m -72.52 -13.77 61.49 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.473 0.709 . . . . 52.340000000000003 111.395 -178.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.79 160.85 14.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.854 0.862 . . . . 74.299999999999997 111.904 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.51 ' H ' HD22 ' A' ' 235' ' ' LEU . . . -73.35 -108.41 0.07 OUTLIER Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.31 -0.859 . . . . 65.340000000000003 111.203 166.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -138.77 176.74 8.44 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.749 0.774 . . . . 42.240000000000002 111.716 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 29.6 m95 -80.82 126.8 31.78 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.601 -1.181 . . . . 64.219999999999999 110.25 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 75.87 -40.95 0.42 Allowed 'General case' 0 C--O 1.248 0.99 0 C-N-CA 126.34 1.856 . . . . 71.219999999999999 112.206 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.426 ' HA3' ' HG2' ' A' ' 234' ' ' ARG . . . 78.51 90.39 0.37 Allowed Glycine 0 C--N 1.35 1.343 0 N-CA-C 110.768 -0.933 . . . . 60.399999999999999 110.768 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -60.09 104.79 0.34 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.971 0.908 . . . . 63.439999999999998 111.261 -172.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.62 -54.89 0.16 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.327 -0.851 . . . . 61.149999999999999 111.534 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.8 m -133.87 75.86 1.62 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.452 0.701 . . . . 51.240000000000002 110.078 -177.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -94.28 35.6 4.12 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.463 -0.789 . . . . 71.420000000000002 112.071 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -79.61 173.98 55.15 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 112.597 -0.201 . . . . 64.129999999999995 112.597 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.3 t -96.58 93.84 7.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.98 -0.748 . . . . 74.310000000000002 108.98 178.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.56 158.45 31.14 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.951 -0.568 . . . . 43.399999999999999 112.481 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.21 -170.22 39.35 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 119.656 -0.524 . . . . 74.099999999999994 111.806 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.8 t 71.1 108.01 0.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.077 1.351 . . . . 55.530000000000001 110.613 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.81 119.76 2.79 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.228 -0.749 . . . . 44.229999999999997 111.228 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 162.36 126.63 0.83 Allowed Glycine 0 C--N 1.344 1.019 0 N-CA-C 111.117 -0.793 . . . . 73.329999999999998 111.117 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 45.6 m -91.09 -65.6 1.0 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.174 0.59 . . . . 51.420000000000002 110.638 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -72.53 -50.3 26.68 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.489 -0.778 . . . . 73.200000000000003 109.704 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -68.03 140.19 56.32 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.193 -0.912 . . . . 63.420000000000002 110.143 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.3 mt -119.35 160.62 21.92 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.656 0.782 . . . . 74.299999999999997 110.914 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 4.4 t80 -121.77 108.33 13.37 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.188 -0.671 . . . . 74.040000000000006 109.188 171.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -116.8 -170.85 1.91 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.42 1.088 . . . . 52.25 109.5 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.9 m -119.12 126.04 50.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.985 0.914 . . . . 72.140000000000001 110.429 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.601 ' HB2' HD13 ' A' ' 251' ' ' LEU . 25.2 tp -84.51 104.76 14.79 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 107.769 -1.197 . . . . 54.109999999999999 107.769 166.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -86.95 106.39 17.77 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.165 -0.68 . . . . 74.329999999999998 109.165 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.652 HG22 HG21 ' A' ' 210' ' ' VAL . 21.7 t -114.13 120.76 37.92 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.65 -0.87 . . . . 71.439999999999998 108.65 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.89 150.61 61.63 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 121.77 1.646 . . . . 52.119999999999997 110.217 170.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.67 -45.24 96.6 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 117.808 -1.091 . . . . 64.109999999999999 112.834 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.2 Cg_endo -56.26 -50.36 12.33 Favored 'Trans proline' 0 C--N 1.401 3.294 0 C-N-CA 122.077 1.851 . . . . 60.109999999999999 112.87 177.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.449 HG21 HG13 ' A' ' 210' ' ' VAL . 28.1 mt -64.74 -34.49 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.41 0.684 . . . . 74.400000000000006 110.626 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.61 95.65 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.072 -0.513 . . . . 44.030000000000001 111.137 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.4 t -73.92 -49.78 32.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 123.982 0.913 . . . . 70.5 111.844 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.2 -28.45 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.373 0.269 . . . . 74.299999999999997 110.878 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.15 77.79 1.18 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.993 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.01 -137.28 8.2 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.725 -0.486 . . . . 64.219999999999999 112.0 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -133.77 139.84 46.58 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.801 0.8 . . . . 73.209999999999994 109.806 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.652 HG21 HG22 ' A' ' 199' ' ' VAL . 35.6 m -133.4 153.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.229 0.612 . . . . 53.520000000000003 111.064 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.428 ' HG2' ' N ' ' A' ' 212' ' ' ALA . 22.9 ttm180 -75.73 154.54 36.34 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.905 0.882 . . . . 73.25 110.716 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -132.23 120.76 22.63 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.521 1.528 . . . . 64.319999999999993 108.383 176.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.06 132.23 48.65 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.766 0.827 . . . . 74.099999999999994 110.467 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.661 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -136.14 -172.72 3.2 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.663 0.785 . . . . 54.539999999999999 110.162 -175.129 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.618 ' H ' HG22 ' A' ' 214' ' ' THR . 6.4 mt -63.78 -67.41 0.43 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.298 1.439 . . . . 73.120000000000005 110.671 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -103.74 -41.55 5.89 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 113.322 -1.763 . . . . 73.340000000000003 111.554 -162.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -150.7 154.02 25.36 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.046 -0.863 . . . . 61.340000000000003 111.76 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.16 142.0 30.11 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.603 2.202 . . . . 70.129999999999995 113.55 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 73.1 t -95.62 163.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 114.471 -1.241 . . . . 63.229999999999997 108.286 175.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -142.81 136.92 29.29 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.371 -1.344 . . . . 74.319999999999993 107.371 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.457 HG11 HD11 ' A' ' 233' ' ' LEU . 12.3 p -132.26 140.38 47.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.481 0.712 . . . . 64.25 110.688 -172.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.31 109.42 9.99 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.063 0.945 . . . . 75.340000000000003 109.323 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.1 t -73.73 131.02 82.52 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.212 1.005 . . . . 63.549999999999997 109.388 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.88 155.2 58.16 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.433 2.089 . . . . 52.340000000000003 111.05 171.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.55 136.23 53.33 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.314 2.009 . . . . 61.219999999999999 112.7 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 51.66 69.25 0.68 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.646 1.579 . . . . 73.439999999999998 112.706 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.443 HG23 ' HD2' ' A' ' 231' ' ' ARG . 69.8 m -85.03 141.08 30.54 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.85 -1.068 . . . . 72.519999999999996 110.613 174.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -102.16 155.63 18.08 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.78 0.832 . . . . 54.200000000000003 110.1 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.495 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -83.91 154.83 23.18 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.652 -1.158 . . . . 62.210000000000001 111.212 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.88 -6.78 57.06 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.935 -0.575 . . . . 51.549999999999997 111.933 -173.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.443 ' HD2' HG23 ' A' ' 227' ' ' THR . 65.9 mtt85 -72.09 179.47 3.28 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.916 0.886 . . . . 71.430000000000007 109.722 168.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.462 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.2 ptpt -168.27 150.94 5.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.882 0.473 . . . . 62.119999999999997 110.464 169.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.489 ' HG ' HD22 ' A' ' 197' ' ' LEU . 56.9 mt -85.18 156.03 21.18 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.751 -0.833 . . . . 65.239999999999995 108.751 169.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.426 ' HG2' ' HA3' ' A' ' 178' ' ' GLY . 12.1 ptp180 -115.32 123.74 49.51 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 106.459 -1.682 . . . . 53.229999999999997 106.459 157.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.659 HD12 HD23 ' A' ' 249' ' ' LEU . 46.5 mt -112.21 108.18 17.33 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.898 -0.779 . . . . 72.310000000000002 108.898 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -70.41 113.2 7.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.136 -1.393 . . . . 74.450000000000003 111.443 -170.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 91.74 -5.88 79.71 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.248 -0.887 . . . . 52.240000000000002 113.771 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.661 ' HD2' HG21 ' A' ' 214' ' ' THR . 48.4 mmtm -86.87 10.08 17.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.405 0.682 . . . . 72.129999999999995 112.213 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.16 169.56 24.07 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.786 -1.326 . . . . 74.019999999999996 109.786 164.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 41.4 m-85 -57.22 139.51 79.57 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 123.363 0.665 . . . . 52.140000000000001 112.129 -173.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 11.7 Cg_exo -69.6 150.04 68.69 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.907 2.405 . . . . 54.340000000000003 113.076 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.68 171.95 21.8 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.801 -0.999 . . . . 54.32 111.018 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -61.66 -48.22 9.57 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.988 2.459 . . . . 74.230000000000004 113.393 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.57 -19.07 28.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.287 0.635 . . . . 64.239999999999995 111.863 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 171.31 169.43 34.24 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.944 -0.462 . . . . 72.109999999999999 111.944 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -85.51 170.22 12.84 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.788 0.835 . . . . 64.430000000000007 110.864 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.95 179.95 48.73 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.299 -0.864 . . . . 53.539999999999999 111.224 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -122.69 153.16 39.78 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.578 -0.527 . . . . 75.530000000000001 109.578 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.659 HD23 HD12 ' A' ' 235' ' ' LEU . 48.8 tp -106.2 106.75 17.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.352 -0.61 . . . . 73.329999999999998 109.352 -172.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 48.8 m-85 -98.98 109.12 21.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.998 -1.482 . . . . 74.140000000000001 106.998 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.647 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -126.55 117.49 22.93 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.95 1.092 . . . . 64.140000000000001 113.95 -177.198 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.86 118.78 10.18 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 113.133 -1.849 . . . . 51.299999999999997 112.518 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.543 HG22 HD23 ' A' ' 197' ' ' LEU . 52.3 t -69.68 109.49 2.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 114.329 -1.305 . . . . 71.219999999999999 110.68 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -100.25 118.17 35.98 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.53 1.132 . . . . 74.340000000000003 108.824 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.495 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 39.8 mm -87.26 107.94 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.462 -1.31 . . . . 53.049999999999997 107.462 170.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.329 0 C-N-CA 124.301 1.04 . . . . 44.409999999999997 108.258 -174.096 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.417 0.627 . . . . 74.519999999999996 109.315 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.04 -168.5 3.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.51 1.124 . . . . 73.109999999999999 108.884 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.7 t -73.85 75.15 1.62 Allowed 'General case' 0 CA--C 1.565 1.543 0 CA-C-O 122.284 1.04 . . . . 74.219999999999999 110.646 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -163.48 158.67 21.21 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.221 1.009 . . . . 75.209999999999994 109.669 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.401 HG22 HG22 ' A' ' 219' ' ' VAL . 17.0 m -78.0 -26.46 48.57 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.374 -0.83 . . . . 75.310000000000002 110.633 176.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.9 -168.79 0.95 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.861 0.865 . . . . 52.039999999999999 112.59 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.07 -87.52 1.03 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 110.194 -1.163 . . . . 63.399999999999999 110.194 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.27 174.51 10.47 Favored 'General case' 0 C--O 1.248 0.98 0 C-N-CA 123.477 0.711 . . . . 64.549999999999997 109.917 172.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.526 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 19.1 m95 -82.33 -84.78 0.12 Allowed 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.313 -0.858 . . . . 73.140000000000001 109.744 167.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 176.25 -173.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.864 1.265 . . . . 54.399999999999999 109.121 -171.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -73.86 -90.36 0.16 Allowed Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.243 -0.743 . . . . 64.349999999999994 111.243 170.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -144.02 113.61 7.08 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.119 -1.067 . . . . 73.239999999999995 108.119 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -60.12 119.46 18.5 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 123.833 0.708 . . . . 73.040000000000006 112.616 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.7 t -147.58 148.15 30.83 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.995 0.518 . . . . 74.019999999999996 110.549 -172.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 78.8 -143.51 26.71 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.925 -0.58 . . . . 71.219999999999999 112.848 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -101.45 -176.93 28.67 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 112.096 -0.402 . . . . 64.230000000000004 112.096 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.9 p -72.77 114.95 11.48 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.93 0.492 . . . . 45.030000000000001 110.171 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -65.92 139.9 39.3 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-O 119.705 -0.497 . . . . 61.130000000000003 112.901 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -64.32 117.01 9.79 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 120.035 -0.314 . . . . 62.32 112.333 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.4 t -135.5 140.61 44.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.76 0.824 . . . . 62.420000000000002 109.855 -175.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -86.48 -152.72 21.66 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.569 0.543 . . . . 61.539999999999999 111.898 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -170.46 77.48 0.1 OUTLIER Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.938 -0.465 . . . . 72.239999999999995 111.938 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 47.6 t -89.44 -95.0 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 109.098 -0.704 . . . . 74.099999999999994 109.098 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -83.01 -33.98 26.41 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.99 -0.745 . . . . 71.430000000000007 108.99 168.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.38 142.49 56.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.661 -1.154 . . . . 63.210000000000001 109.692 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 80.5 mt -129.0 166.52 19.05 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.424 0.63 . . . . 71.310000000000002 111.747 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 25.4 t80 -120.26 139.37 52.81 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.612 -1.176 . . . . 73.329999999999998 109.267 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -151.72 -170.44 3.65 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.003 0.921 . . . . 72.230000000000004 109.819 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.4 m -119.72 140.99 49.83 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.695 0.798 . . . . 64.430000000000007 110.964 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.536 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 19.5 tp -100.48 108.23 20.14 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.105 0.962 . . . . 73.340000000000003 108.413 168.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -83.46 100.1 10.52 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.26 -0.645 . . . . 73.409999999999997 109.26 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.652 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.7 t -108.39 115.17 58.42 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 108.334 -0.987 . . . . 54.219999999999999 108.334 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.81 145.0 49.94 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 121.571 1.514 . . . . 43.009999999999998 110.6 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.27 -47.91 56.35 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 114.252 1.204 . . . . 42.229999999999997 114.252 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.79 -45.85 33.64 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 122.235 1.957 . . . . 73.510000000000005 113.768 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.2 mt -65.87 -34.92 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.942 0.497 . . . . 72.329999999999998 110.535 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.13 -44.39 92.33 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.07 -0.514 . . . . 72.299999999999997 111.385 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.3 t -71.03 -46.4 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.99 0.916 . . . . 72.200000000000003 112.028 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.03 -28.33 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 120.561 0.219 . . . . 73.099999999999994 110.623 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.89 72.3 1.23 Allowed Glycine 0 C--N 1.346 1.084 0 N-CA-C 111.233 -0.747 . . . . 62.409999999999997 111.233 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.7 -126.59 5.74 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 112.33 -0.308 . . . . 53.229999999999997 112.33 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -142.33 148.02 37.27 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.266 1.027 . . . . 74.439999999999998 108.849 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.8 m -142.43 158.89 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 123.134 0.573 . . . . 73.519999999999996 110.69 174.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -75.8 151.11 37.59 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.776 0.83 . . . . 75.340000000000003 110.18 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -128.2 114.59 17.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 73.340000000000003 108.576 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.6 tpt -64.51 109.58 2.01 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.129 0.572 . . . . 73.439999999999998 110.933 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.553 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -93.45 -169.1 2.04 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.247 1.419 . . . . 62.100000000000001 108.933 175.174 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.55 -69.16 0.12 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.464 1.126 . . . . 64.010000000000005 110.581 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.76 -42.52 3.41 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 112.793 -2.003 . . . . 72.319999999999993 110.746 -170.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -101.77 176.78 26.38 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.507 -0.769 . . . . 64.120000000000005 112.607 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -102.4 145.94 0.22 Allowed 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 122.882 2.388 . . . . 61.439999999999998 114.234 168.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.553 HG23 ' OG1' ' A' ' 214' ' ' THR . 50.2 t -104.06 168.79 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.158 1.383 . . . . 55.439999999999998 108.055 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -142.04 139.23 32.27 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.094 -1.076 . . . . 71.540000000000006 108.094 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.54 HG11 HD11 ' A' ' 233' ' ' LEU . 12.7 p -134.25 144.64 34.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 123.627 0.771 . . . . 62.340000000000003 110.153 -173.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.04 113.12 19.02 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.421 0.688 . . . . 62.0 109.373 174.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 89.8 t -76.77 132.14 72.3 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.707 0.803 . . . . 71.120000000000005 109.512 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.83 161.34 44.36 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.803 2.335 . . . . 72.519999999999996 112.376 171.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.37 131.9 22.78 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.135 1.89 . . . . 74.450000000000003 112.315 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 52.79 72.21 0.43 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.998 1.319 . . . . 75.540000000000006 112.63 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 97.3 m -91.51 143.59 26.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.636 -1.166 . . . . 41.130000000000003 110.915 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -108.51 160.49 15.86 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.264 1.025 . . . . 72.120000000000005 110.635 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.528 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -80.07 155.17 27.66 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.991 -1.004 . . . . 65.420000000000002 111.264 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.6 -20.95 35.79 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 112.141 -0.384 . . . . 62.009999999999998 112.141 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -65.68 178.11 1.09 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.11 0.964 . . . . 72.25 110.551 167.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.574 ' HA ' HG23 ' A' ' 253' ' ' VAL . 12.4 ptmt -167.13 153.95 8.54 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 116.703 -0.226 . . . . 74.129999999999995 110.955 173.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.706 HD12 HD11 ' A' ' 251' ' ' LEU . 75.2 mt -84.23 152.03 24.45 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.862 -0.422 . . . . 71.510000000000005 109.862 170.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -117.8 107.18 13.83 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.354 -1.35 . . . . 73.129999999999995 107.354 161.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 65.4 mt -102.97 107.92 18.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.085 -0.961 . . . . 74.340000000000003 109.725 -173.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -78.61 120.7 23.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.635 -1.166 . . . . 74.129999999999995 111.426 -165.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.91 18.98 80.14 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.502 1.126 . . . . 74.239999999999995 113.761 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.44 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 43.4 mmtm -105.09 3.34 30.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.047 0.539 . . . . 73.439999999999998 111.842 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -83.75 -172.57 48.99 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 111.087 -0.805 . . . . 74.109999999999999 111.087 168.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 10.2 m-85 -62.04 137.0 95.49 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 117.213 0.506 . . . . 71.209999999999994 111.802 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.55 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 15.0 Cg_exo -69.64 143.72 52.37 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.038 2.492 . . . . 62.240000000000002 112.257 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.57 173.33 20.9 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.109 -0.95 . . . . 73.340000000000003 112.12 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.83 -14.29 26.74 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 123.106 2.537 . . . . 73.120000000000005 113.415 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.61 -17.94 12.91 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.837 0.855 . . . . 51.25 111.957 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 162.46 -162.13 34.16 Favored Glycine 0 C--O 1.221 -0.719 0 N-CA-C 109.52 -1.432 . . . . 61.119999999999997 109.52 -173.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.55 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 99.0 mtt180 -115.61 160.37 20.09 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 118.511 1.156 . . . . 71.430000000000007 110.67 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 177.28 54.34 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.348 -0.842 . . . . 55.109999999999999 111.765 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -119.31 143.14 47.53 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.367 0.603 . . . . 75.140000000000001 109.72 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 51.7 tp -102.4 108.04 19.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.438 -0.801 . . . . 74.099999999999994 110.006 -168.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 53.6 m-85 -100.58 106.6 18.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.916 -1.038 . . . . 75.409999999999997 108.776 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.706 HD11 HD12 ' A' ' 233' ' ' LEU . 1.8 pp -124.47 118.57 26.93 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.58 0.955 . . . . 25.41 113.58 -174.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.77 116.13 8.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.405 1.482 . . . . 72.340000000000003 112.488 -172.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 232' ' ' LYS . 59.4 t -64.24 118.85 7.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-N 114.092 -1.413 . . . . 75.430000000000007 111.081 175.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -114.32 117.51 31.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.431 1.492 . . . . 71.219999999999999 108.576 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.528 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 36.6 mm -87.82 106.75 16.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.088 -1.079 . . . . 45.420000000000002 108.088 172.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.259 1.581 0 C-N-CA 124.615 1.166 . . . . 64.140000000000001 108.131 -171.833 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 91.7 mtp . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.589 0.233 . . . . 72.239999999999995 110.373 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -78.31 133.68 37.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.119 0.968 . . . . 73.010000000000005 108.969 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.2 t -64.47 100.4 0.36 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.42 0.688 . . . . 71.230000000000004 111.433 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -167.89 148.59 5.14 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.715 0.806 . . . . 71.299999999999997 110.41 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.7 m -78.76 -26.17 44.54 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.78 0.8 . . . . 62.25 108.904 169.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -91.86 164.03 13.82 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.013 -0.994 . . . . 72.340000000000003 110.871 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -99.08 -88.82 1.97 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 111.34 -0.704 . . . . 51.030000000000001 111.34 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.23 159.67 41.77 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.114 0.966 . . . . 72.049999999999997 110.232 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.545 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.0 m95 -76.11 -87.72 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.473 -0.785 . . . . 64.019999999999996 109.201 175.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.07 37.24 4.19 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 106.048 -1.834 . . . . 72.209999999999994 106.048 174.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.39 -68.31 3.17 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 108.019 -2.033 . . . . 44.229999999999997 108.019 -152.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? 170.02 101.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.628 2.371 . . . . 73.430000000000007 105.237 164.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.07 -120.73 0.97 Allowed Glycine 0 C--N 1.341 0.828 0 C-N-CA 121.307 -0.473 . . . . 73.25 112.979 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.5 t -150.47 141.28 22.78 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.505 0.722 . . . . 74.129999999999995 109.956 -168.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.95 -134.86 3.96 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 111.116 -0.794 . . . . 73.230000000000004 111.116 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 146.49 61.86 0.01 OUTLIER Glycine 0 C--N 1.347 1.179 0 CA-C-N 117.226 0.513 . . . . 75.519999999999996 112.349 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 78.3 p -165.36 162.13 19.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.715 0.806 . . . . 71.129999999999995 110.731 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -82.8 -103.51 0.48 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.187 -1.165 . . . . 60.509999999999998 110.187 167.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.82 -64.45 3.34 Favored Glycine 0 C--N 1.351 1.368 0 C-N-CA 123.305 0.479 . . . . 32.140000000000001 113.476 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 250' ' ' TYR . 21.0 m -71.11 -14.66 62.37 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.92 1.288 . . . . 64.109999999999999 113.634 -175.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -74.81 99.67 1.15 Allowed Glycine 0 C--N 1.352 1.451 0 O-C-N 123.618 0.574 . . . . 44.229999999999997 112.614 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -115.6 -100.33 2.25 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.431 -0.65 . . . . 74.340000000000003 112.623 -177.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -145.66 -62.11 0.33 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 117.926 0.863 . . . . 75.030000000000001 111.944 -171.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.65 -33.88 75.84 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 120.65 0.262 . . . . 72.439999999999998 110.414 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.83 146.42 49.7 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.868 -0.605 . . . . 71.340000000000003 110.097 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.5 mt -121.2 146.05 47.19 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.917 0.487 . . . . 75.129999999999995 111.762 -171.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -99.56 111.0 23.4 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.005 -0.998 . . . . 74.219999999999999 108.487 171.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.39 -170.45 1.98 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.416 1.086 . . . . 74.140000000000001 109.752 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.3 m -120.87 138.92 53.84 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 124.274 1.03 . . . . 74.0 111.07 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.8 tp -94.56 107.0 19.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.2 -1.037 . . . . 64.439999999999998 108.2 168.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 210' ' ' VAL . 14.3 t70 -80.52 109.08 14.7 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.983 -0.747 . . . . 61.399999999999999 108.983 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 255' ' ' ILE . 0.9 OUTLIER -132.23 118.36 16.12 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 122.68 0.392 . . . . 74.049999999999997 110.191 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 53.9 Cg_endo -70.62 148.08 58.73 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.982 1.788 . . . . 50.32 111.373 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.37 -45.6 83.82 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.495 1.118 . . . . 74.310000000000002 113.945 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.9 Cg_exo -56.07 -47.48 24.45 Favored 'Trans proline' 0 C--N 1.396 3.052 0 C-N-CA 122.065 1.844 . . . . 55.420000000000002 113.034 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.41 HG21 HG13 ' A' ' 210' ' ' VAL . 25.8 mt -64.57 -37.33 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.406 0.682 . . . . 72.310000000000002 110.717 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.81 -43.74 97.79 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.045 0.538 . . . . 53.130000000000003 110.867 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.3 -48.69 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.405 1.082 . . . . 74.239999999999995 112.031 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.5 p -79.48 -32.09 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 117.955 0.343 . . . . 73.140000000000001 111.192 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.86 106.17 1.35 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.474 -0.65 . . . . 33.310000000000002 111.474 -171.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.48 -138.13 3.6 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 119.518 -0.601 . . . . 72.329999999999998 111.883 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -138.98 137.3 36.25 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.693 0.797 . . . . 74.540000000000006 109.402 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.502 HG21 ' HB ' ' A' ' 199' ' ' VAL . 24.3 m -137.54 153.3 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.92 0.488 . . . . 33.100000000000001 111.19 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -76.91 139.05 40.08 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.559 -0.746 . . . . 61.299999999999997 111.132 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.561 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -111.76 111.43 22.4 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.154 -1.425 . . . . 73.0 107.154 170.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -69.13 114.12 7.12 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.071 0.548 . . . . 61.43 109.888 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.562 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -108.38 -173.12 2.2 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.311 1.044 . . . . 73.409999999999997 109.432 178.683 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.519 ' H ' HG22 ' A' ' 214' ' ' THR . 7.3 mt -56.42 -69.06 0.16 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.505 1.522 . . . . 74.150000000000006 111.7 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.83 -43.59 3.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 113.67 -1.605 . . . . 73.239999999999995 110.843 -168.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -123.9 133.65 8.9 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.545 -1.141 . . . . 65.340000000000003 111.132 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.49 150.65 58.1 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.342 2.028 . . . . 75.140000000000001 112.57 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 53.2 t -104.31 168.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.121 1.368 . . . . 75.450000000000003 107.856 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -148.64 135.23 19.67 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.438 -0.949 . . . . 75.439999999999998 108.438 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.434 HG21 HD21 ' A' ' 233' ' ' LEU . 11.8 p -126.56 139.34 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.509 0.724 . . . . 71.340000000000003 110.6 -173.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.02 104.35 3.53 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.522 -0.763 . . . . 64.530000000000001 109.076 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.43 123.99 90.22 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.141 -0.936 . . . . 74.120000000000005 108.789 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.03 158.67 42.36 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.773 2.316 . . . . 71.5 111.552 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.45 142.44 90.55 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.222 1.948 . . . . 70.400000000000006 111.932 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 46.67 64.9 1.35 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.8 1.64 . . . . 75.329999999999998 113.545 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.464 HG23 ' HD2' ' A' ' 231' ' ' ARG . 90.9 m -93.87 137.98 32.51 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.532 -1.213 . . . . 72.099999999999994 110.501 175.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.464 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 25.9 mp0 -104.25 163.58 12.32 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.854 0.862 . . . . 60.219999999999999 110.24 175.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.538 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -84.27 154.84 22.74 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.29 -1.323 . . . . 52.43 111.002 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.62 -15.59 49.08 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 123.459 0.474 . . . . 71.219999999999999 111.93 -172.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.464 ' HD2' HG23 ' A' ' 227' ' ' THR . 81.1 mtt85 -68.57 -179.35 1.35 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.974 0.909 . . . . 64.340000000000003 109.553 164.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.484 ' HA ' HG23 ' A' ' 253' ' ' VAL . 4.8 ptmt -169.24 147.74 3.81 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 119.288 -0.387 . . . . 75.549999999999997 110.323 176.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.601 HD12 HD11 ' A' ' 251' ' ' LEU . 88.7 mt -79.34 152.79 30.25 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.671 -0.492 . . . . 73.140000000000001 109.671 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -115.88 113.42 23.31 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 107.156 -1.424 . . . . 75.239999999999995 107.156 160.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 57.3 mt -113.3 109.96 19.59 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.908 -0.775 . . . . 74.400000000000006 108.908 -177.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -86.91 117.08 25.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.316 -0.856 . . . . 74.150000000000006 110.879 -167.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 89.83 10.84 64.38 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.197 0.936 . . . . 44.43 113.598 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 39.1 mmtm -98.54 -5.01 32.96 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.814 1.042 . . . . 74.219999999999999 113.814 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -83.49 -172.23 48.53 Favored Glycine 0 N--CA 1.479 1.505 0 CA-C-O 119.79 -0.45 . . . . 73.109999999999999 112.586 171.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -56.89 133.48 79.5 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.458 0.703 . . . . 73.019999999999996 111.964 -175.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.13 145.37 72.81 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.988 2.458 . . . . 72.239999999999995 111.944 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.4 177.08 19.04 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.971 -0.559 . . . . 72.319999999999993 112.899 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.09 -26.32 18.31 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 123.213 2.608 . . . . 73.25 113.41 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.73 -30.87 14.66 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.518 0.727 . . . . 74.019999999999996 111.699 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.07 -132.03 1.59 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 111.214 -0.755 . . . . 70.099999999999994 111.214 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -140.22 147.03 39.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.786 1.235 . . . . 70.230000000000004 108.784 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.93 177.31 42.13 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.897 0.748 . . . . 75.299999999999997 111.585 174.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -108.12 -177.64 3.39 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.144 0.577 . . . . 75.129999999999995 110.424 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.1 tp -141.3 106.21 4.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.514 0.673 . . . . 63.020000000000003 110.454 -176.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 38.3 m-85 -103.6 111.71 24.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.784 -1.561 . . . . 73.439999999999998 106.784 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.9 pp -124.08 118.06 26.08 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.57 0.952 . . . . 71.310000000000002 113.57 -173.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.61 119.24 12.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.751 1.62 . . . . 64.549999999999997 112.002 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.545 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 97.9 t -67.74 122.83 19.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 125.125 1.37 . . . . 74.530000000000001 111.073 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -118.67 111.54 18.65 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.2 1.4 . . . . 73.340000000000003 108.652 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.538 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 24.1 mm -81.84 96.81 3.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 107.586 -1.264 . . . . 60.119999999999997 107.586 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.252 1.228 0 C-N-CA 124.922 1.289 . . . . 64.099999999999994 108.451 -178.088 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 168' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 173' ' ' ALA . 14.1 ptt? . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 111.82 0.304 . . . . 43.109999999999999 111.82 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' A' ' 170' ' ' THR . 19.8 tt0 -156.7 -154.54 0.47 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 108.251 -1.018 . . . . 74.400000000000006 108.251 -161.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.445 ' H ' ' HG2' ' A' ' 169' ' ' GLU . 12.1 t -57.91 -25.07 60.37 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.103 0.561 . . . . 71.5 110.805 167.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.66 129.0 34.26 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 123.508 0.723 . . . . 71.420000000000002 109.535 168.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 27.2 m -67.37 -18.38 65.12 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.288 1.035 . . . . 54.299999999999997 111.942 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 168' ' ' MET . . . -80.02 158.22 26.57 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.5 0.72 . . . . 70.010000000000005 112.073 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.92 -82.4 0.85 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 110.609 -0.997 . . . . 54.399999999999999 110.609 170.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.45 170.6 22.06 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.435 0.694 . . . . 74.349999999999994 111.147 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.614 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 48.2 m95 -70.53 -62.93 1.2 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.827 -1.175 . . . . 75.5 107.827 171.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.47 173.52 9.79 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 113.748 -1.569 . . . . 63.329999999999998 108.482 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -69.64 74.54 0.44 Allowed Glycine 0 C--N 1.343 0.957 0 N-CA-C 109.214 -1.555 . . . . 55.229999999999997 109.214 164.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.09 107.7 2.0 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.76 1.224 . . . . 74.25 110.874 -158.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.39 -115.44 0.33 Allowed Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.881 -0.6 . . . . 34.420000000000002 112.812 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.1 m -83.01 -32.62 26.82 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.313 0.645 . . . . 72.409999999999997 111.634 -175.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -63.89 123.47 28.52 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.416 -0.811 . . . . 62.009999999999998 113.596 -175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -134.49 28.64 3.11 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 123.046 0.355 . . . . 73.200000000000003 112.72 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.2 m -85.87 138.16 32.24 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.075 0.55 . . . . 74.549999999999997 110.017 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -90.37 -148.46 20.37 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 111.567 -0.613 . . . . 52.509999999999998 111.567 173.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -167.61 148.73 13.31 Favored Glycine 0 C--O 1.242 0.644 0 N-CA-C 111.773 -0.531 . . . . 41.119999999999997 111.773 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.6 t -70.82 -45.69 64.1 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.928 0.891 . . . . 73.409999999999997 110.383 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.36 -163.31 21.86 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 111.344 -0.702 . . . . 64.400000000000006 111.344 -172.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.48 -162.26 12.72 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.704 -0.558 . . . . 53.420000000000002 111.704 -176.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.1 m -70.82 -51.01 29.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.018 0.527 . . . . 50.530000000000001 110.501 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -74.85 -62.61 1.48 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.697 0.799 . . . . 74.439999999999998 109.218 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 5.9 p-10 -73.57 126.74 30.94 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.901 -1.045 . . . . 65.010000000000005 110.315 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.1 mt -113.5 164.36 13.73 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.436 0.636 . . . . 71.230000000000004 112.648 -164.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -114.49 125.53 53.92 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.611 -1.177 . . . . 74.299999999999997 108.523 167.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -135.66 -171.53 2.87 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.977 0.911 . . . . 70.400000000000006 109.467 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.1 m -117.93 138.49 52.11 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.945 0.898 . . . . 54.399999999999999 110.494 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.613 ' HB2' HD13 ' A' ' 251' ' ' LEU . 21.8 tp -93.74 128.82 40.16 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.06 -1.089 . . . . 13.24 108.06 165.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.08 100.37 11.69 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.611 -0.514 . . . . 73.230000000000004 109.611 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.634 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.9 t -111.1 108.81 57.26 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 108.444 -0.947 . . . . 74.439999999999998 108.444 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.17 144.57 63.5 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 121.491 1.461 . . . . 74.349999999999994 110.082 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.16 -45.9 65.48 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 114.083 1.142 . . . . 73.439999999999998 114.083 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.08 -47.16 24.15 Favored 'Trans proline' 0 C--N 1.392 2.851 0 C-N-CA 122.104 1.869 . . . . 62.299999999999997 113.744 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.2 mt -64.19 -36.96 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 122.736 0.414 . . . . 74.150000000000006 110.567 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.37 94.43 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.951 0.501 . . . . 43.409999999999997 111.088 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.0 t -72.3 -50.69 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 124.32 1.013 . . . . 74.540000000000006 112.097 -175.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.78 -21.54 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-O 120.851 0.358 . . . . 42.340000000000003 110.899 -176.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.36 84.87 0.53 Allowed Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.996 -0.547 . . . . 72.049999999999997 112.1 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.94 -136.82 5.99 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.839 -0.504 . . . . 64.209999999999994 111.839 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -127.54 151.33 49.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.862 0.865 . . . . 61.210000000000001 109.212 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.634 HG11 ' HA ' ' A' ' 199' ' ' VAL . 28.3 m -140.36 150.18 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.294 0.638 . . . . 73.230000000000004 110.31 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -77.24 138.89 39.68 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 123.621 0.575 . . . . 72.310000000000002 110.426 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.645 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -109.26 114.71 28.63 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.748 -1.575 . . . . 65.099999999999994 106.748 171.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.0 tpt -64.69 126.12 26.91 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.035 0.534 . . . . 62.43 109.691 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.98 -168.98 2.08 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.687 1.195 . . . . 71.140000000000001 109.74 -172.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.4 mt -82.22 -68.73 0.67 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.141 0.972 . . . . 72.25 109.904 -171.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -98.24 -40.78 8.19 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 112.972 -1.922 . . . . 74.230000000000004 109.845 -165.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -145.34 134.29 5.45 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-O 118.448 -1.196 . . . . 62.32 110.242 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.0 144.21 52.01 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.764 2.31 . . . . 75.420000000000002 112.345 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 55.3 t -96.79 168.5 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 125.231 1.413 . . . . 63.140000000000001 108.994 -177.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -148.26 127.92 13.32 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.869 -0.789 . . . . 74.109999999999999 108.869 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.6 p -118.13 143.3 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.472 0.709 . . . . 52.5 109.892 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.46 108.64 7.36 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.853 -0.795 . . . . 73.510000000000005 108.853 170.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.497 ' HA ' ' HZ2' ' A' ' 176' ' ' TRP . 71.1 t -73.61 128.33 87.21 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.737 0.815 . . . . 61.310000000000002 109.821 173.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.62 157.47 60.56 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.704 2.269 . . . . 73.420000000000002 111.411 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.18 134.6 56.87 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.466 2.11 . . . . 53.219999999999999 112.509 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 51.24 67.32 0.97 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.76 1.624 . . . . 74.420000000000002 112.823 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.47 HG23 ' HD2' ' A' ' 231' ' ' ARG . 54.9 m -88.79 140.16 29.73 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.694 -1.139 . . . . 54.509999999999998 110.549 173.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.444 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 28.2 mp0 -100.78 157.52 16.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.074 0.95 . . . . 73.409999999999997 111.156 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.494 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -80.2 155.28 27.46 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.447 -1.251 . . . . 44.420000000000002 110.239 176.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.48 29.86 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 111.649 -0.58 . . . . 64.329999999999998 111.649 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.47 ' HD2' HG23 ' A' ' 227' ' ' THR . 73.7 mtt85 -62.23 178.18 0.41 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.688 0.795 . . . . 71.209999999999994 110.559 168.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.4 ptmt -166.17 147.24 6.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.752 -0.462 . . . . 74.439999999999998 109.752 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.581 HD12 HD11 ' A' ' 251' ' ' LEU . 88.8 mt -79.32 147.63 32.39 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.911 -0.774 . . . . 73.120000000000005 108.911 169.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -108.57 121.39 44.89 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.006 -1.479 . . . . 73.349999999999994 107.006 158.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 80.4 mt -118.28 110.92 18.1 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.365 -0.606 . . . . 63.32 109.365 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -79.02 119.28 21.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 73.400000000000006 110.922 -167.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.34 13.78 77.93 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.454 1.096 . . . . 44.119999999999997 113.948 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.3 mmtt -102.65 8.57 39.63 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 117.512 0.656 . . . . 61.119999999999997 112.665 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.82 172.55 32.66 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 110.644 -0.982 . . . . 63.240000000000002 110.644 168.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -55.42 146.09 44.81 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-N 117.652 0.726 . . . . 65.299999999999997 112.31 -173.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 24.5 Cg_exo -60.31 141.29 95.43 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.933 2.422 . . . . 74.209999999999994 112.272 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -130.26 171.72 20.49 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.958 -1.019 . . . . 71.109999999999999 111.842 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.68 -32.21 38.46 Favored 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 123.014 2.476 . . . . 60.420000000000002 112.793 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.57 -7.36 41.3 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.583 0.753 . . . . 73.439999999999998 111.387 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 135.55 177.08 14.71 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.218 -0.753 . . . . 33.200000000000003 111.218 -177.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 61.8 mtm-85 -69.44 155.77 39.91 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.406 0.682 . . . . 61.149999999999999 112.206 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.12 -172.04 47.04 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.525 -0.761 . . . . 35.049999999999997 111.976 173.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.525 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 12.7 m-20 -115.12 149.08 38.15 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.366 0.666 . . . . 55.509999999999998 110.115 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.2 tp -106.53 108.47 19.99 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.348 0.594 . . . . 62.020000000000003 109.84 -170.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 54.0 m-85 -101.65 101.85 12.44 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.213 -1.032 . . . . 75.329999999999998 108.213 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.2 pp -118.68 119.34 34.15 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.429 0.9 . . . . 73.439999999999998 113.429 -173.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -67.68 116.96 8.97 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.118 0.967 . . . . 72.439999999999998 111.936 -174.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.614 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 94.1 t -63.93 116.77 3.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 113.691 -1.595 . . . . 53.219999999999999 110.717 174.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -111.9 125.16 53.74 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.343 -1.298 . . . . 74.450000000000003 108.645 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.494 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 29.8 mm -91.15 108.83 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.455 -1.313 . . . . 73.519999999999996 107.455 173.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.253 1.257 0 CA-C-O 117.766 -1.112 . . . . 73.329999999999998 108.551 -171.458 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.634 -0.506 . . . . 74.120000000000005 109.634 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -154.36 172.83 17.07 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.925 0.89 . . . . 75.540000000000006 110.193 -175.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.5 p 47.59 80.66 0.05 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.781 1.232 . . . . 75.239999999999995 113.082 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.47 113.78 15.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.948 -0.76 . . . . 45.210000000000001 108.948 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.445 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 7.5 m -66.64 -18.4 65.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.238 1.015 . . . . 71.310000000000002 111.595 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.85 176.27 6.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.03 0.932 . . . . 64.010000000000005 111.851 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.19 -129.23 6.18 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.25 -0.74 . . . . 21.210000000000001 111.25 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.57 158.05 17.81 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.087 0.555 . . . . 64.209999999999994 111.124 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.515 ' CZ3' HG21 ' A' ' 227' ' ' THR . 31.1 m95 -88.12 -80.59 0.27 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.581 -0.896 . . . . 74.329999999999998 108.581 165.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -131.42 39.22 3.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.131 0.972 . . . . 73.040000000000006 109.559 -173.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.78 -42.93 99.6 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 116.277 -0.419 . . . . 72.109999999999999 112.494 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.32 -78.25 0.39 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.093 -1.077 . . . . 75.340000000000003 108.093 174.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 146.67 135.13 2.68 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-N 115.624 -0.716 . . . . 62.43 111.646 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.578 ' HB3' ' HD2' ' A' ' 234' ' ' ARG . 33.9 t -151.7 122.68 7.6 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.003 -0.74 . . . . 52.549999999999997 109.003 176.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -177.07 103.77 0.18 Allowed Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.178 -0.769 . . . . 72.140000000000001 111.178 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 169.08 145.39 4.59 Favored Glycine 0 C--O 1.241 0.578 0 CA-C-O 119.869 -0.406 . . . . 75.239999999999995 112.117 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.0 t 60.81 19.69 9.88 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.775 1.23 . . . . 45.5 112.269 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -66.52 -41.38 94.21 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 111.533 -0.627 . . . . 74.319999999999993 111.533 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.63 71.42 2.7 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 112.316 -0.314 . . . . 32.329999999999998 112.316 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.0 m -81.51 -43.62 18.52 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.548 0.739 . . . . 54.450000000000003 110.42 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 161.29 -71.48 0.22 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 110.814 -0.914 . . . . 23.32 110.814 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -65.9 101.45 0.6 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 110.922 -0.871 . . . . 73.510000000000005 110.922 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.1 m -71.97 93.57 1.38 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.448 0.699 . . . . 72.319999999999993 110.598 -171.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLN . . . . . 0.596 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 24.3 mt-30 -115.65 -35.69 4.46 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.747 -1.115 . . . . 72.030000000000001 108.455 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -55.65 137.55 49.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.412 -1.267 . . . . 73.019999999999996 109.635 165.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 77.0 mt -128.43 158.67 37.67 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.375 0.607 . . . . 64.340000000000003 112.261 -177.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 11.6 t80 -121.14 126.0 48.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.687 -1.142 . . . . 65.040000000000006 108.679 171.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -136.18 -173.81 3.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.953 0.901 . . . . 73.400000000000006 109.274 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.8 m -126.37 117.47 23.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.548 0.739 . . . . 73.439999999999998 110.599 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.55 HD23 HG22 ' A' ' 253' ' ' VAL . 18.4 tp -76.92 105.88 8.26 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.58 -0.896 . . . . 72.209999999999994 108.58 171.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.21 101.86 12.19 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.658 -0.867 . . . . 63.43 108.658 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.667 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.3 t -110.64 115.03 54.24 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.089 -1.078 . . . . 73.109999999999999 108.089 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.03 148.93 70.88 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.558 1.506 . . . . 75.430000000000007 110.194 171.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.455 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -54.11 -40.07 79.05 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 124.014 0.926 . . . . 64.310000000000002 113.4 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 10.9 Cg_endo -54.14 -51.4 10.73 Favored 'Trans proline' 0 C--N 1.395 3.013 0 C-N-CA 122.17 1.913 . . . . 75.230000000000004 113.534 172.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.459 HG21 HG13 ' A' ' 210' ' ' VAL . 49.3 mt -64.8 -36.2 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.25 0.62 . . . . 72.219999999999999 110.979 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.401 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -65.13 -44.08 89.86 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.936 -0.575 . . . . 71.109999999999999 111.656 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.71 -51.03 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.767 0.827 . . . . 73.230000000000004 111.805 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.93 -23.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 120.494 0.188 . . . . 64.209999999999994 110.932 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.97 77.95 1.07 Allowed Glycine 0 C--N 1.349 1.305 0 N-CA-C 111.346 -0.702 . . . . 62.43 111.346 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.13 -139.78 8.41 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.907 -0.477 . . . . 73.140000000000001 111.907 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -132.1 146.27 51.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.286 0.634 . . . . 61.229999999999997 109.458 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' A' ' 199' ' ' VAL . 28.5 m -134.97 152.9 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 123.658 0.599 . . . . 75.510000000000005 109.819 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ARG . . . . . 0.511 ' HE ' ' HB3' ' A' ' 218' ' ' PRO . 40.4 ttt-85 -79.15 143.67 35.22 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.593 0.757 . . . . 70.310000000000002 109.772 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.75 114.28 26.77 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.677 -1.231 . . . . 74.040000000000006 107.677 171.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.91 135.07 54.28 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.866 1.266 . . . . 74.400000000000006 111.193 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.686 HG21 ' HE3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -141.48 -170.83 3.18 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.703 0.801 . . . . 75.140000000000001 110.515 173.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.535 ' H ' HG22 ' A' ' 214' ' ' THR . 7.1 mt -55.69 -69.54 0.14 Allowed 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.613 1.165 . . . . 72.329999999999998 110.815 -172.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -116.37 -42.69 3.0 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.251 -1.795 . . . . 73.510000000000005 110.929 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -113.02 132.88 10.96 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 118.656 -1.08 . . . . 72.219999999999999 111.717 -175.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' PRO . . . . . 0.511 ' HB3' ' HE ' ' A' ' 211' ' ' ARG . 74.6 Cg_endo -73.68 -173.95 1.52 Allowed 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.525 2.15 . . . . 72.219999999999999 112.682 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 8.5 t -140.05 164.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.36 1.464 . . . . 73.019999999999996 107.523 168.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.445 ' H ' ' HB ' ' A' ' 172' ' ' THR . 5.0 tt0 -142.16 127.75 19.07 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.043 -1.095 . . . . 74.109999999999999 108.043 170.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 233' ' ' LEU . 13.8 p -120.22 139.75 46.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 123.6 0.76 . . . . 72.109999999999999 110.603 -173.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.17 104.87 5.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.818 0.847 . . . . 74.239999999999995 109.419 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 204' ' ' ALA . 61.5 t -69.38 128.37 92.38 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.449 0.7 . . . . 72.340000000000003 109.335 173.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.51 154.25 74.57 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.057 2.505 . . . . 53.229999999999997 112.063 171.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.78 129.38 27.45 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.306 2.004 . . . . 72.109999999999999 112.189 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 55.56 74.21 0.39 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.547 1.539 . . . . 72.209999999999994 113.081 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.515 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 64.8 m -97.22 144.15 27.32 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.662 -1.154 . . . . 75.340000000000003 111.204 175.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -108.53 163.89 12.83 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.561 1.144 . . . . 72.409999999999997 110.972 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ALA . . . . . 0.472 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -88.15 152.47 21.96 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.642 -1.163 . . . . 71.510000000000005 111.427 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.02 -12.84 52.67 Favored Glycine 0 N--CA 1.476 1.31 0 CA-C-N 116.342 -0.39 . . . . 60.530000000000001 112.25 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.456 ' HD2' HG23 ' A' ' 227' ' ' THR . 73.3 mtt85 -69.58 178.17 2.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.636 0.774 . . . . 75.209999999999994 109.762 166.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.629 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 10.9 ptmt -168.37 157.02 8.77 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.319 0.104 . . . . 71.519999999999996 111.15 172.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 251' ' ' LEU . 73.0 mt -93.62 158.8 15.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.003 0.521 . . . . 62.25 109.807 170.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 181' ' ' SER . 8.1 ptt-85 -132.61 109.55 9.82 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.914 1.285 . . . . 73.329999999999998 108.363 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 49.5 mt -120.42 117.15 26.96 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.393 0.677 . . . . 74.030000000000001 111.339 -166.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -84.94 134.35 34.25 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.709 -0.678 . . . . 74.439999999999998 110.695 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 76.22 10.14 85.47 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 124.219 0.949 . . . . 64.120000000000005 113.513 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.686 ' HE3' HG21 ' A' ' 214' ' ' THR . 29.3 mmmt -97.68 -25.15 15.2 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 117.142 0.471 . . . . 72.430000000000007 112.232 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -66.09 -172.0 4.19 Favored Glycine 0 CA--C 1.538 1.519 0 O-C-N 123.103 0.252 . . . . 50.119999999999997 113.151 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' PHE . . . . . 0.596 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 17.5 m-30 -59.06 138.68 87.82 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 122.696 0.399 . . . . 71.219999999999999 111.235 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.535 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 32.2 Cg_exo -59.29 152.66 58.79 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.93 2.42 . . . . 74.109999999999999 112.622 175.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.6 -177.77 15.15 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.708 -0.678 . . . . 42.240000000000002 112.509 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.12 -40.67 4.52 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 122.732 2.288 . . . . 75.099999999999994 112.537 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.47 -10.65 14.88 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.683 0.793 . . . . 63.109999999999999 111.854 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.41 166.49 27.56 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 111.467 -0.653 . . . . 72.310000000000002 111.467 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.535 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 16.5 mtp180 -85.66 165.58 16.88 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.204 0.602 . . . . 72.310000000000002 110.871 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.72 -176.61 46.86 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.342 -0.844 . . . . 62.109999999999999 112.826 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.74 169.21 8.65 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.014 0.525 . . . . 72.510000000000005 110.935 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 62.7 tp -131.95 108.98 9.73 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.571 -0.74 . . . . 71.239999999999995 110.201 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.629 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 13.8 m-30 -98.8 116.91 32.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.125 -1.065 . . . . 71.109999999999999 108.125 173.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.6 pp -129.5 116.31 18.76 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.34 0.867 . . . . 63.43 113.34 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.34 123.34 20.5 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 114.751 -1.113 . . . . 75.209999999999994 112.506 -174.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.55 HG22 HD23 ' A' ' 197' ' ' LEU . 60.5 t -70.09 125.23 27.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 114.19 -1.368 . . . . 73.0 110.953 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.92 129.9 55.43 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.551 1.14 . . . . 73.340000000000003 108.484 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.472 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 40.6 mm -99.97 99.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.552 -1.277 . . . . 74.319999999999993 107.552 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.561 1.366 0 CA-C-N 114.37 -1.286 . . . . 70.209999999999994 108.952 -167.59 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 59.4 mtt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.95 -0.759 . . . . 71.25 108.95 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.48 -168.88 0.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.229 1.011 . . . . 62.100000000000001 111.855 -173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.0 t -65.59 -13.44 59.05 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.413 0.685 . . . . 71.519999999999996 112.477 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -105.34 162.03 13.79 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.626 0.77 . . . . 74.010000000000005 110.086 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.488 HG22 HG22 ' A' ' 219' ' ' VAL . 3.4 m -71.78 -27.04 62.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.836 -0.62 . . . . 75.319999999999993 109.892 175.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.03 152.24 18.71 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.634 0.773 . . . . 51.32 111.184 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.64 -102.29 0.06 OUTLIER Glycine 0 C--N 1.351 1.363 0 O-C-N 124.207 0.942 . . . . 74.209999999999994 111.482 165.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -136.51 175.77 9.3 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.537 0.735 . . . . 73.430000000000007 109.84 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.549 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 14.2 m95 -79.52 -82.33 0.1 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.156 -0.929 . . . . 71.430000000000007 109.539 170.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -143.01 138.45 30.02 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 106.84 -1.541 . . . . 74.340000000000003 106.84 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.98 94.52 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.373 -1.091 . . . . 64.439999999999998 110.373 166.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.51 163.07 10.3 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.43 1.492 . . . . 75.019999999999996 108.716 174.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -97.78 57.29 1.12 Allowed Glycine 0 N--CA 1.473 1.14 0 N-CA-C 111.685 -0.566 . . . . 45.350000000000001 111.685 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.5 p -82.11 -41.52 20.38 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.517 0.727 . . . . 73.209999999999994 111.941 -174.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -170.78 142.1 6.91 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 121.437 -0.411 . . . . 64.040000000000006 112.485 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -88.82 59.12 4.0 Favored Glycine 0 C--N 1.348 1.209 0 C-N-CA 122.938 0.304 . . . . 73.209999999999994 112.639 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.0 p -90.44 151.05 21.57 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.779 0.831 . . . . 74.340000000000003 110.291 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.36 170.86 32.72 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.854 -0.612 . . . . 74.150000000000006 112.094 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -68.17 -32.48 76.48 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-O 119.864 -0.409 . . . . 44.109999999999999 112.718 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.7 m 64.74 24.35 12.86 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.718 1.207 . . . . 63.340000000000003 112.508 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 160.65 72.47 0.02 OUTLIER Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.047 -0.821 . . . . 34.219999999999999 111.047 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -88.5 -154.88 28.87 Favored Glycine 0 C--N 1.341 0.845 0 C-N-CA 123.144 0.402 . . . . 72.420000000000002 112.888 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.4 m -112.58 -65.83 1.14 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.52 0.728 . . . . 74.540000000000006 109.81 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -87.36 -40.17 14.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.557 -0.747 . . . . 72.219999999999999 109.659 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 9.2 p-10 -71.56 129.4 38.66 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.62 -0.718 . . . . 50.329999999999998 109.464 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.6 mt -113.71 165.4 12.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.538 0.735 . . . . 51.509999999999998 111.757 -169.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -118.0 122.18 42.56 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 114.741 -1.118 . . . . 74.219999999999999 108.24 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -131.43 -172.98 2.99 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.829 0.852 . . . . 74.340000000000003 110.052 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 52.9 m -119.29 149.77 41.24 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.122 0.969 . . . . 75.420000000000002 109.706 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.534 ' HB2' HD13 ' A' ' 251' ' ' LEU . 22.2 tp -119.95 104.57 10.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.106 1.362 . . . . 72.239999999999995 108.462 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -91.44 99.71 12.61 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.892 0.853 . . . . 62.329999999999998 109.109 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.609 HG22 HG21 ' A' ' 210' ' ' VAL . 23.2 t -94.99 119.85 65.28 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 114.555 -1.202 . . . . 72.030000000000001 108.282 174.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.68 144.95 61.83 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 121.539 1.493 . . . . 72.340000000000003 109.859 173.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.427 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.48 -42.44 75.1 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.501 -1.238 . . . . 50.420000000000002 113.147 -175.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.7 Cg_endo -55.96 -51.62 9.18 Favored 'Trans proline' 0 C--N 1.406 3.602 0 C-N-CA 121.94 1.76 . . . . 71.420000000000002 112.71 174.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 54.5 mt -65.01 -33.55 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.236 0.615 . . . . 71.129999999999995 110.674 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.67 77.14 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.407 0.683 . . . . 62.43 110.898 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.7 t -70.3 -47.12 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.351 1.06 . . . . 62.43 112.281 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.56 -35.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 120.507 0.194 . . . . 45.43 110.761 -174.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.47 105.79 1.13 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.539 -1.024 . . . . 53.210000000000001 110.539 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.93 -129.0 2.29 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.689 -0.506 . . . . 65.420000000000002 111.859 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 4.9 ttmt -145.15 137.7 26.06 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.608 0.763 . . . . 72.019999999999996 109.75 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 199' ' ' VAL . 33.6 m -135.23 155.16 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 122.766 0.427 . . . . 71.099999999999994 110.763 175.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -70.65 146.2 50.13 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.016 0.822 . . . . 72.329999999999998 110.427 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -123.64 120.75 33.68 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.014 1.326 . . . . 74.329999999999998 107.882 172.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -64.76 129.23 39.02 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.987 0.915 . . . . 73.340000000000003 110.899 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 -170.91 2.82 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.207 1.003 . . . . 52.43 110.265 -172.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.4 mt -84.87 -66.76 0.86 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.61 1.195 . . . . 61.32 109.639 -171.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -95.65 -33.3 12.4 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 112.675 -2.057 . . . . 71.329999999999998 110.856 -165.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -160.68 141.97 7.79 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.354 -1.248 . . . . 72.239999999999995 111.294 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.6 142.99 60.72 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.694 2.263 . . . . 51.0 113.001 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 61.6 t -94.06 166.47 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.92 1.288 . . . . 75.129999999999995 109.031 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -144.3 136.68 26.59 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.243 -1.391 . . . . 75.510000000000005 107.243 171.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' VAL . . . . . 0.555 HG11 HD11 ' A' ' 233' ' ' LEU . 14.4 p -132.88 140.71 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.253 0.621 . . . . 74.340000000000003 111.347 -169.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.09 101.17 2.69 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.302 1.041 . . . . 72.209999999999994 110.331 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.484 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 92.9 t -72.25 121.66 85.32 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 118.141 -0.933 . . . . 73.230000000000004 109.226 175.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.67 154.72 72.57 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.592 2.195 . . . . 75.510000000000005 111.783 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.72 130.93 37.3 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.532 2.154 . . . . 74.400000000000006 112.769 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 56.15 74.65 0.38 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.813 1.645 . . . . 63.409999999999997 112.762 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 97.0 m -90.7 142.09 28.11 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.714 -1.13 . . . . 72.519999999999996 111.064 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -107.6 149.71 27.73 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.586 1.154 . . . . 53.219999999999999 109.947 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.68 155.28 37.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.188 -0.914 . . . . 73.030000000000001 110.545 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.1 -19.84 39.56 Favored Glycine 0 N--CA 1.476 1.311 0 N-CA-C 111.162 -0.775 . . . . 72.430000000000007 111.162 -172.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -65.9 179.83 0.83 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.257 1.023 . . . . 74.510000000000005 110.599 168.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.515 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.0 ptmt -166.81 152.89 8.27 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 116.176 -0.465 . . . . 74.420000000000002 109.992 172.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LEU . . . . . 0.65 HD12 HD11 ' A' ' 251' ' ' LEU . 61.6 mt -81.29 142.71 32.85 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.035 -0.728 . . . . 64.400000000000006 109.035 169.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -103.22 104.06 14.16 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.177 -1.416 . . . . 75.450000000000003 107.177 158.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LEU . . . . . 0.566 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 50.6 mt -102.43 113.51 26.9 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 114.939 -1.028 . . . . 74.519999999999996 109.009 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -82.18 125.79 31.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.316 -0.856 . . . . 71.239999999999995 110.142 -172.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.64 25.3 75.67 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 124.448 1.092 . . . . 45.009999999999998 113.804 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.566 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 74.3 mmtt -107.54 -3.17 19.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 112.671 0.619 . . . . 72.230000000000004 112.671 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.93 176.89 50.89 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.825 -1.31 . . . . 74.239999999999995 109.825 164.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -56.65 131.69 77.88 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 117.335 0.567 . . . . 53.299999999999997 111.894 -171.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 28.0 Cg_endo -63.23 138.93 69.31 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.97 2.447 . . . . 74.140000000000001 111.519 174.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.22 177.77 18.49 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.561 -0.745 . . . . 74.439999999999998 113.472 -174.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.61 -33.52 66.93 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.973 2.448 . . . . 62.210000000000001 112.75 177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.48 -8.97 59.6 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.419 0.688 . . . . 62.310000000000002 111.901 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 144.42 -101.18 0.25 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 110.872 -0.891 . . . . 40.039999999999999 110.872 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 59.3 mtt180 -148.35 165.78 30.04 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.788 1.235 . . . . 71.450000000000003 110.176 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.65 174.08 30.23 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 110.792 -0.923 . . . . 70.549999999999997 110.792 167.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 45.7 m-20 -102.85 -179.15 3.88 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.105 0.562 . . . . 71.420000000000002 109.944 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 46.0 tp -141.68 107.63 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.603 0.716 . . . . 73.319999999999993 109.128 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' TYR . . . . . 0.488 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 54.3 m-85 -100.99 107.6 19.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.882 -1.525 . . . . 75.140000000000001 106.882 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 233' ' ' LEU . 2.7 pp -122.94 118.09 27.04 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.759 0.79 . . . . 62.130000000000003 113.086 -175.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -69.75 120.63 15.79 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 125.3 1.44 . . . . 70.109999999999999 112.252 -171.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' VAL . . . . . 0.549 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 58.9 t -68.8 116.56 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 114.09 -1.414 . . . . 74.230000000000004 110.979 177.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -103.35 131.24 50.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.112 1.765 . . . . 72.420000000000002 108.866 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.0 mm -97.46 110.22 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.966 -1.124 . . . . 64.510000000000005 107.966 170.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.257 1.45 0 C-N-CA 124.335 1.054 . . . . 74.540000000000006 108.627 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 219' ' ' VAL . 11.6 m . . . . . 0 CA--C 1.557 1.226 0 CA-C-O 121.484 0.659 . . . . 61.43 110.976 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -111.95 151.6 29.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.621 0.768 . . . . 75.2 110.657 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.34 -113.37 0.07 OUTLIER Glycine 0 C--N 1.349 1.251 0 O-C-N 123.659 0.599 . . . . 72.33 111.71 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -112.5 177.69 4.55 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.406 0.683 . . . . 63.32 110.047 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.506 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 13.6 m95 . . . . . 0 CA--C 1.54 0.57 0 CA-C-N 115.176 -0.92 . . . . 72.12 109.732 170.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 C--O 1.238 0.485 0 CA-C-O 121.616 0.722 . . . . 51.34 112.882 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.1 mt -130.88 147.3 52.51 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.653 -1.158 . . . . 70.14 110.157 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -114.71 122.81 47.58 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.587 -0.894 . . . . 71.44 108.587 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -133.14 -173.24 3.15 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.558 0.536 . . . . 73.22 110.532 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.5 m -123.81 135.88 54.06 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.797 0.839 . . . . 71.02 110.146 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.3 tp -96.01 109.18 21.61 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.746 -1.205 . . . . 54.13 107.746 170.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -85.43 99.69 11.37 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.664 -0.865 . . . . 61.42 108.664 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.682 ' HA ' HG11 ' A' ' 210' ' ' VAL . 18.9 t -111.61 112.31 54.0 Favored Pre-proline 0 C--N 1.344 0.342 0 N-CA-C 107.988 -1.115 . . . . 63.24 107.988 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.3 151.59 80.53 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.538 1.492 . . . . 72.35 110.693 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.424 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.82 -42.2 88.47 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 123.755 0.822 . . . . 74.33 113.203 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 11.1 Cg_endo -55.24 -56.67 2.14 Favored 'Trans proline' 0 C--N 1.392 2.828 0 C-N-CA 122.004 1.803 . . . . 71.25 113.824 172.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.57 -31.28 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 122.942 0.497 . . . . 75.11 111.001 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.33 80.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.076 -0.511 . . . . 43.44 111.045 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.9 t -67.27 -50.41 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.987 0.915 . . . . 71.02 111.801 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.6 p -79.28 -25.89 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 120.813 0.34 . . . . 75.1 110.723 -172.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.95 73.0 1.07 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.92 -0.582 . . . . 75.24 111.778 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.13 -130.22 6.8 Favored Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.59 -0.604 . . . . 65.25 111.59 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -131.9 156.09 46.74 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.519 0.728 . . . . 52.05 110.104 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.682 HG11 ' HA ' ' A' ' 199' ' ' VAL . 26.8 m -144.79 158.05 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.064 0.853 . . . . 75.24 110.145 173.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -81.41 146.65 30.18 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.523 -0.762 . . . . 71.22 111.017 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -121.84 125.68 47.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.727 1.211 . . . . 75.12 108.347 170.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.5 tpt -64.32 131.44 47.3 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.946 0.498 . . . . 75.01 110.851 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.424 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -135.32 -170.78 2.67 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.789 1.236 . . . . 73.52 108.888 -177.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 216' ' ' GLU . 7.1 mt -63.54 -68.65 0.33 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 122.39 1.091 . . . . 61.01 111.869 -172.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 33.9 mt-10 -97.42 -39.83 8.99 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 112.707 -2.042 . . . . 75.13 109.266 -163.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -147.0 -165.39 11.69 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 113.981 -1.463 . . . . 22.12 111.565 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -96.89 151.46 1.07 Allowed 'Trans proline' 0 CA--C 1.551 1.35 0 C-N-CA 122.728 2.285 . . . . 71.41 114.907 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 54.0 t -97.86 162.88 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 114.195 -1.366 . . . . 74.01 107.535 165.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -144.65 119.23 9.74 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.18 -1.044 . . . . 65.31 108.18 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 233' ' ' LEU . 12.7 p -112.07 142.66 23.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.56 0.744 . . . . 64.14 110.207 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.28 112.53 10.54 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.824 -0.806 . . . . 63.2 108.824 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.3 133.02 81.26 Favored Pre-proline 0 CA--C 1.553 1.075 0 N-CA-C 109.211 -0.663 . . . . 74.21 109.211 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.57 157.58 61.23 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.252 2.635 . . . . 65.34 111.237 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.57 135.11 40.86 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 121.98 1.786 . . . . 70.41 112.08 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.7 mtp-105 53.19 65.46 1.51 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.913 1.685 . . . . 64.43 113.34 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.526 HG23 ' HD2' ' A' ' 231' ' ' ARG . 77.7 m -87.95 139.01 30.95 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.87 -1.059 . . . . 61.41 111.711 176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.643 ' HB2' HH12 ' A' ' 231' ' ' ARG . 25.9 mp0 -104.33 159.02 16.06 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.003 0.921 . . . . 74.21 110.086 172.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.45 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -86.19 152.32 22.92 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.111 -0.95 . . . . 74.3 111.46 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.11 -15.21 30.86 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 115.934 -0.575 . . . . 71.4 111.744 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.643 HH12 ' HB2' ' A' ' 228' ' ' GLN . 69.5 mtt85 -69.72 179.26 2.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.959 0.904 . . . . 62.11 109.769 166.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.1 ptmt -166.0 155.66 12.1 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.917 -0.401 . . . . 74.45 109.917 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.585 HD12 HD11 ' A' ' 251' ' ' LEU . 79.8 mt -84.37 147.08 27.35 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.617 -0.512 . . . . 61.45 109.617 170.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -114.21 107.36 15.51 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.66 1.225 . . . . 63.32 107.958 167.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 63.3 mt -116.53 118.32 32.31 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.931 0.492 . . . . 74.01 110.863 -173.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -92.86 126.0 37.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.127 -0.488 . . . . 74.2 110.184 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.23 12.91 72.37 Favored Glycine 0 N--CA 1.471 1.022 0 O-C-N 124.264 0.978 . . . . 54.33 113.021 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -114.11 -3.32 13.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.689 0.796 . . . . 74.42 111.446 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.88 -177.34 51.47 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 110.556 -1.018 . . . . 53.04 110.556 166.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -57.5 141.52 78.43 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.753 0.649 . . . . 74.43 112.753 -171.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 7.8 Cg_exo -69.47 133.72 26.81 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.622 2.214 . . . . 70.04 110.512 171.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -135.31 174.63 21.13 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.888 -1.051 . . . . 54.14 112.621 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.62 -9.98 23.16 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.903 2.402 . . . . 71.43 112.71 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -105.29 11.07 33.32 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.094 0.958 . . . . 72.03 111.407 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 121.83 -113.02 2.16 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.187 -0.765 . . . . 72.32 111.187 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 65.0 mtt180 -143.87 164.06 31.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.276 1.03 . . . . 73.14 110.567 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -98.29 -163.87 30.79 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 114.748 -1.115 . . . . 63.43 113.29 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -115.6 160.21 20.3 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.183 0.993 . . . . 74.31 110.679 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.572 ' HG ' HD23 ' A' ' 251' ' ' LEU . 27.7 tp -131.47 109.66 10.45 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.469 0.708 . . . . 74.32 109.641 -171.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.461 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 20.2 m-85 -102.8 116.3 32.3 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.482 -0.932 . . . . 64.45 108.482 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.585 HD11 HD12 ' A' ' 233' ' ' LEU . 3.0 pp -127.76 114.47 17.33 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.384 0.611 . . . . 54.02 112.42 -173.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -68.74 119.73 13.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.923 1.289 . . . . 72.44 112.984 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 232' ' ' LYS . 64.1 t -70.82 126.12 30.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-N 114.342 -1.299 . . . . 72.13 110.897 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -116.24 133.14 56.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.988 1.315 . . . . 63.51 108.34 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.45 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 43.0 mm -104.94 100.53 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 107.874 -1.158 . . . . 73.32 107.874 175.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.557 1.227 0 CA-C-O 117.773 -1.108 . . . . 73.11 109.506 -171.857 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 10.3 m . . . . . 0 N--CA 1.481 1.113 0 CA-C-O 121.079 0.466 . . . . 74.44 111.114 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.52 151.13 38.0 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.911 -0.586 . . . . 64.03 111.703 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -77.05 -66.3 1.83 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.425 -0.807 . . . . 61.51 111.944 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -162.7 167.91 22.36 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 123.924 0.889 . . . . 64.44 111.096 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.616 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.8 m95 . . . . . 0 CA--C 1.543 0.688 0 CA-C-N 114.516 -1.22 . . . . 71.22 108.613 167.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 C--O 1.239 0.542 0 N-CA-C 109.499 -0.556 . . . . 72.02 109.499 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.19 159.59 29.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.38 0.61 . . . . 63.35 111.046 -172.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 11.9 t80 -125.59 110.47 13.88 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.654 -1.157 . . . . 64.2 107.884 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.96 -171.87 2.18 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.034 0.934 . . . . 54.32 110.056 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 69.2 m -127.26 118.52 24.39 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.438 0.695 . . . . 64.43 110.95 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.521 HD23 HG22 ' A' ' 253' ' ' VAL . 13.8 tp -78.71 111.37 14.74 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.732 -0.84 . . . . 75.13 108.732 169.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.75 109.6 18.75 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.949 -1.13 . . . . 74.05 107.949 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.638 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.5 t -118.36 114.19 36.57 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.602 -1.259 . . . . 55.34 107.602 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.96 146.05 76.18 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 121.214 1.276 . . . . 74.12 109.971 171.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.46 -44.54 82.99 Favored Pre-proline 0 CA--C 1.563 1.451 0 CA-C-O 117.869 -1.063 . . . . 62.23 112.817 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 16.5 Cg_endo -54.89 -48.93 18.55 Favored 'Trans proline' 0 C--N 1.399 3.2 0 C-N-CA 122.19 1.927 . . . . 63.52 112.754 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.489 HG21 HG13 ' A' ' 210' ' ' VAL . 50.8 mt -65.99 -35.3 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.006 0.523 . . . . 73.04 110.649 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.73 99.5 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.06 0.544 . . . . 71.44 111.14 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.0 t -72.93 -50.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.156 0.982 . . . . 60.12 112.078 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 12.4 p -77.72 -27.93 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.703 0.401 . . . . 72.43 110.52 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.83 70.18 1.36 Allowed Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.336 -0.706 . . . . 51.31 111.336 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.69 -130.02 6.86 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.902 -0.479 . . . . 64.51 111.902 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -143.49 137.19 28.34 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.231 0.613 . . . . 61.14 109.921 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.638 HG11 ' HA ' ' A' ' 199' ' ' VAL . 35.4 m -132.55 151.02 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.409 0.684 . . . . 53.15 110.235 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -75.23 140.04 42.97 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.941 0.497 . . . . 74.42 110.856 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.12 113.71 26.13 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.982 -1.488 . . . . 74.43 106.982 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 11.0 tpt -65.54 131.0 45.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.037 0.535 . . . . 65.24 111.489 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -133.71 -171.69 2.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.545 1.138 . . . . 72.21 110.644 -172.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mt -83.5 -64.22 1.21 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.777 1.275 . . . . 75.34 109.679 -168.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.8 -32.07 12.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 112.067 -2.333 . . . . 72.21 110.93 -166.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -164.44 144.29 9.27 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-O 118.672 -1.071 . . . . 51.42 111.442 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.33 143.88 71.99 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.686 2.257 . . . . 72.13 113.278 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 66.0 t -96.54 163.23 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.177 -1.374 . . . . 73.2 108.159 174.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.401 ' H ' ' HB ' ' A' ' 172' ' ' THR . 9.5 tt0 -147.08 134.06 20.28 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.767 -1.197 . . . . 74.01 107.767 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.51 HG21 HD21 ' A' ' 233' ' ' LEU . 12.0 p -126.49 135.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 C-N-CA 123.48 0.712 . . . . 71.34 110.951 -173.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.75 104.4 2.42 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.85 -1.068 . . . . 63.44 108.95 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.4 t -71.75 132.79 84.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 108.551 -0.907 . . . . 63.33 108.551 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.5 157.39 60.82 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.541 2.161 . . . . 74.42 111.839 171.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -64.71 137.48 54.29 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.103 1.868 . . . . 74.31 111.96 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 50.5 65.19 1.53 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.327 1.451 . . . . 72.34 113.192 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.444 HG23 ' HD2' ' A' ' 231' ' ' ARG . 68.1 m -82.87 144.55 30.0 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.947 -1.024 . . . . 70.11 111.071 174.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -105.79 155.92 18.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.749 0.82 . . . . 72.21 110.398 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.439 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -76.61 153.59 35.14 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.618 -1.174 . . . . 74.01 110.369 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.3 -10.93 59.97 Favored Glycine 0 N--CA 1.472 1.099 0 N-CA-C 112.351 -0.3 . . . . 60.1 112.351 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.444 ' HD2' HG23 ' A' ' 227' ' ' THR . 65.8 mtt85 -72.1 -177.23 2.0 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.126 0.97 . . . . 74.0 109.586 165.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.526 ' HA ' HG23 ' A' ' 253' ' ' VAL . 7.5 ptmt -167.25 161.83 14.63 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 111.275 0.102 . . . . 64.04 111.275 172.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.632 HD12 HD11 ' A' ' 251' ' ' LEU . 73.1 mt -88.49 151.28 22.64 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.468 -0.567 . . . . 74.0 109.468 166.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -111.85 109.33 19.09 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.49 -1.3 . . . . 73.42 107.49 162.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 64.0 mt -110.11 102.43 11.14 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.854 0.835 . . . . 70.3 109.784 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -76.68 119.1 20.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.095 -1.411 . . . . 62.33 110.853 -169.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.62 -3.95 86.6 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 124.072 0.858 . . . . 54.03 113.981 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.486 ' HD2' HG21 ' A' ' 214' ' ' THR . 32.6 mmtp -87.09 5.79 35.89 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.645 0.723 . . . . 64.03 112.565 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.98 174.02 49.24 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.123 -0.791 . . . . 74.42 111.123 166.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.04 148.16 88.98 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.85 0.46 . . . . 74.44 111.753 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.519 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 11.7 Cg_exo -68.69 133.32 27.29 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.659 2.239 . . . . 64.22 112.429 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -128.89 173.78 19.26 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.793 -1.094 . . . . 75.42 112.552 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.02 -24.82 20.17 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.92 2.413 . . . . 73.43 112.195 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.22 22.46 14.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.058 0.943 . . . . 72.11 110.833 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 101.16 -177.74 27.67 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.957 -0.857 . . . . 71.42 110.957 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 32.9 mtp180 -81.81 155.49 25.39 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.113 0.457 . . . . 63.55 111.161 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.2 -179.12 52.72 Favored Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.436 -0.802 . . . . 65.44 112.222 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -117.37 138.26 51.92 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.208 0.528 . . . . 75.21 109.789 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 38.8 tp -101.91 105.57 16.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.973 -1.012 . . . . 61.44 109.116 -170.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 60.5 m-85 -102.15 114.13 27.99 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.146 -1.057 . . . . 73.13 108.146 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 233' ' ' LEU . 2.5 pp -125.88 114.74 18.94 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.593 0.96 . . . . 62.4 113.593 -171.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -67.74 125.8 27.37 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.799 1.24 . . . . 74.02 112.766 -173.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.616 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 89.1 t -74.25 131.3 35.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-N 113.55 -1.659 . . . . 75.44 110.936 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -123.81 125.33 44.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.456 1.503 . . . . 75.12 107.851 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.439 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 33.1 mm -97.01 105.91 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.566 -1.272 . . . . 54.14 107.566 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.564 1.495 0 CA-C-O 118.022 -0.99 . . . . 62.14 109.507 -169.724 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.407 HG22 HG22 ' A' ' 219' ' ' VAL . 13.4 m . . . . . 0 CA--C 1.555 1.156 0 CA-C-O 121.207 0.527 . . . . 61.43 110.959 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.74 166.17 12.58 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.744 0.817 . . . . 75.2 111.874 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.68 -96.56 0.92 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.525 -1.03 . . . . 72.33 110.525 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.14 174.86 9.61 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.982 0.513 . . . . 63.32 109.716 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.523 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 9.9 m95 . . . . . 0 CA--C 1.539 0.53 0 CA-C-N 115.266 -0.879 . . . . 72.12 110.097 170.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 7.9 p-10 . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 112.366 0.506 . . . . 51.34 112.366 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.46 ' HB2' HD13 ' A' ' 249' ' ' LEU . 87.4 mt -116.75 147.22 42.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.391 1.076 . . . . 70.14 109.594 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -115.55 117.6 30.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.18 -1.045 . . . . 71.44 108.18 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.577 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -130.17 -173.61 3.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.456 0.702 . . . . 73.22 109.878 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.0 m -124.33 120.63 32.71 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.43 0.692 . . . . 71.02 110.311 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.503 HD23 HG22 ' A' ' 253' ' ' VAL . 18.3 tp -78.6 105.55 9.96 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.003 -1.11 . . . . 54.13 108.003 172.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -86.29 101.0 12.67 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.788 -0.819 . . . . 61.42 108.788 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 210' ' ' VAL . 18.1 t -112.67 113.86 50.12 Favored Pre-proline 0 N--CA 1.47 0.556 0 N-CA-C 108.884 -0.784 . . . . 63.24 108.884 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.38 151.17 83.85 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 121.611 1.541 . . . . 72.35 110.642 171.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.436 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.19 -43.77 95.7 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-O 118.01 -0.995 . . . . 74.33 113.096 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.3 Cg_endo -55.37 -51.76 9.28 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 122.152 1.901 . . . . 71.25 112.98 174.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.48 HG21 HG13 ' A' ' 210' ' ' VAL . 38.6 mt -63.76 -34.85 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.07 0.548 . . . . 75.11 111.016 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.44 87.24 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.19 -0.459 . . . . 43.44 111.017 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.9 t -72.84 -49.03 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.826 0.85 . . . . 71.02 111.833 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.81 -24.72 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 122.329 0.252 . . . . 75.1 110.714 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.06 75.9 1.03 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.95 -0.568 . . . . 75.24 111.776 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.99 -144.78 10.9 Favored Glycine 0 N--CA 1.474 1.209 0 N-CA-C 110.815 -0.914 . . . . 65.25 110.815 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -122.29 150.73 41.94 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.107 0.953 . . . . 52.05 110.762 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.661 HG21 HG22 ' A' ' 199' ' ' VAL . 24.8 m -141.06 149.21 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 115.354 -0.839 . . . . 75.24 109.978 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -73.83 145.13 45.18 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.292 0.568 . . . . 71.22 111.124 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.623 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -119.8 115.95 24.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.256 1.422 . . . . 75.12 107.281 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 15.9 tpt -64.26 130.88 45.6 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.27 0.628 . . . . 75.01 111.529 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.88 -172.41 2.87 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.166 1.386 . . . . 73.52 109.691 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.04 -70.18 0.26 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.074 0.94 . . . . 61.01 110.668 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -114.88 -41.52 3.35 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 113.63 -1.623 . . . . 75.13 111.387 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -116.3 102.97 1.11 Allowed Glycine 0 C--N 1.349 1.294 0 CA-C-O 118.468 -1.184 . . . . 22.12 111.652 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.33 137.99 78.14 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.251 2.634 . . . . 71.41 112.625 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.623 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 91.0 t -90.37 163.46 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.451 1.1 . . . . 74.01 108.955 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -146.19 127.9 15.25 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.704 -1.221 . . . . 65.31 107.704 170.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.453 HG11 HD11 ' A' ' 233' ' ' LEU . 14.0 p -116.94 140.99 37.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 C-N-CA 123.722 0.809 . . . . 64.14 110.276 -174.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.93 106.82 5.81 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.59 -0.732 . . . . 63.2 109.052 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.91 128.61 92.75 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.755 0.822 . . . . 74.21 109.253 173.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -59.39 149.58 80.5 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.956 2.438 . . . . 65.34 111.961 170.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.39 132.18 39.78 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 121.751 1.634 . . . . 70.41 110.77 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 52.92 69.88 0.64 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.287 1.435 . . . . 64.43 112.672 -173.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.502 HG23 ' HD2' ' A' ' 231' ' ' ARG . 32.5 m -92.06 138.42 31.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.222 -1.354 . . . . 61.41 110.135 170.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.422 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 26.3 mp0 -103.55 162.31 13.15 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.555 0.742 . . . . 74.21 111.044 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.455 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.76 155.88 24.02 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.187 -1.37 . . . . 74.3 111.741 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.07 -10.03 59.98 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 111.847 -0.501 . . . . 71.4 111.847 -173.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.502 ' HD2' HG23 ' A' ' 227' ' ' THR . 71.4 mtt85 -72.38 -179.52 2.98 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.067 0.947 . . . . 62.11 110.307 168.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.504 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.4 ptmt -167.8 153.23 7.1 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.88 -0.6 . . . . 74.45 109.909 171.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.574 HD12 HD11 ' A' ' 251' ' ' LEU . 85.4 mt -83.58 152.48 24.82 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.358 -0.608 . . . . 61.45 109.358 169.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -118.65 110.08 16.89 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 124.833 1.333 . . . . 63.32 107.593 168.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 58.6 mt -116.98 117.8 30.66 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.728 -0.669 . . . . 74.01 110.07 -171.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' ' 248' ' ' ASP . 27.2 mmtp -93.03 132.39 37.17 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.702 -0.481 . . . . 74.2 109.702 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.81 20.72 73.11 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 124.261 0.976 . . . . 54.33 112.912 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 26.6 mmtp -116.86 -5.47 11.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.178 0.807 . . . . 74.42 113.178 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.61 -172.32 46.78 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-O 119.794 -0.448 . . . . 53.04 112.124 166.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -58.77 139.14 86.56 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.077 0.551 . . . . 74.43 111.765 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.485 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 6.3 Cg_exo -76.61 136.8 17.61 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.728 2.285 . . . . 70.04 111.508 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -130.93 170.16 21.35 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.952 -0.567 . . . . 54.14 112.764 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.52 -28.9 21.03 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.892 2.395 . . . . 71.43 112.26 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.59 22.17 12.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.855 0.862 . . . . 72.03 110.849 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.91 169.44 24.26 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 111.115 -0.794 . . . . 72.32 111.115 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 96.6 mtt180 -73.78 175.1 7.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.711 0.767 . . . . 73.14 111.994 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.46 -167.43 33.93 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.193 -1.367 . . . . 63.43 112.147 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.524 ' HB3' ' HD3' ' A' ' 236' ' ' LYS . 2.2 p-10 -118.69 176.94 5.03 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.682 0.793 . . . . 74.31 110.41 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 27.2 tp -145.82 109.55 4.8 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.236 0.541 . . . . 74.32 110.973 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 16.9 m-85 -102.16 116.14 32.03 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.449 -0.945 . . . . 64.45 108.449 174.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.0 pp -127.91 115.24 18.27 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.138 0.792 . . . . 54.02 113.138 -175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.42 119.6 13.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.392 1.477 . . . . 72.44 112.856 -170.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.523 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 57.4 t -70.82 120.75 19.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-N 114.57 -1.196 . . . . 72.13 111.105 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -113.59 129.01 56.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.564 1.146 . . . . 63.51 108.908 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.455 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 31.9 mm -94.88 99.59 9.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.643 -1.243 . . . . 73.32 107.643 173.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 124.877 1.271 . . . . 73.11 108.436 -171.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.472 HG22 HG22 ' A' ' 219' ' ' VAL . 1.1 m . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 107.592 -1.262 . . . . 61.12 107.592 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.96 159.73 14.97 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.719 0.808 . . . . 64.01 111.681 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -92.08 -88.95 1.48 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 114.885 -1.052 . . . . 52.13 111.994 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -150.85 165.61 33.07 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.588 0.709 . . . . 73.21 112.801 -175.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.512 ' CZ3' HG21 ' A' ' 227' ' ' THR . 34.5 m95 . . . . . 0 CA--C 1.541 0.601 0 CA-C-N 113.654 -1.612 . . . . 75.21 110.577 -178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 CA--C 1.533 0.303 0 CA-C-O 120.752 0.311 . . . . 72.34 110.292 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.0 mt -111.59 143.39 42.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.196 0.599 . . . . 51.23 110.653 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -113.41 114.82 27.13 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.594 -0.891 . . . . 61.23 108.594 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -128.13 -172.56 2.72 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.238 1.015 . . . . 55.22 109.603 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.504 HG23 ' HG2' ' A' ' 254' ' ' ARG . 88.0 m -111.69 150.19 30.54 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.997 0.919 . . . . 72.53 110.442 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.558 HD22 ' HG ' ' A' ' 233' ' ' LEU . 16.7 tp -110.29 103.29 11.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.61 -1.626 . . . . 73.14 106.61 162.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.85 99.44 12.12 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.676 -0.861 . . . . 72.43 108.676 -173.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.651 HG22 HG21 ' A' ' 210' ' ' VAL . 15.6 t -106.73 113.02 63.29 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.118 -0.946 . . . . 74.04 108.518 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.31 148.37 88.39 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.531 1.487 . . . . 62.12 110.325 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.415 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -51.69 -44.28 89.9 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 117.725 -1.131 . . . . 72.54 112.579 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.1 Cg_endo -56.49 -49.94 13.41 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 122.052 1.835 . . . . 45.31 112.665 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.467 HG21 HG13 ' A' ' 210' ' ' VAL . 38.2 mt -65.36 -32.94 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.225 0.61 . . . . 74.03 110.818 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.84 -47.35 78.29 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.031 0.532 . . . . 43.21 110.344 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -70.25 -49.21 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.25 1.02 . . . . 52.42 111.945 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.0 p -79.68 -27.4 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.375 0.27 . . . . 72.01 110.715 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.3 70.6 1.34 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 112.217 -0.353 . . . . 71.41 112.217 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.33 -123.48 5.2 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 120.031 -0.316 . . . . 71.45 112.797 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -150.22 137.12 19.29 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.97 0.908 . . . . 73.24 110.052 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.651 HG21 HG22 ' A' ' 199' ' ' VAL . 29.6 m -139.17 156.68 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 123.427 0.691 . . . . 75.33 111.317 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -77.6 141.47 39.47 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.007 0.923 . . . . 63.14 111.535 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.504 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -116.4 116.59 27.98 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.421 1.488 . . . . 72.03 108.477 172.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -66.21 130.64 43.93 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.864 0.865 . . . . 74.4 111.189 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.2 -171.2 2.69 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.323 1.049 . . . . 62.42 110.132 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 215' ' ' LEU . 7.1 mt -68.28 -66.83 0.52 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.881 1.273 . . . . 60.5 111.205 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -105.5 -42.32 5.25 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 113.229 -1.805 . . . . 71.41 111.385 -165.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -137.49 145.16 16.79 Favored Glycine 0 N--CA 1.467 0.765 0 CA-C-O 118.695 -1.059 . . . . 63.54 111.716 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.65 137.92 23.24 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.165 1.91 . . . . 74.41 112.38 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 172' ' ' THR . 50.5 t -95.39 164.67 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 114.475 -1.239 . . . . 64.12 108.104 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -144.41 144.32 31.35 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.416 -1.327 . . . . 74.32 107.416 175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.459 HG11 HD21 ' A' ' 197' ' ' LEU . 15.0 p -135.65 140.39 44.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 123.223 0.609 . . . . 74.53 110.824 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.56 112.6 9.79 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.803 0.841 . . . . 45.12 109.392 172.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 176' ' ' TRP . 83.8 t -76.74 132.61 71.43 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.533 0.733 . . . . 72.35 109.406 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.3 155.58 68.76 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.803 2.336 . . . . 74.02 111.353 169.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -65.63 136.22 45.2 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.001 1.801 . . . . 74.5 111.865 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 49.4 69.53 0.58 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.571 1.549 . . . . 63.34 112.773 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.512 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 86.2 m -90.4 144.39 25.86 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.527 -1.215 . . . . 72.43 110.703 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -107.56 156.95 18.45 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.427 1.091 . . . . 63.41 110.556 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.05 155.45 30.63 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.481 -1.236 . . . . 50.3 110.518 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.78 -16.94 43.0 Favored Glycine 0 N--CA 1.471 0.984 0 N-CA-C 111.349 -0.7 . . . . 75.15 111.349 -173.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 227' ' ' THR . 76.1 mtt85 -71.02 -178.96 2.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.247 1.019 . . . . 74.44 109.91 167.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.56 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 8.4 ptmt -167.05 159.97 13.61 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.191 0.307 . . . . 74.01 110.773 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.581 HD12 HD11 ' A' ' 251' ' ' LEU . 85.5 mt -88.19 147.29 24.94 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.35 -0.611 . . . . 73.31 109.35 168.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -113.68 107.17 15.4 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 124.675 1.235 . . . . 73.24 107.733 166.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.553 HD12 HD23 ' A' ' 249' ' ' LEU . 70.4 mt -110.07 110.72 21.71 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.482 0.713 . . . . 74.44 109.45 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -83.41 121.07 26.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.015 -0.993 . . . . 72.41 111.078 -167.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.8 2.53 88.56 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.236 -0.893 . . . . 64.41 113.341 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.546 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 48.2 mmtm -94.05 4.68 53.56 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.618 0.767 . . . . 73.4 111.814 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.97 -175.37 49.95 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.479 -1.048 . . . . 55.15 110.479 166.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -62.77 136.54 96.38 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-N 117.579 0.689 . . . . 74.34 110.906 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.499 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 55.9 Cg_endo -69.51 143.88 53.53 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.307 2.005 . . . . 74.31 112.21 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.21 167.29 23.47 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 119.471 -0.627 . . . . 71.02 112.489 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.77 -22.22 32.32 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 123.157 2.571 . . . . 72.31 113.887 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.2 1.05 16.02 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.278 0.631 . . . . 54.03 111.684 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.54 159.6 8.46 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.517 -0.633 . . . . 75.51 111.517 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 51.9 mtm180 -83.35 169.79 15.25 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.374 0.67 . . . . 75.21 111.438 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.74 -174.79 35.21 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.366 -0.834 . . . . 32.05 111.684 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -126.12 150.55 48.15 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.144 0.497 . . . . 64.52 110.209 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.553 HD23 HD12 ' A' ' 235' ' ' LEU . 37.6 tp -109.09 108.72 19.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.818 0.847 . . . . 73.2 109.95 -171.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.56 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 54.1 m-85 -104.29 116.32 31.95 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.402 1.081 . . . . 74.3 108.458 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.2 pp -130.08 115.19 16.73 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.386 0.884 . . . . 72.22 113.386 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -68.82 119.52 13.31 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.834 1.254 . . . . 74.11 112.061 -170.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.543 HG23 ' HA ' ' A' ' 232' ' ' LYS . 66.6 t -65.13 124.92 21.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 CA-C-N 114.558 -1.201 . . . . 73.52 110.649 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.504 ' HG2' HG23 ' A' ' 196' ' ' THR . 14.1 mmm180 -119.41 135.27 54.82 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.062 1.345 . . . . 71.34 108.539 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.41 111.12 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 107.888 -1.153 . . . . 74.03 107.888 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.564 1.517 0 CA-C-O 117.644 -1.169 . . . . 75.42 108.819 -171.819 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 11.7 m . . . . . 0 CA--C 1.551 1.001 0 CA-C-O 121.198 0.523 . . . . 71.14 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -90.34 143.23 26.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.532 0.733 . . . . 72.45 111.104 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.29 -75.6 0.42 Allowed Glycine 0 C--N 1.344 0.98 0 O-C-N 123.912 0.758 . . . . 73.3 112.358 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -158.14 171.27 20.53 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.906 0.882 . . . . 70.42 111.085 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.581 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 16.0 m95 . . . . . 0 CA--C 1.542 0.659 0 CA-C-N 114.811 -1.086 . . . . 73.42 108.661 168.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.0 p-10 . . . . . 0 N--CA 1.447 -0.583 0 CA-C-O 120.958 0.408 . . . . 74.5 111.672 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.8 mt -123.45 132.79 54.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.204 -0.907 . . . . 61.3 110.215 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -93.32 129.99 39.23 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.579 -0.897 . . . . 71.22 108.579 167.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -138.65 -171.85 3.16 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.12 -0.696 . . . . 62.2 109.12 175.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.1 m -127.74 119.45 25.81 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.423 0.689 . . . . 55.51 110.778 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.516 HD22 ' HG ' ' A' ' 233' ' ' LEU . 17.3 tp -81.47 105.25 12.48 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.152 -1.055 . . . . 71.12 108.152 171.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -92.36 99.5 12.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.825 0.821 . . . . 73.24 108.85 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.682 HG22 HG21 ' A' ' 210' ' ' VAL . 22.8 t -101.15 121.71 51.04 Favored Pre-proline 0 C--N 1.347 0.465 0 N-CA-C 107.645 -1.242 . . . . 75.23 107.645 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.97 149.52 71.99 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 121.76 1.64 . . . . 71.4 110.243 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.423 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.61 -45.95 85.55 Favored Pre-proline 0 CA--C 1.56 1.365 0 O-C-N 124.2 0.937 . . . . 74.25 113.075 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.9 Cg_endo -57.47 -48.83 15.61 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 121.979 1.786 . . . . 61.43 113.67 176.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.435 HG21 HG13 ' A' ' 210' ' ' VAL . 47.9 mt -66.91 -32.47 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 122.813 0.445 . . . . 74.01 110.632 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.8 95.2 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.228 -0.442 . . . . 40.23 110.725 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.23 -51.68 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.612 0.765 . . . . 74.14 111.816 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.5 p -78.95 -22.42 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 120.753 0.311 . . . . 70.33 110.871 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 75.64 62.18 2.75 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 115.635 -0.711 . . . . 63.1 111.902 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.26 -120.68 2.73 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.25 -0.34 . . . . 70.04 112.25 -175.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -146.94 140.84 25.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.691 0.796 . . . . 70.35 109.259 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.682 HG21 HG22 ' A' ' 199' ' ' VAL . 19.1 m -137.19 152.61 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.301 0.64 . . . . 61.44 110.58 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -77.8 140.6 39.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.752 0.821 . . . . 73.13 110.75 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.03 115.8 29.51 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.497 -1.298 . . . . 73.23 107.497 172.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.9 tpt -63.49 127.55 31.81 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.229 0.612 . . . . 64.11 110.894 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.29 -170.23 2.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.786 1.234 . . . . 70.54 109.696 -175.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.04 -68.79 0.52 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.27 1.033 . . . . 72.01 111.224 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.19 -37.64 5.5 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 113.265 -1.789 . . . . 72.41 110.765 -165.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -133.31 119.25 2.3 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 118.566 -1.13 . . . . 51.54 110.669 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.09 141.44 52.79 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.53 2.153 . . . . 73.21 112.833 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 71.0 t -92.62 165.9 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 114.466 -1.243 . . . . 74.42 109.056 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -146.75 136.88 23.51 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 108.028 -1.101 . . . . 55.32 108.028 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.541 HG21 HD21 ' A' ' 233' ' ' LEU . 14.5 p -130.17 142.18 44.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.446 0.698 . . . . 75.31 110.809 -172.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.22 113.45 12.6 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.154 -0.684 . . . . 44.44 109.154 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.9 t -74.09 136.6 76.07 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 123.562 0.745 . . . . 65.42 109.146 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.86 154.04 67.78 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.259 1.973 . . . . 72.21 111.575 170.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.87 132.35 36.8 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.531 2.154 . . . . 64.31 111.916 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 49.56 72.84 0.28 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.139 1.375 . . . . 75.3 112.378 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.564 HG23 ' HD2' ' A' ' 231' ' ' ARG . 67.8 m -82.8 141.95 31.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.307 -1.315 . . . . 44.45 110.923 174.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.494 ' H ' HH11 ' A' ' 231' ' ' ARG . 27.0 mp0 -100.42 151.62 21.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.997 0.919 . . . . 73.42 110.314 171.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -75.94 156.84 33.84 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.049 -0.978 . . . . 42.02 111.078 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.57 -2.42 62.6 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.242 -0.435 . . . . 73.02 112.291 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.564 ' HD2' HG23 ' A' ' 227' ' ' THR . 28.3 mtt85 -77.17 -175.22 3.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.513 0.725 . . . . 32.35 109.737 168.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 9.3 ptmt -167.38 154.75 8.76 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 110.488 -0.189 . . . . 54.51 110.488 170.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.647 HD12 HD11 ' A' ' 251' ' ' LEU . 48.8 mt -80.0 143.58 33.99 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 110.118 -0.326 . . . . 51.4 110.118 167.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 250' ' ' TYR . 7.8 ptp85 -109.89 108.39 18.67 Favored 'General case' 0 C--O 1.243 0.716 0 O-C-N 125.299 1.624 . . . . 63.02 108.39 166.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.519 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 65.9 mt -115.03 138.85 50.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.228 -0.896 . . . . 60.53 109.31 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -108.96 141.05 41.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.201 0.6 . . . . 72.4 109.44 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 68.58 24.16 75.28 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 124.194 0.934 . . . . 70.43 112.956 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 45.5 mmtm -117.43 -11.07 10.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.429 0.692 . . . . 75.43 112.331 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.85 -168.83 40.14 Favored Glycine 0 N--CA 1.479 1.531 0 CA-C-O 119.627 -0.541 . . . . 75.11 111.911 171.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -66.64 142.48 97.6 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-N 117.811 0.805 . . . . 74.42 111.651 -173.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.22 141.79 48.46 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.3 2.666 . . . . 74.51 112.647 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -135.82 172.23 22.36 Favored Glycine 0 N--CA 1.476 1.346 0 C-N-CA 123.243 0.449 . . . . 75.34 113.123 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.02 -25.51 44.2 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.031 2.487 . . . . 65.15 112.409 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.99 21.71 8.37 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.526 0.73 . . . . 71.31 111.623 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 103.03 -172.2 21.36 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 110.495 -1.042 . . . . 75.42 110.495 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.45 149.57 22.55 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 117.693 0.746 . . . . 74.21 110.633 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.1 -173.59 44.19 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.907 0.754 . . . . 71.43 114.394 -173.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 6.9 p-10 -105.07 167.5 9.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.348 0.659 . . . . 55.21 110.917 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.486 HD23 HD12 ' A' ' 235' ' ' LEU . 42.2 tp -137.98 110.62 7.57 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.524 0.73 . . . . 73.22 109.381 -174.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.583 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 20.8 m-85 -108.75 118.86 37.89 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.886 -0.783 . . . . 75.55 108.886 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.647 HD11 HD12 ' A' ' 233' ' ' LEU . 1.6 pp -130.7 114.83 15.87 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.064 0.764 . . . . 64.1 113.064 -175.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -69.04 124.44 23.76 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 124.232 1.013 . . . . 75.32 113.204 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.581 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 65.5 t -73.72 131.62 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 113.573 -1.649 . . . . 72.35 111.689 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -121.09 139.2 53.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.447 1.499 . . . . 71.52 108.15 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 35.0 mm -105.04 103.63 15.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.657 -1.238 . . . . 74.32 107.657 173.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.557 1.247 0 CA-C-O 117.741 -1.123 . . . . 72.02 108.625 -174.185 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.478 0.956 0 CA-C-O 121.469 0.652 . . . . 73.11 109.804 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -86.91 148.68 25.25 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.469 -0.787 . . . . 64.43 111.067 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -67.63 -100.54 0.03 OUTLIER Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.167 -0.773 . . . . 64.22 111.167 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -130.11 173.6 10.59 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.946 0.499 . . . . 72.51 109.861 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.619 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 16.1 m95 . . . . . 0 C--O 1.244 0.771 0 CA-C-N 115.152 -0.931 . . . . 62.21 108.997 168.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 CA--C 1.539 0.553 0 CA-C-O 120.946 0.403 . . . . 72.33 110.839 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.4 mt -135.14 142.48 46.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.478 0.711 . . . . 63.35 110.408 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -106.77 111.2 23.62 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.144 -1.428 . . . . 74.11 107.144 165.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.623 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -123.67 -171.33 2.29 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.698 0.799 . . . . 44.04 110.167 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.1 m -113.64 145.87 40.63 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.483 1.113 . . . . 62.21 110.434 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.561 HD23 HG22 ' A' ' 253' ' ' VAL . 18.4 tp -113.32 104.94 12.82 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.695 -1.595 . . . . 70.24 106.695 167.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.58 100.18 9.99 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.704 -0.85 . . . . 74.2 108.704 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.686 ' HA ' HG11 ' A' ' 210' ' ' VAL . 20.9 t -110.88 103.01 54.05 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.281 -1.007 . . . . 72.42 108.281 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.05 144.87 77.53 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.522 1.481 . . . . 74.23 109.876 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.41 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.03 -41.2 78.62 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 117.743 -1.122 . . . . 72.42 113.08 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.4 Cg_endo -55.28 -46.22 34.33 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.828 1.685 . . . . 71.15 113.06 173.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.413 HG21 HG13 ' A' ' 210' ' ' VAL . 52.0 mt -69.73 -34.82 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.35 0.66 . . . . 53.34 110.616 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.13 91.11 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 122.756 0.422 . . . . 72.34 110.593 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.89 -49.6 62.0 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 O-C-N 124.543 1.152 . . . . 72.42 111.481 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.7 p -79.0 -23.88 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 122.474 0.31 . . . . 62.24 110.738 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.51 71.62 1.11 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.466 -0.654 . . . . 75.22 111.466 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.27 -129.57 6.74 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.765 -0.534 . . . . 64.41 111.765 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -138.85 144.53 39.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.778 0.831 . . . . 45.03 109.537 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.0 m -137.02 153.73 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 115.665 -0.698 . . . . 73.24 110.564 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -74.9 143.51 43.75 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.515 0.726 . . . . 74.4 110.569 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.572 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -116.04 113.15 22.8 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.146 1.378 . . . . 72.33 107.946 172.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.5 tpt -64.87 122.88 17.99 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.342 1.057 . . . . 62.42 111.002 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.521 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -124.09 -171.07 2.25 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.787 1.235 . . . . 75.22 109.084 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.506 ' H ' HG22 ' A' ' 214' ' ' THR . 7.0 mt -60.27 -67.26 0.41 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.632 1.173 . . . . 72.32 111.42 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -109.48 -42.53 4.31 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.105 -1.861 . . . . 61.32 110.918 -163.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -131.86 157.42 22.4 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-O 118.916 -0.936 . . . . 75.12 111.308 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -86.3 143.31 7.63 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.966 1.778 . . . . 73.13 113.064 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 64.4 t -98.43 167.57 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 114.256 -1.338 . . . . 74.13 108.038 174.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -143.53 145.46 32.58 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.444 -0.947 . . . . 73.11 108.444 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.86 141.24 42.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.404 0.681 . . . . 73.42 110.123 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.84 112.74 10.25 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.565 -0.902 . . . . 72.21 108.565 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.7 t -73.27 132.46 81.98 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 108.558 -0.905 . . . . 75.11 108.558 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.6 153.25 76.16 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.667 2.244 . . . . 65.23 111.525 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -64.57 136.07 48.5 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 121.89 1.727 . . . . 73.13 111.979 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 53.24 54.11 10.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.469 1.508 . . . . 71.22 113.275 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.518 HG23 ' HD2' ' A' ' 231' ' ' ARG . 19.4 m -80.02 138.2 36.97 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.92 -0.582 . . . . 64.03 111.403 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -96.16 160.04 14.64 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.124 0.969 . . . . 55.04 111.135 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -79.88 156.02 27.52 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.314 -1.312 . . . . 74.55 110.858 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.64 -18.61 43.77 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 111.958 -0.457 . . . . 65.35 111.958 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.518 ' HD2' HG23 ' A' ' 227' ' ' THR . 78.0 mtt85 -68.48 178.79 1.87 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.039 0.935 . . . . 52.12 109.986 167.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.562 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.2 ptmt -167.02 154.94 9.45 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.142 0.276 . . . . 64.11 110.492 173.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.595 HD12 HD11 ' A' ' 251' ' ' LEU . 82.3 mt -81.66 146.09 30.22 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 108.811 -0.811 . . . . 74.11 108.811 167.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -116.1 106.99 14.36 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.808 -1.182 . . . . 73.14 107.808 165.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 249' ' ' LEU . 58.6 mt -107.97 108.44 19.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.788 -1.097 . . . . 73.23 109.202 -173.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -82.88 121.92 27.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.822 -1.081 . . . . 72.1 110.337 -170.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.06 9.93 79.44 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 124.307 1.004 . . . . 23.55 113.894 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.501 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 46.5 mmtm -99.46 6.25 46.0 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.75 0.775 . . . . 71.24 112.542 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.35 -174.75 50.24 Favored Glycine 0 N--CA 1.472 1.099 0 O-C-N 123.319 0.387 . . . . 73.03 112.291 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -58.35 142.55 81.53 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 123.857 0.863 . . . . 75.32 112.993 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.416 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 48.9 Cg_endo -67.23 132.32 27.38 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.301 2.668 . . . . 74.21 112.791 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.07 -178.37 15.51 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 115.213 -0.903 . . . . 75.22 112.913 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.15 -25.78 21.98 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 123.101 2.534 . . . . 72.02 112.686 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.24 22.11 16.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.308 1.043 . . . . 33.33 111.006 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 98.98 -172.88 26.07 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.142 -0.783 . . . . 51.3 111.142 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 68.7 mtm180 -85.41 156.93 20.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.899 0.479 . . . . 72.22 111.722 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.8 -154.86 6.05 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 123.941 0.776 . . . . 70.43 111.799 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -121.75 166.36 14.44 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.899 0.85 . . . . 73.02 110.825 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.541 HD23 HD12 ' A' ' 235' ' ' LEU . 46.6 tp -126.78 107.22 9.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.496 0.718 . . . . 71.14 109.194 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -105.08 111.3 24.02 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.966 -1.124 . . . . 75.33 107.966 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.8 pp -125.9 120.9 31.64 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.709 1.003 . . . . 74.53 113.709 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -69.26 123.81 22.16 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.733 1.613 . . . . 74.42 112.624 -171.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.619 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 90.4 t -71.86 119.23 18.01 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 C-N-CA 124.821 1.249 . . . . 75.42 111.077 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -113.82 115.41 27.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.626 1.57 . . . . 73.43 107.883 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.87 96.0 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.868 -1.16 . . . . 74.52 107.868 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.556 1.202 0 C-N-CA 124.539 1.135 . . . . 43.4 109.076 -171.91 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.2 m . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 121.055 0.455 . . . . 71.2 112.0 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.0 166.8 18.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.781 0.832 . . . . 54.45 111.713 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.16 -80.96 1.15 Allowed Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.886 -1.052 . . . . 53.15 111.011 172.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -153.9 175.27 13.55 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.165 0.586 . . . . 71.44 111.464 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.519 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 23.7 m95 . . . . . 0 C--O 1.239 0.501 0 CA-C-N 114.846 -1.07 . . . . 61.44 110.743 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 5.5 p-10 . . . . . 0 C--O 1.235 0.333 0 CA-C-O 120.682 0.277 . . . . 73.35 110.639 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.47 ' HB2' HD13 ' A' ' 249' ' ' LEU . 84.2 mt -119.3 147.55 44.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.328 0.651 . . . . 72.04 110.092 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 9.0 t80 -109.31 114.93 29.03 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.882 -1.155 . . . . 74.11 107.882 171.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -127.42 -173.69 2.98 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.729 0.812 . . . . 75.21 110.441 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 60.3 m -121.52 137.93 54.52 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.519 0.728 . . . . 73.44 111.071 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.5 tp -108.1 108.81 20.05 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.973 1.309 . . . . 53.31 107.69 169.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.04 99.35 12.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.42 0.629 . . . . 75.51 109.611 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.66 HG22 HG21 ' A' ' 210' ' ' VAL . 15.1 t -101.59 111.03 63.34 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.675 -1.231 . . . . 71.24 107.675 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.55 154.38 74.56 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.85 1.7 . . . . 74.02 110.418 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.72 -45.37 79.31 Favored Pre-proline 0 CA--C 1.573 1.847 0 CA-C-O 117.809 -1.091 . . . . 63.52 113.394 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.79 -48.89 13.05 Favored 'Trans proline' 0 C--N 1.402 3.351 0 C-N-CA 121.828 1.685 . . . . 73.31 112.484 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.475 HG21 HG13 ' A' ' 210' ' ' VAL . 44.4 mt -68.28 -31.2 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.539 0.736 . . . . 62.3 110.762 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.81 -46.72 77.59 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.0 0.52 . . . . 71.4 110.585 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.56 -48.33 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 124.417 1.073 . . . . 73.42 111.954 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.15 -28.58 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 120.678 0.275 . . . . 74.42 110.715 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.11 76.46 1.0 Allowed Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.626 -0.589 . . . . 72.14 111.626 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.5 -129.4 6.68 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-O 120.049 -0.306 . . . . 72.3 112.817 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.72 135.19 29.57 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.965 0.906 . . . . 73.22 109.132 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.66 HG21 HG22 ' A' ' 199' ' ' VAL . 31.6 m -134.21 149.3 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.573 0.749 . . . . 73.21 110.547 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -75.95 150.4 37.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.945 0.898 . . . . 74.24 110.624 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -122.57 121.58 36.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.838 1.255 . . . . 64.24 108.442 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.23 123.4 19.01 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.732 0.813 . . . . 74.22 110.217 176.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.3 OUTLIER -126.47 -171.87 2.5 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.552 1.141 . . . . 72.14 110.206 -176.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.53 -70.34 0.22 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 122.243 1.021 . . . . 72.34 111.268 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -110.22 -41.59 4.37 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 113.461 -1.7 . . . . 64.23 110.947 -162.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -132.55 145.86 17.7 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 118.348 -1.251 . . . . 53.44 110.549 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.82 152.72 64.05 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.125 1.883 . . . . 60.13 112.628 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 54.1 t -104.09 167.67 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.927 1.291 . . . . 75.31 108.029 174.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -148.64 146.28 28.13 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 107.815 -1.18 . . . . 75.13 107.815 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 233' ' ' LEU . 9.6 p -138.5 144.27 30.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 C-N-CA 122.946 0.498 . . . . 61.5 110.8 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.59 112.89 12.41 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 124.035 0.835 . . . . 74.14 109.675 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.56 134.81 75.71 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.017 0.927 . . . . 41.53 109.45 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.52 154.34 50.08 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.465 2.11 . . . . 52.44 111.533 169.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.93 136.97 64.58 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 121.988 1.792 . . . . 72.21 111.756 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 51.51 70.37 0.55 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.231 1.413 . . . . 75.01 113.434 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.478 HG23 ' HD2' ' A' ' 231' ' ' ARG . 80.8 m -89.01 143.09 27.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.803 -1.089 . . . . 54.24 110.655 173.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -107.61 154.85 20.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.294 1.037 . . . . 71.12 110.35 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.495 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -80.28 150.82 29.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.053 -0.976 . . . . 74.33 110.823 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.1 -21.3 27.3 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.931 -0.868 . . . . 71.52 110.931 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.478 ' HD2' HG23 ' A' ' 227' ' ' THR . 72.2 mtt85 -65.34 179.79 0.71 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.09 0.956 . . . . 53.52 110.525 170.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.729 ' HD3' ' HB3' ' A' ' 250' ' ' TYR . 9.9 ptpt -166.77 159.72 14.03 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.225 0.21 . . . . 74.12 111.033 171.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.565 HD12 HD11 ' A' ' 251' ' ' LEU . 71.2 mt -87.22 154.16 20.93 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.898 -0.408 . . . . 74.23 109.898 170.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -117.84 106.75 13.33 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.791 1.307 . . . . 73.45 108.04 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 44.8 mt -118.13 112.98 20.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.96 -0.564 . . . . 73.13 110.947 -172.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -90.78 127.4 36.33 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.159 -0.473 . . . . 62.3 109.935 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 88.23 11.57 66.79 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 123.981 0.8 . . . . 34.53 112.672 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.515 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.3 mmtt -113.79 -4.93 13.29 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.42 0.688 . . . . 74.33 111.867 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.72 -176.41 51.43 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.277 -0.729 . . . . 71.12 111.277 166.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.3 139.96 94.6 Favored Pre-proline 0 N--CA 1.487 1.375 0 CA-C-N 117.718 0.759 . . . . 75.21 111.405 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.403 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 34.8 Cg_endo -63.26 137.86 63.28 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.838 2.359 . . . . 75.53 112.516 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.99 169.51 22.89 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.126 -0.488 . . . . 65.31 113.875 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -71.35 -20.26 27.96 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 123.202 2.601 . . . . 54.22 112.077 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.1 17.46 15.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.279 1.032 . . . . 41.11 110.462 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.51 169.35 45.49 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.29 -0.724 . . . . 72.52 111.29 -170.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 95.5 mtt180 -65.34 158.2 27.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.877 0.871 . . . . 71.23 111.414 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.47 -164.61 40.46 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.715 -0.675 . . . . 42.23 112.333 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 8.7 p-10 -110.04 170.99 7.72 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.695 0.76 . . . . 71.44 110.574 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.66 ' HG ' HD23 ' A' ' 251' ' ' LEU . 33.5 tp -135.02 109.68 8.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.024 -0.989 . . . . 71.0 109.123 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.729 ' HB3' ' HD3' ' A' ' 232' ' ' LYS . 12.3 m-30 -98.29 112.04 24.17 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.37 -1.344 . . . . 63.13 107.37 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.66 HD23 ' HG ' ' A' ' 249' ' ' LEU . 3.5 pp -124.82 113.52 18.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.673 0.749 . . . . 75.02 112.863 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.51 119.37 12.2 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.826 1.25 . . . . 64.24 112.543 -170.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 232' ' ' LYS . 58.5 t -68.07 131.79 33.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 113.858 -1.519 . . . . 73.02 110.862 174.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -127.35 133.98 50.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.353 1.461 . . . . 74.32 107.913 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.495 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 34.6 mm -103.36 101.37 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.122 -1.066 . . . . 75.22 108.122 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.561 1.374 0 CA-C-N 115.045 -0.98 . . . . 37.22 108.634 -170.429 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 23.6 m . . . . . 0 N--CA 1.482 1.164 0 CA-C-O 121.451 0.643 . . . . 74.14 110.102 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.5 178.34 4.71 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.068 0.947 . . . . 71.11 111.162 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.04 -86.05 1.79 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.059 -1.616 . . . . 74.1 109.059 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.29 164.89 29.44 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.389 1.076 . . . . 62.41 109.651 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.647 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.6 m95 . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 108.484 -0.932 . . . . 72.42 108.484 170.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 11.4 p-10 . . . . . 0 CA--C 1.542 0.646 0 N-CA-C 110.013 -0.365 . . . . 74.52 110.013 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.9 mt -124.54 159.01 31.57 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.383 0.611 . . . . 72.22 111.691 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 8.7 t80 -116.04 109.13 17.1 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.54 -1.209 . . . . 73.35 108.774 174.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.59 -170.42 1.9 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.502 1.121 . . . . 51.25 109.913 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 98.3 m -117.53 127.77 54.31 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.732 0.813 . . . . 73.31 110.761 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.648 HD22 ' HG ' ' A' ' 233' ' ' LEU . 17.0 tp -87.84 105.88 17.71 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.866 -1.161 . . . . 43.54 107.866 165.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -87.1 107.52 18.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.096 -1.076 . . . . 62.43 108.096 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.642 ' HA ' HG11 ' A' ' 210' ' ' VAL . 19.2 t -117.58 115.94 37.12 Favored Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 108.83 -0.804 . . . . 71.11 108.83 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.01 149.61 77.29 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 121.571 1.514 . . . . 40.13 110.371 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.441 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.38 -43.96 92.64 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-O 117.75 -1.119 . . . . 62.43 112.571 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.2 Cg_endo -54.42 -52.57 7.91 Favored 'Trans proline' 0 C--N 1.403 3.446 0 C-N-CA 122.291 1.994 . . . . 51.12 113.077 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.438 HG21 HG13 ' A' ' 210' ' ' VAL . 51.2 mt -64.63 -33.61 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.207 0.603 . . . . 71.23 111.009 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.48 -46.58 85.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.829 0.452 . . . . 61.53 110.837 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.86 -50.62 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.004 0.922 . . . . 74.15 112.316 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.19 -27.01 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-O 120.614 0.245 . . . . 64.3 110.708 -174.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.96 76.7 0.88 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.021 -0.536 . . . . 54.13 111.764 -175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.46 -130.23 6.77 Favored Glycine 0 N--CA 1.476 1.346 0 N-CA-C 111.018 -0.833 . . . . 74.54 111.018 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -133.13 152.91 51.93 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.568 0.747 . . . . 64.43 110.434 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 199' ' ' VAL . 30.7 m -139.9 149.77 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.323 -0.853 . . . . 64.4 109.402 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -73.42 152.62 40.73 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.516 -0.765 . . . . 71.51 110.673 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -130.73 114.27 15.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.147 1.379 . . . . 75.44 108.635 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 12.8 tpt -63.91 123.8 19.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.696 1.198 . . . . 74.04 111.435 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.542 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -121.83 -172.82 2.51 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.709 1.203 . . . . 75.3 109.371 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.521 ' H ' HG22 ' A' ' 214' ' ' THR . 4.8 mt -64.88 -65.96 0.6 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.191 1.396 . . . . 73.53 110.254 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -93.17 -37.4 12.12 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 112.227 -2.26 . . . . 62.34 110.155 -166.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -145.49 -162.43 9.64 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.237 -0.892 . . . . 53.14 112.429 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -100.66 174.73 0.31 Allowed 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 123.145 2.564 . . . . 72.23 113.936 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 43.7 t -130.49 167.78 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 126.06 1.744 . . . . 62.34 106.322 172.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -145.68 120.26 9.76 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.388 -0.967 . . . . 64.43 108.388 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.449 HG11 HD11 ' A' ' 233' ' ' LEU . 15.0 p -112.53 141.37 28.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 123.99 0.916 . . . . 72.23 110.095 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.06 115.91 15.21 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.538 -0.912 . . . . 42.34 108.538 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.92 132.53 74.12 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 108.559 -0.904 . . . . 74.41 108.559 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.73 149.59 78.79 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.939 2.426 . . . . 64.13 111.536 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -56.64 129.99 37.61 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.374 2.049 . . . . 51.33 112.572 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 54.58 68.25 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.456 1.502 . . . . 72.42 113.478 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.403 HG21 ' CH2' ' A' ' 176' ' ' TRP . 54.0 m -95.05 139.27 31.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.901 -1.045 . . . . 70.53 110.184 172.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -104.07 163.87 12.1 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.453 1.101 . . . . 74.43 110.765 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.523 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.4 155.73 24.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.336 -1.302 . . . . 72.01 110.924 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.95 -5.17 57.84 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 111.878 -0.489 . . . . 71.55 111.878 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -81.38 -174.96 5.23 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.998 0.919 . . . . 74.23 109.308 168.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.537 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.6 ptpt -165.98 161.99 17.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.08 0.552 . . . . 62.32 109.692 169.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 251' ' ' LEU . 87.0 mt -85.92 150.71 24.32 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.49 -0.93 . . . . 65.5 108.49 164.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -116.94 106.39 13.38 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.876 -1.157 . . . . 75.15 107.876 160.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 43.3 mt -102.2 104.39 14.97 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.41 -1.268 . . . . 52.32 108.76 -174.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -79.47 118.81 21.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.164 -1.38 . . . . 74.4 110.295 -167.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.94 9.59 82.34 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.436 1.085 . . . . 54.25 114.044 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.555 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.4 mmtt -96.29 -0.04 50.19 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 118.249 1.024 . . . . 73.51 112.772 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.53 -177.35 50.46 Favored Glycine 0 N--CA 1.472 1.066 0 N-CA-C 111.716 -0.553 . . . . 75.42 111.716 170.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -55.46 126.18 62.1 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 123.568 0.747 . . . . 73.25 111.29 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.502 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 35.2 Cg_endo -65.05 134.72 40.82 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.7 2.267 . . . . 73.22 111.918 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -117.4 177.34 16.58 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.244 -0.889 . . . . 51.5 112.356 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.39 -33.36 23.57 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.824 2.349 . . . . 61.41 113.073 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.55 -33.62 12.34 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.137 0.575 . . . . 71.35 111.122 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 177.63 174.86 44.36 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.242 -0.89 . . . . 74.41 111.163 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.502 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 65.9 mtt180 -88.05 160.56 17.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.233 0.613 . . . . 73.32 111.47 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.54 -176.38 50.98 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.688 -0.965 . . . . 75.25 110.688 168.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 27.1 m-20 -110.33 -178.99 3.65 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.118 0.567 . . . . 74.3 110.163 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 55.7 tp -136.38 105.47 5.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.887 0.851 . . . . 55.4 109.499 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 58.9 m-85 -99.56 108.8 21.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.703 -1.221 . . . . 72.55 107.703 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.765 HD11 HD12 ' A' ' 233' ' ' LEU . 1.5 pp -125.49 115.0 19.54 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.965 1.098 . . . . 64.53 113.965 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.65 126.46 29.43 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 113.656 -1.611 . . . . 71.41 113.1 -170.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.647 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 63.3 t -75.01 124.83 33.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 CA-C-N 113.522 -1.672 . . . . 74.01 110.622 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -121.04 122.06 39.27 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.817 1.247 . . . . 72.13 107.788 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.523 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 32.7 mm -92.51 103.73 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.04 -1.096 . . . . 64.32 108.04 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.562 1.42 0 CA-C-O 117.484 -1.246 . . . . 70.24 108.751 -169.384 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 CA--C 1.556 1.188 0 CA-C-O 121.31 0.576 . . . . 63.25 111.097 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.17 167.57 20.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.866 0.866 . . . . 61.12 112.746 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -89.74 -91.53 1.21 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 110.102 -1.199 . . . . 51.52 110.102 169.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -141.19 170.05 16.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.211 1.004 . . . . 72.3 110.495 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.626 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 15.3 m95 . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 123.542 0.737 . . . . 63.43 109.946 173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 12.2 p-10 . . . . . 0 CA--C 1.547 0.84 0 CA-C-O 122.021 0.915 . . . . 72.4 108.757 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.2 mt -91.5 170.33 10.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.859 -1.064 . . . . 63.11 112.981 -168.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 24.8 t80 -124.84 140.32 53.03 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 113.41 -1.723 . . . . 71.4 107.621 171.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -154.43 -170.91 3.68 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.291 0.637 . . . . 64.2 110.176 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 254' ' ' ARG . 91.0 m -117.82 138.27 52.19 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.09 0.956 . . . . 72.35 110.809 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.634 HD23 HG22 ' A' ' 253' ' ' VAL . 17.3 tp -98.55 108.92 21.72 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.727 -1.212 . . . . 64.32 107.727 166.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -82.73 100.6 10.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.211 -0.662 . . . . 71.42 109.211 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.673 HG22 HG21 ' A' ' 210' ' ' VAL . 21.5 t -108.11 109.43 61.9 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 108.715 -0.846 . . . . 52.55 108.715 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.42 145.56 65.51 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.257 1.305 . . . . 72.5 109.597 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.455 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -51.66 -40.53 70.8 Favored Pre-proline 0 CA--C 1.56 1.337 0 N-CA-C 113.979 1.103 . . . . 51.12 113.979 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.2 Cg_endo -56.16 -48.65 18.44 Favored 'Trans proline' 0 C--N 1.397 3.13 0 C-N-CA 122.037 1.825 . . . . 72.24 112.751 174.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.483 HG21 HG13 ' A' ' 210' ' ' VAL . 37.4 mt -67.74 -35.15 71.65 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 C-N-CA 122.905 0.482 . . . . 72.32 110.833 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.409 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -61.21 -46.3 91.02 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.072 0.549 . . . . 64.23 110.817 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.4 t -71.12 -48.1 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.889 0.876 . . . . 35.14 112.119 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.43 -23.58 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 120.607 0.241 . . . . 73.53 110.726 -173.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.26 68.75 1.48 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.759 -0.655 . . . . 34.24 111.791 -175.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.6 -136.83 9.31 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-O 119.741 -0.477 . . . . 52.04 112.308 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 5.3 ttmt -129.57 139.41 51.49 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.014 -0.736 . . . . 74.35 109.014 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.673 HG21 HG22 ' A' ' 199' ' ' VAL . 27.6 m -131.76 146.94 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 122.861 0.464 . . . . 64.14 110.929 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -74.34 144.35 44.51 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.948 -1.024 . . . . 73.1 110.297 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.689 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -117.24 122.35 43.73 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.92 1.288 . . . . 74.34 108.07 172.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.79 119.43 9.94 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.344 0.657 . . . . 60.14 110.037 175.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.96 -170.41 2.1 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.437 1.095 . . . . 72.51 109.378 -175.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.99 -70.24 0.25 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.844 0.83 . . . . 63.44 110.77 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -114.0 -41.29 3.56 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-N 113.719 -1.582 . . . . 61.34 111.445 -166.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -130.49 129.0 5.72 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-O 118.465 -1.186 . . . . 72.15 110.513 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.27 152.96 61.84 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.184 1.923 . . . . 74.33 113.212 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.689 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 55.1 t -97.43 166.39 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.255 -1.339 . . . . 61.24 108.691 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -149.77 135.1 18.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.614 -0.884 . . . . 71.51 108.614 172.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 14.3 p -131.11 142.56 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.526 0.73 . . . . 63.22 110.812 -172.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.1 108.19 5.85 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.93 0.492 . . . . 71.24 109.721 170.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 204' ' ' ALA . 70.6 t -69.58 134.37 88.54 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.84 0.856 . . . . 71.55 109.137 172.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.37 154.56 71.69 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.386 2.057 . . . . 70.15 111.286 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.4 131.18 37.09 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.161 1.907 . . . . 73.0 112.072 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 53.81 69.76 0.68 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.265 1.426 . . . . 74.22 113.389 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.431 HG23 ' HD2' ' A' ' 231' ' ' ARG . 87.1 m -88.2 142.42 27.77 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.666 -1.152 . . . . 62.23 110.908 173.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -103.7 164.78 11.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.047 0.939 . . . . 74.14 110.614 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.468 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -86.87 149.57 24.73 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.196 -0.911 . . . . 73.12 111.17 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.8 -12.28 32.36 Favored Glycine 0 N--CA 1.473 1.123 0 CA-C-N 115.922 -0.581 . . . . 35.2 111.965 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.431 ' HD2' HG23 ' A' ' 227' ' ' THR . 62.0 mtt85 -74.4 -175.49 2.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.24 1.016 . . . . 75.35 110.336 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.536 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.2 ptmt -168.37 165.21 12.85 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 111.752 0.278 . . . . 74.13 111.752 174.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.677 HD12 HD11 ' A' ' 251' ' ' LEU . 84.5 mt -95.57 150.56 20.2 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 123.514 0.509 . . . . 63.43 109.713 167.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -114.15 107.09 15.16 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.659 -1.237 . . . . 70.41 107.659 162.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 57.0 mt -106.99 110.75 22.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.317 -0.856 . . . . 72.41 109.748 -174.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -77.75 118.68 20.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.761 -1.109 . . . . 63.32 110.8 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.35 3.61 89.92 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 114.948 -1.024 . . . . 61.15 114.386 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -95.27 2.67 54.88 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 112.804 0.668 . . . . 75.43 112.804 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.42 -173.12 47.62 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.693 -0.963 . . . . 63.34 110.693 166.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 15.4 m-85 -58.9 134.8 87.11 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 117.737 0.769 . . . . 60.41 110.759 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.442 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 3.5 Cg_exo -76.96 139.44 19.4 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.575 2.183 . . . . 63.04 110.763 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -107.36 -167.93 22.0 Favored Glycine 0 C--O 1.238 0.345 0 CA-C-O 119.132 -0.815 . . . . 44.22 111.73 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.55 -50.44 10.72 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.693 2.262 . . . . 63.23 112.763 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.63 -25.0 5.61 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.159 0.584 . . . . 64.5 112.225 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -133.82 158.87 23.5 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-O 119.925 -0.375 . . . . 54.22 112.349 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 92.7 mtt180 -113.32 157.82 21.34 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.606 0.763 . . . . 74.43 110.763 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.46 175.73 37.77 Favored Glycine 0 N--CA 1.468 0.798 0 CA-C-N 115.528 -0.76 . . . . 53.2 111.556 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 40.2 m-20 -102.67 176.78 5.05 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.762 -0.459 . . . . 72.44 109.762 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.6 tp -134.09 108.84 8.55 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.327 0.584 . . . . 70.24 110.41 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 34.3 m-85 -102.33 103.56 14.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.032 -1.099 . . . . 74.41 108.032 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 233' ' ' LEU . 2.4 pp -121.38 114.55 21.46 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.837 1.051 . . . . 64.42 113.837 -172.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.08 118.32 11.84 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.071 -1.422 . . . . 63.42 113.215 -172.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.634 HG22 HD23 ' A' ' 197' ' ' LEU . 98.2 t -62.36 122.34 12.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 113.73 -1.577 . . . . 55.15 111.701 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.41 ' HG2' HG23 ' A' ' 196' ' ' THR . 17.3 mmm180 -121.43 122.81 40.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.912 -1.04 . . . . 74.1 108.236 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.468 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 30.5 mm -88.78 96.55 6.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 108.993 -0.743 . . . . 60.14 108.993 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.561 1.384 0 C-N-CA 125.077 1.351 . . . . 73.41 108.819 -175.311 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.493 HG22 HG22 ' A' ' 219' ' ' VAL . 3.6 m . . . . . 0 N--CA 1.473 0.717 0 N-CA-C 108.304 -0.999 . . . . 61.12 108.304 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.84 174.49 10.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.328 -0.851 . . . . 64.01 110.914 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.414 ' H ' ' CD2' ' A' ' 235' ' ' LEU . . . -101.97 -85.29 1.86 Allowed Glycine 0 C--N 1.336 0.573 0 N-CA-C 109.323 -1.511 . . . . 52.13 109.323 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -151.82 174.94 12.96 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.453 0.701 . . . . 73.21 110.811 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.519 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 18.5 m95 . . . . . 0 CA--C 1.548 0.888 0 CA-C-N 115.239 -0.892 . . . . 75.21 110.96 177.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 C--O 1.238 0.473 0 CA-C-O 120.725 0.298 . . . . 72.34 110.248 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 58.6 mt -107.01 150.75 26.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.951 -0.759 . . . . 51.23 108.951 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 1.8 t80 -125.86 108.77 11.77 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.19 -1.041 . . . . 61.23 108.19 173.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.69 -174.86 2.77 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.082 0.953 . . . . 55.22 109.575 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 85.0 m -126.79 116.02 20.26 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.746 0.818 . . . . 72.53 109.944 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.545 HD23 HG22 ' A' ' 253' ' ' VAL . 15.7 tp -82.08 105.48 13.21 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.618 -0.882 . . . . 73.14 108.618 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.56 100.32 12.99 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.774 -0.825 . . . . 72.43 108.774 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.621 HG22 HG21 ' A' ' 210' ' ' VAL . 21.4 t -102.87 114.76 65.06 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.22 -1.03 . . . . 74.04 108.22 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.39 145.89 73.01 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 121.515 1.477 . . . . 62.12 110.342 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.76 -43.41 82.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-O 117.696 -1.145 . . . . 72.54 112.717 -176.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.2 Cg_endo -54.42 -50.06 14.78 Favored 'Trans proline' 0 C--N 1.398 3.179 0 C-N-CA 121.948 1.765 . . . . 45.31 112.703 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.455 HG21 HG13 ' A' ' 210' ' ' VAL . 17.3 mt -65.4 -35.65 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.404 0.682 . . . . 74.03 111.011 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.26 93.8 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.847 0.459 . . . . 43.21 111.012 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.5 t -70.58 -50.84 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.626 1.17 . . . . 52.42 111.975 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.41 -15.81 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.852 0.461 . . . . 72.01 110.671 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 70.79 75.57 0.61 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 111.403 -0.679 . . . . 71.41 111.403 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.16 -132.82 7.84 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.842 0.321 . . . . 71.45 112.446 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -142.95 135.42 27.52 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.983 0.913 . . . . 73.24 109.077 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.621 HG21 HG22 ' A' ' 199' ' ' VAL . 23.3 m -132.74 145.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.182 0.593 . . . . 75.33 110.18 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -71.01 142.02 50.94 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.413 0.685 . . . . 63.14 110.758 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -118.35 120.18 36.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.763 1.225 . . . . 72.03 109.02 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . 0.401 ' O ' HD21 ' A' ' 249' ' ' LEU . 13.4 tpt -65.32 136.98 57.23 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.053 0.941 . . . . 74.4 111.77 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.633 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -139.88 -174.26 3.86 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.0 0.92 . . . . 62.42 110.288 -179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.589 ' H ' HG22 ' A' ' 214' ' ' THR . 10.6 mt -52.95 -68.4 0.17 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.656 1.582 . . . . 60.5 112.683 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -111.65 -41.23 4.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.714 -1.585 . . . . 71.41 111.352 -165.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -130.94 158.58 22.7 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-O 119.108 -0.829 . . . . 63.54 112.514 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.25 143.4 8.93 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.567 2.178 . . . . 74.41 113.416 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 78.0 t -97.22 166.13 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.902 1.281 . . . . 64.12 108.245 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -147.72 135.65 21.16 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.463 -1.31 . . . . 74.32 107.463 170.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.512 HG11 HD11 ' A' ' 233' ' ' LEU . 11.3 p -128.46 140.74 48.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 C-N-CA 123.184 0.594 . . . . 74.53 110.931 -170.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.41 108.82 5.71 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.84 0.856 . . . . 45.12 109.384 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.404 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 86.5 t -72.33 130.62 85.86 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.89 -0.782 . . . . 72.35 108.89 174.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.04 155.56 61.47 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.759 2.306 . . . . 74.02 111.202 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.92 139.52 85.36 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.402 2.068 . . . . 74.5 112.403 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 41.44 73.93 0.12 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.703 1.601 . . . . 63.34 113.653 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.545 HG23 ' HD2' ' A' ' 231' ' ' ARG . 92.8 m -84.6 139.12 32.31 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.011 -0.995 . . . . 72.43 110.998 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.51 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 24.8 mp0 -101.75 147.31 26.62 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.208 1.003 . . . . 63.41 109.175 171.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.431 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -73.26 155.91 39.02 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.129 -0.941 . . . . 50.3 110.854 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.62 -19.62 30.84 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.63 -0.588 . . . . 75.15 111.63 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.545 ' HD2' HG23 ' A' ' 227' ' ' THR . 80.5 mtt85 -66.34 177.95 1.34 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.867 0.867 . . . . 74.44 110.276 167.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.613 ' HA ' HG23 ' A' ' 253' ' ' VAL . 2.2 ptmt -167.62 158.04 10.89 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.218 0.324 . . . . 74.01 110.653 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.627 HD12 HD11 ' A' ' 251' ' ' LEU . 67.9 mt -86.02 136.41 33.26 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.995 -0.743 . . . . 73.31 108.995 171.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -103.56 104.77 14.87 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.957 -1.497 . . . . 73.24 106.957 164.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 48.1 mt -107.88 106.8 17.25 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.411 -0.813 . . . . 74.44 109.257 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -80.62 116.76 20.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.736 -1.12 . . . . 72.41 111.076 -168.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 88.37 4.25 77.41 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.79 -0.641 . . . . 64.41 113.652 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.633 ' HD2' HG21 ' A' ' 214' ' ' THR . 46.2 mmtm -93.93 4.84 53.33 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.846 0.684 . . . . 73.4 112.846 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.25 -177.48 50.73 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.429 -0.65 . . . . 55.15 111.554 171.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -60.59 142.78 91.05 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 117.45 0.625 . . . . 74.34 111.636 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.52 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 38.3 Cg_endo -66.68 139.75 53.91 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.709 2.272 . . . . 74.31 113.112 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.77 170.91 22.24 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.399 -0.819 . . . . 71.02 112.548 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.11 -21.01 27.89 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.096 2.531 . . . . 72.31 113.205 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.4 -11.64 17.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.842 0.857 . . . . 54.03 111.297 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 141.28 163.66 9.64 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.717 -0.953 . . . . 75.51 110.717 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.52 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 42.0 mtm180 -69.15 170.66 9.63 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.515 0.726 . . . . 75.21 111.776 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.74 -164.26 39.9 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 112.089 -0.404 . . . . 32.05 112.089 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -121.59 152.03 39.72 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.148 -0.686 . . . . 64.52 109.148 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 23.7 tp -112.19 108.38 17.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.651 0.78 . . . . 73.2 109.227 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 53.7 m-85 -101.58 119.26 38.5 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.788 -1.19 . . . . 74.3 107.788 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.3 pp -131.79 115.7 16.29 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.786 0.803 . . . . 72.22 112.99 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -68.76 118.8 12.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.174 1.39 . . . . 74.11 112.855 -169.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 232' ' ' LYS . 67.9 t -69.6 127.1 30.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-N 114.156 -1.384 . . . . 73.52 111.31 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -124.24 130.49 52.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.591 1.556 . . . . 71.34 108.126 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.431 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 36.3 mm -100.18 98.44 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.336 -0.986 . . . . 74.03 108.336 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.258 1.526 0 C-N-CA 124.637 1.175 . . . . 75.42 108.386 -172.407 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.4 m . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 121.691 0.757 . . . . 72.0 110.196 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.61 175.32 6.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.767 -1.106 . . . . 63.12 111.421 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -105.49 -108.52 3.32 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.183 -0.917 . . . . 74.32 110.901 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.91 153.09 36.4 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.857 0.863 . . . . 72.41 109.98 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.52 ' CZ3' HG21 ' A' ' 227' ' ' THR . 23.2 m95 . . . . . 0 N--CA 1.469 0.506 0 CA-C-N 115.715 -0.675 . . . . 52.11 110.101 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 108.862 -0.792 . . . . 61.01 108.862 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.0 mt -122.72 139.32 54.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.353 0.661 . . . . 63.43 110.987 -170.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -103.62 133.49 48.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.138 -1.06 . . . . 65.23 108.138 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -139.15 -172.19 3.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.523 0.729 . . . . 52.24 110.059 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.4 m -118.08 158.61 24.69 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.126 0.97 . . . . 75.4 109.919 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.554 HD23 HG22 ' A' ' 253' ' ' VAL . 16.8 tp -126.52 114.47 18.16 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.585 1.554 . . . . 71.04 107.479 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.47 99.03 12.11 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.066 -0.716 . . . . 75.25 109.066 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.71 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.4 t -109.01 108.96 60.94 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 108.161 -1.051 . . . . 73.22 108.161 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.427 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 35.9 Cg_endo -66.68 146.14 77.97 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.575 1.517 . . . . 72.42 110.329 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -46.67 -46.91 50.7 Favored Pre-proline 0 CA--C 1.563 1.453 0 O-C-N 124.198 0.936 . . . . 72.23 113.258 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 33.4 Cg_exo -57.5 -47.88 19.78 Favored 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 121.645 1.564 . . . . 72.31 113.679 177.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.6 mt -65.97 -34.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.707 0.403 . . . . 70.52 110.765 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.35 -43.07 99.68 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.411 0.444 . . . . 75.34 110.421 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.0 t -73.24 -51.2 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 124.221 0.951 . . . . 50.43 111.919 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.33 -25.97 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 120.822 0.344 . . . . 72.21 111.02 -172.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.7 75.28 1.13 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.866 -0.606 . . . . 72.2 112.431 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.99 -135.51 7.66 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 112.176 -0.37 . . . . 75.22 112.176 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -130.89 150.63 51.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.068 0.947 . . . . 64.23 110.026 173.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 199' ' ' VAL . 34.8 m -140.59 157.4 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.584 0.754 . . . . 72.42 110.882 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -79.5 141.26 36.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.116 0.566 . . . . 75.32 110.944 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.517 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -119.08 118.68 32.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.2 1.4 . . . . 75.52 108.112 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 12.9 tpt -64.85 132.02 48.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.169 0.587 . . . . 64.44 111.11 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.438 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -139.86 -169.52 2.74 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.577 1.151 . . . . 61.15 109.783 -174.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.451 ' HB2' ' HG2' ' A' ' 216' ' ' GLU . 4.7 mt -77.33 -66.67 0.8 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.294 1.438 . . . . 61.21 110.185 -173.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 215' ' ' LEU . 21.6 mm-40 -87.88 -31.0 19.71 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 112.268 -2.242 . . . . 45.32 110.491 -164.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -164.11 -178.85 37.96 Favored Glycine 0 C--N 1.33 0.218 0 CA-C-N 114.964 -1.017 . . . . 62.41 111.702 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.08 136.6 5.03 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.212 1.941 . . . . 74.43 112.713 172.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 49.7 t -90.41 162.64 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.402 -1.272 . . . . 72.44 107.899 173.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -142.51 129.41 20.63 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.14 -1.059 . . . . 74.53 108.14 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 233' ' ' LEU . 14.9 p -120.69 138.96 49.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 123.552 0.741 . . . . 53.24 110.855 -174.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.7 102.99 2.93 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.037 0.935 . . . . 65.52 109.048 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.97 130.73 91.3 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.414 0.686 . . . . 65.5 109.7 176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.95 154.42 56.64 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.796 2.33 . . . . 73.42 111.827 172.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.91 130.58 29.73 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.131 1.888 . . . . 72.24 111.202 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 51.54 71.8 0.42 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.62 1.568 . . . . 73.51 112.577 -177.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.52 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 92.9 m -96.03 139.89 31.56 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.078 -0.965 . . . . 65.13 110.705 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -99.44 152.21 20.24 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.047 0.939 . . . . 65.11 110.664 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -75.51 155.46 36.11 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.683 -1.144 . . . . 72.54 110.391 175.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.68 5.08 61.66 Favored Glycine 0 N--CA 1.471 0.98 0 CA-C-N 115.747 -0.66 . . . . 42.44 112.576 -174.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.401 ' HD2' HG23 ' A' ' 227' ' ' THR . 67.9 mtt85 -84.36 -175.58 5.85 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.155 0.982 . . . . 70.25 108.589 164.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 253' ' ' VAL . 0.0 OUTLIER -167.46 149.11 5.67 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 110.123 -0.325 . . . . 63.13 110.123 169.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.725 HD12 HD11 ' A' ' 251' ' ' LEU . 62.4 mt -75.97 139.37 41.51 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.628 -0.508 . . . . 63.41 109.628 171.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 250' ' ' TYR . 13.1 ptt180 -105.34 105.05 14.91 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.088 -1.078 . . . . 64.45 108.088 165.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 249' ' ' LEU . 49.1 mt -109.81 110.85 21.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.556 -1.202 . . . . 73.31 109.56 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -88.25 123.56 32.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.243 -0.89 . . . . 62.43 110.098 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.36 4.51 83.49 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.176 -0.92 . . . . 72.13 113.601 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -101.01 9.0 42.71 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.789 0.795 . . . . 62.31 112.414 -176.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.21 -179.03 45.59 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.435 -1.066 . . . . 55.12 110.435 165.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -56.11 137.79 73.55 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 123.073 0.549 . . . . 64.5 112.177 -172.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.03 140.52 72.73 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.816 2.344 . . . . 53.2 111.707 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.28 175.0 20.08 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 116.108 -0.496 . . . . 65.41 113.387 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.41 -34.91 32.94 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 123.425 2.75 . . . . 74.34 114.001 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.47 -0.84 31.74 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.638 0.375 . . . . 61.11 111.783 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 144.11 175.97 17.72 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.497 -0.641 . . . . 75.03 111.497 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -80.91 163.48 23.33 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.425 0.69 . . . . 63.04 111.967 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.66 -175.05 45.84 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.86 -0.896 . . . . 71.22 110.86 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -111.62 168.84 9.24 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 117.969 0.884 . . . . 73.03 110.122 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 235' ' ' LEU . 69.5 tp -134.69 108.94 8.29 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.637 0.775 . . . . 64.13 109.786 -172.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.409 ' HD2' ' HA ' ' A' ' 234' ' ' ARG . 23.2 m-85 -106.9 109.14 20.97 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.028 -1.101 . . . . 73.15 108.028 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.725 HD11 HD12 ' A' ' 233' ' ' LEU . 3.7 pp -118.74 121.93 41.26 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.602 0.715 . . . . 60.31 112.506 -172.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -69.08 130.0 41.5 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 126.501 1.92 . . . . 72.22 112.571 -169.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 232' ' ' LYS . 84.8 t -81.73 120.58 33.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 122.904 0.482 . . . . 74.25 110.958 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -114.47 120.05 38.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.055 1.342 . . . . 74.34 108.611 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.42 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 38.6 mm -91.54 100.52 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.116 -1.068 . . . . 62.22 108.116 173.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.254 1.326 0 C-N-CA 124.816 1.247 . . . . 70.15 108.598 -173.734 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.482 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 6.6 m . . . . . 0 CA--C 1.553 1.058 0 CA-C-O 121.56 0.695 . . . . 61.42 109.624 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -104.24 179.77 4.18 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.456 -0.793 . . . . 31.5 111.641 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -102.86 -85.6 1.88 Allowed Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.416 -0.811 . . . . 73.41 111.999 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.69 158.38 43.89 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.807 0.843 . . . . 71.52 111.584 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.42 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 30.2 m95 . . . . . 0 CA--C 1.55 0.95 0 C-N-CA 124.413 1.085 . . . . 73.5 110.664 176.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 23.7 t70 . . . . . 0 N--CA 1.472 0.67 0 CA-C-O 121.136 0.493 . . . . 65.15 111.096 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.432 ' HG ' ' HA2' ' A' ' 239' ' ' GLY . 63.2 mt -128.22 103.14 7.02 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.509 -0.923 . . . . 64.13 108.509 164.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -83.15 106.49 14.99 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.753 -1.203 . . . . 72.41 107.753 164.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.27 -173.6 2.6 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.053 0.541 . . . . 73.03 110.095 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.3 m -119.95 150.82 39.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.646 0.778 . . . . 73.51 110.009 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.5 tp -113.7 105.68 13.59 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.845 -1.539 . . . . 53.22 106.845 168.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.55 101.43 12.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.698 -1.223 . . . . 72.33 107.698 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.622 HG22 HG21 ' A' ' 210' ' ' VAL . 30.9 t -110.83 118.65 47.96 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.197 -1.038 . . . . 71.0 108.197 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.02 149.91 82.69 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 121.654 1.569 . . . . 65.24 110.166 171.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.95 -41.07 83.55 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 113.061 0.763 . . . . 73.23 113.061 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 9.4 Cg_endo -54.7 -57.22 1.86 Allowed 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 121.907 1.738 . . . . 53.0 113.71 171.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.84 -31.98 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 123.206 0.602 . . . . 73.25 111.121 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -50.43 68.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.68 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.52 -48.39 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 124.023 0.827 . . . . 64.11 111.746 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.77 -32.5 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 117.824 0.284 . . . . 61.21 111.403 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.33 101.48 0.85 Allowed Glycine 0 C--N 1.343 0.946 0 N-CA-C 111.793 -0.523 . . . . 73.41 111.793 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.76 -129.49 2.95 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.603 -0.554 . . . . 70.22 112.24 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -138.33 151.64 47.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.805 0.803 . . . . 73.32 109.546 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.622 HG21 HG22 ' A' ' 199' ' ' VAL . 22.6 m -145.58 158.01 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.719 0.807 . . . . 70.12 110.352 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -74.33 154.06 39.05 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.411 1.084 . . . . 72.45 111.36 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.62 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -132.13 113.93 13.9 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.208 1.003 . . . . 72.34 108.648 177.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.7 tpt -65.64 131.46 46.41 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.454 0.701 . . . . 70.42 111.771 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.663 HG21 ' HE3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -130.97 -170.68 2.4 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.708 1.203 . . . . 72.44 108.586 176.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.444 ' H ' HG22 ' A' ' 214' ' ' THR . 10.5 mt -59.32 -70.14 0.17 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.583 0.706 . . . . 62.24 111.018 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -111.57 -42.2 3.91 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.019 -1.446 . . . . 75.41 111.446 -168.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -122.42 120.59 4.36 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 118.854 -0.97 . . . . 41.13 111.469 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.28 154.85 46.49 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.058 1.839 . . . . 64.44 112.935 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 39.5 t -101.84 168.71 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.109 1.364 . . . . 75.32 108.136 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.482 ' H ' ' HB ' ' A' ' 172' ' ' THR . 8.9 tt0 -141.19 134.7 29.91 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.425 -1.324 . . . . 73.24 107.425 171.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.509 HG11 HD11 ' A' ' 233' ' ' LEU . 14.6 p -131.2 141.46 45.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 122.937 0.495 . . . . 53.13 110.414 -173.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.03 117.3 15.66 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.395 -0.594 . . . . 44.33 109.395 173.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.7 t -78.91 128.66 75.89 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 109.407 -0.59 . . . . 73.15 109.407 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.07 157.32 60.14 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.763 2.309 . . . . 61.31 111.619 173.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.97 133.5 38.89 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.353 2.035 . . . . 62.44 112.455 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 54.4 68.72 0.81 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.919 1.688 . . . . 73.32 113.04 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.472 HG23 ' HD2' ' A' ' 231' ' ' ARG . 75.9 m -89.25 138.33 31.52 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.806 -1.088 . . . . 75.32 111.264 175.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -103.31 149.66 24.52 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.988 0.915 . . . . 74.01 110.746 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.87 155.29 40.05 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.227 0.954 . . . . 65.25 110.946 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 101.33 -16.82 56.48 Favored Glycine 0 N--CA 1.476 1.322 0 N-CA-C 111.081 -0.807 . . . . 55.13 111.081 -174.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.472 ' HD2' HG23 ' A' ' 227' ' ' THR . 65.4 mtt85 -65.87 172.16 3.82 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.108 0.563 . . . . 73.33 109.834 163.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.536 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.4 ptmt -168.03 151.49 5.93 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.359 0.412 . . . . 73.23 110.688 174.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.543 HD12 HD11 ' A' ' 251' ' ' LEU . 85.6 mt -83.48 152.85 24.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 110.318 -0.253 . . . . 75.11 110.318 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -120.93 106.93 12.09 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.751 1.282 . . . . 74.12 107.957 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.512 HD12 HD23 ' A' ' 249' ' ' LEU . 59.4 mt -117.03 127.99 54.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.764 0.826 . . . . 74.41 109.673 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . 0.442 ' HD3' ' HB3' ' A' ' 248' ' ' ASP . 32.5 mmtp -101.36 138.75 37.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.692 0.397 . . . . 73.52 110.126 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.01 13.5 83.3 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 124.279 0.987 . . . . 65.42 113.167 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.663 ' HE3' HG21 ' A' ' 214' ' ' THR . 27.6 mmmt -108.87 -14.32 14.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.467 0.634 . . . . 73.24 112.632 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.432 ' HA2' ' HG ' ' A' ' 193' ' ' LEU . . . -74.66 -170.92 26.09 Favored Glycine 0 N--CA 1.478 1.443 0 CA-C-O 119.855 -0.414 . . . . 74.14 113.349 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -58.56 147.1 71.15 Favored Pre-proline 0 N--CA 1.487 1.425 0 C-N-CA 123.41 0.684 . . . . 64.23 111.806 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -63.7 137.82 60.88 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.707 2.271 . . . . 74.4 111.871 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.9 175.13 20.49 Favored Glycine 0 N--CA 1.468 0.828 0 CA-C-N 115.179 -0.919 . . . . 64.1 113.606 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.76 -28.54 20.31 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 123.149 2.566 . . . . 62.54 112.285 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.7 23.38 7.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.613 0.765 . . . . 60.13 110.92 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 117.84 -95.83 0.66 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.482 -0.647 . . . . 74.22 111.482 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 40.9 mtm-85 -148.53 165.44 31.22 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.571 1.148 . . . . 65.32 109.683 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -90.86 -155.09 31.17 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.621 0.575 . . . . 55.23 112.981 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.442 ' HB3' ' HD3' ' A' ' 236' ' ' LYS . 31.9 p30 -127.17 163.51 23.68 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.991 0.9 . . . . 72.33 112.234 -176.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.662 HD22 HG23 ' A' ' 214' ' ' THR . 12.6 tp -130.32 109.42 10.74 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.027 -1.442 . . . . 43.34 109.697 -171.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 25.6 m-85 -107.63 110.07 21.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.421 -0.955 . . . . 73.01 108.421 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.543 HD11 HD12 ' A' ' 233' ' ' LEU . 3.7 pp -120.43 114.78 22.32 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.687 0.625 . . . . 73.31 112.687 -170.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.0 113.34 6.29 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.67 1.188 . . . . 60.24 112.706 -171.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.604 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 53.1 t -64.08 127.3 24.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.54 1.136 . . . . 63.35 110.893 173.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -126.27 129.7 49.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.986 1.314 . . . . 74.03 108.769 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.9 mm -99.55 107.46 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.33 -0.989 . . . . 74.11 108.33 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.56 1.337 0 CA-C-N 114.861 -1.063 . . . . 74.13 109.029 -169.419 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.41 HG22 HG22 ' A' ' 219' ' ' VAL . 18.2 m . . . . . 0 CA--C 1.55 0.975 0 CA-C-O 121.44 0.638 . . . . 62.22 109.718 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.22 149.39 23.13 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.19 -0.914 . . . . 63.3 111.139 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -69.79 -89.1 0.09 OUTLIER Glycine 0 C--N 1.347 1.147 0 O-C-N 124.026 0.829 . . . . 64.23 111.393 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.97 -178.36 5.89 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.896 0.879 . . . . 74.25 110.209 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.531 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 23.5 m95 . . . . . 0 C--O 1.244 0.772 0 CA-C-N 115.549 -0.751 . . . . 62.1 109.579 168.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 . . . . . 0 C--O 1.239 0.506 0 CA-C-O 120.63 0.252 . . . . 74.5 110.753 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 79.5 mt -117.01 137.13 52.43 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.054 0.541 . . . . 73.2 110.3 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -103.38 108.87 20.28 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.952 -1.129 . . . . 65.22 107.952 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.27 -172.12 2.3 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.412 1.085 . . . . 74.11 109.243 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . 0.418 HG23 ' HG2' ' A' ' 254' ' ' ARG . 90.8 m -124.9 139.37 53.9 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.673 0.789 . . . . 71.04 110.164 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 16.0 tp -97.23 105.84 18.06 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.664 -0.865 . . . . 72.5 108.664 170.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -86.77 101.59 13.46 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.999 -0.741 . . . . 72.33 108.999 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.574 ' HA ' HG11 ' A' ' 210' ' ' VAL . 1.4 p -119.46 113.68 34.93 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.703 0.801 . . . . 65.03 109.351 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.4 145.7 78.08 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.945 1.763 . . . . 64.55 111.054 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -44.35 -47.68 25.2 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.334 1.053 . . . . 71.34 113.625 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.5 -48.09 23.32 Favored 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 121.935 1.757 . . . . 75.32 113.976 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.502 HG21 HG13 ' A' ' 210' ' ' VAL . 60.5 mt -65.84 -33.74 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 122.938 0.495 . . . . 64.52 110.471 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.47 93.73 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.914 0.485 . . . . 74.23 111.16 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.94 -45.88 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.39 1.076 . . . . 74.1 111.912 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.62 -29.66 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 120.71 0.29 . . . . 73.21 110.255 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.65 73.21 1.18 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.415 -0.674 . . . . 70.44 111.415 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.01 -127.2 6.04 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 120.135 -0.258 . . . . 74.21 112.457 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -143.75 137.59 28.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.647 0.779 . . . . 64.14 109.752 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.574 HG11 ' HA ' ' A' ' 199' ' ' VAL . 31.5 m -137.29 154.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.833 0.453 . . . . 55.5 111.108 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -76.13 142.93 41.49 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.758 -1.11 . . . . 72.11 111.192 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -113.97 117.39 31.2 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.917 1.287 . . . . 71.2 108.283 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.0 tpt -63.82 121.08 13.16 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.057 0.943 . . . . 71.15 111.498 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.475 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -123.82 -171.25 2.28 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.053 1.341 . . . . 72.03 109.653 -178.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.45 ' H ' HG22 ' A' ' 214' ' ' THR . 9.2 mt -59.58 -69.4 0.21 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.583 1.153 . . . . 73.52 112.044 -175.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.92 -42.11 3.45 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 113.94 -1.482 . . . . 74.34 111.445 -166.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -119.33 167.3 13.28 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.283 -0.871 . . . . 63.53 111.172 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.41 154.81 10.67 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.987 1.792 . . . . 60.24 113.202 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.653 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 69.5 t -106.3 166.26 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 107.086 -1.45 . . . . 61.12 107.086 165.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.28 140.2 25.05 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.32 -0.992 . . . . 61.24 108.32 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.459 HG11 HD11 ' A' ' 233' ' ' LEU . 8.7 p -134.18 142.24 41.54 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 C-N-CA 123.162 0.585 . . . . 53.54 110.86 -172.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.97 108.23 8.71 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.961 0.904 . . . . 74.02 109.187 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.459 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 59.5 t -71.54 132.61 85.43 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.132 0.973 . . . . 73.24 109.279 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -64.02 155.44 64.52 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.794 2.329 . . . . 73.2 112.483 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.51 130.48 31.89 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.273 1.982 . . . . 61.51 111.804 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.3 mtp-105 49.7 71.23 0.41 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.514 1.526 . . . . 64.12 113.266 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.442 HG23 ' HD2' ' A' ' 231' ' ' ARG . 98.7 m -87.45 142.74 27.64 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.884 -1.053 . . . . 65.55 111.1 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -103.06 154.67 19.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.001 0.92 . . . . 74.41 110.604 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.529 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -78.72 155.41 29.4 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.452 -1.249 . . . . 71.15 110.615 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.03 -13.02 52.69 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 111.594 -0.602 . . . . 63.45 111.594 -173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.442 ' HD2' HG23 ' A' ' 227' ' ' THR . 68.0 mtt85 -70.43 -176.34 1.21 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.04 0.936 . . . . 72.33 110.55 170.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.608 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 10.3 ptmt -167.57 156.32 9.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.341 0.256 . . . . 72.14 110.573 171.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.559 HD12 HD11 ' A' ' 251' ' ' LEU . 73.5 mt -87.51 151.58 22.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.509 -0.552 . . . . 63.23 109.509 168.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -119.85 105.87 11.52 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.335 -1.357 . . . . 73.45 107.335 168.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 67.6 mt -114.19 117.04 30.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.281 0.633 . . . . 74.44 110.698 -170.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -84.99 133.36 34.26 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 116.275 -0.42 . . . . 43.12 111.287 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.27 1.11 89.89 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 114.884 -1.053 . . . . 74.13 113.77 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 47.6 mmtm -98.02 -0.38 44.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.384 0.674 . . . . 70.42 112.523 -174.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.86 -172.35 48.36 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 111.18 -0.768 . . . . 71.43 111.18 167.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -65.17 142.61 98.61 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-N 117.24 0.52 . . . . 75.33 111.541 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.92 133.7 34.59 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.853 2.368 . . . . 54.43 112.093 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.42 172.92 21.65 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 119.436 -0.647 . . . . 45.51 113.192 -176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.68 -23.33 26.72 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.097 2.531 . . . . 63.32 112.543 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.71 22.26 8.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.958 0.903 . . . . 74.32 110.751 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 94.9 -173.36 31.87 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 110.471 -1.052 . . . . 70.12 110.471 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -84.11 158.35 21.41 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 117.417 0.608 . . . . 73.31 110.883 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.78 -164.66 38.61 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.502 -0.772 . . . . 64.44 111.933 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -124.57 164.47 19.75 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.583 0.706 . . . . 64.22 110.634 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.0 tp -123.01 108.56 13.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.078 -0.964 . . . . 73.42 108.613 -171.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.608 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 33.3 m-85 -100.53 112.75 25.16 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.091 -1.448 . . . . 73.42 107.091 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.627 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.6 pp -127.86 115.81 19.18 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.498 0.925 . . . . 74.15 113.498 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -67.64 117.65 9.86 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.556 -1.202 . . . . 73.04 112.05 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.599 HG23 ' HA ' ' A' ' 232' ' ' LYS . 95.1 t -68.82 116.73 9.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 125.167 1.387 . . . . 75.14 111.509 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . 0.418 ' HG2' HG23 ' A' ' 196' ' ' THR . 24.7 mmt85 -106.65 117.03 32.99 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.355 -1.293 . . . . 64.3 108.803 170.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.542 HD13 HG13 ' A' ' 199' ' ' VAL . 42.3 mm -79.1 96.28 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 106.529 -1.656 . . . . 51.42 106.529 168.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.26 1.651 0 CA-C-O 117.31 -1.329 . . . . 60.43 108.64 -174.718 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.57 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 16.8 m . . . . . 0 CA--C 1.556 1.174 0 CA-C-O 121.745 0.783 . . . . 62.42 110.78 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.54 -176.0 6.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.298 1.039 . . . . 71.4 113.045 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -106.15 -88.95 2.07 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 114.473 -1.24 . . . . 73.01 110.269 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -146.98 153.66 40.32 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 112.734 0.642 . . . . 72.41 112.734 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.454 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 34.3 m95 . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 124.275 1.03 . . . . 74.23 109.993 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 . . . . . 0 C--O 1.238 0.496 0 CA-C-O 120.734 0.302 . . . . 73.32 110.976 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 74.5 mt -120.9 145.33 47.78 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.572 0.749 . . . . 74.31 110.89 -176.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 31.2 t80 -102.26 132.39 48.24 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.68 0.792 . . . . 72.13 109.082 172.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -138.05 -171.84 3.12 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.383 0.673 . . . . 71.54 109.536 173.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 95.8 m -131.04 109.2 10.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.457 0.703 . . . . 72.24 111.14 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.584 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 16.3 tp -72.88 105.29 4.33 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.171 -1.048 . . . . 63.12 108.171 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -80.26 99.58 7.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.968 -1.015 . . . . 71.25 108.867 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 210' ' ' VAL . 13.6 t -113.96 106.44 53.41 Favored Pre-proline 0 N--CA 1.472 0.666 0 N-CA-C 108.362 -0.977 . . . . 61.05 108.362 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.29 152.77 78.78 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.414 1.41 . . . . 72.44 110.495 174.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.18 -45.86 75.95 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 114.017 1.117 . . . . 24.52 114.017 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.72 -48.2 17.87 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 121.76 1.64 . . . . 72.23 112.9 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.463 HG21 HG13 ' A' ' 210' ' ' VAL . 50.0 mt -67.75 -33.68 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.332 0.653 . . . . 54.33 110.973 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.31 87.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.045 -0.525 . . . . 73.44 110.473 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.05 -47.74 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.415 1.086 . . . . 53.32 111.495 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.99 -32.19 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-O 120.775 0.321 . . . . 64.54 110.729 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.84 68.58 1.41 Allowed Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.789 -0.642 . . . . 72.52 112.047 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.91 -123.99 5.33 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 112.523 -0.231 . . . . 75.14 112.523 -175.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -142.49 143.68 32.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.747 0.819 . . . . 61.21 109.713 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.721 HG21 HG22 ' A' ' 199' ' ' VAL . 28.8 m -140.79 151.66 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.423 0.689 . . . . 72.34 111.114 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -78.22 150.22 33.5 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.862 0.865 . . . . 61.22 111.399 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -130.63 114.21 15.15 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.375 1.47 . . . . 52.2 109.001 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -64.11 124.03 20.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.653 0.781 . . . . 75.32 110.781 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 215' ' ' LEU . 0.2 OUTLIER -111.54 -169.66 1.5 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.936 1.294 . . . . 71.0 108.095 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.466 ' H ' HG22 ' A' ' 214' ' ' THR . 7.8 mt -45.81 -70.33 0.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.863 1.265 . . . . 63.22 112.001 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -113.29 -43.56 3.34 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 113.892 -1.504 . . . . 45.04 110.84 -168.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -114.9 -179.25 18.72 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 115.646 -0.706 . . . . 52.24 112.426 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -92.65 164.07 2.81 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.213 1.942 . . . . 52.15 113.968 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 12.7 t -121.47 168.79 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 106.173 -1.788 . . . . 72.25 106.173 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.57 ' H ' ' HB ' ' A' ' 172' ' ' THR . 13.5 tt0 -148.67 143.28 26.39 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.116 -1.068 . . . . 72.03 108.116 173.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.409 HG11 HD21 ' A' ' 197' ' ' LEU . 13.3 p -136.35 143.12 36.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 C-N-CA 123.256 0.623 . . . . 75.35 111.475 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.14 110.29 8.32 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.408 1.083 . . . . 74.33 109.73 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 79.9 t -77.16 134.92 66.87 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 123.888 0.875 . . . . 54.32 109.852 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.0 155.64 61.5 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.904 2.402 . . . . 54.2 112.249 169.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.35 132.34 45.88 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.978 2.452 . . . . 73.22 112.134 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 49.58 73.27 0.25 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.376 1.47 . . . . 72.2 113.105 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.0 m -89.56 142.26 27.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.504 -1.226 . . . . 52.23 111.069 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -105.45 158.37 16.71 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.107 0.963 . . . . 70.34 110.383 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.455 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.26 148.73 28.22 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.22 -1.354 . . . . 64.24 110.411 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.46 -28.74 8.03 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 110.843 -0.903 . . . . 72.22 110.843 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.433 ' HD2' HG23 ' A' ' 227' ' ' THR . 75.1 mtt85 -58.92 171.72 0.64 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.078 0.951 . . . . 73.32 110.645 165.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.467 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.9 ptmt -165.89 149.84 7.98 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.126 0.266 . . . . 73.15 110.691 172.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.713 HD12 HD11 ' A' ' 251' ' ' LEU . 84.1 mt -79.49 155.64 28.17 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 123.532 0.52 . . . . 74.34 109.715 171.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -126.58 106.66 9.58 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.405 -1.332 . . . . 74.11 107.405 169.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 39.4 mt -105.32 112.21 25.23 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.531 -0.759 . . . . 61.31 110.045 -172.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -77.18 117.44 18.72 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.429 -1.26 . . . . 60.3 111.0 -171.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 92.55 -4.73 76.67 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.329 1.018 . . . . 72.53 113.612 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.459 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 33.9 mmtp -95.58 5.62 51.02 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.588 0.755 . . . . 61.13 112.518 -172.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.95 -178.28 50.04 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 110.81 -0.916 . . . . 45.32 110.81 166.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.48 138.22 96.44 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-N 117.402 0.601 . . . . 65.45 111.476 -174.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.49 143.62 69.98 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.316 2.677 . . . . 75.5 112.949 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.67 -178.67 15.82 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 115.844 -0.616 . . . . 73.32 113.61 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.04 -49.76 3.56 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.598 2.865 . . . . 62.13 113.393 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.28 -34.01 37.3 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 122.92 0.488 . . . . 72.44 110.989 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.32 179.88 46.14 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 114.766 -1.107 . . . . 52.4 111.391 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -79.0 168.37 19.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.523 0.729 . . . . 73.44 110.899 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.21 -167.58 39.93 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.608 -0.724 . . . . 40.05 112.063 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -119.91 171.0 8.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 122.238 -0.566 . . . . 65.31 109.873 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 43.8 tp -129.41 108.73 10.51 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.57 0.7 . . . . 65.12 110.682 -174.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 46.0 m-85 -100.11 110.5 22.78 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.141 -1.059 . . . . 65.01 108.141 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 233' ' ' LEU . 3.1 pp -125.66 114.99 19.4 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.435 0.636 . . . . 74.23 112.417 -173.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -70.15 120.29 15.63 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 114.689 -1.141 . . . . 63.42 113.452 -170.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.584 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 48.4 t -65.1 126.83 24.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 113.89 -1.505 . . . . 65.42 110.031 174.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -129.67 128.23 42.14 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.045 1.338 . . . . 74.31 108.975 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.455 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 29.2 mm -95.92 104.4 15.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.183 -1.043 . . . . 74.53 108.183 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.293 0 CA-C-O 117.386 -1.292 . . . . 62.13 108.783 -168.878 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 19.1 m . . . . . 0 CA--C 1.554 1.123 0 CA-C-O 120.863 0.363 . . . . 52.34 111.395 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.79 160.85 14.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.854 0.862 . . . . 74.3 111.904 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . 0.51 ' H ' HD22 ' A' ' 235' ' ' LEU . . . -73.35 -108.41 0.07 OUTLIER Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.31 -0.859 . . . . 65.34 111.203 166.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -138.77 176.74 8.44 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.749 0.774 . . . . 42.24 111.716 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 29.6 m95 . . . . . 0 C--O 1.239 0.527 0 CA-C-N 114.601 -1.181 . . . . 64.22 110.25 177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 110.143 -0.317 . . . . 63.42 110.143 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.3 mt -119.35 160.62 21.92 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.656 0.782 . . . . 74.3 110.914 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 4.4 t80 -121.77 108.33 13.37 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.188 -0.671 . . . . 74.04 109.188 171.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -116.8 -170.85 1.91 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.42 1.088 . . . . 52.25 109.5 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.9 m -119.12 126.04 50.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.985 0.914 . . . . 72.14 110.429 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.601 ' HB2' HD13 ' A' ' 251' ' ' LEU . 25.2 tp -84.51 104.76 14.79 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 107.769 -1.197 . . . . 54.11 107.769 166.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -86.95 106.39 17.77 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.165 -0.68 . . . . 74.33 109.165 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.652 HG22 HG21 ' A' ' 210' ' ' VAL . 21.7 t -114.13 120.76 37.92 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.65 -0.87 . . . . 71.44 108.65 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.89 150.61 61.63 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 121.77 1.646 . . . . 52.12 110.217 170.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.67 -45.24 96.6 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 117.808 -1.091 . . . . 64.11 112.834 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.2 Cg_endo -56.26 -50.36 12.33 Favored 'Trans proline' 0 C--N 1.401 3.294 0 C-N-CA 122.077 1.851 . . . . 60.11 112.87 177.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.449 HG21 HG13 ' A' ' 210' ' ' VAL . 28.1 mt -64.74 -34.49 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.41 0.684 . . . . 74.4 110.626 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.61 95.65 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.072 -0.513 . . . . 44.03 111.137 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.4 t -73.92 -49.78 32.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 123.982 0.913 . . . . 70.5 111.844 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.2 -28.45 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.373 0.269 . . . . 74.3 110.878 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.15 77.79 1.18 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.993 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.01 -137.28 8.2 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.725 -0.486 . . . . 64.22 112.0 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -133.77 139.84 46.58 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.801 0.8 . . . . 73.21 109.806 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.652 HG21 HG22 ' A' ' 199' ' ' VAL . 35.6 m -133.4 153.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.229 0.612 . . . . 53.52 111.064 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.428 ' HG2' ' N ' ' A' ' 212' ' ' ALA . 22.9 ttm180 -75.73 154.54 36.34 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.905 0.882 . . . . 73.25 110.716 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -132.23 120.76 22.63 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.521 1.528 . . . . 64.32 108.383 176.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.06 132.23 48.65 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.766 0.827 . . . . 74.1 110.467 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.661 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -136.14 -172.72 3.2 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.663 0.785 . . . . 54.54 110.162 -175.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.618 ' H ' HG22 ' A' ' 214' ' ' THR . 6.4 mt -63.78 -67.41 0.43 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.298 1.439 . . . . 73.12 110.671 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -103.74 -41.55 5.89 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 113.322 -1.763 . . . . 73.34 111.554 -162.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -150.7 154.02 25.36 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.046 -0.863 . . . . 61.34 111.76 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.16 142.0 30.11 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.603 2.202 . . . . 70.13 113.55 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 73.1 t -95.62 163.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 114.471 -1.241 . . . . 63.23 108.286 175.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -142.81 136.92 29.29 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.371 -1.344 . . . . 74.32 107.371 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.457 HG11 HD11 ' A' ' 233' ' ' LEU . 12.3 p -132.26 140.38 47.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.481 0.712 . . . . 64.25 110.688 -172.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.31 109.42 9.99 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.063 0.945 . . . . 75.34 109.323 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.1 t -73.73 131.02 82.52 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.212 1.005 . . . . 63.55 109.388 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.88 155.2 58.16 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.433 2.089 . . . . 52.34 111.05 171.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.55 136.23 53.33 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.314 2.009 . . . . 61.22 112.7 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 51.66 69.25 0.68 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.646 1.579 . . . . 73.44 112.706 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.443 HG23 ' HD2' ' A' ' 231' ' ' ARG . 69.8 m -85.03 141.08 30.54 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.85 -1.068 . . . . 72.52 110.613 174.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -102.16 155.63 18.08 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.78 0.832 . . . . 54.2 110.1 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.495 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -83.91 154.83 23.18 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.652 -1.158 . . . . 62.21 111.212 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.88 -6.78 57.06 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.935 -0.575 . . . . 51.55 111.933 -173.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.443 ' HD2' HG23 ' A' ' 227' ' ' THR . 65.9 mtt85 -72.09 179.47 3.28 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.916 0.886 . . . . 71.43 109.722 168.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.462 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.2 ptpt -168.27 150.94 5.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.882 0.473 . . . . 62.12 110.464 169.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.489 ' HG ' HD22 ' A' ' 197' ' ' LEU . 56.9 mt -85.18 156.03 21.18 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.751 -0.833 . . . . 65.24 108.751 169.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -115.32 123.74 49.51 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 106.459 -1.682 . . . . 53.23 106.459 157.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.659 HD12 HD23 ' A' ' 249' ' ' LEU . 46.5 mt -112.21 108.18 17.33 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.898 -0.779 . . . . 72.31 108.898 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -70.41 113.2 7.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.136 -1.393 . . . . 74.45 111.443 -170.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 91.74 -5.88 79.71 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.248 -0.887 . . . . 52.24 113.771 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.661 ' HD2' HG21 ' A' ' 214' ' ' THR . 48.4 mmtm -86.87 10.08 17.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.405 0.682 . . . . 72.13 112.213 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.16 169.56 24.07 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.786 -1.326 . . . . 74.02 109.786 164.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 41.4 m-85 -57.22 139.51 79.57 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 123.363 0.665 . . . . 52.14 112.129 -173.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 11.7 Cg_exo -69.6 150.04 68.69 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.907 2.405 . . . . 54.34 113.076 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.68 171.95 21.8 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.801 -0.999 . . . . 54.32 111.018 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -61.66 -48.22 9.57 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.988 2.459 . . . . 74.23 113.393 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.57 -19.07 28.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.287 0.635 . . . . 64.24 111.863 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 171.31 169.43 34.24 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.944 -0.462 . . . . 72.11 111.944 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -85.51 170.22 12.84 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.788 0.835 . . . . 64.43 110.864 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.95 179.95 48.73 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.299 -0.864 . . . . 53.54 111.224 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -122.69 153.16 39.78 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.578 -0.527 . . . . 75.53 109.578 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.659 HD23 HD12 ' A' ' 235' ' ' LEU . 48.8 tp -106.2 106.75 17.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.352 -0.61 . . . . 73.33 109.352 -172.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 48.8 m-85 -98.98 109.12 21.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.998 -1.482 . . . . 74.14 106.998 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.647 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -126.55 117.49 22.93 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.95 1.092 . . . . 64.14 113.95 -177.198 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.86 118.78 10.18 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 113.133 -1.849 . . . . 51.3 112.518 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.543 HG22 HD23 ' A' ' 197' ' ' LEU . 52.3 t -69.68 109.49 2.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 114.329 -1.305 . . . . 71.22 110.68 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -100.25 118.17 35.98 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.53 1.132 . . . . 74.34 108.824 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.495 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 39.8 mm -87.26 107.94 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.462 -1.31 . . . . 53.05 107.462 170.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.329 0 C-N-CA 124.301 1.04 . . . . 44.41 108.258 -174.096 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.401 HG22 HG22 ' A' ' 219' ' ' VAL . 17.0 m . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 121.315 0.578 . . . . 75.31 110.633 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.9 -168.79 0.95 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.861 0.865 . . . . 52.04 112.59 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.07 -87.52 1.03 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 110.194 -1.163 . . . . 63.4 110.194 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.27 174.51 10.47 Favored 'General case' 0 C--O 1.248 0.98 0 C-N-CA 123.477 0.711 . . . . 64.55 109.917 172.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.526 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 19.1 m95 . . . . . 0 C--O 1.243 0.751 0 CA-C-N 115.313 -0.858 . . . . 73.14 109.744 167.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 109.692 -0.484 . . . . 63.21 109.692 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 80.5 mt -129.0 166.52 19.05 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.424 0.63 . . . . 71.31 111.747 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 25.4 t80 -120.26 139.37 52.81 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.612 -1.176 . . . . 73.33 109.267 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -151.72 -170.44 3.65 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.003 0.921 . . . . 72.23 109.819 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.4 m -119.72 140.99 49.83 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.695 0.798 . . . . 64.43 110.964 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.536 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 19.5 tp -100.48 108.23 20.14 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.105 0.962 . . . . 73.34 108.413 168.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -83.46 100.1 10.52 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.26 -0.645 . . . . 73.41 109.26 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.652 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.7 t -108.39 115.17 58.42 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 108.334 -0.987 . . . . 54.22 108.334 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.81 145.0 49.94 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 121.571 1.514 . . . . 43.01 110.6 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.27 -47.91 56.35 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 114.252 1.204 . . . . 42.23 114.252 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.79 -45.85 33.64 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 122.235 1.957 . . . . 73.51 113.768 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.2 mt -65.87 -34.92 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.942 0.497 . . . . 72.33 110.535 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.13 -44.39 92.33 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.07 -0.514 . . . . 72.3 111.385 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.3 t -71.03 -46.4 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.99 0.916 . . . . 72.2 112.028 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.03 -28.33 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 120.561 0.219 . . . . 73.1 110.623 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.89 72.3 1.23 Allowed Glycine 0 C--N 1.346 1.084 0 N-CA-C 111.233 -0.747 . . . . 62.41 111.233 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.7 -126.59 5.74 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 112.33 -0.308 . . . . 53.23 112.33 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -142.33 148.02 37.27 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.266 1.027 . . . . 74.44 108.849 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.8 m -142.43 158.89 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 123.134 0.573 . . . . 73.52 110.69 174.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -75.8 151.11 37.59 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.776 0.83 . . . . 75.34 110.18 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -128.2 114.59 17.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 73.34 108.576 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.6 tpt -64.51 109.58 2.01 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.129 0.572 . . . . 73.44 110.933 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.553 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -93.45 -169.1 2.04 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.247 1.419 . . . . 62.1 108.933 175.174 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.55 -69.16 0.12 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.464 1.126 . . . . 64.01 110.581 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.76 -42.52 3.41 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 112.793 -2.003 . . . . 72.32 110.746 -170.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -101.77 176.78 26.38 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.507 -0.769 . . . . 64.12 112.607 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -102.4 145.94 0.22 Allowed 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 122.882 2.388 . . . . 61.44 114.234 168.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.553 HG23 ' OG1' ' A' ' 214' ' ' THR . 50.2 t -104.06 168.79 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.158 1.383 . . . . 55.44 108.055 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -142.04 139.23 32.27 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.094 -1.076 . . . . 71.54 108.094 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.54 HG11 HD11 ' A' ' 233' ' ' LEU . 12.7 p -134.25 144.64 34.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 123.627 0.771 . . . . 62.34 110.153 -173.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.04 113.12 19.02 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.421 0.688 . . . . 62.0 109.373 174.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 89.8 t -76.77 132.14 72.3 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.707 0.803 . . . . 71.12 109.512 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.83 161.34 44.36 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.803 2.335 . . . . 72.52 112.376 171.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.37 131.9 22.78 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.135 1.89 . . . . 74.45 112.315 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 52.79 72.21 0.43 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.998 1.319 . . . . 75.54 112.63 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 97.3 m -91.51 143.59 26.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.636 -1.166 . . . . 41.13 110.915 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -108.51 160.49 15.86 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.264 1.025 . . . . 72.12 110.635 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.528 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -80.07 155.17 27.66 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.991 -1.004 . . . . 65.42 111.264 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.6 -20.95 35.79 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 112.141 -0.384 . . . . 62.01 112.141 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -65.68 178.11 1.09 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.11 0.964 . . . . 72.25 110.551 167.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.574 ' HA ' HG23 ' A' ' 253' ' ' VAL . 12.4 ptmt -167.13 153.95 8.54 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 116.703 -0.226 . . . . 74.13 110.955 173.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.706 HD12 HD11 ' A' ' 251' ' ' LEU . 75.2 mt -84.23 152.03 24.45 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.862 -0.422 . . . . 71.51 109.862 170.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -117.8 107.18 13.83 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.354 -1.35 . . . . 73.13 107.354 161.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 65.4 mt -102.97 107.92 18.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.085 -0.961 . . . . 74.34 109.725 -173.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -78.61 120.7 23.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.635 -1.166 . . . . 74.13 111.426 -165.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.91 18.98 80.14 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.502 1.126 . . . . 74.24 113.761 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.44 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 43.4 mmtm -105.09 3.34 30.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.047 0.539 . . . . 73.44 111.842 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -83.75 -172.57 48.99 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 111.087 -0.805 . . . . 74.11 111.087 168.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 10.2 m-85 -62.04 137.0 95.49 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 117.213 0.506 . . . . 71.21 111.802 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.55 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 15.0 Cg_exo -69.64 143.72 52.37 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.038 2.492 . . . . 62.24 112.257 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.57 173.33 20.9 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.109 -0.95 . . . . 73.34 112.12 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.83 -14.29 26.74 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 123.106 2.537 . . . . 73.12 113.415 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.61 -17.94 12.91 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.837 0.855 . . . . 51.25 111.957 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 162.46 -162.13 34.16 Favored Glycine 0 C--O 1.221 -0.719 0 N-CA-C 109.52 -1.432 . . . . 61.12 109.52 -173.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.55 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 99.0 mtt180 -115.61 160.37 20.09 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 118.511 1.156 . . . . 71.43 110.67 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 177.28 54.34 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.348 -0.842 . . . . 55.11 111.765 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -119.31 143.14 47.53 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.367 0.603 . . . . 75.14 109.72 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 51.7 tp -102.4 108.04 19.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.438 -0.801 . . . . 74.1 110.006 -168.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 53.6 m-85 -100.58 106.6 18.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.916 -1.038 . . . . 75.41 108.776 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.706 HD11 HD12 ' A' ' 233' ' ' LEU . 1.8 pp -124.47 118.57 26.93 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.58 0.955 . . . . 25.41 113.58 -174.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.77 116.13 8.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.405 1.482 . . . . 72.34 112.488 -172.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 232' ' ' LYS . 59.4 t -64.24 118.85 7.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-N 114.092 -1.413 . . . . 75.43 111.081 175.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -114.32 117.51 31.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.431 1.492 . . . . 71.22 108.576 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.528 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 36.6 mm -87.82 106.75 16.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.088 -1.079 . . . . 45.42 108.088 172.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.259 1.581 0 C-N-CA 124.615 1.166 . . . . 64.14 108.131 -171.833 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.7 m . . . . . 0 CA--C 1.548 0.892 0 CA-C-O 121.78 0.8 . . . . 62.25 108.904 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -91.86 164.03 13.82 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.013 -0.994 . . . . 72.34 110.871 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -99.08 -88.82 1.97 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 111.34 -0.704 . . . . 51.03 111.34 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.23 159.67 41.77 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.114 0.966 . . . . 72.05 110.232 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.545 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.0 m95 . . . . . 0 CA--C 1.544 0.728 0 CA-C-N 115.473 -0.785 . . . . 64.02 109.201 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 . . . . . 0 C--O 1.239 0.543 0 N-CA-C 110.097 -0.335 . . . . 71.34 110.097 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.5 mt -121.2 146.05 47.19 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.917 0.487 . . . . 75.13 111.762 -171.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -99.56 111.0 23.4 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.005 -0.998 . . . . 74.22 108.487 171.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.39 -170.45 1.98 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.416 1.086 . . . . 74.14 109.752 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.3 m -120.87 138.92 53.84 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 124.274 1.03 . . . . 74.0 111.07 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.8 tp -94.56 107.0 19.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.2 -1.037 . . . . 64.44 108.2 168.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 210' ' ' VAL . 14.3 t70 -80.52 109.08 14.7 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.983 -0.747 . . . . 61.4 108.983 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 255' ' ' ILE . 0.9 OUTLIER -132.23 118.36 16.12 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 122.68 0.392 . . . . 74.05 110.191 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 53.9 Cg_endo -70.62 148.08 58.73 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.982 1.788 . . . . 50.32 111.373 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.37 -45.6 83.82 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.495 1.118 . . . . 74.31 113.945 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.9 Cg_exo -56.07 -47.48 24.45 Favored 'Trans proline' 0 C--N 1.396 3.052 0 C-N-CA 122.065 1.844 . . . . 55.42 113.034 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.41 HG21 HG13 ' A' ' 210' ' ' VAL . 25.8 mt -64.57 -37.33 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.406 0.682 . . . . 72.31 110.717 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.81 -43.74 97.79 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.045 0.538 . . . . 53.13 110.867 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.3 -48.69 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.405 1.082 . . . . 74.24 112.031 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.5 p -79.48 -32.09 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 117.955 0.343 . . . . 73.14 111.192 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.86 106.17 1.35 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.474 -0.65 . . . . 33.31 111.474 -171.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.48 -138.13 3.6 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 119.518 -0.601 . . . . 72.33 111.883 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -138.98 137.3 36.25 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.693 0.797 . . . . 74.54 109.402 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.502 HG21 ' HB ' ' A' ' 199' ' ' VAL . 24.3 m -137.54 153.3 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.92 0.488 . . . . 33.1 111.19 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -76.91 139.05 40.08 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.559 -0.746 . . . . 61.3 111.132 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.561 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -111.76 111.43 22.4 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.154 -1.425 . . . . 73.0 107.154 170.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -69.13 114.12 7.12 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.071 0.548 . . . . 61.43 109.888 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.562 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -108.38 -173.12 2.2 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.311 1.044 . . . . 73.41 109.432 178.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.519 ' H ' HG22 ' A' ' 214' ' ' THR . 7.3 mt -56.42 -69.06 0.16 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.505 1.522 . . . . 74.15 111.7 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.83 -43.59 3.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 113.67 -1.605 . . . . 73.24 110.843 -168.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -123.9 133.65 8.9 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.545 -1.141 . . . . 65.34 111.132 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.49 150.65 58.1 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.342 2.028 . . . . 75.14 112.57 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 53.2 t -104.31 168.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.121 1.368 . . . . 75.45 107.856 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -148.64 135.23 19.67 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.438 -0.949 . . . . 75.44 108.438 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.434 HG21 HD21 ' A' ' 233' ' ' LEU . 11.8 p -126.56 139.34 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.509 0.724 . . . . 71.34 110.6 -173.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.02 104.35 3.53 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.522 -0.763 . . . . 64.53 109.076 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.43 123.99 90.22 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.141 -0.936 . . . . 74.12 108.789 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.03 158.67 42.36 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.773 2.316 . . . . 71.5 111.552 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.45 142.44 90.55 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.222 1.948 . . . . 70.4 111.932 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 46.67 64.9 1.35 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.8 1.64 . . . . 75.33 113.545 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.464 HG23 ' HD2' ' A' ' 231' ' ' ARG . 90.9 m -93.87 137.98 32.51 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.532 -1.213 . . . . 72.1 110.501 175.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.464 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 25.9 mp0 -104.25 163.58 12.32 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.854 0.862 . . . . 60.22 110.24 175.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.538 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -84.27 154.84 22.74 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.29 -1.323 . . . . 52.43 111.002 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.62 -15.59 49.08 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 123.459 0.474 . . . . 71.22 111.93 -172.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.464 ' NH1' ' H ' ' A' ' 228' ' ' GLN . 81.1 mtt85 -68.57 -179.35 1.35 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.974 0.909 . . . . 64.34 109.553 164.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.484 ' HA ' HG23 ' A' ' 253' ' ' VAL . 4.8 ptmt -169.24 147.74 3.81 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 119.288 -0.387 . . . . 75.55 110.323 176.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.601 HD12 HD11 ' A' ' 251' ' ' LEU . 88.7 mt -79.34 152.79 30.25 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.671 -0.492 . . . . 73.14 109.671 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -115.88 113.42 23.31 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 107.156 -1.424 . . . . 75.24 107.156 160.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 57.3 mt -113.3 109.96 19.59 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.908 -0.775 . . . . 74.4 108.908 -177.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -86.91 117.08 25.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.316 -0.856 . . . . 74.15 110.879 -167.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 89.83 10.84 64.38 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.197 0.936 . . . . 44.43 113.598 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 39.1 mmtm -98.54 -5.01 32.96 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.814 1.042 . . . . 74.22 113.814 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -83.49 -172.23 48.53 Favored Glycine 0 N--CA 1.479 1.505 0 CA-C-O 119.79 -0.45 . . . . 73.11 112.586 171.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -56.89 133.48 79.5 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.458 0.703 . . . . 73.02 111.964 -175.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.13 145.37 72.81 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.988 2.458 . . . . 72.24 111.944 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.4 177.08 19.04 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.971 -0.559 . . . . 72.32 112.899 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.09 -26.32 18.31 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 123.213 2.608 . . . . 73.25 113.41 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.73 -30.87 14.66 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.518 0.727 . . . . 74.02 111.699 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.07 -132.03 1.59 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 111.214 -0.755 . . . . 70.1 111.214 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -140.22 147.03 39.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.786 1.235 . . . . 70.23 108.784 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.93 177.31 42.13 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.897 0.748 . . . . 75.3 111.585 174.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -108.12 -177.64 3.39 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.144 0.577 . . . . 75.13 110.424 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.1 tp -141.3 106.21 4.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.514 0.673 . . . . 63.02 110.454 -176.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 38.3 m-85 -103.6 111.71 24.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.784 -1.561 . . . . 73.44 106.784 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.9 pp -124.08 118.06 26.08 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.57 0.952 . . . . 71.31 113.57 -173.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.61 119.24 12.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.751 1.62 . . . . 64.55 112.002 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.545 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 97.9 t -67.74 122.83 19.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 125.125 1.37 . . . . 74.53 111.073 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -118.67 111.54 18.65 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.2 1.4 . . . . 73.34 108.652 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.538 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 24.1 mm -81.84 96.81 3.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 107.586 -1.264 . . . . 60.12 107.586 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.252 1.228 0 C-N-CA 124.922 1.289 . . . . 64.1 108.451 -178.088 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 121.05 0.453 . . . . 54.3 111.942 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -80.02 158.22 26.57 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.5 0.72 . . . . 70.01 112.073 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.92 -82.4 0.85 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 110.609 -0.997 . . . . 54.4 110.609 170.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.45 170.6 22.06 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.435 0.694 . . . . 74.35 111.147 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.614 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 48.2 m95 . . . . . 0 N--CA 1.469 0.495 0 N-CA-C 107.827 -1.175 . . . . 75.5 107.827 171.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 5.9 p-10 . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 120.816 0.341 . . . . 65.01 110.315 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.1 mt -113.5 164.36 13.73 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.436 0.636 . . . . 71.23 112.648 -164.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -114.49 125.53 53.92 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.611 -1.177 . . . . 74.3 108.523 167.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -135.66 -171.53 2.87 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.977 0.911 . . . . 70.4 109.467 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.1 m -117.93 138.49 52.11 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.945 0.898 . . . . 54.4 110.494 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.613 ' HB2' HD13 ' A' ' 251' ' ' LEU . 21.8 tp -93.74 128.82 40.16 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.06 -1.089 . . . . 13.24 108.06 165.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.08 100.37 11.69 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.611 -0.514 . . . . 73.23 109.611 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.634 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.9 t -111.1 108.81 57.26 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 108.444 -0.947 . . . . 74.44 108.444 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.17 144.57 63.5 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 121.491 1.461 . . . . 74.35 110.082 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.16 -45.9 65.48 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 114.083 1.142 . . . . 73.44 114.083 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.08 -47.16 24.15 Favored 'Trans proline' 0 C--N 1.392 2.851 0 C-N-CA 122.104 1.869 . . . . 62.3 113.744 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.2 mt -64.19 -36.96 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 122.736 0.414 . . . . 74.15 110.567 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.37 94.43 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.951 0.501 . . . . 43.41 111.088 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.0 t -72.3 -50.69 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 124.32 1.013 . . . . 74.54 112.097 -175.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.78 -21.54 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-O 120.851 0.358 . . . . 42.34 110.899 -176.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.36 84.87 0.53 Allowed Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.996 -0.547 . . . . 72.05 112.1 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.94 -136.82 5.99 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.839 -0.504 . . . . 64.21 111.839 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -127.54 151.33 49.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.862 0.865 . . . . 61.21 109.212 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.634 HG11 ' HA ' ' A' ' 199' ' ' VAL . 28.3 m -140.36 150.18 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.294 0.638 . . . . 73.23 110.31 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -77.24 138.89 39.68 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 123.621 0.575 . . . . 72.31 110.426 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.645 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -109.26 114.71 28.63 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.748 -1.575 . . . . 65.1 106.748 171.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.0 tpt -64.69 126.12 26.91 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.035 0.534 . . . . 62.43 109.691 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.98 -168.98 2.08 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.687 1.195 . . . . 71.14 109.74 -172.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.4 mt -82.22 -68.73 0.67 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.141 0.972 . . . . 72.25 109.904 -171.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -98.24 -40.78 8.19 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 112.972 -1.922 . . . . 74.23 109.845 -165.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -145.34 134.29 5.45 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-O 118.448 -1.196 . . . . 62.32 110.242 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.0 144.21 52.01 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.764 2.31 . . . . 75.42 112.345 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 55.3 t -96.79 168.5 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 125.231 1.413 . . . . 63.14 108.994 -177.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -148.26 127.92 13.32 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.869 -0.789 . . . . 74.11 108.869 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.6 p -118.13 143.3 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.472 0.709 . . . . 52.5 109.892 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.46 108.64 7.36 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.853 -0.795 . . . . 73.51 108.853 170.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.497 ' HA ' ' HZ2' ' A' ' 176' ' ' TRP . 71.1 t -73.61 128.33 87.21 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.737 0.815 . . . . 61.31 109.821 173.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.62 157.47 60.56 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.704 2.269 . . . . 73.42 111.411 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.18 134.6 56.87 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.466 2.11 . . . . 53.22 112.509 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 51.24 67.32 0.97 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.76 1.624 . . . . 74.42 112.823 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.47 HG23 ' HD2' ' A' ' 231' ' ' ARG . 54.9 m -88.79 140.16 29.73 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.694 -1.139 . . . . 54.51 110.549 173.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.444 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 28.2 mp0 -100.78 157.52 16.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.074 0.95 . . . . 73.41 111.156 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.494 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -80.2 155.28 27.46 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.447 -1.251 . . . . 44.42 110.239 176.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.48 29.86 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 111.649 -0.58 . . . . 64.33 111.649 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.47 ' HD2' HG23 ' A' ' 227' ' ' THR . 73.7 mtt85 -62.23 178.18 0.41 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.688 0.795 . . . . 71.21 110.559 168.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.4 ptmt -166.17 147.24 6.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.752 -0.462 . . . . 74.44 109.752 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.581 HD12 HD11 ' A' ' 251' ' ' LEU . 88.8 mt -79.32 147.63 32.39 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.911 -0.774 . . . . 73.12 108.911 169.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -108.57 121.39 44.89 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.006 -1.479 . . . . 73.35 107.006 158.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 80.4 mt -118.28 110.92 18.1 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.365 -0.606 . . . . 63.32 109.365 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -79.02 119.28 21.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 73.4 110.922 -167.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.34 13.78 77.93 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.454 1.096 . . . . 44.12 113.948 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.3 mmtt -102.65 8.57 39.63 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 117.512 0.656 . . . . 61.12 112.665 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.82 172.55 32.66 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 110.644 -0.982 . . . . 63.24 110.644 168.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -55.42 146.09 44.81 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-N 117.652 0.726 . . . . 65.3 112.31 -173.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 24.5 Cg_exo -60.31 141.29 95.43 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.933 2.422 . . . . 74.21 112.272 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -130.26 171.72 20.49 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.958 -1.019 . . . . 71.11 111.842 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.68 -32.21 38.46 Favored 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 123.014 2.476 . . . . 60.42 112.793 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.57 -7.36 41.3 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.583 0.753 . . . . 73.44 111.387 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 135.55 177.08 14.71 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.218 -0.753 . . . . 33.2 111.218 -177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 61.8 mtm-85 -69.44 155.77 39.91 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.406 0.682 . . . . 61.15 112.206 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.12 -172.04 47.04 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.525 -0.761 . . . . 35.05 111.976 173.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.525 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 12.7 m-20 -115.12 149.08 38.15 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.366 0.666 . . . . 55.51 110.115 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.2 tp -106.53 108.47 19.99 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.348 0.594 . . . . 62.02 109.84 -170.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 54.0 m-85 -101.65 101.85 12.44 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.213 -1.032 . . . . 75.33 108.213 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.2 pp -118.68 119.34 34.15 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.429 0.9 . . . . 73.44 113.429 -173.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -67.68 116.96 8.97 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.118 0.967 . . . . 72.44 111.936 -174.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.614 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 94.1 t -63.93 116.77 3.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 113.691 -1.595 . . . . 53.22 110.717 174.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -111.9 125.16 53.74 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.343 -1.298 . . . . 74.45 108.645 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.494 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 29.8 mm -91.15 108.83 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.455 -1.313 . . . . 73.52 107.455 173.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.253 1.257 0 CA-C-O 117.766 -1.112 . . . . 73.33 108.551 -171.458 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.445 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 7.5 m . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 121.55 0.691 . . . . 71.31 111.595 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.85 176.27 6.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.03 0.932 . . . . 64.01 111.851 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.19 -129.23 6.18 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.25 -0.74 . . . . 21.21 111.25 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.57 158.05 17.81 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.087 0.555 . . . . 64.21 111.124 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.515 ' CZ3' HG21 ' A' ' 227' ' ' THR . 31.1 m95 . . . . . 0 N--CA 1.469 0.512 0 N-CA-C 108.581 -0.896 . . . . 74.33 108.581 165.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 109.635 -0.506 . . . . 73.02 109.635 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 77.0 mt -128.43 158.67 37.67 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.375 0.607 . . . . 64.34 112.261 -177.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 11.6 t80 -121.14 126.0 48.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.687 -1.142 . . . . 65.04 108.679 171.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -136.18 -173.81 3.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.953 0.901 . . . . 73.4 109.274 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.8 m -126.37 117.47 23.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.548 0.739 . . . . 73.44 110.599 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.55 HD23 HG22 ' A' ' 253' ' ' VAL . 18.4 tp -76.92 105.88 8.26 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.58 -0.896 . . . . 72.21 108.58 171.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.21 101.86 12.19 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.658 -0.867 . . . . 63.43 108.658 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.667 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.3 t -110.64 115.03 54.24 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.089 -1.078 . . . . 73.11 108.089 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.03 148.93 70.88 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.558 1.506 . . . . 75.43 110.194 171.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.455 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -54.11 -40.07 79.05 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 124.014 0.926 . . . . 64.31 113.4 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 10.9 Cg_endo -54.14 -51.4 10.73 Favored 'Trans proline' 0 C--N 1.395 3.013 0 C-N-CA 122.17 1.913 . . . . 75.23 113.534 172.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.459 HG21 HG13 ' A' ' 210' ' ' VAL . 49.3 mt -64.8 -36.2 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.25 0.62 . . . . 72.22 110.979 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.401 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -65.13 -44.08 89.86 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.936 -0.575 . . . . 71.11 111.656 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.71 -51.03 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.767 0.827 . . . . 73.23 111.805 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.93 -23.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 120.494 0.188 . . . . 64.21 110.932 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.97 77.95 1.07 Allowed Glycine 0 C--N 1.349 1.305 0 N-CA-C 111.346 -0.702 . . . . 62.43 111.346 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.13 -139.78 8.41 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.907 -0.477 . . . . 73.14 111.907 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -132.1 146.27 51.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.286 0.634 . . . . 61.23 109.458 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' A' ' 199' ' ' VAL . 28.5 m -134.97 152.9 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 123.658 0.599 . . . . 75.51 109.819 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . 0.511 ' HE ' ' HB3' ' A' ' 218' ' ' PRO . 40.4 ttt-85 -79.15 143.67 35.22 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.593 0.757 . . . . 70.31 109.772 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.75 114.28 26.77 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.677 -1.231 . . . . 74.04 107.677 171.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.91 135.07 54.28 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.866 1.266 . . . . 74.4 111.193 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.686 HG21 ' HE3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -141.48 -170.83 3.18 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.703 0.801 . . . . 75.14 110.515 173.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.535 ' H ' HG22 ' A' ' 214' ' ' THR . 7.1 mt -55.69 -69.54 0.14 Allowed 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.613 1.165 . . . . 72.33 110.815 -172.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -116.37 -42.69 3.0 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.251 -1.795 . . . . 73.51 110.929 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -113.02 132.88 10.96 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 118.656 -1.08 . . . . 72.22 111.717 -175.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . 0.511 ' HB3' ' HE ' ' A' ' 211' ' ' ARG . 74.6 Cg_endo -73.68 -173.95 1.52 Allowed 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.525 2.15 . . . . 72.22 112.682 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 8.5 t -140.05 164.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.36 1.464 . . . . 73.02 107.523 168.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.445 ' H ' ' HB ' ' A' ' 172' ' ' THR . 5.0 tt0 -142.16 127.75 19.07 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.043 -1.095 . . . . 74.11 108.043 170.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 233' ' ' LEU . 13.8 p -120.22 139.75 46.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 123.6 0.76 . . . . 72.11 110.603 -173.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.17 104.87 5.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.818 0.847 . . . . 74.24 109.419 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 204' ' ' ALA . 61.5 t -69.38 128.37 92.38 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.449 0.7 . . . . 72.34 109.335 173.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.51 154.25 74.57 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.057 2.505 . . . . 53.23 112.063 171.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.78 129.38 27.45 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.306 2.004 . . . . 72.11 112.189 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 55.56 74.21 0.39 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.547 1.539 . . . . 72.21 113.081 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . 0.515 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 64.8 m -97.22 144.15 27.32 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.662 -1.154 . . . . 75.34 111.204 175.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -108.53 163.89 12.83 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.561 1.144 . . . . 72.41 110.972 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . 0.472 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -88.15 152.47 21.96 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.642 -1.163 . . . . 71.51 111.427 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.02 -12.84 52.67 Favored Glycine 0 N--CA 1.476 1.31 0 CA-C-N 116.342 -0.39 . . . . 60.53 112.25 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.456 ' HD2' HG23 ' A' ' 227' ' ' THR . 73.3 mtt85 -69.58 178.17 2.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.636 0.774 . . . . 75.21 109.762 166.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.629 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 10.9 ptmt -168.37 157.02 8.77 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.319 0.104 . . . . 71.52 111.15 172.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 251' ' ' LEU . 73.0 mt -93.62 158.8 15.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.003 0.521 . . . . 62.25 109.807 170.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 8.1 ptt-85 -132.61 109.55 9.82 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.914 1.285 . . . . 73.33 108.363 177.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 49.5 mt -120.42 117.15 26.96 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.393 0.677 . . . . 74.03 111.339 -166.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -84.94 134.35 34.25 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.709 -0.678 . . . . 74.44 110.695 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 76.22 10.14 85.47 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 124.219 0.949 . . . . 64.12 113.513 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.686 ' HE3' HG21 ' A' ' 214' ' ' THR . 29.3 mmmt -97.68 -25.15 15.2 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 117.142 0.471 . . . . 72.43 112.232 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -66.09 -172.0 4.19 Favored Glycine 0 CA--C 1.538 1.519 0 O-C-N 123.103 0.252 . . . . 50.12 113.151 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -59.06 138.68 87.82 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 122.696 0.399 . . . . 71.22 111.235 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.535 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 32.2 Cg_exo -59.29 152.66 58.79 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.93 2.42 . . . . 74.11 112.622 175.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.6 -177.77 15.15 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.708 -0.678 . . . . 42.24 112.509 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.12 -40.67 4.52 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 122.732 2.288 . . . . 75.1 112.537 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.47 -10.65 14.88 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.683 0.793 . . . . 63.11 111.854 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.41 166.49 27.56 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 111.467 -0.653 . . . . 72.31 111.467 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.535 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 16.5 mtp180 -85.66 165.58 16.88 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.204 0.602 . . . . 72.31 110.871 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.72 -176.61 46.86 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.342 -0.844 . . . . 62.11 112.826 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.74 169.21 8.65 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.014 0.525 . . . . 72.51 110.935 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 62.7 tp -131.95 108.98 9.73 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.571 -0.74 . . . . 71.24 110.201 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.629 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 13.8 m-30 -98.8 116.91 32.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.125 -1.065 . . . . 71.11 108.125 173.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.6 pp -129.5 116.31 18.76 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.34 0.867 . . . . 63.43 113.34 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.34 123.34 20.5 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 114.751 -1.113 . . . . 75.21 112.506 -174.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.55 HG22 HD23 ' A' ' 197' ' ' LEU . 60.5 t -70.09 125.23 27.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 114.19 -1.368 . . . . 73.0 110.953 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.92 129.9 55.43 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.551 1.14 . . . . 73.34 108.484 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.472 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 40.6 mm -99.97 99.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.552 -1.277 . . . . 74.32 107.552 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.561 1.366 0 CA-C-N 114.37 -1.286 . . . . 70.21 108.952 -167.59 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.488 HG22 HG22 ' A' ' 219' ' ' VAL . 3.4 m . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.026 0.441 . . . . 75.32 109.892 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.03 152.24 18.71 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.634 0.773 . . . . 51.32 111.184 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.64 -102.29 0.06 OUTLIER Glycine 0 C--N 1.351 1.363 0 O-C-N 124.207 0.942 . . . . 74.21 111.482 165.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -136.51 175.77 9.3 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.537 0.735 . . . . 73.43 109.84 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . 0.549 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 14.2 m95 . . . . . 0 C--O 1.24 0.565 0 CA-C-N 115.156 -0.929 . . . . 71.43 109.539 170.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 9.2 p-10 . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 109.464 -0.569 . . . . 50.33 109.464 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.6 mt -113.71 165.4 12.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.538 0.735 . . . . 51.51 111.757 -169.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -118.0 122.18 42.56 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 114.741 -1.118 . . . . 74.22 108.24 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -131.43 -172.98 2.99 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.829 0.852 . . . . 74.34 110.052 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 52.9 m -119.29 149.77 41.24 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.122 0.969 . . . . 75.42 109.706 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.534 ' HB2' HD13 ' A' ' 251' ' ' LEU . 22.2 tp -119.95 104.57 10.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.106 1.362 . . . . 72.24 108.462 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -91.44 99.71 12.61 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.892 0.853 . . . . 62.33 109.109 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.609 HG22 HG21 ' A' ' 210' ' ' VAL . 23.2 t -94.99 119.85 65.28 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 114.555 -1.202 . . . . 72.03 108.282 174.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.68 144.95 61.83 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 121.539 1.493 . . . . 72.34 109.859 173.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.427 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.48 -42.44 75.1 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.501 -1.238 . . . . 50.42 113.147 -175.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.7 Cg_endo -55.96 -51.62 9.18 Favored 'Trans proline' 0 C--N 1.406 3.602 0 C-N-CA 121.94 1.76 . . . . 71.42 112.71 174.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 54.5 mt -65.01 -33.55 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.236 0.615 . . . . 71.13 110.674 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.67 77.14 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.407 0.683 . . . . 62.43 110.898 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.7 t -70.3 -47.12 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.351 1.06 . . . . 62.43 112.281 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.56 -35.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 120.507 0.194 . . . . 45.43 110.761 -174.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.47 105.79 1.13 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.539 -1.024 . . . . 53.21 110.539 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.93 -129.0 2.29 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.689 -0.506 . . . . 65.42 111.859 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 4.9 ttmt -145.15 137.7 26.06 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.608 0.763 . . . . 72.02 109.75 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 199' ' ' VAL . 33.6 m -135.23 155.16 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 122.766 0.427 . . . . 71.1 110.763 175.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -70.65 146.2 50.13 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.016 0.822 . . . . 72.33 110.427 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -123.64 120.75 33.68 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.014 1.326 . . . . 74.33 107.882 172.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -64.76 129.23 39.02 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.987 0.915 . . . . 73.34 110.899 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 -170.91 2.82 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.207 1.003 . . . . 52.43 110.265 -172.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.4 mt -84.87 -66.76 0.86 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.61 1.195 . . . . 61.32 109.639 -171.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -95.65 -33.3 12.4 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 112.675 -2.057 . . . . 71.33 110.856 -165.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -160.68 141.97 7.79 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.354 -1.248 . . . . 72.24 111.294 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.6 142.99 60.72 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.694 2.263 . . . . 51.0 113.001 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 61.6 t -94.06 166.47 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.92 1.288 . . . . 75.13 109.031 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -144.3 136.68 26.59 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.243 -1.391 . . . . 75.51 107.243 171.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' VAL . . . . . 0.555 HG11 HD11 ' A' ' 233' ' ' LEU . 14.4 p -132.88 140.71 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.253 0.621 . . . . 74.34 111.347 -169.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.09 101.17 2.69 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.302 1.041 . . . . 72.21 110.331 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.484 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 92.9 t -72.25 121.66 85.32 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 118.141 -0.933 . . . . 73.23 109.226 175.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.67 154.72 72.57 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.592 2.195 . . . . 75.51 111.783 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.72 130.93 37.3 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.532 2.154 . . . . 74.4 112.769 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 56.15 74.65 0.38 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.813 1.645 . . . . 63.41 112.762 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 97.0 m -90.7 142.09 28.11 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.714 -1.13 . . . . 72.52 111.064 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -107.6 149.71 27.73 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.586 1.154 . . . . 53.22 109.947 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.68 155.28 37.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.188 -0.914 . . . . 73.03 110.545 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.1 -19.84 39.56 Favored Glycine 0 N--CA 1.476 1.311 0 N-CA-C 111.162 -0.775 . . . . 72.43 111.162 -172.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -65.9 179.83 0.83 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.257 1.023 . . . . 74.51 110.599 168.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.515 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.0 ptmt -166.81 152.89 8.27 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 116.176 -0.465 . . . . 74.42 109.992 172.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LEU . . . . . 0.65 HD12 HD11 ' A' ' 251' ' ' LEU . 61.6 mt -81.29 142.71 32.85 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.035 -0.728 . . . . 64.4 109.035 169.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -103.22 104.06 14.16 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.177 -1.416 . . . . 75.45 107.177 158.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . 0.566 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 50.6 mt -102.43 113.51 26.9 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 114.939 -1.028 . . . . 74.52 109.009 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -82.18 125.79 31.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.316 -0.856 . . . . 71.24 110.142 -172.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.64 25.3 75.67 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 124.448 1.092 . . . . 45.01 113.804 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.566 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 74.3 mmtt -107.54 -3.17 19.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 112.671 0.619 . . . . 72.23 112.671 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.93 176.89 50.89 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.825 -1.31 . . . . 74.24 109.825 164.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -56.65 131.69 77.88 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 117.335 0.567 . . . . 53.3 111.894 -171.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 28.0 Cg_endo -63.23 138.93 69.31 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.97 2.447 . . . . 74.14 111.519 174.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.22 177.77 18.49 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.561 -0.745 . . . . 74.44 113.472 -174.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.61 -33.52 66.93 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.973 2.448 . . . . 62.21 112.75 177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.48 -8.97 59.6 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.419 0.688 . . . . 62.31 111.901 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 144.42 -101.18 0.25 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 110.872 -0.891 . . . . 40.04 110.872 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 59.3 mtt180 -148.35 165.78 30.04 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.788 1.235 . . . . 71.45 110.176 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.65 174.08 30.23 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 110.792 -0.923 . . . . 70.55 110.792 167.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 45.7 m-20 -102.85 -179.15 3.88 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.105 0.562 . . . . 71.42 109.944 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 46.0 tp -141.68 107.63 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.603 0.716 . . . . 73.32 109.128 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' TYR . . . . . 0.488 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 54.3 m-85 -100.99 107.6 19.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.882 -1.525 . . . . 75.14 106.882 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 233' ' ' LEU . 2.7 pp -122.94 118.09 27.04 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.759 0.79 . . . . 62.13 113.086 -175.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -69.75 120.63 15.79 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 125.3 1.44 . . . . 70.11 112.252 -171.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' VAL . . . . . 0.549 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 58.9 t -68.8 116.56 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 114.09 -1.414 . . . . 74.23 110.979 177.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -103.35 131.24 50.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.112 1.765 . . . . 72.42 108.866 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.0 mm -97.46 110.22 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.966 -1.124 . . . . 64.51 107.966 170.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.257 1.45 0 C-N-CA 124.335 1.054 . . . . 74.54 108.627 -175.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.433 ' N ' ' SD ' ' A' ' 168' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 109.985 -0.376 . . . . 61.53 109.985 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -79.29 162.18 25.8 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.381 0.672 . . . . 74.3 110.106 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.7 p -57.81 -32.81 67.94 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.333 1.053 . . . . 63.32 112.411 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.19 142.95 54.16 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.451 0.7 . . . . 34.12 110.978 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.446 HG22 HG22 ' A' ' 219' ' ' VAL . 11.6 m -75.15 -10.76 59.77 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 123.675 0.79 . . . . 61.43 110.976 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -111.95 151.6 29.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.621 0.768 . . . . 75.2 110.657 176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -73.34 -113.37 0.07 OUTLIER Glycine 0 C--N 1.349 1.251 0 O-C-N 123.659 0.599 . . . . 72.33 111.71 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -112.5 177.69 4.55 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.406 0.683 . . . . 63.32 110.047 177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.506 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 13.6 m95 -85.26 -76.09 0.34 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.176 -0.92 . . . . 72.12 109.732 170.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -168.92 34.8 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.06 0.944 . . . . 64.52 109.101 -174.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 134.7 -41.08 1.49 Allowed Glycine 0 C--N 1.34 0.784 0 N-CA-C 110.144 -1.182 . . . . 53.13 110.144 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.505 ' HB2' ' HB2' ' A' ' 176' ' ' TRP . 44.7 mmtm -63.81 141.3 58.82 Favored 'General case' 0 C--O 1.245 0.84 0 C-N-CA 123.819 0.848 . . . . 61.45 111.37 176.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 86.12 -69.7 3.13 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 109.895 -1.282 . . . . 51.3 109.895 -168.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 52.4 p -166.53 139.29 3.8 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.576 1.15 . . . . 62.11 108.712 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -72.41 79.22 0.67 Allowed Glycine 0 C--N 1.346 1.102 0 N-CA-C 110.664 -0.974 . . . . 71.12 110.664 172.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -67.94 -58.12 7.89 Favored Glycine 0 C--N 1.349 1.298 0 C-N-CA 123.307 0.479 . . . . 63.44 112.114 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 24.2 p -164.71 99.65 0.79 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.583 0.753 . . . . 52.35 109.759 -178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -76.84 81.54 1.14 Allowed Glycine 0 C--N 1.348 1.225 0 CA-C-N 115.835 -0.62 . . . . 71.13 112.221 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -157.67 101.43 0.2 Allowed Glycine 0 C--N 1.344 1.016 0 N-CA-C 112.33 -0.308 . . . . 75.43 112.33 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.1 m -90.35 102.62 15.35 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.569 0.748 . . . . 61.2 109.732 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 174.49 142.06 3.86 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.405 -1.078 . . . . 63.25 110.405 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 176.52 -143.84 6.62 Favored Glycine 0 C--N 1.34 0.8 0 N-CA-C 111.713 -0.555 . . . . 54.54 111.713 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.6 m -157.74 167.8 29.04 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 124.849 1.259 . . . . 62.13 109.064 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 58.74 24.62 12.46 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.882 0.873 . . . . 61.54 110.704 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -80.06 163.39 24.21 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.621 0.769 . . . . 51.34 112.882 -166.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.1 mt -130.88 147.3 52.51 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 114.653 -1.158 . . . . 70.14 110.157 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -114.71 122.81 47.58 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 108.587 -0.894 . . . . 71.44 108.587 169.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -133.14 -173.24 3.15 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.558 0.536 . . . . 73.22 110.532 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.5 m -123.81 135.88 54.06 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.797 0.839 . . . . 71.02 110.146 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.3 tp -96.01 109.18 21.61 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.746 -1.205 . . . . 54.13 107.746 170.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -85.43 99.69 11.37 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 108.664 -0.865 . . . . 61.42 108.664 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.682 ' HA ' HG11 ' A' ' 210' ' ' VAL . 18.9 t -111.61 112.31 54.0 Favored Pre-proline 0 C--N 1.344 0.342 0 N-CA-C 107.988 -1.115 . . . . 63.24 107.988 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.3 151.59 80.53 Favored 'Trans proline' 0 C--N 1.362 1.24 0 C-N-CA 121.538 1.492 . . . . 72.35 110.693 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.424 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.82 -42.2 88.47 Favored Pre-proline 0 CA--C 1.56 1.354 0 C-N-CA 123.755 0.822 . . . . 74.33 113.203 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 11.1 Cg_endo -55.24 -56.67 2.14 Favored 'Trans proline' 0 C--N 1.392 2.828 0 C-N-CA 122.004 1.803 . . . . 71.25 113.824 172.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.57 -31.28 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 122.942 0.497 . . . . 75.11 111.001 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.33 80.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 116.076 -0.511 . . . . 43.44 111.045 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.9 t -67.27 -50.41 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.987 0.915 . . . . 71.02 111.801 -179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 11.6 p -79.28 -25.89 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 120.813 0.34 . . . . 75.1 110.723 -172.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.95 73.0 1.07 Allowed Glycine 0 C--N 1.341 0.855 0 CA-C-N 115.92 -0.582 . . . . 75.24 111.778 -177.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.13 -130.22 6.8 Favored Glycine 0 C--N 1.344 0.986 0 N-CA-C 111.59 -0.604 . . . . 65.25 111.59 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -131.9 156.09 46.74 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.519 0.728 . . . . 52.05 110.104 172.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.682 HG11 ' HA ' ' A' ' 199' ' ' VAL . 26.8 m -144.79 158.05 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 124.064 0.853 . . . . 75.24 110.145 173.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -81.41 146.65 30.18 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.523 -0.762 . . . . 71.22 111.017 176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.597 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -121.84 125.68 47.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.727 1.211 . . . . 75.12 108.347 170.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.5 tpt -64.32 131.44 47.3 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.946 0.498 . . . . 75.01 110.851 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.424 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -135.32 -170.78 2.67 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.789 1.236 . . . . 73.52 108.888 -177.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.451 ' HB2' ' HG3' ' A' ' 216' ' ' GLU . 7.1 mt -63.54 -68.65 0.33 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 122.39 1.091 . . . . 61.01 111.869 -172.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 215' ' ' LEU . 33.9 mt-10 -97.42 -39.83 8.99 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 112.707 -2.042 . . . . 75.13 109.266 -163.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -147.0 -165.39 11.69 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 113.981 -1.463 . . . . 22.12 111.565 -178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -96.89 151.46 1.07 Allowed 'Trans proline' 0 CA--C 1.551 1.35 0 C-N-CA 122.728 2.285 . . . . 71.41 114.907 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.597 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 54.0 t -97.86 162.88 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 114.195 -1.366 . . . . 74.01 107.535 165.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -144.65 119.23 9.74 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.18 -1.044 . . . . 65.31 108.18 174.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.401 HG11 HD11 ' A' ' 233' ' ' LEU . 12.7 p -112.07 142.66 23.77 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.56 0.744 . . . . 64.14 110.207 -176.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.28 112.53 10.54 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 108.824 -0.806 . . . . 63.2 108.824 170.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.9 t -73.3 133.02 81.26 Favored Pre-proline 0 CA--C 1.553 1.075 0 N-CA-C 109.211 -0.663 . . . . 74.21 109.211 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.57 157.58 61.23 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 123.252 2.635 . . . . 65.34 111.237 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.57 135.11 40.86 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 121.98 1.786 . . . . 70.41 112.08 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 28.7 mtp-105 53.19 65.46 1.51 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.913 1.685 . . . . 64.43 113.34 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.526 HG23 ' HD2' ' A' ' 231' ' ' ARG . 77.7 m -87.95 139.01 30.95 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.87 -1.059 . . . . 61.41 111.711 176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.643 ' HB2' HH12 ' A' ' 231' ' ' ARG . 25.9 mp0 -104.33 159.02 16.06 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.003 0.921 . . . . 74.21 110.086 172.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.45 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -86.19 152.32 22.92 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.111 -0.95 . . . . 74.3 111.46 -177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 110.11 -15.21 30.86 Favored Glycine 0 N--CA 1.472 1.063 0 CA-C-N 115.934 -0.575 . . . . 71.4 111.744 -170.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.643 HH12 ' HB2' ' A' ' 228' ' ' GLN . 69.5 mtt85 -69.72 179.26 2.24 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.959 0.904 . . . . 62.11 109.769 166.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.1 ptmt -166.0 155.66 12.1 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 109.917 -0.401 . . . . 74.45 109.917 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.585 HD12 HD11 ' A' ' 251' ' ' LEU . 79.8 mt -84.37 147.08 27.35 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 109.617 -0.512 . . . . 61.45 109.617 170.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.8 ptt180 -114.21 107.36 15.51 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 124.66 1.225 . . . . 63.32 107.958 167.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 63.3 mt -116.53 118.32 32.31 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.931 0.492 . . . . 74.01 110.863 -173.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -92.86 126.0 37.73 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.127 -0.488 . . . . 74.2 110.184 -176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.23 12.91 72.37 Favored Glycine 0 N--CA 1.471 1.022 0 O-C-N 124.264 0.978 . . . . 54.33 113.021 -176.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -114.11 -3.32 13.27 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.689 0.796 . . . . 74.42 111.446 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.88 -177.34 51.47 Favored Glycine 0 C--N 1.353 1.515 0 N-CA-C 110.556 -1.018 . . . . 53.04 110.556 166.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -57.5 141.52 78.43 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 112.753 0.649 . . . . 74.43 112.753 -171.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.423 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 7.8 Cg_exo -69.47 133.72 26.81 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.622 2.214 . . . . 70.04 110.512 171.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -135.31 174.63 21.13 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-N 114.888 -1.051 . . . . 54.14 112.621 -177.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.62 -9.98 23.16 Favored 'Trans proline' 0 C--N 1.368 1.581 0 C-N-CA 122.903 2.402 . . . . 71.43 112.71 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -105.29 11.07 33.32 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.094 0.958 . . . . 72.03 111.407 176.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 121.83 -113.02 2.16 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 111.187 -0.765 . . . . 72.32 111.187 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.423 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 65.0 mtt180 -143.87 164.06 31.63 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.276 1.03 . . . . 73.14 110.567 174.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -98.29 -163.87 30.79 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 114.748 -1.115 . . . . 63.43 113.29 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -115.6 160.21 20.3 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 124.183 0.993 . . . . 74.31 110.679 -175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.572 ' HG ' HD23 ' A' ' 251' ' ' LEU . 27.7 tp -131.47 109.66 10.45 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.469 0.708 . . . . 74.32 109.641 -171.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.461 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 20.2 m-85 -102.8 116.3 32.3 Favored 'General case' 0 C--O 1.242 0.662 0 N-CA-C 108.482 -0.932 . . . . 64.45 108.482 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.585 HD11 HD12 ' A' ' 233' ' ' LEU . 3.0 pp -127.76 114.47 17.33 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 121.384 0.611 . . . . 54.02 112.42 -173.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -68.74 119.73 13.58 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.923 1.289 . . . . 72.44 112.984 -172.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 232' ' ' LYS . 64.1 t -70.82 126.12 30.47 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 CA-C-N 114.342 -1.299 . . . . 72.13 110.897 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -116.24 133.14 56.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 124.988 1.315 . . . . 63.51 108.34 173.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.45 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 43.0 mm -104.94 100.53 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 N-CA-C 107.874 -1.158 . . . . 73.32 107.874 175.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.557 1.227 0 CA-C-O 117.773 -1.108 . . . . 73.11 109.506 -171.857 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 23.6 ptm . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 120.824 0.345 . . . . 63.14 111.119 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.438 ' HG3' ' H ' ' A' ' 171' ' ' ALA . 11.6 tp10 -162.29 163.93 27.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.54 1.136 . . . . 72.54 108.251 -167.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 63.6 p -54.73 -38.92 67.71 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.512 0.725 . . . . 61.5 111.219 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.438 ' H ' ' HG3' ' A' ' 169' ' ' GLU . . . -131.02 91.39 3.04 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 108.123 -1.066 . . . . 62.44 108.123 167.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 10.3 m -78.0 -23.97 48.11 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 115.931 -0.577 . . . . 74.44 111.114 -176.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.52 151.13 38.0 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 115.911 -0.586 . . . . 64.03 111.703 -177.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -77.05 -66.3 1.83 Allowed Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.425 -0.807 . . . . 61.51 111.944 175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -162.7 167.91 22.36 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 123.924 0.889 . . . . 64.44 111.096 179.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.616 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.8 m95 -77.51 -67.92 0.67 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.516 -1.22 . . . . 71.22 108.613 167.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 168.7 -131.56 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.818 2.047 . . . . 73.11 105.676 -168.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.86 20.82 42.95 Favored Glycine 0 C--N 1.352 1.467 0 CA-C-O 119.242 -0.754 . . . . 63.22 112.011 160.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 51.9 pttt 31.99 48.97 0.12 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 126.852 2.061 . . . . 74.31 113.257 -174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 163.95 -47.37 0.31 Allowed Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.163 -1.575 . . . . 72.43 109.163 -175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 50.7 m -75.66 95.36 3.37 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.107 -0.701 . . . . 51.44 109.107 170.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -75.47 75.34 1.41 Allowed Glycine 0 C--N 1.349 1.277 0 CA-C-N 115.09 -0.959 . . . . 62.22 112.671 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -125.9 49.58 0.91 Allowed Glycine 0 C--N 1.344 0.982 0 C-N-CA 123.312 0.482 . . . . 72.03 111.922 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.489 ' HA ' ' NH2' ' A' ' 234' ' ' ARG . 45.4 t -85.73 -74.14 0.42 Allowed 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.188 0.595 . . . . 75.24 110.178 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 70.9 -172.02 44.23 Favored Glycine 0 CA--C 1.535 1.318 0 N-CA-C 112.514 -0.234 . . . . 54.13 112.514 -171.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 176.96 -123.07 0.87 Allowed Glycine 0 N--CA 1.469 0.842 0 CA-C-O 119.695 -0.503 . . . . 74.02 112.065 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.2 m 63.62 92.32 0.07 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.929 1.291 . . . . 50.41 112.268 176.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -120.03 -95.06 1.51 Allowed Glycine 0 C--N 1.342 0.882 0 N-CA-C 111.07 -0.812 . . . . 65.42 111.07 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 179.05 83.94 0.06 OUTLIER Glycine 0 C--N 1.34 0.802 0 CA-C-O 119.61 -0.55 . . . . 72.3 111.915 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.3 t 78.5 -41.1 0.29 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 125.785 1.634 . . . . 73.41 113.773 173.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -63.17 -55.59 23.84 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.607 1.163 . . . . 72.12 110.176 -176.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -63.53 140.89 58.92 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 114.369 -1.287 . . . . 72.02 109.499 173.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.19 159.59 29.77 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.38 0.61 . . . . 63.35 111.046 -172.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 11.9 t80 -125.59 110.47 13.88 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.654 -1.157 . . . . 64.2 107.884 171.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.63 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.96 -171.87 2.18 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.034 0.934 . . . . 54.32 110.056 -178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 69.2 m -127.26 118.52 24.39 Favored 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 123.438 0.695 . . . . 64.43 110.95 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.521 HD23 HG22 ' A' ' 253' ' ' VAL . 13.8 tp -78.71 111.37 14.74 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 108.732 -0.84 . . . . 75.13 108.732 169.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -85.75 109.6 18.75 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 107.949 -1.13 . . . . 74.05 107.949 175.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.638 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.5 t -118.36 114.19 36.57 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 107.602 -1.259 . . . . 55.34 107.602 175.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.96 146.05 76.18 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 121.214 1.276 . . . . 74.12 109.971 171.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 205' ' ' VAL . . . -50.46 -44.54 82.99 Favored Pre-proline 0 CA--C 1.563 1.451 0 CA-C-O 117.869 -1.063 . . . . 62.23 112.817 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 16.5 Cg_endo -54.89 -48.93 18.55 Favored 'Trans proline' 0 C--N 1.399 3.2 0 C-N-CA 122.19 1.927 . . . . 63.52 112.754 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.489 HG21 HG13 ' A' ' 210' ' ' VAL . 50.8 mt -65.99 -35.3 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.006 0.523 . . . . 73.04 110.649 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.73 99.5 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.06 0.544 . . . . 71.44 111.14 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 201' ' ' ALA . 90.0 t -72.93 -50.35 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.156 0.982 . . . . 60.12 112.078 -177.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 12.4 p -77.72 -27.93 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 122.703 0.401 . . . . 72.43 110.52 -173.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.83 70.18 1.36 Allowed Glycine 0 C--N 1.342 0.895 0 N-CA-C 111.336 -0.706 . . . . 51.31 111.336 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.69 -130.02 6.86 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 111.902 -0.479 . . . . 64.51 111.902 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.4 ttmt -143.49 137.19 28.34 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.231 0.613 . . . . 61.14 109.921 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.638 HG11 ' HA ' ' A' ' 199' ' ' VAL . 35.4 m -132.55 151.02 33.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.409 0.684 . . . . 53.15 110.235 176.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.9 ttm180 -75.23 140.04 42.97 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 122.941 0.497 . . . . 74.42 110.856 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.12 113.71 26.13 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.982 -1.488 . . . . 74.43 106.982 171.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 11.0 tpt -65.54 131.0 45.28 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.037 0.535 . . . . 65.24 111.489 -176.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -133.71 -171.69 2.78 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.545 1.138 . . . . 72.21 110.644 -172.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.3 mt -83.5 -64.22 1.21 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 122.777 1.275 . . . . 75.34 109.679 -168.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -95.8 -32.07 12.87 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 112.067 -2.333 . . . . 72.21 110.93 -166.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -164.44 144.29 9.27 Favored Glycine 0 C--N 1.34 0.77 0 CA-C-O 118.672 -1.071 . . . . 51.42 111.442 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -66.33 143.88 71.99 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.686 2.257 . . . . 72.13 113.278 -174.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 66.0 t -96.54 163.23 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 114.177 -1.374 . . . . 73.2 108.159 174.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.401 ' H ' ' HB ' ' A' ' 172' ' ' THR . 9.5 tt0 -147.08 134.06 20.28 Favored 'General case' 0 C--O 1.245 0.834 0 N-CA-C 107.767 -1.197 . . . . 74.01 107.767 174.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.51 HG21 HD21 ' A' ' 233' ' ' LEU . 12.0 p -126.49 135.74 62.86 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 C-N-CA 123.48 0.712 . . . . 71.34 110.951 -173.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.75 104.4 2.42 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 114.85 -1.068 . . . . 63.44 108.95 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.4 t -71.75 132.79 84.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 N-CA-C 108.551 -0.907 . . . . 63.33 108.551 176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.5 157.39 60.82 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.541 2.161 . . . . 74.42 111.839 171.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -64.71 137.48 54.29 Favored 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.103 1.868 . . . . 74.31 111.96 178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 50.5 65.19 1.53 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.327 1.451 . . . . 72.34 113.192 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.444 HG23 ' HD2' ' A' ' 231' ' ' ARG . 68.1 m -82.87 144.55 30.0 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 114.947 -1.024 . . . . 70.11 111.071 174.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.4 mp0 -105.79 155.92 18.83 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.749 0.82 . . . . 72.21 110.398 172.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.439 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -76.61 153.59 35.14 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.618 -1.174 . . . . 74.01 110.369 176.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.3 -10.93 59.97 Favored Glycine 0 N--CA 1.472 1.099 0 N-CA-C 112.351 -0.3 . . . . 60.1 112.351 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.444 ' HD2' HG23 ' A' ' 227' ' ' THR . 65.8 mtt85 -72.1 -177.23 2.0 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.126 0.97 . . . . 74.0 109.586 165.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.526 ' HA ' HG23 ' A' ' 253' ' ' VAL . 7.5 ptmt -167.25 161.83 14.63 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 111.275 0.102 . . . . 64.04 111.275 172.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.632 HD12 HD11 ' A' ' 251' ' ' LEU . 73.1 mt -88.49 151.28 22.64 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 109.468 -0.567 . . . . 74.0 109.468 166.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.489 ' NH2' ' HA ' ' A' ' 184' ' ' SER . 4.3 ptp180 -111.85 109.33 19.09 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 107.49 -1.3 . . . . 73.42 107.49 162.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 64.0 mt -110.11 102.43 11.14 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.854 0.835 . . . . 70.3 109.784 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -76.68 119.1 20.02 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.095 -1.411 . . . . 62.33 110.853 -169.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.62 -3.95 86.6 Favored Glycine 0 CA--C 1.533 1.209 0 O-C-N 124.072 0.858 . . . . 54.03 113.981 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.486 ' HD2' HG21 ' A' ' 214' ' ' THR . 32.6 mmtp -87.09 5.79 35.89 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 117.645 0.723 . . . . 64.03 112.565 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.98 174.02 49.24 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.123 -0.791 . . . . 74.42 111.123 166.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -62.04 148.16 88.98 Favored Pre-proline 0 CA--C 1.553 1.095 0 C-N-CA 122.85 0.46 . . . . 74.44 111.753 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.519 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 11.7 Cg_exo -68.69 133.32 27.29 Favored 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.659 2.239 . . . . 64.22 112.429 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -128.89 173.78 19.26 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-N 114.793 -1.094 . . . . 75.42 112.552 -173.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.02 -24.82 20.17 Favored 'Trans proline' 0 C--N 1.37 1.693 0 C-N-CA 122.92 2.413 . . . . 73.43 112.195 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.22 22.46 14.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.058 0.943 . . . . 72.11 110.833 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 101.16 -177.74 27.67 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.957 -0.857 . . . . 71.42 110.957 -175.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.519 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 32.9 mtp180 -81.81 155.49 25.39 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 117.113 0.457 . . . . 63.55 111.161 -178.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.2 -179.12 52.72 Favored Glycine 0 N--CA 1.466 0.664 0 CA-C-N 115.436 -0.802 . . . . 65.44 112.222 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -117.37 138.26 51.92 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 121.208 0.528 . . . . 75.21 109.789 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 38.8 tp -101.91 105.57 16.39 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.973 -1.012 . . . . 61.44 109.116 -170.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.444 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 60.5 m-85 -102.15 114.13 27.99 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.146 -1.057 . . . . 73.13 108.146 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.632 HD11 HD12 ' A' ' 233' ' ' LEU . 2.5 pp -125.88 114.74 18.94 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 113.593 0.96 . . . . 62.4 113.593 -171.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -67.74 125.8 27.37 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.799 1.24 . . . . 74.02 112.766 -173.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.616 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 89.1 t -74.25 131.3 35.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 CA-C-N 113.55 -1.659 . . . . 75.44 110.936 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -123.81 125.33 44.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 125.456 1.503 . . . . 75.12 107.851 176.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.439 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 33.1 mm -97.01 105.91 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 107.566 -1.272 . . . . 54.14 107.566 176.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.564 1.495 0 CA-C-O 118.022 -0.99 . . . . 62.14 109.507 -169.724 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.498 ' N ' ' SD ' ' A' ' 168' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 109.524 -0.547 . . . . 61.53 109.524 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -85.38 161.93 19.25 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.461 0.704 . . . . 74.3 110.606 -178.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.8 p -59.63 -35.44 74.38 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.454 1.102 . . . . 63.32 111.433 175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.05 141.32 40.34 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.377 -0.601 . . . . 34.12 109.377 170.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.407 HG22 HG22 ' A' ' 219' ' ' VAL . 13.4 m -70.88 -19.64 62.6 Favored 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 123.351 0.66 . . . . 61.43 110.959 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.74 166.17 12.58 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.744 0.817 . . . . 75.2 111.874 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -87.68 -96.56 0.92 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 110.525 -1.03 . . . . 72.33 110.525 177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -131.14 174.86 9.61 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.982 0.513 . . . . 63.32 109.716 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.523 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 9.9 m95 -87.29 -73.1 0.49 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.266 -0.879 . . . . 72.12 110.097 170.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.651 HE22 ' HG2' ' A' ' 231' ' ' ARG . 3.8 pt20 -169.51 32.43 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.241 0.617 . . . . 64.52 110.033 -170.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 89.09 69.15 1.25 Allowed Glycine 0 C--N 1.341 0.851 0 CA-C-N 115.923 -0.58 . . . . 53.13 111.7 -169.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 27.2 mmtm -124.54 113.25 17.84 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.631 1.172 . . . . 61.45 107.915 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 79.02 -60.05 4.23 Favored Glycine 0 C--N 1.351 1.402 0 N-CA-C 110.918 -0.873 . . . . 51.3 110.918 -170.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 70.0 p -139.68 149.86 44.19 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.566 1.146 . . . . 62.11 108.71 171.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -120.88 135.62 10.87 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.044 -0.823 . . . . 71.12 111.044 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -76.62 -58.84 3.42 Favored Glycine 0 C--N 1.344 0.992 0 N-CA-C 111.81 -0.516 . . . . 63.44 111.81 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.0 p -162.6 149.24 13.02 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.268 0.627 . . . . 52.35 110.172 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -92.47 65.99 2.07 Favored Glycine 0 C--N 1.344 1.017 0 O-C-N 123.29 0.369 . . . . 71.13 112.553 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.67 143.84 6.32 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 112.168 -0.373 . . . . 75.43 112.168 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.6 m -138.45 139.39 38.84 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.665 0.786 . . . . 61.2 110.644 -178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 159.52 83.62 0.05 OUTLIER Glycine 0 C--N 1.342 0.915 0 N-CA-C 110.525 -1.03 . . . . 63.25 110.525 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -106.0 -159.32 22.46 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 113.929 0.332 . . . . 54.54 113.929 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.2 m -130.08 152.28 49.71 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.338 1.055 . . . . 62.13 109.521 -175.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 58.92 21.1 8.8 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 124.185 0.994 . . . . 61.54 110.89 -174.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 7.9 p-10 -76.67 154.6 34.11 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 114.741 -1.118 . . . . 51.34 112.366 -169.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.46 ' HB2' HD13 ' A' ' 249' ' ' LEU . 87.4 mt -116.75 147.22 42.23 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.391 1.076 . . . . 70.14 109.594 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -115.55 117.6 30.79 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 108.18 -1.045 . . . . 71.44 108.18 172.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.577 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -130.17 -173.61 3.1 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.456 0.702 . . . . 73.22 109.878 -179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.0 m -124.33 120.63 32.71 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.43 0.692 . . . . 71.02 110.311 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.503 HD23 HG22 ' A' ' 253' ' ' VAL . 18.3 tp -78.6 105.55 9.96 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 108.003 -1.11 . . . . 54.13 108.003 172.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -86.29 101.0 12.67 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 108.788 -0.819 . . . . 61.42 108.788 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.661 HG22 HG21 ' A' ' 210' ' ' VAL . 18.1 t -112.67 113.86 50.12 Favored Pre-proline 0 N--CA 1.47 0.556 0 N-CA-C 108.884 -0.784 . . . . 63.24 108.884 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.38 151.17 83.85 Favored 'Trans proline' 0 C--N 1.366 1.475 0 C-N-CA 121.611 1.541 . . . . 72.35 110.642 171.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.436 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -53.19 -43.77 95.7 Favored Pre-proline 0 CA--C 1.559 1.304 0 CA-C-O 118.01 -0.995 . . . . 74.33 113.096 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.3 Cg_endo -55.37 -51.76 9.28 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 122.152 1.901 . . . . 71.25 112.98 174.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.48 HG21 HG13 ' A' ' 210' ' ' VAL . 38.6 mt -63.76 -34.85 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.07 0.548 . . . . 75.11 111.016 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.52 -45.44 87.24 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.19 -0.459 . . . . 43.44 111.017 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 77.9 t -72.84 -49.03 42.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.826 0.85 . . . . 71.02 111.833 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.81 -24.72 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 122.329 0.252 . . . . 75.1 110.714 -174.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.06 75.9 1.03 Allowed Glycine 0 C--N 1.346 1.129 0 CA-C-N 115.95 -0.568 . . . . 75.24 111.776 -178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.99 -144.78 10.9 Favored Glycine 0 N--CA 1.474 1.209 0 N-CA-C 110.815 -0.914 . . . . 65.25 110.815 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -122.29 150.73 41.94 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 118.107 0.953 . . . . 52.05 110.762 174.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.661 HG21 HG22 ' A' ' 199' ' ' VAL . 24.8 m -141.06 149.21 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 115.354 -0.839 . . . . 75.24 109.978 173.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -73.83 145.13 45.18 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.292 0.568 . . . . 71.22 111.124 177.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.623 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -119.8 115.95 24.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.256 1.422 . . . . 75.12 107.281 174.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 15.9 tpt -64.26 130.88 45.6 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.27 0.628 . . . . 75.01 111.529 -176.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.88 -172.41 2.87 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.166 1.386 . . . . 73.52 109.691 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.04 -70.18 0.26 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.074 0.94 . . . . 61.01 110.668 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -114.88 -41.52 3.35 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 113.63 -1.623 . . . . 75.13 111.387 -169.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -116.3 102.97 1.11 Allowed Glycine 0 C--N 1.349 1.294 0 CA-C-O 118.468 -1.184 . . . . 22.12 111.652 -175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -60.33 137.99 78.14 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.251 2.634 . . . . 71.41 112.625 -177.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.623 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 91.0 t -90.37 163.46 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.451 1.1 . . . . 74.01 108.955 -177.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -146.19 127.9 15.25 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.704 -1.221 . . . . 65.31 107.704 170.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.453 HG11 HD11 ' A' ' 233' ' ' LEU . 14.0 p -116.94 140.99 37.15 Favored 'Isoleucine or valine' 0 C--O 1.244 0.779 0 C-N-CA 123.722 0.809 . . . . 64.14 110.276 -174.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.93 106.82 5.81 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 115.59 -0.732 . . . . 63.2 109.052 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.4 t -68.91 128.61 92.75 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 123.755 0.822 . . . . 74.21 109.253 173.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -59.39 149.58 80.5 Favored 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.956 2.438 . . . . 65.34 111.961 170.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -61.39 132.18 39.78 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 121.751 1.634 . . . . 70.41 110.77 174.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 52.92 69.88 0.64 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.287 1.435 . . . . 64.43 112.672 -173.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.502 HG23 ' HD2' ' A' ' 231' ' ' ARG . 32.5 m -92.06 138.42 31.55 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.222 -1.354 . . . . 61.41 110.135 170.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.422 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 26.3 mp0 -103.55 162.31 13.15 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.555 0.742 . . . . 74.21 111.044 176.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.455 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.76 155.88 24.02 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.187 -1.37 . . . . 74.3 111.741 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.07 -10.03 59.98 Favored Glycine 0 N--CA 1.474 1.207 0 N-CA-C 111.847 -0.501 . . . . 71.4 111.847 -173.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.651 ' HG2' HE22 ' A' ' 177' ' ' GLN . 71.4 mtt85 -72.38 -179.52 2.98 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.067 0.947 . . . . 62.11 110.307 168.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.504 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.4 ptmt -167.8 153.23 7.1 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.88 -0.6 . . . . 74.45 109.909 171.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.574 HD12 HD11 ' A' ' 251' ' ' LEU . 85.4 mt -83.58 152.48 24.82 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 109.358 -0.608 . . . . 61.45 109.358 169.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -118.65 110.08 16.89 Favored 'General case' 0 C--O 1.243 0.751 0 O-C-N 124.833 1.333 . . . . 63.32 107.593 168.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.503 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 58.6 mt -116.98 117.8 30.66 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.728 -0.669 . . . . 74.01 110.07 -171.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.524 ' HD3' ' HB3' ' A' ' 248' ' ' ASP . 27.2 mmtp -93.03 132.39 37.17 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 109.702 -0.481 . . . . 74.2 109.702 -177.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 77.81 20.72 73.11 Favored Glycine 0 C--N 1.342 0.891 0 O-C-N 124.261 0.976 . . . . 54.33 112.912 -175.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.457 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 26.6 mmtp -116.86 -5.47 11.51 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.178 0.807 . . . . 74.42 113.178 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.61 -172.32 46.78 Favored Glycine 0 C--N 1.344 1.014 0 CA-C-O 119.794 -0.448 . . . . 53.04 112.124 166.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -58.77 139.14 86.56 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.077 0.551 . . . . 74.43 111.765 -173.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.485 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 6.3 Cg_exo -76.61 136.8 17.61 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.728 2.285 . . . . 70.04 111.508 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -130.93 170.16 21.35 Favored Glycine 0 CA--C 1.526 0.721 0 CA-C-N 115.952 -0.567 . . . . 54.14 112.764 -170.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.52 -28.9 21.03 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 122.892 2.395 . . . . 71.43 112.26 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -100.59 22.17 12.24 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.855 0.862 . . . . 72.03 110.849 178.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 104.91 169.44 24.26 Favored Glycine 0 C--N 1.346 1.101 0 N-CA-C 111.115 -0.794 . . . . 72.32 111.115 -174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.485 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 96.6 mtt180 -73.78 175.1 7.54 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.711 0.767 . . . . 73.14 111.994 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.46 -167.43 33.93 Favored Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 114.193 -1.367 . . . . 63.43 112.147 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.524 ' HB3' ' HD3' ' A' ' 236' ' ' LYS . 2.2 p-10 -118.69 176.94 5.03 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 123.682 0.793 . . . . 74.31 110.41 -177.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.503 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 27.2 tp -145.82 109.55 4.8 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.236 0.541 . . . . 74.32 110.973 -171.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 16.9 m-85 -102.16 116.14 32.03 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.449 -0.945 . . . . 64.45 108.449 174.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.0 pp -127.91 115.24 18.27 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 113.138 0.792 . . . . 54.02 113.138 -175.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -68.42 119.6 13.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.392 1.477 . . . . 72.44 112.856 -170.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.523 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 57.4 t -70.82 120.75 19.31 Favored 'Isoleucine or valine' 0 C--O 1.244 0.809 0 CA-C-N 114.57 -1.196 . . . . 72.13 111.105 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -113.59 129.01 56.64 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.564 1.146 . . . . 63.51 108.908 171.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.455 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 31.9 mm -94.88 99.59 9.66 Favored 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 107.643 -1.243 . . . . 73.32 107.643 173.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.555 1.141 0 C-N-CA 124.877 1.271 . . . . 73.11 108.436 -171.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.501 ' N ' ' SD ' ' A' ' 168' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.843 0 N-CA-C 108.393 -0.966 . . . . 61.14 108.393 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -76.22 139.27 41.11 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.656 -0.702 . . . . 72.33 110.389 -176.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.614 HG22 ' HA2' ' A' ' 174' ' ' GLY . 82.2 p -89.28 120.62 30.8 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.117 -0.947 . . . . 75.14 109.39 -179.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.48 -50.12 74.82 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 108.551 -0.907 . . . . 75.33 108.551 170.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.472 HG22 HG22 ' A' ' 219' ' ' VAL . 1.1 m -147.14 -40.76 0.19 Allowed 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 107.592 -1.262 . . . . 61.12 107.592 162.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.96 159.73 14.97 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.719 0.808 . . . . 64.01 111.681 177.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.614 ' HA2' HG22 ' A' ' 170' ' ' THR . . . -92.08 -88.95 1.48 Allowed Glycine 0 C--N 1.344 0.995 0 CA-C-N 114.885 -1.052 . . . . 52.13 111.994 -179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.408 ' CB ' ' HB2' ' A' ' 179' ' ' LYS . 12.8 pt-20 -150.85 165.61 33.07 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-O 121.588 0.709 . . . . 73.21 112.801 -175.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.512 ' CZ3' HG21 ' A' ' 227' ' ' THR . 34.5 m95 -87.03 -86.74 0.15 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 113.654 -1.612 . . . . 75.21 110.577 -178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -127.53 15.59 7.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.794 0.838 . . . . 74.32 110.548 -168.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 127.02 86.9 0.58 Allowed Glycine 0 C--N 1.337 0.602 0 N-CA-C 109.462 -1.455 . . . . 65.24 109.462 -168.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.408 ' HB2' ' CB ' ' A' ' 175' ' ' GLU . 14.4 tmtt? -64.02 100.0 0.29 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.607 -0.886 . . . . 73.54 108.607 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.08 -40.52 0.42 Allowed Glycine 0 C--N 1.334 0.455 0 CA-C-N 114.827 -1.079 . . . . 63.42 110.67 -171.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 34.5 t -162.48 -52.32 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.613 0.765 . . . . 73.42 109.329 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 145.22 -166.73 27.54 Favored Glycine 0 C--N 1.345 1.053 0 CA-C-N 115.264 -0.88 . . . . 72.43 111.712 -175.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 143.64 -96.67 0.19 Allowed Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.435 -0.666 . . . . 52.12 111.435 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 69.0 p -158.77 132.67 7.65 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.433 1.093 . . . . 75.13 108.961 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.4 ' O ' ' HD3' ' A' ' 234' ' ' ARG . . . -87.87 -43.07 5.82 Favored Glycine 0 C--N 1.35 1.342 0 CA-C-O 121.22 0.344 . . . . 73.34 112.797 -176.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 113.3 162.11 14.9 Favored Glycine 0 N--CA 1.467 0.736 0 O-C-N 122.49 -0.418 . . . . 54.11 112.063 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 15.1 t -163.89 128.3 2.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.726 0.81 . . . . 65.2 109.0 -176.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 127.15 161.55 10.89 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-O 120.231 -0.205 . . . . 73.54 112.592 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 140.51 -158.01 25.89 Favored Glycine 0 C--N 1.344 1.018 0 C-N-CA 123.094 0.378 . . . . 71.33 112.262 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 58.0 p -118.8 151.84 37.32 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.968 0.907 . . . . 63.33 108.651 173.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 63.97 8.82 4.16 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 124.054 0.942 . . . . 72.33 112.347 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -90.1 148.3 23.1 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.106 0.962 . . . . 72.34 110.292 -169.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.0 mt -111.59 143.39 42.54 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.196 0.599 . . . . 51.23 110.653 -176.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -113.41 114.82 27.13 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.594 -0.891 . . . . 61.23 108.594 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.602 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -128.13 -172.56 2.72 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.238 1.015 . . . . 55.22 109.603 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.504 HG23 ' HG2' ' A' ' 254' ' ' ARG . 88.0 m -111.69 150.19 30.54 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 123.997 0.919 . . . . 72.53 110.442 174.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.558 HD22 ' HG ' ' A' ' 233' ' ' LEU . 16.7 tp -110.29 103.29 11.94 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 106.61 -1.626 . . . . 73.14 106.61 162.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -87.85 99.44 12.12 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 108.676 -0.861 . . . . 72.43 108.676 -173.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.651 HG22 HG21 ' A' ' 210' ' ' VAL . 15.6 t -106.73 113.02 63.29 Favored Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.118 -0.946 . . . . 74.04 108.518 -178.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -65.31 148.37 88.39 Favored 'Trans proline' 0 C--N 1.371 1.735 0 C-N-CA 121.531 1.487 . . . . 62.12 110.325 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.415 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -51.69 -44.28 89.9 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 117.725 -1.131 . . . . 72.54 112.579 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.1 Cg_endo -56.49 -49.94 13.41 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 122.052 1.835 . . . . 45.31 112.665 174.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.467 HG21 HG13 ' A' ' 210' ' ' VAL . 38.2 mt -65.36 -32.94 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 C-N-CA 123.225 0.61 . . . . 74.03 110.818 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.84 -47.35 78.29 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.031 0.532 . . . . 43.21 110.344 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -70.25 -49.21 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.25 1.02 . . . . 52.42 111.945 -176.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.0 p -79.68 -27.4 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 122.375 0.27 . . . . 72.01 110.715 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 84.3 70.6 1.34 Allowed Glycine 0 C--N 1.347 1.144 0 N-CA-C 112.217 -0.353 . . . . 71.41 112.217 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.33 -123.48 5.2 Favored Glycine 0 C--N 1.349 1.273 0 CA-C-O 120.031 -0.316 . . . . 71.45 112.797 -174.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -150.22 137.12 19.29 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.97 0.908 . . . . 73.24 110.052 -177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.651 HG21 HG22 ' A' ' 199' ' ' VAL . 29.6 m -139.17 156.68 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 123.427 0.691 . . . . 75.33 111.317 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -77.6 141.47 39.47 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.007 0.923 . . . . 63.14 111.535 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.504 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -116.4 116.59 27.98 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.421 1.488 . . . . 72.03 108.477 172.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -66.21 130.64 43.93 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.864 0.865 . . . . 74.4 111.189 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.2 -171.2 2.69 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.323 1.049 . . . . 62.42 110.132 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 215' ' ' LEU . 7.1 mt -68.28 -66.83 0.52 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.881 1.273 . . . . 60.5 111.205 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -105.5 -42.32 5.25 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 113.229 -1.805 . . . . 71.41 111.385 -165.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -137.49 145.16 16.79 Favored Glycine 0 N--CA 1.467 0.765 0 CA-C-O 118.695 -1.059 . . . . 63.54 111.716 -174.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.65 137.92 23.24 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.165 1.91 . . . . 74.41 112.38 -177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 172' ' ' THR . 50.5 t -95.39 164.67 2.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 114.475 -1.239 . . . . 64.12 108.104 177.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -144.41 144.32 31.35 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 107.416 -1.327 . . . . 74.32 107.416 175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.459 HG11 HD21 ' A' ' 197' ' ' LEU . 15.0 p -135.65 140.39 44.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 123.223 0.609 . . . . 74.53 110.824 -171.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.56 112.6 9.79 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 123.803 0.841 . . . . 45.12 109.392 172.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 176' ' ' TRP . 83.8 t -76.74 132.61 71.43 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 123.533 0.733 . . . . 72.35 109.406 176.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -68.3 155.58 68.76 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.803 2.336 . . . . 74.02 111.353 169.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -65.63 136.22 45.2 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 122.001 1.801 . . . . 74.5 111.865 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 49.4 69.53 0.58 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.571 1.549 . . . . 63.34 112.773 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.512 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 86.2 m -90.4 144.39 25.86 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 114.527 -1.215 . . . . 72.43 110.703 174.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -107.56 156.95 18.45 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.427 1.091 . . . . 63.41 110.556 175.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -78.05 155.45 30.63 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.481 -1.236 . . . . 50.3 110.518 175.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.78 -16.94 43.0 Favored Glycine 0 N--CA 1.471 0.984 0 N-CA-C 111.349 -0.7 . . . . 75.15 111.349 -173.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 227' ' ' THR . 76.1 mtt85 -71.02 -178.96 2.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.247 1.019 . . . . 74.44 109.91 167.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.56 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 8.4 ptmt -167.05 159.97 13.61 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.191 0.307 . . . . 74.01 110.773 171.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.581 HD12 HD11 ' A' ' 251' ' ' LEU . 85.5 mt -88.19 147.29 24.94 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 109.35 -0.611 . . . . 73.31 109.35 168.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.4 ' HD3' ' O ' ' A' ' 185' ' ' GLY . 16.1 ptt180 -113.68 107.17 15.4 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 124.675 1.235 . . . . 73.24 107.733 166.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.553 HD12 HD23 ' A' ' 249' ' ' LEU . 70.4 mt -110.07 110.72 21.71 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.482 0.713 . . . . 74.44 109.45 -176.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -83.41 121.07 26.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.015 -0.993 . . . . 72.41 111.078 -167.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 84.8 2.53 88.56 Favored Glycine 0 C--N 1.346 1.128 0 CA-C-N 115.236 -0.893 . . . . 64.41 113.341 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.546 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 48.2 mmtm -94.05 4.68 53.56 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.618 0.767 . . . . 73.4 111.814 -178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.97 -175.37 49.95 Favored Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.479 -1.048 . . . . 55.15 110.479 166.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -62.77 136.54 96.38 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-N 117.579 0.689 . . . . 74.34 110.906 -176.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.499 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 55.9 Cg_endo -69.51 143.88 53.53 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.307 2.005 . . . . 74.31 112.21 176.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.21 167.29 23.47 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-O 119.471 -0.627 . . . . 71.02 112.489 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -69.77 -22.22 32.32 Favored 'Trans proline' 0 C--N 1.366 1.451 0 C-N-CA 123.157 2.571 . . . . 72.31 113.887 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.2 1.05 16.02 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.278 0.631 . . . . 54.03 111.684 178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 147.54 159.6 8.46 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.517 -0.633 . . . . 75.51 111.517 -177.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.499 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 51.9 mtm180 -83.35 169.79 15.25 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.374 0.67 . . . . 75.21 111.438 -179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.74 -174.79 35.21 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.366 -0.834 . . . . 32.05 111.684 173.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -126.12 150.55 48.15 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.144 0.497 . . . . 64.52 110.209 -174.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.553 HD23 HD12 ' A' ' 235' ' ' LEU . 37.6 tp -109.09 108.72 19.52 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.818 0.847 . . . . 73.2 109.95 -171.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.56 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 54.1 m-85 -104.29 116.32 31.95 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 124.402 1.081 . . . . 74.3 108.458 177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.2 pp -130.08 115.19 16.73 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.386 0.884 . . . . 72.22 113.386 -175.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -68.82 119.52 13.31 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 124.834 1.254 . . . . 74.11 112.061 -170.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.543 HG23 ' HA ' ' A' ' 232' ' ' LYS . 66.6 t -65.13 124.92 21.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 CA-C-N 114.558 -1.201 . . . . 73.52 110.649 174.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.504 ' HG2' HG23 ' A' ' 196' ' ' THR . 14.1 mmm180 -119.41 135.27 54.82 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.062 1.345 . . . . 71.34 108.539 175.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 33.8 mm -99.41 111.12 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 N-CA-C 107.888 -1.153 . . . . 74.03 107.888 175.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.564 1.517 0 CA-C-O 117.644 -1.169 . . . . 75.42 108.819 -171.819 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 53.0 mtm . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.133 -0.691 . . . . 72.52 109.133 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.46 -175.71 2.8 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.628 0.771 . . . . 74.03 109.599 174.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 8.1 t -80.79 68.61 7.09 Favored 'General case' 0 CA--C 1.557 1.245 0 CA-C-O 122.122 0.963 . . . . 71.33 110.491 176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -172.42 155.38 3.45 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.33 1.052 . . . . 43.45 109.188 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 11.7 m -76.87 -26.61 54.44 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.56 0.744 . . . . 71.14 110.064 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -90.34 143.23 26.96 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.532 0.733 . . . . 72.45 111.104 178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -66.29 -75.6 0.42 Allowed Glycine 0 C--N 1.344 0.98 0 O-C-N 123.912 0.758 . . . . 73.3 112.358 174.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -158.14 171.27 20.53 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 123.906 0.882 . . . . 70.42 111.085 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.592 ' HB2' ' HB3' ' A' ' 179' ' ' LYS . 16.0 m95 -85.27 -69.56 0.65 Allowed 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 114.811 -1.086 . . . . 73.42 108.661 168.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.441 ' HA ' ' NH1' ' A' ' 234' ' ' ARG . 0.0 OUTLIER -173.19 -131.99 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 105.808 -1.923 . . . . 50.13 105.808 -175.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -80.0 66.08 3.65 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 110.279 -1.128 . . . . 53.31 110.279 162.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.592 ' HB3' ' HB2' ' A' ' 176' ' ' TRP . 20.6 pttp -58.33 117.39 4.39 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.265 1.026 . . . . 71.3 111.817 -172.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 127.77 -28.13 4.49 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.194 -0.912 . . . . 72.31 112.279 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 29.2 p -141.35 -54.46 0.47 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.117 0.567 . . . . 73.12 110.702 -179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -67.17 140.84 38.35 Favored Glycine 0 C--N 1.353 1.513 0 CA-C-O 119.726 -0.485 . . . . 72.23 112.235 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.481 ' HA2' ' HG2' ' A' ' 231' ' ' ARG . . . -135.49 -3.86 2.61 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 117.391 0.595 . . . . 72.54 114.481 -172.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 50.0 m -93.91 118.3 31.29 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 117.818 0.809 . . . . 72.34 111.084 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -104.52 159.27 16.16 Favored Glycine 0 C--N 1.341 0.858 0 N-CA-C 110.942 -0.863 . . . . 75.51 110.942 170.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -91.71 170.28 33.46 Favored Glycine 0 C--N 1.341 0.816 0 N-CA-C 114.737 0.655 . . . . 55.24 114.737 -171.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 37.3 p -76.13 165.26 25.18 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.276 1.03 . . . . 72.04 110.83 174.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -57.93 146.13 39.44 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 123.756 0.66 . . . . 71.21 114.527 -172.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -95.17 -87.47 1.72 Allowed Glycine 0 C--N 1.347 1.187 0 CA-C-N 116.848 0.324 . . . . 73.43 113.402 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 70.3 m -154.27 129.64 9.79 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.169 0.988 . . . . 72.12 109.288 -174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.469 ' HB2' ' HA3' ' A' ' 247' ' ' GLY . 22.8 mt-30 59.83 20.02 8.9 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 124.342 1.057 . . . . 63.23 110.346 -174.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 6.0 p-10 -80.54 155.98 26.71 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 113.746 -1.57 . . . . 74.5 111.672 -164.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 82.8 mt -123.45 132.79 54.04 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.204 -0.907 . . . . 61.3 110.215 174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -93.32 129.99 39.23 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.579 -0.897 . . . . 71.22 108.579 167.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.641 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -138.65 -171.85 3.16 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.12 -0.696 . . . . 62.2 109.12 175.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 48.1 m -127.74 119.45 25.81 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.423 0.689 . . . . 55.51 110.778 179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.516 HD22 ' HG ' ' A' ' 233' ' ' LEU . 17.3 tp -81.47 105.25 12.48 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 108.152 -1.055 . . . . 71.12 108.152 171.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -92.36 99.5 12.25 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.825 0.821 . . . . 73.24 108.85 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.682 HG22 HG21 ' A' ' 210' ' ' VAL . 22.8 t -101.15 121.71 51.04 Favored Pre-proline 0 C--N 1.347 0.465 0 N-CA-C 107.645 -1.242 . . . . 75.23 107.645 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.97 149.52 71.99 Favored 'Trans proline' 0 C--N 1.364 1.349 0 C-N-CA 121.76 1.64 . . . . 71.4 110.243 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.423 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.61 -45.95 85.55 Favored Pre-proline 0 CA--C 1.56 1.365 0 O-C-N 124.2 0.937 . . . . 74.25 113.075 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 18.9 Cg_endo -57.47 -48.83 15.61 Favored 'Trans proline' 0 C--N 1.391 2.776 0 C-N-CA 121.979 1.786 . . . . 61.43 113.67 176.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.435 HG21 HG13 ' A' ' 210' ' ' VAL . 47.9 mt -66.91 -32.47 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 122.813 0.445 . . . . 74.01 110.632 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.8 95.2 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.228 -0.442 . . . . 40.23 110.725 177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.5 t -69.23 -51.68 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.612 0.765 . . . . 74.14 111.816 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.5 p -78.95 -22.42 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 120.753 0.311 . . . . 70.33 110.871 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 75.64 62.18 2.75 Favored Glycine 0 C--N 1.344 0.992 0 CA-C-N 115.635 -0.711 . . . . 63.1 111.902 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -92.26 -120.68 2.73 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 112.25 -0.34 . . . . 70.04 112.25 -175.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -146.94 140.84 25.92 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.691 0.796 . . . . 70.35 109.259 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.682 HG21 HG22 ' A' ' 199' ' ' VAL . 19.1 m -137.19 152.61 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 123.301 0.64 . . . . 61.44 110.58 176.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -77.8 140.6 39.44 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.752 0.821 . . . . 73.13 110.75 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.567 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.03 115.8 29.51 Favored 'General case' 0 C--O 1.24 0.582 0 N-CA-C 107.497 -1.298 . . . . 73.23 107.497 172.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.9 tpt -63.49 127.55 31.81 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.229 0.612 . . . . 64.11 110.894 -178.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -131.29 -170.23 2.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.786 1.234 . . . . 70.54 109.696 -175.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.04 -68.79 0.52 Allowed 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 122.27 1.033 . . . . 72.01 111.224 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -110.19 -37.64 5.5 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 113.265 -1.789 . . . . 72.41 110.765 -165.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -133.31 119.25 2.3 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 118.566 -1.13 . . . . 51.54 110.669 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -68.09 141.44 52.79 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.53 2.153 . . . . 73.21 112.833 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 71.0 t -92.62 165.9 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-N 114.466 -1.243 . . . . 74.42 109.056 -177.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -146.75 136.88 23.51 Favored 'General case' 0 C--O 1.246 0.872 0 N-CA-C 108.028 -1.101 . . . . 55.32 108.028 173.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.541 HG21 HD21 ' A' ' 233' ' ' LEU . 14.5 p -130.17 142.18 44.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.651 0 C-N-CA 123.446 0.698 . . . . 75.31 110.809 -172.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.22 113.45 12.6 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.154 -0.684 . . . . 44.44 109.154 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 91.9 t -74.09 136.6 76.07 Favored Pre-proline 0 CA--C 1.558 1.27 0 C-N-CA 123.562 0.745 . . . . 65.42 109.146 177.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.86 154.04 67.78 Favored 'Trans proline' 0 C--N 1.377 2.036 0 C-N-CA 122.259 1.973 . . . . 72.21 111.575 170.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.87 132.35 36.8 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.531 2.154 . . . . 64.31 111.916 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 42.8 mtp180 49.56 72.84 0.28 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.139 1.375 . . . . 75.3 112.378 -175.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.564 HG23 ' HD2' ' A' ' 231' ' ' ARG . 67.8 m -82.8 141.95 31.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.307 -1.315 . . . . 44.45 110.923 174.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.494 ' H ' HH11 ' A' ' 231' ' ' ARG . 27.0 mp0 -100.42 151.62 21.32 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.997 0.919 . . . . 73.42 110.314 171.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -75.94 156.84 33.84 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.049 -0.978 . . . . 42.02 111.078 177.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 96.57 -2.42 62.6 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-N 116.242 -0.435 . . . . 73.02 112.291 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.564 ' HD2' HG23 ' A' ' 227' ' ' THR . 28.3 mtt85 -77.17 -175.22 3.53 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.513 0.725 . . . . 32.35 109.737 168.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.583 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 9.3 ptmt -167.38 154.75 8.76 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 110.488 -0.189 . . . . 54.51 110.488 170.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.647 HD12 HD11 ' A' ' 251' ' ' LEU . 48.8 mt -80.0 143.58 33.99 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 110.118 -0.326 . . . . 51.4 110.118 167.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.441 ' NH1' ' HA ' ' A' ' 177' ' ' GLN . 7.8 ptp85 -109.89 108.39 18.67 Favored 'General case' 0 C--O 1.243 0.716 0 O-C-N 125.299 1.624 . . . . 63.02 108.39 166.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.519 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 65.9 mt -115.03 138.85 50.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.228 -0.896 . . . . 60.53 109.31 179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -108.96 141.05 41.62 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.201 0.6 . . . . 72.4 109.44 176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 68.58 24.16 75.28 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 124.194 0.934 . . . . 70.43 112.956 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 45.5 mmtm -117.43 -11.07 10.58 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.429 0.692 . . . . 75.43 112.331 -179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -80.85 -168.83 40.14 Favored Glycine 0 N--CA 1.479 1.531 0 CA-C-O 119.627 -0.541 . . . . 75.11 111.911 171.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 4.4 m-30 -66.64 142.48 97.6 Favored Pre-proline 0 N--CA 1.484 1.228 0 CA-C-N 117.811 0.805 . . . . 74.42 111.651 -173.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.22 141.79 48.46 Favored 'Trans proline' 0 C--N 1.38 2.225 0 C-N-CA 123.3 2.666 . . . . 74.51 112.647 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -135.82 172.23 22.36 Favored Glycine 0 N--CA 1.476 1.346 0 C-N-CA 123.243 0.449 . . . . 75.34 113.123 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -67.02 -25.51 44.2 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.031 2.487 . . . . 65.15 112.409 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.99 21.71 8.37 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.526 0.73 . . . . 71.31 111.623 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 103.03 -172.2 21.36 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 110.495 -1.042 . . . . 75.42 110.495 -176.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.45 149.57 22.55 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 117.693 0.746 . . . . 74.21 110.633 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 191' ' ' GLN . . . -79.1 -173.59 44.19 Favored Glycine 0 C--N 1.344 0.992 0 O-C-N 123.907 0.754 . . . . 71.43 114.394 -173.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.473 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 6.9 p-10 -105.07 167.5 9.67 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.348 0.659 . . . . 55.21 110.917 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.486 HD23 HD12 ' A' ' 235' ' ' LEU . 42.2 tp -137.98 110.62 7.57 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 123.524 0.73 . . . . 73.22 109.381 -174.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.583 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 20.8 m-85 -108.75 118.86 37.89 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.886 -0.783 . . . . 75.55 108.886 176.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.647 HD11 HD12 ' A' ' 233' ' ' LEU . 1.6 pp -130.7 114.83 15.87 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 113.064 0.764 . . . . 64.1 113.064 -175.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -69.04 124.44 23.76 Favored 'General case' 0 C--N 1.352 0.678 0 C-N-CA 124.232 1.013 . . . . 75.32 113.204 -171.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.581 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 65.5 t -73.72 131.62 34.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 113.573 -1.649 . . . . 72.35 111.689 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 22.3 mmt85 -121.09 139.2 53.65 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 125.447 1.499 . . . . 71.52 108.15 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 35.0 mm -105.04 103.63 15.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 107.657 -1.238 . . . . 74.32 107.657 173.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.557 1.247 0 CA-C-O 117.741 -1.123 . . . . 72.02 108.625 -174.185 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.444 -0.206 . . . . 63.04 110.444 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.425 ' HG2' ' H ' ' A' ' 171' ' ' ALA . 38.6 tt0 -171.32 143.02 1.79 Allowed 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.178 0.991 . . . . 64.41 109.19 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 34.7 p -63.98 -36.18 83.14 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.763 0.825 . . . . 72.41 111.935 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.425 ' H ' ' HG2' ' A' ' 169' ' ' GLU . . . -79.96 139.81 36.89 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.006 0.522 . . . . 73.42 110.9 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 18.6 m -81.67 -22.66 37.35 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.905 0.882 . . . . 73.11 109.804 171.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -86.91 148.68 25.25 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-N 115.469 -0.787 . . . . 64.43 111.067 176.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -67.63 -100.54 0.03 OUTLIER Glycine 0 C--N 1.346 1.086 0 N-CA-C 111.167 -0.773 . . . . 64.22 111.167 170.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -130.11 173.6 10.59 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 122.946 0.499 . . . . 72.51 109.861 176.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.619 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 16.1 m95 -72.32 -81.52 0.05 Allowed 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.152 -0.931 . . . . 62.21 108.997 168.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -172.12 121.46 0.46 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.215 0.606 . . . . 70.11 109.664 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.47 7.55 88.4 Favored Glycine 0 C--N 1.348 1.242 0 N-CA-C 114.195 0.438 . . . . 72.33 114.195 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.404 ' HA ' ' HE2' ' A' ' 179' ' ' LYS . 0.4 OUTLIER -80.04 -33.01 39.43 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.686 0.794 . . . . 71.34 109.904 177.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -112.63 -98.59 2.38 Favored Glycine 0 C--N 1.339 0.733 0 CA-C-N 115.827 -0.624 . . . . 55.42 111.645 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 58.1 p -73.05 122.99 22.66 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 122.983 0.513 . . . . 61.35 111.859 -171.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -83.67 59.97 4.91 Favored Glycine 0 C--N 1.343 0.969 0 N-CA-C 111.899 -0.481 . . . . 73.42 111.899 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -168.33 151.95 19.43 Favored Glycine 0 C--N 1.351 1.378 0 N-CA-C 111.987 -0.445 . . . . 64.54 111.987 -175.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 32.1 t -166.11 97.47 0.62 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.447 1.099 . . . . 61.11 108.857 179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.73 64.79 0.05 OUTLIER Glycine 0 C--N 1.345 1.071 0 N-CA-C 112.084 -0.406 . . . . 64.03 112.084 -178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -166.31 62.66 0.22 Allowed Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.715 -0.554 . . . . 74.25 111.715 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.3 p -86.63 92.51 8.94 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.528 0.731 . . . . 64.31 110.426 177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -79.77 85.9 1.27 Allowed Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.617 -0.593 . . . . 62.34 111.617 175.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 86.23 -129.07 9.18 Favored Glycine 0 C--N 1.343 0.953 0 N-CA-C 110.827 -0.909 . . . . 54.45 110.827 -171.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 44.8 m -146.24 -89.99 0.09 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.016 0.526 . . . . 65.24 109.753 176.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 54.61 16.58 1.39 Allowed 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.591 1.156 . . . . 75.44 113.007 -175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -100.14 172.79 6.96 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.202 0.601 . . . . 72.33 110.839 -170.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 32.4 mt -135.14 142.48 46.18 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.478 0.711 . . . . 63.35 110.408 175.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -106.77 111.2 23.62 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 107.144 -1.428 . . . . 74.11 107.144 165.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.623 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -123.67 -171.33 2.29 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.698 0.799 . . . . 44.04 110.167 -175.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 51.1 m -113.64 145.87 40.63 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.483 1.113 . . . . 62.21 110.434 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.561 HD23 HG22 ' A' ' 253' ' ' VAL . 18.4 tp -113.32 104.94 12.82 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 106.695 -1.595 . . . . 70.24 106.695 167.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -82.58 100.18 9.99 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.704 -0.85 . . . . 74.2 108.704 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.686 ' HA ' HG11 ' A' ' 210' ' ' VAL . 20.9 t -110.88 103.01 54.05 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.281 -1.007 . . . . 72.42 108.281 178.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.05 144.87 77.53 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 121.522 1.481 . . . . 74.23 109.876 175.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.41 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.03 -41.2 78.62 Favored Pre-proline 0 CA--C 1.555 1.147 0 CA-C-O 117.743 -1.122 . . . . 72.42 113.08 -174.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.4 Cg_endo -55.28 -46.22 34.33 Favored 'Trans proline' 0 C--N 1.399 3.19 0 C-N-CA 121.828 1.685 . . . . 71.15 113.06 173.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.413 HG21 HG13 ' A' ' 210' ' ' VAL . 52.0 mt -69.73 -34.82 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.35 0.66 . . . . 53.34 110.616 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.79 -45.13 91.11 Favored 'General case' 0 C--N 1.346 0.419 0 C-N-CA 122.756 0.422 . . . . 72.34 110.593 179.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.89 -49.6 62.0 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 O-C-N 124.543 1.152 . . . . 72.42 111.481 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.7 p -79.0 -23.88 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 122.474 0.31 . . . . 62.24 110.738 -173.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 74.51 71.62 1.11 Allowed Glycine 0 C--N 1.342 0.897 0 N-CA-C 111.466 -0.654 . . . . 75.22 111.466 -174.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.27 -129.57 6.74 Favored Glycine 0 C--N 1.345 1.03 0 N-CA-C 111.765 -0.534 . . . . 64.41 111.765 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -138.85 144.53 39.27 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.778 0.831 . . . . 45.03 109.537 176.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.686 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.0 m -137.02 153.73 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-N 115.665 -0.698 . . . . 73.24 110.564 175.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -74.9 143.51 43.75 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.515 0.726 . . . . 74.4 110.569 176.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.572 ' HB1' HD21 ' A' ' 251' ' ' LEU . . . -116.04 113.15 22.8 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.146 1.378 . . . . 72.33 107.946 172.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.5 tpt -64.87 122.88 17.99 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.342 1.057 . . . . 62.42 111.002 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.521 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -124.09 -171.07 2.25 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.787 1.235 . . . . 75.22 109.084 -178.396 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.506 ' H ' HG22 ' A' ' 214' ' ' THR . 7.0 mt -60.27 -67.26 0.41 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.632 1.173 . . . . 72.32 111.42 -176.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -109.48 -42.53 4.31 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 113.105 -1.861 . . . . 61.32 110.918 -163.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -131.86 157.42 22.4 Favored Glycine 0 N--CA 1.47 0.911 0 CA-C-O 118.916 -0.936 . . . . 75.12 111.308 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -86.3 143.31 7.63 Favored 'Trans proline' 0 C--N 1.369 1.61 0 C-N-CA 121.966 1.778 . . . . 73.13 113.064 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 64.4 t -98.43 167.57 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 114.256 -1.338 . . . . 74.13 108.038 174.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -143.53 145.46 32.58 Favored 'General case' 0 C--O 1.243 0.715 0 N-CA-C 108.444 -0.947 . . . . 73.11 108.444 173.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 11.4 p -135.86 141.24 42.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 C-N-CA 123.404 0.681 . . . . 73.42 110.123 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.84 112.74 10.25 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.565 -0.902 . . . . 72.21 108.565 169.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.7 t -73.27 132.46 81.98 Favored Pre-proline 0 CA--C 1.553 1.092 0 N-CA-C 108.558 -0.905 . . . . 75.11 108.558 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -63.6 153.25 76.16 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.667 2.244 . . . . 65.23 111.525 169.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -64.57 136.07 48.5 Favored 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 121.89 1.727 . . . . 73.13 111.979 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 55.6 mtp180 53.24 54.11 10.78 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.469 1.508 . . . . 71.22 113.275 -178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.518 HG23 ' HD2' ' A' ' 231' ' ' ARG . 19.4 m -80.02 138.2 36.97 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.92 -0.582 . . . . 64.03 111.403 176.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -96.16 160.04 14.64 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.124 0.969 . . . . 55.04 111.135 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -79.88 156.02 27.52 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.314 -1.312 . . . . 74.55 110.858 177.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.64 -18.61 43.77 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 111.958 -0.457 . . . . 65.35 111.958 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.518 ' HD2' HG23 ' A' ' 227' ' ' THR . 78.0 mtt85 -68.48 178.79 1.87 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.039 0.935 . . . . 52.12 109.986 167.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.562 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.2 ptmt -167.02 154.94 9.45 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 123.142 0.276 . . . . 64.11 110.492 173.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.595 HD12 HD11 ' A' ' 251' ' ' LEU . 82.3 mt -81.66 146.09 30.22 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 108.811 -0.811 . . . . 74.11 108.811 167.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -116.1 106.99 14.36 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.808 -1.182 . . . . 73.14 107.808 165.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 249' ' ' LEU . 58.6 mt -107.97 108.44 19.57 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.788 -1.097 . . . . 73.23 109.202 -173.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -82.88 121.92 27.57 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.822 -1.081 . . . . 72.1 110.337 -170.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 85.06 9.93 79.44 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 124.307 1.004 . . . . 23.55 113.894 -178.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.501 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 46.5 mmtm -99.46 6.25 46.0 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 117.75 0.775 . . . . 71.24 112.542 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.35 -174.75 50.24 Favored Glycine 0 N--CA 1.472 1.099 0 O-C-N 123.319 0.387 . . . . 73.03 112.291 171.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -58.35 142.55 81.53 Favored Pre-proline 0 N--CA 1.482 1.145 0 C-N-CA 123.857 0.863 . . . . 75.32 112.993 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.416 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 48.9 Cg_endo -67.23 132.32 27.38 Favored 'Trans proline' 0 C--N 1.384 2.431 0 C-N-CA 123.301 2.668 . . . . 74.21 112.791 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.07 -178.37 15.51 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-N 115.213 -0.903 . . . . 75.22 112.913 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.15 -25.78 21.98 Favored 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 123.101 2.534 . . . . 72.02 112.686 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.24 22.11 16.27 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.308 1.043 . . . . 33.33 111.006 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 98.98 -172.88 26.07 Favored Glycine 0 C--N 1.346 1.139 0 N-CA-C 111.142 -0.783 . . . . 51.3 111.142 -174.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.416 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 68.7 mtm180 -85.41 156.93 20.64 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 122.899 0.479 . . . . 72.22 111.722 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -76.8 -154.86 6.05 Favored Glycine 0 C--N 1.352 1.434 0 O-C-N 123.941 0.776 . . . . 70.43 111.799 171.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -121.75 166.36 14.44 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 117.899 0.85 . . . . 73.02 110.825 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.541 HD23 HD12 ' A' ' 235' ' ' LEU . 46.6 tp -126.78 107.22 9.94 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 123.496 0.718 . . . . 71.14 109.194 -178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -105.08 111.3 24.02 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.966 -1.124 . . . . 75.33 107.966 178.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.623 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.8 pp -125.9 120.9 31.64 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.709 1.003 . . . . 74.53 113.709 -173.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -69.26 123.81 22.16 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 125.733 1.613 . . . . 74.42 112.624 -171.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.619 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 90.4 t -71.86 119.23 18.01 Favored 'Isoleucine or valine' 0 C--O 1.246 0.901 0 C-N-CA 124.821 1.249 . . . . 75.42 111.077 176.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -113.82 115.41 27.72 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 125.626 1.57 . . . . 73.43 107.883 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 36.2 mm -86.87 96.0 5.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 107.868 -1.16 . . . . 74.52 107.868 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.6 t . . . . . 0 CA--C 1.556 1.202 0 C-N-CA 124.539 1.135 . . . . 43.4 109.076 -171.91 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.482 1.174 0 CA-C-O 121.416 0.627 . . . . 63.44 109.456 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -88.21 96.6 10.61 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 107.877 -1.157 . . . . 71.14 107.877 177.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 27.4 m -136.39 135.41 38.74 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 115.365 -0.834 . . . . 72.43 109.227 -172.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -65.01 163.64 14.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.298 0.639 . . . . 72.11 110.251 173.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 9.2 m -62.24 -21.33 65.08 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.432 0.693 . . . . 71.2 112.0 -176.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.0 166.8 18.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.781 0.832 . . . . 54.45 111.713 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -86.16 -80.96 1.15 Allowed Glycine 0 C--N 1.341 0.853 0 CA-C-N 114.886 -1.052 . . . . 53.15 111.011 172.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.536 ' HB2' ' HD3' ' A' ' 179' ' ' LYS . 12.7 pt-20 -153.9 175.27 13.55 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.165 0.586 . . . . 71.44 111.464 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.519 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 23.7 m95 -84.9 -94.9 0.07 Allowed 'General case' 0 C--O 1.239 0.501 0 CA-C-N 114.846 -1.07 . . . . 61.44 110.743 177.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 179.91 165.47 1.19 Allowed 'General case' 0 C--O 1.238 0.496 0 C-N-CA 124.131 0.973 . . . . 72.12 109.014 -170.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 82.07 -47.17 3.65 Favored Glycine 0 N--CA 1.476 1.341 0 N-CA-C 111.765 -0.534 . . . . 74.42 111.765 -177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.536 ' HD3' ' HB2' ' A' ' 175' ' ' GLU . 13.3 ptmm? -69.09 -11.34 60.7 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 123.978 0.911 . . . . 74.2 111.301 165.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -175.41 86.3 0.08 OUTLIER Glycine 0 C--N 1.348 1.197 0 N-CA-C 110.884 -0.886 . . . . 64.34 110.884 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 75.3 m -156.79 172.25 18.95 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.63 1.172 . . . . 44.01 110.419 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 173.03 -171.31 44.36 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 111.611 -0.595 . . . . 64.31 111.611 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -81.51 75.38 2.32 Favored Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.357 -0.697 . . . . 74.23 111.357 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 23.3 t -163.63 138.23 6.05 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.382 0.673 . . . . 74.32 109.694 -176.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -152.81 178.51 29.89 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.672 -0.571 . . . . 63.21 111.672 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -71.71 157.03 53.02 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 116.679 0.24 . . . . 52.13 113.537 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.8 p -154.38 145.66 22.94 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.81 0.844 . . . . 61.03 110.649 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.77 -117.92 4.52 Favored Glycine 0 C--N 1.35 1.307 0 N-CA-C 112.168 -0.373 . . . . 32.31 112.168 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -87.3 59.03 4.47 Favored Glycine 0 C--N 1.348 1.208 0 N-CA-C 111.125 -0.79 . . . . 62.21 111.125 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.2 m -68.9 -41.69 77.92 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.935 0.894 . . . . 74.12 112.216 -169.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 63.88 16.44 9.85 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 124.313 1.008 . . . . 71.34 112.119 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 5.5 p-10 -75.35 148.37 39.32 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 123.742 0.817 . . . . 73.35 110.639 -174.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.47 ' HB2' HD13 ' A' ' 249' ' ' LEU . 84.2 mt -119.3 147.55 44.17 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.328 0.651 . . . . 72.04 110.092 176.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 9.0 t80 -109.31 114.93 29.03 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.882 -1.155 . . . . 74.11 107.882 171.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.428 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -127.42 -173.69 2.98 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.729 0.812 . . . . 75.21 110.441 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 60.3 m -121.52 137.93 54.52 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.519 0.728 . . . . 73.44 111.071 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.5 tp -108.1 108.81 20.05 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.973 1.309 . . . . 53.31 107.69 169.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -92.04 99.35 12.19 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.42 0.629 . . . . 75.51 109.611 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.66 HG22 HG21 ' A' ' 210' ' ' VAL . 15.1 t -101.59 111.03 63.34 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 107.675 -1.231 . . . . 71.24 107.675 175.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -66.55 154.38 74.56 Favored 'Trans proline' 0 C--N 1.359 1.09 0 C-N-CA 121.85 1.7 . . . . 74.02 110.418 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.72 -45.37 79.31 Favored Pre-proline 0 CA--C 1.573 1.847 0 CA-C-O 117.809 -1.091 . . . . 63.52 113.394 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.79 -48.89 13.05 Favored 'Trans proline' 0 C--N 1.402 3.351 0 C-N-CA 121.828 1.685 . . . . 73.31 112.484 178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.475 HG21 HG13 ' A' ' 210' ' ' VAL . 44.4 mt -68.28 -31.2 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.539 0.736 . . . . 62.3 110.762 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.81 -46.72 77.59 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.0 0.52 . . . . 71.4 110.585 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 49.8 t -70.56 -48.33 59.65 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 O-C-N 124.417 1.073 . . . . 73.42 111.954 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.15 -28.58 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-O 120.678 0.275 . . . . 74.42 110.715 -175.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.11 76.46 1.0 Allowed Glycine 0 C--N 1.343 0.931 0 N-CA-C 111.626 -0.589 . . . . 72.14 111.626 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.5 -129.4 6.68 Favored Glycine 0 C--N 1.35 1.335 0 CA-C-O 120.049 -0.306 . . . . 72.3 112.817 -176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.72 135.19 29.57 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.965 0.906 . . . . 73.22 109.132 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.66 HG21 HG22 ' A' ' 199' ' ' VAL . 31.6 m -134.21 149.3 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 123.573 0.749 . . . . 73.21 110.547 178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 16.3 ttm180 -75.95 150.4 37.5 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.945 0.898 . . . . 74.24 110.624 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -122.57 121.58 36.84 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.838 1.255 . . . . 64.24 108.442 173.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.23 123.4 19.01 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.732 0.813 . . . . 74.22 110.217 176.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.486 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.3 OUTLIER -126.47 -171.87 2.5 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.552 1.141 . . . . 72.14 110.206 -176.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.3 mt -63.53 -70.34 0.22 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 122.243 1.021 . . . . 72.34 111.268 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -110.22 -41.59 4.37 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 113.461 -1.7 . . . . 64.23 110.947 -162.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -132.55 145.86 17.7 Favored Glycine 0 C--N 1.338 0.657 0 CA-C-O 118.348 -1.251 . . . . 53.44 110.549 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -70.82 152.72 64.05 Favored 'Trans proline' 0 C--N 1.365 1.409 0 C-N-CA 122.125 1.883 . . . . 60.13 112.628 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 54.1 t -104.09 167.67 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.927 1.291 . . . . 75.31 108.029 174.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -148.64 146.28 28.13 Favored 'General case' 0 C--O 1.244 0.772 0 N-CA-C 107.815 -1.18 . . . . 75.13 107.815 170.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 233' ' ' LEU . 9.6 p -138.5 144.27 30.58 Favored 'Isoleucine or valine' 0 C--O 1.246 0.918 0 C-N-CA 122.946 0.498 . . . . 61.5 110.8 -174.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.59 112.89 12.41 Favored 'General case' 0 C--O 1.24 0.567 0 O-C-N 124.035 0.835 . . . . 74.14 109.675 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.56 134.81 75.71 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.017 0.927 . . . . 41.53 109.45 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.52 154.34 50.08 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.465 2.11 . . . . 52.44 111.533 169.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -61.93 136.97 64.58 Favored 'Trans proline' 0 C--N 1.373 1.846 0 C-N-CA 121.988 1.792 . . . . 72.21 111.756 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 51.51 70.37 0.55 Allowed 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.231 1.413 . . . . 75.01 113.434 -176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.478 HG23 ' HD2' ' A' ' 231' ' ' ARG . 80.8 m -89.01 143.09 27.09 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.803 -1.089 . . . . 54.24 110.655 173.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -107.61 154.85 20.83 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.294 1.037 . . . . 71.12 110.35 174.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.495 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -80.28 150.82 29.85 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 115.053 -0.976 . . . . 74.33 110.823 178.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.1 -21.3 27.3 Favored Glycine 0 N--CA 1.47 0.934 0 N-CA-C 110.931 -0.868 . . . . 71.52 110.931 -171.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.478 ' HD2' HG23 ' A' ' 227' ' ' THR . 72.2 mtt85 -65.34 179.79 0.71 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.09 0.956 . . . . 53.52 110.525 170.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.729 ' HD3' ' HB3' ' A' ' 250' ' ' TYR . 9.9 ptpt -166.77 159.72 14.03 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.225 0.21 . . . . 74.12 111.033 171.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.565 HD12 HD11 ' A' ' 251' ' ' LEU . 71.2 mt -87.22 154.16 20.93 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 109.898 -0.408 . . . . 74.23 109.898 170.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 11.6 ptp180 -117.84 106.75 13.33 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 124.791 1.307 . . . . 73.45 108.04 169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 44.8 mt -118.13 112.98 20.9 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.96 -0.564 . . . . 73.13 110.947 -172.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -90.78 127.4 36.33 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.159 -0.473 . . . . 62.3 109.935 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 88.23 11.57 66.79 Favored Glycine 0 C--N 1.343 0.937 0 O-C-N 123.981 0.8 . . . . 34.53 112.672 -175.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.515 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.3 mmtt -113.79 -4.93 13.29 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.42 0.688 . . . . 74.33 111.867 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.72 -176.41 51.43 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.277 -0.729 . . . . 71.12 111.277 166.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -61.3 139.96 94.6 Favored Pre-proline 0 N--CA 1.487 1.375 0 CA-C-N 117.718 0.759 . . . . 75.21 111.405 -173.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.403 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 34.8 Cg_endo -63.26 137.86 63.28 Favored 'Trans proline' 0 C--N 1.374 1.89 0 C-N-CA 122.838 2.359 . . . . 75.53 112.516 176.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.99 169.51 22.89 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.126 -0.488 . . . . 65.31 113.875 -177.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -71.35 -20.26 27.96 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 123.202 2.601 . . . . 54.22 112.077 172.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.1 17.46 15.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.279 1.032 . . . . 41.11 110.462 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.51 169.35 45.49 Favored Glycine 0 C--N 1.35 1.314 0 N-CA-C 111.29 -0.724 . . . . 72.52 111.29 -170.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.403 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 95.5 mtt180 -65.34 158.2 27.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.877 0.871 . . . . 71.23 111.414 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.47 -164.61 40.46 Favored Glycine 0 C--N 1.338 0.692 0 CA-C-N 115.715 -0.675 . . . . 42.23 112.333 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 8.7 p-10 -110.04 170.99 7.72 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 121.695 0.76 . . . . 71.44 110.574 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.66 ' HG ' HD23 ' A' ' 251' ' ' LEU . 33.5 tp -135.02 109.68 8.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.024 -0.989 . . . . 71.0 109.123 -177.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.729 ' HB3' ' HD3' ' A' ' 232' ' ' LYS . 12.3 m-30 -98.29 112.04 24.17 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.37 -1.344 . . . . 63.13 107.37 173.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.66 HD23 ' HG ' ' A' ' 249' ' ' LEU . 3.5 pp -124.82 113.52 18.01 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.673 0.749 . . . . 75.02 112.863 -174.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -67.51 119.37 12.2 Favored 'General case' 0 C--N 1.349 0.585 0 C-N-CA 124.826 1.25 . . . . 64.24 112.543 -170.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 232' ' ' LYS . 58.5 t -68.07 131.79 33.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 113.858 -1.519 . . . . 73.02 110.862 174.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -127.35 133.98 50.01 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.353 1.461 . . . . 74.32 107.913 -178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.495 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 34.6 mm -103.36 101.37 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 N-CA-C 108.122 -1.066 . . . . 75.22 108.122 177.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.2 t . . . . . 0 CA--C 1.561 1.374 0 CA-C-N 115.045 -0.98 . . . . 37.22 108.634 -170.429 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.453 ' N ' ' SD ' ' A' ' 168' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.476 0.862 0 N-CA-C 108.482 -0.933 . . . . 71.12 108.482 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -127.61 151.5 48.85 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.553 0.741 . . . . 65.52 110.428 -173.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.8 p -134.84 130.35 35.89 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.298 1.039 . . . . 62.21 108.714 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 63.78 14.96 8.67 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.663 1.185 . . . . 43.51 113.652 173.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 23.6 m -65.03 -26.94 68.48 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.314 0.645 . . . . 74.14 110.102 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.5 178.34 4.71 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.068 0.947 . . . . 71.11 111.162 174.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.04 -86.05 1.79 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 109.059 -1.616 . . . . 74.1 109.059 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -144.29 164.89 29.44 Favored 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.389 1.076 . . . . 62.41 109.651 172.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.647 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.6 m95 -70.24 -61.67 1.68 Allowed 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.484 -0.932 . . . . 72.42 108.484 170.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -174.27 -165.08 0.21 Allowed 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 114.502 -1.226 . . . . 70.41 108.209 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -69.62 78.57 0.35 Allowed Glycine 0 C--N 1.34 0.753 0 N-CA-C 109.484 -1.446 . . . . 71.43 109.484 163.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -71.1 89.84 0.84 Allowed 'General case' 0 C--N 1.355 0.806 0 C-N-CA 124.215 1.006 . . . . 74.12 109.562 -170.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 161.67 -50.5 0.34 Allowed Glycine 0 C--O 1.239 0.466 0 CA-C-N 114.059 -1.428 . . . . 45.32 110.708 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 19.2 t -164.41 143.06 7.14 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.462 0.705 . . . . 71.34 109.689 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 172.28 156.17 12.07 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.151 0.282 . . . . 73.51 112.899 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -90.47 -156.33 32.29 Favored Glycine 0 C--N 1.344 1.025 0 C-N-CA 122.832 0.254 . . . . 42.51 112.741 176.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 28.5 m -99.75 169.15 9.45 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.843 0.857 . . . . 73.13 110.356 177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 122.73 141.58 5.98 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 111.99 -0.444 . . . . 72.12 111.99 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 159.65 62.0 0.01 OUTLIER Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.987 -0.845 . . . . 72.32 110.987 -177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.1 t -154.01 129.63 9.99 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.862 0.865 . . . . 62.31 108.902 -178.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -135.85 -130.81 2.96 Favored Glycine 0 C--N 1.344 1.016 0 O-C-N 123.046 0.216 . . . . 73.04 112.984 -174.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -86.34 30.53 4.42 Favored Glycine 0 C--N 1.348 1.238 0 CA-C-O 119.403 -0.665 . . . . 71.45 114.627 -170.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.2 t 71.72 -7.82 1.18 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.812 1.245 . . . . 43.45 113.26 172.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -69.31 -42.69 75.06 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 108.449 -0.945 . . . . 71.41 108.449 169.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 11.4 p-10 -64.97 145.79 55.86 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.585 -1.189 . . . . 74.52 110.013 171.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 65.9 mt -124.54 159.01 31.57 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 121.383 0.611 . . . . 72.22 111.691 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.492 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 8.7 t80 -116.04 109.13 17.1 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 114.54 -1.209 . . . . 73.35 108.774 174.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.636 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.59 -170.42 1.9 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.502 1.121 . . . . 51.25 109.913 -178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 98.3 m -117.53 127.77 54.31 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.732 0.813 . . . . 73.31 110.761 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.648 HD22 ' HG ' ' A' ' 233' ' ' LEU . 17.0 tp -87.84 105.88 17.71 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.866 -1.161 . . . . 43.54 107.866 165.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -87.1 107.52 18.48 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.096 -1.076 . . . . 62.43 108.096 -176.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.642 ' HA ' HG11 ' A' ' 210' ' ' VAL . 19.2 t -117.58 115.94 37.12 Favored Pre-proline 0 N--CA 1.47 0.53 0 N-CA-C 108.83 -0.804 . . . . 71.11 108.83 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.01 149.61 77.29 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 121.571 1.514 . . . . 40.13 110.371 171.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.441 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.38 -43.96 92.64 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-O 117.75 -1.119 . . . . 62.43 112.571 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.441 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.2 Cg_endo -54.42 -52.57 7.91 Favored 'Trans proline' 0 C--N 1.403 3.446 0 C-N-CA 122.291 1.994 . . . . 51.12 113.077 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.438 HG21 HG13 ' A' ' 210' ' ' VAL . 51.2 mt -64.63 -33.61 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 123.207 0.603 . . . . 71.23 111.009 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.48 -46.58 85.5 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.829 0.452 . . . . 61.53 110.837 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.86 -50.62 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 124.004 0.922 . . . . 74.15 112.316 -177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.19 -27.01 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 CA-C-O 120.614 0.245 . . . . 64.3 110.708 -174.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 77.96 76.7 0.88 Allowed Glycine 0 C--N 1.344 0.986 0 CA-C-N 116.021 -0.536 . . . . 54.13 111.764 -175.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -104.46 -130.23 6.77 Favored Glycine 0 N--CA 1.476 1.346 0 N-CA-C 111.018 -0.833 . . . . 74.54 111.018 177.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -133.13 152.91 51.93 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.568 0.747 . . . . 64.43 110.434 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 199' ' ' VAL . 30.7 m -139.9 149.77 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 115.323 -0.853 . . . . 64.4 109.402 173.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -73.42 152.62 40.73 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.516 -0.765 . . . . 71.51 110.673 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -130.73 114.27 15.17 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.147 1.379 . . . . 75.44 108.635 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 12.8 tpt -63.91 123.8 19.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 124.696 1.198 . . . . 74.04 111.435 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.542 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -121.83 -172.82 2.51 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.709 1.203 . . . . 75.3 109.371 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.521 ' H ' HG22 ' A' ' 214' ' ' THR . 4.8 mt -64.88 -65.96 0.6 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 125.191 1.396 . . . . 73.53 110.254 -175.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -93.17 -37.4 12.12 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 112.227 -2.26 . . . . 62.34 110.155 -166.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -145.49 -162.43 9.64 Favored Glycine 0 C--N 1.346 1.09 0 CA-C-N 115.237 -0.892 . . . . 53.14 112.429 -177.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -100.66 174.73 0.31 Allowed 'Trans proline' 0 CA--C 1.553 1.44 0 C-N-CA 123.145 2.564 . . . . 72.23 113.936 171.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.646 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 43.7 t -130.49 167.78 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 126.06 1.744 . . . . 62.34 106.322 172.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -145.68 120.26 9.76 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 108.388 -0.967 . . . . 64.43 108.388 172.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.449 HG11 HD11 ' A' ' 233' ' ' LEU . 15.0 p -112.53 141.37 28.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.681 0 C-N-CA 123.99 0.916 . . . . 72.23 110.095 -177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.06 115.91 15.21 Favored 'General case' 0 C--O 1.243 0.748 0 N-CA-C 108.538 -0.912 . . . . 42.34 108.538 170.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 88.6 t -75.92 132.53 74.12 Favored Pre-proline 0 CA--C 1.549 0.911 0 N-CA-C 108.559 -0.904 . . . . 74.41 108.559 175.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -67.73 149.59 78.79 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.939 2.426 . . . . 64.13 111.536 172.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -56.64 129.99 37.61 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.374 2.049 . . . . 51.33 112.572 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 17.6 mtp180 54.58 68.25 0.89 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.456 1.502 . . . . 72.42 113.478 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.403 HG21 ' CH2' ' A' ' 176' ' ' TRP . 54.0 m -95.05 139.27 31.64 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 114.901 -1.045 . . . . 70.53 110.184 172.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -104.07 163.87 12.1 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.453 1.101 . . . . 74.43 110.765 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.523 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.4 155.73 24.53 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.336 -1.302 . . . . 72.01 110.924 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 99.95 -5.17 57.84 Favored Glycine 0 N--CA 1.477 1.367 0 N-CA-C 111.878 -0.489 . . . . 71.55 111.878 -173.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -81.38 -174.96 5.23 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.998 0.919 . . . . 74.23 109.308 168.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.537 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.6 ptpt -165.98 161.99 17.78 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.08 0.552 . . . . 62.32 109.692 169.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.765 HD12 HD11 ' A' ' 251' ' ' LEU . 87.0 mt -85.92 150.71 24.32 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.49 -0.93 . . . . 65.5 108.49 164.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -116.94 106.39 13.38 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 107.876 -1.157 . . . . 75.15 107.876 160.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.628 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 43.3 mt -102.2 104.39 14.97 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 114.41 -1.268 . . . . 52.32 108.76 -174.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -79.47 118.81 21.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 114.164 -1.38 . . . . 74.4 110.295 -167.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.94 9.59 82.34 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.436 1.085 . . . . 54.25 114.044 -177.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.555 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.4 mmtt -96.29 -0.04 50.19 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 118.249 1.024 . . . . 73.51 112.772 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.53 -177.35 50.46 Favored Glycine 0 N--CA 1.472 1.066 0 N-CA-C 111.716 -0.553 . . . . 75.42 111.716 170.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -55.46 126.18 62.1 Favored Pre-proline 0 N--CA 1.476 0.843 0 C-N-CA 123.568 0.747 . . . . 73.25 111.29 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.502 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 35.2 Cg_endo -65.05 134.72 40.82 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.7 2.267 . . . . 73.22 111.918 175.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -117.4 177.34 16.58 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.244 -0.889 . . . . 51.5 112.356 -176.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -68.39 -33.36 23.57 Favored 'Trans proline' 0 C--N 1.372 1.787 0 C-N-CA 122.824 2.349 . . . . 61.41 113.073 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -95.55 -33.62 12.34 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.137 0.575 . . . . 71.35 111.122 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 177.63 174.86 44.36 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.242 -0.89 . . . . 74.41 111.163 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.502 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 65.9 mtt180 -88.05 160.56 17.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.233 0.613 . . . . 73.32 111.47 -176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.54 -176.38 50.98 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.688 -0.965 . . . . 75.25 110.688 168.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 27.1 m-20 -110.33 -178.99 3.65 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.118 0.567 . . . . 74.3 110.163 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.628 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 55.7 tp -136.38 105.47 5.96 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.887 0.851 . . . . 55.4 109.499 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.492 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 58.9 m-85 -99.56 108.8 21.31 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.703 -1.221 . . . . 72.55 107.703 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.765 HD11 HD12 ' A' ' 233' ' ' LEU . 1.5 pp -125.49 115.0 19.54 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.965 1.098 . . . . 64.53 113.965 -174.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -67.65 126.46 29.43 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 113.656 -1.611 . . . . 71.41 113.1 -170.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.647 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 63.3 t -75.01 124.83 33.64 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 CA-C-N 113.522 -1.672 . . . . 74.01 110.622 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -121.04 122.06 39.27 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 124.817 1.247 . . . . 72.13 107.788 176.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.523 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 32.7 mm -92.51 103.73 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.04 -1.096 . . . . 64.32 108.04 177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 CA--C 1.562 1.42 0 CA-C-O 117.484 -1.246 . . . . 70.24 108.751 -169.384 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 75.9 mtp . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 121.198 0.523 . . . . 61.44 109.757 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.46 ' HG2' ' H ' ' A' ' 170' ' ' THR . 29.7 tt0 -167.88 -177.29 3.36 Favored 'General case' 0 CA--C 1.552 1.043 0 N-CA-C 108.528 -0.916 . . . . 74.01 108.528 -174.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.46 ' H ' ' HG2' ' A' ' 169' ' ' GLU . 11.0 t -56.71 -30.59 63.65 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.573 0.749 . . . . 74.54 111.704 170.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.34 133.65 47.15 Favored 'General case' 0 C--N 1.349 0.547 0 N-CA-C 109.509 -0.552 . . . . 71.43 109.509 171.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 22.5 m -66.68 -15.38 63.46 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.818 0.847 . . . . 63.25 111.097 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.17 167.57 20.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.866 0.866 . . . . 61.12 112.746 178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -89.74 -91.53 1.21 Allowed Glycine 0 C--N 1.346 1.094 0 N-CA-C 110.102 -1.199 . . . . 51.52 110.102 169.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -141.19 170.05 16.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.211 1.004 . . . . 72.3 110.495 177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.626 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 15.3 m95 -70.88 -77.66 0.09 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.542 0.737 . . . . 63.43 109.946 173.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.412 ' NE2' ' H ' ' A' ' 232' ' ' LYS . 9.2 pt20 -173.71 -162.32 0.15 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 108.388 -0.968 . . . . 75.14 108.388 -175.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -67.13 76.85 0.17 Allowed Glycine 0 C--N 1.347 1.164 0 N-CA-C 110.309 -1.116 . . . . 63.21 110.309 164.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.21 84.64 1.38 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 122.442 1.115 . . . . 61.04 110.773 -167.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -162.38 -116.07 0.37 Allowed Glycine 0 C--N 1.339 0.722 0 CA-C-N 114.3 -1.318 . . . . 73.41 111.228 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 39.9 p -79.08 -30.06 43.71 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.504 0.722 . . . . 73.23 111.69 178.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 131.94 -124.85 4.11 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 111.839 -0.504 . . . . 62.14 111.839 178.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 171.84 -157.68 28.0 Favored Glycine 0 C--N 1.344 1.01 0 N-CA-C 111.059 -0.816 . . . . 65.13 111.059 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 59.0 p -82.43 -29.45 30.69 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 117.468 0.634 . . . . 62.45 110.927 177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 141.03 -144.17 14.27 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 116.183 -0.462 . . . . 73.04 112.292 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.28 168.33 40.82 Favored Glycine 0 C--N 1.346 1.098 0 N-CA-C 111.533 -0.627 . . . . 64.03 111.533 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 23.0 t -128.67 162.64 26.88 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.473 0.709 . . . . 41.31 110.486 -176.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -137.9 130.03 4.87 Favored Glycine 0 C--N 1.345 1.057 0 N-CA-C 110.586 -1.006 . . . . 73.33 110.586 177.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -117.01 -121.06 3.18 Favored Glycine 0 C--N 1.344 1.01 0 CA-C-N 117.182 0.491 . . . . 52.24 112.772 -175.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.2 m -91.66 -73.43 0.54 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.865 0.466 . . . . 54.34 111.198 -175.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.494 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 23.0 mt-30 -75.67 -39.83 56.98 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.099 0.56 . . . . 64.55 110.049 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.431 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 12.2 p-10 -73.92 103.83 4.57 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 122.021 0.915 . . . . 72.4 108.757 175.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.2 mt -91.5 170.33 10.03 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 114.859 -1.064 . . . . 63.11 112.981 -168.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.409 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 24.8 t80 -124.84 140.32 53.03 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 113.41 -1.723 . . . . 71.4 107.621 171.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.632 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -154.43 -170.91 3.68 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.291 0.637 . . . . 64.2 110.176 -178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 254' ' ' ARG . 91.0 m -117.82 138.27 52.19 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.09 0.956 . . . . 72.35 110.809 177.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.634 HD23 HG22 ' A' ' 253' ' ' VAL . 17.3 tp -98.55 108.92 21.72 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.727 -1.212 . . . . 64.32 107.727 166.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -82.73 100.6 10.36 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.211 -0.662 . . . . 71.42 109.211 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.673 HG22 HG21 ' A' ' 210' ' ' VAL . 21.5 t -108.11 109.43 61.9 Favored Pre-proline 0 N--CA 1.468 0.473 0 N-CA-C 108.715 -0.846 . . . . 52.55 108.715 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.42 145.56 65.51 Favored 'Trans proline' 0 C--N 1.366 1.469 0 C-N-CA 121.257 1.305 . . . . 72.5 109.597 173.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.455 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -51.66 -40.53 70.8 Favored Pre-proline 0 CA--C 1.56 1.337 0 N-CA-C 113.979 1.103 . . . . 51.12 113.979 -175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 19.2 Cg_endo -56.16 -48.65 18.44 Favored 'Trans proline' 0 C--N 1.397 3.13 0 C-N-CA 122.037 1.825 . . . . 72.24 112.751 174.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.483 HG21 HG13 ' A' ' 210' ' ' VAL . 37.4 mt -67.74 -35.15 71.65 Favored 'Isoleucine or valine' 0 C--N 1.362 1.131 0 C-N-CA 122.905 0.482 . . . . 72.32 110.833 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.409 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -61.21 -46.3 91.02 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 123.072 0.549 . . . . 64.23 110.817 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 50.4 t -71.12 -48.1 57.19 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 C-N-CA 123.889 0.876 . . . . 35.14 112.119 -178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.3 p -78.43 -23.58 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 CA-C-O 120.607 0.241 . . . . 73.53 110.726 -173.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 76.26 68.75 1.48 Allowed Glycine 0 C--N 1.343 0.918 0 CA-C-N 115.759 -0.655 . . . . 34.24 111.791 -175.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.6 -136.83 9.31 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-O 119.741 -0.477 . . . . 52.04 112.308 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 5.3 ttmt -129.57 139.41 51.49 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 109.014 -0.736 . . . . 74.35 109.014 177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.673 HG21 HG22 ' A' ' 199' ' ' VAL . 27.6 m -131.76 146.94 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 122.861 0.464 . . . . 64.14 110.929 175.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -74.34 144.35 44.51 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.948 -1.024 . . . . 73.1 110.297 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.689 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -117.24 122.35 43.73 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.92 1.288 . . . . 74.34 108.07 172.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -63.79 119.43 9.94 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.344 0.657 . . . . 60.14 110.037 175.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.96 -170.41 2.1 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.437 1.095 . . . . 72.51 109.378 -175.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.6 mt -65.99 -70.24 0.25 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.844 0.83 . . . . 63.44 110.77 -175.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -114.0 -41.29 3.56 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-N 113.719 -1.582 . . . . 61.34 111.445 -166.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -130.49 129.0 5.72 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-O 118.465 -1.186 . . . . 72.15 110.513 179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -71.27 152.96 61.84 Favored 'Trans proline' 0 C--N 1.371 1.747 0 C-N-CA 122.184 1.923 . . . . 74.33 113.212 -173.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.689 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 55.1 t -97.43 166.39 1.93 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 CA-C-N 114.255 -1.339 . . . . 61.24 108.691 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -149.77 135.1 18.21 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.614 -0.884 . . . . 71.51 108.614 172.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 209' ' ' LYS . 14.3 p -131.11 142.56 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.526 0.73 . . . . 63.22 110.812 -172.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -73.1 108.19 5.85 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 122.93 0.492 . . . . 71.24 109.721 170.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 204' ' ' ALA . 70.6 t -69.58 134.37 88.54 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 123.84 0.856 . . . . 71.55 109.137 172.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.37 154.56 71.69 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.386 2.057 . . . . 70.15 111.286 172.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.4 131.18 37.09 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 122.161 1.907 . . . . 73.0 112.072 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 29.7 mtp180 53.81 69.76 0.68 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.265 1.426 . . . . 74.22 113.389 -177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.431 HG23 ' HD2' ' A' ' 231' ' ' ARG . 87.1 m -88.2 142.42 27.77 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.666 -1.152 . . . . 62.23 110.908 173.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -103.7 164.78 11.46 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.047 0.939 . . . . 74.14 110.614 174.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.468 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -86.87 149.57 24.73 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.196 -0.911 . . . . 73.12 111.17 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 109.8 -12.28 32.36 Favored Glycine 0 N--CA 1.473 1.123 0 CA-C-N 115.922 -0.581 . . . . 35.2 111.965 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.431 ' HD2' HG23 ' A' ' 227' ' ' THR . 62.0 mtt85 -74.4 -175.49 2.36 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.24 1.016 . . . . 75.35 110.336 172.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.536 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.2 ptmt -168.37 165.21 12.85 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 111.752 0.278 . . . . 74.13 111.752 174.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.677 HD12 HD11 ' A' ' 251' ' ' LEU . 84.5 mt -95.57 150.56 20.2 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 123.514 0.509 . . . . 63.43 109.713 167.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -114.15 107.09 15.16 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 107.659 -1.237 . . . . 70.41 107.659 162.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.626 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 57.0 mt -106.99 110.75 22.97 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.317 -0.856 . . . . 72.41 109.748 -174.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -77.75 118.68 20.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.761 -1.109 . . . . 63.32 110.8 -169.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 83.35 3.61 89.92 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-N 114.948 -1.024 . . . . 61.15 114.386 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -95.27 2.67 54.88 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 112.804 0.668 . . . . 75.43 112.804 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -81.42 -173.12 47.62 Favored Glycine 0 C--N 1.341 0.846 0 N-CA-C 110.693 -0.963 . . . . 63.34 110.693 166.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.494 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 15.4 m-85 -58.9 134.8 87.11 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 117.737 0.769 . . . . 60.41 110.759 -178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.442 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 3.5 Cg_exo -76.96 139.44 19.4 Favored 'Trans proline' 0 C--N 1.363 1.303 0 C-N-CA 122.575 2.183 . . . . 63.04 110.763 174.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -107.36 -167.93 22.0 Favored Glycine 0 C--O 1.238 0.345 0 CA-C-O 119.132 -0.815 . . . . 44.22 111.73 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.55 -50.44 10.72 Favored 'Trans proline' 0 C--N 1.369 1.611 0 C-N-CA 122.693 2.262 . . . . 63.23 112.763 -177.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -120.63 -25.0 5.61 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.159 0.584 . . . . 64.5 112.225 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -133.82 158.87 23.5 Favored Glycine 0 N--CA 1.478 1.486 0 CA-C-O 119.925 -0.375 . . . . 54.22 112.349 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.442 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 92.7 mtt180 -113.32 157.82 21.34 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.606 0.763 . . . . 74.43 110.763 -175.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.46 175.73 37.77 Favored Glycine 0 N--CA 1.468 0.798 0 CA-C-N 115.528 -0.76 . . . . 53.2 111.556 175.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 40.2 m-20 -102.67 176.78 5.05 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.762 -0.459 . . . . 72.44 109.762 -177.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.626 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 48.6 tp -134.09 108.84 8.55 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.327 0.584 . . . . 70.24 110.41 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 194' ' ' TYR . 34.3 m-85 -102.33 103.56 14.01 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 108.032 -1.099 . . . . 74.41 108.032 -177.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.677 HD11 HD12 ' A' ' 233' ' ' LEU . 2.4 pp -121.38 114.55 21.46 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 113.837 1.051 . . . . 64.42 113.837 -172.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.08 118.32 11.84 Favored 'General case' 0 C--N 1.349 0.563 0 CA-C-N 114.071 -1.422 . . . . 63.42 113.215 -172.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.634 HG22 HD23 ' A' ' 197' ' ' LEU . 98.2 t -62.36 122.34 12.91 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-N 113.73 -1.577 . . . . 55.15 111.701 174.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.41 ' HG2' HG23 ' A' ' 196' ' ' THR . 17.3 mmm180 -121.43 122.81 40.59 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 114.912 -1.04 . . . . 74.1 108.236 176.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.468 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 30.5 mm -88.78 96.55 6.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 108.993 -0.743 . . . . 60.14 108.993 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 CA--C 1.561 1.384 0 C-N-CA 125.077 1.351 . . . . 73.41 108.819 -175.311 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.441 ' N ' ' SD ' ' A' ' 168' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.483 1.225 0 N-CA-C 109.513 -0.551 . . . . 61.14 109.513 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -74.69 128.23 35.06 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.791 0.437 . . . . 72.33 110.237 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 40.5 p -104.2 115.04 29.7 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.117 -0.947 . . . . 75.14 108.957 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -60.19 -53.9 52.19 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 109.448 -0.575 . . . . 75.33 109.448 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.493 HG22 HG22 ' A' ' 219' ' ' VAL . 3.6 m -153.17 -41.36 0.1 Allowed 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.304 -0.999 . . . . 61.12 108.304 169.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.84 174.49 10.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.328 -0.851 . . . . 64.01 110.914 173.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.414 ' H ' ' CD2' ' A' ' 235' ' ' LEU . . . -101.97 -85.29 1.86 Allowed Glycine 0 C--N 1.336 0.573 0 N-CA-C 109.323 -1.511 . . . . 52.13 109.323 177.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 179' ' ' LYS . 14.1 pt-20 -151.82 174.94 12.96 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 123.453 0.701 . . . . 73.21 110.811 175.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.519 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 18.5 m95 -85.78 -90.5 0.1 Allowed 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 115.239 -0.892 . . . . 75.21 110.96 177.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -126.97 -15.63 5.3 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.839 0.856 . . . . 74.32 110.724 -170.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 168.83 74.33 0.04 OUTLIER Glycine 0 C--N 1.345 1.06 0 N-CA-C 110.342 -1.103 . . . . 65.24 110.342 -175.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 175' ' ' GLU . 12.8 tmtt? -70.82 99.64 1.77 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 108.608 -0.886 . . . . 73.54 108.608 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 144.61 -38.22 1.31 Allowed Glycine 0 C--N 1.338 0.663 0 CA-C-N 115.01 -0.995 . . . . 63.42 111.344 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 32.9 t -147.7 -64.94 0.26 Allowed 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.371 0.669 . . . . 73.42 109.484 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 158.22 -178.64 34.39 Favored Glycine 0 C--N 1.342 0.89 0 CA-C-N 115.797 -0.638 . . . . 72.43 112.177 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 155.71 -146.95 15.1 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 111.194 -0.763 . . . . 52.12 111.194 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.2 p -159.14 124.32 4.19 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.557 0.743 . . . . 75.13 109.306 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -79.71 178.59 53.67 Favored Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.411 -0.359 . . . . 73.34 113.347 -175.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -89.05 178.03 44.8 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 112.483 -0.247 . . . . 54.11 112.483 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 8.6 t -147.01 19.83 1.25 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.099 0.56 . . . . 65.2 110.375 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -149.08 175.27 28.39 Favored Glycine 0 C--N 1.343 0.922 0 CA-C-N 116.551 -0.295 . . . . 73.54 112.438 -178.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 150.01 -129.67 3.04 Favored Glycine 0 C--N 1.337 0.622 0 N-CA-C 110.941 -0.863 . . . . 71.33 110.941 178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 24.6 p -152.02 137.91 18.07 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.138 0.975 . . . . 63.33 108.693 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.8 mt-30 63.57 12.78 6.74 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 124.492 1.117 . . . . 72.33 111.34 -169.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -85.45 145.22 27.54 Favored 'General case' 0 C--N 1.349 0.568 0 C-N-CA 123.827 0.851 . . . . 72.34 110.248 -172.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 58.6 mt -107.01 150.75 26.18 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.951 -0.759 . . . . 51.23 108.951 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 1.8 t80 -125.86 108.77 11.77 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 108.19 -1.041 . . . . 61.23 108.19 173.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -118.69 -174.86 2.77 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.082 0.953 . . . . 55.22 109.575 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 85.0 m -126.79 116.02 20.26 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.746 0.818 . . . . 72.53 109.944 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.545 HD23 HG22 ' A' ' 253' ' ' VAL . 15.7 tp -82.08 105.48 13.21 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 108.618 -0.882 . . . . 73.14 108.618 172.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -88.56 100.32 12.99 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.774 -0.825 . . . . 72.43 108.774 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.621 HG22 HG21 ' A' ' 210' ' ' VAL . 21.4 t -102.87 114.76 65.06 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 108.22 -1.03 . . . . 74.04 108.22 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.39 145.89 73.01 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 121.515 1.477 . . . . 62.12 110.342 174.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.76 -43.41 82.29 Favored Pre-proline 0 CA--C 1.562 1.417 0 CA-C-O 117.696 -1.145 . . . . 72.54 112.717 -176.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 12.2 Cg_endo -54.42 -50.06 14.78 Favored 'Trans proline' 0 C--N 1.398 3.179 0 C-N-CA 121.948 1.765 . . . . 45.31 112.703 174.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.455 HG21 HG13 ' A' ' 210' ' ' VAL . 17.3 mt -65.4 -35.65 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 123.404 0.682 . . . . 74.03 111.011 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.82 -44.26 93.8 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 122.847 0.459 . . . . 43.21 111.012 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.5 t -70.58 -50.84 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.626 1.17 . . . . 52.42 111.975 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.6 p -80.41 -15.81 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 122.852 0.461 . . . . 72.01 110.671 -174.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 70.79 75.57 0.61 Allowed Glycine 0 C--N 1.352 1.441 0 N-CA-C 111.403 -0.679 . . . . 71.41 111.403 -178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -102.16 -132.82 7.84 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-N 116.842 0.321 . . . . 71.45 112.446 -176.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.2 ttmt -142.95 135.42 27.52 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.983 0.913 . . . . 73.24 109.077 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.621 HG21 HG22 ' A' ' 199' ' ' VAL . 23.3 m -132.74 145.95 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 123.182 0.593 . . . . 75.33 110.18 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -71.01 142.02 50.94 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.413 0.685 . . . . 63.14 110.758 178.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.555 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -118.35 120.18 36.85 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.763 1.225 . . . . 72.03 109.02 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.401 ' O ' HD21 ' A' ' 249' ' ' LEU . 13.4 tpt -65.32 136.98 57.23 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 124.053 0.941 . . . . 74.4 111.77 179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.633 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -139.88 -174.26 3.86 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 124.0 0.92 . . . . 62.42 110.288 -179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.589 ' H ' HG22 ' A' ' 214' ' ' THR . 10.6 mt -52.95 -68.4 0.17 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.656 1.582 . . . . 60.5 112.683 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -111.65 -41.23 4.11 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 113.714 -1.585 . . . . 71.41 111.352 -165.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -130.94 158.58 22.7 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-O 119.108 -0.829 . . . . 63.54 112.514 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.25 143.4 8.93 Favored 'Trans proline' 0 C--N 1.369 1.62 0 C-N-CA 122.567 2.178 . . . . 74.41 113.416 -178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.555 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 78.0 t -97.22 166.13 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.902 1.281 . . . . 64.12 108.245 174.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -147.72 135.65 21.16 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.463 -1.31 . . . . 74.32 107.463 170.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.512 HG11 HD11 ' A' ' 233' ' ' LEU . 11.3 p -128.46 140.74 48.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.955 0 C-N-CA 123.184 0.594 . . . . 74.53 110.931 -170.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.41 108.82 5.71 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.84 0.856 . . . . 45.12 109.384 174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.404 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 86.5 t -72.33 130.62 85.86 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.89 -0.782 . . . . 72.35 108.89 174.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.04 155.56 61.47 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.759 2.306 . . . . 74.02 111.202 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -60.92 139.52 85.36 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.402 2.068 . . . . 74.5 112.403 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 41.44 73.93 0.12 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.703 1.601 . . . . 63.34 113.653 -174.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.545 HG23 ' HD2' ' A' ' 231' ' ' ARG . 92.8 m -84.6 139.12 32.31 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.011 -0.995 . . . . 72.43 110.998 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.51 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 24.8 mp0 -101.75 147.31 26.62 Favored 'General case' 0 C--O 1.243 0.756 0 C-N-CA 124.208 1.003 . . . . 63.41 109.175 171.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.431 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -73.26 155.91 39.02 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.129 -0.941 . . . . 50.3 110.854 178.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 108.62 -19.62 30.84 Favored Glycine 0 N--CA 1.47 0.928 0 N-CA-C 111.63 -0.588 . . . . 75.15 111.63 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.545 ' HD2' HG23 ' A' ' 227' ' ' THR . 80.5 mtt85 -66.34 177.95 1.34 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.867 0.867 . . . . 74.44 110.276 167.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.613 ' HA ' HG23 ' A' ' 253' ' ' VAL . 2.2 ptmt -167.62 158.04 10.89 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.218 0.324 . . . . 74.01 110.653 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.627 HD12 HD11 ' A' ' 251' ' ' LEU . 67.9 mt -86.02 136.41 33.26 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.995 -0.743 . . . . 73.31 108.995 171.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -103.56 104.77 14.87 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 106.957 -1.497 . . . . 73.24 106.957 164.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 48.1 mt -107.88 106.8 17.25 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.411 -0.813 . . . . 74.44 109.257 -176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.0 mmmt -80.62 116.76 20.81 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.736 -1.12 . . . . 72.41 111.076 -168.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 88.37 4.25 77.41 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.79 -0.641 . . . . 64.41 113.652 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.633 ' HD2' HG21 ' A' ' 214' ' ' THR . 46.2 mmtm -93.93 4.84 53.33 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 112.846 0.684 . . . . 73.4 112.846 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.25 -177.48 50.73 Favored Glycine 0 C--N 1.347 1.171 0 CA-C-O 119.429 -0.65 . . . . 55.15 111.554 171.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -60.59 142.78 91.05 Favored Pre-proline 0 N--CA 1.488 1.446 0 CA-C-N 117.45 0.625 . . . . 74.34 111.636 -174.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.52 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 38.3 Cg_endo -66.68 139.75 53.91 Favored 'Trans proline' 0 C--N 1.378 2.129 0 C-N-CA 122.709 2.272 . . . . 74.31 113.112 177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.77 170.91 22.24 Favored Glycine 0 C--N 1.349 1.292 0 CA-C-N 115.399 -0.819 . . . . 71.02 112.548 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.11 -21.01 27.89 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 123.096 2.531 . . . . 72.31 113.205 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.4 -11.64 17.73 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.842 0.857 . . . . 54.03 111.297 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 141.28 163.66 9.64 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.717 -0.953 . . . . 75.51 110.717 -174.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.52 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 42.0 mtm180 -69.15 170.66 9.63 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.515 0.726 . . . . 75.21 111.776 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.74 -164.26 39.9 Favored Glycine 0 C--N 1.346 1.126 0 N-CA-C 112.089 -0.404 . . . . 32.05 112.089 173.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -121.59 152.03 39.72 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 109.148 -0.686 . . . . 64.52 109.148 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.559 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 23.7 tp -112.19 108.38 17.61 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.651 0.78 . . . . 73.2 109.227 -174.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 53.7 m-85 -101.58 119.26 38.5 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.788 -1.19 . . . . 74.3 107.788 175.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.631 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.3 pp -131.79 115.7 16.29 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.786 0.803 . . . . 72.22 112.99 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -68.76 118.8 12.2 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.174 1.39 . . . . 74.11 112.855 -169.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.613 HG23 ' HA ' ' A' ' 232' ' ' LYS . 67.9 t -69.6 127.1 30.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 CA-C-N 114.156 -1.384 . . . . 73.52 111.31 176.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -124.24 130.49 52.61 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.591 1.556 . . . . 71.34 108.126 179.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.431 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 36.3 mm -100.18 98.44 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.336 -0.986 . . . . 74.03 108.336 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 C--O 1.258 1.526 0 C-N-CA 124.637 1.175 . . . . 75.42 108.386 -172.407 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 111.284 0.105 . . . . 63.11 111.284 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -73.71 115.34 13.01 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.836 0.855 . . . . 71.42 109.268 -176.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.0 t -159.38 136.04 9.29 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 109.035 -0.728 . . . . 70.31 109.035 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 61.46 25.73 15.62 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 124.539 1.136 . . . . 71.34 110.934 -174.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.4 m -77.48 -21.82 52.25 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 123.9 0.88 . . . . 72.0 110.196 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -98.61 175.32 6.04 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.767 -1.106 . . . . 63.12 111.421 175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -105.49 -108.52 3.32 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 115.183 -0.917 . . . . 74.32 110.901 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.91 153.09 36.4 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 123.857 0.863 . . . . 72.41 109.98 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.52 ' CZ3' HG21 ' A' ' 227' ' ' THR . 23.2 m95 -77.79 -83.56 0.08 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.715 -0.675 . . . . 52.11 110.101 177.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.441 ' HG3' ' HG2' ' A' ' 231' ' ' ARG . 23.4 mm-40 -131.25 -59.63 0.97 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.076 -1.083 . . . . 71.35 108.076 -172.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 69.91 -74.69 0.47 Allowed Glycine 0 C--N 1.35 1.347 0 N-CA-C 110.824 -0.91 . . . . 75.45 110.824 -170.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -123.77 147.54 47.44 Favored 'General case' 0 C--O 1.243 0.725 0 C-N-CA 124.47 1.108 . . . . 61.32 109.234 173.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -171.93 102.44 0.18 Allowed Glycine 0 C--N 1.338 0.667 0 N-CA-C 110.962 -0.855 . . . . 23.03 110.962 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 19.0 m -72.18 -6.2 41.1 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.422 0.689 . . . . 50.21 112.012 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 96.61 57.17 1.12 Allowed Glycine 0 C--N 1.352 1.462 0 C-N-CA 122.959 0.314 . . . . 65.04 112.518 172.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -172.62 110.46 0.34 Allowed Glycine 0 C--N 1.344 0.992 0 N-CA-C 111.665 -0.574 . . . . 62.15 111.665 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 27.8 p -164.25 -17.59 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.746 0.818 . . . . 73.3 111.729 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 78.29 -82.1 1.28 Allowed Glycine 0 C--N 1.347 1.139 0 O-C-N 123.282 0.364 . . . . 75.24 112.85 179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 69.66 55.34 9.94 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 112.103 -0.399 . . . . 73.32 112.103 -178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 49.8 m -107.75 -29.23 9.23 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.375 0.67 . . . . 75.14 111.007 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 118.95 178.44 16.73 Favored Glycine 0 C--N 1.349 1.271 0 CA-C-N 116.341 -0.391 . . . . 62.41 113.297 176.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -146.5 -135.19 2.71 Favored Glycine 0 C--N 1.341 0.845 0 N-CA-C 110.046 -1.222 . . . . 62.42 110.046 178.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.4 m -81.87 -70.91 0.51 Allowed 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 117.544 0.672 . . . . 72.33 109.466 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -88.15 -26.51 22.41 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.602 0.761 . . . . 63.2 110.063 177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -67.14 128.26 35.72 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.209 -0.905 . . . . 61.01 108.862 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 67.0 mt -122.72 139.32 54.1 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.353 0.661 . . . . 63.43 110.987 -170.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 21.1 t80 -103.62 133.49 48.55 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.138 -1.06 . . . . 65.23 108.138 169.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -139.15 -172.19 3.28 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.523 0.729 . . . . 52.24 110.059 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 43.4 m -118.08 158.61 24.69 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.126 0.97 . . . . 75.4 109.919 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.554 HD23 HG22 ' A' ' 253' ' ' VAL . 16.8 tp -126.52 114.47 18.16 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.585 1.554 . . . . 71.04 107.479 174.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.47 99.03 12.11 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.066 -0.716 . . . . 75.25 109.066 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.71 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.4 t -109.01 108.96 60.94 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 108.161 -1.051 . . . . 73.22 108.161 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.427 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 35.9 Cg_endo -66.68 146.14 77.97 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 121.575 1.517 . . . . 72.42 110.329 174.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -46.67 -46.91 50.7 Favored Pre-proline 0 CA--C 1.563 1.453 0 O-C-N 124.198 0.936 . . . . 72.23 113.258 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 33.4 Cg_exo -57.5 -47.88 19.78 Favored 'Trans proline' 0 C--N 1.394 2.937 0 C-N-CA 121.645 1.564 . . . . 72.31 113.679 177.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 47.6 mt -65.97 -34.48 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 122.707 0.403 . . . . 70.52 110.765 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -62.35 -43.07 99.68 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.411 0.444 . . . . 75.34 110.421 177.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 78.0 t -73.24 -51.2 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 124.221 0.951 . . . . 50.43 111.919 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.33 -25.97 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-O 120.822 0.344 . . . . 72.21 111.02 -172.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 81.7 75.28 1.13 Allowed Glycine 0 C--N 1.342 0.882 0 CA-C-N 115.866 -0.606 . . . . 72.2 112.431 -178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -107.99 -135.51 7.66 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 112.176 -0.37 . . . . 75.22 112.176 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 3.5 mtmp? -130.89 150.63 51.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.068 0.947 . . . . 64.23 110.026 173.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.71 HG11 ' HA ' ' A' ' 199' ' ' VAL . 34.8 m -140.59 157.4 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 C-N-CA 123.584 0.754 . . . . 72.42 110.882 175.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -79.5 141.26 36.87 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.116 0.566 . . . . 75.32 110.944 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.517 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -119.08 118.68 32.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.2 1.4 . . . . 75.52 108.112 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 12.9 tpt -64.85 132.02 48.33 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.169 0.587 . . . . 64.44 111.11 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.438 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -139.86 -169.52 2.74 Favored 'General case' 0 CA--C 1.558 1.255 0 C-N-CA 124.577 1.151 . . . . 61.15 109.783 -174.218 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.451 ' HB2' ' HG2' ' A' ' 216' ' ' GLU . 4.7 mt -77.33 -66.67 0.8 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.294 1.438 . . . . 61.21 110.185 -173.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.451 ' HG2' ' HB2' ' A' ' 215' ' ' LEU . 21.6 mm-40 -87.88 -31.0 19.71 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 112.268 -2.242 . . . . 45.32 110.491 -164.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -164.11 -178.85 37.96 Favored Glycine 0 C--N 1.33 0.218 0 CA-C-N 114.964 -1.017 . . . . 62.41 111.702 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.08 136.6 5.03 Favored 'Trans proline' 0 C--N 1.361 1.213 0 C-N-CA 122.212 1.941 . . . . 74.43 112.713 172.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.517 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 49.7 t -90.41 162.64 2.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.402 -1.272 . . . . 72.44 107.899 173.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -142.51 129.41 20.63 Favored 'General case' 0 C--O 1.247 0.935 0 N-CA-C 108.14 -1.059 . . . . 74.53 108.14 173.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 233' ' ' LEU . 14.9 p -120.69 138.96 49.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 123.552 0.741 . . . . 53.24 110.855 -174.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -71.7 102.99 2.93 Favored 'General case' 0 C--O 1.242 0.701 0 C-N-CA 124.037 0.935 . . . . 65.52 109.048 172.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.5 t -68.97 130.73 91.3 Favored Pre-proline 0 CA--C 1.551 0.986 0 C-N-CA 123.414 0.686 . . . . 65.5 109.7 176.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -60.95 154.42 56.64 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.796 2.33 . . . . 73.42 111.827 172.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.91 130.58 29.73 Favored 'Trans proline' 0 C--N 1.369 1.655 0 C-N-CA 122.131 1.888 . . . . 72.24 111.202 172.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 51.54 71.8 0.42 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.62 1.568 . . . . 73.51 112.577 -177.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.52 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 92.9 m -96.03 139.89 31.56 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.078 -0.965 . . . . 65.13 110.705 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -99.44 152.21 20.24 Favored 'General case' 0 C--O 1.243 0.744 0 C-N-CA 124.047 0.939 . . . . 65.11 110.664 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.42 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -75.51 155.46 36.11 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 114.683 -1.144 . . . . 72.54 110.391 175.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 94.68 5.08 61.66 Favored Glycine 0 N--CA 1.471 0.98 0 CA-C-N 115.747 -0.66 . . . . 42.44 112.576 -174.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.441 ' HG2' ' HG3' ' A' ' 177' ' ' GLN . 67.9 mtt85 -84.36 -175.58 5.85 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.155 0.982 . . . . 70.25 108.589 164.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 253' ' ' VAL . 0.0 OUTLIER -167.46 149.11 5.67 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 110.123 -0.325 . . . . 63.13 110.123 169.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.725 HD12 HD11 ' A' ' 251' ' ' LEU . 62.4 mt -75.97 139.37 41.51 Favored 'General case' 0 N--CA 1.478 0.925 0 N-CA-C 109.628 -0.508 . . . . 63.41 109.628 171.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.409 ' HA ' ' HD2' ' A' ' 250' ' ' TYR . 13.1 ptt180 -105.34 105.05 14.91 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.088 -1.078 . . . . 64.45 108.088 165.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.451 HD12 HD23 ' A' ' 249' ' ' LEU . 49.1 mt -109.81 110.85 21.98 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 114.556 -1.202 . . . . 73.31 109.56 -177.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -88.25 123.56 32.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.243 -0.89 . . . . 62.43 110.098 -172.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 86.36 4.51 83.49 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.176 -0.92 . . . . 72.13 113.601 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -101.01 9.0 42.71 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 117.789 0.795 . . . . 62.31 112.414 -176.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -89.21 -179.03 45.59 Favored Glycine 0 C--N 1.344 0.999 0 N-CA-C 110.435 -1.066 . . . . 55.12 110.435 165.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -56.11 137.79 73.55 Favored Pre-proline 0 N--CA 1.483 1.188 0 C-N-CA 123.073 0.549 . . . . 64.5 112.177 -172.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -64.03 140.52 72.73 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 122.816 2.344 . . . . 53.2 111.707 176.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.28 175.0 20.08 Favored Glycine 0 C--N 1.343 0.94 0 CA-C-N 116.108 -0.496 . . . . 65.41 113.387 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.41 -34.91 32.94 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 123.425 2.75 . . . . 74.34 114.001 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.47 -0.84 31.74 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 122.638 0.375 . . . . 61.11 111.783 178.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 144.11 175.97 17.72 Favored Glycine 0 C--N 1.345 1.067 0 N-CA-C 111.497 -0.641 . . . . 75.03 111.497 -177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.1 mtm180 -80.91 163.48 23.33 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.425 0.69 . . . . 63.04 111.967 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -89.66 -175.05 45.84 Favored Glycine 0 C--N 1.346 1.113 0 N-CA-C 110.86 -0.896 . . . . 71.22 110.86 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -111.62 168.84 9.24 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 117.969 0.884 . . . . 73.03 110.122 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 235' ' ' LEU . 69.5 tp -134.69 108.94 8.29 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.637 0.775 . . . . 64.13 109.786 -172.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.409 ' HD2' ' HA ' ' A' ' 234' ' ' ARG . 23.2 m-85 -106.9 109.14 20.97 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.028 -1.101 . . . . 73.15 108.028 177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.725 HD11 HD12 ' A' ' 233' ' ' LEU . 3.7 pp -118.74 121.93 41.26 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.602 0.715 . . . . 60.31 112.506 -172.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -69.08 130.0 41.5 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 126.501 1.92 . . . . 72.22 112.571 -169.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 232' ' ' LYS . 84.8 t -81.73 120.58 33.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 122.904 0.482 . . . . 74.25 110.958 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -114.47 120.05 38.94 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.055 1.342 . . . . 74.34 108.611 176.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.42 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 38.6 mm -91.54 100.52 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 N-CA-C 108.116 -1.068 . . . . 62.22 108.116 173.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 C--O 1.254 1.326 0 C-N-CA 124.816 1.247 . . . . 70.15 108.598 -173.734 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 48.9 tpp . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 109.013 -0.736 . . . . 70.33 109.013 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -141.1 -160.38 1.07 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.243 1.017 . . . . 61.43 109.408 -177.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 21.5 p -57.02 95.77 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 123.387 0.675 . . . . 74.32 112.165 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -178.74 150.73 0.52 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.169 1.388 . . . . 63.43 108.574 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.482 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 6.6 m -86.27 -19.02 30.54 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-O 121.56 0.695 . . . . 61.42 109.624 175.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -104.24 179.77 4.18 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.456 -0.793 . . . . 31.5 111.641 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -102.86 -85.6 1.88 Allowed Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.416 -0.811 . . . . 73.41 111.999 -175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.69 158.38 43.89 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.807 0.843 . . . . 71.52 111.584 -176.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.42 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 30.2 m95 -92.0 -102.99 0.11 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.413 1.085 . . . . 73.5 110.664 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.465 ' NE2' ' H ' ' A' ' 232' ' ' LYS . 9.7 pt20 165.21 161.68 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.855 2.062 . . . . 73.34 107.312 -167.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 126.4 -27.44 5.0 Favored Glycine 0 N--CA 1.473 1.124 0 N-CA-C 110.534 -1.026 . . . . 74.34 110.534 -169.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -83.98 9.71 11.66 Favored 'General case' 0 CA--C 1.558 1.253 0 C-N-CA 123.627 0.771 . . . . 72.03 111.008 168.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -150.62 148.97 20.73 Favored Glycine 0 C--N 1.347 1.18 0 N-CA-C 111.351 -0.699 . . . . 71.21 111.351 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 35.1 p -81.99 137.92 35.02 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.573 0.749 . . . . 42.42 111.068 -177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 105.95 143.73 11.79 Favored Glycine 0 C--N 1.347 1.168 0 O-C-N 123.488 0.492 . . . . 75.11 113.48 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -121.73 10.73 9.63 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 123.142 0.401 . . . . 74.55 112.686 177.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 34.3 m -88.55 83.19 6.8 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.584 0.692 . . . . 65.41 109.778 174.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -88.45 85.3 1.47 Allowed Glycine 0 C--N 1.338 0.684 0 N-CA-C 110.193 -1.163 . . . . 64.14 110.193 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -52.62 121.9 17.0 Favored Glycine 0 C--N 1.35 1.312 0 O-C-N 124.202 0.589 . . . . 75.52 114.213 -173.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.0 m -119.41 140.87 49.7 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.698 0.799 . . . . 63.12 110.035 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 122.69 46.53 0.28 Allowed Glycine 0 N--CA 1.468 0.773 0 CA-C-N 116.123 -0.489 . . . . 71.44 112.009 178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -71.43 -80.22 0.36 Allowed Glycine 0 C--N 1.346 1.098 0 N-CA-C 112.348 -0.301 . . . . 63.03 112.348 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 64.6 p -162.01 -56.46 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.025 -0.731 . . . . 43.34 109.025 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -98.13 26.83 4.99 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.307 1.043 . . . . 71.31 109.363 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.71 155.64 37.48 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.428 -1.26 . . . . 65.15 111.096 -171.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.432 ' HG ' ' HA2' ' A' ' 239' ' ' GLY . 63.2 mt -128.22 103.14 7.02 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 108.509 -0.923 . . . . 64.13 108.509 164.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -83.15 106.49 14.99 Favored 'General case' 0 C--O 1.233 0.203 0 N-CA-C 107.753 -1.203 . . . . 72.41 107.753 164.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.27 -173.6 2.6 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.053 0.541 . . . . 73.03 110.095 -177.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 86.3 m -119.95 150.82 39.89 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.646 0.778 . . . . 73.51 110.009 176.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.604 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.5 tp -113.7 105.68 13.59 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.845 -1.539 . . . . 53.22 106.845 168.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -84.55 101.43 12.09 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.698 -1.223 . . . . 72.33 107.698 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.622 HG22 HG21 ' A' ' 210' ' ' VAL . 30.9 t -110.83 118.65 47.96 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 108.197 -1.038 . . . . 71.0 108.197 177.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.02 149.91 82.69 Favored 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 121.654 1.569 . . . . 65.24 110.166 171.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.435 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.95 -41.07 83.55 Favored Pre-proline 0 CA--C 1.556 1.18 0 N-CA-C 113.061 0.763 . . . . 73.23 113.061 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 9.4 Cg_endo -54.7 -57.22 1.86 Allowed 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 121.907 1.738 . . . . 53.0 113.71 171.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 51.1 mt -60.84 -31.98 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 C-N-CA 123.206 0.602 . . . . 73.25 111.121 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.23 -50.43 68.02 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.15 -0.477 . . . . 74.11 110.68 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 55.2 t -71.52 -48.39 53.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 124.023 0.827 . . . . 64.11 111.746 -176.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.2 p -80.77 -32.5 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-N 117.824 0.284 . . . . 61.21 111.403 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 87.33 101.48 0.85 Allowed Glycine 0 C--N 1.343 0.946 0 N-CA-C 111.793 -0.523 . . . . 73.41 111.793 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.76 -129.49 2.95 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-O 119.603 -0.554 . . . . 70.22 112.24 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -138.33 151.64 47.74 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 117.805 0.803 . . . . 73.32 109.546 175.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.622 HG21 HG22 ' A' ' 199' ' ' VAL . 22.6 m -145.58 158.01 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 123.719 0.807 . . . . 70.12 110.352 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -74.33 154.06 39.05 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.411 1.084 . . . . 72.45 111.36 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.62 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -132.13 113.93 13.9 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 124.208 1.003 . . . . 72.34 108.648 177.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.7 tpt -65.64 131.46 46.41 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.454 0.701 . . . . 70.42 111.771 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.663 HG21 ' HE3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -130.97 -170.68 2.4 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.708 1.203 . . . . 72.44 108.586 176.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.444 ' H ' HG22 ' A' ' 214' ' ' THR . 10.5 mt -59.32 -70.14 0.17 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.583 0.706 . . . . 62.24 111.018 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -111.57 -42.2 3.91 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 114.019 -1.446 . . . . 75.41 111.446 -168.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -122.42 120.59 4.36 Favored Glycine 0 C--N 1.339 0.732 0 CA-C-O 118.854 -0.97 . . . . 41.13 111.469 -175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.28 154.85 46.49 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 122.058 1.839 . . . . 64.44 112.935 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 39.5 t -101.84 168.71 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 125.109 1.364 . . . . 75.32 108.136 -178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.482 ' H ' ' HB ' ' A' ' 172' ' ' THR . 8.9 tt0 -141.19 134.7 29.91 Favored 'General case' 0 C--O 1.242 0.661 0 N-CA-C 107.425 -1.324 . . . . 73.24 107.425 171.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.509 HG11 HD11 ' A' ' 233' ' ' LEU . 14.6 p -131.2 141.46 45.97 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 122.937 0.495 . . . . 53.13 110.414 -173.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.03 117.3 15.66 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 109.395 -0.594 . . . . 44.33 109.395 173.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.7 t -78.91 128.66 75.89 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 109.407 -0.59 . . . . 73.15 109.407 174.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.07 157.32 60.14 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.763 2.309 . . . . 61.31 111.619 173.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -63.97 133.5 38.89 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.353 2.035 . . . . 62.44 112.455 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 54.4 68.72 0.81 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.919 1.688 . . . . 73.32 113.04 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.472 HG23 ' HD2' ' A' ' 231' ' ' ARG . 75.9 m -89.25 138.33 31.52 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 114.806 -1.088 . . . . 75.32 111.264 175.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -103.31 149.66 24.52 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.988 0.915 . . . . 74.01 110.746 174.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -72.87 155.29 40.05 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 124.227 0.954 . . . . 65.25 110.946 177.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 101.33 -16.82 56.48 Favored Glycine 0 N--CA 1.476 1.322 0 N-CA-C 111.081 -0.807 . . . . 55.13 111.081 -174.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.472 ' HD2' HG23 ' A' ' 227' ' ' THR . 65.4 mtt85 -65.87 172.16 3.82 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.108 0.563 . . . . 73.33 109.834 163.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.536 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.4 ptmt -168.03 151.49 5.93 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 123.359 0.412 . . . . 73.23 110.688 174.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.543 HD12 HD11 ' A' ' 251' ' ' LEU . 85.6 mt -83.48 152.85 24.74 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 110.318 -0.253 . . . . 75.11 110.318 173.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -120.93 106.93 12.09 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.751 1.282 . . . . 74.12 107.957 173.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.512 HD12 HD23 ' A' ' 249' ' ' LEU . 59.4 mt -117.03 127.99 54.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.764 0.826 . . . . 74.41 109.673 -175.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . 0.442 ' HD3' ' HB3' ' A' ' 248' ' ' ASP . 32.5 mmtp -101.36 138.75 37.96 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.692 0.397 . . . . 73.52 110.126 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 78.01 13.5 83.3 Favored Glycine 0 C--N 1.339 0.698 0 O-C-N 124.279 0.987 . . . . 65.42 113.167 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.663 ' HE3' HG21 ' A' ' 214' ' ' THR . 27.6 mmmt -108.87 -14.32 14.6 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 117.467 0.634 . . . . 73.24 112.632 -178.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.432 ' HA2' ' HG ' ' A' ' 193' ' ' LEU . . . -74.66 -170.92 26.09 Favored Glycine 0 N--CA 1.478 1.443 0 CA-C-O 119.855 -0.414 . . . . 74.14 113.349 173.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -58.56 147.1 71.15 Favored Pre-proline 0 N--CA 1.487 1.425 0 C-N-CA 123.41 0.684 . . . . 64.23 111.806 -175.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -63.7 137.82 60.88 Favored 'Trans proline' 0 C--N 1.381 2.243 0 C-N-CA 122.707 2.271 . . . . 74.4 111.871 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.9 175.13 20.49 Favored Glycine 0 N--CA 1.468 0.828 0 CA-C-N 115.179 -0.919 . . . . 64.1 113.606 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -70.76 -28.54 20.31 Favored 'Trans proline' 0 C--N 1.37 1.694 0 C-N-CA 123.149 2.566 . . . . 62.54 112.285 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.7 23.38 7.05 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.613 0.765 . . . . 60.13 110.92 175.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 117.84 -95.83 0.66 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.482 -0.647 . . . . 74.22 111.482 176.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 40.9 mtm-85 -148.53 165.44 31.22 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.571 1.148 . . . . 65.32 109.683 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -90.86 -155.09 31.17 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.621 0.575 . . . . 55.23 112.981 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.442 ' HB3' ' HD3' ' A' ' 236' ' ' LYS . 31.9 p30 -127.17 163.51 23.68 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.991 0.9 . . . . 72.33 112.234 -176.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.662 HD22 HG23 ' A' ' 214' ' ' THR . 12.6 tp -130.32 109.42 10.74 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-N 114.027 -1.442 . . . . 43.34 109.697 -171.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 25.6 m-85 -107.63 110.07 21.85 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.421 -0.955 . . . . 73.01 108.421 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.543 HD11 HD12 ' A' ' 233' ' ' LEU . 3.7 pp -120.43 114.78 22.32 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.687 0.625 . . . . 73.31 112.687 -170.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -69.0 113.34 6.29 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.67 1.188 . . . . 60.24 112.706 -171.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.604 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 53.1 t -64.08 127.3 24.43 Favored 'Isoleucine or valine' 0 C--O 1.242 0.67 0 C-N-CA 124.54 1.136 . . . . 63.35 110.893 173.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -126.27 129.7 49.43 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.986 1.314 . . . . 74.03 108.769 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 28.9 mm -99.55 107.46 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.33 -0.989 . . . . 74.11 108.33 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.56 1.337 0 CA-C-N 114.861 -1.063 . . . . 74.13 109.029 -169.419 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 120.71 0.29 . . . . 74.24 110.629 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -82.32 -160.52 0.38 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.593 0.757 . . . . 73.02 111.421 -177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 18.3 m -57.38 -49.87 74.81 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 124.063 0.945 . . . . 65.03 111.969 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.31 139.83 57.27 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.01 0.524 . . . . 61.31 109.894 174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.41 HG22 HG22 ' A' ' 219' ' ' VAL . 18.2 m -69.35 -25.69 64.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.65 0.78 . . . . 62.22 109.718 175.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -89.22 149.39 23.13 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.19 -0.914 . . . . 63.3 111.139 174.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -69.79 -89.1 0.09 OUTLIER Glycine 0 C--N 1.347 1.147 0 O-C-N 124.026 0.829 . . . . 64.23 111.393 170.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.97 -178.36 5.89 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.896 0.879 . . . . 74.25 110.209 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.531 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 23.5 m95 -80.58 -91.9 0.05 Allowed 'General case' 0 C--O 1.244 0.772 0 CA-C-N 115.549 -0.751 . . . . 62.1 109.579 168.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -174.83 80.77 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.981 0.913 . . . . 74.51 108.677 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -78.89 64.29 3.69 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.792 -0.923 . . . . 44.25 110.792 173.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -115.34 5.04 14.53 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.707 0.803 . . . . 61.2 111.694 -169.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 81.31 -71.77 2.86 Favored Glycine 0 C--N 1.348 1.244 0 O-C-N 123.173 0.295 . . . . 72.33 112.922 178.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 33.9 p -82.67 56.56 3.41 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.217 1.007 . . . . 71.41 110.518 178.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 65.24 -91.97 0.13 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 110.845 -0.902 . . . . 71.33 110.845 -169.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 132.9 12.82 1.66 Allowed Glycine 0 C--N 1.345 1.029 0 C-N-CA 123.097 0.38 . . . . 64.14 112.546 -178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 31.0 t -65.1 102.28 0.61 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.788 0.835 . . . . 64.52 109.736 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.08 -173.06 29.23 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 115.513 -0.767 . . . . 73.31 111.572 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 67.1 54.83 18.93 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 111.779 -0.528 . . . . 71.11 111.779 -176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.2 m -63.77 -32.97 74.65 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.062 0.545 . . . . 55.32 110.793 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -149.77 147.81 18.45 Favored Glycine 0 C--N 1.346 1.121 0 CA-C-N 115.068 -0.969 . . . . 74.42 111.132 174.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.03 -103.07 0.27 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 111.282 -0.727 . . . . 41.22 111.282 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 42.8 p -152.9 119.18 5.53 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.533 0.733 . . . . 74.01 109.692 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 61.8 12.96 5.05 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 124.33 1.052 . . . . 72.34 111.945 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -83.33 151.24 25.66 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.483 1.113 . . . . 74.5 110.753 -169.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 79.5 mt -117.01 137.13 52.43 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.054 0.541 . . . . 73.2 110.3 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -103.38 108.87 20.28 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 107.952 -1.129 . . . . 65.22 107.952 169.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.627 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.27 -172.12 2.3 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.412 1.085 . . . . 74.11 109.243 -179.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . 0.418 HG23 ' HG2' ' A' ' 254' ' ' ARG . 90.8 m -124.9 139.37 53.9 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.673 0.789 . . . . 71.04 110.164 177.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.511 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 16.0 tp -97.23 105.84 18.06 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.664 -0.865 . . . . 72.5 108.664 170.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -86.77 101.59 13.46 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.999 -0.741 . . . . 72.33 108.999 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.574 ' HA ' HG11 ' A' ' 210' ' ' VAL . 1.4 p -119.46 113.68 34.93 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.703 0.801 . . . . 65.03 109.351 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.4 145.7 78.08 Favored 'Trans proline' 0 C--N 1.373 1.817 0 C-N-CA 121.945 1.763 . . . . 64.55 111.054 178.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -44.35 -47.68 25.2 Favored Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.334 1.053 . . . . 71.34 113.625 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.5 -48.09 23.32 Favored 'Trans proline' 0 C--N 1.392 2.863 0 C-N-CA 121.935 1.757 . . . . 75.32 113.976 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.502 HG21 HG13 ' A' ' 210' ' ' VAL . 60.5 mt -65.84 -33.74 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 122.938 0.495 . . . . 64.52 110.471 178.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.59 -43.47 93.73 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.914 0.485 . . . . 74.23 111.16 179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 58.9 t -72.94 -45.88 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.39 1.076 . . . . 74.1 111.912 -175.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.2 p -77.62 -29.66 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 CA-C-O 120.71 0.29 . . . . 73.21 110.255 -179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.65 73.21 1.18 Allowed Glycine 0 C--N 1.343 0.938 0 N-CA-C 111.415 -0.674 . . . . 70.44 111.415 -175.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -103.01 -127.2 6.04 Favored Glycine 0 C--N 1.347 1.192 0 CA-C-O 120.135 -0.258 . . . . 74.21 112.457 -176.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.1 ttmt -143.75 137.59 28.21 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.647 0.779 . . . . 64.14 109.752 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.574 HG11 ' HA ' ' A' ' 199' ' ' VAL . 31.5 m -137.29 154.93 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 122.833 0.453 . . . . 55.5 111.108 176.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -76.13 142.93 41.49 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 114.758 -1.11 . . . . 72.11 111.192 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.653 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -113.97 117.39 31.2 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 124.917 1.287 . . . . 71.2 108.283 173.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.0 tpt -63.82 121.08 13.16 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.057 0.943 . . . . 71.15 111.498 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.475 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -123.82 -171.25 2.28 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 125.053 1.341 . . . . 72.03 109.653 -178.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.45 ' H ' HG22 ' A' ' 214' ' ' THR . 9.2 mt -59.58 -69.4 0.21 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.583 1.153 . . . . 73.52 112.044 -175.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -113.92 -42.11 3.45 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 113.94 -1.482 . . . . 74.34 111.445 -166.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -119.33 167.3 13.28 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 115.283 -0.871 . . . . 63.53 111.172 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -85.41 154.81 10.67 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 121.987 1.792 . . . . 60.24 113.202 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.653 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 69.5 t -106.3 166.26 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 107.086 -1.45 . . . . 61.12 107.086 165.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -147.28 140.2 25.05 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.32 -0.992 . . . . 61.24 108.32 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.459 HG11 HD11 ' A' ' 233' ' ' LEU . 8.7 p -134.18 142.24 41.54 Favored 'Isoleucine or valine' 0 C--O 1.247 0.954 0 C-N-CA 123.162 0.585 . . . . 53.54 110.86 -172.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -75.97 108.23 8.71 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 123.961 0.904 . . . . 74.02 109.187 174.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.459 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 59.5 t -71.54 132.61 85.43 Favored Pre-proline 0 CA--C 1.551 1.003 0 C-N-CA 124.132 0.973 . . . . 73.24 109.279 177.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -64.02 155.44 64.52 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.794 2.329 . . . . 73.2 112.483 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.51 130.48 31.89 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.273 1.982 . . . . 61.51 111.804 173.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 33.3 mtp-105 49.7 71.23 0.41 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.514 1.526 . . . . 64.12 113.266 -176.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.442 HG23 ' HD2' ' A' ' 231' ' ' ARG . 98.7 m -87.45 142.74 27.64 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.884 -1.053 . . . . 65.55 111.1 176.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -103.06 154.67 19.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.001 0.92 . . . . 74.41 110.604 174.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.529 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -78.72 155.41 29.4 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 114.452 -1.249 . . . . 71.15 110.615 177.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.03 -13.02 52.69 Favored Glycine 0 N--CA 1.47 0.961 0 N-CA-C 111.594 -0.602 . . . . 63.45 111.594 -173.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.442 ' HD2' HG23 ' A' ' 227' ' ' THR . 68.0 mtt85 -70.43 -176.34 1.21 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.04 0.936 . . . . 72.33 110.55 170.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.608 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 10.3 ptmt -167.57 156.32 9.66 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.341 0.256 . . . . 72.14 110.573 171.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.559 HD12 HD11 ' A' ' 251' ' ' LEU . 73.5 mt -87.51 151.58 22.9 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.509 -0.552 . . . . 63.23 109.509 168.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -119.85 105.87 11.52 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.335 -1.357 . . . . 73.45 107.335 168.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 67.6 mt -114.19 117.04 30.06 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.281 0.633 . . . . 74.44 110.698 -170.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -84.99 133.36 34.26 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 116.275 -0.42 . . . . 43.12 111.287 -174.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 81.27 1.11 89.89 Favored Glycine 0 C--N 1.351 1.412 0 CA-C-N 114.884 -1.053 . . . . 74.13 113.77 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.422 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 47.6 mmtm -98.02 -0.38 44.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.384 0.674 . . . . 70.42 112.523 -174.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -82.86 -172.35 48.36 Favored Glycine 0 C--N 1.348 1.22 0 N-CA-C 111.18 -0.768 . . . . 71.43 111.18 167.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -65.17 142.61 98.61 Favored Pre-proline 0 CA--C 1.555 1.168 0 CA-C-N 117.24 0.52 . . . . 75.33 111.541 -178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.92 133.7 34.59 Favored 'Trans proline' 0 C--N 1.38 2.229 0 C-N-CA 122.853 2.368 . . . . 54.43 112.093 172.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.42 172.92 21.65 Favored Glycine 0 C--N 1.341 0.814 0 CA-C-O 119.436 -0.647 . . . . 45.51 113.192 -176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.68 -23.33 26.72 Favored 'Trans proline' 0 C--N 1.373 1.829 0 C-N-CA 123.097 2.531 . . . . 63.32 112.543 176.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -96.71 22.26 8.37 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.958 0.903 . . . . 74.32 110.751 175.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 94.9 -173.36 31.87 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 110.471 -1.052 . . . . 70.12 110.471 -175.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 -84.11 158.35 21.41 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 117.417 0.608 . . . . 73.31 110.883 178.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -84.78 -164.66 38.61 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.502 -0.772 . . . . 64.44 111.933 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -124.57 164.47 19.75 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.583 0.706 . . . . 64.22 110.634 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.554 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 32.0 tp -123.01 108.56 13.06 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.078 -0.964 . . . . 73.42 108.613 -171.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.608 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 33.3 m-85 -100.53 112.75 25.16 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 107.091 -1.448 . . . . 73.42 107.091 176.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.627 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 2.6 pp -127.86 115.81 19.18 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 113.498 0.925 . . . . 74.15 113.498 -175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -67.64 117.65 9.86 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.556 -1.202 . . . . 73.04 112.05 -173.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.599 HG23 ' HA ' ' A' ' 232' ' ' LYS . 95.1 t -68.82 116.73 9.97 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 C-N-CA 125.167 1.387 . . . . 75.14 111.509 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . 0.418 ' HG2' HG23 ' A' ' 196' ' ' THR . 24.7 mmt85 -106.65 117.03 32.99 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.355 -1.293 . . . . 64.3 108.803 170.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.542 HD13 HG13 ' A' ' 199' ' ' VAL . 42.3 mm -79.1 96.28 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 106.529 -1.656 . . . . 51.42 106.529 168.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.26 1.651 0 CA-C-O 117.31 -1.329 . . . . 60.43 108.64 -174.718 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 17.1 tmm? . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.184 0.516 . . . . 54.2 109.79 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -133.23 172.02 13.24 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.881 1.273 . . . . 72.12 110.244 -170.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 46.1 p -90.66 26.64 1.97 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.045 0.938 . . . . 70.2 111.819 -175.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' A' ' 221' ' ' VAL . . . -151.44 155.88 39.49 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.833 0.853 . . . . 73.14 110.173 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.57 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 16.8 m -71.76 -19.93 61.96 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.741 0.816 . . . . 62.42 110.78 175.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.54 -176.0 6.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.298 1.039 . . . . 71.4 113.045 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -106.15 -88.95 2.07 Favored Glycine 0 C--N 1.346 1.089 0 CA-C-N 114.473 -1.24 . . . . 73.01 110.269 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -146.98 153.66 40.32 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 112.734 0.642 . . . . 72.41 112.734 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.454 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 34.3 m95 -82.99 -83.56 0.13 Allowed 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.275 1.03 . . . . 74.23 109.993 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.543 ' HG3' ' HA3' ' A' ' 182' ' ' GLY . 19.4 mm-40 -113.5 29.58 7.89 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 106.793 -1.558 . . . . 75.35 106.793 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 100.44 -72.55 0.43 Allowed Glycine 0 C--N 1.35 1.31 0 N-CA-C 108.402 -1.879 . . . . 64.21 108.402 -156.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -177.94 -175.22 0.48 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 125.257 1.423 . . . . 71.42 109.826 174.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 74.31 -88.01 0.7 Allowed Glycine 0 C--N 1.346 1.119 0 O-C-N 123.198 0.311 . . . . 20.44 112.51 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 15.1 t -162.48 179.91 7.43 Favored 'General case' 0 C--O 1.247 0.931 0 C-N-CA 123.586 0.754 . . . . 61.41 109.502 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . 0.543 ' HA3' ' HG3' ' A' ' 177' ' ' GLN . . . 177.65 -142.73 5.8 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-O 119.811 -0.438 . . . . 44.53 112.112 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -154.1 -34.79 0.03 OUTLIER Glycine 0 C--N 1.346 1.098 0 CA-C-O 119.612 -0.549 . . . . 60.15 113.34 -174.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.4 t -149.57 -79.99 0.13 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.637 0.718 . . . . 74.13 110.535 -176.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 67.99 178.93 15.19 Favored Glycine 0 C--N 1.349 1.3 0 N-CA-C 114.026 0.37 . . . . 74.43 114.026 175.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 65.85 94.97 0.03 OUTLIER Glycine 0 C--N 1.347 1.192 0 C-N-CA 123.161 0.41 . . . . 32.05 113.7 176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.3 t -82.77 -167.85 1.8 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.556 0.742 . . . . 62.34 110.18 178.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -83.28 -175.06 50.8 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-O 119.904 -0.387 . . . . 54.53 112.176 172.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -167.49 -136.04 1.97 Allowed Glycine 0 C--N 1.342 0.89 0 CA-C-N 117.703 0.751 . . . . 71.34 113.107 178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.1 m -142.57 133.21 25.28 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.744 1.218 . . . . 62.4 107.959 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 62.75 16.04 8.65 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 123.774 0.829 . . . . 74.12 111.654 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -87.41 151.72 22.83 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-N 115.1 -0.954 . . . . 73.32 110.976 -169.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 74.5 mt -120.9 145.33 47.78 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.572 0.749 . . . . 74.31 110.89 -176.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 31.2 t80 -102.26 132.39 48.24 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 123.68 0.792 . . . . 72.13 109.082 172.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.609 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -138.05 -171.84 3.12 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.383 0.673 . . . . 71.54 109.536 173.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 95.8 m -131.04 109.2 10.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.457 0.703 . . . . 72.24 111.14 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.584 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 16.3 tp -72.88 105.29 4.33 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.171 -1.048 . . . . 63.12 108.171 177.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -80.26 99.58 7.92 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.968 -1.015 . . . . 71.25 108.867 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 210' ' ' VAL . 13.6 t -113.96 106.44 53.41 Favored Pre-proline 0 N--CA 1.472 0.666 0 N-CA-C 108.362 -0.977 . . . . 61.05 108.362 178.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -67.29 152.77 78.78 Favored 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.414 1.41 . . . . 72.44 110.495 174.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -49.18 -45.86 75.95 Favored Pre-proline 0 CA--C 1.561 1.388 0 N-CA-C 114.017 1.117 . . . . 24.52 114.017 -178.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.72 -48.2 17.87 Favored 'Trans proline' 0 C--N 1.389 2.698 0 C-N-CA 121.76 1.64 . . . . 72.23 112.9 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.463 HG21 HG13 ' A' ' 210' ' ' VAL . 50.0 mt -67.75 -33.68 63.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 123.332 0.653 . . . . 54.33 110.973 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.31 87.03 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.045 -0.525 . . . . 73.44 110.473 179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.4 t -70.05 -47.74 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.415 1.086 . . . . 53.32 111.495 -177.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 8.7 p -77.99 -32.19 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 CA-C-O 120.775 0.321 . . . . 64.54 110.729 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.84 68.58 1.41 Allowed Glycine 0 C--N 1.341 0.85 0 CA-C-N 115.789 -0.642 . . . . 72.52 112.047 -174.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -101.91 -123.99 5.33 Favored Glycine 0 C--N 1.341 0.842 0 N-CA-C 112.523 -0.231 . . . . 75.14 112.523 -175.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.6 ttmt -142.49 143.68 32.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.747 0.819 . . . . 61.21 109.713 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.721 HG21 HG22 ' A' ' 199' ' ' VAL . 28.8 m -140.79 151.66 20.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 123.423 0.689 . . . . 72.34 111.114 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -78.22 150.22 33.5 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 123.862 0.865 . . . . 61.22 111.399 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -130.63 114.21 15.15 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.375 1.47 . . . . 52.2 109.001 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -64.11 124.03 20.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.653 0.781 . . . . 75.32 110.781 177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 215' ' ' LEU . 0.2 OUTLIER -111.54 -169.66 1.5 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.936 1.294 . . . . 71.0 108.095 -179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.466 ' H ' HG22 ' A' ' 214' ' ' THR . 7.8 mt -45.81 -70.33 0.1 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.863 1.265 . . . . 63.22 112.001 176.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -113.29 -43.56 3.34 Favored 'General case' 0 C--N 1.344 0.364 0 CA-C-N 113.892 -1.504 . . . . 45.04 110.84 -168.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -114.9 -179.25 18.72 Favored Glycine 0 N--CA 1.467 0.763 0 CA-C-N 115.646 -0.706 . . . . 52.24 112.426 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -92.65 164.07 2.81 Favored 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 122.213 1.942 . . . . 52.15 113.968 174.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 12.7 t -121.47 168.79 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 106.173 -1.788 . . . . 72.25 106.173 169.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.57 ' H ' ' HB ' ' A' ' 172' ' ' THR . 13.5 tt0 -148.67 143.28 26.39 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.116 -1.068 . . . . 72.03 108.116 173.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.473 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 13.3 p -136.35 143.12 36.57 Favored 'Isoleucine or valine' 0 C--O 1.242 0.68 0 C-N-CA 123.256 0.623 . . . . 75.35 111.475 -171.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.14 110.29 8.32 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.408 1.083 . . . . 74.33 109.73 173.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 79.9 t -77.16 134.92 66.87 Favored Pre-proline 0 CA--C 1.56 1.352 0 C-N-CA 123.888 0.875 . . . . 54.32 109.852 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.0 155.64 61.5 Favored 'Trans proline' 0 C--N 1.382 2.309 0 C-N-CA 122.904 2.402 . . . . 54.2 112.249 169.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -59.35 132.34 45.88 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.978 2.452 . . . . 73.22 112.134 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 49.58 73.27 0.25 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.376 1.47 . . . . 72.2 113.105 -177.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.433 HG23 ' HD2' ' A' ' 231' ' ' ARG . 97.0 m -89.56 142.26 27.84 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.504 -1.226 . . . . 52.23 111.069 175.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.2 mp0 -105.45 158.37 16.71 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 124.107 0.963 . . . . 70.34 110.383 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.455 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -82.26 148.73 28.22 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.22 -1.354 . . . . 64.24 110.411 176.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 114.46 -28.74 8.03 Favored Glycine 0 N--CA 1.472 1.084 0 N-CA-C 110.843 -0.903 . . . . 72.22 110.843 -173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.433 ' HD2' HG23 ' A' ' 227' ' ' THR . 75.1 mtt85 -58.92 171.72 0.64 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.078 0.951 . . . . 73.32 110.645 165.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.467 ' HA ' HG23 ' A' ' 253' ' ' VAL . 11.9 ptmt -165.89 149.84 7.98 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.126 0.266 . . . . 73.15 110.691 172.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.713 HD12 HD11 ' A' ' 251' ' ' LEU . 84.1 mt -79.49 155.64 28.17 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 123.532 0.52 . . . . 74.34 109.715 171.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 8.3 ptt180 -126.58 106.66 9.58 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.405 -1.332 . . . . 74.11 107.405 169.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 39.4 mt -105.32 112.21 25.23 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.531 -0.759 . . . . 61.31 110.045 -172.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -77.18 117.44 18.72 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.429 -1.26 . . . . 60.3 111.0 -171.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 92.55 -4.73 76.67 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.329 1.018 . . . . 72.53 113.612 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.459 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 33.9 mmtp -95.58 5.62 51.02 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.588 0.755 . . . . 61.13 112.518 -172.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -85.95 -178.28 50.04 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 110.81 -0.916 . . . . 45.32 110.81 166.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -62.48 138.22 96.44 Favored Pre-proline 0 CA--C 1.553 1.096 0 CA-C-N 117.402 0.601 . . . . 65.45 111.476 -174.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -66.49 143.62 69.98 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.316 2.677 . . . . 75.5 112.949 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -134.67 -178.67 15.82 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-N 115.844 -0.616 . . . . 73.32 113.61 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.04 -49.76 3.56 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.598 2.865 . . . . 62.13 113.393 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -80.28 -34.01 37.3 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 122.92 0.488 . . . . 72.44 110.989 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 175.32 179.88 46.14 Favored Glycine 0 N--CA 1.47 0.937 0 CA-C-N 114.766 -1.107 . . . . 52.4 111.391 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -79.0 168.37 19.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.523 0.729 . . . . 73.44 110.899 178.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -92.21 -167.58 39.93 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.608 -0.724 . . . . 40.05 112.063 172.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -119.91 171.0 8.74 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 122.238 -0.566 . . . . 65.31 109.873 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.656 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 43.8 tp -129.41 108.73 10.51 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 121.57 0.7 . . . . 65.12 110.682 -174.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 46.0 m-85 -100.11 110.5 22.78 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.141 -1.059 . . . . 65.01 108.141 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.713 HD11 HD12 ' A' ' 233' ' ' LEU . 3.1 pp -125.66 114.99 19.4 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 121.435 0.636 . . . . 74.23 112.417 -173.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -70.15 120.29 15.63 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 114.689 -1.141 . . . . 63.42 113.452 -170.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.584 ' HA ' ' HB3' ' A' ' 197' ' ' LEU . 48.4 t -65.1 126.83 24.91 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 CA-C-N 113.89 -1.505 . . . . 65.42 110.031 174.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -129.67 128.23 42.14 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 125.045 1.338 . . . . 74.31 108.975 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.455 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 29.2 mm -95.92 104.4 15.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 108.183 -1.043 . . . . 74.53 108.183 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.293 0 CA-C-O 117.386 -1.292 . . . . 62.13 108.783 -168.878 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.437 ' HB3' ' HA2' ' A' ' 174' ' ' GLY . 20.1 ptp . . . . . 0 CA--C 1.548 0.884 0 CA-C-O 122.087 0.946 . . . . 74.1 109.726 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.18 -150.09 0.06 Allowed 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 114.888 -1.051 . . . . 70.04 109.534 175.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.0 p -63.08 80.84 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 CA-C-O 121.427 0.632 . . . . 70.44 110.529 172.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -168.98 136.87 1.95 Allowed 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.533 1.533 . . . . 63.24 107.554 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 19.1 m -72.52 -13.77 61.49 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.473 0.709 . . . . 52.34 111.395 -178.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.79 160.85 14.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.854 0.862 . . . . 74.3 111.904 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.51 ' H ' HD22 ' A' ' 235' ' ' LEU . . . -73.35 -108.41 0.07 OUTLIER Glycine 0 C--N 1.35 1.308 0 CA-C-N 115.31 -0.859 . . . . 65.34 111.203 166.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -138.77 176.74 8.44 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 117.749 0.774 . . . . 42.24 111.716 178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.465 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 29.6 m95 -80.82 126.8 31.78 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 114.601 -1.181 . . . . 64.22 110.25 177.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 75.87 -40.95 0.42 Allowed 'General case' 0 C--O 1.248 0.99 0 C-N-CA 126.34 1.856 . . . . 71.22 112.206 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.426 ' HA3' ' HG2' ' A' ' 234' ' ' ARG . . . 78.51 90.39 0.37 Allowed Glycine 0 C--N 1.35 1.343 0 N-CA-C 110.768 -0.933 . . . . 60.4 110.768 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 57.6 tttm -60.09 104.79 0.34 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 123.971 0.908 . . . . 63.44 111.261 -172.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 172.62 -54.89 0.16 Allowed Glycine 0 C--N 1.338 0.649 0 CA-C-N 115.327 -0.851 . . . . 61.15 111.534 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 68.8 m -133.87 75.86 1.62 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.452 0.701 . . . . 51.24 110.078 -177.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -94.28 35.6 4.12 Favored Glycine 0 C--N 1.343 0.93 0 CA-C-N 115.463 -0.789 . . . . 71.42 112.071 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -79.61 173.98 55.15 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 112.597 -0.201 . . . . 64.13 112.597 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.3 t -96.58 93.84 7.0 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 108.98 -0.748 . . . . 74.31 108.98 178.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.56 158.45 31.14 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.951 -0.568 . . . . 43.4 112.481 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.21 -170.22 39.35 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-O 119.656 -0.524 . . . . 74.1 111.806 177.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 24.8 t 71.1 108.01 0.06 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.077 1.351 . . . . 55.53 110.613 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 119.81 119.76 2.79 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.228 -0.749 . . . . 44.23 111.228 -178.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 162.36 126.63 0.83 Allowed Glycine 0 C--N 1.344 1.019 0 N-CA-C 111.117 -0.793 . . . . 73.33 111.117 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 45.6 m -91.09 -65.6 1.0 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.174 0.59 . . . . 51.42 110.638 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -72.53 -50.3 26.68 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.489 -0.778 . . . . 73.2 109.704 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -68.03 140.19 56.32 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.193 -0.912 . . . . 63.42 110.143 174.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.3 mt -119.35 160.62 21.92 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.656 0.782 . . . . 74.3 110.914 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 4.4 t80 -121.77 108.33 13.37 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 109.188 -0.671 . . . . 74.04 109.188 171.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.647 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -116.8 -170.85 1.91 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.42 1.088 . . . . 52.25 109.5 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 54.9 m -119.12 126.04 50.69 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 123.985 0.914 . . . . 72.14 110.429 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.601 ' HB2' HD13 ' A' ' 251' ' ' LEU . 25.2 tp -84.51 104.76 14.79 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 107.769 -1.197 . . . . 54.11 107.769 166.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -86.95 106.39 17.77 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.165 -0.68 . . . . 74.33 109.165 -175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.652 HG22 HG21 ' A' ' 210' ' ' VAL . 21.7 t -114.13 120.76 37.92 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 108.65 -0.87 . . . . 71.44 108.65 178.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.89 150.61 61.63 Favored 'Trans proline' 0 C--N 1.369 1.652 0 C-N-CA 121.77 1.646 . . . . 52.12 110.217 170.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -52.67 -45.24 96.6 Favored Pre-proline 0 CA--C 1.563 1.456 0 CA-C-O 117.808 -1.091 . . . . 64.11 112.834 -178.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 17.2 Cg_endo -56.26 -50.36 12.33 Favored 'Trans proline' 0 C--N 1.401 3.294 0 C-N-CA 122.077 1.851 . . . . 60.11 112.87 177.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.449 HG21 HG13 ' A' ' 210' ' ' VAL . 28.1 mt -64.74 -34.49 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 C-N-CA 123.41 0.684 . . . . 74.4 110.626 179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.53 -42.61 95.65 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.072 -0.513 . . . . 44.03 111.137 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.4 t -73.92 -49.78 32.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 123.982 0.913 . . . . 70.5 111.844 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 10.6 p -80.2 -28.45 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 122.373 0.269 . . . . 74.3 110.878 -175.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 85.15 77.79 1.18 Allowed Glycine 0 C--N 1.346 1.117 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.993 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -108.01 -137.28 8.2 Favored Glycine 0 C--N 1.352 1.426 0 CA-C-O 119.725 -0.486 . . . . 64.22 112.0 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -133.77 139.84 46.58 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-N 117.801 0.8 . . . . 73.21 109.806 178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.652 HG21 HG22 ' A' ' 199' ' ' VAL . 35.6 m -133.4 153.74 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 123.229 0.612 . . . . 53.52 111.064 176.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.428 ' HG2' ' N ' ' A' ' 212' ' ' ALA . 22.9 ttm180 -75.73 154.54 36.34 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 123.905 0.882 . . . . 73.25 110.716 177.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -132.23 120.76 22.63 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.521 1.528 . . . . 64.32 108.383 176.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.06 132.23 48.65 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.766 0.827 . . . . 74.1 110.467 176.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.661 HG21 ' HD2' ' A' ' 238' ' ' LYS . 0.5 OUTLIER -136.14 -172.72 3.2 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 123.663 0.785 . . . . 54.54 110.162 -175.129 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.618 ' H ' HG22 ' A' ' 214' ' ' THR . 6.4 mt -63.78 -67.41 0.43 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.298 1.439 . . . . 73.12 110.671 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 38.9 mm-40 -103.74 -41.55 5.89 Favored 'General case' 0 C--N 1.348 0.533 0 CA-C-N 113.322 -1.763 . . . . 73.34 111.554 -162.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -150.7 154.02 25.36 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-O 119.046 -0.863 . . . . 61.34 111.76 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.16 142.0 30.11 Favored 'Trans proline' 0 C--N 1.368 1.575 0 C-N-CA 122.603 2.202 . . . . 70.13 113.55 -174.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 73.1 t -95.62 163.52 2.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 114.471 -1.241 . . . . 63.23 108.286 175.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -142.81 136.92 29.29 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 107.371 -1.344 . . . . 74.32 107.371 173.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.457 HG11 HD11 ' A' ' 233' ' ' LEU . 12.3 p -132.26 140.38 47.92 Favored 'Isoleucine or valine' 0 C--O 1.243 0.723 0 C-N-CA 123.481 0.712 . . . . 64.25 110.688 -172.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -76.31 109.42 9.99 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 124.063 0.945 . . . . 75.34 109.323 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 93.1 t -73.73 131.02 82.52 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.212 1.005 . . . . 63.55 109.388 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.88 155.2 58.16 Favored 'Trans proline' 0 C--N 1.38 2.221 0 C-N-CA 122.433 2.089 . . . . 52.34 111.05 171.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -63.55 136.23 53.33 Favored 'Trans proline' 0 C--N 1.371 1.753 0 C-N-CA 122.314 2.009 . . . . 61.22 112.7 -176.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 51.66 69.25 0.68 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.646 1.579 . . . . 73.44 112.706 -177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.443 HG23 ' HD2' ' A' ' 231' ' ' ARG . 69.8 m -85.03 141.08 30.54 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.85 -1.068 . . . . 72.52 110.613 174.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -102.16 155.63 18.08 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.78 0.832 . . . . 54.2 110.1 174.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.495 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -83.91 154.83 23.18 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 114.652 -1.158 . . . . 62.21 111.212 -177.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 100.88 -6.78 57.06 Favored Glycine 0 C--N 1.342 0.898 0 CA-C-N 115.935 -0.575 . . . . 51.55 111.933 -173.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.443 ' HD2' HG23 ' A' ' 227' ' ' THR . 65.9 mtt85 -72.09 179.47 3.28 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.916 0.886 . . . . 71.43 109.722 168.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.462 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.2 ptpt -168.27 150.94 5.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.882 0.473 . . . . 62.12 110.464 169.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.489 ' HG ' HD22 ' A' ' 197' ' ' LEU . 56.9 mt -85.18 156.03 21.18 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.751 -0.833 . . . . 65.24 108.751 169.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.426 ' HG2' ' HA3' ' A' ' 178' ' ' GLY . 12.1 ptp180 -115.32 123.74 49.51 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 106.459 -1.682 . . . . 53.23 106.459 157.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.659 HD12 HD23 ' A' ' 249' ' ' LEU . 46.5 mt -112.21 108.18 17.33 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.898 -0.779 . . . . 72.31 108.898 -179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -70.41 113.2 7.32 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.136 -1.393 . . . . 74.45 111.443 -170.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 91.74 -5.88 79.71 Favored Glycine 0 C--N 1.344 0.976 0 CA-C-N 115.248 -0.887 . . . . 52.24 113.771 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.661 ' HD2' HG21 ' A' ' 214' ' ' THR . 48.4 mmtm -86.87 10.08 17.25 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.405 0.682 . . . . 72.13 112.213 -179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -98.16 169.56 24.07 Favored Glycine 0 C--N 1.345 1.031 0 N-CA-C 109.786 -1.326 . . . . 74.02 109.786 164.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.425 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 41.4 m-85 -57.22 139.51 79.57 Favored Pre-proline 0 CA--C 1.556 1.198 0 C-N-CA 123.363 0.665 . . . . 52.14 112.129 -173.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 240' ' ' PHE . 11.7 Cg_exo -69.6 150.04 68.69 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.907 2.405 . . . . 54.34 113.076 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.68 171.95 21.8 Favored Glycine 0 CA--C 1.527 0.825 0 CA-C-O 118.801 -0.999 . . . . 54.32 111.018 177.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -61.66 -48.22 9.57 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.988 2.459 . . . . 74.23 113.393 -178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -87.57 -19.07 28.35 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.287 0.635 . . . . 64.24 111.863 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 171.31 169.43 34.24 Favored Glycine 0 C--N 1.34 0.787 0 N-CA-C 111.944 -0.462 . . . . 72.11 111.944 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 69.0 mtt85 -85.51 170.22 12.84 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.788 0.835 . . . . 64.43 110.864 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -86.95 179.95 48.73 Favored Glycine 0 C--N 1.343 0.934 0 CA-C-N 115.299 -0.864 . . . . 53.54 111.224 171.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -122.69 153.16 39.78 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 109.578 -0.527 . . . . 75.53 109.578 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.659 HD23 HD12 ' A' ' 235' ' ' LEU . 48.8 tp -106.2 106.75 17.41 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.352 -0.61 . . . . 73.33 109.352 -172.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 48.8 m-85 -98.98 109.12 21.93 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 106.998 -1.482 . . . . 74.14 106.998 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.647 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 0.6 OUTLIER -126.55 117.49 22.93 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 113.95 1.092 . . . . 64.14 113.95 -177.198 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -65.86 118.78 10.18 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 113.133 -1.849 . . . . 51.3 112.518 -172.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.543 HG22 HD23 ' A' ' 197' ' ' LEU . 52.3 t -69.68 109.49 2.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 114.329 -1.305 . . . . 71.22 110.68 176.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -100.25 118.17 35.98 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.53 1.132 . . . . 74.34 108.824 170.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.495 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 39.8 mm -87.26 107.94 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 107.462 -1.31 . . . . 53.05 107.462 170.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 C--O 1.254 1.329 0 C-N-CA 124.301 1.04 . . . . 44.41 108.258 -174.096 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.417 0.627 . . . . 74.52 109.315 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -150.04 -168.5 3.12 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.51 1.124 . . . . 73.11 108.884 -177.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.7 t -73.85 75.15 1.62 Allowed 'General case' 0 CA--C 1.565 1.543 0 CA-C-O 122.284 1.04 . . . . 74.22 110.646 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -163.48 158.67 21.21 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.221 1.009 . . . . 75.21 109.669 -174.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.401 HG22 HG22 ' A' ' 219' ' ' VAL . 17.0 m -78.0 -26.46 48.57 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.374 -0.83 . . . . 75.31 110.633 176.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -75.9 -168.79 0.95 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.861 0.865 . . . . 52.04 112.59 -177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -120.07 -87.52 1.03 Allowed Glycine 0 C--N 1.344 1.017 0 N-CA-C 110.194 -1.163 . . . . 63.4 110.194 175.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.27 174.51 10.47 Favored 'General case' 0 C--O 1.248 0.98 0 C-N-CA 123.477 0.711 . . . . 64.55 109.917 172.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.526 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 19.1 m95 -82.33 -84.78 0.12 Allowed 'General case' 0 C--O 1.243 0.751 0 CA-C-N 115.313 -0.858 . . . . 73.14 109.744 167.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 176.25 -173.14 0.09 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.864 1.265 . . . . 54.4 109.121 -171.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -73.86 -90.36 0.16 Allowed Glycine 0 C--N 1.347 1.171 0 N-CA-C 111.243 -0.743 . . . . 64.35 111.243 170.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -144.02 113.61 7.08 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.119 -1.067 . . . . 73.24 108.119 177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -60.12 119.46 18.5 Favored Glycine 0 C--N 1.353 1.515 0 O-C-N 123.833 0.708 . . . . 73.04 112.616 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 42.7 t -147.58 148.15 30.83 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 122.995 0.518 . . . . 74.02 110.549 -172.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . 78.8 -143.51 26.71 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.925 -0.58 . . . . 71.22 112.848 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -101.45 -176.93 28.67 Favored Glycine 0 C--N 1.342 0.872 0 N-CA-C 112.096 -0.402 . . . . 64.23 112.096 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.9 p -72.77 114.95 11.48 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 122.93 0.492 . . . . 45.03 110.171 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -65.92 139.9 39.3 Favored Glycine 0 C--N 1.354 1.565 0 CA-C-O 119.705 -0.497 . . . . 61.13 112.901 -176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -64.32 117.01 9.79 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 120.035 -0.314 . . . . 62.32 112.333 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 39.4 t -135.5 140.61 44.92 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.76 0.824 . . . . 62.42 109.855 -175.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -86.48 -152.72 21.66 Favored Glycine 0 C--N 1.348 1.205 0 O-C-N 123.569 0.543 . . . . 61.54 111.898 173.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -170.46 77.48 0.1 OUTLIER Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.938 -0.465 . . . . 72.24 111.938 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 47.6 t -89.44 -95.0 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 109.098 -0.704 . . . . 74.1 109.098 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -83.01 -33.98 26.41 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 108.99 -0.745 . . . . 71.43 108.99 168.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -67.38 142.49 56.72 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 114.661 -1.154 . . . . 63.21 109.692 174.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 80.5 mt -129.0 166.52 19.05 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.424 0.63 . . . . 71.31 111.747 -173.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.429 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 25.4 t80 -120.26 139.37 52.81 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.612 -1.176 . . . . 73.33 109.267 177.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.638 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -151.72 -170.44 3.65 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.003 0.921 . . . . 72.23 109.819 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 26.4 m -119.72 140.99 49.83 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.695 0.798 . . . . 64.43 110.964 175.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.536 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 19.5 tp -100.48 108.23 20.14 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.105 0.962 . . . . 73.34 108.413 168.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -83.46 100.1 10.52 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.26 -0.645 . . . . 73.41 109.26 178.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.652 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.7 t -108.39 115.17 58.42 Favored Pre-proline 0 N--CA 1.472 0.631 0 N-CA-C 108.334 -0.987 . . . . 54.22 108.334 175.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -70.81 145.0 49.94 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 121.571 1.514 . . . . 43.01 110.6 174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -47.27 -47.91 56.35 Favored Pre-proline 0 N--CA 1.486 1.369 0 N-CA-C 114.252 1.204 . . . . 42.23 114.252 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -56.79 -45.85 33.64 Favored 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 122.235 1.957 . . . . 73.51 113.768 176.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 35.2 mt -65.87 -34.92 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.942 0.497 . . . . 72.33 110.535 178.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -64.13 -44.39 92.33 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.07 -0.514 . . . . 72.3 111.385 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 68.3 t -71.03 -46.4 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.99 0.916 . . . . 72.2 112.028 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.03 -28.33 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-O 120.561 0.219 . . . . 73.1 110.623 -176.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 80.89 72.3 1.23 Allowed Glycine 0 C--N 1.346 1.084 0 N-CA-C 111.233 -0.747 . . . . 62.41 111.233 -175.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.7 -126.59 5.74 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 112.33 -0.308 . . . . 53.23 112.33 -176.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -142.33 148.02 37.27 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.266 1.027 . . . . 74.44 108.849 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' A' ' 199' ' ' VAL . 27.8 m -142.43 158.89 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 123.134 0.573 . . . . 73.52 110.69 174.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -75.8 151.11 37.59 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.776 0.83 . . . . 75.34 110.18 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -128.2 114.59 17.17 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.845 1.258 . . . . 73.34 108.576 177.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 14.6 tpt -64.51 109.58 2.01 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.129 0.572 . . . . 73.44 110.933 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.553 ' OG1' HG23 ' A' ' 219' ' ' VAL . 0.2 OUTLIER -93.45 -169.1 2.04 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.247 1.419 . . . . 62.1 108.933 175.174 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 9.9 mt -52.55 -69.16 0.12 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.464 1.126 . . . . 64.01 110.581 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -113.76 -42.52 3.41 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 112.793 -2.003 . . . . 72.32 110.746 -170.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -101.77 176.78 26.38 Favored Glycine 0 C--N 1.344 1.024 0 CA-C-N 115.507 -0.769 . . . . 64.12 112.607 -177.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -102.4 145.94 0.22 Allowed 'Trans proline' 0 CA--C 1.557 1.657 0 C-N-CA 122.882 2.388 . . . . 61.44 114.234 168.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.553 HG23 ' OG1' ' A' ' 214' ' ' THR . 50.2 t -104.06 168.79 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 125.158 1.383 . . . . 55.44 108.055 171.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -142.04 139.23 32.27 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.094 -1.076 . . . . 71.54 108.094 173.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.54 HG11 HD11 ' A' ' 233' ' ' LEU . 12.7 p -134.25 144.64 34.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 123.627 0.771 . . . . 62.34 110.153 -173.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -81.04 113.12 19.02 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.421 0.688 . . . . 62.0 109.373 174.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 89.8 t -76.77 132.14 72.3 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.707 0.803 . . . . 71.12 109.512 177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.83 161.34 44.36 Favored 'Trans proline' 0 C--N 1.384 2.395 0 C-N-CA 122.803 2.335 . . . . 72.52 112.376 171.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.37 131.9 22.78 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.135 1.89 . . . . 74.45 112.315 -177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 51.2 mtp180 52.79 72.21 0.43 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.998 1.319 . . . . 75.54 112.63 -175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 97.3 m -91.51 143.59 26.43 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.636 -1.166 . . . . 41.13 110.915 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -108.51 160.49 15.86 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.264 1.025 . . . . 72.12 110.635 175.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.528 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -80.07 155.17 27.66 Favored 'General case' 0 N--CA 1.478 0.968 0 CA-C-N 114.991 -1.004 . . . . 65.42 111.264 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.6 -20.95 35.79 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 112.141 -0.384 . . . . 62.01 112.141 -174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 72.8 mtt85 -65.68 178.11 1.09 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.11 0.964 . . . . 72.25 110.551 167.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.574 ' HA ' HG23 ' A' ' 253' ' ' VAL . 12.4 ptmt -167.13 153.95 8.54 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-N 116.703 -0.226 . . . . 74.13 110.955 173.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.706 HD12 HD11 ' A' ' 251' ' ' LEU . 75.2 mt -84.23 152.03 24.45 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.862 -0.422 . . . . 71.51 109.862 170.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -117.8 107.18 13.83 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 107.354 -1.35 . . . . 73.13 107.354 161.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 65.4 mt -102.97 107.92 18.91 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.085 -0.961 . . . . 74.34 109.725 -173.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -78.61 120.7 23.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 114.635 -1.166 . . . . 74.13 111.426 -165.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 74.91 18.98 80.14 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.502 1.126 . . . . 74.24 113.761 -177.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.44 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 43.4 mmtm -105.09 3.34 30.29 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.047 0.539 . . . . 73.44 111.842 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -83.75 -172.57 48.99 Favored Glycine 0 C--N 1.347 1.139 0 N-CA-C 111.087 -0.805 . . . . 74.11 111.087 168.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.439 ' HA ' ' HD3' ' A' ' 241' ' ' PRO . 10.2 m-85 -62.04 137.0 95.49 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 117.213 0.506 . . . . 71.21 111.802 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.55 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 15.0 Cg_exo -69.64 143.72 52.37 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.038 2.492 . . . . 62.24 112.257 176.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.57 173.33 20.9 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 115.109 -0.95 . . . . 73.34 112.12 -175.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.83 -14.29 26.74 Favored 'Trans proline' 0 C--N 1.363 1.291 0 C-N-CA 123.106 2.537 . . . . 73.12 113.415 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.61 -17.94 12.91 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.837 0.855 . . . . 51.25 111.957 -178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 162.46 -162.13 34.16 Favored Glycine 0 C--O 1.221 -0.719 0 N-CA-C 109.52 -1.432 . . . . 61.12 109.52 -173.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.55 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 99.0 mtt180 -115.61 160.37 20.09 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 118.511 1.156 . . . . 71.43 110.67 177.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -79.4 177.28 54.34 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.348 -0.842 . . . . 55.11 111.765 175.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -119.31 143.14 47.53 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.367 0.603 . . . . 75.14 109.72 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.678 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 51.7 tp -102.4 108.04 19.23 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.438 -0.801 . . . . 74.1 110.006 -168.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 53.6 m-85 -100.58 106.6 18.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 114.916 -1.038 . . . . 75.41 108.776 -178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.706 HD11 HD12 ' A' ' 233' ' ' LEU . 1.8 pp -124.47 118.57 26.93 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 113.58 0.955 . . . . 25.41 113.58 -174.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -67.77 116.13 8.11 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.405 1.482 . . . . 72.34 112.488 -172.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 232' ' ' LYS . 59.4 t -64.24 118.85 7.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 CA-C-N 114.092 -1.413 . . . . 75.43 111.081 175.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -114.32 117.51 31.3 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 125.431 1.492 . . . . 71.22 108.576 173.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.528 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 36.6 mm -87.82 106.75 16.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 108.088 -1.079 . . . . 45.42 108.088 172.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.259 1.581 0 C-N-CA 124.615 1.166 . . . . 64.14 108.131 -171.833 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 91.7 mtp . . . . . 0 N--CA 1.483 1.194 0 CA-C-O 120.589 0.233 . . . . 72.24 110.373 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -78.31 133.68 37.59 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.119 0.968 . . . . 73.01 108.969 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.2 t -64.47 100.4 0.36 Allowed 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 123.42 0.688 . . . . 71.23 111.433 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -167.89 148.59 5.14 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 123.715 0.806 . . . . 71.3 110.41 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.7 m -78.76 -26.17 44.54 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.78 0.8 . . . . 62.25 108.904 169.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -91.86 164.03 13.82 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 115.013 -0.994 . . . . 72.34 110.871 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -99.08 -88.82 1.97 Allowed Glycine 0 C--N 1.335 0.524 0 N-CA-C 111.34 -0.704 . . . . 51.03 111.34 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -142.23 159.67 41.77 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 124.114 0.966 . . . . 72.05 110.232 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.545 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 26.0 m95 -76.11 -87.72 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.473 -0.785 . . . . 64.02 109.201 175.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.07 37.24 4.19 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 106.048 -1.834 . . . . 72.21 106.048 174.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.39 -68.31 3.17 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 108.019 -2.033 . . . . 44.23 108.019 -152.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.3 tmmm? 170.02 101.62 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.628 2.371 . . . . 73.43 105.237 164.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 162.07 -120.73 0.97 Allowed Glycine 0 C--N 1.341 0.828 0 C-N-CA 121.307 -0.473 . . . . 73.25 112.979 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 48.5 t -150.47 141.28 22.78 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.505 0.722 . . . . 74.13 109.956 -168.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -127.95 -134.86 3.96 Favored Glycine 0 C--N 1.347 1.189 0 N-CA-C 111.116 -0.794 . . . . 73.23 111.116 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 146.49 61.86 0.01 OUTLIER Glycine 0 C--N 1.347 1.179 0 CA-C-N 117.226 0.513 . . . . 75.52 112.349 176.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 78.3 p -165.36 162.13 19.4 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.715 0.806 . . . . 71.13 110.731 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -82.8 -103.51 0.48 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 110.187 -1.165 . . . . 60.51 110.187 167.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 77.82 -64.45 3.34 Favored Glycine 0 C--N 1.351 1.368 0 C-N-CA 123.305 0.479 . . . . 32.14 113.476 175.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.415 ' HB3' ' CZ ' ' A' ' 250' ' ' TYR . 21.0 m -71.11 -14.66 62.37 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.92 1.288 . . . . 64.11 113.634 -175.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -74.81 99.67 1.15 Allowed Glycine 0 C--N 1.352 1.451 0 O-C-N 123.618 0.574 . . . . 44.23 112.614 -179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -115.6 -100.33 2.25 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 119.431 -0.65 . . . . 74.34 112.623 -177.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.6 t -145.66 -62.11 0.33 Allowed 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 117.926 0.863 . . . . 75.03 111.944 -171.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -67.65 -33.88 75.84 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 120.65 0.262 . . . . 72.44 110.414 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.83 146.42 49.7 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.868 -0.605 . . . . 71.34 110.097 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.5 mt -121.2 146.05 47.19 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.917 0.487 . . . . 75.13 111.762 -171.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -99.56 111.0 23.4 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.005 -0.998 . . . . 74.22 108.487 171.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.613 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -120.39 -170.45 1.98 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.416 1.086 . . . . 74.14 109.752 -177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.3 m -120.87 138.92 53.84 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 124.274 1.03 . . . . 74.0 111.07 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 253' ' ' VAL . 15.8 tp -94.56 107.0 19.0 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.2 -1.037 . . . . 64.44 108.2 168.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 210' ' ' VAL . 14.3 t70 -80.52 109.08 14.7 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.983 -0.747 . . . . 61.4 108.983 178.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.53 HG13 HD13 ' A' ' 255' ' ' ILE . 0.9 OUTLIER -132.23 118.36 16.12 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 122.68 0.392 . . . . 74.05 110.191 178.772 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.455 ' HB2' ' HD2' ' A' ' 202' ' ' PRO . 53.9 Cg_endo -70.62 148.08 58.73 Favored 'Trans proline' 0 C--N 1.374 1.896 0 C-N-CA 121.982 1.788 . . . . 50.32 111.373 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -50.37 -45.6 83.82 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.495 1.118 . . . . 74.31 113.945 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 200' ' ' PRO . 52.9 Cg_exo -56.07 -47.48 24.45 Favored 'Trans proline' 0 C--N 1.396 3.052 0 C-N-CA 122.065 1.844 . . . . 55.42 113.034 177.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.41 HG21 HG13 ' A' ' 210' ' ' VAL . 25.8 mt -64.57 -37.33 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.406 0.682 . . . . 72.31 110.717 177.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.81 -43.74 97.79 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.045 0.538 . . . . 53.13 110.867 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 64.5 t -75.3 -48.69 30.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.405 1.082 . . . . 74.24 112.031 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.5 p -79.48 -32.09 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 117.955 0.343 . . . . 73.14 111.192 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 90.86 106.17 1.35 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.474 -0.65 . . . . 33.31 111.474 -171.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.48 -138.13 3.6 Favored Glycine 0 C--N 1.346 1.122 0 CA-C-O 119.518 -0.601 . . . . 72.33 111.883 -177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -138.98 137.3 36.25 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.693 0.797 . . . . 74.54 109.402 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.502 HG21 ' HB ' ' A' ' 199' ' ' VAL . 24.3 m -137.54 153.3 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 122.92 0.488 . . . . 33.1 111.19 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -76.91 139.05 40.08 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 115.559 -0.746 . . . . 61.3 111.132 -176.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.561 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -111.76 111.43 22.4 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.154 -1.425 . . . . 73.0 107.154 170.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -69.13 114.12 7.12 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.071 0.548 . . . . 61.43 109.888 -178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.562 HG23 HD22 ' A' ' 249' ' ' LEU . 0.2 OUTLIER -108.38 -173.12 2.2 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.311 1.044 . . . . 73.41 109.432 178.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.519 ' H ' HG22 ' A' ' 214' ' ' THR . 7.3 mt -56.42 -69.06 0.16 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.505 1.522 . . . . 74.15 111.7 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -112.83 -43.59 3.41 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 113.67 -1.605 . . . . 73.24 110.843 -168.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -123.9 133.65 8.9 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.545 -1.141 . . . . 65.34 111.132 -177.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.49 150.65 58.1 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 122.342 2.028 . . . . 75.14 112.57 -177.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 53.2 t -104.31 168.82 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.121 1.368 . . . . 75.45 107.856 174.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -148.64 135.23 19.67 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.438 -0.949 . . . . 75.44 108.438 174.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.434 HG21 HD21 ' A' ' 233' ' ' LEU . 11.8 p -126.56 139.34 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.509 0.724 . . . . 71.34 110.6 -173.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.02 104.35 3.53 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.522 -0.763 . . . . 64.53 109.076 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 98.1 t -72.43 123.99 90.22 Favored Pre-proline 0 CA--C 1.541 0.632 0 CA-C-N 115.141 -0.936 . . . . 74.12 108.789 175.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.03 158.67 42.36 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.773 2.316 . . . . 71.5 111.552 174.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -62.45 142.44 90.55 Favored 'Trans proline' 0 C--N 1.371 1.739 0 C-N-CA 122.222 1.948 . . . . 70.4 111.932 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 60.8 mtp180 46.67 64.9 1.35 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.8 1.64 . . . . 75.33 113.545 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.464 HG23 ' HD2' ' A' ' 231' ' ' ARG . 90.9 m -93.87 137.98 32.51 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.532 -1.213 . . . . 72.1 110.501 175.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.464 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 25.9 mp0 -104.25 163.58 12.32 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.854 0.862 . . . . 60.22 110.24 175.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.538 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -84.27 154.84 22.74 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 114.29 -1.323 . . . . 52.43 111.002 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.62 -15.59 49.08 Favored Glycine 0 N--CA 1.474 1.187 0 O-C-N 123.459 0.474 . . . . 71.22 111.93 -172.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.464 ' NH1' ' H ' ' A' ' 228' ' ' GLN . 81.1 mtt85 -68.57 -179.35 1.35 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.974 0.909 . . . . 64.34 109.553 164.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.484 ' HA ' HG23 ' A' ' 253' ' ' VAL . 4.8 ptmt -169.24 147.74 3.81 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 119.288 -0.387 . . . . 75.55 110.323 176.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.601 HD12 HD11 ' A' ' 251' ' ' LEU . 88.7 mt -79.34 152.79 30.25 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.671 -0.492 . . . . 73.14 109.671 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -115.88 113.42 23.31 Favored 'General case' 0 C--O 1.248 0.992 0 N-CA-C 107.156 -1.424 . . . . 75.24 107.156 160.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.641 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 57.3 mt -113.3 109.96 19.59 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 108.908 -0.775 . . . . 74.4 108.908 -177.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 3.9 mmmp? -86.91 117.08 25.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.316 -0.856 . . . . 74.15 110.879 -167.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 89.83 10.84 64.38 Favored Glycine 0 CA--C 1.528 0.902 0 O-C-N 124.197 0.936 . . . . 44.43 113.598 -177.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.517 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 39.1 mmtm -98.54 -5.01 32.96 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.814 1.042 . . . . 74.22 113.814 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -83.49 -172.23 48.53 Favored Glycine 0 N--CA 1.479 1.505 0 CA-C-O 119.79 -0.45 . . . . 73.11 112.586 171.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -56.89 133.48 79.5 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 123.458 0.703 . . . . 73.02 111.964 -175.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.13 145.37 72.81 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.988 2.458 . . . . 72.24 111.944 177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.4 177.08 19.04 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-N 115.971 -0.559 . . . . 72.32 112.899 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.09 -26.32 18.31 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 123.213 2.608 . . . . 73.25 113.41 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -93.73 -30.87 14.66 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.518 0.727 . . . . 74.02 111.699 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -177.07 -132.03 1.59 Allowed Glycine 0 C--O 1.223 -0.592 0 N-CA-C 111.214 -0.755 . . . . 70.1 111.214 -178.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 91.1 mtm180 -140.22 147.03 39.44 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.786 1.235 . . . . 70.23 108.784 176.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -72.93 177.31 42.13 Favored Glycine 0 C--N 1.341 0.85 0 O-C-N 123.897 0.748 . . . . 75.3 111.585 174.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -108.12 -177.64 3.39 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.144 0.577 . . . . 75.13 110.424 -177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.641 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.1 tp -141.3 106.21 4.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.514 0.673 . . . . 63.02 110.454 -176.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.451 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 38.3 m-85 -103.6 111.71 24.31 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 106.784 -1.561 . . . . 73.44 106.784 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.613 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.9 pp -124.08 118.06 26.08 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 113.57 0.952 . . . . 71.31 113.57 -173.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -67.61 119.24 12.05 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.751 1.62 . . . . 64.55 112.002 -174.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.545 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 97.9 t -67.74 122.83 19.67 Favored 'Isoleucine or valine' 0 C--O 1.24 0.6 0 C-N-CA 125.125 1.37 . . . . 74.53 111.073 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -118.67 111.54 18.65 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 125.2 1.4 . . . . 73.34 108.652 173.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.538 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 24.1 mm -81.84 96.81 3.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 107.586 -1.264 . . . . 60.12 107.586 173.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--O 1.252 1.228 0 C-N-CA 124.922 1.289 . . . . 64.1 108.451 -178.088 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 173' ' ' ALA . 14.1 ptt? . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 111.82 0.304 . . . . 43.11 111.82 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.445 ' HG2' ' H ' ' A' ' 170' ' ' THR . 19.8 tt0 -156.7 -154.54 0.47 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 108.251 -1.018 . . . . 74.4 108.251 -161.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.445 ' H ' ' HG2' ' A' ' 169' ' ' GLU . 12.1 t -57.91 -25.07 60.37 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 123.103 0.561 . . . . 71.5 110.805 167.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.66 129.0 34.26 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 123.508 0.723 . . . . 71.42 109.535 168.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 27.2 m -67.37 -18.38 65.12 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.288 1.035 . . . . 54.3 111.942 -177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 168' ' ' MET . . . -80.02 158.22 26.57 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.5 0.72 . . . . 70.01 112.073 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -81.92 -82.4 0.85 Allowed Glycine 0 C--N 1.344 1.026 0 N-CA-C 110.609 -0.997 . . . . 54.4 110.609 170.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -157.45 170.6 22.06 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.435 0.694 . . . . 74.35 111.147 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.614 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 48.2 m95 -70.53 -62.93 1.2 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.827 -1.175 . . . . 75.5 107.827 171.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.47 173.52 9.79 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-N 113.748 -1.569 . . . . 63.33 108.482 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -69.64 74.54 0.44 Allowed Glycine 0 C--N 1.343 0.957 0 N-CA-C 109.214 -1.555 . . . . 55.23 109.214 164.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.09 107.7 2.0 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 124.76 1.224 . . . . 74.25 110.874 -158.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -169.39 -115.44 0.33 Allowed Glycine 0 C--N 1.35 1.342 0 CA-C-N 115.881 -0.6 . . . . 34.42 112.812 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 25.1 m -83.01 -32.62 26.82 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.313 0.645 . . . . 72.41 111.634 -175.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -63.89 123.47 28.52 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 115.416 -0.811 . . . . 62.01 113.596 -175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -134.49 28.64 3.11 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 123.046 0.355 . . . . 73.2 112.72 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 67.2 m -85.87 138.16 32.24 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.075 0.55 . . . . 74.55 110.017 174.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -90.37 -148.46 20.37 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 111.567 -0.613 . . . . 52.51 111.567 173.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -167.61 148.73 13.31 Favored Glycine 0 C--O 1.242 0.644 0 N-CA-C 111.773 -0.531 . . . . 41.12 111.773 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 35.6 t -70.82 -45.69 64.1 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.928 0.891 . . . . 73.41 110.383 176.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 97.36 -163.31 21.86 Favored Glycine 0 C--N 1.342 0.864 0 N-CA-C 111.344 -0.702 . . . . 64.4 111.344 -172.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.48 -162.26 12.72 Favored Glycine 0 C--N 1.335 0.491 0 N-CA-C 111.704 -0.558 . . . . 53.42 111.704 -176.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 67.1 m -70.82 -51.01 29.4 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.018 0.527 . . . . 50.53 110.501 178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -74.85 -62.61 1.48 Allowed 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.697 0.799 . . . . 74.44 109.218 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 248' ' ' ASP . 5.9 p-10 -73.57 126.74 30.94 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.901 -1.045 . . . . 65.01 110.315 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 89.1 mt -113.5 164.36 13.73 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 121.436 0.636 . . . . 71.23 112.648 -164.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -114.49 125.53 53.92 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.611 -1.177 . . . . 74.3 108.523 167.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -135.66 -171.53 2.87 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.977 0.911 . . . . 70.4 109.467 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 44.1 m -117.93 138.49 52.11 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.945 0.898 . . . . 54.4 110.494 173.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.613 ' HB2' HD13 ' A' ' 251' ' ' LEU . 21.8 tp -93.74 128.82 40.16 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 108.06 -1.089 . . . . 13.24 108.06 165.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -98.08 100.37 11.69 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 109.611 -0.514 . . . . 73.23 109.611 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.634 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.9 t -111.1 108.81 57.26 Favored Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 108.444 -0.947 . . . . 74.44 108.444 176.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -68.17 144.57 63.5 Favored 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 121.491 1.461 . . . . 74.35 110.082 173.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -48.16 -45.9 65.48 Favored Pre-proline 0 CA--C 1.558 1.277 0 N-CA-C 114.083 1.142 . . . . 73.44 114.083 -175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_exo -57.08 -47.16 24.15 Favored 'Trans proline' 0 C--N 1.392 2.851 0 C-N-CA 122.104 1.869 . . . . 62.3 113.744 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 44.2 mt -64.19 -36.96 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 122.736 0.414 . . . . 74.15 110.567 177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.58 -45.37 94.43 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 122.951 0.501 . . . . 43.41 111.088 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 54.0 t -72.3 -50.69 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 O-C-N 124.32 1.013 . . . . 74.54 112.097 -175.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 7.1 p -80.78 -21.54 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 CA-C-O 120.851 0.358 . . . . 42.34 110.899 -176.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 78.36 84.87 0.53 Allowed Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.996 -0.547 . . . . 72.05 112.1 -178.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -115.94 -136.82 5.99 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 111.839 -0.504 . . . . 64.21 111.839 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 14.1 mtmt -127.54 151.33 49.02 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.862 0.865 . . . . 61.21 109.212 174.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.634 HG11 ' HA ' ' A' ' 199' ' ' VAL . 28.3 m -140.36 150.18 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 C-N-CA 123.294 0.638 . . . . 73.23 110.31 177.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -77.24 138.89 39.68 Favored 'General case' 0 C--O 1.238 0.499 0 O-C-N 123.621 0.575 . . . . 72.31 110.426 176.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.645 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -109.26 114.71 28.63 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 106.748 -1.575 . . . . 65.1 106.748 171.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.0 tpt -64.69 126.12 26.91 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.035 0.534 . . . . 62.43 109.691 177.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.98 -168.98 2.08 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.687 1.195 . . . . 71.14 109.74 -172.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.4 mt -82.22 -68.73 0.67 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 122.141 0.972 . . . . 72.25 109.904 -171.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -98.24 -40.78 8.19 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 112.972 -1.922 . . . . 74.23 109.845 -165.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -145.34 134.29 5.45 Favored Glycine 0 C--N 1.337 0.631 0 CA-C-O 118.448 -1.196 . . . . 62.32 110.242 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.0 144.21 52.01 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.764 2.31 . . . . 75.42 112.345 -178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.645 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 55.3 t -96.79 168.5 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 C-N-CA 125.231 1.413 . . . . 63.14 108.994 -177.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -148.26 127.92 13.32 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 108.869 -0.789 . . . . 74.11 108.869 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . . . . . . . . . 9.6 p -118.13 143.3 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.472 0.709 . . . . 52.5 109.892 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.46 108.64 7.36 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 108.853 -0.795 . . . . 73.51 108.853 170.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.497 ' HA ' ' HZ2' ' A' ' 176' ' ' TRP . 71.1 t -73.61 128.33 87.21 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.737 0.815 . . . . 61.31 109.821 173.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.62 157.47 60.56 Favored 'Trans proline' 0 C--N 1.38 2.208 0 C-N-CA 122.704 2.269 . . . . 73.42 111.411 173.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -60.18 134.6 56.87 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.466 2.11 . . . . 53.22 112.509 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 51.24 67.32 0.97 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.76 1.624 . . . . 74.42 112.823 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.47 HG23 ' HD2' ' A' ' 231' ' ' ARG . 54.9 m -88.79 140.16 29.73 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.694 -1.139 . . . . 54.51 110.549 173.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.444 ' H ' ' NH1' ' A' ' 231' ' ' ARG . 28.2 mp0 -100.78 157.52 16.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.074 0.95 . . . . 73.41 111.156 177.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.494 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -80.2 155.28 27.46 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 114.447 -1.251 . . . . 44.42 110.239 176.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.48 29.86 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 111.649 -0.58 . . . . 64.33 111.649 -173.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.47 ' HD2' HG23 ' A' ' 227' ' ' THR . 73.7 mtt85 -62.23 178.18 0.41 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.688 0.795 . . . . 71.21 110.559 168.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 253' ' ' VAL . 10.4 ptmt -166.17 147.24 6.6 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.752 -0.462 . . . . 74.44 109.752 172.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.581 HD12 HD11 ' A' ' 251' ' ' LEU . 88.8 mt -79.32 147.63 32.39 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.911 -0.774 . . . . 73.12 108.911 169.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 28.6 ptt180 -108.57 121.39 44.89 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 107.006 -1.479 . . . . 73.35 107.006 158.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 80.4 mt -118.28 110.92 18.1 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 109.365 -0.606 . . . . 63.32 109.365 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -79.02 119.28 21.94 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 73.4 110.922 -167.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 82.34 13.78 77.93 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.454 1.096 . . . . 44.12 113.948 -178.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.473 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 75.3 mmtt -102.65 8.57 39.63 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 117.512 0.656 . . . . 61.12 112.665 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -93.82 172.55 32.66 Favored Glycine 0 N--CA 1.475 1.275 0 N-CA-C 110.644 -0.982 . . . . 63.24 110.644 168.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -55.42 146.09 44.81 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-N 117.652 0.726 . . . . 65.3 112.31 -173.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.438 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 24.5 Cg_exo -60.31 141.29 95.43 Favored 'Trans proline' 0 C--N 1.384 2.444 0 C-N-CA 122.933 2.422 . . . . 74.21 112.272 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -130.26 171.72 20.49 Favored Glycine 0 CA--C 1.523 0.548 0 CA-C-N 114.958 -1.019 . . . . 71.11 111.842 -177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -66.68 -32.21 38.46 Favored 'Trans proline' 0 CA--C 1.555 1.526 0 C-N-CA 123.014 2.476 . . . . 60.42 112.793 -176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -94.57 -7.36 41.3 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.583 0.753 . . . . 73.44 111.387 175.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 135.55 177.08 14.71 Favored Glycine 0 C--N 1.345 1.063 0 N-CA-C 111.218 -0.753 . . . . 33.2 111.218 -177.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 61.8 mtm-85 -69.44 155.77 39.91 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.406 0.682 . . . . 61.15 112.206 -178.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -82.12 -172.04 47.04 Favored Glycine 0 C--N 1.349 1.28 0 CA-C-N 115.525 -0.761 . . . . 35.05 111.976 173.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.525 ' H ' ' HB3' ' A' ' 192' ' ' ASP . 12.7 m-20 -115.12 149.08 38.15 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.366 0.666 . . . . 55.51 110.115 -178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 45.2 tp -106.53 108.47 19.99 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-O 121.348 0.594 . . . . 62.02 109.84 -170.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 233' ' ' LEU . 54.0 m-85 -101.65 101.85 12.44 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 108.213 -1.032 . . . . 75.33 108.213 179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.673 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.2 pp -118.68 119.34 34.15 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 113.429 0.9 . . . . 73.44 113.429 -173.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -67.68 116.96 8.97 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.118 0.967 . . . . 72.44 111.936 -174.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.614 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 94.1 t -63.93 116.77 3.8 Favored 'Isoleucine or valine' 0 C--O 1.238 0.455 0 CA-C-N 113.691 -1.595 . . . . 53.22 110.717 174.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -111.9 125.16 53.74 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 114.343 -1.298 . . . . 74.45 108.645 175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.494 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 29.8 mm -91.15 108.83 20.31 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 107.455 -1.313 . . . . 73.52 107.455 173.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.3 t . . . . . 0 C--O 1.253 1.257 0 CA-C-O 117.766 -1.112 . . . . 73.33 108.551 -171.458 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 109.634 -0.506 . . . . 74.12 109.634 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -154.36 172.83 17.07 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.925 0.89 . . . . 75.54 110.193 -175.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.5 p 47.59 80.66 0.05 Allowed 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.781 1.232 . . . . 75.24 113.082 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.47 113.78 15.63 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 108.948 -0.76 . . . . 45.21 108.948 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.445 ' HB ' ' H ' ' A' ' 220' ' ' GLU . 7.5 m -66.64 -18.4 65.35 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.238 1.015 . . . . 71.31 111.595 -176.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.85 176.27 6.04 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.03 0.932 . . . . 64.01 111.851 176.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -97.19 -129.23 6.18 Favored Glycine 0 C--N 1.347 1.193 0 N-CA-C 111.25 -0.74 . . . . 21.21 111.25 178.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -89.57 158.05 17.81 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.087 0.555 . . . . 64.21 111.124 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.515 ' CZ3' HG21 ' A' ' 227' ' ' THR . 31.1 m95 -88.12 -80.59 0.27 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 108.581 -0.896 . . . . 74.33 108.581 165.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 35.8 mm-40 -131.42 39.22 3.54 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.131 0.972 . . . . 73.04 109.559 -173.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.78 -42.93 99.6 Favored Glycine 0 C--N 1.348 1.204 0 CA-C-N 116.277 -0.419 . . . . 72.11 112.494 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -137.32 -78.25 0.39 Allowed 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.093 -1.077 . . . . 75.34 108.093 174.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . 146.67 135.13 2.68 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-N 115.624 -0.716 . . . . 62.43 111.646 -173.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.578 ' HB3' ' HD2' ' A' ' 234' ' ' ARG . 33.9 t -151.7 122.68 7.6 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.003 -0.74 . . . . 52.55 109.003 176.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -177.07 103.77 0.18 Allowed Glycine 0 C--N 1.339 0.744 0 N-CA-C 111.178 -0.769 . . . . 72.14 111.178 -175.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 169.08 145.39 4.59 Favored Glycine 0 C--O 1.241 0.578 0 CA-C-O 119.869 -0.406 . . . . 75.24 112.117 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.0 t 60.81 19.69 9.88 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 124.775 1.23 . . . . 45.5 112.269 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -66.52 -41.38 94.21 Favored Glycine 0 C--N 1.354 1.575 0 N-CA-C 111.533 -0.627 . . . . 74.32 111.533 176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -79.63 71.42 2.7 Favored Glycine 0 C--N 1.351 1.415 0 N-CA-C 112.316 -0.314 . . . . 32.33 112.316 173.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.0 m -81.51 -43.62 18.52 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.548 0.739 . . . . 54.45 110.42 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 161.29 -71.48 0.22 Allowed Glycine 0 C--N 1.344 0.998 0 N-CA-C 110.814 -0.914 . . . . 23.32 110.814 -178.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -65.9 101.45 0.6 Allowed Glycine 0 C--N 1.351 1.41 0 N-CA-C 110.922 -0.871 . . . . 73.51 110.922 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.1 m -71.97 93.57 1.38 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.448 0.699 . . . . 72.32 110.598 -171.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . 0.596 ' HA ' ' HB2' ' A' ' 240' ' ' PHE . 24.3 mt-30 -115.65 -35.69 4.46 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 114.747 -1.115 . . . . 72.03 108.455 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -55.65 137.55 49.01 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.412 -1.267 . . . . 73.02 109.635 165.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 77.0 mt -128.43 158.67 37.67 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 121.375 0.607 . . . . 64.34 112.261 -177.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 250' ' ' TYR . 11.6 t80 -121.14 126.0 48.62 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 114.687 -1.142 . . . . 65.04 108.679 171.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.625 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -136.18 -173.81 3.5 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.953 0.901 . . . . 73.4 109.274 178.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 56.8 m -126.37 117.47 23.04 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.548 0.739 . . . . 73.44 110.599 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.55 HD23 HG22 ' A' ' 253' ' ' VAL . 18.4 tp -76.92 105.88 8.26 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.58 -0.896 . . . . 72.21 108.58 171.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.21 101.86 12.19 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.658 -0.867 . . . . 63.43 108.658 -177.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.667 ' HA ' HG11 ' A' ' 210' ' ' VAL . 21.3 t -110.64 115.03 54.24 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 108.089 -1.078 . . . . 73.11 108.089 176.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.03 148.93 70.88 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 121.558 1.506 . . . . 75.43 110.194 171.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.455 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -54.11 -40.07 79.05 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 124.014 0.926 . . . . 64.31 113.4 -177.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 10.9 Cg_endo -54.14 -51.4 10.73 Favored 'Trans proline' 0 C--N 1.395 3.013 0 C-N-CA 122.17 1.913 . . . . 75.23 113.534 172.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.459 HG21 HG13 ' A' ' 210' ' ' VAL . 49.3 mt -64.8 -36.2 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.25 0.62 . . . . 72.22 110.979 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.401 ' HA ' HG11 ' A' ' 223' ' ' VAL . . . -65.13 -44.08 89.86 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 115.936 -0.575 . . . . 71.11 111.656 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 41.7 t -70.71 -51.03 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.767 0.827 . . . . 73.23 111.805 -177.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 9.8 p -79.93 -23.5 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 CA-C-O 120.494 0.188 . . . . 64.21 110.932 -174.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 82.97 77.95 1.07 Allowed Glycine 0 C--N 1.349 1.305 0 N-CA-C 111.346 -0.702 . . . . 62.43 111.346 -177.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -110.13 -139.78 8.41 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 111.907 -0.477 . . . . 73.14 111.907 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -132.1 146.27 51.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.286 0.634 . . . . 61.23 109.458 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' A' ' 199' ' ' VAL . 28.5 m -134.97 152.9 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 123.658 0.599 . . . . 75.51 109.819 173.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . 0.511 ' HE ' ' HB3' ' A' ' 218' ' ' PRO . 40.4 ttt-85 -79.15 143.67 35.22 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 123.593 0.757 . . . . 70.31 109.772 176.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.673 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -112.75 114.28 26.77 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.677 -1.231 . . . . 74.04 107.677 171.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 1.4 tmt? -65.91 135.07 54.28 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.866 1.266 . . . . 74.4 111.193 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.686 HG21 ' HE3' ' A' ' 238' ' ' LYS . 0.2 OUTLIER -141.48 -170.83 3.18 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.703 0.801 . . . . 75.14 110.515 173.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.535 ' H ' HG22 ' A' ' 214' ' ' THR . 7.1 mt -55.69 -69.54 0.14 Allowed 'General case' 0 C--N 1.362 1.124 0 C-N-CA 124.613 1.165 . . . . 72.33 110.815 -172.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -116.37 -42.69 3.0 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-N 113.251 -1.795 . . . . 73.51 110.929 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -113.02 132.88 10.96 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-O 118.656 -1.08 . . . . 72.22 111.717 -175.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . 0.511 ' HB3' ' HE ' ' A' ' 211' ' ' ARG . 74.6 Cg_endo -73.68 -173.95 1.52 Allowed 'Trans proline' 0 C--N 1.369 1.63 0 C-N-CA 122.525 2.15 . . . . 72.22 112.682 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 8.5 t -140.05 164.73 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 125.36 1.464 . . . . 73.02 107.523 168.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.445 ' H ' ' HB ' ' A' ' 172' ' ' THR . 5.0 tt0 -142.16 127.75 19.07 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 108.043 -1.095 . . . . 74.11 108.043 170.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 233' ' ' LEU . 13.8 p -120.22 139.75 46.52 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 123.6 0.76 . . . . 72.11 110.603 -173.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -74.17 104.87 5.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.818 0.847 . . . . 74.24 109.419 173.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.401 HG11 ' HA ' ' A' ' 204' ' ' ALA . 61.5 t -69.38 128.37 92.38 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 123.449 0.7 . . . . 72.34 109.335 173.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.51 154.25 74.57 Favored 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.057 2.505 . . . . 53.23 112.063 171.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -61.78 129.38 27.45 Favored 'Trans proline' 0 C--N 1.374 1.917 0 C-N-CA 122.306 2.004 . . . . 72.11 112.189 175.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 50.9 mtp180 55.56 74.21 0.39 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.547 1.539 . . . . 72.21 113.081 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.515 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 64.8 m -97.22 144.15 27.32 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.662 -1.154 . . . . 75.34 111.204 175.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -108.53 163.89 12.83 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.561 1.144 . . . . 72.41 110.972 176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . 0.472 ' HB2' ' H ' ' A' ' 255' ' ' ILE . . . -88.15 152.47 21.96 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.642 -1.163 . . . . 71.51 111.427 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 104.02 -12.84 52.67 Favored Glycine 0 N--CA 1.476 1.31 0 CA-C-N 116.342 -0.39 . . . . 60.53 112.25 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.456 ' HD2' HG23 ' A' ' 227' ' ' THR . 73.3 mtt85 -69.58 178.17 2.63 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.636 0.774 . . . . 75.21 109.762 166.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.629 ' HE2' ' HB3' ' A' ' 250' ' ' TYR . 10.9 ptmt -168.37 157.02 8.77 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 120.319 0.104 . . . . 71.52 111.15 172.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.577 HD12 HD11 ' A' ' 251' ' ' LEU . 73.0 mt -93.62 158.8 15.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.003 0.521 . . . . 62.25 109.807 170.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . 0.578 ' HD2' ' HB3' ' A' ' 181' ' ' SER . 8.1 ptt-85 -132.61 109.55 9.82 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 124.914 1.285 . . . . 73.33 108.363 177.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 249' ' ' LEU . 49.5 mt -120.42 117.15 26.96 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.393 0.677 . . . . 74.03 111.339 -166.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -84.94 134.35 34.25 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.709 -0.678 . . . . 74.44 110.695 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 246' ' ' ARG . . . 76.22 10.14 85.47 Favored Glycine 0 C--N 1.343 0.944 0 O-C-N 124.219 0.949 . . . . 64.12 113.513 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.686 ' HE3' HG21 ' A' ' 214' ' ' THR . 29.3 mmmt -97.68 -25.15 15.2 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 117.142 0.471 . . . . 72.43 112.232 -179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -66.09 -172.0 4.19 Favored Glycine 0 CA--C 1.538 1.519 0 O-C-N 123.103 0.252 . . . . 50.12 113.151 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . 0.596 ' HB2' ' HA ' ' A' ' 191' ' ' GLN . 17.5 m-30 -59.06 138.68 87.82 Favored Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 122.696 0.399 . . . . 71.22 111.235 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.535 ' HA ' ' HG2' ' A' ' 246' ' ' ARG . 32.2 Cg_exo -59.29 152.66 58.79 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.93 2.42 . . . . 74.11 112.622 175.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -133.6 -177.77 15.15 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-N 115.708 -0.678 . . . . 42.24 112.509 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.12 -40.67 4.52 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 122.732 2.288 . . . . 75.1 112.537 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.47 -10.65 14.88 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.683 0.793 . . . . 63.11 111.854 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.41 166.49 27.56 Favored Glycine 0 C--N 1.338 0.663 0 N-CA-C 111.467 -0.653 . . . . 72.31 111.467 -176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.535 ' HG2' ' HA ' ' A' ' 241' ' ' PRO . 16.5 mtp180 -85.66 165.58 16.88 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.204 0.602 . . . . 72.31 110.871 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -88.72 -176.61 46.86 Favored Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.342 -0.844 . . . . 62.11 112.826 178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.74 169.21 8.65 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.014 0.525 . . . . 72.51 110.935 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 62.7 tp -131.95 108.98 9.73 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.571 -0.74 . . . . 71.24 110.201 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.629 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 13.8 m-30 -98.8 116.91 32.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.125 -1.065 . . . . 71.11 108.125 173.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.625 ' HB3' ' HB3' ' A' ' 195' ' ' ALA . 1.6 pp -129.5 116.31 18.76 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.34 0.867 . . . . 63.43 113.34 -178.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -68.34 123.34 20.5 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 114.751 -1.113 . . . . 75.21 112.506 -174.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.55 HG22 HD23 ' A' ' 197' ' ' LEU . 60.5 t -70.09 125.23 27.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 114.19 -1.368 . . . . 73.0 110.953 174.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -118.92 129.9 55.43 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.551 1.14 . . . . 73.34 108.484 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.472 ' H ' ' HB2' ' A' ' 229' ' ' ALA . 40.6 mm -99.97 99.12 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 N-CA-C 107.552 -1.277 . . . . 74.32 107.552 177.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.561 1.366 0 CA-C-N 114.37 -1.286 . . . . 70.21 108.952 -167.59 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 59.4 mtt . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.95 -0.759 . . . . 71.25 108.95 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.48 -168.88 0.9 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.229 1.011 . . . . 62.1 111.855 -173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.0 t -65.59 -13.44 59.05 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.413 0.685 . . . . 71.52 112.477 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -105.34 162.03 13.79 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.626 0.77 . . . . 74.01 110.086 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.488 HG22 HG22 ' A' ' 219' ' ' VAL . 3.4 m -71.78 -27.04 62.68 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 115.836 -0.62 . . . . 75.32 109.892 175.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.03 152.24 18.71 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.634 0.773 . . . . 51.32 111.184 177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -71.64 -102.29 0.06 OUTLIER Glycine 0 C--N 1.351 1.363 0 O-C-N 124.207 0.942 . . . . 74.21 111.482 165.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -136.51 175.77 9.3 Favored 'General case' 0 C--O 1.243 0.75 0 C-N-CA 123.537 0.735 . . . . 73.43 109.84 178.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.549 ' CZ3' HG21 ' A' ' 253' ' ' VAL . 14.2 m95 -79.52 -82.33 0.1 Allowed 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.156 -0.929 . . . . 71.43 109.539 170.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -143.01 138.45 30.02 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 106.84 -1.541 . . . . 74.34 106.84 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.81 -37.98 94.52 Favored Glycine 0 C--N 1.342 0.9 0 N-CA-C 110.373 -1.091 . . . . 64.44 110.373 166.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.51 163.07 10.3 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.43 1.492 . . . . 75.02 108.716 174.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -97.78 57.29 1.12 Allowed Glycine 0 N--CA 1.473 1.14 0 N-CA-C 111.685 -0.566 . . . . 45.35 111.685 177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 17.5 p -82.11 -41.52 20.38 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.517 0.727 . . . . 73.21 111.941 -174.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -170.78 142.1 6.91 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 121.437 -0.411 . . . . 64.04 112.485 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -88.82 59.12 4.0 Favored Glycine 0 C--N 1.348 1.209 0 C-N-CA 122.938 0.304 . . . . 73.21 112.639 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 35.0 p -90.44 151.05 21.57 Favored 'General case' 0 C--O 1.246 0.919 0 C-N-CA 123.779 0.831 . . . . 74.34 110.291 177.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.36 170.86 32.72 Favored Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.854 -0.612 . . . . 74.15 112.094 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -68.17 -32.48 76.48 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-O 119.864 -0.409 . . . . 44.11 112.718 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 17.7 m 64.74 24.35 12.86 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.718 1.207 . . . . 63.34 112.508 171.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 160.65 72.47 0.02 OUTLIER Glycine 0 C--N 1.346 1.118 0 N-CA-C 111.047 -0.821 . . . . 34.22 111.047 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -88.5 -154.88 28.87 Favored Glycine 0 C--N 1.341 0.845 0 C-N-CA 123.144 0.402 . . . . 72.42 112.888 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.4 m -112.58 -65.83 1.14 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.52 0.728 . . . . 74.54 109.81 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -87.36 -40.17 14.67 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.557 -0.747 . . . . 72.22 109.659 177.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.461 ' HA ' ' O ' ' A' ' 248' ' ' ASP . 9.2 p-10 -71.56 129.4 38.66 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.62 -0.718 . . . . 50.33 109.464 178.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 69.6 mt -113.71 165.4 12.58 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.538 0.735 . . . . 51.51 111.757 -169.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -118.0 122.18 42.56 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 114.741 -1.118 . . . . 74.22 108.24 172.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.642 ' HB3' ' HB3' ' A' ' 251' ' ' LEU . . . -131.43 -172.98 2.99 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 123.829 0.852 . . . . 74.34 110.052 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 52.9 m -119.29 149.77 41.24 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.122 0.969 . . . . 75.42 109.706 177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.534 ' HB2' HD13 ' A' ' 251' ' ' LEU . 22.2 tp -119.95 104.57 10.27 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.106 1.362 . . . . 72.24 108.462 173.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -91.44 99.71 12.61 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-O 121.892 0.853 . . . . 62.33 109.109 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.609 HG22 HG21 ' A' ' 210' ' ' VAL . 23.2 t -94.99 119.85 65.28 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-N 114.555 -1.202 . . . . 72.03 108.282 174.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.68 144.95 61.83 Favored 'Trans proline' 0 C--N 1.368 1.557 0 C-N-CA 121.539 1.493 . . . . 72.34 109.859 173.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.427 ' N ' ' HD2' ' A' ' 202' ' ' PRO . . . -50.48 -42.44 75.1 Favored Pre-proline 0 CA--C 1.567 1.615 0 CA-C-O 117.501 -1.238 . . . . 50.42 113.147 -175.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 201' ' ' ALA . 13.7 Cg_endo -55.96 -51.62 9.18 Favored 'Trans proline' 0 C--N 1.406 3.602 0 C-N-CA 121.94 1.76 . . . . 71.42 112.71 174.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 54.5 mt -65.01 -33.55 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.236 0.615 . . . . 71.13 110.674 -178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -63.28 -48.67 77.14 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 123.407 0.683 . . . . 62.43 110.898 179.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 51.7 t -70.3 -47.12 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.351 1.06 . . . . 62.43 112.281 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 13.0 p -78.56 -35.16 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 120.507 0.194 . . . . 45.43 110.761 -174.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 89.47 105.79 1.13 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 110.539 -1.024 . . . . 53.21 110.539 -169.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.93 -129.0 2.29 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-O 119.689 -0.506 . . . . 65.42 111.859 -176.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 221' ' ' VAL . 4.9 ttmt -145.15 137.7 26.06 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.608 0.763 . . . . 72.02 109.75 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 199' ' ' VAL . 33.6 m -135.23 155.16 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 C-N-CA 122.766 0.427 . . . . 71.1 110.763 175.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -70.65 146.2 50.13 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.016 0.822 . . . . 72.33 110.427 176.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . 0.59 ' HB3' ' HB ' ' A' ' 219' ' ' VAL . . . -123.64 120.75 33.68 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.014 1.326 . . . . 74.33 107.882 172.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 13.4 tpt -64.76 129.23 39.02 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.987 0.915 . . . . 73.34 110.899 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.12 -170.91 2.82 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.207 1.003 . . . . 52.43 110.265 -172.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 5.4 mt -84.87 -66.76 0.86 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.61 1.195 . . . . 61.32 109.639 -171.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -95.65 -33.3 12.4 Favored 'General case' 0 C--N 1.343 0.297 0 CA-C-N 112.675 -2.057 . . . . 71.33 110.856 -165.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . -160.68 141.97 7.79 Favored Glycine 0 C--N 1.339 0.731 0 CA-C-O 118.354 -1.248 . . . . 72.24 111.294 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.6 142.99 60.72 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 122.694 2.263 . . . . 51.0 113.001 -175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.59 ' HB ' ' HB3' ' A' ' 212' ' ' ALA . 61.6 t -94.06 166.47 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.92 1.288 . . . . 75.13 109.031 179.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -144.3 136.68 26.59 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.243 -1.391 . . . . 75.51 107.243 171.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' VAL . . . . . 0.555 HG11 HD11 ' A' ' 233' ' ' LEU . 14.4 p -132.88 140.71 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.253 0.621 . . . . 74.34 111.347 -169.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -72.09 101.17 2.69 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 124.302 1.041 . . . . 72.21 110.331 176.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.484 HG22 ' HZ2' ' A' ' 176' ' ' TRP . 92.9 t -72.25 121.66 85.32 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-O 118.141 -0.933 . . . . 73.23 109.226 175.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.67 154.72 72.57 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.592 2.195 . . . . 75.51 111.783 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.72 130.93 37.3 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.532 2.154 . . . . 74.4 112.769 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ARG . . . . . . . . . . . . . 49.8 mtp180 56.15 74.65 0.38 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.813 1.645 . . . . 63.41 112.762 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 97.0 m -90.7 142.09 28.11 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.714 -1.13 . . . . 72.52 111.064 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 24.6 mp0 -107.6 149.71 27.73 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.586 1.154 . . . . 53.22 109.947 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ALA . . . . . . . . . . . . . . . -74.68 155.28 37.91 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 115.188 -0.914 . . . . 73.03 110.545 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 105.1 -19.84 39.56 Favored Glycine 0 N--CA 1.476 1.311 0 N-CA-C 111.162 -0.775 . . . . 72.43 111.162 -172.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 61.5 mtt85 -65.9 179.83 0.83 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.257 1.023 . . . . 74.51 110.599 168.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.515 ' HA ' HG23 ' A' ' 253' ' ' VAL . 8.0 ptmt -166.81 152.89 8.27 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 116.176 -0.465 . . . . 74.42 109.992 172.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LEU . . . . . 0.65 HD12 HD11 ' A' ' 251' ' ' LEU . 61.6 mt -81.29 142.71 32.85 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.035 -0.728 . . . . 64.4 109.035 169.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -103.22 104.06 14.16 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 107.177 -1.416 . . . . 75.45 107.177 158.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . 0.566 ' HB3' ' HG3' ' A' ' 238' ' ' LYS . 50.6 mt -102.43 113.51 26.9 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 114.939 -1.028 . . . . 74.52 109.009 -179.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 54.6 mmtt -82.18 125.79 31.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.316 -0.856 . . . . 71.24 110.142 -172.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . . . . . . . . . . . 69.64 25.3 75.67 Favored Glycine 0 C--N 1.345 1.05 0 O-C-N 124.448 1.092 . . . . 45.01 113.804 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.566 ' HG3' ' HB3' ' A' ' 235' ' ' LEU . 74.3 mmtt -107.54 -3.17 19.64 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 112.671 0.619 . . . . 72.23 112.671 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . -84.93 176.89 50.89 Favored Glycine 0 C--N 1.342 0.91 0 N-CA-C 109.825 -1.31 . . . . 74.24 109.825 164.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -56.65 131.69 77.88 Favored Pre-proline 0 CA--C 1.554 1.125 0 CA-C-N 117.335 0.567 . . . . 53.3 111.894 -171.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PRO . . . . . 0.407 ' HA ' ' HA ' ' A' ' 246' ' ' ARG . 28.0 Cg_endo -63.23 138.93 69.31 Favored 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.97 2.447 . . . . 74.14 111.519 174.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -132.22 177.77 18.49 Favored Glycine 0 C--N 1.335 0.512 0 CA-C-N 115.561 -0.745 . . . . 74.44 113.472 -174.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.61 -33.52 66.93 Favored 'Trans proline' 0 C--N 1.372 1.793 0 C-N-CA 122.973 2.448 . . . . 62.21 112.75 177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -82.48 -8.97 59.6 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.419 0.688 . . . . 62.31 111.901 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 144.42 -101.18 0.25 Allowed Glycine 0 C--N 1.347 1.15 0 N-CA-C 110.872 -0.891 . . . . 40.04 110.872 -178.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 241' ' ' PRO . 59.3 mtt180 -148.35 165.78 30.04 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.788 1.235 . . . . 71.45 110.176 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . -96.65 174.08 30.23 Favored Glycine 0 C--N 1.344 0.993 0 N-CA-C 110.792 -0.923 . . . . 70.55 110.792 167.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 192' ' ' ASP . 45.7 m-20 -102.85 -179.15 3.88 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 123.105 0.562 . . . . 71.42 109.944 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . 0.505 ' HB3' ' HB2' ' A' ' 235' ' ' LEU . 46.0 tp -141.68 107.63 5.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.603 0.716 . . . . 73.32 109.128 -176.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' TYR . . . . . 0.488 ' HB3' ' HE2' ' A' ' 232' ' ' LYS . 54.3 m-85 -100.99 107.6 19.1 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.882 -1.525 . . . . 75.14 106.882 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LEU . . . . . 0.65 HD11 HD12 ' A' ' 233' ' ' LEU . 2.7 pp -122.94 118.09 27.04 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.759 0.79 . . . . 62.13 113.086 -175.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -69.75 120.63 15.79 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 125.3 1.44 . . . . 70.11 112.252 -171.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' VAL . . . . . 0.549 HG21 ' CZ3' ' A' ' 176' ' ' TRP . 58.9 t -68.8 116.56 9.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 114.09 -1.414 . . . . 74.23 110.979 177.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -103.35 131.24 50.59 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.112 1.765 . . . . 72.42 108.866 167.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 44.0 mm -97.46 110.22 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 N-CA-C 107.966 -1.124 . . . . 64.51 107.966 170.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.257 1.45 0 C-N-CA 124.335 1.054 . . . . 74.54 108.627 -175.324 . . . . . . . . 1 1 . 1 stop_ save_